data_1eq3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eq3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 131' ' ' LYS . 19.9 p30 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 86' ' ' THR . . . -125.93 173.73 8.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.564 HG21 ' N ' ' A' ' 39' ' ' LYS . 2.5 p -132.52 154.58 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 110.065 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 84' ' ' TRP . 37.7 mtpt -100.05 115.18 29.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 82' ' ' LEU . 69.9 t -120.04 125.54 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 111.497 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -124.98 109.62 13.2 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 4.0 p80 -134.96 166.97 21.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.701 -1.249 . . . . 0.0 112.427 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' A' ' 68' ' ' ALA . 17.9 pt -118.56 134.04 63.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -107.44 132.15 53.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.549 -0.719 . . . . 0.0 111.097 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 42.8 t -140.26 163.57 32.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 109.088 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 59.5 mm-40 -72.54 158.31 35.94 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.153 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.559 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.6 tttp -78.38 122.69 26.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.248 -0.907 . . . . 0.0 111.333 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 9.2 m-70 -129.79 -13.74 4.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 0.0 110.416 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.38 2.95 50.79 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HE2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -88.59 18.39 4.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.177 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.524 ' N ' ' HE3' ' A' ' 50' ' ' LYS . 53.5 mt -45.68 -46.78 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 109.293 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 55' ' ' MET . 23.5 ptt? -65.74 -35.32 80.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.412 -0.805 . . . . 0.0 109.52 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 34.9 tt0 -75.19 -27.5 59.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.289 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.2 -45.99 44.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 21.0 ptm -64.92 -44.91 87.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 77.6 tt0 -65.44 -41.32 93.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.451 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 28.5 mmtt -67.42 -31.21 71.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 108.524 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' SER . 24.3 tp -73.93 -29.36 61.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.748 -0.595 . . . . 0.0 109.83 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 20.0 mttm 39.46 -92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 58' ' ' LEU . 83.0 p -129.48 -158.03 0.86 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . -73.17 -1.92 57.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.8 ttp -65.0 -46.15 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 110.463 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.413 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 81.6 mtt180 -106.21 11.36 31.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.765 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 73.7 t80 -50.23 -43.96 53.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 109.748 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.84 -38.7 80.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 109.897 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 64.9 mt-10 -61.64 -51.07 69.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.892 . . . . 0.0 109.841 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.569 HG11 ' CE2' ' A' ' 71' ' ' TYR . 93.6 t -69.65 -39.44 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -60.51 -53.25 59.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.71 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.9 mm-40 -70.73 -28.0 64.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CE2' HG11 ' A' ' 67' ' ' VAL . 12.0 m-30 -102.62 9.25 39.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 68' ' ' ALA . 47.4 t -79.07 88.18 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -104.33 7.66 35.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' ' CB ' ' A' ' 44' ' ' LEU . 43.0 p30 -132.01 40.49 3.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.468 -0.77 . . . . 0.0 109.982 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -64.89 -43.97 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.0 110.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.2 64.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -74.91 -33.09 61.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' ASP . 60.5 mt-30 -137.02 157.4 46.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.973 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.94 14.92 37.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.21 2.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 34.9 p-10 -121.3 137.37 54.72 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.318 -1.107 . . . . 0.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' CD1' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -104.35 -9.17 18.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 78.29 -143.98 27.81 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.581 ' CE2' ' HD2' ' A' ' 39' ' ' LYS . 89.5 m95 -79.99 140.33 36.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.589 -0.948 . . . . 0.0 111.302 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.528 ' HG3' ' CD1' ' A' ' 82' ' ' LEU . 68.7 mmm -131.66 114.6 15.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.6 -0.688 . . . . 0.0 109.171 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.468 HG23 ' HB1' ' A' ' 37' ' ' ALA . 51.4 p -74.6 -43.38 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.979 -1.076 . . . . 0.0 109.896 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 8.6 mtt180 -107.55 -62.58 1.41 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.833 . . . . 0.0 110.015 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 89.6 111.01 1.31 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -141.94 86.3 1.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -1.165 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.457 ' O ' HG11 ' A' ' 91' ' ' VAL . 49.4 mtt -121.71 -37.26 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.095 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.03 -88.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.254 -0.904 . . . . 0.0 110.142 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -170.55 -69.45 0.04 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 -37.92 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.874 1.46 . . . . 0.0 110.571 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 125' ' ' ILE . 60.5 t80 -60.92 -49.99 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 3.5 tm0? -74.54 -55.25 6.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 110.094 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 3.1 tp10 -42.05 -45.65 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.54 -39.7 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.68 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 95' ' ' GLN . . . -55.98 -41.36 74.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 87' ' ' ARG . 34.8 m-85 -89.5 -5.47 57.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 110.156 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -116.43 8.73 14.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.32 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.159 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.071 0.462 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.416 ' HE1' ' CE1' ' A' ' 64' ' ' PHE . 73.6 m-85 -106.55 146.89 30.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.611 ' CG2' ' CG1' ' A' ' 125' ' ' ILE . 13.3 p -72.04 86.87 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.002 -1.061 . . . . 0.0 109.065 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.1 125.77 38.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.446 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.3 Cg_endo -75.12 165.47 85.79 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 -2.147 . . . . 0.0 110.08 -0.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 -179.44 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.896 1.472 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 23.9 m -102.95 139.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.011 . . . . 0.0 110.558 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HE3' ' CD1' ' A' ' 51' ' ' ILE . 12.0 ttmt -112.08 123.81 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.585 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 73.7 p -130.65 176.1 8.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.981 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -72.03 -16.75 62.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.77 . . . . 0.0 110.551 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.1 p90 -98.18 19.4 14.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 0.0 110.187 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 111.29 -179.11 19.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 54.7 p90 -101.53 160.37 14.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -1.224 . . . . 0.0 110.034 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.57 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.3 m-70 -138.67 138.17 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 111.819 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 87.2 mt -115.27 111.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.611 ' CG1' ' CG2' ' A' ' 112' ' ' THR . 0.0 OUTLIER -103.23 143.86 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.066 . . . . 0.0 111.807 -178.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.8 tmm? -118.61 119.81 35.6 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 46.8 t -97.56 121.2 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -110.53 -8.13 14.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.481 -0.762 . . . . 0.0 109.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.487 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -144.44 149.96 22.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.02 149.31 52.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.922 -1.34 . . . . 0.0 110.653 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HG3' ' HA ' ' A' ' 36' ' ' ASN . 71.6 tttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.081 0.944 . . . . 0.0 110.368 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' CB ' ' HB3' ' A' ' 84' ' ' TRP . . . -133.8 156.45 48.0 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.785 -1.197 . . . . 0.0 111.263 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 130' ' ' ARG . 1.5 m -116.86 152.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HG3' ' CH2' ' A' ' 84' ' ' TRP . 5.5 mtmt -98.49 113.08 24.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.884 -1.135 . . . . 0.0 108.815 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG11 ' CG2' ' A' ' 125' ' ' ILE . 70.3 t -113.94 130.81 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.118 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -134.41 129.95 36.1 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.0 p80 -145.04 168.7 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.448 -1.407 . . . . 0.0 112.565 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 71' ' ' TYR . 89.4 mt -108.88 131.86 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -118.49 125.12 49.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 111.838 -178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' CG ' ' A' ' 73' ' ' GLU . 19.1 t -137.62 136.22 37.31 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.4 mm-40 -55.23 -157.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.502 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 92.8 mttt -97.91 105.04 17.12 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.47 -1.394 . . . . 0.0 112.509 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -133.02 16.7 4.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.242 -0.911 . . . . 0.0 109.897 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.28 23.49 73.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 91.7 mttt -94.51 6.18 49.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -1.006 . . . . 0.0 110.808 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG13 ' CD2' ' A' ' 122' ' ' TYR . 3.0 mp -51.27 -50.1 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.029 . . . . 0.0 110.392 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 39.5 ttp -69.62 -40.13 76.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -0.757 . . . . 0.0 111.288 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 54.1 tp10 -70.62 -41.09 72.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.656 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' O ' HD22 ' A' ' 58' ' ' LEU . . . -61.49 -54.51 42.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 111.18 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 4.9 ptt? -61.79 -44.12 97.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.085 -1.009 . . . . 0.0 111.178 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.525 ' N ' ' CG ' ' A' ' 55' ' ' MET . 10.2 pt-20 -72.04 -23.61 61.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.929 -1.107 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.7 tptt -70.26 -45.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.805 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' CB ' HG22 ' A' ' 67' ' ' VAL . 1.3 pp -81.02 -23.06 38.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' HD11 ' A' ' 58' ' ' LEU . 61.5 mmtt 52.2 -133.62 1.77 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.116 -0.99 . . . . 0.0 111.178 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -36.28 66.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 110.622 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.2 -0.3 3.54 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.221 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.4 mtm -47.86 -36.87 12.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.007 -1.29 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 7.1 mtp180 -110.3 29.28 7.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.703 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.96 -47.78 43.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.527 -0.733 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.18 -37.55 78.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.881 . . . . 0.0 109.945 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 8.3 tp10 -65.48 -47.67 75.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG22 ' CB ' ' A' ' 58' ' ' LEU . 41.0 t -63.52 -47.42 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.319 -0.863 . . . . 0.0 109.639 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -53.4 -51.06 63.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 110.127 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.97 67.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.687 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.462 ' NE2' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -70.81 -29.94 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' LEU . 57.3 m-85 -106.94 11.12 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.009 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ALA . 79.7 p -76.58 69.67 3.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.398 -0.813 . . . . 0.0 109.741 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 11.7 pt-20 -111.24 26.79 10.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.638 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 47.9 p-10 -100.66 14.45 31.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 74' ' ' ASP . 21.9 tttm -38.32 -35.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 110.166 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.15 -37.63 47.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.565 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 41.8 ttt85 -121.82 17.74 11.04 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.462 -0.774 . . . . 0.0 109.744 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 62.61 -77.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 110.612 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . 53.62 -116.14 5.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 66.74 -84.15 0.11 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -132.69 136.5 46.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -1.117 . . . . 0.0 110.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 6.0 mp -102.09 147.44 26.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.77 -125.14 0.19 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.541 ' CH2' ' HG3' ' A' ' 39' ' ' LYS . 94.2 m95 -93.79 131.61 38.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.549 -0.971 . . . . 0.0 111.001 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -127.6 122.24 32.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.104 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.0 p -72.14 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 111.04 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -87.19 -37.9 16.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' GLN . . . 57.66 77.82 0.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.448 ' HA ' ' NE2' ' A' ' 95' ' ' GLN . 90.1 p -123.91 103.24 8.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -1.135 . . . . 0.0 109.718 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -141.65 -86.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.403 HG21 ' HB2' ' A' ' 94' ' ' PHE . 13.6 m -67.37 -41.39 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 111.25 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' GLU . . . 132.03 -77.41 0.39 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.301 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -24.17 44.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.759 1.4 . . . . 0.0 112.03 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.403 ' HB2' HG21 ' A' ' 91' ' ' VAL . 45.9 t80 -62.68 -47.82 81.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.759 -1.213 . . . . 0.0 110.323 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -78.2 -38.12 43.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.531 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 89.6 mt-10 -55.35 -32.17 62.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.432 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -85.89 -40.24 16.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.036 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.37 7.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.841 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -70.56 -32.38 69.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.0 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -50.04 -35.36 24.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 110' ' ' VAL . 7.0 tt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 111' ' ' PHE . 95.7 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.699 0.761 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 52.8 p90 -120.19 163.87 17.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 6.4 m -48.87 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.485 -0.759 . . . . 0.0 110.533 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 37.5 p-10 -127.05 120.36 22.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.097 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.91 165.77 83.09 Favored 'Cis proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.623 -2.24 . . . . 0.0 109.736 0.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HG2' HG22 ' A' ' 51' ' ' ILE . 43.8 Cg_endo -71.09 178.55 5.27 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.784 1.413 . . . . 0.0 109.765 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.505 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 26.8 m -101.43 161.99 3.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -124.54 118.55 26.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 109.208 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -136.6 171.78 13.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.734 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -65.37 -9.07 21.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.549 -0.72 . . . . 0.0 110.277 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER -89.54 -20.18 24.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 109.043 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.17 -160.97 25.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD2' HG13 ' A' ' 51' ' ' ILE . 16.3 m-30 -100.72 134.54 43.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -1.077 . . . . 0.0 109.247 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.522 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 61.6 m-70 -125.39 121.75 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.011 -1.055 . . . . 0.0 112.556 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 4.8 tt -115.71 114.62 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 7.1 mt -107.13 125.56 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.942 -1.099 . . . . 0.0 113.543 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 9.8 tpt -100.09 114.12 27.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 128' ' ' GLU . 5.7 p -107.43 156.83 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.677 -1.265 . . . . 0.0 112.071 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' ' 127' ' ' VAL . 3.5 tt0 -103.85 -29.29 11.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.79 -175.42 23.04 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.528 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 17.8 ttp180 -132.41 -85.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.525 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 50.6 tttm . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.538 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.172 0.511 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 86' ' ' THR . . . -127.24 -172.89 2.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.672 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.1 m -135.92 145.67 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 110.337 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -98.73 137.15 37.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.822 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 m -138.43 157.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.3 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 7.7 mmt85 -123.1 115.8 22.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.525 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -125.52 157.61 36.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.715 -1.24 . . . . 0.0 112.633 -177.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 16.3 pt -130.57 125.49 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.586 HD12 ' CE1' ' A' ' 123' ' ' HIS . 6.5 tt -106.42 123.84 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.16 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 1.4 t -143.26 -171.47 3.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.906 -1.121 . . . . 0.0 111.8 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.634 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 4.4 mt-10 -77.41 117.15 18.61 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.595 -0.69 . . . . 0.0 111.403 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -82.58 77.28 9.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.711 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 19.3 m80 -134.61 71.05 1.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.983 -1.073 . . . . 0.0 110.155 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.18 78.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.184 -1.567 . . . . 0.0 109.184 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 59.6 tttt -108.7 -11.55 15.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -1.044 . . . . 0.0 110.385 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 47' ' ' LYS . 34.2 mt -47.58 -53.11 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 73.1 mtm -59.21 -37.34 77.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.446 -0.784 . . . . 0.0 110.598 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 75.0 mm-40 -61.41 -39.8 92.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.928 . . . . 0.0 110.568 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.47 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -66.38 -60.7 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.458 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.471 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 22.6 ptm -58.93 -44.44 91.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.026 . . . . 0.0 110.336 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 55' ' ' MET . 32.4 mm-40 -59.1 -42.98 91.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 62' ' ' MET . 66.2 tttt -72.07 -38.0 69.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 111.0 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 124' ' ' ILE . 2.3 pp -93.98 10.81 31.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.956 -1.09 . . . . 0.0 110.807 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.9 ptmt -42.55 161.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.145 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -52.09 115.99 1.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.004 . . . . 0.0 110.087 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.11 -44.05 1.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 7.5 tpt -77.3 162.72 27.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -1.098 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.36 100.25 8.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CD1' ' SD ' ' A' ' 126' ' ' MET . 76.9 t80 -50.64 -32.54 19.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.966 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -55.38 -43.64 75.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.558 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.22 -44.1 84.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.696 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 58' ' ' LEU . 59.3 t -55.81 -57.54 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 43' ' ' ILE . . . -46.13 -58.02 3.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.54 -38.7 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.375 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.527 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.6 mm-40 -78.77 -32.36 46.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.212 -0.93 . . . . 0.0 110.584 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.78 23.15 13.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -1.0 . . . . 0.0 110.616 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 m -83.86 100.27 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.385 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' OE1' ' HG3' ' A' ' 46' ' ' GLU . 28.7 tt0 -100.66 4.62 43.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.506 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLN . 85.3 m-20 -102.07 72.1 1.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.459 -0.776 . . . . 0.0 109.357 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -50.55 -35.49 30.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.467 -0.77 . . . . 0.0 110.87 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.41 -54.41 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -73.3 -15.7 61.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.102 -0.999 . . . . 0.0 110.589 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.603 ' CG ' ' O ' ' A' ' 78' ' ' GLN . 1.6 pt20 33.92 99.94 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.249 1.023 . . . . 0.0 111.431 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -70.38 -90.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . 46.73 -91.63 0.01 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 79' ' ' GLY . 19.9 p-10 -106.13 132.45 52.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.589 -0.948 . . . . 0.0 110.075 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 50.4 tp -116.88 135.08 54.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -56.48 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' HB2' ' A' ' 39' ' ' LYS . 24.8 m-90 -88.56 138.69 31.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.972 . . . . 0.0 110.466 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.5 mmm -101.41 119.45 38.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 108.999 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 37' ' ' ALA . 3.6 p -119.36 -29.42 5.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 7.2 ptp180 -63.61 -33.67 76.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.429 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . 52.85 20.7 8.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -130.36 78.71 1.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -1.166 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 92' ' ' GLY . 7.9 ttt -136.9 153.23 50.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.618 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 90' ' ' MET . 57.0 t 34.51 -91.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.368 0.604 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 90' ' ' MET . . . 178.44 -74.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 43.9 Cg_endo -70.14 -11.8 31.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.137 1.598 . . . . 0.0 110.391 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -73.94 -66.63 0.69 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' HA2' ' A' ' 88' ' ' GLY . 13.3 mm-40 -65.4 -40.2 93.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 110.944 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 9.8 pt-20 -55.07 -38.5 68.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.749 -1.219 . . . . 0.0 109.848 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.525 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . . . -68.12 -55.13 13.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.989 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.34 -49.57 12.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 7.3 m-30 -88.58 0.78 56.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.33 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 97' ' ' ALA . . . -83.23 -25.76 31.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.151 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.451 ' N ' HD13 ' A' ' 101' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.51 0.672 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 54.3 p90 -123.65 172.56 8.71 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.587 ' CG2' HG12 ' A' ' 125' ' ' ILE . 3.1 p -58.26 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.607 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 10.5 p-10 -120.24 113.87 33.7 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.956 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.8 Cg_endo -73.4 164.53 86.89 Favored 'Cis proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.971 -2.095 . . . . 0.0 110.563 0.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 44.4 Cg_endo -73.02 -175.83 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.019 1.536 . . . . 0.0 110.385 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.63 146.55 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.515 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 51' ' ' ILE . 64.7 mttt -112.61 130.53 56.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 73.8 p -142.31 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.889 -1.132 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.24 -29.73 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 109.997 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 3.5 p90 -88.6 43.26 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.533 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.6 -157.75 27.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p90 -130.61 160.18 34.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -1.037 . . . . 0.0 108.476 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 1.4 m-70 -140.32 133.24 29.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.666 -1.271 . . . . 0.0 112.135 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -112.66 136.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.587 HG12 ' CG2' ' A' ' 112' ' ' THR . 0.0 OUTLIER -126.52 133.71 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.598 -1.314 . . . . 0.0 112.278 -176.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.567 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 31.2 mtm -94.42 99.01 11.28 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.78 110.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.429 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -139.4 151.09 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.17 60.26 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.18 169.23 14.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.58 -0.953 . . . . 0.0 110.392 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.328 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.4 t30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.748 0.785 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 130' ' ' ARG . . . -136.36 164.2 28.67 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.645 -1.285 . . . . 0.0 110.648 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 85' ' ' MET . 17.9 m -139.48 146.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 33.0 tttm -100.57 130.34 46.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.918 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.407 HG23 ' HE3' ' A' ' 85' ' ' MET . 22.1 t -130.78 149.68 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.863 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 45.6 mtt180 -140.17 126.32 19.81 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.596 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 2.3 p80 -144.9 -178.65 6.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.612 -1.305 . . . . 0.0 112.206 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' A' ' 124' ' ' ILE . 9.2 pt -138.37 138.47 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -103.47 126.81 50.84 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.273 0.558 . . . . 0.0 110.386 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.8 p -134.38 171.09 14.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.063 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 48' ' ' HIS . 73.3 mm-40 -61.69 171.17 1.65 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.261 -0.899 . . . . 0.0 110.623 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 6.0 tttt -116.56 80.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.988 . . . . 0.0 110.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 47' ' ' LYS . 18.4 m-70 -134.78 63.21 1.63 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.936 -1.103 . . . . 0.0 111.966 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.97 9.95 12.53 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.241 -0.912 . . . . 0.0 111.114 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 37.4 ttmt -89.2 13.29 13.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.973 -1.31 . . . . 0.0 110.482 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.609 HG13 ' CE2' ' A' ' 122' ' ' TYR . 82.0 mt -64.29 -42.58 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.569 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.446 ' CE ' ' SD ' ' A' ' 55' ' ' MET . 38.6 mmt -69.26 -44.4 71.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.895 . . . . 0.0 111.273 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -70.65 -38.92 73.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.08 . . . . 0.0 110.746 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.586 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.5 -52.73 56.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.446 ' SD ' ' CE ' ' A' ' 52' ' ' MET . 5.7 ptt? -65.39 -34.39 78.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.887 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 16.0 tp10 -58.03 -46.41 85.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HB3' HG21 ' A' ' 67' ' ' VAL . 22.2 tttt -67.57 -32.86 73.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 109.181 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.555 HD22 ' CE2' ' A' ' 111' ' ' PHE . 2.0 tp -74.41 -13.02 60.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 109.253 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 39.9 tptt -40.4 144.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.746 . . . . 0.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -50.4 149.43 3.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.235 -0.916 . . . . 0.0 108.953 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.88 -44.25 1.6 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.6 mmt -78.36 165.77 23.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.509 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.533 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -71.69 99.16 2.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.108 -0.995 . . . . 0.0 110.811 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 60.9 t80 -48.47 -29.54 4.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 109.304 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -77.79 -40.23 41.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 11.2 tp10 -56.54 -46.21 80.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.866 . . . . 0.0 109.67 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 71' ' ' TYR . 69.5 t -67.07 -44.06 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 109.558 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . . . -54.89 -50.89 67.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.92 57.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.2 mm-40 -63.1 -29.08 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 21.9 m-85 -108.99 18.77 20.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.46 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 68' ' ' ALA . 30.3 t -91.25 96.06 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -99.77 0.03 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.233 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 75' ' ' LYS . 41.2 t0 -105.97 15.26 26.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.464 -0.772 . . . . 0.0 109.953 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 14.4 pttm -41.81 -35.15 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -86.02 134.75 33.83 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 81.14 -18.39 0.5 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.683 -0.636 . . . . 0.0 109.962 -178.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.3 tt0 70.38 177.33 0.27 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 110.982 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 82' ' ' LEU . . . 154.8 -20.81 0.59 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 42' ' ' HIS . . . -48.29 -44.99 28.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 34.6 p-10 -115.01 126.43 54.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -1.016 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 9.0 mp -101.35 7.8 42.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 60.26 -147.66 44.63 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.585 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 35.3 m95 -96.73 132.29 42.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.743 -0.857 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 38' ' ' VAL . 9.0 ptp -135.87 149.77 49.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.58 -0.7 . . . . 0.0 109.206 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 26.4 p -111.47 -64.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.375 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' ' OG1' ' A' ' 86' ' ' THR . 7.3 mtp180 -71.69 -38.23 70.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 109.758 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 95' ' ' GLN . . . 60.03 55.38 30.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' HE2' ' A' ' 90' ' ' MET . 48.8 m -103.67 106.23 16.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.251 . . . . 0.0 109.522 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.404 ' HE2' ' O ' ' A' ' 89' ' ' SER . 16.0 mmt -130.16 -83.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 111.107 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.47 HG21 ' HD2' ' A' ' 93' ' ' PRO . 4.0 p -96.46 -28.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.235 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.453 ' N ' HG11 ' A' ' 91' ' ' VAL . . . 132.46 -73.12 0.47 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.025 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HD2' HG21 ' A' ' 91' ' ' VAL . 44.0 Cg_endo -69.84 -41.67 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.849 1.447 . . . . 0.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -53.91 -38.41 64.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.071 -1.018 . . . . 0.0 109.393 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 88' ' ' GLY . 44.9 tt0 -67.33 -52.35 41.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 38.3 tt0 -54.45 -44.45 72.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -59.67 -56.12 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.07 -54.9 6.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.346 -0.846 . . . . 0.0 110.264 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.435 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 61.1 m-85 -85.08 11.29 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 0.0 110.478 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -102.15 -19.9 14.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.736 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 112' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.91 . . . . 0.0 112.638 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.43 ' CG2' ' H ' ' A' ' 111' ' ' PHE . 2.7 m . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CE2' HD22 ' A' ' 58' ' ' LEU . 40.6 t80 -116.58 152.19 34.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.896 -1.127 . . . . 0.0 110.806 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.512 ' CG2' HG12 ' A' ' 125' ' ' ILE . 7.3 p -74.84 110.43 9.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 110.936 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -133.81 121.69 16.12 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.32 172.7 58.49 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.164 -2.015 . . . . 0.0 110.362 -0.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.473 ' HG3' ' CD1' ' A' ' 124' ' ' ILE . 47.2 Cg_endo -73.15 178.12 6.95 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.956 1.503 . . . . 0.0 109.725 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 123' ' ' HIS . 16.2 m -99.91 155.11 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.008 -1.058 . . . . 0.0 109.378 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HB3' HD11 ' A' ' 51' ' ' ILE . 49.5 pttt -125.26 130.43 52.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.58 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.592 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 71.2 p -134.04 178.23 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -72.89 -15.83 61.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -0.955 . . . . 0.0 110.617 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 1.8 p90 -95.84 24.62 5.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.174 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 109.97 -176.41 19.19 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.4 m-85 -100.02 154.04 18.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 53.4 m-70 -129.91 122.52 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.872 -1.143 . . . . 0.0 110.487 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.58 HG22 ' CG1' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -117.92 108.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -109.01 157.47 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.69 -1.256 . . . . 0.0 112.959 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.508 ' HA ' ' CD1' ' A' ' 111' ' ' PHE . 3.7 ttt -116.26 119.29 35.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.95 115.52 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.814 -1.179 . . . . 0.0 111.947 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -106.0 -18.28 14.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 70.7 -163.64 53.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.502 ' HG3' ' CZ3' ' A' ' 84' ' ' TRP . 66.1 ttt180 -132.77 -35.69 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.943 . . . . 0.0 110.003 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.288 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 86' ' ' THR . 38.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.26 0.553 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CA ' ' OG1' ' A' ' 86' ' ' THR . . . -113.14 168.73 9.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.0 110.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 14.3 m -130.3 169.5 21.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.558 -0.714 . . . . 0.0 109.882 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CG ' ' CE2' ' A' ' 84' ' ' TRP . 19.0 mtpt -98.53 119.61 37.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.095 -1.003 . . . . 0.0 109.193 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 95.9 t -111.72 126.39 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.023 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NH1' ' OE1' ' A' ' 128' ' ' GLU . 71.0 mtm180 -119.77 125.67 49.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.51 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.1 p80 -143.92 178.81 7.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.392 -1.442 . . . . 0.0 112.416 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 64' ' ' PHE . 88.6 mt -121.61 135.48 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -111.75 119.42 38.57 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.681 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 15.4 m -130.22 168.31 17.05 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 67.6 mt-10 -88.5 -172.6 3.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 110.283 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 35.9 mtmt -102.83 101.66 11.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.962 -1.086 . . . . 0.0 111.442 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 47' ' ' LYS . 28.7 m170 -134.57 6.56 3.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.888 . . . . 0.0 111.459 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.6 44.05 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.427 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 27.9 mttt -96.88 6.79 47.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.26 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 122' ' ' TYR . 69.5 mt -46.14 -57.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 55' ' ' MET . 51.1 mtt -65.08 -40.24 94.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.482 -0.761 . . . . 0.0 109.842 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 tp10 -67.37 -22.01 65.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.192 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -75.56 -60.51 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.167 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.495 ' HB2' ' HG2' ' A' ' 114' ' ' PRO . 11.6 ptt? -56.93 -32.52 66.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -71.09 -42.55 69.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 39.3 mmtm -64.37 -50.64 66.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' A' ' 59' ' ' LYS . 2.5 pp -78.17 -14.88 59.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 109.522 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 60' ' ' SER . 4.5 ptmm? 23.41 -134.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.517 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 41.3 t -52.0 -22.1 3.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.938 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 126.77 2.46 6.71 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.402 ' HB2' ' HE2' ' A' ' 62' ' ' MET . 58.3 ttm -56.86 -39.27 74.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -1.179 . . . . 0.0 109.675 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 4.3 mtt180 -108.86 13.26 24.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.0 110.132 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 43' ' ' ILE . 77.3 t80 -51.1 -48.87 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 49.5 m-80 -57.76 -43.38 85.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.35 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.422 ' CD ' ' HG2' ' A' ' 63' ' ' ARG . 41.4 mt-10 -68.09 -38.24 82.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 97.4 t -62.74 -71.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.416 -0.803 . . . . 0.0 109.134 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.555 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -48.65 -50.8 31.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 65' ' ' ASN . . . -42.92 -42.24 3.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.822 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.525 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.1 tp60 -106.02 -6.61 18.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.378 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-85 -103.42 11.74 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.6 p -83.27 100.5 10.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 110.383 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -106.03 20.12 19.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.953 . . . . 0.0 110.067 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 30.2 t0 -137.85 39.84 2.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -59.84 -24.29 64.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.857 . . . . 0.0 110.189 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.93 81.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -103.26 -57.6 2.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.138 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ASP . 1.2 pt20 -135.19 164.83 26.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.84 23.21 31.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 97.76 1.32 58.77 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 76.1 m-20 -134.15 132.01 39.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.799 -1.412 . . . . 0.0 110.929 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.51 HD11 ' CD2' ' A' ' 42' ' ' HIS . 7.3 mp -109.58 151.87 26.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.795 . . . . 0.0 109.368 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -77.56 -132.5 0.6 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.619 ' CE2' ' CG ' ' A' ' 39' ' ' LYS . 86.0 m95 -95.08 122.71 38.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.928 -0.748 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.421 ' HE3' ' CG2' ' A' ' 40' ' ' VAL . 6.6 ptt? -141.54 137.47 32.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 36' ' ' ASN . 89.1 m -103.38 -45.13 4.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.762 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -73.27 -32.22 64.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.0 -145.66 16.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -120.96 -62.16 1.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.147 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 85.9 mmm -137.44 -86.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.394 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.61 176.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 96' ' ' GLU . . . 93.93 -151.14 20.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 43.0 Cg_endo -69.3 -8.34 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.245 1.656 . . . . 0.0 110.093 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 125' ' ' ILE . 1.1 t80 -76.71 -48.52 18.58 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.514 -0.741 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -78.87 -47.6 16.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.129 -0.982 . . . . 0.0 110.835 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -62.43 -20.65 64.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.499 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -93.16 -55.02 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.786 -1.196 . . . . 0.0 110.545 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.31 -54.51 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.967 . . . . 0.0 111.388 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 38.8 m-85 -89.81 -21.85 22.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.158 -0.964 . . . . 0.0 111.609 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -119.05 32.43 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.823 -1.173 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 14.4 tp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 111' ' ' PHE . 48.9 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.572 ' CE2' HG13 ' A' ' 110' ' ' VAL . 92.8 m-85 -98.37 167.29 10.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.481 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 96.8 m -62.15 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 112.558 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 54.2 t0 -70.33 -34.08 3.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.686 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 52.9 Cg_endo -76.16 -25.76 10.25 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.466 -1.056 . . . . 0.0 114.729 1.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 42.0 Cg_endo -71.14 115.56 4.32 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 122.341 0.653 . . . . 0.0 112.895 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 123' ' ' HIS . 32.3 t -111.39 153.08 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 14.6 ptmm? -143.06 117.93 9.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.795 -1.191 . . . . 0.0 110.697 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' ' CD2' ' A' ' 120' ' ' PHE . 1.3 t -145.37 179.65 7.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -64.12 -11.97 35.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER -87.78 -17.99 30.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 108.673 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.522 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 129.08 -149.84 18.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.95 142.85 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -1.092 . . . . 0.0 108.446 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 35.2 m-70 -132.32 144.09 50.32 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.229 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 7.6 mt -132.72 109.96 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 94' ' ' PHE . 1.2 mt -115.32 129.66 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.735 -1.228 . . . . 0.0 112.271 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 111' ' ' PHE . 88.1 mtp -99.55 135.19 41.33 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.8 125.4 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.949 -1.095 . . . . 0.0 111.141 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.52 ' OE1' ' NH1' ' A' ' 41' ' ' ARG . 79.7 tt0 -142.21 147.75 37.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.08 76.47 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.473 ' HA ' HG13 ' A' ' 38' ' ' VAL . 76.2 ttt180 -122.34 131.89 54.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -1.119 . . . . 0.0 110.179 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.164 0.507 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' CB ' HG23 ' A' ' 86' ' ' THR . . . -128.92 172.03 11.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 110.7 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 85' ' ' MET . 3.6 p -141.45 156.94 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.357 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -100.13 119.72 38.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' CG2' ' CD2' ' A' ' 82' ' ' LEU . 4.5 m -127.31 157.36 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.7 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 37.9 mtt-85 -139.8 118.84 12.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.52 ' HB3' ' CG2' ' A' ' 125' ' ' ILE . 2.8 p80 -132.03 161.96 31.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.838 -1.164 . . . . 0.0 112.262 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.565 HG12 ' CB ' ' A' ' 68' ' ' ALA . 3.4 mt -115.81 128.15 73.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 5.1 tt -110.36 129.37 55.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.226 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.402 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 45.1 t -132.33 152.5 51.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.588 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 33.8 mt-10 -64.76 -171.64 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.716 -1.24 . . . . 0.0 109.463 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 48.0 tttt -97.94 106.66 18.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.587 -1.32 . . . . 0.0 113.312 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.588 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 2.8 m-70 -131.63 -5.9 3.67 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.161 -0.962 . . . . 0.0 110.032 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.6 30.29 10.84 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' GLU . 82.3 mttt -109.63 -2.75 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 111.111 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.562 ' HB ' ' CG ' ' A' ' 122' ' ' TYR . 11.3 tt -45.64 -40.94 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.497 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 16.6 ttt -65.66 -34.4 78.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.334 -0.854 . . . . 0.0 109.001 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' LYS . 79.5 tt0 -72.24 -41.75 66.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 108.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.94 -57.03 13.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.716 . . . . 0.0 110.12 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.525 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 28.3 ptm -68.83 -28.13 66.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.862 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.3 tt0 -74.57 -26.25 59.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' CB ' HG13 ' A' ' 67' ' ' VAL . 17.2 mmtm -81.41 -36.84 29.03 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.538 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 0.3 OUTLIER -83.96 -19.04 35.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.453 -0.78 . . . . 0.0 109.259 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 56' ' ' GLU . 60.8 mmtt 44.57 -138.75 0.38 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.48 -0.762 . . . . 0.0 110.052 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.8 t -54.86 -25.91 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 110.912 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 139.7 -11.47 3.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.4 mtp -48.21 -35.39 11.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -112.91 26.64 10.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.154 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.548 ' CE1' HD13 ' A' ' 43' ' ' ILE . 79.6 t80 -55.49 -37.51 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -75.37 -39.56 59.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.339 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 61.1 mm-40 -62.43 -58.15 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.794 . . . . 0.0 109.534 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.592 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 16.6 m -50.92 -44.7 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.242 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.565 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -62.72 -37.26 85.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.602 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -55.66 -36.9 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.176 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 4.1 tp60 -105.74 -10.83 16.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 110.794 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 67' ' ' VAL . 24.8 m-85 -114.23 18.94 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.247 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 36.6 t -111.77 113.24 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.831 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.94 -5.3 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.655 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 96.2 m-20 -104.43 59.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.452 -0.78 . . . . 0.0 109.607 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -55.43 -28.88 57.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.343 -0.848 . . . . 0.0 111.773 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.15 -36.12 6.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.729 -1.232 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -65.12 -55.54 18.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.12 . . . . 0.0 110.307 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' HG3' ' C ' ' A' ' 77' ' ' ARG . 19.7 mt-30 -143.45 -72.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 110.696 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.84 -107.83 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -99.35 -37.97 3.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 39.2 p30 -128.5 134.65 48.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.076 -1.249 . . . . 0.0 110.959 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 85' ' ' MET . 2.1 pp -103.3 1.33 32.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.5 -134.81 11.84 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.532 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.6 m-90 -99.23 155.41 17.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.552 -0.97 . . . . 0.0 110.915 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.538 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -126.87 133.63 50.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.442 -0.786 . . . . 0.0 109.471 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.526 HG23 ' CB ' ' A' ' 37' ' ' ALA . 30.5 p -128.77 -37.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.035 -1.04 . . . . 0.0 111.011 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 3.1 mtm105 -116.63 -14.96 10.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.907 -1.121 . . . . 0.0 111.507 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.463 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . 126.92 -176.66 17.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.446 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 9.5 t -141.8 -32.09 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.45 -1.029 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 3.7 mmt -104.33 -145.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.913 -1.117 . . . . 0.0 110.956 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CG2' ' HD2' ' A' ' 93' ' ' PRO . 13.3 m -86.53 -29.41 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.073 -1.017 . . . . 0.0 112.467 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.547 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 177.04 -54.44 0.1 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 118.451 -1.833 . . . . 0.0 111.877 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 37.9 Cg_endo -62.23 -27.04 77.97 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.352 1.185 . . . . 0.0 111.856 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 90' ' ' MET . 78.1 t80 -70.79 -52.39 20.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.749 -1.219 . . . . 0.0 109.948 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 2.6 tt0 -73.25 -29.42 62.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 109.548 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 83.0 mt-10 -70.42 -25.86 63.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 109.832 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ALA . . . -87.09 -53.88 4.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.67 -50.62 60.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -76.05 -14.69 60.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.253 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -67.7 -58.01 5.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.694 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 100' ' ' ALA . 11.2 mp . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.842 0.353 . . . . 0.0 111.76 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 9.3 t80 -133.95 156.11 48.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 111.109 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 114' ' ' PRO . 23.2 p -70.63 63.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.407 -0.808 . . . . 0.0 109.712 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -97.88 130.73 28.17 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.5 Cg_endo -74.9 168.8 76.28 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.773 -2.178 . . . . 0.0 110.033 -0.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 41.6 Cg_endo -70.75 171.51 15.4 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.049 1.552 . . . . 0.0 110.407 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.33 150.32 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.494 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG2' HD12 ' A' ' 51' ' ' ILE . 50.4 mtmt -113.33 133.32 55.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 75.5 p -139.28 -178.7 5.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.804 -1.185 . . . . 0.0 111.485 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -81.43 -18.03 46.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.449 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.3 OUTLIER -91.23 -0.77 57.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.062 -1.024 . . . . 0.0 109.455 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 132.46 -176.38 19.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 94.8 m-85 -100.95 153.77 19.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.489 -1.007 . . . . 0.0 109.426 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.583 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 5.0 m-70 -141.6 141.35 33.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 112.286 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -124.55 114.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 176.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -103.38 157.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.225 1.012 . . . . 0.0 112.175 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.561 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 19.5 ttt -136.94 134.07 36.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.71 136.55 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.74 -1.225 . . . . 0.0 111.353 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.02 109.19 7.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 109.669 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.66 115.24 0.26 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -130.07 150.5 51.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 pttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.269 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 86' ' ' THR . 26.4 p30 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.434 0.635 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 131' ' ' LYS . . . -90.31 129.19 36.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 110.309 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -141.63 164.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HD3' ' CZ2' ' A' ' 84' ' ' TRP . 12.1 mtmm -98.76 121.31 40.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.221 -0.925 . . . . 0.0 108.773 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.507 ' HB ' ' CD1' ' A' ' 82' ' ' LEU . 91.2 t -130.15 143.84 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.934 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' N ' HG11 ' A' ' 40' ' ' VAL . 31.1 mtt85 -140.4 107.17 5.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 3.8 p80 -132.45 179.33 6.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.615 -1.303 . . . . 0.0 112.149 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 6.7 mt -127.81 133.66 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -117.33 121.44 41.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.988 . . . . 0.0 111.149 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 54.0 t -142.07 137.25 30.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.143 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.587 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 71.5 mm-40 -58.28 162.03 3.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.467 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 2.9 tttm -72.68 113.28 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.033 -1.042 . . . . 0.0 112.674 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.587 ' CE1' ' CB ' ' A' ' 46' ' ' GLU . 7.2 m-70 -132.06 14.41 4.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.28 76.23 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 12.4 mtpt -93.92 -5.66 47.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.984 . . . . 0.0 110.475 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.592 HG13 ' CD2' ' A' ' 122' ' ' TYR . 2.8 mp -40.13 -58.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.225 -0.922 . . . . 0.0 110.426 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 6.0 ttt -69.12 -45.29 70.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.99 -46.94 78.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -59.84 -62.63 1.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.551 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.537 ' CE ' ' HD3' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -61.19 -39.86 91.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.12 -179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 4.5 tp10 -52.82 -54.98 26.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.794 -1.191 . . . . 0.0 109.54 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -57.55 -38.2 74.36 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.506 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.92 -68.83 0.14 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 25.9 mmtt 39.17 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.588 -0.695 . . . . 0.0 110.281 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -110.08 133.64 53.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.05 -1.031 . . . . 0.0 110.725 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.86 -12.22 59.19 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.406 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 tpt -81.49 161.22 23.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.32 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -82.79 99.34 9.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.344 -0.848 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' CD1' ' HE3' ' A' ' 126' ' ' MET . 66.0 t80 -49.17 -29.37 5.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 110.379 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -63.37 -35.12 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -77.19 -41.02 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 58' ' ' LEU . 23.3 t -68.69 -38.11 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.955 -1.091 . . . . 0.0 110.195 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -68.68 -41.92 78.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.95 -1.094 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.11 81.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.862 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.9 tp60 -70.25 -34.81 73.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 110.757 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 54.1 m-85 -104.42 21.81 16.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.023 -1.048 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -86.01 90.91 8.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.1 tp10 -100.33 -2.42 33.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.336 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 32.0 p-10 -136.25 12.33 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 79' ' ' GLY . 81.4 tttt -56.46 -34.17 66.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.416 -0.802 . . . . 0.0 110.386 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.5 94.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 5.9 ptp180 -98.81 -12.9 20.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.044 -1.035 . . . . 0.0 110.967 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -129.05 -38.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.911 -1.118 . . . . 0.0 110.241 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . 93.23 -12.66 69.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 90.83 -43.79 2.86 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.8 p-10 -124.56 142.74 51.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -1.207 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.507 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 2.9 pp -136.59 156.08 49.05 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.02 -119.16 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.802 -1.189 . . . . 0.0 111.047 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.594 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 19.0 m-90 -90.7 121.42 32.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.065 -0.668 . . . . 0.0 110.802 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.462 ' SD ' HD11 ' A' ' 82' ' ' LEU . 23.3 ptm -144.38 155.12 43.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 1.5 p -87.0 134.85 33.45 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.585 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 50.8 mtt-85 -98.96 46.11 0.99 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.178 . . . . 0.0 112.48 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.08 36.27 4.38 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 106.586 -2.606 . . . . 0.0 106.586 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -137.08 -7.93 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.874 -0.78 . . . . 0.0 111.792 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.93 -166.15 1.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.719 -1.238 . . . . 0.0 110.391 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.27 178.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.883 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.74 -151.54 19.64 Favored Glycine 0 N--CA 1.483 1.799 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.933 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 47.4 Cg_endo -75.16 -24.17 12.83 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.717 1.904 . . . . 0.0 110.664 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 44.6 t80 -45.71 -65.85 0.48 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 87' ' ' ARG . 4.0 tm0? -79.56 -32.04 42.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 41.0 tt0 -56.15 -39.77 72.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.952 -1.092 . . . . 0.0 110.403 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.64 -39.76 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . . . -44.99 -59.25 2.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 110.774 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -81.69 -41.02 21.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 111.373 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -51.33 -21.22 2.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' ALA . 14.5 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.276 0.56 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.497 ' CA ' ' O ' ' A' ' 125' ' ' ILE . 37.4 p90 -122.85 158.87 29.35 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.094 -1.003 . . . . 0.0 110.147 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 14.8 m -50.43 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.362 -0.836 . . . . 0.0 112.197 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.478 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 46.4 t0 -132.36 118.64 16.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 41.4 Cg_endo -66.82 176.42 23.35 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.315 -1.952 . . . . 0.0 111.011 1.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.537 ' HD3' ' CE ' ' A' ' 55' ' ' MET . 47.5 Cg_endo -81.89 -178.76 4.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.16 1.611 . . . . 0.0 110.398 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 25.2 m -104.49 142.9 16.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.839 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -115.33 124.99 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 109.246 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.601 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 69.5 p -137.01 -179.38 5.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.621 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 3.9 tttm -68.07 -11.72 59.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.601 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 0.4 OUTLIER -107.56 22.5 15.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.82 -1.175 . . . . 0.0 110.816 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 46' ' ' GLU . . . 104.35 -179.32 24.67 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.592 ' CD2' HG13 ' A' ' 51' ' ' ILE . 32.7 p90 -101.58 155.28 18.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.942 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 3.0 m-70 -134.25 147.35 50.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 111.881 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.525 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 3.0 tt -126.83 115.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 mp -104.68 141.57 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 112.354 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.491 ' HE3' ' CD1' ' A' ' 64' ' ' PHE . 1.3 mmm -113.63 102.69 10.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.76 132.5 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.177 -0.952 . . . . 0.0 111.194 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.13 70.84 1.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 128.14 127.32 2.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -126.64 148.74 49.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 1.7 tttp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.155 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -130.61 164.46 24.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 127' ' ' VAL . 7.3 p -143.33 156.01 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 8.2 tttm -101.05 126.5 47.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.256 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 ' CE ' ' A' ' 85' ' ' MET . 35.2 m -131.05 152.91 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.585 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -136.32 123.26 21.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 124' ' ' ILE . 1.7 p80 -130.01 157.46 42.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.747 -1.22 . . . . 0.0 112.192 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CD1' HD13 ' A' ' 124' ' ' ILE . 1.4 pt -112.66 131.94 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 1.6 tt -104.77 131.46 52.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.913 -1.117 . . . . 0.0 111.852 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 48.7 t -136.17 156.18 49.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 48' ' ' HIS . 97.5 mt-10 -112.96 -12.68 13.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.044 -1.035 . . . . 0.0 111.774 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 14.9 mmtm -64.72 114.33 4.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 46' ' ' GLU . 7.1 m-70 -89.71 144.07 26.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.855 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 -15.99 58.9 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.535 ' NZ ' ' CE1' ' A' ' 71' ' ' TYR . 27.9 tttm -97.37 -9.76 26.82 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 122' ' ' TYR . 38.9 mt -46.29 -44.86 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.457 ' O ' ' HG2' ' A' ' 55' ' ' MET . 21.2 ptt? -62.45 -36.52 82.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 110.7 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' A' ' 52' ' ' MET . 59.2 tt0 -72.44 -37.46 68.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.318 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.33 -49.2 72.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 59' ' ' LYS . 13.8 ptt? -65.29 -31.89 73.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.008 . . . . 0.0 110.385 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -70.96 -44.02 66.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.042 -1.036 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -58.79 -53.45 58.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -76.57 -27.53 55.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 108.8 179.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 55' ' ' MET . 33.0 tttt 45.83 -99.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -0.789 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 p -98.41 -12.47 21.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.897 -1.127 . . . . 0.0 110.561 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 64' ' ' PHE . . . 124.47 2.05 8.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.1 mmm -50.28 -49.86 52.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.029 -1.277 . . . . 0.0 109.745 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -103.82 32.64 3.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.349 -0.845 . . . . 0.0 109.491 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 9.8 t80 -52.22 -48.67 65.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.431 -0.793 . . . . 0.0 110.72 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 33.7 t30 -54.91 -47.52 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.73 -42.49 77.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 45.1 t -65.42 -53.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -59.96 -52.62 64.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 110.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -62.37 -18.43 61.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 111.353 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -24.61 11.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 110.89 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.535 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 45.4 m-85 -100.31 6.47 44.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.075 -1.016 . . . . 0.0 109.517 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 28.7 t -72.16 103.74 3.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.386 -0.822 . . . . 0.0 110.575 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 45' ' ' CYS . 11.0 mt-10 -101.01 5.49 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.953 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 78' ' ' GLN . 17.6 t0 -111.8 24.61 12.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HG2' ' OG ' ' A' ' 72' ' ' SER . 20.3 mmtt -62.83 -36.25 82.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.116 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.06 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.26 -59.96 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.258 -0.902 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.468 ' O ' ' OD2' ' A' ' 74' ' ' ASP . 8.5 pt20 -169.52 105.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.765 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 74' ' ' ASP . . . -129.45 91.36 0.31 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.84 -96.94 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 56.1 p30 -114.76 160.61 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 110.951 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 7.5 mp -103.99 -11.55 17.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 85.65 -143.48 19.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -106.96 129.59 54.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.567 -0.96 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.537 ' CE ' HG22 ' A' ' 40' ' ' VAL . 14.3 ptp -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.049 -1.032 . . . . 0.0 109.924 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.4 p -101.63 -67.6 0.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 111.457 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 84.8 mtt85 -80.83 -29.19 35.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.961 . . . . 0.0 111.24 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 95' ' ' GLN . . . 168.31 -170.28 42.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -142.87 -50.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -1.195 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.521 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -117.63 -95.59 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 111.578 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 6.1 m -114.91 -175.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.875 -1.141 . . . . 0.0 111.941 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.613 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -63.86 -46.36 91.87 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.613 -0.68 . . . . 0.0 111.922 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.6 Cg_endo -66.35 -40.76 13.77 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.066 1.035 . . . . 0.0 110.755 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 87.8 t80 -75.44 -37.22 60.51 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 45.6 tt0 -76.38 -51.73 11.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.773 . . . . 0.0 110.433 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 80.5 tt0 -57.4 -40.19 77.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.979 . . . . 0.0 110.409 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -63.82 -63.52 1.14 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -37.61 -58.57 0.87 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.296 0.57 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.29 -15.34 63.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 111.118 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -135.15 40.66 2.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.748 -1.22 . . . . 0.0 111.951 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 O-C-N 120.848 -1.158 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 126' ' ' MET . 6.4 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.61 ' CE2' HD23 ' A' ' 58' ' ' LEU . 6.3 t80 -142.91 151.53 41.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.582 ' O ' ' CE1' ' A' ' 111' ' ' PHE . 40.3 m -86.06 111.38 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.672 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -133.23 117.66 14.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.0 Cg_endo -78.19 173.67 55.59 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.014 -2.078 . . . . 0.0 110.066 0.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.467 ' HB3' HG13 ' A' ' 124' ' ' ILE . 42.4 Cg_endo -71.32 177.3 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.848 1.446 . . . . 0.0 110.014 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -105.02 150.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.846 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -116.13 121.1 41.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 67.4 p -135.51 176.01 9.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.666 -1.271 . . . . 0.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.29 -14.48 62.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 110.426 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -105.28 33.31 3.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.293 -0.88 . . . . 0.0 108.706 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' HA2' ' HE1' ' A' ' 48' ' ' HIS . . . 89.47 174.22 46.01 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 35.3 p90 -100.85 151.72 21.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.16 -1.2 . . . . 0.0 108.681 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 3.7 m-70 -130.75 160.22 34.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.893 -1.13 . . . . 0.0 112.532 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.598 HG21 ' CE2' ' A' ' 111' ' ' PHE . 1.8 mp -126.04 124.96 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 125' ' ' ILE . 1.7 mt -107.04 136.14 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.821 -1.175 . . . . 0.0 112.759 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 38.1 tpp -122.89 102.75 8.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 38' ' ' VAL . 14.7 p -103.09 129.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.022 -1.049 . . . . 0.0 112.189 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -142.48 135.65 28.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.672 -0.642 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.48 121.51 1.55 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -108.79 151.87 25.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 0.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 67.8 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.131 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.0 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.578 0.704 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.02 134.6 44.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 4.4 p -127.31 153.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.985 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 11.8 tttp -101.64 133.14 46.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.939 . . . . 0.0 109.995 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' HD11 ' A' ' 82' ' ' LEU . 3.6 t -128.29 139.12 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.09 -1.006 . . . . 0.0 111.342 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 90.2 mtt180 -120.98 121.97 39.14 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -135.5 150.51 49.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.757 -1.214 . . . . 0.0 111.406 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG1' ' HB ' ' A' ' 124' ' ' ILE . 32.9 pt -121.19 133.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.1 tt -104.93 134.58 47.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.916 -1.115 . . . . 0.0 112.087 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 7.6 p -139.49 168.01 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 109.523 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.3 mm-40 -73.44 -159.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.007 . . . . 0.0 110.747 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 4.4 mtmt -122.9 99.52 6.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 110.623 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 8.3 m-70 -132.35 30.9 4.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.857 . . . . 0.0 110.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.07 21.38 75.5 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 48' ' ' HIS . 94.4 mttt -93.14 15.91 14.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 HD11 ' HG2' ' A' ' 117' ' ' LYS . 56.4 mt -61.89 -43.95 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.075 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 55' ' ' MET . 8.0 ttt -70.59 -40.64 73.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.518 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 52.2 mp0 -70.42 -37.2 74.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.872 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . -59.72 -60.73 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.661 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 15.5 ptt? -52.73 -38.09 60.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 55' ' ' MET . 96.8 mt-10 -73.61 -11.94 60.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 29.8 tptt -80.83 -40.0 25.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD22 ' CG ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -94.17 -22.28 18.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.601 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 58.6 mttp 49.3 -142.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -52.95 -34.26 54.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.432 -0.792 . . . . 0.0 110.935 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.98 -11.66 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 36.3 ttm -50.64 -34.85 27.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.14 -1.212 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 89.3 mtt180 -112.7 31.12 6.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.974 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 78.3 t80 -51.98 -40.46 60.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 110.083 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -70.69 -33.37 70.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 13.4 tp10 -63.26 -52.4 62.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.613 HG11 ' N ' ' A' ' 68' ' ' ALA . 9.4 p -62.28 -36.46 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 109.57 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.613 ' N ' HG11 ' A' ' 67' ' ' VAL . . . -65.31 -35.44 81.0 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.243 -0.911 . . . . 0.0 109.111 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -59.95 -51.62 68.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.515 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 7.0 mm-40 -71.61 -19.65 62.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.003 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.511 ' O ' ' O ' ' A' ' 44' ' ' LEU . 29.1 m-85 -116.22 23.92 11.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.44 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' ALA . 55.9 p -78.12 76.22 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.023 -1.048 . . . . 0.0 109.767 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 80.8 mm-40 -105.76 1.47 27.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.25 13.92 9.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HA ' ' CA ' ' A' ' 79' ' ' GLY . 12.5 tmtt? -48.57 -34.72 11.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.534 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.26 96.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -94.7 -61.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 110.233 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -121.36 -61.56 1.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.893 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 75' ' ' LYS . . . 92.25 -104.19 3.14 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -103.04 -73.78 0.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 27.8 p-10 -81.19 153.27 27.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.29 -1.124 . . . . 0.0 110.781 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 9.0 mp -113.82 -12.34 12.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.83 . . . . 0.0 109.794 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.38 -165.36 24.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.617 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 93.6 m95 -93.87 136.8 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.981 . . . . 0.0 110.091 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.447 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.5 ptp -140.52 135.56 32.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.89 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 18.1 p -83.83 -37.63 22.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.482 -0.761 . . . . 0.0 110.443 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -113.41 -38.54 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 95' ' ' GLN . . . 58.69 66.2 2.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 31.3 t -113.08 105.63 13.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -1.171 . . . . 0.0 109.437 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.2 tpt -125.69 -60.38 1.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 111.291 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 92' ' ' GLY . 11.8 p -114.63 -30.22 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.882 -1.137 . . . . 0.0 111.312 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.543 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 130.64 -65.83 0.59 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.006 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 49.0 Cg_endo -71.1 -24.76 23.28 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.811 1.427 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.593 ' CE2' HG23 ' A' ' 125' ' ' ILE . 39.9 t80 -74.3 -35.47 63.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 64.5 tt0 -78.62 -39.76 36.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.42 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 17.5 pt-20 -63.42 -25.04 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.779 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -88.45 -46.15 9.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.123 -0.986 . . . . 0.0 111.174 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.37 -35.21 75.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.465 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.85 -1.04 35.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.85 -1.156 . . . . 0.0 111.818 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -99.45 -26.12 14.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.706 -1.246 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.479 ' CD2' HG21 ' A' ' 127' ' ' VAL . 14.4 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.013 . . . . 0.0 110.001 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.447 HG23 ' HE2' ' A' ' 126' ' ' MET . 33.7 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.878 0.371 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.633 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 3.6 p90 -128.68 177.63 6.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.723 -1.236 . . . . 0.0 111.472 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.554 ' CG2' HD11 ' A' ' 125' ' ' ILE . 3.2 p -71.58 -105.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.46 -0.775 . . . . 0.0 111.708 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.784 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 28.0 m-20 -79.8 -29.11 0.55 Allowed Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.784 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 38.2 Cg_endo -76.78 -26.04 10.1 Favored 'Cis proline' 0 N--CA 1.487 1.129 0 C-N-CA 124.169 -1.179 . . . . 0.0 115.075 2.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.602 ' N ' HG13 ' A' ' 124' ' ' ILE . 43.2 Cg_endo -69.18 121.39 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-O 121.69 0.621 . . . . 0.0 112.422 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 2.9 t -97.5 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HG2' HD11 ' A' ' 51' ' ' ILE . 37.5 mtmm -103.91 112.96 26.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.027 . . . . 0.0 110.253 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.636 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 14.6 p -138.36 166.36 24.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 110.663 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -66.43 -9.35 33.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.636 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.2 OUTLIER -105.78 21.88 16.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.839 -1.163 . . . . 0.0 110.312 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.559 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 108.71 -173.51 17.68 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.855 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.617 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.97 150.55 21.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.547 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 33.3 m-70 -138.31 127.45 24.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.534 -1.354 . . . . 0.0 112.631 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.602 HG13 ' N ' ' A' ' 115' ' ' PRO . 1.2 mp -106.83 105.2 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.593 HG23 ' CE2' ' A' ' 94' ' ' PHE . 34.3 pt -108.76 141.47 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.447 ' HE2' HG23 ' A' ' 110' ' ' VAL . 16.7 ttt -119.07 141.87 48.37 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 101' ' ' LEU . 23.3 m -113.5 105.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.846 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 63.2 tt0 -111.44 132.98 54.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.782 . . . . 0.0 109.674 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 73.31 80.21 0.46 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -110.23 146.64 35.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.99 . . . . 0.0 109.712 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 1.3 mmmm . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 0.0 110.288 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 10.4 p30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.532 0.682 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 84' ' ' TRP . . . -112.32 166.59 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.403 -0.81 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 26.8 m -138.72 148.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.709 -0.62 . . . . 0.0 109.808 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' CE ' ' HD2' ' A' ' 130' ' ' ARG . 26.5 mttt -98.64 114.3 26.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 108.74 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 78.5 t -114.61 136.36 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 45.7 ttp180 -130.82 118.35 20.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 4.3 p80 -128.15 177.65 6.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.713 -1.242 . . . . 0.0 112.068 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 68' ' ' ALA . 46.1 mt -126.49 140.69 48.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.3 tt -112.32 127.05 55.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.48 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 56.8 m -132.06 138.79 48.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 109.859 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.623 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 72.1 mt-10 -59.63 155.58 15.28 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.003 -1.061 . . . . 0.0 108.786 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.539 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 4.1 tttt -80.42 118.77 22.34 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.027 -1.046 . . . . 0.0 113.101 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 8.0 m80 -135.2 1.75 2.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.697 . . . . 0.0 110.384 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.16 5.38 73.08 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 18.4 ptpt -99.71 22.17 11.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.745 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.522 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 69.6 mt -49.28 -53.1 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.419 -0.801 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.54 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 44.0 ttm -59.38 -34.39 72.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 81.2 mm-40 -63.15 -41.84 99.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.75 -52.35 57.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 0.0 110.67 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.489 ' HA ' ' CB ' ' A' ' 58' ' ' LEU . 2.6 ppp? -69.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 52' ' ' MET . 32.9 mm-40 -68.13 -33.03 73.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 108.909 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' CG ' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -87.55 -14.82 39.2 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -74.91 -29.64 61.03 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.746 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 58' ' ' LEU . 13.0 ptpt -30.9 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.43 0.633 . . . . 0.0 111.385 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -52.4 -42.92 64.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.356 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.97 -26.57 2.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.495 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 6.5 tpt -106.44 150.33 26.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -1.137 . . . . 0.0 110.296 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 66' ' ' GLU . 3.3 ptm180 -75.23 109.61 8.88 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.306 1.051 . . . . 0.0 110.72 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.553 ' CE1' ' SD ' ' A' ' 126' ' ' MET . 84.2 t80 -41.96 -36.31 1.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.743 -0.598 . . . . 0.0 109.665 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -58.64 -44.62 90.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 110.664 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 35.7 tt0 -65.04 -48.68 72.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.052 . . . . 0.0 110.812 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 27.4 m -63.68 -44.12 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.081 -1.448 . . . . 0.0 109.493 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 64' ' ' PHE . . . -63.31 -39.42 94.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 109.571 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.69 71.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.436 -0.79 . . . . 0.0 109.699 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -80.31 -7.14 58.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.594 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m-30 -108.79 9.0 26.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.858 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.7 t -80.8 83.52 6.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.174 -0.954 . . . . 0.0 111.251 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -99.54 7.02 45.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 77' ' ' ARG . 18.8 p30 -104.1 41.46 1.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.686 -0.634 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -50.4 -42.04 53.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 110.586 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 9.38 28.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.6 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 74' ' ' ASP . 2.6 ttt180 -105.29 -15.12 15.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 55.58 55.98 6.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -116.48 25.43 9.16 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -82.74 -60.0 2.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 9.5 p-10 -133.5 133.57 42.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.29 . . . . 0.0 111.059 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.1 mp -104.04 157.07 17.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 109.212 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 -127.92 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.177 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 23.5 m-90 -90.92 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.872 -0.781 . . . . 0.0 110.611 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 84' ' ' TRP . 13.9 mmt -132.14 140.82 48.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.9 t -110.37 -45.49 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.314 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' THR . 2.2 mmp_? -117.4 1.9 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.443 -0.786 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.557 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 72.8 146.47 0.71 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.476 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 38.8 p -146.37 40.67 1.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.594 -1.533 . . . . 0.0 111.541 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.591 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 2.1 tpt -125.48 137.02 53.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.033 -1.042 . . . . 0.0 110.123 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.498 ' CG2' ' C ' ' A' ' 90' ' ' MET . 5.8 m 35.0 -110.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.748 -0.595 . . . . 0.0 111.149 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.78 -67.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.432 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 38.2 Cg_endo -64.08 -14.07 41.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.709 1.373 . . . . 0.0 110.813 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 90' ' ' MET . 68.5 t80 -68.27 -47.03 68.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.56 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 14.5 mt-30 -71.05 -41.48 70.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 109.285 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 60.9 mm-40 -58.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.491 -0.756 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -68.11 -41.41 81.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.449 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -50.19 -51.8 40.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.702 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.41 -1.39 57.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 0.0 111.118 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -116.92 12.2 14.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.85 -1.156 . . . . 0.0 110.891 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD22 ' CG2' ' A' ' 112' ' ' THR . 52.5 mt . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.564 -0.71 . . . . 0.0 110.66 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.087 0.47 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.497 ' HB3' ' HG2' ' A' ' 126' ' ' MET . 33.8 p90 -124.86 156.11 38.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.012 -1.055 . . . . 0.0 110.425 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.517 ' CG2' HD22 ' A' ' 101' ' ' LEU . 24.8 p -46.16 124.51 5.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.0 111.08 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 34.1 t0 -133.35 119.75 15.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.7 Cg_endo -79.11 174.33 51.2 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.12 -2.033 . . . . 0.0 110.163 -0.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.522 ' HG2' ' CG2' ' A' ' 51' ' ' ILE . 46.5 Cg_endo -72.12 177.33 7.31 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.863 1.454 . . . . 0.0 109.993 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.32 158.98 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.9 ptmm? -119.64 136.23 54.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.585 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 74.3 p -142.13 168.62 19.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.62 -23.69 59.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 15.2 p90 -98.81 46.22 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 84.08 175.65 50.9 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 41.8 p90 -98.53 166.12 11.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -1.112 . . . . 0.0 108.844 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 22.8 m-70 -141.77 140.49 33.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.802 -1.186 . . . . 0.0 112.624 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.515 ' O ' ' CG1' ' A' ' 124' ' ' ILE . 5.1 pt -128.1 110.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.567 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 12.0 pt -106.98 149.61 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.055 -1.028 . . . . 0.0 112.867 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 49.5 mtp -107.0 124.43 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.46 107.78 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 111.319 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.35 -3.36 27.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.422 -0.799 . . . . 0.0 109.4 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 58.39 -164.54 8.34 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.475 ' HD2' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tpm_? -134.26 -35.45 0.93 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.776 -0.838 . . . . 0.0 109.894 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 36' ' ' ASN . 23.7 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.35 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 23.2 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.082 0.468 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -86.86 129.46 34.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.986 -1.071 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 22.9 m -144.1 151.12 16.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.917 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 2.3 tmtt? -96.11 124.27 40.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.049 -1.032 . . . . 0.0 108.858 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 82' ' ' LEU . 42.9 t -119.75 132.55 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.022 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 53.0 mtm180 -120.25 112.35 18.94 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.566 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 2.7 p80 -134.86 158.82 43.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.518 -1.364 . . . . 0.0 113.047 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.605 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 7.8 pt -119.82 133.42 66.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.618 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -106.28 136.09 46.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.462 0.649 . . . . 0.0 111.719 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 26.0 m -142.57 144.88 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.975 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.644 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt-10 -59.0 172.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.062 -1.024 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.1 ttmt -105.48 113.18 26.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.686 -1.259 . . . . 0.0 113.29 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.644 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 1.5 m80 -134.3 26.56 3.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.56 9.21 82.02 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 ttmt -90.76 -10.65 42.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.622 -0.928 . . . . 0.0 109.975 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 52' ' ' MET . 16.4 tt -44.2 -42.72 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.464 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.531 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 11.9 ttt -67.09 -29.73 69.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.0 109.139 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' LYS . 65.7 tt0 -72.2 -42.92 65.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.356 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.85 74.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.787 . . . . 0.0 110.164 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 22.1 ptm -74.1 -22.43 59.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 32.2 tp10 -69.92 -38.03 76.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -80.78 -25.65 37.75 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 111' ' ' PHE . 35.4 tp -76.2 -44.34 38.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.564 0.697 . . . . 0.0 109.275 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 32.1 mtmt 48.43 -112.51 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.598 -0.689 . . . . 0.0 111.081 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.7 p -78.79 -14.37 59.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.954 -1.091 . . . . 0.0 110.261 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' HA2' HD11 ' A' ' 58' ' ' LEU . . . 103.33 0.32 47.17 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 61' ' ' GLY . 56.8 ttp -44.72 -34.65 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.268 . . . . 0.0 109.641 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' PHE . 10.6 mtp180 -112.89 19.38 17.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 63' ' ' ARG . 87.1 t80 -43.72 -40.36 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 28.9 p-10 -66.12 -40.37 90.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 43.5 mm-40 -70.59 -43.36 69.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 109.491 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 18.4 t -69.79 -41.02 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.573 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.577 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . . . -63.68 -43.33 96.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 110.226 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -59.71 -43.45 94.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.56 -9.1 59.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 8.5 m-85 -111.82 5.51 19.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.942 . . . . 0.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.2 m -73.86 87.44 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE1' HD23 ' A' ' 44' ' ' LEU . 2.6 tm-20 -101.41 32.04 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.59 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 78.6 m-20 -100.13 83.55 2.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 14.8 tptt -70.79 -52.21 22.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 111.087 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.447 ' HB1' ' HD3' ' A' ' 77' ' ' ARG . . . -77.05 -13.14 60.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.111 -0.993 . . . . 0.0 110.599 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.543 ' CD ' ' N ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -102.42 -48.6 4.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.129 -0.982 . . . . 0.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 38.1 mm-40 51.56 34.73 13.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 110.035 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -93.64 -55.87 1.49 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 67.86 -64.41 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 79' ' ' GLY . 75.5 m-20 -116.47 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.693 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 8.3 mp -102.78 139.86 37.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -71.8 -138.47 0.23 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.626 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 1.5 m95 -91.58 134.18 34.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -1.02 . . . . 0.0 110.343 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.491 ' CE ' ' HA3' ' A' ' 88' ' ' GLY . 21.2 ptm -134.01 150.75 51.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 47.3 p -101.56 -38.67 7.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.953 -1.092 . . . . 0.0 110.126 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -114.01 -92.58 0.49 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.491 ' HA3' ' CE ' ' A' ' 85' ' ' MET . . . 73.14 75.12 0.75 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.1 m -110.86 93.28 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -31.15 8.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -150.6 -171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.044 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -88.33 -56.5 2.02 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.314 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -66.55 -29.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.372 1.196 . . . . 0.0 112.343 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.507 ' HB2' HG23 ' A' ' 91' ' ' VAL . 32.5 t80 -69.18 -43.4 74.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.71 -1.244 . . . . 0.0 110.756 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' OE1' ' CD1' ' A' ' 99' ' ' PHE . 7.7 tp-100 -72.52 -52.07 17.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.904 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 62.8 mt-10 -59.94 -20.97 60.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.149 -0.969 . . . . 0.0 110.912 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -82.76 -59.24 2.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.905 -1.122 . . . . 0.0 110.557 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.84 -59.31 5.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CD1' ' OE1' ' A' ' 95' ' ' GLN . 29.2 m-85 -74.3 -28.32 61.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -118.11 34.97 4.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.909 -1.119 . . . . 0.0 110.764 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.554 ' CD1' ' HA ' ' A' ' 112' ' ' THR . 8.8 tp . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.113 -0.992 . . . . 0.0 110.345 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.311 0.577 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.62 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 29.2 p90 -119.08 165.03 14.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.527 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.554 ' HA ' ' CD1' ' A' ' 101' ' ' LEU . 46.0 p -48.22 113.62 0.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 110.776 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 37.3 p-10 -132.26 120.61 17.15 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.765 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.77 165.26 74.1 Favored 'Cis proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.769 -2.179 . . . . 0.0 110.248 0.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.542 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 45.1 Cg_endo -70.46 -179.88 3.56 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.926 1.487 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 116' ' ' VAL . 29.2 m -105.8 134.33 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.895 . . . . 0.0 110.509 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.499 ' HB2' ' CE ' ' A' ' 47' ' ' LYS . 10.0 ptpt -109.65 126.99 54.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 0.0 109.187 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.604 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 44.0 p -130.33 -177.6 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.039 -1.038 . . . . 0.0 111.013 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -69.53 -18.8 63.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -0.772 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 p90 -100.36 32.58 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.044 . . . . 0.0 109.88 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 97.68 177.04 33.96 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 53.8 p90 -99.74 162.21 13.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -1.179 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.626 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 7.6 m-70 -141.69 151.49 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.001 -1.062 . . . . 0.0 112.238 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.605 ' CG1' ' CG1' ' A' ' 43' ' ' ILE . 1.8 pt -133.94 118.92 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 8.2 pt -121.56 142.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.673 -1.267 . . . . 0.0 112.83 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.481 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 34.8 mmm -97.43 125.04 41.83 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.16 121.36 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.664 -1.273 . . . . 0.0 111.889 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.473 ' CG ' ' HB3' ' A' ' 39' ' ' LYS . 8.7 pt-20 -115.16 -22.17 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.527 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 80.9 -167.47 49.9 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.585 ' HD3' ' CE3' ' A' ' 84' ' ' TRP . 12.7 tpt180 -132.66 -75.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.983 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 3.6 p30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.459 0.647 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 86' ' ' THR . . . -130.84 150.98 51.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.9 OUTLIER -111.39 164.93 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HD3' ' CE2' ' A' ' 84' ' ' TRP . 30.0 mtmt -99.05 117.35 33.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 109.544 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 13.1 t -116.67 133.25 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 110.763 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -141.49 113.04 7.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 79' ' ' GLY . 5.0 p80 -132.16 -179.29 5.33 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.98 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 68' ' ' ALA . 5.2 mt -124.31 117.43 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.15 120.19 40.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.864 -1.147 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 71' ' ' TYR . 5.4 m -133.54 155.59 49.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.042 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.596 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.27 -163.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.835 -1.165 . . . . 0.0 110.561 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -92.48 106.43 18.42 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.739 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 17.9 m-70 -123.27 -2.83 8.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.7 27.89 73.52 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -107.17 8.97 30.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.54 -0.976 . . . . 0.0 110.11 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 122' ' ' TYR . 75.9 mt -41.23 -43.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.02 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -31.94 72.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' LYS . 2.1 tp10 -76.18 -37.36 57.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.412 -0.805 . . . . 0.0 110.109 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.83 -52.69 64.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.43 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 14.0 ptm -66.55 -35.46 80.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.387 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 55' ' ' MET . 26.8 tt0 -70.15 -36.06 74.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.55 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HG3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -71.0 -35.7 72.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.778 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 59' ' ' LYS . 4.6 pp -97.14 -46.12 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 110.823 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.601 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 13.4 mttt 37.87 -157.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.0 t -103.01 7.8 39.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.029 -1.044 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.89 -40.07 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 33.7 mmt -67.44 166.79 13.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -1.149 . . . . 0.0 110.37 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.3 mtt85 -72.02 97.97 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 110.715 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -52.33 -31.48 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.25 -35.71 71.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.346 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 43.7 tt0 -63.62 -39.1 93.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.567 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' A' ' 58' ' ' LEU . 30.5 t -68.61 -45.75 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -59.18 -47.98 83.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.36 79.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 111.013 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.1 mm-40 -83.92 -23.54 31.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.026 -1.046 . . . . 0.0 111.395 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.442 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 21.9 m-30 -112.86 18.79 17.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.933 -1.104 . . . . 0.0 110.677 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -89.15 112.59 23.63 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.75 -4.95 29.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 80' ' ' GLY . 58.5 p30 -104.67 33.77 3.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.708 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -52.89 -41.01 63.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 110.21 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.56 90.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 mtt85 -85.61 -11.33 54.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.158 -0.964 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 58.21 30.58 19.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.747 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -68.83 -25.6 75.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 74' ' ' ASP . . . -49.73 -34.3 21.12 Favored Glycine 0 N--CA 1.489 2.19 0 O-C-N 121.127 -1.219 . . . . 0.0 110.391 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -134.59 109.21 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.784 -1.421 . . . . 0.0 111.483 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.3 mp -100.48 145.06 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.65 -141.27 4.54 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.536 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.58 ' CE2' ' HD3' ' A' ' 39' ' ' LYS . 77.5 m95 -81.82 100.67 9.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.899 -0.765 . . . . 0.0 109.678 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' MET . 1.8 ptp -139.04 146.66 41.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.011 -1.056 . . . . 0.0 111.149 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -126.3 -0.0 7.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.564 -0.71 . . . . 0.0 109.301 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -90.43 -175.48 4.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.473 ' CA ' ' NE2' ' A' ' 95' ' ' GLN . . . -99.05 124.73 8.32 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.45 -9.98 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.084 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.587 ' HG3' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -136.28 -165.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.77 151.74 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.982 -1.074 . . . . 0.0 111.05 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -169.14 19.81 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 97' ' ' ALA . 40.5 Cg_endo -66.96 -11.23 31.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.161 1.611 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 90' ' ' MET . 0.9 OUTLIER -57.39 -58.38 8.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.107 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 46.4 tt0 -72.1 -40.61 68.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 31.8 tt0 -64.05 -40.53 96.5 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -66.26 -56.03 13.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.124 -0.985 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.72 -47.47 5.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 10.5 m-30 -94.87 17.94 12.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.134 -0.978 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . . . -111.24 -21.9 11.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.4 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.03 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.1 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.505 0.669 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 23.9 p90 -114.31 164.42 13.94 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.333 -0.854 . . . . 0.0 109.687 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.486 HG23 ' CG1' ' A' ' 125' ' ' ILE . 30.4 p -63.5 109.42 1.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 111.654 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 25.8 p-10 -132.66 113.11 13.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.07 166.55 67.19 Favored 'Cis proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.343 0.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.518 ' HB3' HG13 ' A' ' 124' ' ' ILE . 47.5 Cg_endo -71.45 -174.79 1.33 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.086 1.572 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.6 t -101.66 136.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.753 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.411 ' C ' HG22 ' A' ' 118' ' ' THR . 52.9 tttm -110.21 120.12 41.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.855 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.643 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -130.69 170.64 14.05 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -70.25 -14.65 62.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.408 -0.807 . . . . 0.0 110.554 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.643 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -91.57 5.15 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.834 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 126.91 -169.84 18.78 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CE2' HG13 ' A' ' 51' ' ' ILE . 18.1 m-30 -99.59 159.26 15.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -1.083 . . . . 0.0 108.609 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 67.0 m-70 -143.44 110.13 5.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.783 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 4.4 mp -100.52 111.71 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' CB ' ' A' ' 42' ' ' HIS . 33.6 pt -115.67 142.76 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.557 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 tpt -115.11 124.02 50.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 131.08 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.107 -0.996 . . . . 0.0 111.373 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 71.1 mt-10 -141.98 143.56 33.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.51 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 56.9 117.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -113.68 156.68 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -1.216 . . . . 0.0 110.137 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.0 pttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.326 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB1' ' CD ' ' A' ' 131' ' ' LYS . . . -79.13 115.5 18.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.852 -1.155 . . . . 0.0 109.596 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -127.97 160.91 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 8.7 mttt -98.82 128.96 45.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.373 -0.83 . . . . 0.0 109.61 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 72.8 t -109.82 129.97 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.372 -0.83 . . . . 0.0 111.45 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 83.2 mtt180 -120.69 125.14 46.92 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.573 ' CD2' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -134.98 172.61 12.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 0.0 112.351 -178.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HB3' ' A' ' 71' ' ' TYR . 58.9 mt -126.79 116.58 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 4.6 tt -102.56 124.07 47.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.901 -1.124 . . . . 0.0 111.629 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 19.0 m -142.77 160.42 40.35 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.591 ' O ' ' CE2' ' A' ' 122' ' ' TYR . 87.1 mt-10 -71.7 172.31 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.903 -1.123 . . . . 0.0 109.789 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 74.6 tttt -93.12 111.4 23.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.851 -1.156 . . . . 0.0 112.547 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 5.8 m-70 -132.43 9.61 4.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.47 -8.79 77.96 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 51' ' ' ILE . 7.6 tttp -73.81 -15.44 61.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.708 -0.878 . . . . 0.0 109.611 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 122' ' ' TYR . 10.8 tt -40.5 -44.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.798 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.474 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 50.8 ttp -65.38 -42.61 92.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 67.0 tt0 -56.49 -44.19 80.43 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.268 -0.895 . . . . 0.0 109.147 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.37 -60.76 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 59' ' ' LYS . 52.7 ttp -59.93 -33.38 71.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.557 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 45.1 tt0 -62.93 -33.92 76.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 108.793 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' O ' ' SD ' ' A' ' 62' ' ' MET . 16.9 tptt -62.55 -45.68 91.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.493 -0.754 . . . . 0.0 109.185 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 111' ' ' PHE . 1.4 pp -108.76 27.61 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.384 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' MET . 36.4 tttp -54.74 -60.13 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.398 0.618 . . . . 0.0 110.722 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.4 m -81.37 33.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 74.16 25.59 70.66 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.551 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 3.7 ttm -53.79 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.837 -1.39 . . . . 0.0 109.572 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CG ' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -70.69 78.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.998 -1.064 . . . . 0.0 111.288 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' ' SD ' ' A' ' 126' ' ' MET . 5.2 t80 -46.65 -27.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.865 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.565 ' OD1' ' CG ' ' A' ' 63' ' ' ARG . 33.9 p-10 -67.68 -46.91 70.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.219 . . . . 0.0 110.092 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 83.9 mt-10 -63.27 -32.47 73.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 109.496 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' TYR . 45.8 t -61.55 -53.63 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -51.11 -60.5 3.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.952 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.48 19.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.802 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' NE2' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -71.32 -26.71 62.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.541 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 48.6 m-85 -111.04 30.05 7.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.385 -0.822 . . . . 0.0 110.282 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 68' ' ' ALA . 43.4 t -100.21 101.95 13.11 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.095 -1.003 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -101.72 2.25 38.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 15.3 m-20 -116.69 30.75 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.741 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -67.42 -23.86 65.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.78 . . . . 0.0 110.255 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.4 -56.34 21.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.143 -0.973 . . . . 0.0 109.181 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 4.2 ttm180 -96.31 -52.01 4.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.482 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 9.6 pt20 179.96 133.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.656 -0.653 . . . . 0.0 109.866 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.39 96.72 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.96 -85.96 0.1 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 95.5 m-20 -121.19 137.2 54.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -1.169 . . . . 0.0 110.731 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 42' ' ' HIS . 6.9 mp -100.56 163.55 12.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.822 . . . . 0.0 109.577 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.17 -143.68 0.61 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 94.1 m95 -82.78 160.53 22.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.496 -1.002 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -138.13 143.8 40.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.0 109.799 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 11.4 t -131.34 -46.43 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.941 -1.099 . . . . 0.0 111.689 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.514 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -117.48 -5.98 11.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.667 -1.271 . . . . 0.0 112.807 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . 118.65 -168.31 13.21 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 118.949 -1.595 . . . . 0.0 110.611 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' C ' ' HG3' ' A' ' 90' ' ' MET . 26.2 t -125.68 -88.8 0.58 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.614 -0.933 . . . . 0.0 110.708 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' GLY . 65.9 mtm -147.43 -85.49 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.046 -1.034 . . . . 0.0 112.87 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -9.0 -58.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 125.34 -72.43 0.44 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.538 -1.351 . . . . 0.0 109.811 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 38.1 Cg_endo -63.42 -37.14 50.94 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.851 1.448 . . . . 0.0 109.333 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' A' ' 91' ' ' VAL . 74.9 t80 -60.09 -33.78 72.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.561 0.696 . . . . 0.0 109.259 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 38.0 tt0 -75.64 -45.06 39.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.562 -0.711 . . . . 0.0 110.148 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 46.6 mt-10 -55.62 -42.68 75.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.0 110.566 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -81.02 -58.7 2.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.509 -1.37 . . . . 0.0 110.711 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 94' ' ' PHE . . . -50.76 -34.41 27.09 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.83 -1.169 . . . . 0.0 111.859 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -117.9 -46.92 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.558 -1.339 . . . . 0.0 112.435 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -76.26 -11.18 59.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.841 -1.162 . . . . 0.0 111.575 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 4.2 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 120.826 -1.171 . . . . 0.0 109.425 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.514 0.674 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 21.0 t80 -108.72 134.41 51.47 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.466 ' CG2' ' HA ' ' A' ' 115' ' ' PRO . 6.5 m -53.65 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 110.418 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 26.3 p-10 -133.03 113.52 13.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.58 163.3 90.07 Favored 'Cis proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.073 -2.053 . . . . 0.0 110.382 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.474 ' HG2' HG12 ' A' ' 51' ' ' ILE . 46.7 Cg_endo -72.87 -179.66 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.99 1.521 . . . . 0.0 110.054 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.6 161.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.005 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.8 ptmt -129.93 119.46 23.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 39.5 p -122.94 -177.16 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.84 -1.162 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -71.49 -16.69 62.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 0.0 110.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -98.87 27.13 5.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.909 -1.119 . . . . 0.0 109.301 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 103.18 179.69 26.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 52.6 p90 -99.22 159.22 15.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.302 . . . . 0.0 109.797 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.59 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 34.8 m-70 -132.66 140.17 48.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 111' ' ' PHE . 3.7 mp -115.55 136.99 50.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.98 147.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.32 -1.488 . . . . 0.0 112.066 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.562 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 13.6 ttt -127.17 135.09 50.19 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.55 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.938 -1.101 . . . . 0.0 111.077 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -141.69 160.82 39.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.674 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 78.62 81.38 0.69 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.468 ' HD2' ' OXT' ' A' ' 131' ' ' LYS . 8.5 tmm_? -97.1 142.73 28.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 110.402 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.494 ' CD ' ' HB1' ' A' ' 37' ' ' ALA . 9.6 tttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' THR . 12.3 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.083 0.468 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 131' ' ' LYS . . . -131.86 143.42 50.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 0.0 110.684 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 129' ' ' GLY . 7.4 p -142.7 176.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.91 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.535 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -97.04 121.97 39.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.919 -1.113 . . . . 0.0 108.353 178.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 77.2 t -108.2 138.27 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.05 0.929 . . . . 0.0 112.946 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -140.76 117.0 10.63 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 1.2 p80 -138.61 -175.04 3.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.446 -1.409 . . . . 0.0 112.565 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 67' ' ' VAL . 73.8 mt -130.91 114.31 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.3 tt -104.54 117.27 33.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 110.555 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.653 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 41.7 t -142.52 152.06 42.27 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.223 -0.923 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 18.9 pt-20 -52.5 153.63 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 109.372 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 3.1 tptt -127.24 113.44 16.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.84 -1.163 . . . . 0.0 111.79 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.633 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.7 m-70 -133.29 -60.74 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.063 0.935 . . . . 0.0 108.584 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.33 25.71 0.23 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -116.14 -10.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.555 -0.968 . . . . 0.0 110.148 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -51.08 -32.61 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -0.799 . . . . 0.0 110.444 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.485 ' O ' ' HG2' ' A' ' 55' ' ' MET . 40.0 mtp -72.01 -34.02 68.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.975 -1.078 . . . . 0.0 109.553 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -74.51 -32.5 62.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.331 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.427 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.02 -39.94 87.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.643 -0.661 . . . . 0.0 109.986 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.509 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 4.0 ptt? -70.8 -34.19 71.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -0.968 . . . . 0.0 109.676 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 70.4 tt0 -57.72 -50.48 73.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' C ' HG21 ' A' ' 67' ' ' VAL . 34.0 mmtt -71.16 -21.16 62.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.903 . . . . 0.0 108.943 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 64' ' ' PHE . 39.5 tp -75.77 -15.49 60.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.647 -0.658 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 29.1 mmmt -40.0 136.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.816 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -50.01 -30.4 10.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.98 -21.81 25.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.25 157.51 20.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 0.0 110.036 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.526 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 24.3 ttm180 -66.45 105.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 111.192 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 58' ' ' LEU . 34.6 t80 -46.82 -30.42 2.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.62 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.526 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 38.9 t30 -64.11 -43.37 95.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -62.21 -43.21 99.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 58' ' ' LEU . 1.9 t -63.14 -42.73 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.914 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -64.91 -43.62 92.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.46 -48.73 76.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 0.0 110.993 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.4 HE21 ' CA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -72.1 -30.03 64.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.001 -1.062 . . . . 0.0 111.044 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 22.2 m-85 -100.35 15.3 28.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.1 p -73.93 91.9 2.05 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 50.4 tt0 -101.41 10.62 40.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.11 . . . . 0.0 110.283 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' O ' ' CA ' ' A' ' 78' ' ' GLN . 51.7 t0 -110.91 104.9 13.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.13 -42.66 31.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.359 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -38.49 78.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.558 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -111.42 0.42 16.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.334 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER 54.26 91.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 78' ' ' GLN . . . -44.69 100.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 78' ' ' GLN . . . -174.66 -115.5 0.4 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 46.8 p-10 -117.62 142.34 47.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -1.05 . . . . 0.0 110.861 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 6.7 mp -110.47 175.84 5.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.49 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.96 -147.63 9.12 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 23.5 m-90 -98.78 117.3 32.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.724 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 20.6 ptm -130.71 171.72 12.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.036 -1.04 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 14.8 t -101.2 -147.95 0.36 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 33.7 ptt-85 -115.39 119.73 37.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.346 -0.846 . . . . 0.0 110.579 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.7 -157.06 33.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -141.58 52.26 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -1.151 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.6 tpt -100.96 -90.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 109.041 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.565 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -77.84 132.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 108.799 178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.95 -53.49 18.79 Favored Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.654 -0.654 . . . . 0.0 112.997 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.4 Cg_endo -65.01 -42.09 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.276 1.146 . . . . 0.0 111.669 -177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.565 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 56.4 t80 -65.46 -49.18 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.103 -0.998 . . . . 0.0 110.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 12.6 mm100 -72.89 -58.84 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 111.251 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 13.1 mm-40 -53.17 -49.84 65.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.958 -1.089 . . . . 0.0 111.199 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -59.24 -57.98 10.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 0.0 110.35 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.11 -52.76 4.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.647 -0.658 . . . . 0.0 111.183 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.42 10.36 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 110.555 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -87.65 -48.07 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.597 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.409 ' CG1' ' H ' ' A' ' 111' ' ' PHE . 11.9 t . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CD2' ' HB3' ' A' ' 113' ' ' ASP . 5.4 p90 -114.02 168.8 9.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.012 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 114' ' ' PRO . 26.5 m -56.78 -5.73 0.26 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.582 ' HB3' ' CD2' ' A' ' 111' ' ' PHE . 9.2 p-10 -50.74 126.59 24.27 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.027 -1.671 . . . . 0.0 109.378 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' THR . 45.5 Cg_endo -70.1 134.78 31.5 Favored 'Cis proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.287 -1.964 . . . . 0.0 111.124 0.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 123' ' ' HIS . 40.3 Cg_endo -66.22 -174.69 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.054 1.555 . . . . 0.0 111.289 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.12 157.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.648 . . . . 0.0 109.899 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -113.56 118.21 33.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.601 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 30.0 p -130.73 170.98 13.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 110.623 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.35 -17.69 63.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 110.224 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.601 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.6 OUTLIER -98.26 24.36 7.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.215 -0.928 . . . . 0.0 109.357 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 98.06 174.43 33.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 5.3 p90 -98.49 152.0 20.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.378 -1.072 . . . . 0.0 108.567 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.61 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 3.4 m-70 -131.28 141.48 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.825 -1.172 . . . . 0.0 113.053 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.514 ' CD1' HD21 ' A' ' 58' ' ' LEU . 57.9 mt -115.51 112.93 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 111' ' ' PHE . 25.0 mt -102.01 144.88 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.665 -1.272 . . . . 0.0 111.065 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ARG . 7.6 tpt -121.12 111.66 17.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.9 t -94.96 102.19 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.036 -1.04 . . . . 0.0 111.65 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 88.3 tt0 -144.66 135.02 24.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.483 ' O ' HG21 ' A' ' 38' ' ' VAL . . . 107.14 132.84 7.08 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.12 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -107.74 169.25 8.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.386 -1.067 . . . . 0.0 110.323 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 37' ' ' ALA . 45.2 mtmt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.354 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' HB ' ' A' ' 86' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.395 0.617 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.13 155.47 20.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.361 -0.837 . . . . 0.0 109.161 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.65 156.69 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.024 -1.048 . . . . 0.0 110.517 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HD2' ' NE1' ' A' ' 84' ' ' TRP . 1.5 mppt? -100.06 126.27 46.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.098 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -125.38 113.49 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.009 . . . . 0.0 111.57 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HA ' ' CB ' ' A' ' 81' ' ' ASP . 15.3 mtp180 -114.33 115.75 27.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.839 . . . . 0.0 108.819 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 3.7 p80 -138.14 160.81 38.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.968 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.594 ' CG1' HG22 ' A' ' 124' ' ' ILE . 27.3 pt -116.89 124.53 73.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.2 tt -108.53 129.96 55.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.585 . . . . 0.0 111.055 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 32.6 t -142.62 165.42 27.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 83.0 mt-10 -69.13 154.1 42.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 26.9 tttm -87.88 116.62 26.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.76 -1.212 . . . . 0.0 112.834 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.58 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.5 m-70 -131.32 9.08 4.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.502 -0.749 . . . . 0.0 109.268 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.14 41.91 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -88.52 9.09 25.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.489 -1.006 . . . . 0.0 110.378 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.5 mt -48.8 -59.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.906 -1.121 . . . . 0.0 110.0 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.463 ' HA ' ' SD ' ' A' ' 55' ' ' MET . 72.3 mtm -69.06 -28.12 66.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.771 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -73.98 -42.47 60.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.784 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.31 79.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.506 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.52 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 25.2 ptm -63.7 -46.18 86.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.995 . . . . 0.0 110.467 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 55' ' ' MET . 79.0 tt0 -56.6 -33.46 66.26 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.041 -1.037 . . . . 0.0 110.161 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' A' ' 67' ' ' VAL . 66.1 tttt -77.72 -27.78 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.738 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' O ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -104.59 16.18 26.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.871 -1.143 . . . . 0.0 110.582 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 58' ' ' LEU . 38.5 mttm -50.65 -161.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.507 -0.745 . . . . 0.0 110.438 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.2 m -87.0 154.49 20.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.574 -1.329 . . . . 0.0 110.931 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.41 -3.83 86.32 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -113.89 -168.39 1.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.065 -1.256 . . . . 0.0 110.862 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 13.5 mtm180 -95.71 95.34 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.411 -0.805 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -50.65 -35.51 31.07 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.121 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 21.8 p-10 -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.797 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.7 tt0 -58.52 -49.02 78.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG11 ' CD2' ' A' ' 71' ' ' TYR . 59.1 t -62.94 -52.27 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.922 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -45.2 -50.09 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.44 76.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 110.399 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.466 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.4 tp60 -74.38 -26.05 59.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.995 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' A' ' 67' ' ' VAL . 20.8 m-85 -109.89 17.47 21.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.109 . . . . 0.0 110.483 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.5 t -82.1 97.5 8.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.998 -1.064 . . . . 0.0 110.4 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -100.52 1.39 40.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.378 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 78' ' ' GLN . 4.0 m-20 -114.07 23.28 13.08 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.459 -0.776 . . . . 0.0 109.538 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -56.6 -35.49 68.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -39.24 68.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.891 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -106.4 -53.3 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.851 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . 54.3 mm-40 -141.01 -80.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 110.05 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.46 24.43 76.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -144.32 -104.8 0.48 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.537 ' CB ' ' HA ' ' A' ' 41' ' ' ARG . 27.3 p-10 -128.13 171.77 11.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -1.133 . . . . 0.0 110.322 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 9.1 mp -100.51 16.91 23.11 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.358 -0.838 . . . . 0.0 109.092 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.29 -134.12 33.26 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.523 ' NE1' ' HD2' ' A' ' 39' ' ' LYS . 3.4 m-90 -87.37 125.99 34.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.842 -0.799 . . . . 0.0 109.542 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 88' ' ' GLY . 8.6 ttm -137.65 140.86 41.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' ' ND2' ' A' ' 36' ' ' ASN . 76.5 p -111.4 -33.03 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.438 -0.789 . . . . 0.0 109.979 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -66.71 -31.32 71.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.435 -0.791 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 99' ' ' PHE . . . 147.79 -107.01 0.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -143.22 -65.78 0.38 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.403 -1.057 . . . . 0.0 109.502 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.56 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 23.0 mtp -144.08 -77.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.762 . . . . 0.0 110.951 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -175.09 166.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 0.0 110.936 -179.138 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . 68.36 -143.65 41.2 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.16 -35.92 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.104 1.581 . . . . 0.0 109.284 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 89' ' ' SER . 50.5 t80 -51.17 -30.52 17.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.475 ' OE1' ' HA3' ' A' ' 88' ' ' GLY . 16.7 tp60 -83.01 -54.68 4.88 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.597 0.713 . . . . 0.0 109.225 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.61 -45.26 92.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.615 -0.678 . . . . 0.0 110.215 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.44 -52.4 53.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 110.161 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -41.7 -53.88 3.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CZ ' ' HA2' ' A' ' 88' ' ' GLY . 4.0 m-30 -81.43 -0.84 43.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.412 -0.805 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.25 21.15 6.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.87 -1.144 . . . . 0.0 111.927 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.586 ' CD2' ' HA ' ' A' ' 98' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.576 -1.327 . . . . 0.0 110.861 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.405 0.621 . . . . 0.0 109.779 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 113' ' ' ASP . 38.0 p90 -114.57 164.39 14.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.8 p -74.43 117.4 16.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.515 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.57 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.5 p-10 -132.58 122.98 18.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 109.574 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.5 Cg_endo -69.07 170.27 56.31 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.232 0.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.449 ' HB3' ' CB ' ' A' ' 124' ' ' ILE . 47.5 Cg_endo -73.57 -175.93 2.29 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.146 1.603 . . . . 0.0 110.081 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 123' ' ' HIS . 11.4 m -100.94 147.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 109.503 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -118.02 128.59 54.92 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.614 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 77.1 p -131.63 174.4 10.15 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -67.96 -16.95 64.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 1.2 p90 -96.67 28.19 3.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 105.38 -166.13 14.35 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 31.6 p90 -116.57 152.79 33.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.39 -1.065 . . . . 0.0 109.905 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 2.2 m-70 -134.74 136.23 42.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.966 -1.084 . . . . 0.0 112.346 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.594 HG22 ' CG1' ' A' ' 43' ' ' ILE . 19.0 tt -121.17 108.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 24.9 pt -107.4 157.34 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.935 -1.103 . . . . 0.0 113.289 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 3.9 ttt -121.46 124.6 44.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 127' ' ' VAL . 16.3 m -109.74 120.88 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.649 -1.282 . . . . 0.0 111.903 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 129' ' ' GLY . 46.3 tt0 -115.29 149.21 38.19 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 48.22 95.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -131.56 150.7 52.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -1.0 . . . . 0.0 109.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.081 . . . . 0.0 110.16 -179.783 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' C ' HG21 ' A' ' 86' ' ' THR . 45.7 t30 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' CB ' ' OG1' ' A' ' 86' ' ' THR . . . -100.69 159.2 15.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.52 -0.737 . . . . 0.0 109.282 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG11 ' CE1' ' A' ' 99' ' ' PHE . 2.7 p -143.3 154.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.53 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.8 ttpt -98.49 125.4 43.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 74.5 t -121.97 132.56 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.833 -177.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.2 mtt180 -120.16 130.91 54.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.615 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 2.7 p80 -143.81 170.34 16.06 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.971 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.589 HG12 ' CE2' ' A' ' 71' ' ' TYR . 2.5 tt -124.32 113.77 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 8.1 tt -107.64 119.43 39.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 53.8 t -141.36 150.64 42.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.573 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 30.2 mt-10 -53.68 168.25 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 108.888 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' C ' ' CD2' ' A' ' 48' ' ' HIS . 8.6 ttmt -99.03 115.22 28.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.594 -1.316 . . . . 0.0 113.021 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 2.7 m80 -134.73 20.57 3.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.607 . . . . 0.0 109.651 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.14 11.92 83.84 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 tttm -81.2 5.22 17.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.958 . . . . 0.0 110.401 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.565 HD11 ' CB ' ' A' ' 122' ' ' TYR . 14.3 mm -51.22 -44.58 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 96.7 mtp -69.25 -43.16 74.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.818 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.77 -57.35 13.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 0.0 110.526 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -55.53 -55.82 27.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 9.8 ptt? -60.84 -41.25 95.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.049 . . . . 0.0 110.3 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 55' ' ' MET . 81.9 tt0 -52.86 -50.18 64.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.925 -1.109 . . . . 0.0 109.173 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 62' ' ' MET . 12.9 ttmt -74.13 -28.64 61.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -0.768 . . . . 0.0 109.466 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -57.98 -24.52 58.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.401 -0.812 . . . . 0.0 109.229 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 58' ' ' LEU . 16.3 tptt -22.37 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.41 0.624 . . . . 0.0 112.082 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLY . 53.9 p -50.68 -52.29 41.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.394 -0.816 . . . . 0.0 109.63 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 60' ' ' SER . . . -45.0 -36.12 4.9 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 33.8 mmt -82.68 149.86 27.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -1.098 . . . . 0.0 110.315 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.544 ' HG3' ' CB ' ' A' ' 66' ' ' GLU . 1.3 ptm180 -73.55 106.54 5.37 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.961 0.886 . . . . 0.0 110.583 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.531 ' CD2' HD11 ' A' ' 58' ' ' LEU . 9.0 t80 -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.484 0.659 . . . . 0.0 110.484 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.91 -56.88 16.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 111.075 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.544 ' CB ' ' HG3' ' A' ' 63' ' ' ARG . 10.5 tp10 -55.81 -41.14 73.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.118 -0.989 . . . . 0.0 110.966 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.593 HG13 ' CE1' ' A' ' 71' ' ' TYR . 71.4 t -52.61 -59.09 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.748 -1.22 . . . . 0.0 109.803 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . . . -64.94 -54.87 23.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -42.07 -27.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.413 -0.804 . . . . 0.0 109.838 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 3.7 tp60 -80.59 -62.85 1.55 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 109.992 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CE1' HG13 ' A' ' 67' ' ' VAL . 50.9 p90 -109.96 51.16 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.606 -1.308 . . . . 0.0 111.084 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 31.1 t -89.83 131.14 35.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.248 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 68.4 mm-40 -102.4 -3.15 27.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.886 -1.134 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 78' ' ' GLN . 84.6 m-20 -104.6 26.89 8.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.922 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.77 -19.96 64.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.895 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -75.14 -29.82 60.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.092 -1.005 . . . . 0.0 110.802 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 55.9 mtt180 -118.62 -25.33 6.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.534 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 170.07 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.04 98.95 0.81 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.9 -103.8 0.25 Allowed Glycine 0 N--CA 1.491 2.333 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.2 m-20 -97.21 162.2 13.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -1.092 . . . . 0.0 110.739 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.615 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 1.3 mp -101.64 -35.69 9.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 117.84 -161.99 13.2 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.482 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 17.1 m-90 -98.6 115.64 29.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.891 -0.77 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 ptm -134.78 138.24 44.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 110.208 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 37' ' ' ALA . 93.3 m -104.14 -14.08 16.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.473 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 88' ' ' GLY . 27.6 ttt180 -100.0 -72.29 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 111.125 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . 44.83 66.41 1.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.459 ' O ' ' HE2' ' A' ' 90' ' ' MET . 64.6 p -120.44 66.3 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -1.092 . . . . 0.0 110.432 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.459 ' HE2' ' O ' ' A' ' 89' ' ' SER . 37.1 mmt -107.95 -49.06 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.554 HG12 ' HD2' ' A' ' 93' ' ' PRO . 72.0 t -114.02 153.96 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.912 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 91' ' ' VAL . . . -72.81 -64.77 2.47 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 121.2 -0.937 . . . . 0.0 111.062 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.554 ' HD2' HG12 ' A' ' 91' ' ' VAL . 37.0 Cg_endo -60.89 -30.9 90.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.71 1.374 . . . . 0.0 112.104 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 51.1 t80 -68.93 -40.67 78.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.738 -1.226 . . . . 0.0 110.426 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 89' ' ' SER . 42.1 tt0 -72.86 -30.99 64.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.298 -0.876 . . . . 0.0 110.651 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 7.5 mm-40 -62.24 -26.51 68.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.82 . . . . 0.0 111.025 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.02 -54.63 3.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 111.315 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.41 -47.02 76.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.125 -0.984 . . . . 0.0 111.594 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' HG11 ' A' ' 38' ' ' VAL . 1.8 m-85 -96.04 -8.63 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 111.544 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -130.33 25.88 5.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.698 -1.251 . . . . 0.0 111.89 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 127' ' ' VAL . 14.7 tp . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.712 -1.243 . . . . 0.0 109.373 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.646 0.736 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 125' ' ' ILE . 39.3 p90 -123.2 164.33 18.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.6 p -50.43 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -122.32 116.85 29.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.931 . . . . 0.0 109.756 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.72 164.33 82.27 Favored 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.987 -2.089 . . . . 0.0 110.535 0.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HG2' HG21 ' A' ' 51' ' ' ILE . 43.5 Cg_endo -70.85 -176.25 1.72 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.967 1.509 . . . . 0.0 110.291 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.69 155.08 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.988 . . . . 0.0 110.402 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.458 ' HE2' HG13 ' A' ' 51' ' ' ILE . 38.8 ttmt -124.03 127.4 47.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.53 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.577 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 38.9 p -138.81 -175.85 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.945 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -71.74 -35.09 70.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CE1' ' OG1' ' A' ' 118' ' ' THR . 1.4 p90 -80.03 7.54 8.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.014 -1.054 . . . . 0.0 109.956 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 118' ' ' THR . . . 117.48 175.82 17.24 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.565 ' CB ' HD11 ' A' ' 51' ' ' ILE . 55.6 p90 -101.67 151.72 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -1.056 . . . . 0.0 109.453 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 2.2 m-70 -132.23 140.68 48.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.867 -1.146 . . . . 0.0 111.95 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 8.0 tt -118.46 106.22 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 14.8 pt -115.07 149.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.492 -1.38 . . . . 0.0 112.695 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 26.1 ptm -122.46 145.53 48.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.49 HG23 HD21 ' A' ' 101' ' ' LEU . 6.3 m -114.78 101.16 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.951 -1.093 . . . . 0.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 76.3 tt0 -143.59 87.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 110.486 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 39' ' ' LYS . . . 162.27 115.68 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.546 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.408 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 72.3 ttt180 -130.35 157.3 42.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -1.037 . . . . 0.0 109.533 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.5 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.129 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' CB ' ' OG1' ' A' ' 86' ' ' THR . . . -105.01 -156.53 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.281 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 2.4 p -139.21 161.15 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HE3' ' CZ2' ' A' ' 84' ' ' TRP . 47.1 mttt -99.61 111.55 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.885 -1.135 . . . . 0.0 109.309 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.48 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 46.3 mtt-85 -111.86 125.73 54.34 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 0.6 OUTLIER -138.47 162.63 34.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.441 -1.412 . . . . 0.0 112.609 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 10.0 pt -129.85 137.64 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' CD1' ' OD2' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -107.74 131.56 54.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 111.1 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 71' ' ' TYR . 62.5 m -126.76 168.73 14.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 73.4 tt0 -74.04 158.91 33.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.0 ttpt -96.41 96.02 8.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.043 -1.036 . . . . 0.0 110.565 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 2.2 p-80 -132.71 6.82 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.554 -0.716 . . . . 0.0 110.009 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.77 2.37 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -114.72 10.87 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -1.185 . . . . 0.0 110.271 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 HG21 ' CG ' ' A' ' 115' ' ' PRO . 60.0 mt -53.63 -49.33 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.454 -0.779 . . . . 0.0 111.026 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.6 mmm -65.31 -50.68 64.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.987 . . . . 0.0 110.989 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.02 -42.88 99.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.948 . . . . 0.0 111.334 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB1' ' CE ' ' A' ' 50' ' ' LYS . . . -61.38 -50.41 72.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.372 -0.83 . . . . 0.0 112.198 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.544 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 3.5 ptt? -65.48 -37.74 87.73 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.802 -1.186 . . . . 0.0 111.718 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.558 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 60.7 tt0 -65.39 -46.09 81.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -63.58 -34.19 77.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.962 -1.086 . . . . 0.0 108.594 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD23 ' CG2' ' A' ' 124' ' ' ILE . 13.6 tp -71.59 -35.5 70.56 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.558 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 12.9 mttp 46.38 -92.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.504 -0.747 . . . . 0.0 111.161 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' LEU . 75.6 p -122.59 -3.61 8.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.147 -0.971 . . . . 0.0 110.976 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 -9.06 13.8 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 38.6 mmt -50.8 -34.95 29.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -1.159 . . . . 0.0 110.056 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -113.45 27.02 9.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.115 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.563 ' CD1' ' HE1' ' A' ' 126' ' ' MET . 8.9 t80 -53.11 -46.1 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 0.0 109.841 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 47.9 t30 -60.31 -40.3 90.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.601 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -65.25 -58.36 6.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 71.1 t -60.44 -63.23 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . . . -46.29 -42.46 14.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' ASN . . . -49.5 -56.15 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 109.935 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.545 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 8.2 mm-40 -90.04 -0.01 57.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 5.7 m-85 -104.33 3.16 32.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 110.382 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.2 t -99.89 93.65 5.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 0.0 109.729 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 24.6 mp0 -106.27 9.78 31.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.19 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.547 ' OD2' ' CD1' ' A' ' 44' ' ' LEU . 80.8 m-20 -117.29 46.17 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -66.15 -14.71 62.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.72 -37.07 42.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 111.363 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -121.99 15.66 10.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 111.599 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' CD ' ' NE2' ' A' ' 42' ' ' HIS . 0.5 OUTLIER -159.99 154.77 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.792 -1.193 . . . . 0.0 110.687 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.93 9.84 13.98 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 103.39 -52.98 0.75 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 41' ' ' ARG . 93.2 m-20 -115.44 137.94 51.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -1.085 . . . . 0.0 109.68 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 85' ' ' MET . 0.7 OUTLIER -100.52 -13.96 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 109.986 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 89.95 -115.62 4.6 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.356 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 79.5 m95 -89.46 133.56 34.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.989 . . . . 0.0 111.502 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.527 ' HE3' ' NE2' ' A' ' 95' ' ' GLN . 22.8 ttt -122.59 124.81 44.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.542 ' OG1' ' CB ' ' A' ' 37' ' ' ALA . 1.2 m -134.92 -47.22 0.73 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.974 -1.079 . . . . 0.0 112.172 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' CG ' HG23 ' A' ' 86' ' ' THR . 11.8 mtt180 -103.06 -88.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.69 -1.256 . . . . 0.0 111.744 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . -138.18 151.79 21.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 90' ' ' MET . 9.9 p -143.78 -53.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.273 . . . . 0.0 111.143 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.564 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 57.5 mmm -107.69 -98.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 111.362 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.587 HG21 ' CE1' ' A' ' 120' ' ' PHE . 5.4 t -129.23 174.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.909 -1.119 . . . . 0.0 111.448 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.515 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -42.23 -54.16 4.67 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.746 -0.596 . . . . 0.0 112.284 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 97' ' ' ALA . 43.5 Cg_endo -67.7 -19.75 47.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.459 1.242 . . . . 0.0 111.712 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HB2' ' A' ' 90' ' ' MET . 42.6 t80 -79.6 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.797 -1.19 . . . . 0.0 110.107 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.527 ' NE2' ' HE3' ' A' ' 85' ' ' MET . 28.4 mm100 -70.99 -38.23 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 4.7 mm-40 -70.75 -33.98 71.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -69.7 -48.15 60.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.148 -0.97 . . . . 0.0 110.574 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.0 97.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 111.291 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.82 0.3 57.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.013 -1.054 . . . . 0.0 111.563 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -127.04 4.89 6.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.771 -1.206 . . . . 0.0 111.186 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 112' ' ' THR . 41.4 tp . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.906 -1.121 . . . . 0.0 109.842 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.412 0.625 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CZ ' ' CE ' ' A' ' 126' ' ' MET . 19.1 m-30 -101.42 171.18 7.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.519 -0.738 . . . . 0.0 110.039 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.525 ' OG1' HG12 ' A' ' 125' ' ' ILE . 65.0 m -65.18 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 111.802 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.66 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 99.0 m-20 -93.39 -24.93 0.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 42.5 Cg_endo -71.04 -27.36 7.5 Favored 'Cis proline' 0 N--CA 1.493 1.442 0 C-N-CA 124.306 -1.122 . . . . 0.0 114.484 1.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 51.5 Cg_endo -80.92 130.68 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 122.404 0.686 . . . . 0.0 112.576 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 60.6 t -98.66 143.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.479 ' O ' ' CG ' ' A' ' 117' ' ' LYS . 11.9 ptpt -102.51 108.55 19.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.53 -0.731 . . . . 0.0 111.065 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.629 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 19.4 p -136.84 158.37 44.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -65.82 -13.62 59.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.629 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.6 p90 -100.41 21.56 12.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.78 -1.2 . . . . 0.0 110.039 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 112.66 -169.9 13.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.527 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 33.7 m-85 -105.68 156.61 18.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 109.25 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 60.8 m-70 -135.16 128.57 32.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 112.199 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.537 ' CG2' HD23 ' A' ' 58' ' ' LEU . 95.7 mt -117.93 102.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.525 HG12 ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -106.78 152.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.468 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.634 ' CE ' ' CZ ' ' A' ' 111' ' ' PHE . 20.3 mtt -124.17 136.21 54.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.69 139.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.888 -1.133 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -117.39 -37.57 3.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 110.46 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -145.64 121.6 1.53 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 41.5 ttt180 -110.25 149.4 30.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -1.132 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.128 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.288 0.566 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' CB ' ' OG1' ' A' ' 86' ' ' THR . . . -90.63 -170.54 2.75 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 85' ' ' MET . 1.6 p -143.46 151.62 16.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.724 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HG3' ' CE3' ' A' ' 84' ' ' TRP . 49.7 mtmt -99.27 129.6 45.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 109.257 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 82' ' ' LEU . 5.0 p -139.34 139.39 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.02 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.1 mtt-85 -110.74 122.5 47.97 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 80' ' ' GLY . 3.7 p80 -138.27 148.25 44.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.821 -1.174 . . . . 0.0 111.501 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.569 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 19.4 mt -102.7 119.35 50.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 120' ' ' PHE . 4.4 tt -101.79 116.31 32.44 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 41.8 t -129.0 163.56 25.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.546 -0.721 . . . . 0.0 109.642 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 32.0 mt-10 -71.55 -178.91 2.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.598 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . 22.7 tttm -97.0 104.27 16.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.024 -1.048 . . . . 0.0 112.639 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.61 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.9 m-70 -133.13 0.42 3.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.254 -0.904 . . . . 0.0 110.504 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 122' ' ' TYR . . . 94.03 11.77 57.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' ILE . 98.0 mttt -85.56 3.85 38.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.253 -1.145 . . . . 0.0 110.739 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 122' ' ' TYR . 67.8 mt -42.28 -53.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 98.5 mmm -66.01 -45.19 82.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.144 -0.972 . . . . 0.0 110.637 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.28 -48.1 81.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.781 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.452 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -59.0 -61.19 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.539 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.526 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 3.9 ppp? -63.19 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 110.712 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 52' ' ' MET . 39.5 tp10 -71.54 -28.25 63.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.073 -1.017 . . . . 0.0 110.016 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -74.65 -34.77 62.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 110.372 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 3.7 pp -91.56 -16.98 26.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.3 mtpt 43.45 -135.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.551 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 100.0 p -57.26 -24.98 58.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.138 -0.976 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.03 9.92 2.94 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtp -50.73 -44.79 58.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.892 -1.357 . . . . 0.0 109.723 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 65.0 mtt-85 -114.24 38.82 2.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.455 -0.778 . . . . 0.0 109.702 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -52.55 -49.98 63.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.371 -0.831 . . . . 0.0 110.341 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 16.9 p30 -61.88 -42.26 98.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 39.5 mm-40 -59.25 -50.93 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.052 -1.03 . . . . 0.0 108.993 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 58' ' ' LEU . 92.4 t -57.5 -52.42 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 0.0 109.817 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.485 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -60.12 -40.57 90.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -49.89 -44.99 50.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.483 -0.761 . . . . 0.0 110.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 14.7 mm-40 -94.89 -11.79 28.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.529 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 32.9 m-85 -117.81 25.75 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 111.1 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 t -103.68 115.43 30.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.927 -1.108 . . . . 0.0 110.214 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -100.34 -7.51 24.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.488 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 m-20 -104.92 23.7 13.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.491 -0.755 . . . . 0.0 109.065 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -49.89 -32.17 13.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.63 88.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 16.4 mtt-85 -112.09 -45.22 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.125 -0.984 . . . . 0.0 110.274 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mp0 -118.91 149.56 41.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.09 13.23 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 101.58 -5.91 54.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 36.5 p-10 -124.84 140.5 52.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -1.204 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 63.3 tp -110.6 127.8 55.39 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.06 -1.025 . . . . 0.0 109.484 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -59.3 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 39' ' ' LYS . 98.3 m95 -80.31 142.21 34.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -1.017 . . . . 0.0 110.727 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.541 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 19.2 ttt -128.89 121.81 28.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.619 -0.676 . . . . 0.0 109.269 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.511 ' OG1' ' CB ' ' A' ' 37' ' ' ALA . 1.1 m -118.28 -46.65 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.732 -1.23 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -100.41 -54.48 2.85 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.005 . . . . 0.0 110.502 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA2' ' HE2' ' A' ' 85' ' ' MET . . . 160.74 -165.73 35.22 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -133.19 -75.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.513 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 41.7 mtp -140.37 -80.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.081 -1.012 . . . . 0.0 110.74 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.47 HG12 ' HD2' ' A' ' 93' ' ' PRO . 97.3 t -50.69 127.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.62 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.58 -51.48 30.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 38.9 Cg_endo -65.15 -8.78 19.49 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.461 1.243 . . . . 0.0 110.817 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.454 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 46.9 t80 -80.56 -46.17 16.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.04 . . . . 0.0 109.014 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.45 ' NE2' ' HA3' ' A' ' 88' ' ' GLY . 19.9 mt-30 -68.52 -30.72 69.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 92' ' ' GLY . 79.9 mm-40 -54.41 -40.73 68.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -77.75 -51.08 11.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.55 -53.0 15.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -77.03 -17.48 58.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.407 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' ALA . . . -58.76 -44.68 90.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.99 -1.069 . . . . 0.0 109.253 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.468 HD13 HG23 ' A' ' 127' ' ' VAL . 69.4 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.367 -0.833 . . . . 0.0 109.396 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 45.6 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.255 0.55 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 113' ' ' ASP . 50.5 p90 -123.21 157.06 33.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 0.0 110.139 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.452 ' CG2' ' HB ' ' A' ' 125' ' ' ILE . 77.3 p -56.86 109.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 110.642 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 22.3 p-10 -132.33 124.14 19.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.763 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 44.8 Cg_endo -70.79 164.74 81.43 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.208 0.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.436 ' HB3' HG23 ' A' ' 124' ' ' ILE . 46.3 Cg_endo -72.55 -178.5 3.41 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.085 1.571 . . . . 0.0 109.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 3.7 m -99.61 146.3 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.053 . . . . 0.0 109.396 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HG3' ' CD1' ' A' ' 122' ' ' TYR . 40.1 ttpt -120.83 134.58 55.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.006 -1.059 . . . . 0.0 110.46 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.32 -164.29 1.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -0.88 . . . . 0.0 109.75 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -73.37 -45.91 52.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.992 . . . . 0.0 112.059 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.757 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 6.8 p90 -53.6 -41.62 66.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.065 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.673 ' N ' ' CG ' ' A' ' 120' ' ' PHE . . . 164.81 -124.4 1.25 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -177.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' OH ' ' HG3' ' A' ' 47' ' ' LYS . 15.7 m-85 -133.41 162.53 31.59 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.81 -1.406 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.757 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 97.6 m-70 -137.58 110.63 7.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.308 -0.87 . . . . 0.0 111.071 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.569 ' CG1' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.05 118.57 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 3.4 mp -105.78 134.89 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.902 -1.124 . . . . 0.0 113.505 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 tpt -118.23 121.76 41.27 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.468 HG23 HD13 ' A' ' 101' ' ' LEU . 17.0 t -92.8 144.14 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.808 -1.183 . . . . 0.0 111.389 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.2 -48.25 3.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.8 . . . . 0.0 110.234 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.14 149.25 16.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.18 157.2 44.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -1.134 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 pttt . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.083 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.368 0.604 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -99.44 155.37 17.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 30.4 m -138.63 158.16 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -100.54 122.48 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.724 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 7.9 p -124.22 162.62 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.917 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 126' ' ' MET . 41.1 ttm180 -143.17 128.2 18.52 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 1.9 p80 -140.29 175.15 9.83 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.151 -1.593 . . . . 0.0 113.173 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 36.0 mt -128.55 125.15 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.581 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.3 tt -105.56 131.38 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 110.566 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 20.0 m -142.85 162.33 35.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.914 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.585 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 85.4 mt-10 -75.91 161.44 28.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 79.5 tttt -72.58 119.5 16.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.195 -0.941 . . . . 0.0 111.692 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.585 ' CE1' ' CB ' ' A' ' 46' ' ' GLU . 12.3 m-70 -133.32 -1.57 3.19 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.42 -0.8 . . . . 0.0 110.45 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.58 81.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HG2' ' HB2' ' A' ' 48' ' ' HIS . 21.7 ptmt -107.34 15.46 24.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.478 -1.013 . . . . 0.0 109.948 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.475 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 3.9 mp -46.66 -52.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.386 -0.822 . . . . 0.0 110.44 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.3 ttp -53.95 -38.29 64.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 88.6 mt-10 -70.4 -39.13 74.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -59.04 6.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.454 ' HA ' HD22 ' A' ' 58' ' ' LEU . 22.9 ptm -59.01 -33.26 70.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.918 . . . . 0.0 110.171 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' O ' ' CD ' ' A' ' 59' ' ' LYS . 33.8 tp10 -72.93 -32.96 65.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 110.189 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 24.4 mmtp -63.54 -50.74 68.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 55' ' ' MET . 3.2 pp -73.65 -20.26 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' CD ' ' O ' ' A' ' 56' ' ' GLU . 28.9 mmmt 53.66 -137.31 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.878 . . . . 0.0 110.781 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -52.35 -39.14 60.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.485 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.45 2.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.429 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 16.1 ptp -51.88 -35.44 45.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' N ' ' CG ' ' A' ' 62' ' ' MET . 25.8 mtt180 -101.5 9.19 41.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 110.163 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -44.35 -48.73 9.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.05 -39.22 77.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.233 -0.917 . . . . 0.0 109.849 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.23 -40.84 74.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.602 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 71' ' ' TYR . 42.2 t -67.17 -49.16 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.443 -0.786 . . . . 0.0 110.044 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -58.22 -54.74 43.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.138 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.68 -51.26 16.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.4 mm-40 -75.7 -15.58 60.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 110.101 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' CD2' HG11 ' A' ' 67' ' ' VAL . 15.1 m-30 -111.14 18.32 19.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.454 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ALA . 19.4 p -79.48 93.56 5.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.015 -1.053 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 45' ' ' CYS . 3.5 mp0 -108.95 8.26 26.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 4.3 p30 -112.12 37.08 3.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -48.81 -31.05 6.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.01 -39.21 51.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -91.19 4.91 51.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.306 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 51.18 51.41 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.958 . . . . 0.0 109.592 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.454 ' HA3' ' CG ' ' A' ' 74' ' ' ASP . . . -78.06 115.32 4.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.66 -122.79 0.64 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 40.4 p-10 -86.71 131.55 34.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.128 -1.219 . . . . 0.0 109.007 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.596 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 7.2 mp -102.91 162.77 12.66 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.987 -1.071 . . . . 0.0 110.226 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -93.37 -135.39 7.43 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 13.3 m-90 -96.38 133.03 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.968 -0.725 . . . . 0.0 110.8 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -140.52 168.35 20.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.738 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.8 p -128.02 -125.48 0.22 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.301 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -113.91 174.76 5.77 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.915 -1.116 . . . . 0.0 109.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.89 56.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 t -110.36 -29.51 8.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -1.125 . . . . 0.0 110.098 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 95' ' ' GLN . 2.1 ptt? -126.35 176.7 6.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.409 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 19.3 m -68.44 -174.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.354 -0.841 . . . . 0.0 110.76 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.606 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -77.61 -47.38 8.85 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 121.468 -0.77 . . . . 0.0 111.897 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.9 Cg_endo -65.52 -46.77 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.064 1.033 . . . . 0.0 110.986 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.56 -39.88 88.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.938 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 34.9 tt0 -69.64 -44.39 70.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 34.2 tt0 -51.36 -26.83 8.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.38 -38.25 13.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.247 -0.908 . . . . 0.0 110.479 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.57 99.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.399 -0.813 . . . . 0.0 111.642 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -101.39 -12.85 18.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.162 . . . . 0.0 111.788 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -113.1 8.91 18.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.734 -1.229 . . . . 0.0 111.021 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 2.6 pt? . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.038 . . . . 0.0 109.575 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 111' ' ' PHE . 62.2 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.879 0.371 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 46.3 p90 -108.52 169.39 8.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 110.962 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 125' ' ' ILE . 25.3 m -70.07 116.45 10.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.506 -0.746 . . . . 0.0 110.919 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.564 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 22.7 p-10 -133.85 112.78 12.59 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.33 160.2 94.23 Favored 'Cis proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.153 -2.02 . . . . 0.0 110.36 -0.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 46.0 Cg_endo -72.86 -175.86 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.957 1.504 . . . . 0.0 109.908 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.1 m -102.25 146.53 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.274 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -114.53 138.05 51.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 108.975 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.602 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 81.1 p -136.39 -173.9 3.54 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.708 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.36 -11.23 59.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -104.38 11.01 35.15 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.736 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.79 -167.1 12.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 45.6 p90 -108.86 157.91 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.315 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.604 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 12.2 m-70 -133.72 140.54 47.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 111.419 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 19.9 tt -128.04 111.21 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 28.8 pt -108.62 161.2 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.789 -1.194 . . . . 0.0 111.836 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.548 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 39.5 mtm -128.05 143.88 51.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.37 128.59 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.981 -1.074 . . . . 0.0 110.552 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -144.26 -38.08 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.985 -1.072 . . . . 0.0 111.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . -89.26 88.32 1.51 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.418 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -118.66 135.89 54.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -1.167 . . . . 0.0 110.04 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.289 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 57.9 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.16 0.505 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 86' ' ' THR . . . -59.9 139.43 57.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.534 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 28.8 m -147.02 165.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.507 -0.746 . . . . 0.0 111.298 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -97.06 126.32 42.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.11 134.05 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.867 -1.145 . . . . 0.0 112.226 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 48.2 mtm-85 -114.15 126.03 54.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -133.51 151.47 51.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.535 -1.353 . . . . 0.0 112.231 -178.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 71' ' ' TYR . 86.3 mt -113.4 126.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -113.99 121.17 43.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 110.934 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 19.4 p -132.95 177.52 7.59 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.635 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 74.3 mm-40 -64.14 158.16 23.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.573 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.626 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 5.0 ttmt -101.84 73.17 1.4 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.942 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 30.0 m80 -135.12 51.55 2.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 111.728 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.52 -10.35 55.82 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.759 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -71.15 -15.15 62.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.336 . . . . 0.0 110.675 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.586 HD13 ' CD1' ' A' ' 122' ' ' TYR . 7.3 tt -52.95 -36.16 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.427 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 26.0 ttt -67.23 -40.14 86.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 110.143 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -67.56 -34.63 77.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.909 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 58' ' ' LEU . . . -61.65 -63.06 1.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 18.5 ptt? -56.32 -34.75 66.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.797 . . . . 0.0 111.0 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 55' ' ' MET . 87.6 tt0 -69.91 -42.02 73.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 111.288 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 62' ' ' MET . 53.0 mtpt -80.27 -24.95 39.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.978 . . . . 0.0 111.246 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 54' ' ' ALA . 2.3 pp -104.35 2.87 31.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 58' ' ' LEU . 6.2 mttt -49.46 178.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.07 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -52.47 139.48 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 110.095 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.05 -10.95 69.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 29.5 mmt -100.9 163.71 12.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -1.049 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.476 ' CG ' ' HG3' ' A' ' 66' ' ' GLU . 4.9 ttm180 -93.77 95.04 8.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -46.24 -31.43 2.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 0.0 110.337 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 51.3 t30 -65.61 -41.24 92.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.127 -0.983 . . . . 0.0 110.011 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HG3' ' CG ' ' A' ' 63' ' ' ARG . 3.4 mt-10 -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG12 ' CE2' ' A' ' 71' ' ' TYR . 53.6 t -68.94 -38.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.897 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -70.9 -51.38 26.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 110.465 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -57.12 -31.34 65.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.672 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.527 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 8.1 mm-40 -91.42 -19.75 22.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.031 -1.043 . . . . 0.0 110.735 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.545 ' CE2' HG12 ' A' ' 67' ' ' VAL . 17.2 m-30 -108.71 10.44 26.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 0.0 111.078 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 16.7 m -76.44 116.76 17.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.937 -1.102 . . . . 0.0 110.154 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 25.3 tp10 -104.5 10.41 35.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 22.0 t70 -114.9 108.29 16.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.158 -0.964 . . . . 0.0 110.543 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 78' ' ' GLN . 17.1 ptpt -61.3 -25.18 66.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.04 -21.72 29.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.474 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -129.51 25.54 5.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.385 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.484 ' HG3' ' HA ' ' A' ' 75' ' ' LYS . 52.6 mt-30 -43.53 -28.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.93 -15.61 14.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . 61.39 24.03 63.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 55.4 t0 -130.74 142.84 50.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -1.116 . . . . 0.0 110.493 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 82' ' ' LEU . 8.7 mp -104.04 -20.5 13.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.68 -170.06 34.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 28.9 m-90 -84.26 127.75 34.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -1.016 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 19.2 ptp -140.37 137.48 34.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 49.1 m -76.53 -54.64 6.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -111.14 -173.55 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.385 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . -149.62 146.07 14.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.6 p -137.9 16.07 2.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -1.182 . . . . 0.0 110.759 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.508 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 6.4 mmt -100.8 108.4 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.241 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 11.4 t 64.84 117.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -51.81 -53.05 31.44 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.49 -0.756 . . . . 0.0 111.461 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -65.66 -32.7 47.13 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.438 1.231 . . . . 0.0 111.705 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.561 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 42.1 t80 -63.77 -52.46 60.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.851 -1.156 . . . . 0.0 109.932 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' HA3' ' A' ' 88' ' ' GLY . 39.5 tt0 -55.12 -46.05 75.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 62.4 mt-10 -58.62 -48.63 80.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.12 77.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.343 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.23 91.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 36' ' ' ASN . 6.5 m-85 -103.63 13.23 33.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.957 . . . . 0.0 110.906 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -130.76 3.33 4.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.133 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 110' ' ' VAL . 61.0 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 111.34 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 4.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.534 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 31.4 p90 -102.56 158.06 16.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.828 -1.17 . . . . 0.0 110.134 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.464 ' OG1' HG12 ' A' ' 125' ' ' ILE . 22.4 m -40.61 121.98 1.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.8 p-10 -133.51 104.76 12.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.909 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.506 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 49.5 Cg_endo -76.78 176.91 41.88 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.198 -2.001 . . . . 0.0 110.471 0.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 114' ' ' PRO . 41.7 Cg_endo -69.32 166.67 26.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.764 1.402 . . . . 0.0 109.686 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 123' ' ' HIS . 34.2 m -110.3 139.18 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.01 . . . . 0.0 110.656 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . 1.2 pttp -114.03 131.39 56.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.474 -0.766 . . . . 0.0 108.934 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 69.8 p -134.75 176.21 8.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.965 -1.084 . . . . 0.0 110.822 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -61.49 -8.73 4.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.74 -0.6 . . . . 0.0 111.369 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 11.0 p90 -112.73 37.95 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.705 -1.247 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . 99.65 -173.38 25.84 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 20.5 m-85 -99.01 158.62 15.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -1.05 . . . . 0.0 108.417 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.68 ' CE1' ' CD2' ' A' ' 120' ' ' PHE . 73.0 m-70 -141.35 137.71 32.54 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.063 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.432 HD11 HD23 ' A' ' 58' ' ' LEU . 69.9 mt -128.29 96.38 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 15.4 pt -103.79 137.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.942 -1.099 . . . . 0.0 112.029 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.489 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 48.9 mtp -107.42 142.08 37.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.435 HG23 HD21 ' A' ' 101' ' ' LEU . 30.0 t -119.83 125.2 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.719 -1.238 . . . . 0.0 111.576 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -107.82 -47.62 3.55 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 119.54 176.83 16.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 46.3 tpt85 -116.96 -48.48 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.968 . . . . 0.0 109.117 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.235 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.835 0.35 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 131' ' ' LYS . . . -117.99 176.62 5.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.5 OUTLIER -120.98 151.24 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.509 ' HG3' ' CZ2' ' A' ' 84' ' ' TRP . 1.9 tmmt? -100.42 121.85 42.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.106 -0.996 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 10.2 p -142.44 147.94 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 119.344 -0.943 . . . . 0.0 112.876 -178.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' NE ' ' HB2' ' A' ' 81' ' ' ASP . 65.8 mtp180 -130.06 137.38 50.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 0.4 OUTLIER -142.69 167.75 21.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.162 -1.587 . . . . 0.0 113.061 -177.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CD1' HG11 ' A' ' 67' ' ' VAL . 5.1 mt -127.55 130.36 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.7 tt -113.91 118.86 35.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.482 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 48.1 t -129.68 154.22 47.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 35.0 tp10 -60.24 163.83 4.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 0.0 109.86 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 18.2 ttpt -97.58 96.74 8.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 0.0 110.38 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 1.8 p-80 -132.07 21.89 4.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.48 19.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 120.107 -1.044 . . . . 0.0 110.603 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.538 ' HD3' ' CE2' ' A' ' 71' ' ' TYR . 8.9 tttt -114.65 18.35 16.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.889 -1.359 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.583 HG13 ' CD2' ' A' ' 122' ' ' TYR . 4.2 mt -57.41 -42.39 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.488 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 62.8 ttp -65.86 -46.96 76.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.888 . . . . 0.0 110.869 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 50' ' ' LYS . 72.1 mm-40 -59.89 -47.41 85.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -0.985 . . . . 0.0 110.641 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -60.73 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.529 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' LYS . 3.7 tmm? -62.47 -33.33 74.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 110.088 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.5 tt0 -59.15 -46.13 89.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -60.21 -46.64 89.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.76 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 111' ' ' PHE . 4.1 pp -101.26 25.33 8.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 110.365 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' MET . 7.9 tptt -35.09 -70.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.744 -0.598 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.4 m -91.3 25.0 2.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.77 32.78 66.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.78 40.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -1.05 . . . . 0.0 110.568 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' HG21 ' A' ' 67' ' ' VAL . 71.5 mtt180 -117.71 37.36 3.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 111.715 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CE2' ' CZ ' ' A' ' 111' ' ' PHE . 25.7 t80 -49.28 -46.92 47.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.707 -1.245 . . . . 0.0 109.988 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -63.97 -45.96 86.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 110.73 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 38.9 tt0 -64.94 -45.2 86.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 110.426 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 58' ' ' LEU . 67.2 t -55.1 -41.81 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.749 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -64.13 -59.2 4.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.0 109.638 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.49 -40.21 1.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 0.0 111.688 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.649 ' NE2' ' CD1' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -101.18 -30.27 11.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 112.002 -178.696 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.649 ' CD1' ' NE2' ' A' ' 70' ' ' GLN . 8.3 m-85 -100.79 28.36 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.641 -1.287 . . . . 0.0 109.945 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 41.0 t -115.82 123.27 47.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -101.83 -8.14 21.9 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' GLN . 46.6 p30 -108.04 32.43 4.77 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -60.03 -37.01 78.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.4 71.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.383 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' C ' ' HG3' ' A' ' 78' ' ' GLN . 13.7 ptp180 -87.58 -47.64 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.8 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' ASP . 20.2 mt-30 -138.6 -127.15 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.256 -0.903 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.56 25.8 8.48 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.22 -135.43 1.81 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.018 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 82' ' ' LEU . 59.8 t0 -73.98 150.18 40.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -1.099 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 8.0 mp -100.9 -15.47 17.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.47 -0.769 . . . . 0.0 108.941 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 82.39 -145.34 24.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.6 m-90 -109.08 133.3 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.667 -0.902 . . . . 0.0 110.101 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 82' ' ' LEU . 25.0 ptp -141.1 154.37 45.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.404 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 32.8 p -115.81 -66.05 1.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 110.371 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -104.35 37.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.879 . . . . 0.0 110.709 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.2 97.59 1.8 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 25.2 t -101.69 114.89 29.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.368 -1.078 . . . . 0.0 109.93 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 30.5 mmt -100.42 -106.35 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.436 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 70.1 t -64.42 -51.33 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.911 -1.118 . . . . 0.0 110.397 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.64 -67.19 0.45 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 45.1 Cg_endo -70.49 -25.08 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.105 1.581 . . . . 0.0 109.612 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.53 ' CE1' HD13 ' A' ' 125' ' ' ILE . 58.7 t80 -70.61 -33.92 71.57 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.468 -0.77 . . . . 0.0 109.567 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 65.4 tt0 -73.04 -54.88 7.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 110.154 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 29.2 tp10 -48.02 -61.9 1.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -62.13 -66.55 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.422 -0.799 . . . . 0.0 111.504 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' PHE . . . -54.3 -63.46 1.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 112.206 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 18.5 t80 -41.71 -42.91 2.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.528 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -96.86 -89.55 0.27 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 111.484 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.665 ' CZ ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -100.34 149.56 23.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.251 179.792 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 115' ' ' PRO . 21.2 m -75.1 101.63 4.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.48 111.94 13.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.146 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.33 160.45 94.32 Favored 'Cis proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.849 -2.146 . . . . 0.0 110.271 0.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 112' ' ' THR . 45.0 Cg_endo -72.46 -168.92 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.964 1.508 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.21 131.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.529 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 122' ' ' TYR . 8.4 mtmm -102.03 123.14 45.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.312 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.581 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 41.4 p -134.62 -178.03 4.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -73.02 -16.48 61.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 111.369 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 3.8 p90 -97.1 1.6 50.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.738 -1.226 . . . . 0.0 110.983 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 131.52 -171.92 21.02 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.168 -1.491 . . . . 0.0 111.357 178.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 47' ' ' LYS . 26.2 m-85 -101.23 150.54 22.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.742 -0.858 . . . . 0.0 109.34 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 15.0 m-70 -136.31 122.67 20.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.895 -1.128 . . . . 0.0 112.11 -179.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.609 ' CG2' ' CE1' ' A' ' 111' ' ' PHE . 25.8 mt -102.06 120.89 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.53 HD13 ' CE1' ' A' ' 94' ' ' PHE . 20.3 mt -108.88 126.87 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.777 -1.202 . . . . 0.0 112.54 -177.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 13.5 tpt -110.3 99.01 8.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 t -107.77 138.04 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.955 . . . . 0.0 111.471 -178.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -143.1 3.72 1.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -0.834 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -125.52 139.78 11.79 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -132.59 133.05 43.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -1.21 . . . . 0.0 110.199 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.965 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 8.9 p-10 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.409 0.623 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.25 -177.02 4.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 39' ' ' LYS . 7.7 p -144.74 156.11 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HE2' ' CZ2' ' A' ' 84' ' ' TRP . 42.1 mttt -98.23 136.18 38.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.08 -1.012 . . . . 0.0 109.411 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 59.7 t -133.53 146.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.874 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 126' ' ' MET . 84.0 mtt180 -141.62 123.34 15.18 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.585 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -136.72 -176.55 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.671 -1.268 . . . . 0.0 112.597 -178.342 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 124' ' ' ILE . 82.5 mt -126.75 131.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 1.3 tt -106.7 126.38 52.21 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 110.68 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 48' ' ' HIS . 16.4 t -137.54 149.89 47.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 6.6 mm-40 -73.27 -155.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HA ' ' CE1' ' A' ' 122' ' ' TYR . 83.9 tttt -98.09 102.81 14.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.881 -1.137 . . . . 0.0 112.231 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.608 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.5 m-70 -132.56 -19.83 2.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.383 -0.823 . . . . 0.0 110.469 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.63 24.99 22.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 19.1 mttt -97.78 14.1 28.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.48 -1.012 . . . . 0.0 110.43 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.533 HG23 ' CG ' ' A' ' 115' ' ' PRO . 2.7 mp -44.37 -62.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.988 . . . . 0.0 109.997 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 22.1 ptm -66.33 -34.5 78.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.0 110.948 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -65.13 -39.71 93.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.612 ' CB ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.07 -56.68 9.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.833 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.538 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -62.46 -31.84 72.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.894 -1.129 . . . . 0.0 110.385 -179.559 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 55' ' ' MET . 18.3 tp10 -62.58 -38.75 91.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.489 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HD2' ' OH ' ' A' ' 71' ' ' TYR . 44.8 mttm -76.86 -37.8 54.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 4.2 pp -83.7 -2.28 55.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.911 -1.118 . . . . 0.0 111.128 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 56' ' ' GLU . 12.1 mttt -48.93 178.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 109.986 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -54.33 139.83 35.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.9 -23.55 29.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.484 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -110.45 149.04 30.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.116 . . . . 0.0 110.283 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.532 ' HG3' ' CG ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -87.16 107.39 18.45 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.043 0.925 . . . . 0.0 110.515 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' ARG . 72.7 t80 -39.28 -40.92 0.83 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.493 0.663 . . . . 0.0 109.906 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -48.99 -46.98 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.251 -0.906 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' CG ' ' HG3' ' A' ' 63' ' ' ARG . 80.2 mm-40 -65.35 -43.39 90.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 58' ' ' LEU . 44.2 t -59.95 -41.05 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -55.38 -46.72 76.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.689 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.56 55.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.4 mm-40 -64.92 -23.79 67.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 54' ' ' ALA . 12.3 m-85 -118.39 26.38 9.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 109.744 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ALA . 7.1 t -88.24 87.3 7.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 110.942 -179.078 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 1.1 tm-20 -101.79 5.27 41.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -0.975 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 44' ' ' LEU . 48.6 p30 -126.07 12.86 7.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -53.9 -18.6 3.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.538 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.03 -26.17 56.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.9 mmm180 -127.44 -2.3 6.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.05 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 77' ' ' ARG . 6.7 tt0 -178.63 150.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.62 38.32 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 42' ' ' HIS . . . 65.24 18.95 65.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -128.3 118.34 23.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.126 . . . . 0.0 110.119 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 42' ' ' HIS . 4.4 mp -101.69 150.91 22.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.928 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.72 -122.24 0.61 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.559 ' CZ2' ' HE2' ' A' ' 39' ' ' LYS . 61.8 m95 -95.3 143.32 26.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.765 -0.844 . . . . 0.0 110.525 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 38' ' ' VAL . 8.5 mmt -125.64 139.29 53.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.028 179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.51 HG21 ' N ' ' A' ' 87' ' ' ARG . 11.9 t -134.02 -37.59 0.89 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG21 ' A' ' 86' ' ' THR . 15.0 mtp85 -119.67 151.79 38.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 111.849 -177.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . -100.92 113.86 4.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p -139.16 12.49 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.324 . . . . 0.0 111.722 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.539 ' CG ' HG11 ' A' ' 91' ' ' VAL . 6.8 ptp -105.26 -26.59 11.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.78 -1.2 . . . . 0.0 110.077 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG11 ' CG ' ' A' ' 90' ' ' MET . 11.5 p -167.36 -46.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 132.93 -63.28 0.62 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.63 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.503 ' HD2' HG13 ' A' ' 91' ' ' VAL . 38.7 Cg_endo -63.55 -37.68 46.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.907 1.478 . . . . 0.0 112.13 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.72 -45.94 91.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.619 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HG3' ' CA ' ' A' ' 88' ' ' GLY . 1.5 tm0? -74.55 -42.04 59.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.15 -0.969 . . . . 0.0 110.791 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -64.75 -39.71 94.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 111.572 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.5 18.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.9 -1.125 . . . . 0.0 110.27 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.63 -42.28 23.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 110.399 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -70.42 -39.4 74.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.351 -0.843 . . . . 0.0 111.659 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.11 51.53 1.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 113.067 -177.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.494 1.731 0 O-C-N 120.482 -1.386 . . . . 0.0 109.453 178.57 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' MET . 86.0 t . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 26.4 p90 -131.77 161.13 33.62 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.95 -1.094 . . . . 0.0 109.966 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 114' ' ' PRO . 18.9 m -68.12 118.18 10.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 111.543 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.608 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 32.3 p-10 -133.93 108.34 11.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 0.0 110.447 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 48.6 Cg_endo -75.28 176.17 44.73 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.093 -2.044 . . . . 0.0 110.344 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.533 ' CG ' HG23 ' A' ' 51' ' ' ILE . 44.2 Cg_endo -69.65 -175.03 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.877 1.462 . . . . 0.0 109.702 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.07 137.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 0.0 110.111 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -102.11 125.54 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 109.064 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 38.7 p -142.04 -175.98 4.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.631 -1.293 . . . . 0.0 111.68 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 1.8 tttt -74.36 -10.67 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.768 -0.582 . . . . 0.0 110.132 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.61 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -103.55 37.92 1.91 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.065 -1.022 . . . . 0.0 109.605 179.117 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.6 -167.71 37.28 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.639 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 6.9 m-85 -103.72 144.13 31.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -1.084 . . . . 0.0 108.879 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 120' ' ' PHE . 10.1 m-70 -137.94 135.29 35.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.666 -1.272 . . . . 0.0 112.32 -178.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 11.5 tt -120.64 116.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 125' ' ' ILE . 12.1 pt -114.46 158.28 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.571 -1.33 . . . . 0.0 112.651 -177.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.522 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 44.9 mtp -118.87 151.07 38.77 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 126' ' ' MET . 18.3 t -126.91 121.36 57.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.55 -1.344 . . . . 0.0 111.822 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.8 pt-20 -133.67 157.41 45.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 61.45 82.65 0.07 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.539 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 10.1 ttm180 -116.77 154.1 31.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.992 . . . . 0.0 110.173 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.539 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.9 mtpt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.184 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.174 0.511 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' CB ' ' CG2' ' A' ' 86' ' ' THR . . . -129.65 -170.35 2.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 85' ' ' MET . 1.5 p -128.76 150.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.576 -0.703 . . . . 0.0 109.244 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.677 ' HD2' ' CD2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -101.0 113.93 27.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.637 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 82' ' ' LEU . 38.6 t -127.14 152.31 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.836 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 93.5 mtt180 -133.73 121.93 22.62 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.585 ' CD2' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -131.06 159.23 38.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.638 -1.289 . . . . 0.0 113.008 -177.763 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.539 HD11 ' CE1' ' A' ' 64' ' ' PHE . 24.9 mt -122.82 123.21 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -104.63 120.97 42.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.503 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.6 p -133.09 -168.81 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.892 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 92.4 mt-10 -70.98 176.61 4.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.0 111.419 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 28.1 pttt -118.66 56.77 0.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.356 -0.84 . . . . 0.0 110.947 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.543 ' N ' ' CE2' ' A' ' 122' ' ' TYR . 19.3 m80 -134.6 64.04 1.61 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 111.576 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 -0.95 34.05 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.88 178.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.78 -10.78 59.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.984 -1.304 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.601 ' HB ' ' CD2' ' A' ' 122' ' ' TYR . 3.1 tt -62.15 -36.81 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 53' ' ' GLU . 23.3 ptm -74.54 -42.97 57.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.957 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' N ' ' CG ' ' A' ' 52' ' ' MET . 19.1 mm-40 -68.12 -38.82 82.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.675 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . . . -65.73 -49.38 68.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.893 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.539 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 27.1 ptm -61.68 -35.39 77.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.916 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 55' ' ' MET . 91.7 mt-10 -68.44 -33.44 74.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.062 -1.024 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -68.72 -46.01 70.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -74.45 -27.77 60.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.977 -1.077 . . . . 0.0 110.446 -179.454 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.504 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 91.1 mttt 49.82 -126.98 2.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 62' ' ' MET . 55.7 p -65.45 -28.5 69.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 110.587 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . 130.73 -5.82 5.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.427 ' HG3' ' OG ' ' A' ' 60' ' ' SER . 60.0 mtt -49.47 -31.43 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -1.225 . . . . 0.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.72 29.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.565 ' CD1' ' HE3' ' A' ' 126' ' ' MET . 30.9 t80 -54.71 -40.99 69.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.904 . . . . 0.0 110.477 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 20.6 p-10 -58.59 -44.48 89.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -69.21 -44.13 72.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 97.2 t -69.75 -26.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 110.413 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -74.16 -57.59 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.11 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.89 62.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.619 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -29.81 33.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.173 -0.954 . . . . 0.0 111.124 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 23.4 m-85 -114.57 26.71 10.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.034 -1.041 . . . . 0.0 111.049 -179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 26.7 t -102.28 116.93 33.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.911 -1.118 . . . . 0.0 110.68 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.32 -7.42 24.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.404 ' OD2' ' NE2' ' A' ' 42' ' ' HIS . 49.8 p-10 -111.86 21.22 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.508 -0.745 . . . . 0.0 109.212 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 6.4 tmtt? -53.8 -31.3 48.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.625 -0.672 . . . . 0.0 110.68 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.28 81.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.173 -0.955 . . . . 0.0 110.927 -179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.27 9.27 36.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.097 -1.002 . . . . 0.0 110.795 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 2.1 tt0 -169.07 172.62 7.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.054 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.69 27.49 6.83 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 72.66 11.5 77.4 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 41.2 p-10 -133.08 129.46 38.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -1.182 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 42' ' ' HIS . 7.9 mp -110.09 109.29 19.78 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 110.159 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -60.12 -123.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.081 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.677 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 78.2 m95 -76.45 130.26 37.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.795 -0.826 . . . . 0.0 110.808 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.534 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 10.8 tpt -137.28 136.04 37.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 0.0 109.767 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.592 ' CG2' ' CB ' ' A' ' 37' ' ' ALA . 19.0 p -122.78 -57.98 1.69 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.827 -1.171 . . . . 0.0 110.675 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' A' ' 86' ' ' THR . 21.9 ttm-85 -68.22 -48.99 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.739 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 46.65 64.79 2.46 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -122.93 43.59 2.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -1.06 . . . . 0.0 110.634 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.477 ' O ' HG21 ' A' ' 91' ' ' VAL . 16.2 mtp -99.78 -32.04 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.768 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 89.9 t -142.96 112.38 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.524 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -43.04 -53.93 5.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.514 -0.741 . . . . 0.0 111.874 -178.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 42.8 Cg_endo -69.33 -19.66 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.511 1.269 . . . . 0.0 111.765 -178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.576 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 23.4 t80 -76.56 -54.09 7.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 110.771 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -66.52 -41.76 88.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.972 . . . . 0.0 110.897 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 14.1 pt-20 -60.23 -25.15 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.894 -1.128 . . . . 0.0 110.42 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -79.61 -50.74 10.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.773 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.32 -54.63 7.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.755 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 58.4 m-85 -56.42 -47.0 79.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 0.0 110.975 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -66.17 -39.69 89.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.202 -0.937 . . . . 0.0 111.196 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD23 HG21 ' A' ' 112' ' ' THR . 27.3 tp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.985 -1.072 . . . . 0.0 110.802 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 4.1 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.155 0.502 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' CD2' ' HG2' ' A' ' 126' ' ' MET . 8.2 t80 -103.62 163.12 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 111.185 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.507 ' OG1' HG12 ' A' ' 125' ' ' ILE . 1.7 p -84.47 29.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 38.1 p-10 -71.73 130.17 87.42 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.986 -1.071 . . . . 0.0 110.389 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 112' ' ' THR . 49.0 Cg_endo -76.16 146.33 84.72 Favored 'Cis proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.949 -2.105 . . . . 0.0 110.082 -0.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HG2' ' CG1' ' A' ' 51' ' ' ILE . 40.8 Cg_endo -66.34 -174.24 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.097 1.577 . . . . 0.0 110.902 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 28.5 m -101.68 158.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 110.248 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' C ' HG22 ' A' ' 118' ' ' THR . 42.3 mttm -113.57 142.07 46.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.608 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 24.8 p -143.12 177.12 8.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.758 -1.214 . . . . 0.0 111.078 -179.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -80.85 -11.6 59.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.678 -0.639 . . . . 0.0 109.533 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.3 p90 -104.82 20.96 17.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 110.01 179.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.13 -173.04 14.52 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 16.4 m-85 -100.25 160.87 13.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -1.033 . . . . 0.0 108.729 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.58 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 63.9 m-70 -141.98 122.48 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.708 -1.245 . . . . 0.0 112.061 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.598 ' HB ' ' CE1' ' A' ' 111' ' ' PHE . 30.9 pt -118.46 125.06 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 18.2 pt -123.88 173.03 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.684 -1.26 . . . . 0.0 112.944 -176.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.614 ' HG2' ' CD2' ' A' ' 111' ' ' PHE . 73.1 mtm -133.4 146.71 51.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m -121.32 120.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.867 -1.145 . . . . 0.0 109.974 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -107.12 -20.86 13.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 111.331 -178.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.492 ' HA3' ' NZ ' ' A' ' 39' ' ' LYS . . . -161.62 156.09 27.5 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.101 -1.523 . . . . 0.0 110.637 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.461 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 7.0 ttt180 -126.05 145.51 50.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.922 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 58.9 pttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 53.5 p30 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.724 0.773 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' A' ' 86' ' ' THR . . . -103.71 168.39 9.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 -178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 129' ' ' GLY . 1.3 p -128.78 153.63 38.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 110.022 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 2.9 mtpm? -98.87 132.99 43.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 109.084 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 82.5 t -130.36 143.12 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.292 -178.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -125.34 120.88 32.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -144.78 164.95 29.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.738 -1.227 . . . . 0.0 112.256 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' CD1' HD11 ' A' ' 124' ' ' ILE . 13.5 pt -126.47 144.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -101.34 122.36 43.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.881 -1.137 . . . . 0.0 110.041 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 36.5 m -111.51 170.07 8.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 110.275 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.593 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 27.8 mt-10 -88.45 -158.63 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 110.318 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.1 mtmm -128.04 92.63 3.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.923 -1.111 . . . . 0.0 111.142 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.593 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 6.3 m-70 -132.88 17.26 4.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.95 2.25 81.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 5.0 ttmt -83.81 -12.95 54.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -1.079 . . . . 0.0 110.089 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.564 HG12 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -43.22 -41.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 110.298 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.503 ' O ' ' HG2' ' A' ' 55' ' ' MET . 41.7 ttm -60.94 -44.77 96.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.063 -1.023 . . . . 0.0 109.841 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -72.16 -31.73 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.05 -1.031 . . . . 0.0 109.385 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -59.6 -54.68 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.757 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 52' ' ' MET . 25.5 ptm -65.97 -23.91 66.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 24.1 tp10 -64.35 -41.98 96.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.042 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -79.79 -38.42 33.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 0.0 109.057 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD22 ' CZ ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -65.96 -49.14 68.94 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.616 -0.677 . . . . 0.0 109.218 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 33.4 mtmt 50.09 -124.66 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 0.0 110.384 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -70.66 -31.72 68.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.0 -1.062 . . . . 0.0 109.932 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.94 7.26 5.61 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 ttt -47.73 -42.07 24.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.861 -1.376 . . . . 0.0 109.247 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 27.3 mtt-85 -108.5 30.51 6.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.524 -0.735 . . . . 0.0 109.255 179.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -46.94 -47.8 21.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.886 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -57.74 -39.05 76.45 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 77.4 mt-10 -67.67 -42.65 81.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 71' ' ' TYR . 96.5 t -70.11 -52.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.56 -40.25 51.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.092 -1.005 . . . . 0.0 110.331 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.72 91.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 7.6 mm-40 -89.77 8.31 32.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.683 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 54' ' ' ALA . 33.1 m-85 -134.25 4.37 3.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.916 -1.115 . . . . 0.0 111.289 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -67.86 111.25 4.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 16.7 tt0 -102.06 5.59 40.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.748 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 79' ' ' GLY . 29.3 t70 -132.98 45.33 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.975 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -66.65 -32.59 74.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.032 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.94 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 108.842 179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.4 mmm-85 -104.74 8.25 34.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.65 -0.656 . . . . 0.0 109.408 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 52.86 42.35 31.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.775 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 74' ' ' ASP . . . -79.79 108.5 2.75 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -160.42 -92.45 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -90.39 140.67 29.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -1.149 . . . . 0.0 109.771 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -124.61 169.57 11.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -82.04 -122.99 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.466 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.629 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 18.4 m-90 -96.48 144.83 26.22 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.786 0.803 . . . . 0.0 112.116 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 40' ' ' VAL . 23.2 ptm -139.88 155.54 47.15 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 37' ' ' ALA . 31.3 p -129.84 -72.95 0.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.554 -1.341 . . . . 0.0 110.315 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 86' ' ' THR . 4.2 ttp85 -116.76 136.57 52.86 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.311 -0.955 . . . . 0.0 111.598 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' ARG . . . 58.34 144.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 90' ' ' MET . 53.2 p -142.37 -66.45 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.042 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.502 ' N ' ' OG ' ' A' ' 89' ' ' SER . 20.0 ptm -142.06 -39.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.541 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 38.4 t -153.01 157.55 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 110.085 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.52 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -37.99 -60.67 1.26 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 37.9 Cg_endo -63.62 -175.55 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.759 1.399 . . . . 0.0 110.334 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.577 ' CE1' HG21 ' A' ' 125' ' ' ILE . 59.9 t80 68.48 -78.03 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.611 -0.68 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.459 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 12.0 tm0? -66.51 -47.93 71.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 81.8 mt-10 -61.68 -38.75 88.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.05 70.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 0.0 109.003 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.5 83.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.086 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -69.51 -21.48 63.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.25 -12.8 48.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.468 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 110.641 -179.98 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.632 0.73 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.615 ' CZ ' HG23 ' A' ' 124' ' ' ILE . 7.5 t80 -114.34 153.8 29.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.77 -0.581 . . . . 0.0 110.409 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.548 ' CG2' HG12 ' A' ' 125' ' ' ILE . 66.2 p -72.85 119.38 17.0 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.352 -0.842 . . . . 0.0 110.732 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 111' ' ' PHE . 81.3 m-20 -133.45 121.9 16.64 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.257 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 48.8 Cg_endo -78.81 174.59 50.36 Favored 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.188 -2.005 . . . . 0.0 110.396 -0.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -70.83 175.78 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.957 1.504 . . . . 0.0 109.926 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 32.6 m -103.19 155.44 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -123.08 136.11 54.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.603 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 36.4 p -139.02 168.02 20.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.103 -0.998 . . . . 0.0 110.645 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -64.89 -17.28 64.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.796 . . . . 0.0 110.017 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.603 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -97.38 19.62 12.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.985 -1.072 . . . . 0.0 110.366 179.526 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.549 ' HA2' ' CG ' ' A' ' 47' ' ' LYS . . . 117.72 -176.91 16.37 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-30 -97.82 158.8 15.31 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . 75.9 m-70 -138.09 140.19 39.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.403 -1.436 . . . . 0.0 112.302 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.615 HG23 ' CZ ' ' A' ' 111' ' ' PHE . 84.2 mt -123.0 114.49 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.577 HG21 ' CE1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -122.43 149.49 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 0.0 112.102 -178.725 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' A' ' 111' ' ' PHE . 89.8 mtp -128.5 150.75 50.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.503 HG13 ' CG2' ' A' ' 38' ' ' VAL . 15.2 t -124.62 138.86 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.75 -1.219 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -114.9 -24.61 8.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 110.93 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.547 ' O ' ' CG2' ' A' ' 38' ' ' VAL . . . -150.27 132.67 4.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -76.97 -42.67 38.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.969 . . . . 0.0 110.949 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 38.0 mtmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.229 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 49.8 p30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.411 0.624 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -107.47 164.69 11.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 130' ' ' ARG . 5.9 m -136.72 161.46 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.917 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HD3' ' NE1' ' A' ' 84' ' ' TRP . 7.3 mmmt -99.71 112.09 24.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.415 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 4.0 p -127.88 128.4 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.949 . . . . 0.0 111.465 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 46.6 mtm180 -118.42 134.0 55.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 3.7 p80 -135.81 162.86 31.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.59 -1.319 . . . . 0.0 111.704 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 124' ' ' ILE . 23.6 mt -116.64 121.86 68.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.608 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.8 tt -101.83 101.0 11.39 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.909 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' SG ' HG21 ' A' ' 43' ' ' ILE . 35.2 m -101.36 162.49 12.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.4 mt-10 -63.35 165.75 7.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.82 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 21.2 tttt -89.7 59.09 4.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.133 -0.979 . . . . 0.0 111.419 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 20.3 m80 -135.87 66.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.66 -1.275 . . . . 0.0 111.584 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.44 28.47 44.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.02 7.22 45.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.992 -1.299 . . . . 0.0 109.445 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.506 HG13 ' CD2' ' A' ' 122' ' ' TYR . 43.2 mt -62.51 -50.81 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.541 -0.725 . . . . 0.0 110.581 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.451 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 49.2 mtm -69.15 -32.26 71.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.451 -0.781 . . . . 0.0 110.617 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.54 -49.37 75.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.457 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -69.86 -51.32 34.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 111.479 -179.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 28.6 ptm -65.69 -43.9 87.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.315 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 55' ' ' MET . 64.3 tt0 -65.09 -41.23 95.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.956 -1.09 . . . . 0.0 110.686 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 55.3 mmtt -60.23 -56.14 25.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' HD11 ' A' ' 124' ' ' ILE . 1.2 pp -68.1 -14.04 62.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.62 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 21.0 mtpt 45.66 -133.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.795 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -57.87 -21.66 44.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.846 -1.159 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 123.45 10.73 5.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.4 ttm -51.16 -45.55 61.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -1.232 . . . . 0.0 109.927 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 10.7 mtp180 -109.66 31.6 5.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.903 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.61 -49.1 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -58.28 -46.86 85.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 109.374 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 51.4 mp0 -62.37 -41.53 98.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.299 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 54.3 t -65.54 -44.38 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.553 -0.717 . . . . 0.0 109.294 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -57.76 -51.88 67.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.925 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -46.74 88.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.0 mm-40 -73.29 -28.06 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.315 -0.866 . . . . 0.0 111.27 -179.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 63.5 m-85 -108.76 13.82 24.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.057 . . . . 0.0 110.86 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 8.4 t -78.9 105.23 10.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.876 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 31.9 tp10 -101.4 1.34 38.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.734 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 74' ' ' ASP . 20.4 p30 -103.4 24.56 10.82 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 110.112 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 43.8 tttm -46.96 -49.25 21.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.87 -50.38 10.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.0 109.734 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 7.1 tpm_? -80.4 -11.55 59.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.605 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 75' ' ' LYS . 84.5 mm-40 54.4 47.9 21.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.531 -0.731 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -81.61 -76.42 1.07 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.32 -84.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' GLY . 62.9 m-20 -109.25 150.61 27.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.579 -0.953 . . . . 0.0 109.632 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 2.9 mp -102.67 2.76 36.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 49.88 -139.53 18.06 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.1 m95 -89.94 114.8 26.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.395 -1.062 . . . . 0.0 110.574 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.513 ' HE2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -126.09 152.21 46.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.209 -0.932 . . . . 0.0 110.186 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.7 p -100.58 -89.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 110.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' OG1' ' A' ' 86' ' ' THR . 39.3 ptt180 -116.61 138.71 51.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.375 -1.453 . . . . 0.0 110.901 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . -131.56 164.45 23.52 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -137.71 34.24 2.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.842 -1.387 . . . . 0.0 111.209 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.47 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 43.3 mmm -100.65 123.94 45.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.536 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 30.2 t 60.11 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 109.97 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.602 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -55.31 -43.95 84.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 43.7 Cg_endo -71.89 -12.12 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.369 1.194 . . . . 0.0 111.243 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.536 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 53.0 t80 -88.65 -54.48 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.0 110.18 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 2.0 tt0 -64.7 -43.64 92.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 110.677 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 47.1 tp10 -59.36 -42.97 92.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.973 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -60.35 -58.13 9.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.5 -56.33 2.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.473 -0.767 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HZ ' ' O ' ' A' ' 86' ' ' THR . 38.0 m-85 -83.16 3.68 29.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.524 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . . . -80.69 -29.74 36.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.193 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.165 179.492 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 126' ' ' MET . 7.2 p . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -118.52 172.37 7.53 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.105 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.556 ' O ' ' O ' ' A' ' 114' ' ' PRO . 2.1 m -76.97 -4.83 46.02 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.58 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 65.6 m-20 -48.44 122.48 10.35 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.344 -1.473 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' A' ' 112' ' ' THR . 43.4 Cg_endo -66.38 128.08 8.81 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.359 1.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.507 ' HB3' ' CB ' ' A' ' 124' ' ' ILE . 38.4 Cg_endo -63.65 -179.3 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.086 1.572 . . . . 0.0 111.616 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 116' ' ' VAL . 31.5 m -102.47 144.87 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.568 -0.707 . . . . 0.0 109.86 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 34.1 pttt -110.28 130.14 55.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.045 -1.035 . . . . 0.0 110.296 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.599 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 71.8 p -137.35 173.1 12.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.059 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -19.31 65.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.179 -0.95 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 2.8 p90 -93.46 19.32 8.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.803 -1.185 . . . . 0.0 110.369 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 114.88 -174.11 15.17 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.512 178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-85 -104.12 153.22 21.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.702 -0.881 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 13.1 m-70 -141.34 133.48 27.84 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.684 -1.26 . . . . 0.0 112.948 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.56 ' O ' ' CG1' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -125.36 106.14 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.375 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.567 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 35.1 pt -105.11 157.0 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.857 -1.152 . . . . 0.0 111.864 -177.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.612 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 16.3 ptm -133.36 160.86 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.996 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 126' ' ' MET . 14.5 t -133.74 131.79 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.928 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.09 -4.51 16.55 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.486 -0.759 . . . . 0.0 110.225 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 38' ' ' VAL . . . -172.18 126.75 1.31 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.521 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.2 ttt-85 -127.22 152.6 47.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -1.121 . . . . 0.0 109.857 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 36' ' ' ASN . 30.5 tttm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.063 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 131' ' ' LYS . 19.9 p30 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 86' ' ' THR . . . -125.93 173.73 8.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.564 HG21 ' N ' ' A' ' 39' ' ' LYS . 2.5 p -132.52 154.58 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 110.065 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 84' ' ' TRP . 37.7 mtpt -100.05 115.18 29.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 82' ' ' LEU . 69.9 t -120.04 125.54 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 111.497 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -124.98 109.62 13.2 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 4.0 p80 -134.96 166.97 21.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.701 -1.249 . . . . 0.0 112.427 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' A' ' 68' ' ' ALA . 17.9 pt -118.56 134.04 63.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -107.44 132.15 53.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.549 -0.719 . . . . 0.0 111.097 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 42.8 t -140.26 163.57 32.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 109.088 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 59.5 mm-40 -72.54 158.31 35.94 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.153 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.559 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.6 tttp -78.38 122.69 26.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.248 -0.907 . . . . 0.0 111.333 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 9.2 m-70 -129.79 -13.74 4.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 0.0 110.416 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.38 2.95 50.79 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HE2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -88.59 18.39 4.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.177 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.524 ' N ' ' HE3' ' A' ' 50' ' ' LYS . 53.5 mt -45.68 -46.78 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 109.293 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 55' ' ' MET . 23.5 ptt? -65.74 -35.32 80.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.412 -0.805 . . . . 0.0 109.52 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 34.9 tt0 -75.19 -27.5 59.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.289 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.2 -45.99 44.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 21.0 ptm -64.92 -44.91 87.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 77.6 tt0 -65.44 -41.32 93.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.451 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 28.5 mmtt -67.42 -31.21 71.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 108.524 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' SER . 24.3 tp -73.93 -29.36 61.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.748 -0.595 . . . . 0.0 109.83 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 20.0 mttm 39.46 -92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 58' ' ' LEU . 83.0 p -129.48 -158.03 0.86 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . -73.17 -1.92 57.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.8 ttp -65.0 -46.15 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 110.463 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.413 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 81.6 mtt180 -106.21 11.36 31.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.765 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 73.7 t80 -50.23 -43.96 53.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 109.748 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.84 -38.7 80.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 109.897 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 64.9 mt-10 -61.64 -51.07 69.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.892 . . . . 0.0 109.841 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.569 HG11 ' CE2' ' A' ' 71' ' ' TYR . 93.6 t -69.65 -39.44 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -60.51 -53.25 59.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.71 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.9 mm-40 -70.73 -28.0 64.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CE2' HG11 ' A' ' 67' ' ' VAL . 12.0 m-30 -102.62 9.25 39.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 68' ' ' ALA . 47.4 t -79.07 88.18 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -104.33 7.66 35.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' ' CB ' ' A' ' 44' ' ' LEU . 43.0 p30 -132.01 40.49 3.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.468 -0.77 . . . . 0.0 109.982 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -64.89 -43.97 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.0 110.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.2 64.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -74.91 -33.09 61.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' ASP . 60.5 mt-30 -137.02 157.4 46.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.973 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.94 14.92 37.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.21 2.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 34.9 p-10 -121.3 137.37 54.72 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.318 -1.107 . . . . 0.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' CD1' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -104.35 -9.17 18.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 78.29 -143.98 27.81 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.581 ' CE2' ' HD2' ' A' ' 39' ' ' LYS . 89.5 m95 -79.99 140.33 36.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.589 -0.948 . . . . 0.0 111.302 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.528 ' HG3' ' CD1' ' A' ' 82' ' ' LEU . 68.7 mmm -131.66 114.6 15.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.6 -0.688 . . . . 0.0 109.171 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.468 HG23 ' HB1' ' A' ' 37' ' ' ALA . 51.4 p -74.6 -43.38 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.979 -1.076 . . . . 0.0 109.896 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 8.6 mtt180 -107.55 -62.58 1.41 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.833 . . . . 0.0 110.015 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 89.6 111.01 1.31 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -141.94 86.3 1.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -1.165 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.457 ' O ' HG11 ' A' ' 91' ' ' VAL . 49.4 mtt -121.71 -37.26 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.095 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.03 -88.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.254 -0.904 . . . . 0.0 110.142 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -170.55 -69.45 0.04 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 -37.92 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.874 1.46 . . . . 0.0 110.571 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 125' ' ' ILE . 60.5 t80 -60.92 -49.99 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 3.5 tm0? -74.54 -55.25 6.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 110.094 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 3.1 tp10 -42.05 -45.65 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.54 -39.7 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.68 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 95' ' ' GLN . . . -55.98 -41.36 74.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 87' ' ' ARG . 34.8 m-85 -89.5 -5.47 57.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 110.156 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -116.43 8.73 14.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.32 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' CD1' ' HD2' ' A' ' 102' ' ' PRO . 56.8 tp -52.75 127.48 43.33 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.159 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 101' ' ' LEU . 41.1 Cg_endo -67.61 149.77 79.55 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.913 1.481 . . . . 0.0 110.376 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 m -87.38 -10.51 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 111.073 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.1 p -111.51 112.55 24.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.403 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . -167.82 136.11 3.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 107' ' ' ASP . 5.5 ptt? -62.6 -40.38 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -1.12 . . . . 0.0 110.348 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' N ' ' CG ' ' A' ' 106' ' ' MET . 50.6 t0 -125.09 25.42 7.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.713 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 24.1 mttp -93.96 -18.5 0.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.429 -0.794 . . . . 0.0 112.671 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 45.6 Cg_endo -75.33 4.21 5.1 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 O-C-N 122.432 0.701 . . . . 0.0 110.56 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -133.28 -77.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 110.046 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.416 ' HE1' ' CE1' ' A' ' 64' ' ' PHE . 73.6 m-85 -106.55 146.89 30.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.611 ' CG2' ' CG1' ' A' ' 125' ' ' ILE . 13.3 p -72.04 86.87 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.002 -1.061 . . . . 0.0 109.065 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.1 125.77 38.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.446 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.3 Cg_endo -75.12 165.47 85.79 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 -2.147 . . . . 0.0 110.08 -0.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 -179.44 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.896 1.472 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 23.9 m -102.95 139.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.011 . . . . 0.0 110.558 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HE3' ' CD1' ' A' ' 51' ' ' ILE . 12.0 ttmt -112.08 123.81 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.585 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 73.7 p -130.65 176.1 8.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.981 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -72.03 -16.75 62.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.77 . . . . 0.0 110.551 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.1 p90 -98.18 19.4 14.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 0.0 110.187 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 111.29 -179.11 19.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 54.7 p90 -101.53 160.37 14.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -1.224 . . . . 0.0 110.034 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.57 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.3 m-70 -138.67 138.17 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 111.819 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 87.2 mt -115.27 111.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.611 ' CG1' ' CG2' ' A' ' 112' ' ' THR . 0.0 OUTLIER -103.23 143.86 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.066 . . . . 0.0 111.807 -178.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.8 tmm? -118.61 119.81 35.6 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 46.8 t -97.56 121.2 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -110.53 -8.13 14.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.481 -0.762 . . . . 0.0 109.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.487 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -144.44 149.96 22.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.02 149.31 52.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.922 -1.34 . . . . 0.0 110.653 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HG3' ' HA ' ' A' ' 36' ' ' ASN . 71.6 tttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.081 0.944 . . . . 0.0 110.368 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' CB ' ' HB3' ' A' ' 84' ' ' TRP . . . -133.8 156.45 48.0 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.785 -1.197 . . . . 0.0 111.263 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 130' ' ' ARG . 1.5 m -116.86 152.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HG3' ' CH2' ' A' ' 84' ' ' TRP . 5.5 mtmt -98.49 113.08 24.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.884 -1.135 . . . . 0.0 108.815 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG11 ' CG2' ' A' ' 125' ' ' ILE . 70.3 t -113.94 130.81 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.118 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -134.41 129.95 36.1 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.0 p80 -145.04 168.7 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.448 -1.407 . . . . 0.0 112.565 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 71' ' ' TYR . 89.4 mt -108.88 131.86 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -118.49 125.12 49.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 111.838 -178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' CG ' ' A' ' 73' ' ' GLU . 19.1 t -137.62 136.22 37.31 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.4 mm-40 -55.23 -157.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.502 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 92.8 mttt -97.91 105.04 17.12 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.47 -1.394 . . . . 0.0 112.509 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -133.02 16.7 4.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.242 -0.911 . . . . 0.0 109.897 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.28 23.49 73.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 91.7 mttt -94.51 6.18 49.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -1.006 . . . . 0.0 110.808 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG13 ' CD2' ' A' ' 122' ' ' TYR . 3.0 mp -51.27 -50.1 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.029 . . . . 0.0 110.392 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 39.5 ttp -69.62 -40.13 76.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -0.757 . . . . 0.0 111.288 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 54.1 tp10 -70.62 -41.09 72.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.656 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' O ' HD22 ' A' ' 58' ' ' LEU . . . -61.49 -54.51 42.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 111.18 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 4.9 ptt? -61.79 -44.12 97.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.085 -1.009 . . . . 0.0 111.178 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.525 ' N ' ' CG ' ' A' ' 55' ' ' MET . 10.2 pt-20 -72.04 -23.61 61.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.929 -1.107 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.7 tptt -70.26 -45.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.805 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' CB ' HG22 ' A' ' 67' ' ' VAL . 1.3 pp -81.02 -23.06 38.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' HD11 ' A' ' 58' ' ' LEU . 61.5 mmtt 52.2 -133.62 1.77 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.116 -0.99 . . . . 0.0 111.178 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -36.28 66.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 110.622 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.2 -0.3 3.54 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.221 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.4 mtm -47.86 -36.87 12.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.007 -1.29 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 7.1 mtp180 -110.3 29.28 7.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.703 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.96 -47.78 43.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.527 -0.733 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.18 -37.55 78.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.881 . . . . 0.0 109.945 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 8.3 tp10 -65.48 -47.67 75.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG22 ' CB ' ' A' ' 58' ' ' LEU . 41.0 t -63.52 -47.42 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.319 -0.863 . . . . 0.0 109.639 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -53.4 -51.06 63.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 110.127 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.97 67.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.687 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.462 ' NE2' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -70.81 -29.94 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' LEU . 57.3 m-85 -106.94 11.12 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.009 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ALA . 79.7 p -76.58 69.67 3.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.398 -0.813 . . . . 0.0 109.741 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 11.7 pt-20 -111.24 26.79 10.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.638 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 47.9 p-10 -100.66 14.45 31.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 74' ' ' ASP . 21.9 tttm -38.32 -35.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 110.166 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.15 -37.63 47.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.565 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 41.8 ttt85 -121.82 17.74 11.04 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.462 -0.774 . . . . 0.0 109.744 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 62.61 -77.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 110.612 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . 53.62 -116.14 5.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 66.74 -84.15 0.11 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -132.69 136.5 46.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -1.117 . . . . 0.0 110.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 6.0 mp -102.09 147.44 26.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.77 -125.14 0.19 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.541 ' CH2' ' HG3' ' A' ' 39' ' ' LYS . 94.2 m95 -93.79 131.61 38.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.549 -0.971 . . . . 0.0 111.001 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -127.6 122.24 32.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.104 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.0 p -72.14 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 111.04 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -87.19 -37.9 16.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' GLN . . . 57.66 77.82 0.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.448 ' HA ' ' NE2' ' A' ' 95' ' ' GLN . 90.1 p -123.91 103.24 8.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -1.135 . . . . 0.0 109.718 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -141.65 -86.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.403 HG21 ' HB2' ' A' ' 94' ' ' PHE . 13.6 m -67.37 -41.39 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 111.25 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' GLU . . . 132.03 -77.41 0.39 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.301 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -24.17 44.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.759 1.4 . . . . 0.0 112.03 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.403 ' HB2' HG21 ' A' ' 91' ' ' VAL . 45.9 t80 -62.68 -47.82 81.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.759 -1.213 . . . . 0.0 110.323 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -78.2 -38.12 43.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.531 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 89.6 mt-10 -55.35 -32.17 62.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.432 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -85.89 -40.24 16.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.036 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.37 7.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.841 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -70.56 -32.38 69.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.0 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -50.04 -35.36 24.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD23 ' CD ' ' A' ' 102' ' ' PRO . 7.0 tt -61.17 144.09 91.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' CD ' HD23 ' A' ' 101' ' ' LEU . 38.9 Cg_endo -65.25 159.57 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.707 1.372 . . . . 0.0 110.059 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 104' ' ' SER . 3.1 p -74.19 -44.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 111.568 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 77.6 p -130.09 4.5 4.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 104' ' ' SER . . . 48.27 -170.93 0.06 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 82.3 mmm -67.02 -31.91 72.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 107' ' ' ASP . 46.2 t0 -144.23 -86.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . 24.1 mtmm -82.99 166.67 34.2 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 110.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 108' ' ' LYS . 41.9 Cg_endo -69.89 171.96 13.64 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.84 1.442 . . . . 0.0 109.657 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 111' ' ' PHE . 95.7 t -139.96 172.7 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.076 -1.015 . . . . 0.0 110.934 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 52.8 p90 -120.19 163.87 17.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 6.4 m -48.87 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.485 -0.759 . . . . 0.0 110.533 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 37.5 p-10 -127.05 120.36 22.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.097 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.91 165.77 83.09 Favored 'Cis proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.623 -2.24 . . . . 0.0 109.736 0.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HG2' HG22 ' A' ' 51' ' ' ILE . 43.8 Cg_endo -71.09 178.55 5.27 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.784 1.413 . . . . 0.0 109.765 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.505 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 26.8 m -101.43 161.99 3.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -124.54 118.55 26.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 109.208 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -136.6 171.78 13.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.734 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -65.37 -9.07 21.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.549 -0.72 . . . . 0.0 110.277 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER -89.54 -20.18 24.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 109.043 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.17 -160.97 25.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.581 ' CD2' HG13 ' A' ' 51' ' ' ILE . 16.3 m-30 -100.72 134.54 43.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -1.077 . . . . 0.0 109.247 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.522 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 61.6 m-70 -125.39 121.75 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.011 -1.055 . . . . 0.0 112.556 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 4.8 tt -115.71 114.62 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 7.1 mt -107.13 125.56 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.942 -1.099 . . . . 0.0 113.543 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 9.8 tpt -100.09 114.12 27.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 128' ' ' GLU . 5.7 p -107.43 156.83 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.677 -1.265 . . . . 0.0 112.071 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' ' 127' ' ' VAL . 3.5 tt0 -103.85 -29.29 11.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.79 -175.42 23.04 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.528 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 17.8 ttp180 -132.41 -85.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.525 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 50.6 tttm . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.538 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.172 0.511 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 86' ' ' THR . . . -127.24 -172.89 2.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.672 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.1 m -135.92 145.67 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 110.337 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -98.73 137.15 37.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.822 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 m -138.43 157.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.3 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 7.7 mmt85 -123.1 115.8 22.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.525 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -125.52 157.61 36.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.715 -1.24 . . . . 0.0 112.633 -177.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 16.3 pt -130.57 125.49 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.586 HD12 ' CE1' ' A' ' 123' ' ' HIS . 6.5 tt -106.42 123.84 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.16 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 1.4 t -143.26 -171.47 3.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.906 -1.121 . . . . 0.0 111.8 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.634 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 4.4 mt-10 -77.41 117.15 18.61 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.595 -0.69 . . . . 0.0 111.403 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -82.58 77.28 9.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.711 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 19.3 m80 -134.61 71.05 1.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.983 -1.073 . . . . 0.0 110.155 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.18 78.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.184 -1.567 . . . . 0.0 109.184 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 59.6 tttt -108.7 -11.55 15.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -1.044 . . . . 0.0 110.385 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 47' ' ' LYS . 34.2 mt -47.58 -53.11 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 73.1 mtm -59.21 -37.34 77.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.446 -0.784 . . . . 0.0 110.598 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 75.0 mm-40 -61.41 -39.8 92.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.928 . . . . 0.0 110.568 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.47 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -66.38 -60.7 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.458 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.471 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 22.6 ptm -58.93 -44.44 91.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.026 . . . . 0.0 110.336 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 55' ' ' MET . 32.4 mm-40 -59.1 -42.98 91.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 62' ' ' MET . 66.2 tttt -72.07 -38.0 69.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 111.0 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 124' ' ' ILE . 2.3 pp -93.98 10.81 31.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.956 -1.09 . . . . 0.0 110.807 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.9 ptmt -42.55 161.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.145 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -52.09 115.99 1.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.004 . . . . 0.0 110.087 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.11 -44.05 1.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 7.5 tpt -77.3 162.72 27.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -1.098 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.36 100.25 8.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CD1' ' SD ' ' A' ' 126' ' ' MET . 76.9 t80 -50.64 -32.54 19.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.966 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -55.38 -43.64 75.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.558 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.22 -44.1 84.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.696 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 58' ' ' LEU . 59.3 t -55.81 -57.54 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 43' ' ' ILE . . . -46.13 -58.02 3.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.54 -38.7 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.375 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.527 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.6 mm-40 -78.77 -32.36 46.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.212 -0.93 . . . . 0.0 110.584 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.78 23.15 13.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -1.0 . . . . 0.0 110.616 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 m -83.86 100.27 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.385 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' OE1' ' HG3' ' A' ' 46' ' ' GLU . 28.7 tt0 -100.66 4.62 43.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.506 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 78' ' ' GLN . 85.3 m-20 -102.07 72.1 1.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.459 -0.776 . . . . 0.0 109.357 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -50.55 -35.49 30.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.467 -0.77 . . . . 0.0 110.87 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.41 -54.41 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -73.3 -15.7 61.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.102 -0.999 . . . . 0.0 110.589 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' CG ' ' O ' ' A' ' 78' ' ' GLN . 1.6 pt20 33.92 99.94 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.249 1.023 . . . . 0.0 111.431 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -70.38 -90.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . 46.73 -91.63 0.01 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 79' ' ' GLY . 19.9 p-10 -106.13 132.45 52.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.589 -0.948 . . . . 0.0 110.075 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 50.4 tp -116.88 135.08 54.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -56.48 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.528 ' NE1' ' HB2' ' A' ' 39' ' ' LYS . 24.8 m-90 -88.56 138.69 31.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.972 . . . . 0.0 110.466 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.5 mmm -101.41 119.45 38.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 108.999 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 37' ' ' ALA . 3.6 p -119.36 -29.42 5.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 7.2 ptp180 -63.61 -33.67 76.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.429 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . 52.85 20.7 8.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -130.36 78.71 1.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -1.166 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 92' ' ' GLY . 7.9 ttt -136.9 153.23 50.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.618 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 90' ' ' MET . 57.0 t 34.51 -91.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.368 0.604 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 90' ' ' MET . . . 178.44 -74.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 43.9 Cg_endo -70.14 -11.8 31.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.137 1.598 . . . . 0.0 110.391 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -73.94 -66.63 0.69 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' HA2' ' A' ' 88' ' ' GLY . 13.3 mm-40 -65.4 -40.2 93.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 110.944 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 9.8 pt-20 -55.07 -38.5 68.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.749 -1.219 . . . . 0.0 109.848 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.525 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . . . -68.12 -55.13 13.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.989 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.34 -49.57 12.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 7.3 m-30 -88.58 0.78 56.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.33 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 97' ' ' ALA . . . -83.23 -25.76 31.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.151 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.451 ' N ' HD13 ' A' ' 101' ' ' LEU . 9.5 mp -106.03 65.77 0.17 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 111.267 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 100' ' ' ALA . 50.0 Cg_endo -72.17 -21.33 23.76 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.729 1.384 . . . . 0.0 110.616 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.66 -13.39 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.9 m -101.22 116.54 33.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.108 -0.995 . . . . 0.0 109.111 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.31 -135.44 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.607 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 106' ' ' MET . 3.2 ttt -85.06 13.4 6.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -1.023 . . . . 0.0 110.959 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -102.68 -40.43 6.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.825 -1.172 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -133.81 98.17 14.9 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.06 126.44 10.56 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.918 1.483 . . . . 0.0 109.835 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.71 -178.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.668 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 54.3 p90 -123.65 172.56 8.71 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.587 ' CG2' HG12 ' A' ' 125' ' ' ILE . 3.1 p -58.26 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.607 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 10.5 p-10 -120.24 113.87 33.7 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.956 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.8 Cg_endo -73.4 164.53 86.89 Favored 'Cis proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.971 -2.095 . . . . 0.0 110.563 0.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 44.4 Cg_endo -73.02 -175.83 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.019 1.536 . . . . 0.0 110.385 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.63 146.55 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.515 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.484 ' HG2' HD12 ' A' ' 51' ' ' ILE . 64.7 mttt -112.61 130.53 56.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 73.8 p -142.31 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.889 -1.132 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.24 -29.73 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 109.997 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 3.5 p90 -88.6 43.26 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.533 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.6 -157.75 27.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p90 -130.61 160.18 34.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -1.037 . . . . 0.0 108.476 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 1.4 m-70 -140.32 133.24 29.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.666 -1.271 . . . . 0.0 112.135 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -112.66 136.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.587 HG12 ' CG2' ' A' ' 112' ' ' THR . 0.0 OUTLIER -126.52 133.71 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.598 -1.314 . . . . 0.0 112.278 -176.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.567 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 31.2 mtm -94.42 99.01 11.28 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.78 110.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.429 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -139.4 151.09 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.17 60.26 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.18 169.23 14.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.58 -0.953 . . . . 0.0 110.392 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.328 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.4 t30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.748 0.785 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 130' ' ' ARG . . . -136.36 164.2 28.67 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.645 -1.285 . . . . 0.0 110.648 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 85' ' ' MET . 17.9 m -139.48 146.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 33.0 tttm -100.57 130.34 46.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.918 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.407 HG23 ' HE3' ' A' ' 85' ' ' MET . 22.1 t -130.78 149.68 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.863 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 45.6 mtt180 -140.17 126.32 19.81 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.596 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 2.3 p80 -144.9 -178.65 6.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.612 -1.305 . . . . 0.0 112.206 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' A' ' 124' ' ' ILE . 9.2 pt -138.37 138.47 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -103.47 126.81 50.84 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.273 0.558 . . . . 0.0 110.386 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.8 p -134.38 171.09 14.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.063 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 48' ' ' HIS . 73.3 mm-40 -61.69 171.17 1.65 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.261 -0.899 . . . . 0.0 110.623 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 6.0 tttt -116.56 80.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.988 . . . . 0.0 110.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' A' ' 47' ' ' LYS . 18.4 m-70 -134.78 63.21 1.63 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.936 -1.103 . . . . 0.0 111.966 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.97 9.95 12.53 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.241 -0.912 . . . . 0.0 111.114 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 37.4 ttmt -89.2 13.29 13.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.973 -1.31 . . . . 0.0 110.482 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.609 HG13 ' CE2' ' A' ' 122' ' ' TYR . 82.0 mt -64.29 -42.58 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.569 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.446 ' CE ' ' SD ' ' A' ' 55' ' ' MET . 38.6 mmt -69.26 -44.4 71.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.895 . . . . 0.0 111.273 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -70.65 -38.92 73.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.08 . . . . 0.0 110.746 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.586 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.5 -52.73 56.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.446 ' SD ' ' CE ' ' A' ' 52' ' ' MET . 5.7 ptt? -65.39 -34.39 78.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.887 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 16.0 tp10 -58.03 -46.41 85.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HB3' HG21 ' A' ' 67' ' ' VAL . 22.2 tttt -67.57 -32.86 73.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 109.181 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.555 HD22 ' CE2' ' A' ' 111' ' ' PHE . 2.0 tp -74.41 -13.02 60.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 109.253 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 39.9 tptt -40.4 144.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.746 . . . . 0.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -50.4 149.43 3.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.235 -0.916 . . . . 0.0 108.953 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.88 -44.25 1.6 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.6 mmt -78.36 165.77 23.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.509 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.533 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -71.69 99.16 2.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.108 -0.995 . . . . 0.0 110.811 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 60.9 t80 -48.47 -29.54 4.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 109.304 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -77.79 -40.23 41.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 11.2 tp10 -56.54 -46.21 80.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.866 . . . . 0.0 109.67 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 71' ' ' TYR . 69.5 t -67.07 -44.06 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 109.558 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . . . -54.89 -50.89 67.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.92 57.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.2 mm-40 -63.1 -29.08 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 21.9 m-85 -108.99 18.77 20.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.46 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 68' ' ' ALA . 30.3 t -91.25 96.06 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -99.77 0.03 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.233 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 75' ' ' LYS . 41.2 t0 -105.97 15.26 26.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.464 -0.772 . . . . 0.0 109.953 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 14.4 pttm -41.81 -35.15 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -86.02 134.75 33.83 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 81.14 -18.39 0.5 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.683 -0.636 . . . . 0.0 109.962 -178.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.3 tt0 70.38 177.33 0.27 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 110.982 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 82' ' ' LEU . . . 154.8 -20.81 0.59 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 42' ' ' HIS . . . -48.29 -44.99 28.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 34.6 p-10 -115.01 126.43 54.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -1.016 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 9.0 mp -101.35 7.8 42.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 60.26 -147.66 44.63 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.585 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 35.3 m95 -96.73 132.29 42.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.743 -0.857 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 38' ' ' VAL . 9.0 ptp -135.87 149.77 49.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.58 -0.7 . . . . 0.0 109.206 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 26.4 p -111.47 -64.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.375 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' ' OG1' ' A' ' 86' ' ' THR . 7.3 mtp180 -71.69 -38.23 70.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 109.758 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 95' ' ' GLN . . . 60.03 55.38 30.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' HE2' ' A' ' 90' ' ' MET . 48.8 m -103.67 106.23 16.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.251 . . . . 0.0 109.522 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.404 ' HE2' ' O ' ' A' ' 89' ' ' SER . 16.0 mmt -130.16 -83.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 111.107 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.47 HG21 ' HD2' ' A' ' 93' ' ' PRO . 4.0 p -96.46 -28.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.235 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.453 ' N ' HG11 ' A' ' 91' ' ' VAL . . . 132.46 -73.12 0.47 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.025 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HD2' HG21 ' A' ' 91' ' ' VAL . 44.0 Cg_endo -69.84 -41.67 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.849 1.447 . . . . 0.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -53.91 -38.41 64.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.071 -1.018 . . . . 0.0 109.393 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 88' ' ' GLY . 44.9 tt0 -67.33 -52.35 41.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 38.3 tt0 -54.45 -44.45 72.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -59.67 -56.12 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.07 -54.9 6.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.346 -0.846 . . . . 0.0 110.264 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.435 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 61.1 m-85 -85.08 11.29 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 0.0 110.478 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -102.15 -19.9 14.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.736 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.69 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -109.05 21.94 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.91 . . . . 0.0 112.638 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 101' ' ' LEU . 52.1 Cg_endo -78.05 -8.51 16.57 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 m -107.04 25.4 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.49 -0.757 . . . . 0.0 110.081 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -101.26 -1.49 33.52 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.746 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.27 137.66 10.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 ttp -55.39 -44.87 76.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -1.221 . . . . 0.0 110.393 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -103.9 -62.93 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.49 162.63 49.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 110.158 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 127' ' ' VAL . 47.8 Cg_endo -74.27 142.15 29.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.144 1.602 . . . . 0.0 110.083 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.43 ' CG2' ' H ' ' A' ' 111' ' ' PHE . 2.7 m -106.87 -99.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CE2' HD22 ' A' ' 58' ' ' LEU . 40.6 t80 -116.58 152.19 34.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.896 -1.127 . . . . 0.0 110.806 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.512 ' CG2' HG12 ' A' ' 125' ' ' ILE . 7.3 p -74.84 110.43 9.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 110.936 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -133.81 121.69 16.12 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.32 172.7 58.49 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.164 -2.015 . . . . 0.0 110.362 -0.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.473 ' HG3' ' CD1' ' A' ' 124' ' ' ILE . 47.2 Cg_endo -73.15 178.12 6.95 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.956 1.503 . . . . 0.0 109.725 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 123' ' ' HIS . 16.2 m -99.91 155.11 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.008 -1.058 . . . . 0.0 109.378 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HB3' HD11 ' A' ' 51' ' ' ILE . 49.5 pttt -125.26 130.43 52.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.58 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.592 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 71.2 p -134.04 178.23 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -72.89 -15.83 61.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -0.955 . . . . 0.0 110.617 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 1.8 p90 -95.84 24.62 5.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.174 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 109.97 -176.41 19.19 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.4 m-85 -100.02 154.04 18.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 53.4 m-70 -129.91 122.52 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.872 -1.143 . . . . 0.0 110.487 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.58 HG22 ' CG1' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -117.92 108.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -109.01 157.47 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.69 -1.256 . . . . 0.0 112.959 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.508 ' HA ' ' CD1' ' A' ' 111' ' ' PHE . 3.7 ttt -116.26 119.29 35.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' PRO . 21.3 t -107.95 115.52 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.814 -1.179 . . . . 0.0 111.947 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -106.0 -18.28 14.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 70.7 -163.64 53.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.502 ' HG3' ' CZ3' ' A' ' 84' ' ' TRP . 66.1 ttt180 -132.77 -35.69 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.943 . . . . 0.0 110.003 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.288 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 86' ' ' THR . 38.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.26 0.553 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CA ' ' OG1' ' A' ' 86' ' ' THR . . . -113.14 168.73 9.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.0 110.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 14.3 m -130.3 169.5 21.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.558 -0.714 . . . . 0.0 109.882 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CG ' ' CE2' ' A' ' 84' ' ' TRP . 19.0 mtpt -98.53 119.61 37.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.095 -1.003 . . . . 0.0 109.193 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 95.9 t -111.72 126.39 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.023 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NH1' ' OE1' ' A' ' 128' ' ' GLU . 71.0 mtm180 -119.77 125.67 49.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.51 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.1 p80 -143.92 178.81 7.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.392 -1.442 . . . . 0.0 112.416 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 64' ' ' PHE . 88.6 mt -121.61 135.48 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -111.75 119.42 38.57 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.681 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 15.4 m -130.22 168.31 17.05 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 67.6 mt-10 -88.5 -172.6 3.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 110.283 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 35.9 mtmt -102.83 101.66 11.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.962 -1.086 . . . . 0.0 111.442 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 47' ' ' LYS . 28.7 m170 -134.57 6.56 3.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.888 . . . . 0.0 111.459 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.6 44.05 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.427 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 27.9 mttt -96.88 6.79 47.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.26 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 122' ' ' TYR . 69.5 mt -46.14 -57.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 55' ' ' MET . 51.1 mtt -65.08 -40.24 94.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.482 -0.761 . . . . 0.0 109.842 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 tp10 -67.37 -22.01 65.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.192 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -75.56 -60.51 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.167 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.495 ' HB2' ' HG2' ' A' ' 114' ' ' PRO . 11.6 ptt? -56.93 -32.52 66.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -71.09 -42.55 69.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 39.3 mmtm -64.37 -50.64 66.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' A' ' 59' ' ' LYS . 2.5 pp -78.17 -14.88 59.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 109.522 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 60' ' ' SER . 4.5 ptmm? 23.41 -134.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.517 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 41.3 t -52.0 -22.1 3.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.938 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 126.77 2.46 6.71 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.402 ' HB2' ' HE2' ' A' ' 62' ' ' MET . 58.3 ttm -56.86 -39.27 74.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -1.179 . . . . 0.0 109.675 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 4.3 mtt180 -108.86 13.26 24.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.0 110.132 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 43' ' ' ILE . 77.3 t80 -51.1 -48.87 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 49.5 m-80 -57.76 -43.38 85.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.35 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' CD ' ' HG2' ' A' ' 63' ' ' ARG . 41.4 mt-10 -68.09 -38.24 82.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 97.4 t -62.74 -71.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.416 -0.803 . . . . 0.0 109.134 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -48.65 -50.8 31.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 65' ' ' ASN . . . -42.92 -42.24 3.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.822 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.525 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.1 tp60 -106.02 -6.61 18.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.378 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-85 -103.42 11.74 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.6 p -83.27 100.5 10.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 110.383 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -106.03 20.12 19.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.953 . . . . 0.0 110.067 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 30.2 t0 -137.85 39.84 2.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -59.84 -24.29 64.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.857 . . . . 0.0 110.189 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.93 81.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -103.26 -57.6 2.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.138 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ASP . 1.2 pt20 -135.19 164.83 26.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.84 23.21 31.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 97.76 1.32 58.77 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 76.1 m-20 -134.15 132.01 39.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.799 -1.412 . . . . 0.0 110.929 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.51 HD11 ' CD2' ' A' ' 42' ' ' HIS . 7.3 mp -109.58 151.87 26.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.795 . . . . 0.0 109.368 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -77.56 -132.5 0.6 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.619 ' CE2' ' CG ' ' A' ' 39' ' ' LYS . 86.0 m95 -95.08 122.71 38.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.928 -0.748 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.421 ' HE3' ' CG2' ' A' ' 40' ' ' VAL . 6.6 ptt? -141.54 137.47 32.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 36' ' ' ASN . 89.1 m -103.38 -45.13 4.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.762 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -73.27 -32.22 64.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.0 -145.66 16.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -120.96 -62.16 1.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.147 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 85.9 mmm -137.44 -86.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.394 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.61 176.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 96' ' ' GLU . . . 93.93 -151.14 20.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 43.0 Cg_endo -69.3 -8.34 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.245 1.656 . . . . 0.0 110.093 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 125' ' ' ILE . 1.1 t80 -76.71 -48.52 18.58 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.514 -0.741 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -78.87 -47.6 16.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.129 -0.982 . . . . 0.0 110.835 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -62.43 -20.65 64.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.499 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -93.16 -55.02 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.786 -1.196 . . . . 0.0 110.545 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.31 -54.51 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.967 . . . . 0.0 111.388 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 38.8 m-85 -89.81 -21.85 22.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.158 -0.964 . . . . 0.0 111.609 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -119.05 32.43 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.823 -1.173 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 14.4 tp -56.1 140.71 70.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HD2' ' HG ' ' A' ' 101' ' ' LEU . 43.8 Cg_endo -70.45 150.72 64.41 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.946 1.498 . . . . 0.0 110.036 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 103' ' ' VAL . 7.1 p -68.78 90.98 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 110.522 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 p -100.33 -10.57 21.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.061 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.69 145.08 18.65 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.33 -28.97 69.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 111.298 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 31.9 p-10 -140.3 -46.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.886 -1.134 . . . . 0.0 110.951 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 4.0 mttp -128.04 126.49 23.75 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.571 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.52 162.16 36.2 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.938 1.494 . . . . 0.0 110.491 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 111' ' ' PHE . 48.9 t -121.33 -74.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.241 -0.912 . . . . 0.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.572 ' CE2' HG13 ' A' ' 110' ' ' VAL . 92.8 m-85 -98.37 167.29 10.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.481 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 96.8 m -62.15 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 112.558 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 54.2 t0 -70.33 -34.08 3.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.686 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 52.9 Cg_endo -76.16 -25.76 10.25 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.466 -1.056 . . . . 0.0 114.729 1.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 42.0 Cg_endo -71.14 115.56 4.32 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 122.341 0.653 . . . . 0.0 112.895 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 123' ' ' HIS . 32.3 t -111.39 153.08 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 14.6 ptmm? -143.06 117.93 9.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.795 -1.191 . . . . 0.0 110.697 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' ' CD2' ' A' ' 120' ' ' PHE . 1.3 t -145.37 179.65 7.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -64.12 -11.97 35.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER -87.78 -17.99 30.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 108.673 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.522 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 129.08 -149.84 18.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.95 142.85 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -1.092 . . . . 0.0 108.446 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 116' ' ' VAL . 35.2 m-70 -132.32 144.09 50.32 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.229 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 7.6 mt -132.72 109.96 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 94' ' ' PHE . 1.2 mt -115.32 129.66 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.735 -1.228 . . . . 0.0 112.271 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' CE1' ' A' ' 111' ' ' PHE . 88.1 mtp -99.55 135.19 41.33 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.8 125.4 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.949 -1.095 . . . . 0.0 111.141 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.52 ' OE1' ' NH1' ' A' ' 41' ' ' ARG . 79.7 tt0 -142.21 147.75 37.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.08 76.47 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.473 ' HA ' HG13 ' A' ' 38' ' ' VAL . 76.2 ttt180 -122.34 131.89 54.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -1.119 . . . . 0.0 110.179 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.164 0.507 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' CB ' HG23 ' A' ' 86' ' ' THR . . . -128.92 172.03 11.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 110.7 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 85' ' ' MET . 3.6 p -141.45 156.94 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.357 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -100.13 119.72 38.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' CG2' ' CD2' ' A' ' 82' ' ' LEU . 4.5 m -127.31 157.36 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.7 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 37.9 mtt-85 -139.8 118.84 12.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.52 ' HB3' ' CG2' ' A' ' 125' ' ' ILE . 2.8 p80 -132.03 161.96 31.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.838 -1.164 . . . . 0.0 112.262 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.565 HG12 ' CB ' ' A' ' 68' ' ' ALA . 3.4 mt -115.81 128.15 73.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 5.1 tt -110.36 129.37 55.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.226 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.402 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 45.1 t -132.33 152.5 51.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.588 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 33.8 mt-10 -64.76 -171.64 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.716 -1.24 . . . . 0.0 109.463 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 48.0 tttt -97.94 106.66 18.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.587 -1.32 . . . . 0.0 113.312 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.588 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 2.8 m-70 -131.63 -5.9 3.67 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.161 -0.962 . . . . 0.0 110.032 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.6 30.29 10.84 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' GLU . 82.3 mttt -109.63 -2.75 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 111.111 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.562 ' HB ' ' CG ' ' A' ' 122' ' ' TYR . 11.3 tt -45.64 -40.94 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.497 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 16.6 ttt -65.66 -34.4 78.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.334 -0.854 . . . . 0.0 109.001 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' LYS . 79.5 tt0 -72.24 -41.75 66.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 108.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.94 -57.03 13.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.716 . . . . 0.0 110.12 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.525 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 28.3 ptm -68.83 -28.13 66.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.862 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.3 tt0 -74.57 -26.25 59.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' CB ' HG13 ' A' ' 67' ' ' VAL . 17.2 mmtm -81.41 -36.84 29.03 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.538 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 0.3 OUTLIER -83.96 -19.04 35.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.453 -0.78 . . . . 0.0 109.259 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 56' ' ' GLU . 60.8 mmtt 44.57 -138.75 0.38 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.48 -0.762 . . . . 0.0 110.052 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.8 t -54.86 -25.91 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 110.912 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 139.7 -11.47 3.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.4 mtp -48.21 -35.39 11.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -112.91 26.64 10.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.154 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.548 ' CE1' HD13 ' A' ' 43' ' ' ILE . 79.6 t80 -55.49 -37.51 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -75.37 -39.56 59.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.339 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 61.1 mm-40 -62.43 -58.15 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.794 . . . . 0.0 109.534 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.592 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 16.6 m -50.92 -44.7 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.242 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.565 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -62.72 -37.26 85.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.602 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -55.66 -36.9 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.176 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 4.1 tp60 -105.74 -10.83 16.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 110.794 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 67' ' ' VAL . 24.8 m-85 -114.23 18.94 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.247 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 36.6 t -111.77 113.24 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.831 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.94 -5.3 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.655 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 96.2 m-20 -104.43 59.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.452 -0.78 . . . . 0.0 109.607 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -55.43 -28.88 57.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.343 -0.848 . . . . 0.0 111.773 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.15 -36.12 6.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.729 -1.232 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -65.12 -55.54 18.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.12 . . . . 0.0 110.307 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' HG3' ' C ' ' A' ' 77' ' ' ARG . 19.7 mt-30 -143.45 -72.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 110.696 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.84 -107.83 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -99.35 -37.97 3.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 39.2 p30 -128.5 134.65 48.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.076 -1.249 . . . . 0.0 110.959 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 85' ' ' MET . 2.1 pp -103.3 1.33 32.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.5 -134.81 11.84 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.532 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.6 m-90 -99.23 155.41 17.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.552 -0.97 . . . . 0.0 110.915 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.538 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -126.87 133.63 50.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.442 -0.786 . . . . 0.0 109.471 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.526 HG23 ' CB ' ' A' ' 37' ' ' ALA . 30.5 p -128.77 -37.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.035 -1.04 . . . . 0.0 111.011 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 3.1 mtm105 -116.63 -14.96 10.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.907 -1.121 . . . . 0.0 111.507 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.463 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . 126.92 -176.66 17.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.446 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 9.5 t -141.8 -32.09 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.45 -1.029 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 3.7 mmt -104.33 -145.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.913 -1.117 . . . . 0.0 110.956 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CG2' ' HD2' ' A' ' 93' ' ' PRO . 13.3 m -86.53 -29.41 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.073 -1.017 . . . . 0.0 112.467 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.547 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 177.04 -54.44 0.1 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 118.451 -1.833 . . . . 0.0 111.877 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 37.9 Cg_endo -62.23 -27.04 77.97 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.352 1.185 . . . . 0.0 111.856 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' A' ' 90' ' ' MET . 78.1 t80 -70.79 -52.39 20.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.749 -1.219 . . . . 0.0 109.948 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 2.6 tt0 -73.25 -29.42 62.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 109.548 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 83.0 mt-10 -70.42 -25.86 63.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 109.832 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ALA . . . -87.09 -53.88 4.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.67 -50.62 60.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -76.05 -14.69 60.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.253 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -67.7 -58.01 5.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.694 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 100' ' ' ALA . 11.2 mp -41.07 120.5 1.84 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.36 164.97 30.09 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.802 1.422 . . . . 0.0 110.606 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.06 107.92 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.873 . . . . 0.0 109.849 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.7 p -102.13 3.82 38.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -159.15 178.09 35.44 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.9 ttt -73.98 -31.53 63.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.309 -1.112 . . . . 0.0 110.243 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -122.14 23.47 9.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 110.186 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 28.4 mmtt -71.04 -40.07 9.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 110.8 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 45.7 Cg_endo -73.7 155.98 49.09 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.167 1.088 . . . . 0.0 110.135 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -144.86 -85.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.119 -0.988 . . . . 0.0 111.76 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 9.3 t80 -133.95 156.11 48.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 111.109 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 114' ' ' PRO . 23.2 p -70.63 63.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.407 -0.808 . . . . 0.0 109.712 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -97.88 130.73 28.17 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.5 Cg_endo -74.9 168.8 76.28 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.773 -2.178 . . . . 0.0 110.033 -0.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 41.6 Cg_endo -70.75 171.51 15.4 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.049 1.552 . . . . 0.0 110.407 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.33 150.32 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.494 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG2' HD12 ' A' ' 51' ' ' ILE . 50.4 mtmt -113.33 133.32 55.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 75.5 p -139.28 -178.7 5.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.804 -1.185 . . . . 0.0 111.485 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -81.43 -18.03 46.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.449 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.3 OUTLIER -91.23 -0.77 57.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.062 -1.024 . . . . 0.0 109.455 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 132.46 -176.38 19.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 94.8 m-85 -100.95 153.77 19.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.489 -1.007 . . . . 0.0 109.426 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.583 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 5.0 m-70 -141.6 141.35 33.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 112.286 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -124.55 114.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 176.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -103.38 157.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.225 1.012 . . . . 0.0 112.175 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.561 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 19.5 ttt -136.94 134.07 36.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.71 136.55 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.74 -1.225 . . . . 0.0 111.353 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.02 109.19 7.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 109.669 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.66 115.24 0.26 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -130.07 150.5 51.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 pttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.269 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 86' ' ' THR . 26.4 p30 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.434 0.635 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 131' ' ' LYS . . . -90.31 129.19 36.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 110.309 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -141.63 164.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HD3' ' CZ2' ' A' ' 84' ' ' TRP . 12.1 mtmm -98.76 121.31 40.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.221 -0.925 . . . . 0.0 108.773 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.507 ' HB ' ' CD1' ' A' ' 82' ' ' LEU . 91.2 t -130.15 143.84 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.934 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' N ' HG11 ' A' ' 40' ' ' VAL . 31.1 mtt85 -140.4 107.17 5.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 3.8 p80 -132.45 179.33 6.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.615 -1.303 . . . . 0.0 112.149 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 6.7 mt -127.81 133.66 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -117.33 121.44 41.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.988 . . . . 0.0 111.149 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 54.0 t -142.07 137.25 30.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.143 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 71.5 mm-40 -58.28 162.03 3.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 2.9 tttm -72.68 113.28 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.033 -1.042 . . . . 0.0 112.674 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.587 ' CE1' ' CB ' ' A' ' 46' ' ' GLU . 7.2 m-70 -132.06 14.41 4.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.28 76.23 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 12.4 mtpt -93.92 -5.66 47.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.984 . . . . 0.0 110.475 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.592 HG13 ' CD2' ' A' ' 122' ' ' TYR . 2.8 mp -40.13 -58.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.225 -0.922 . . . . 0.0 110.426 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 6.0 ttt -69.12 -45.29 70.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.99 -46.94 78.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -59.84 -62.63 1.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.551 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.537 ' CE ' ' HD3' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -61.19 -39.86 91.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.12 -179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 4.5 tp10 -52.82 -54.98 26.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.794 -1.191 . . . . 0.0 109.54 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -57.55 -38.2 74.36 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.506 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.92 -68.83 0.14 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 25.9 mmtt 39.17 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.588 -0.695 . . . . 0.0 110.281 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -110.08 133.64 53.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.05 -1.031 . . . . 0.0 110.725 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.86 -12.22 59.19 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.406 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 tpt -81.49 161.22 23.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.32 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -82.79 99.34 9.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.344 -0.848 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' CD1' ' HE3' ' A' ' 126' ' ' MET . 66.0 t80 -49.17 -29.37 5.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 110.379 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -63.37 -35.12 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -77.19 -41.02 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 58' ' ' LEU . 23.3 t -68.69 -38.11 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.955 -1.091 . . . . 0.0 110.195 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -68.68 -41.92 78.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.95 -1.094 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.11 81.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.862 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.9 tp60 -70.25 -34.81 73.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 110.757 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 54.1 m-85 -104.42 21.81 16.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.023 -1.048 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -86.01 90.91 8.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.1 tp10 -100.33 -2.42 33.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.336 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 32.0 p-10 -136.25 12.33 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 79' ' ' GLY . 81.4 tttt -56.46 -34.17 66.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.416 -0.802 . . . . 0.0 110.386 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.5 94.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 5.9 ptp180 -98.81 -12.9 20.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.044 -1.035 . . . . 0.0 110.967 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -129.05 -38.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.911 -1.118 . . . . 0.0 110.241 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . 93.23 -12.66 69.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 90.83 -43.79 2.86 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.8 p-10 -124.56 142.74 51.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -1.207 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.507 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 2.9 pp -136.59 156.08 49.05 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.02 -119.16 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.802 -1.189 . . . . 0.0 111.047 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.594 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 19.0 m-90 -90.7 121.42 32.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.065 -0.668 . . . . 0.0 110.802 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.462 ' SD ' HD11 ' A' ' 82' ' ' LEU . 23.3 ptm -144.38 155.12 43.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 1.5 p -87.0 134.85 33.45 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.585 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 50.8 mtt-85 -98.96 46.11 0.99 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.178 . . . . 0.0 112.48 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.08 36.27 4.38 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 106.586 -2.606 . . . . 0.0 106.586 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -137.08 -7.93 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.874 -0.78 . . . . 0.0 111.792 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.93 -166.15 1.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.719 -1.238 . . . . 0.0 110.391 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.27 178.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.883 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.74 -151.54 19.64 Favored Glycine 0 N--CA 1.483 1.799 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.933 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 47.4 Cg_endo -75.16 -24.17 12.83 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.717 1.904 . . . . 0.0 110.664 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 44.6 t80 -45.71 -65.85 0.48 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 87' ' ' ARG . 4.0 tm0? -79.56 -32.04 42.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 41.0 tt0 -56.15 -39.77 72.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.952 -1.092 . . . . 0.0 110.403 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.64 -39.76 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . . . -44.99 -59.25 2.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 110.774 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -81.69 -41.02 21.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 111.373 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -51.33 -21.22 2.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 103' ' ' VAL . 14.5 tp -45.38 127.4 6.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 110.008 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -27.3 16.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.944 1.497 . . . . 0.0 110.895 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.487 ' O ' HD21 ' A' ' 101' ' ' LEU . 30.4 m -124.11 125.92 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.112 -0.993 . . . . 0.0 110.629 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 130' ' ' ARG . 69.3 m -131.58 66.79 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.63 65.73 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.7 ttm -52.02 -39.6 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.179 -1.189 . . . . 0.0 110.092 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -137.84 -59.09 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.275 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 19.5 tptm -132.53 143.04 47.11 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 108' ' ' LYS . 42.6 Cg_endo -69.94 130.62 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.882 1.464 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -134.44 157.49 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.251 -0.905 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.497 ' CA ' ' O ' ' A' ' 125' ' ' ILE . 37.4 p90 -122.85 158.87 29.35 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.094 -1.003 . . . . 0.0 110.147 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 14.8 m -50.43 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.362 -0.836 . . . . 0.0 112.197 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.478 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 46.4 t0 -132.36 118.64 16.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 41.4 Cg_endo -66.82 176.42 23.35 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.315 -1.952 . . . . 0.0 111.011 1.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.537 ' HD3' ' CE ' ' A' ' 55' ' ' MET . 47.5 Cg_endo -81.89 -178.76 4.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.16 1.611 . . . . 0.0 110.398 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 25.2 m -104.49 142.9 16.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.839 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -115.33 124.99 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 109.246 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.601 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 69.5 p -137.01 -179.38 5.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.621 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 3.9 tttm -68.07 -11.72 59.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.601 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 0.4 OUTLIER -107.56 22.5 15.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.82 -1.175 . . . . 0.0 110.816 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 46' ' ' GLU . . . 104.35 -179.32 24.67 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.592 ' CD2' HG13 ' A' ' 51' ' ' ILE . 32.7 p90 -101.58 155.28 18.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.942 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 3.0 m-70 -134.25 147.35 50.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 111.881 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.525 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 3.0 tt -126.83 115.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 mp -104.68 141.57 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 112.354 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.491 ' HE3' ' CD1' ' A' ' 64' ' ' PHE . 1.3 mmm -113.63 102.69 10.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.76 132.5 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.177 -0.952 . . . . 0.0 111.194 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.13 70.84 1.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 128.14 127.32 2.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 104' ' ' SER . 3.6 ptp180 -126.64 148.74 49.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 1.7 tttp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.155 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -130.61 164.46 24.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 127' ' ' VAL . 7.3 p -143.33 156.01 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 8.2 tttm -101.05 126.5 47.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.256 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 ' CE ' ' A' ' 85' ' ' MET . 35.2 m -131.05 152.91 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.585 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -136.32 123.26 21.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 124' ' ' ILE . 1.7 p80 -130.01 157.46 42.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.747 -1.22 . . . . 0.0 112.192 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CD1' HD13 ' A' ' 124' ' ' ILE . 1.4 pt -112.66 131.94 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 1.6 tt -104.77 131.46 52.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.913 -1.117 . . . . 0.0 111.852 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 48.7 t -136.17 156.18 49.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 48' ' ' HIS . 97.5 mt-10 -112.96 -12.68 13.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.044 -1.035 . . . . 0.0 111.774 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 14.9 mmtm -64.72 114.33 4.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 46' ' ' GLU . 7.1 m-70 -89.71 144.07 26.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.855 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 -15.99 58.9 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.535 ' NZ ' ' CE1' ' A' ' 71' ' ' TYR . 27.9 tttm -97.37 -9.76 26.82 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 122' ' ' TYR . 38.9 mt -46.29 -44.86 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.457 ' O ' ' HG2' ' A' ' 55' ' ' MET . 21.2 ptt? -62.45 -36.52 82.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 110.7 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' A' ' 52' ' ' MET . 59.2 tt0 -72.44 -37.46 68.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.318 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.33 -49.2 72.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 59' ' ' LYS . 13.8 ptt? -65.29 -31.89 73.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.008 . . . . 0.0 110.385 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -70.96 -44.02 66.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.042 -1.036 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -58.79 -53.45 58.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -76.57 -27.53 55.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 108.8 179.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 55' ' ' MET . 33.0 tttt 45.83 -99.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -0.789 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 p -98.41 -12.47 21.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.897 -1.127 . . . . 0.0 110.561 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 64' ' ' PHE . . . 124.47 2.05 8.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.1 mmm -50.28 -49.86 52.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.029 -1.277 . . . . 0.0 109.745 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -103.82 32.64 3.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.349 -0.845 . . . . 0.0 109.491 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 9.8 t80 -52.22 -48.67 65.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.431 -0.793 . . . . 0.0 110.72 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 33.7 t30 -54.91 -47.52 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.73 -42.49 77.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 45.1 t -65.42 -53.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -59.96 -52.62 64.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 110.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -62.37 -18.43 61.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 111.353 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -24.61 11.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 110.89 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.535 ' CE1' ' NZ ' ' A' ' 50' ' ' LYS . 45.4 m-85 -100.31 6.47 44.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.075 -1.016 . . . . 0.0 109.517 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 28.7 t -72.16 103.74 3.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.386 -0.822 . . . . 0.0 110.575 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 45' ' ' CYS . 11.0 mt-10 -101.01 5.49 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.953 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 78' ' ' GLN . 17.6 t0 -111.8 24.61 12.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HG2' ' OG ' ' A' ' 72' ' ' SER . 20.3 mmtt -62.83 -36.25 82.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.116 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.06 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.26 -59.96 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.258 -0.902 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.468 ' O ' ' OD2' ' A' ' 74' ' ' ASP . 8.5 pt20 -169.52 105.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.765 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 74' ' ' ASP . . . -129.45 91.36 0.31 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.84 -96.94 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 56.1 p30 -114.76 160.61 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 110.951 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 7.5 mp -103.99 -11.55 17.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 85.65 -143.48 19.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -106.96 129.59 54.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.567 -0.96 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.537 ' CE ' HG22 ' A' ' 40' ' ' VAL . 14.3 ptp -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.049 -1.032 . . . . 0.0 109.924 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.4 p -101.63 -67.6 0.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 111.457 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 84.8 mtt85 -80.83 -29.19 35.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.961 . . . . 0.0 111.24 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 95' ' ' GLN . . . 168.31 -170.28 42.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -142.87 -50.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -1.195 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.521 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -117.63 -95.59 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 111.578 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 6.1 m -114.91 -175.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.875 -1.141 . . . . 0.0 111.941 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.613 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -63.86 -46.36 91.87 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.613 -0.68 . . . . 0.0 111.922 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.6 Cg_endo -66.35 -40.76 13.77 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.066 1.035 . . . . 0.0 110.755 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 87.8 t80 -75.44 -37.22 60.51 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 45.6 tt0 -76.38 -51.73 11.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.773 . . . . 0.0 110.433 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 80.5 tt0 -57.4 -40.19 77.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.979 . . . . 0.0 110.409 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -63.82 -63.52 1.14 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -37.61 -58.57 0.87 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.296 0.57 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.29 -15.34 63.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 111.118 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 102' ' ' PRO . . . -135.15 40.66 2.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.748 -1.22 . . . . 0.0 111.951 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -105.67 67.52 0.17 Allowed Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.848 -1.158 . . . . 0.0 111.015 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 100' ' ' ALA . 42.4 Cg_endo -68.14 93.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.616 1.324 . . . . 0.0 110.974 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 104' ' ' SER . 11.2 p -66.24 -40.41 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 109.851 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.475 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 84.3 p -138.81 -36.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.853 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.95 155.87 15.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.0 ttt -65.11 -37.33 87.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -1.17 . . . . 0.0 110.456 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.463 ' C ' ' CD ' ' A' ' 109' ' ' PRO . 6.8 p-10 -127.31 13.27 7.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.578 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 86.8 mttt -118.19 39.13 0.29 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.0 111.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 51.4 Cg_endo -77.55 149.32 26.99 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.223 1.117 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 126' ' ' MET . 6.4 p -132.18 -21.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.43 -0.794 . . . . 0.0 110.481 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' CE2' HD23 ' A' ' 58' ' ' LEU . 6.3 t80 -142.91 151.53 41.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.582 ' O ' ' CE1' ' A' ' 111' ' ' PHE . 40.3 m -86.06 111.38 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.672 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -133.23 117.66 14.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.0 Cg_endo -78.19 173.67 55.59 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.014 -2.078 . . . . 0.0 110.066 0.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.467 ' HB3' HG13 ' A' ' 124' ' ' ILE . 42.4 Cg_endo -71.32 177.3 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.848 1.446 . . . . 0.0 110.014 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -105.02 150.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.846 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -116.13 121.1 41.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 67.4 p -135.51 176.01 9.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.666 -1.271 . . . . 0.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.29 -14.48 62.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 110.426 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -105.28 33.31 3.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.293 -0.88 . . . . 0.0 108.706 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' HA2' ' HE1' ' A' ' 48' ' ' HIS . . . 89.47 174.22 46.01 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 35.3 p90 -100.85 151.72 21.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.16 -1.2 . . . . 0.0 108.681 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 3.7 m-70 -130.75 160.22 34.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.893 -1.13 . . . . 0.0 112.532 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.598 HG21 ' CE2' ' A' ' 111' ' ' PHE . 1.8 mp -126.04 124.96 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 125' ' ' ILE . 1.7 mt -107.04 136.14 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.821 -1.175 . . . . 0.0 112.759 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 38.1 tpp -122.89 102.75 8.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 38' ' ' VAL . 14.7 p -103.09 129.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.022 -1.049 . . . . 0.0 112.189 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -142.48 135.65 28.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.672 -0.642 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.48 121.51 1.55 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -108.79 151.87 25.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 0.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 67.8 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.131 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.0 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.578 0.704 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.02 134.6 44.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 4.4 p -127.31 153.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.985 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 11.8 tttp -101.64 133.14 46.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.939 . . . . 0.0 109.995 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' HD11 ' A' ' 82' ' ' LEU . 3.6 t -128.29 139.12 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.09 -1.006 . . . . 0.0 111.342 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 90.2 mtt180 -120.98 121.97 39.14 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -135.5 150.51 49.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.757 -1.214 . . . . 0.0 111.406 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG1' ' HB ' ' A' ' 124' ' ' ILE . 32.9 pt -121.19 133.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.1 tt -104.93 134.58 47.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.916 -1.115 . . . . 0.0 112.087 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 7.6 p -139.49 168.01 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 109.523 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.3 mm-40 -73.44 -159.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.007 . . . . 0.0 110.747 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 4.4 mtmt -122.9 99.52 6.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 110.623 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 8.3 m-70 -132.35 30.9 4.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.857 . . . . 0.0 110.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.07 21.38 75.5 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 48' ' ' HIS . 94.4 mttt -93.14 15.91 14.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 HD11 ' HG2' ' A' ' 117' ' ' LYS . 56.4 mt -61.89 -43.95 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.075 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 55' ' ' MET . 8.0 ttt -70.59 -40.64 73.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.518 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 52.2 mp0 -70.42 -37.2 74.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.872 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . -59.72 -60.73 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.661 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 15.5 ptt? -52.73 -38.09 60.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 55' ' ' MET . 96.8 mt-10 -73.61 -11.94 60.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 29.8 tptt -80.83 -40.0 25.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD22 ' CG ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -94.17 -22.28 18.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.601 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 58.6 mttp 49.3 -142.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -52.95 -34.26 54.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.432 -0.792 . . . . 0.0 110.935 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.98 -11.66 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 36.3 ttm -50.64 -34.85 27.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.14 -1.212 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 89.3 mtt180 -112.7 31.12 6.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.974 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 78.3 t80 -51.98 -40.46 60.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 110.083 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -70.69 -33.37 70.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 13.4 tp10 -63.26 -52.4 62.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.613 HG11 ' N ' ' A' ' 68' ' ' ALA . 9.4 p -62.28 -36.46 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 109.57 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' N ' HG11 ' A' ' 67' ' ' VAL . . . -65.31 -35.44 81.0 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.243 -0.911 . . . . 0.0 109.111 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -59.95 -51.62 68.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.515 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 7.0 mm-40 -71.61 -19.65 62.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.003 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.511 ' O ' ' O ' ' A' ' 44' ' ' LEU . 29.1 m-85 -116.22 23.92 11.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.44 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' ALA . 55.9 p -78.12 76.22 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.023 -1.048 . . . . 0.0 109.767 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 80.8 mm-40 -105.76 1.47 27.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.25 13.92 9.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HA ' ' CA ' ' A' ' 79' ' ' GLY . 12.5 tmtt? -48.57 -34.72 11.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.534 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.26 96.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -94.7 -61.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 110.233 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -121.36 -61.56 1.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.893 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 75' ' ' LYS . . . 92.25 -104.19 3.14 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -103.04 -73.78 0.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 27.8 p-10 -81.19 153.27 27.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.29 -1.124 . . . . 0.0 110.781 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 9.0 mp -113.82 -12.34 12.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.83 . . . . 0.0 109.794 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.38 -165.36 24.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.617 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 93.6 m95 -93.87 136.8 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.981 . . . . 0.0 110.091 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.447 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.5 ptp -140.52 135.56 32.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.89 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 18.1 p -83.83 -37.63 22.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.482 -0.761 . . . . 0.0 110.443 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -113.41 -38.54 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 95' ' ' GLN . . . 58.69 66.2 2.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 31.3 t -113.08 105.63 13.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -1.171 . . . . 0.0 109.437 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.2 tpt -125.69 -60.38 1.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 111.291 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 92' ' ' GLY . 11.8 p -114.63 -30.22 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.882 -1.137 . . . . 0.0 111.312 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 130.64 -65.83 0.59 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.006 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 49.0 Cg_endo -71.1 -24.76 23.28 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.811 1.427 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.593 ' CE2' HG23 ' A' ' 125' ' ' ILE . 39.9 t80 -74.3 -35.47 63.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.445 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 64.5 tt0 -78.62 -39.76 36.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.42 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.556 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 17.5 pt-20 -63.42 -25.04 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.779 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -88.45 -46.15 9.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.123 -0.986 . . . . 0.0 111.174 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.37 -35.21 75.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.465 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -100.85 -1.04 35.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.85 -1.156 . . . . 0.0 111.818 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -99.45 -26.12 14.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.706 -1.246 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.479 ' CD2' HG21 ' A' ' 127' ' ' VAL . 14.4 tp -45.37 135.35 5.61 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.013 . . . . 0.0 110.001 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.44 141.29 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.974 1.513 . . . . 0.0 110.47 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 103' ' ' VAL . 6.6 p -131.0 101.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 108' ' ' LYS . 96.6 p -119.12 8.94 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.38 -123.85 5.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.81 16.74 25.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -1.228 . . . . 0.0 110.388 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -104.32 8.98 36.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HG2' ' OG ' ' A' ' 104' ' ' SER . 74.8 mmtt -122.53 157.58 58.8 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.71 166.23 30.11 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.97 1.51 . . . . 0.0 110.017 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.447 HG23 ' HE2' ' A' ' 126' ' ' MET . 33.7 m -106.74 -14.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.542 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.633 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 3.6 p90 -128.68 177.63 6.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.723 -1.236 . . . . 0.0 111.472 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.554 ' CG2' HD11 ' A' ' 125' ' ' ILE . 3.2 p -71.58 -105.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.46 -0.775 . . . . 0.0 111.708 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.784 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 28.0 m-20 -79.8 -29.11 0.55 Allowed Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.784 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 38.2 Cg_endo -76.78 -26.04 10.1 Favored 'Cis proline' 0 N--CA 1.487 1.129 0 C-N-CA 124.169 -1.179 . . . . 0.0 115.075 2.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.602 ' N ' HG13 ' A' ' 124' ' ' ILE . 43.2 Cg_endo -69.18 121.39 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-O 121.69 0.621 . . . . 0.0 112.422 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 2.9 t -97.5 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HG2' HD11 ' A' ' 51' ' ' ILE . 37.5 mtmm -103.91 112.96 26.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.027 . . . . 0.0 110.253 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.636 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 14.6 p -138.36 166.36 24.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 110.663 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -66.43 -9.35 33.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.636 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.2 OUTLIER -105.78 21.88 16.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.839 -1.163 . . . . 0.0 110.312 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.559 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 108.71 -173.51 17.68 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.855 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.617 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.97 150.55 21.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.547 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 33.3 m-70 -138.31 127.45 24.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.534 -1.354 . . . . 0.0 112.631 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.602 HG13 ' N ' ' A' ' 115' ' ' PRO . 1.2 mp -106.83 105.2 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.593 HG23 ' CE2' ' A' ' 94' ' ' PHE . 34.3 pt -108.76 141.47 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.447 ' HE2' HG23 ' A' ' 110' ' ' VAL . 16.7 ttt -119.07 141.87 48.37 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 101' ' ' LEU . 23.3 m -113.5 105.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.846 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 63.2 tt0 -111.44 132.98 54.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.782 . . . . 0.0 109.674 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 73.31 80.21 0.46 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -110.23 146.64 35.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.99 . . . . 0.0 109.712 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 1.3 mmmm . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 0.0 110.288 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 10.4 p30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.532 0.682 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 84' ' ' TRP . . . -112.32 166.59 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.403 -0.81 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 26.8 m -138.72 148.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.709 -0.62 . . . . 0.0 109.808 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' CE ' ' HD2' ' A' ' 130' ' ' ARG . 26.5 mttt -98.64 114.3 26.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 108.74 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 78.5 t -114.61 136.36 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 45.7 ttp180 -130.82 118.35 20.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 4.3 p80 -128.15 177.65 6.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.713 -1.242 . . . . 0.0 112.068 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 68' ' ' ALA . 46.1 mt -126.49 140.69 48.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.3 tt -112.32 127.05 55.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.48 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 56.8 m -132.06 138.79 48.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 109.859 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.623 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 72.1 mt-10 -59.63 155.58 15.28 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.003 -1.061 . . . . 0.0 108.786 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.539 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 4.1 tttt -80.42 118.77 22.34 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.027 -1.046 . . . . 0.0 113.101 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 8.0 m80 -135.2 1.75 2.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.697 . . . . 0.0 110.384 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.16 5.38 73.08 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 18.4 ptpt -99.71 22.17 11.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.745 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.522 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 69.6 mt -49.28 -53.1 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.419 -0.801 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.54 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 44.0 ttm -59.38 -34.39 72.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 81.2 mm-40 -63.15 -41.84 99.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.75 -52.35 57.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 0.0 110.67 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.489 ' HA ' ' CB ' ' A' ' 58' ' ' LEU . 2.6 ppp? -69.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 52' ' ' MET . 32.9 mm-40 -68.13 -33.03 73.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 108.909 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' CG ' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -87.55 -14.82 39.2 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -74.91 -29.64 61.03 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.746 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 58' ' ' LEU . 13.0 ptpt -30.9 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.43 0.633 . . . . 0.0 111.385 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -52.4 -42.92 64.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.356 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.97 -26.57 2.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.495 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 6.5 tpt -106.44 150.33 26.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -1.137 . . . . 0.0 110.296 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 66' ' ' GLU . 3.3 ptm180 -75.23 109.61 8.88 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.306 1.051 . . . . 0.0 110.72 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.553 ' CE1' ' SD ' ' A' ' 126' ' ' MET . 84.2 t80 -41.96 -36.31 1.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.743 -0.598 . . . . 0.0 109.665 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -58.64 -44.62 90.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 110.664 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 35.7 tt0 -65.04 -48.68 72.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.052 . . . . 0.0 110.812 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 27.4 m -63.68 -44.12 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.081 -1.448 . . . . 0.0 109.493 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 64' ' ' PHE . . . -63.31 -39.42 94.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 109.571 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.69 71.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.436 -0.79 . . . . 0.0 109.699 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -80.31 -7.14 58.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.594 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m-30 -108.79 9.0 26.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.858 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.7 t -80.8 83.52 6.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.174 -0.954 . . . . 0.0 111.251 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -99.54 7.02 45.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 77' ' ' ARG . 18.8 p30 -104.1 41.46 1.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.686 -0.634 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -50.4 -42.04 53.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 110.586 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 9.38 28.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.6 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 74' ' ' ASP . 2.6 ttt180 -105.29 -15.12 15.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 55.58 55.98 6.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -116.48 25.43 9.16 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -82.74 -60.0 2.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 9.5 p-10 -133.5 133.57 42.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.29 . . . . 0.0 111.059 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.1 mp -104.04 157.07 17.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 109.212 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 -127.92 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.177 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 23.5 m-90 -90.92 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.872 -0.781 . . . . 0.0 110.611 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 84' ' ' TRP . 13.9 mmt -132.14 140.82 48.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.9 t -110.37 -45.49 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.314 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' THR . 2.2 mmp_? -117.4 1.9 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.443 -0.786 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.557 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 72.8 146.47 0.71 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.476 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 38.8 p -146.37 40.67 1.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.594 -1.533 . . . . 0.0 111.541 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.591 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 2.1 tpt -125.48 137.02 53.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.033 -1.042 . . . . 0.0 110.123 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.498 ' CG2' ' C ' ' A' ' 90' ' ' MET . 5.8 m 35.0 -110.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.748 -0.595 . . . . 0.0 111.149 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.78 -67.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.432 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 38.2 Cg_endo -64.08 -14.07 41.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.709 1.373 . . . . 0.0 110.813 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.591 ' CD2' ' HB3' ' A' ' 90' ' ' MET . 68.5 t80 -68.27 -47.03 68.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.56 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 14.5 mt-30 -71.05 -41.48 70.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 109.285 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 60.9 mm-40 -58.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.491 -0.756 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -68.11 -41.41 81.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.449 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -50.19 -51.8 40.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.702 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.41 -1.39 57.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 0.0 111.118 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -116.92 12.2 14.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.85 -1.156 . . . . 0.0 110.891 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD22 ' CG2' ' A' ' 112' ' ' THR . 52.5 mt -37.53 97.66 0.14 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.564 -0.71 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 49.6 Cg_endo -77.09 -2.15 12.37 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.041 1.548 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 104' ' ' SER . 11.7 p -69.56 -44.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.681 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.443 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 44.1 m -142.54 -42.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 110.282 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.3 -80.27 0.87 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 79.1 mtp -63.96 -42.63 97.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -1.189 . . . . 0.0 109.953 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' C ' ' CD ' ' A' ' 109' ' ' PRO . 94.5 m-20 -107.1 81.86 1.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -116.73 42.9 0.38 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.364 -0.835 . . . . 0.0 111.225 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 50.0 Cg_endo -75.09 -6.85 18.51 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.468 1.247 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.33 -140.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 0.0 109.905 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.497 ' HB3' ' HG2' ' A' ' 126' ' ' MET . 33.8 p90 -124.86 156.11 38.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.012 -1.055 . . . . 0.0 110.425 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.517 ' CG2' HD22 ' A' ' 101' ' ' LEU . 24.8 p -46.16 124.51 5.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.0 111.08 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 34.1 t0 -133.35 119.75 15.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.7 Cg_endo -79.11 174.33 51.2 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.12 -2.033 . . . . 0.0 110.163 -0.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.522 ' HG2' ' CG2' ' A' ' 51' ' ' ILE . 46.5 Cg_endo -72.12 177.33 7.31 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.863 1.454 . . . . 0.0 109.993 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.32 158.98 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.9 ptmm? -119.64 136.23 54.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.585 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 74.3 p -142.13 168.62 19.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.62 -23.69 59.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 15.2 p90 -98.81 46.22 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.539 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 84.08 175.65 50.9 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 41.8 p90 -98.53 166.12 11.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -1.112 . . . . 0.0 108.844 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 22.8 m-70 -141.77 140.49 33.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.802 -1.186 . . . . 0.0 112.624 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.515 ' O ' ' CG1' ' A' ' 124' ' ' ILE . 5.1 pt -128.1 110.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.567 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 12.0 pt -106.98 149.61 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.055 -1.028 . . . . 0.0 112.867 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 49.5 mtp -107.0 124.43 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.46 107.78 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 111.319 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.35 -3.36 27.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.422 -0.799 . . . . 0.0 109.4 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 58.39 -164.54 8.34 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.475 ' HD2' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tpm_? -134.26 -35.45 0.93 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.776 -0.838 . . . . 0.0 109.894 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 36' ' ' ASN . 23.7 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.35 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 23.2 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.082 0.468 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -86.86 129.46 34.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.986 -1.071 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 22.9 m -144.1 151.12 16.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.917 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 2.3 tmtt? -96.11 124.27 40.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.049 -1.032 . . . . 0.0 108.858 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 82' ' ' LEU . 42.9 t -119.75 132.55 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.022 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 53.0 mtm180 -120.25 112.35 18.94 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.566 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 2.7 p80 -134.86 158.82 43.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.518 -1.364 . . . . 0.0 113.047 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.605 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 7.8 pt -119.82 133.42 66.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.618 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -106.28 136.09 46.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.462 0.649 . . . . 0.0 111.719 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 26.0 m -142.57 144.88 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.975 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.644 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt-10 -59.0 172.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.062 -1.024 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.1 ttmt -105.48 113.18 26.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.686 -1.259 . . . . 0.0 113.29 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.644 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 1.5 m80 -134.3 26.56 3.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.56 9.21 82.02 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 ttmt -90.76 -10.65 42.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.622 -0.928 . . . . 0.0 109.975 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 52' ' ' MET . 16.4 tt -44.2 -42.72 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.464 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.531 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 11.9 ttt -67.09 -29.73 69.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.0 109.139 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' LYS . 65.7 tt0 -72.2 -42.92 65.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.356 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.85 74.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.787 . . . . 0.0 110.164 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 22.1 ptm -74.1 -22.43 59.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 32.2 tp10 -69.92 -38.03 76.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -80.78 -25.65 37.75 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 111' ' ' PHE . 35.4 tp -76.2 -44.34 38.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.564 0.697 . . . . 0.0 109.275 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 32.1 mtmt 48.43 -112.51 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.598 -0.689 . . . . 0.0 111.081 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.7 p -78.79 -14.37 59.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.954 -1.091 . . . . 0.0 110.261 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' HA2' HD11 ' A' ' 58' ' ' LEU . . . 103.33 0.32 47.17 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 61' ' ' GLY . 56.8 ttp -44.72 -34.65 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.268 . . . . 0.0 109.641 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' PHE . 10.6 mtp180 -112.89 19.38 17.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 63' ' ' ARG . 87.1 t80 -43.72 -40.36 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 28.9 p-10 -66.12 -40.37 90.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 43.5 mm-40 -70.59 -43.36 69.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 109.491 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 18.4 t -69.79 -41.02 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.573 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.577 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . . . -63.68 -43.33 96.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 110.226 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -59.71 -43.45 94.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.56 -9.1 59.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 8.5 m-85 -111.82 5.51 19.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.942 . . . . 0.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.2 m -73.86 87.44 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE1' HD23 ' A' ' 44' ' ' LEU . 2.6 tm-20 -101.41 32.04 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.59 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 78.6 m-20 -100.13 83.55 2.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 14.8 tptt -70.79 -52.21 22.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 111.087 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' HB1' ' HD3' ' A' ' 77' ' ' ARG . . . -77.05 -13.14 60.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.111 -0.993 . . . . 0.0 110.599 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.543 ' CD ' ' N ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -102.42 -48.6 4.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.129 -0.982 . . . . 0.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 38.1 mm-40 51.56 34.73 13.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 110.035 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -93.64 -55.87 1.49 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 67.86 -64.41 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 79' ' ' GLY . 75.5 m-20 -116.47 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.693 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 8.3 mp -102.78 139.86 37.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -71.8 -138.47 0.23 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.626 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 1.5 m95 -91.58 134.18 34.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -1.02 . . . . 0.0 110.343 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.491 ' CE ' ' HA3' ' A' ' 88' ' ' GLY . 21.2 ptm -134.01 150.75 51.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 47.3 p -101.56 -38.67 7.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.953 -1.092 . . . . 0.0 110.126 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -114.01 -92.58 0.49 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.491 ' HA3' ' CE ' ' A' ' 85' ' ' MET . . . 73.14 75.12 0.75 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.1 m -110.86 93.28 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -31.15 8.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -150.6 -171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.044 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -88.33 -56.5 2.02 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.314 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -66.55 -29.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.372 1.196 . . . . 0.0 112.343 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.507 ' HB2' HG23 ' A' ' 91' ' ' VAL . 32.5 t80 -69.18 -43.4 74.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.71 -1.244 . . . . 0.0 110.756 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' OE1' ' CD1' ' A' ' 99' ' ' PHE . 7.7 tp-100 -72.52 -52.07 17.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.904 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 62.8 mt-10 -59.94 -20.97 60.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.149 -0.969 . . . . 0.0 110.912 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -82.76 -59.24 2.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.905 -1.122 . . . . 0.0 110.557 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.84 -59.31 5.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CD1' ' OE1' ' A' ' 95' ' ' GLN . 29.2 m-85 -74.3 -28.32 61.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -118.11 34.97 4.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.909 -1.119 . . . . 0.0 110.764 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.554 ' CD1' ' HA ' ' A' ' 112' ' ' THR . 8.8 tp -56.68 142.69 70.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.113 -0.992 . . . . 0.0 110.345 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' HD2' ' CD1' ' A' ' 101' ' ' LEU . 46.1 Cg_endo -71.31 -178.11 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.819 1.431 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.7 t -53.75 122.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 20.1 m -136.61 84.35 2.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.374 -0.829 . . . . 0.0 109.683 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.82 -149.54 33.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 37.4 ttm -66.27 -45.09 81.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.031 -1.276 . . . . 0.0 108.52 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -141.55 -96.32 0.13 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 34.7 mttm -134.15 42.29 0.79 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 47.5 Cg_endo -73.49 -0.93 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.491 1.259 . . . . 0.0 110.792 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 104' ' ' SER . 34.5 m -128.65 -156.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.568 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.62 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 29.2 p90 -119.08 165.03 14.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.527 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.554 ' HA ' ' CD1' ' A' ' 101' ' ' LEU . 46.0 p -48.22 113.62 0.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 110.776 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 37.3 p-10 -132.26 120.61 17.15 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.765 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.77 165.26 74.1 Favored 'Cis proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.769 -2.179 . . . . 0.0 110.248 0.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.542 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 45.1 Cg_endo -70.46 -179.88 3.56 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.926 1.487 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 116' ' ' VAL . 29.2 m -105.8 134.33 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.895 . . . . 0.0 110.509 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.499 ' HB2' ' CE ' ' A' ' 47' ' ' LYS . 10.0 ptpt -109.65 126.99 54.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 0.0 109.187 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.604 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 44.0 p -130.33 -177.6 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.039 -1.038 . . . . 0.0 111.013 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -69.53 -18.8 63.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -0.772 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 p90 -100.36 32.58 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.044 . . . . 0.0 109.88 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 97.68 177.04 33.96 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 53.8 p90 -99.74 162.21 13.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -1.179 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.626 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 7.6 m-70 -141.69 151.49 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.001 -1.062 . . . . 0.0 112.238 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.605 ' CG1' ' CG1' ' A' ' 43' ' ' ILE . 1.8 pt -133.94 118.92 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 8.2 pt -121.56 142.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.673 -1.267 . . . . 0.0 112.83 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.481 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 34.8 mmm -97.43 125.04 41.83 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 108' ' ' LYS . 42.9 t -113.16 121.36 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.664 -1.273 . . . . 0.0 111.889 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.473 ' CG ' ' HB3' ' A' ' 39' ' ' LYS . 8.7 pt-20 -115.16 -22.17 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.527 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 80.9 -167.47 49.9 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.585 ' HD3' ' CE3' ' A' ' 84' ' ' TRP . 12.7 tpt180 -132.66 -75.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.983 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 3.6 p30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.459 0.647 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 86' ' ' THR . . . -130.84 150.98 51.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.9 OUTLIER -111.39 164.93 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HD3' ' CE2' ' A' ' 84' ' ' TRP . 30.0 mtmt -99.05 117.35 33.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 109.544 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 13.1 t -116.67 133.25 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 110.763 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -141.49 113.04 7.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 79' ' ' GLY . 5.0 p80 -132.16 -179.29 5.33 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.98 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 68' ' ' ALA . 5.2 mt -124.31 117.43 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.15 120.19 40.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.864 -1.147 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 71' ' ' TYR . 5.4 m -133.54 155.59 49.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.042 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.596 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.27 -163.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.835 -1.165 . . . . 0.0 110.561 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -92.48 106.43 18.42 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.739 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 17.9 m-70 -123.27 -2.83 8.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.7 27.89 73.52 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -107.17 8.97 30.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.54 -0.976 . . . . 0.0 110.11 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 122' ' ' TYR . 75.9 mt -41.23 -43.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.02 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -31.94 72.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' LYS . 2.1 tp10 -76.18 -37.36 57.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.412 -0.805 . . . . 0.0 110.109 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.83 -52.69 64.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.43 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 14.0 ptm -66.55 -35.46 80.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.387 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 55' ' ' MET . 26.8 tt0 -70.15 -36.06 74.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.55 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HG3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -71.0 -35.7 72.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.778 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 59' ' ' LYS . 4.6 pp -97.14 -46.12 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 110.823 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.601 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 13.4 mttt 37.87 -157.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.0 t -103.01 7.8 39.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.029 -1.044 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.89 -40.07 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 33.7 mmt -67.44 166.79 13.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -1.149 . . . . 0.0 110.37 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.3 mtt85 -72.02 97.97 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 110.715 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -52.33 -31.48 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.25 -35.71 71.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.346 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 43.7 tt0 -63.62 -39.1 93.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.567 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' A' ' 58' ' ' LEU . 30.5 t -68.61 -45.75 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -59.18 -47.98 83.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.36 79.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 111.013 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.1 mm-40 -83.92 -23.54 31.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.026 -1.046 . . . . 0.0 111.395 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.442 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 21.9 m-30 -112.86 18.79 17.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.933 -1.104 . . . . 0.0 110.677 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -89.15 112.59 23.63 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.75 -4.95 29.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 80' ' ' GLY . 58.5 p30 -104.67 33.77 3.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.708 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -52.89 -41.01 63.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 110.21 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.56 90.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 mtt85 -85.61 -11.33 54.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.158 -0.964 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 58.21 30.58 19.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.747 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -68.83 -25.6 75.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 74' ' ' ASP . . . -49.73 -34.3 21.12 Favored Glycine 0 N--CA 1.489 2.19 0 O-C-N 121.127 -1.219 . . . . 0.0 110.391 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -134.59 109.21 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.784 -1.421 . . . . 0.0 111.483 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.3 mp -100.48 145.06 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.65 -141.27 4.54 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.536 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.58 ' CE2' ' HD3' ' A' ' 39' ' ' LYS . 77.5 m95 -81.82 100.67 9.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.899 -0.765 . . . . 0.0 109.678 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' MET . 1.8 ptp -139.04 146.66 41.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.011 -1.056 . . . . 0.0 111.149 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -126.3 -0.0 7.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.564 -0.71 . . . . 0.0 109.301 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -90.43 -175.48 4.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.473 ' CA ' ' NE2' ' A' ' 95' ' ' GLN . . . -99.05 124.73 8.32 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.45 -9.98 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.084 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.587 ' HG3' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -136.28 -165.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.77 151.74 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.982 -1.074 . . . . 0.0 111.05 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -169.14 19.81 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 97' ' ' ALA . 40.5 Cg_endo -66.96 -11.23 31.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.161 1.611 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 90' ' ' MET . 0.9 OUTLIER -57.39 -58.38 8.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.107 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 46.4 tt0 -72.1 -40.61 68.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 31.8 tt0 -64.05 -40.53 96.5 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -66.26 -56.03 13.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.124 -0.985 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.72 -47.47 5.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 10.5 m-30 -94.87 17.94 12.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.134 -0.978 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . . . -111.24 -21.9 11.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.4 mt -49.0 131.32 15.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.77 -17.84 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.92 1.484 . . . . 0.0 110.507 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 103' ' ' VAL . 29.0 m -67.51 129.18 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 61.9 p -126.1 16.36 7.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.009 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 140.16 15.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -93.25 -5.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -1.102 . . . . 0.0 110.279 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.455 ' OD1' ' HG3' ' A' ' 108' ' ' LYS . 44.6 p-10 -101.35 6.25 42.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.76 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' A' ' 107' ' ' ASP . 28.8 mtmt -127.11 62.03 50.64 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.983 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.438 ' HB3' ' HG2' ' A' ' 128' ' ' GLU . 46.6 Cg_endo -71.06 124.55 10.65 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.949 1.499 . . . . 0.0 110.344 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.1 t -142.5 164.43 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 23.9 p90 -114.31 164.42 13.94 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.333 -0.854 . . . . 0.0 109.687 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.486 HG23 ' CG1' ' A' ' 125' ' ' ILE . 30.4 p -63.5 109.42 1.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 111.654 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 25.8 p-10 -132.66 113.11 13.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.07 166.55 67.19 Favored 'Cis proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.343 0.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.518 ' HB3' HG13 ' A' ' 124' ' ' ILE . 47.5 Cg_endo -71.45 -174.79 1.33 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.086 1.572 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.6 t -101.66 136.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.753 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.411 ' C ' HG22 ' A' ' 118' ' ' THR . 52.9 tttm -110.21 120.12 41.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.855 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.643 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -130.69 170.64 14.05 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -70.25 -14.65 62.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.408 -0.807 . . . . 0.0 110.554 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.643 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -91.57 5.15 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.834 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 126.91 -169.84 18.78 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CE2' HG13 ' A' ' 51' ' ' ILE . 18.1 m-30 -99.59 159.26 15.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -1.083 . . . . 0.0 108.609 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 67.0 m-70 -143.44 110.13 5.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.783 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 4.4 mp -100.52 111.71 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' CB ' ' A' ' 42' ' ' HIS . 33.6 pt -115.67 142.76 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.557 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.431 ' HE1' ' C ' ' A' ' 109' ' ' PRO . 12.4 tpt -115.11 124.02 50.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 131.08 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.107 -0.996 . . . . 0.0 111.373 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 71.1 mt-10 -141.98 143.56 33.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.51 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 56.9 117.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -113.68 156.68 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -1.216 . . . . 0.0 110.137 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.0 pttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.326 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB1' ' CD ' ' A' ' 131' ' ' LYS . . . -79.13 115.5 18.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.852 -1.155 . . . . 0.0 109.596 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -127.97 160.91 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 8.7 mttt -98.82 128.96 45.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.373 -0.83 . . . . 0.0 109.61 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 72.8 t -109.82 129.97 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.372 -0.83 . . . . 0.0 111.45 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 83.2 mtt180 -120.69 125.14 46.92 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.573 ' CD2' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -134.98 172.61 12.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 0.0 112.351 -178.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HB3' ' A' ' 71' ' ' TYR . 58.9 mt -126.79 116.58 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 4.6 tt -102.56 124.07 47.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.901 -1.124 . . . . 0.0 111.629 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 19.0 m -142.77 160.42 40.35 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.591 ' O ' ' CE2' ' A' ' 122' ' ' TYR . 87.1 mt-10 -71.7 172.31 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.903 -1.123 . . . . 0.0 109.789 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 74.6 tttt -93.12 111.4 23.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.851 -1.156 . . . . 0.0 112.547 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.562 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 5.8 m-70 -132.43 9.61 4.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.47 -8.79 77.96 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 51' ' ' ILE . 7.6 tttp -73.81 -15.44 61.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.708 -0.878 . . . . 0.0 109.611 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 122' ' ' TYR . 10.8 tt -40.5 -44.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.798 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.474 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 50.8 ttp -65.38 -42.61 92.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 67.0 tt0 -56.49 -44.19 80.43 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.268 -0.895 . . . . 0.0 109.147 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.37 -60.76 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 59' ' ' LYS . 52.7 ttp -59.93 -33.38 71.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.557 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 45.1 tt0 -62.93 -33.92 76.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 108.793 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' O ' ' SD ' ' A' ' 62' ' ' MET . 16.9 tptt -62.55 -45.68 91.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.493 -0.754 . . . . 0.0 109.185 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 111' ' ' PHE . 1.4 pp -108.76 27.61 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.384 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' MET . 36.4 tttp -54.74 -60.13 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.398 0.618 . . . . 0.0 110.722 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.4 m -81.37 33.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 74.16 25.59 70.66 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.551 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 3.7 ttm -53.79 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.837 -1.39 . . . . 0.0 109.572 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CG ' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -70.69 78.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.998 -1.064 . . . . 0.0 111.288 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' ' SD ' ' A' ' 126' ' ' MET . 5.2 t80 -46.65 -27.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.865 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.565 ' OD1' ' CG ' ' A' ' 63' ' ' ARG . 33.9 p-10 -67.68 -46.91 70.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.219 . . . . 0.0 110.092 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 83.9 mt-10 -63.27 -32.47 73.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 109.496 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' TYR . 45.8 t -61.55 -53.63 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -51.11 -60.5 3.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.952 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.48 19.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.802 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' NE2' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -71.32 -26.71 62.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 48.6 m-85 -111.04 30.05 7.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.385 -0.822 . . . . 0.0 110.282 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 68' ' ' ALA . 43.4 t -100.21 101.95 13.11 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.095 -1.003 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -101.72 2.25 38.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 15.3 m-20 -116.69 30.75 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.741 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -67.42 -23.86 65.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.78 . . . . 0.0 110.255 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.4 -56.34 21.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.143 -0.973 . . . . 0.0 109.181 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 4.2 ttm180 -96.31 -52.01 4.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.482 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 9.6 pt20 179.96 133.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.656 -0.653 . . . . 0.0 109.866 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.39 96.72 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.96 -85.96 0.1 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 95.5 m-20 -121.19 137.2 54.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -1.169 . . . . 0.0 110.731 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 42' ' ' HIS . 6.9 mp -100.56 163.55 12.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.822 . . . . 0.0 109.577 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.17 -143.68 0.61 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 94.1 m95 -82.78 160.53 22.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.496 -1.002 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -138.13 143.8 40.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.0 109.799 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 87' ' ' ARG . 11.4 t -131.34 -46.43 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.941 -1.099 . . . . 0.0 111.689 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.514 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -117.48 -5.98 11.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.667 -1.271 . . . . 0.0 112.807 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . 118.65 -168.31 13.21 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 118.949 -1.595 . . . . 0.0 110.611 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.416 ' C ' ' HG3' ' A' ' 90' ' ' MET . 26.2 t -125.68 -88.8 0.58 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.614 -0.933 . . . . 0.0 110.708 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' GLY . 65.9 mtm -147.43 -85.49 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.046 -1.034 . . . . 0.0 112.87 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -9.0 -58.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 125.34 -72.43 0.44 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.538 -1.351 . . . . 0.0 109.811 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 38.1 Cg_endo -63.42 -37.14 50.94 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.851 1.448 . . . . 0.0 109.333 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' A' ' 91' ' ' VAL . 74.9 t80 -60.09 -33.78 72.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.561 0.696 . . . . 0.0 109.259 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 38.0 tt0 -75.64 -45.06 39.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.562 -0.711 . . . . 0.0 110.148 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.562 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 46.6 mt-10 -55.62 -42.68 75.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.0 110.566 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -81.02 -58.7 2.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.509 -1.37 . . . . 0.0 110.711 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 94' ' ' PHE . . . -50.76 -34.41 27.09 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.83 -1.169 . . . . 0.0 111.859 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -117.9 -46.92 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.558 -1.339 . . . . 0.0 112.435 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -76.26 -11.18 59.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.841 -1.162 . . . . 0.0 111.575 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 4.2 tp -55.6 141.61 63.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.826 -1.171 . . . . 0.0 109.425 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' ' HG ' ' A' ' 101' ' ' LEU . 42.2 Cg_endo -68.88 134.56 30.2 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.948 1.499 . . . . 0.0 110.947 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.454 ' O ' HG21 ' A' ' 103' ' ' VAL . 28.3 m -112.37 117.42 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 110.025 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.4 m -138.88 76.57 1.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.72 -24.72 13.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mmm -75.34 -22.96 57.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -1.212 . . . . 0.0 110.447 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -113.98 -56.02 2.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 110.787 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.468 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 6.0 pttm -131.98 164.2 44.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.401 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 108' ' ' LYS . 47.3 Cg_endo -71.57 175.06 10.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.968 1.509 . . . . 0.0 110.357 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.06 33.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 21.0 t80 -108.72 134.41 51.47 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.466 ' CG2' ' HA ' ' A' ' 115' ' ' PRO . 6.5 m -53.65 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 110.418 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 26.3 p-10 -133.03 113.52 13.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.58 163.3 90.07 Favored 'Cis proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.073 -2.053 . . . . 0.0 110.382 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.474 ' HG2' HG12 ' A' ' 51' ' ' ILE . 46.7 Cg_endo -72.87 -179.66 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.99 1.521 . . . . 0.0 110.054 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.6 161.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.005 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.8 ptmt -129.93 119.46 23.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 39.5 p -122.94 -177.16 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.84 -1.162 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -71.49 -16.69 62.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 0.0 110.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -98.87 27.13 5.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.909 -1.119 . . . . 0.0 109.301 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 103.18 179.69 26.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 52.6 p90 -99.22 159.22 15.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.302 . . . . 0.0 109.797 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.59 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 34.8 m-70 -132.66 140.17 48.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 111' ' ' PHE . 3.7 mp -115.55 136.99 50.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.98 147.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.32 -1.488 . . . . 0.0 112.066 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.562 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 13.6 ttt -127.17 135.09 50.19 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.55 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.938 -1.101 . . . . 0.0 111.077 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -141.69 160.82 39.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.674 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 78.62 81.38 0.69 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.468 ' HD2' ' OXT' ' A' ' 131' ' ' LYS . 8.5 tmm_? -97.1 142.73 28.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 110.402 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.494 ' CD ' ' HB1' ' A' ' 37' ' ' ALA . 9.6 tttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 86' ' ' THR . 12.3 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.083 0.468 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 131' ' ' LYS . . . -131.86 143.42 50.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 0.0 110.684 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 129' ' ' GLY . 7.4 p -142.7 176.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.91 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.535 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -97.04 121.97 39.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.919 -1.113 . . . . 0.0 108.353 178.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 77.2 t -108.2 138.27 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.05 0.929 . . . . 0.0 112.946 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -140.76 117.0 10.63 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 1.2 p80 -138.61 -175.04 3.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.446 -1.409 . . . . 0.0 112.565 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 67' ' ' VAL . 73.8 mt -130.91 114.31 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.3 tt -104.54 117.27 33.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 110.555 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.653 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 41.7 t -142.52 152.06 42.27 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.223 -0.923 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 18.9 pt-20 -52.5 153.63 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 109.372 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 3.1 tptt -127.24 113.44 16.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.84 -1.163 . . . . 0.0 111.79 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.633 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.7 m-70 -133.29 -60.74 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.063 0.935 . . . . 0.0 108.584 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.33 25.71 0.23 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -116.14 -10.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.555 -0.968 . . . . 0.0 110.148 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -51.08 -32.61 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -0.799 . . . . 0.0 110.444 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.485 ' O ' ' HG2' ' A' ' 55' ' ' MET . 40.0 mtp -72.01 -34.02 68.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.975 -1.078 . . . . 0.0 109.553 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -74.51 -32.5 62.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.331 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.427 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.02 -39.94 87.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.643 -0.661 . . . . 0.0 109.986 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.509 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 4.0 ptt? -70.8 -34.19 71.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -0.968 . . . . 0.0 109.676 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 70.4 tt0 -57.72 -50.48 73.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' C ' HG21 ' A' ' 67' ' ' VAL . 34.0 mmtt -71.16 -21.16 62.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.903 . . . . 0.0 108.943 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 64' ' ' PHE . 39.5 tp -75.77 -15.49 60.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.647 -0.658 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 29.1 mmmt -40.0 136.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.816 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -50.01 -30.4 10.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.98 -21.81 25.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.25 157.51 20.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 0.0 110.036 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.526 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 24.3 ttm180 -66.45 105.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 111.192 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 58' ' ' LEU . 34.6 t80 -46.82 -30.42 2.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.62 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.526 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 38.9 t30 -64.11 -43.37 95.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -62.21 -43.21 99.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 58' ' ' LEU . 1.9 t -63.14 -42.73 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.914 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -64.91 -43.62 92.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.46 -48.73 76.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 0.0 110.993 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.4 HE21 ' CA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -72.1 -30.03 64.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.001 -1.062 . . . . 0.0 111.044 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 22.2 m-85 -100.35 15.3 28.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.1 p -73.93 91.9 2.05 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 50.4 tt0 -101.41 10.62 40.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.11 . . . . 0.0 110.283 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' O ' ' CA ' ' A' ' 78' ' ' GLN . 51.7 t0 -110.91 104.9 13.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.13 -42.66 31.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.359 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -38.49 78.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.558 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -111.42 0.42 16.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.334 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER 54.26 91.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 78' ' ' GLN . . . -44.69 100.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 78' ' ' GLN . . . -174.66 -115.5 0.4 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 46.8 p-10 -117.62 142.34 47.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -1.05 . . . . 0.0 110.861 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 6.7 mp -110.47 175.84 5.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.49 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.96 -147.63 9.12 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 23.5 m-90 -98.78 117.3 32.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.724 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 20.6 ptm -130.71 171.72 12.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.036 -1.04 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 14.8 t -101.2 -147.95 0.36 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 33.7 ptt-85 -115.39 119.73 37.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.346 -0.846 . . . . 0.0 110.579 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.7 -157.06 33.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -141.58 52.26 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -1.151 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.6 tpt -100.96 -90.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 109.041 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.565 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -77.84 132.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 108.799 178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.95 -53.49 18.79 Favored Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.654 -0.654 . . . . 0.0 112.997 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.4 Cg_endo -65.01 -42.09 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.276 1.146 . . . . 0.0 111.669 -177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.565 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 56.4 t80 -65.46 -49.18 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.103 -0.998 . . . . 0.0 110.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 12.6 mm100 -72.89 -58.84 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 111.251 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 13.1 mm-40 -53.17 -49.84 65.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.958 -1.089 . . . . 0.0 111.199 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -59.24 -57.98 10.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 0.0 110.35 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.11 -52.76 4.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.647 -0.658 . . . . 0.0 111.183 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.42 10.36 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 110.555 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -87.65 -48.07 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.597 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -62.54 134.14 95.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.5 -58.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.446 1.235 . . . . 0.0 110.048 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.04 134.9 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.459 -0.776 . . . . 0.0 109.885 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 110' ' ' VAL . 83.9 p -101.84 -7.93 22.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 110.0 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 108' ' ' LYS . . . -156.72 148.16 17.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 75.5 mtm -61.93 -41.14 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -1.146 . . . . 0.0 110.881 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 59.4 p30 -130.35 -10.89 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.0 111.104 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 10.5 pttm -132.2 153.26 81.23 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 0.0 110.3 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.427 ' HG3' ' HG3' ' A' ' 128' ' ' GLU . 45.7 Cg_endo -73.0 146.64 41.95 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.936 1.493 . . . . 0.0 110.582 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.486 ' N ' ' OG ' ' A' ' 104' ' ' SER . 11.9 t -134.28 -175.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 109.69 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CD2' ' HB3' ' A' ' 113' ' ' ASP . 5.4 p90 -114.02 168.8 9.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.012 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 114' ' ' PRO . 26.5 m -56.78 -5.73 0.26 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.582 ' HB3' ' CD2' ' A' ' 111' ' ' PHE . 9.2 p-10 -50.74 126.59 24.27 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.027 -1.671 . . . . 0.0 109.378 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' THR . 45.5 Cg_endo -70.1 134.78 31.5 Favored 'Cis proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.287 -1.964 . . . . 0.0 111.124 0.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 123' ' ' HIS . 40.3 Cg_endo -66.22 -174.69 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.054 1.555 . . . . 0.0 111.289 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.12 157.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.648 . . . . 0.0 109.899 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -113.56 118.21 33.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.601 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 30.0 p -130.73 170.98 13.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 110.623 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.35 -17.69 63.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 110.224 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.601 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.6 OUTLIER -98.26 24.36 7.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.215 -0.928 . . . . 0.0 109.357 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 98.06 174.43 33.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 5.3 p90 -98.49 152.0 20.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.378 -1.072 . . . . 0.0 108.567 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.61 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 3.4 m-70 -131.28 141.48 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.825 -1.172 . . . . 0.0 113.053 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.514 ' CD1' HD21 ' A' ' 58' ' ' LEU . 57.9 mt -115.51 112.93 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 111' ' ' PHE . 25.0 mt -102.01 144.88 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.665 -1.272 . . . . 0.0 111.065 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ARG . 7.6 tpt -121.12 111.66 17.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.9 t -94.96 102.19 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.036 -1.04 . . . . 0.0 111.65 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 88.3 tt0 -144.66 135.02 24.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.483 ' O ' HG21 ' A' ' 38' ' ' VAL . . . 107.14 132.84 7.08 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.12 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -107.74 169.25 8.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.386 -1.067 . . . . 0.0 110.323 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 37' ' ' ALA . 45.2 mtmt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.354 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' HB ' ' A' ' 86' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.395 0.617 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.13 155.47 20.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.361 -0.837 . . . . 0.0 109.161 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.65 156.69 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.024 -1.048 . . . . 0.0 110.517 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HD2' ' NE1' ' A' ' 84' ' ' TRP . 1.5 mppt? -100.06 126.27 46.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.098 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -125.38 113.49 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.009 . . . . 0.0 111.57 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HA ' ' CB ' ' A' ' 81' ' ' ASP . 15.3 mtp180 -114.33 115.75 27.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.839 . . . . 0.0 108.819 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 3.7 p80 -138.14 160.81 38.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.968 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.594 ' CG1' HG22 ' A' ' 124' ' ' ILE . 27.3 pt -116.89 124.53 73.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.2 tt -108.53 129.96 55.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.585 . . . . 0.0 111.055 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 32.6 t -142.62 165.42 27.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 83.0 mt-10 -69.13 154.1 42.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 26.9 tttm -87.88 116.62 26.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.76 -1.212 . . . . 0.0 112.834 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.58 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.5 m-70 -131.32 9.08 4.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.502 -0.749 . . . . 0.0 109.268 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.14 41.91 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -88.52 9.09 25.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.489 -1.006 . . . . 0.0 110.378 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.5 mt -48.8 -59.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.906 -1.121 . . . . 0.0 110.0 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.463 ' HA ' ' SD ' ' A' ' 55' ' ' MET . 72.3 mtm -69.06 -28.12 66.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.771 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -73.98 -42.47 60.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.784 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.31 79.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.506 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.52 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 25.2 ptm -63.7 -46.18 86.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.995 . . . . 0.0 110.467 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 55' ' ' MET . 79.0 tt0 -56.6 -33.46 66.26 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.041 -1.037 . . . . 0.0 110.161 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' A' ' 67' ' ' VAL . 66.1 tttt -77.72 -27.78 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.738 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' O ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -104.59 16.18 26.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.871 -1.143 . . . . 0.0 110.582 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 58' ' ' LEU . 38.5 mttm -50.65 -161.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.507 -0.745 . . . . 0.0 110.438 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.2 m -87.0 154.49 20.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.574 -1.329 . . . . 0.0 110.931 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.41 -3.83 86.32 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -113.89 -168.39 1.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.065 -1.256 . . . . 0.0 110.862 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 13.5 mtm180 -95.71 95.34 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.411 -0.805 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -50.65 -35.51 31.07 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.121 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 21.8 p-10 -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.797 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.7 tt0 -58.52 -49.02 78.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG11 ' CD2' ' A' ' 71' ' ' TYR . 59.1 t -62.94 -52.27 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.922 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -45.2 -50.09 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.44 76.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 110.399 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.466 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.4 tp60 -74.38 -26.05 59.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.995 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' A' ' 67' ' ' VAL . 20.8 m-85 -109.89 17.47 21.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.109 . . . . 0.0 110.483 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.5 t -82.1 97.5 8.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.998 -1.064 . . . . 0.0 110.4 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -100.52 1.39 40.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.378 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 78' ' ' GLN . 4.0 m-20 -114.07 23.28 13.08 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.459 -0.776 . . . . 0.0 109.538 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -56.6 -35.49 68.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -39.24 68.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.891 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -106.4 -53.3 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.851 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . 54.3 mm-40 -141.01 -80.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 110.05 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.46 24.43 76.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -144.32 -104.8 0.48 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.537 ' CB ' ' HA ' ' A' ' 41' ' ' ARG . 27.3 p-10 -128.13 171.77 11.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -1.133 . . . . 0.0 110.322 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 9.1 mp -100.51 16.91 23.11 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.358 -0.838 . . . . 0.0 109.092 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.29 -134.12 33.26 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.523 ' NE1' ' HD2' ' A' ' 39' ' ' LYS . 3.4 m-90 -87.37 125.99 34.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.842 -0.799 . . . . 0.0 109.542 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 88' ' ' GLY . 8.6 ttm -137.65 140.86 41.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' ' ND2' ' A' ' 36' ' ' ASN . 76.5 p -111.4 -33.03 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.438 -0.789 . . . . 0.0 109.979 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -66.71 -31.32 71.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.435 -0.791 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 99' ' ' PHE . . . 147.79 -107.01 0.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.599 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -143.22 -65.78 0.38 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.403 -1.057 . . . . 0.0 109.502 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.56 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 23.0 mtp -144.08 -77.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.762 . . . . 0.0 110.951 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -175.09 166.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 0.0 110.936 -179.138 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . 68.36 -143.65 41.2 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.16 -35.92 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.104 1.581 . . . . 0.0 109.284 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 89' ' ' SER . 50.5 t80 -51.17 -30.52 17.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.475 ' OE1' ' HA3' ' A' ' 88' ' ' GLY . 16.7 tp60 -83.01 -54.68 4.88 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.597 0.713 . . . . 0.0 109.225 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.61 -45.26 92.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.615 -0.678 . . . . 0.0 110.215 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.44 -52.4 53.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 110.161 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -41.7 -53.88 3.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CZ ' ' HA2' ' A' ' 88' ' ' GLY . 4.0 m-30 -81.43 -0.84 43.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.412 -0.805 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' ' CD ' ' A' ' 102' ' ' PRO . . . -128.25 21.15 6.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.87 -1.144 . . . . 0.0 111.927 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.586 ' CD2' ' HA ' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -107.31 67.69 0.25 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.576 -1.327 . . . . 0.0 110.861 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' CD ' ' O ' ' A' ' 100' ' ' ALA . 47.8 Cg_endo -70.81 127.43 13.75 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.57 1.3 . . . . 0.0 110.364 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.62 142.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.178 -0.951 . . . . 0.0 110.083 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.3 p -120.85 -83.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.86 -124.34 17.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.4 ptm -113.01 -27.07 8.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -105.15 -144.04 0.37 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.614 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 13.3 mtpt -138.68 -68.75 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.876 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.701 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 48.0 Cg_endo -71.49 117.99 5.43 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 O-C-N 123.356 1.187 . . . . 0.0 111.581 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -141.86 -175.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.779 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 113' ' ' ASP . 38.0 p90 -114.57 164.39 14.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.8 p -74.43 117.4 16.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.515 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.57 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.5 p-10 -132.58 122.98 18.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 109.574 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.5 Cg_endo -69.07 170.27 56.31 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.232 0.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.449 ' HB3' ' CB ' ' A' ' 124' ' ' ILE . 47.5 Cg_endo -73.57 -175.93 2.29 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.146 1.603 . . . . 0.0 110.081 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 123' ' ' HIS . 11.4 m -100.94 147.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 109.503 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -118.02 128.59 54.92 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.614 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 77.1 p -131.63 174.4 10.15 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -67.96 -16.95 64.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 1.2 p90 -96.67 28.19 3.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 105.38 -166.13 14.35 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 31.6 p90 -116.57 152.79 33.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.39 -1.065 . . . . 0.0 109.905 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 2.2 m-70 -134.74 136.23 42.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.966 -1.084 . . . . 0.0 112.346 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.594 HG22 ' CG1' ' A' ' 43' ' ' ILE . 19.0 tt -121.17 108.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 24.9 pt -107.4 157.34 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.935 -1.103 . . . . 0.0 113.289 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 3.9 ttt -121.46 124.6 44.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 127' ' ' VAL . 16.3 m -109.74 120.88 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.649 -1.282 . . . . 0.0 111.903 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 129' ' ' GLY . 46.3 tt0 -115.29 149.21 38.19 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 48.22 95.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -131.56 150.7 52.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -1.0 . . . . 0.0 109.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.081 . . . . 0.0 110.16 -179.783 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' C ' HG21 ' A' ' 86' ' ' THR . 45.7 t30 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' CB ' ' OG1' ' A' ' 86' ' ' THR . . . -100.69 159.2 15.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.52 -0.737 . . . . 0.0 109.282 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG11 ' CE1' ' A' ' 99' ' ' PHE . 2.7 p -143.3 154.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.53 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.8 ttpt -98.49 125.4 43.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 74.5 t -121.97 132.56 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.833 -177.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.2 mtt180 -120.16 130.91 54.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.615 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 2.7 p80 -143.81 170.34 16.06 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.971 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.589 HG12 ' CE2' ' A' ' 71' ' ' TYR . 2.5 tt -124.32 113.77 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 8.1 tt -107.64 119.43 39.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 53.8 t -141.36 150.64 42.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.573 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 30.2 mt-10 -53.68 168.25 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 108.888 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' C ' ' CD2' ' A' ' 48' ' ' HIS . 8.6 ttmt -99.03 115.22 28.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.594 -1.316 . . . . 0.0 113.021 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 2.7 m80 -134.73 20.57 3.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.607 . . . . 0.0 109.651 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.14 11.92 83.84 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 tttm -81.2 5.22 17.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.958 . . . . 0.0 110.401 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.565 HD11 ' CB ' ' A' ' 122' ' ' TYR . 14.3 mm -51.22 -44.58 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 96.7 mtp -69.25 -43.16 74.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.818 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.77 -57.35 13.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 0.0 110.526 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -55.53 -55.82 27.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 9.8 ptt? -60.84 -41.25 95.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.049 . . . . 0.0 110.3 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 55' ' ' MET . 81.9 tt0 -52.86 -50.18 64.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.925 -1.109 . . . . 0.0 109.173 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 62' ' ' MET . 12.9 ttmt -74.13 -28.64 61.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -0.768 . . . . 0.0 109.466 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -57.98 -24.52 58.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.401 -0.812 . . . . 0.0 109.229 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 58' ' ' LEU . 16.3 tptt -22.37 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.41 0.624 . . . . 0.0 112.082 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLY . 53.9 p -50.68 -52.29 41.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.394 -0.816 . . . . 0.0 109.63 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 60' ' ' SER . . . -45.0 -36.12 4.9 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 33.8 mmt -82.68 149.86 27.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -1.098 . . . . 0.0 110.315 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.544 ' HG3' ' CB ' ' A' ' 66' ' ' GLU . 1.3 ptm180 -73.55 106.54 5.37 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.961 0.886 . . . . 0.0 110.583 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.531 ' CD2' HD11 ' A' ' 58' ' ' LEU . 9.0 t80 -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.484 0.659 . . . . 0.0 110.484 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.91 -56.88 16.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 111.075 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.544 ' CB ' ' HG3' ' A' ' 63' ' ' ARG . 10.5 tp10 -55.81 -41.14 73.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.118 -0.989 . . . . 0.0 110.966 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.593 HG13 ' CE1' ' A' ' 71' ' ' TYR . 71.4 t -52.61 -59.09 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.748 -1.22 . . . . 0.0 109.803 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . . . -64.94 -54.87 23.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -42.07 -27.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.413 -0.804 . . . . 0.0 109.838 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 3.7 tp60 -80.59 -62.85 1.55 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 109.992 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CE1' HG13 ' A' ' 67' ' ' VAL . 50.9 p90 -109.96 51.16 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.606 -1.308 . . . . 0.0 111.084 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 31.1 t -89.83 131.14 35.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.248 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 68.4 mm-40 -102.4 -3.15 27.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.886 -1.134 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 78' ' ' GLN . 84.6 m-20 -104.6 26.89 8.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.922 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.77 -19.96 64.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.895 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -75.14 -29.82 60.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.092 -1.005 . . . . 0.0 110.802 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 55.9 mtt180 -118.62 -25.33 6.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.534 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 170.07 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.04 98.95 0.81 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.9 -103.8 0.25 Allowed Glycine 0 N--CA 1.491 2.333 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.2 m-20 -97.21 162.2 13.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -1.092 . . . . 0.0 110.739 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.615 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 1.3 mp -101.64 -35.69 9.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 117.84 -161.99 13.2 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.482 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 17.1 m-90 -98.6 115.64 29.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.891 -0.77 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 ptm -134.78 138.24 44.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 110.208 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.528 ' OG1' ' CB ' ' A' ' 37' ' ' ALA . 93.3 m -104.14 -14.08 16.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.473 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 88' ' ' GLY . 27.6 ttt180 -100.0 -72.29 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 111.125 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . 44.83 66.41 1.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.459 ' O ' ' HE2' ' A' ' 90' ' ' MET . 64.6 p -120.44 66.3 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -1.092 . . . . 0.0 110.432 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.459 ' HE2' ' O ' ' A' ' 89' ' ' SER . 37.1 mmt -107.95 -49.06 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.554 HG12 ' HD2' ' A' ' 93' ' ' PRO . 72.0 t -114.02 153.96 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.912 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 91' ' ' VAL . . . -72.81 -64.77 2.47 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 121.2 -0.937 . . . . 0.0 111.062 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.554 ' HD2' HG12 ' A' ' 91' ' ' VAL . 37.0 Cg_endo -60.89 -30.9 90.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.71 1.374 . . . . 0.0 112.104 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 51.1 t80 -68.93 -40.67 78.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.738 -1.226 . . . . 0.0 110.426 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 89' ' ' SER . 42.1 tt0 -72.86 -30.99 64.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.298 -0.876 . . . . 0.0 110.651 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 7.5 mm-40 -62.24 -26.51 68.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.82 . . . . 0.0 111.025 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.02 -54.63 3.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 111.315 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.41 -47.02 76.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.125 -0.984 . . . . 0.0 111.594 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' HG11 ' A' ' 38' ' ' VAL . 1.8 m-85 -96.04 -8.63 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 111.544 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -130.33 25.88 5.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.698 -1.251 . . . . 0.0 111.89 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 127' ' ' VAL . 14.7 tp -57.81 135.54 83.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.712 -1.243 . . . . 0.0 109.373 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' HD13 ' A' ' 101' ' ' LEU . 43.5 Cg_endo -69.82 -27.53 26.05 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.837 1.44 . . . . 0.0 110.991 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 14.9 m -102.54 112.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.016 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.4 m -143.73 32.71 1.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.575 -0.703 . . . . 0.0 110.211 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 108' ' ' LYS . . . -61.27 154.39 37.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -71.45 -24.86 62.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -1.152 . . . . 0.0 110.335 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -111.31 0.11 16.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.388 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 14.8 ptpt -132.74 43.61 1.11 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 45.8 Cg_endo -73.45 131.77 16.72 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.623 1.328 . . . . 0.0 109.39 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.65 -157.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.972 -1.08 . . . . 0.0 111.094 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 125' ' ' ILE . 39.3 p90 -123.2 164.33 18.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.6 p -50.43 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -122.32 116.85 29.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.931 . . . . 0.0 109.756 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.72 164.33 82.27 Favored 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.987 -2.089 . . . . 0.0 110.535 0.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HG2' HG21 ' A' ' 51' ' ' ILE . 43.5 Cg_endo -70.85 -176.25 1.72 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.967 1.509 . . . . 0.0 110.291 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.69 155.08 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.988 . . . . 0.0 110.402 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.458 ' HE2' HG13 ' A' ' 51' ' ' ILE . 38.8 ttmt -124.03 127.4 47.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.53 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.577 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 38.9 p -138.81 -175.85 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.945 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -71.74 -35.09 70.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.577 ' CE1' ' OG1' ' A' ' 118' ' ' THR . 1.4 p90 -80.03 7.54 8.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.014 -1.054 . . . . 0.0 109.956 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 118' ' ' THR . . . 117.48 175.82 17.24 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.565 ' CB ' HD11 ' A' ' 51' ' ' ILE . 55.6 p90 -101.67 151.72 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -1.056 . . . . 0.0 109.453 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.635 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 2.2 m-70 -132.23 140.68 48.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.867 -1.146 . . . . 0.0 111.95 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 8.0 tt -118.46 106.22 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 14.8 pt -115.07 149.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.492 -1.38 . . . . 0.0 112.695 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 26.1 ptm -122.46 145.53 48.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.49 HG23 HD21 ' A' ' 101' ' ' LEU . 6.3 m -114.78 101.16 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.951 -1.093 . . . . 0.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 76.3 tt0 -143.59 87.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 110.486 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 39' ' ' LYS . . . 162.27 115.68 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.546 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.408 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 72.3 ttt180 -130.35 157.3 42.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -1.037 . . . . 0.0 109.533 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.5 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.129 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' CB ' ' OG1' ' A' ' 86' ' ' THR . . . -105.01 -156.53 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.281 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 2.4 p -139.21 161.15 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HE3' ' CZ2' ' A' ' 84' ' ' TRP . 47.1 mttt -99.61 111.55 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.885 -1.135 . . . . 0.0 109.309 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.48 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 46.3 mtt-85 -111.86 125.73 54.34 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 0.6 OUTLIER -138.47 162.63 34.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.441 -1.412 . . . . 0.0 112.609 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 10.0 pt -129.85 137.64 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' CD1' ' OD2' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -107.74 131.56 54.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 111.1 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 71' ' ' TYR . 62.5 m -126.76 168.73 14.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 73.4 tt0 -74.04 158.91 33.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.0 ttpt -96.41 96.02 8.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.043 -1.036 . . . . 0.0 110.565 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 2.2 p-80 -132.71 6.82 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.554 -0.716 . . . . 0.0 110.009 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.77 2.37 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -114.72 10.87 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -1.185 . . . . 0.0 110.271 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 HG21 ' CG ' ' A' ' 115' ' ' PRO . 60.0 mt -53.63 -49.33 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.454 -0.779 . . . . 0.0 111.026 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.6 mmm -65.31 -50.68 64.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.987 . . . . 0.0 110.989 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.02 -42.88 99.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.948 . . . . 0.0 111.334 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB1' ' CE ' ' A' ' 50' ' ' LYS . . . -61.38 -50.41 72.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.372 -0.83 . . . . 0.0 112.198 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.544 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 3.5 ptt? -65.48 -37.74 87.73 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.802 -1.186 . . . . 0.0 111.718 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.558 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 60.7 tt0 -65.39 -46.09 81.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -63.58 -34.19 77.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.962 -1.086 . . . . 0.0 108.594 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD23 ' CG2' ' A' ' 124' ' ' ILE . 13.6 tp -71.59 -35.5 70.56 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.558 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 12.9 mttp 46.38 -92.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.504 -0.747 . . . . 0.0 111.161 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' LEU . 75.6 p -122.59 -3.61 8.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.147 -0.971 . . . . 0.0 110.976 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 -9.06 13.8 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 38.6 mmt -50.8 -34.95 29.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -1.159 . . . . 0.0 110.056 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -113.45 27.02 9.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.115 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.563 ' CD1' ' HE1' ' A' ' 126' ' ' MET . 8.9 t80 -53.11 -46.1 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 0.0 109.841 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 47.9 t30 -60.31 -40.3 90.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.601 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -65.25 -58.36 6.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 71.1 t -60.44 -63.23 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . . . -46.29 -42.46 14.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' ASN . . . -49.5 -56.15 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 109.935 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.545 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 8.2 mm-40 -90.04 -0.01 57.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 5.7 m-85 -104.33 3.16 32.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 110.382 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.2 t -99.89 93.65 5.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 0.0 109.729 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 24.6 mp0 -106.27 9.78 31.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.19 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.547 ' OD2' ' CD1' ' A' ' 44' ' ' LEU . 80.8 m-20 -117.29 46.17 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -66.15 -14.71 62.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.72 -37.07 42.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 111.363 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -121.99 15.66 10.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 111.599 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' CD ' ' NE2' ' A' ' 42' ' ' HIS . 0.5 OUTLIER -159.99 154.77 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.792 -1.193 . . . . 0.0 110.687 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.93 9.84 13.98 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 103.39 -52.98 0.75 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 41' ' ' ARG . 93.2 m-20 -115.44 137.94 51.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -1.085 . . . . 0.0 109.68 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 85' ' ' MET . 0.7 OUTLIER -100.52 -13.96 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 109.986 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 89.95 -115.62 4.6 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.356 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 79.5 m95 -89.46 133.56 34.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.989 . . . . 0.0 111.502 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.527 ' HE3' ' NE2' ' A' ' 95' ' ' GLN . 22.8 ttt -122.59 124.81 44.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.542 ' OG1' ' CB ' ' A' ' 37' ' ' ALA . 1.2 m -134.92 -47.22 0.73 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.974 -1.079 . . . . 0.0 112.172 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.521 ' CG ' HG23 ' A' ' 86' ' ' THR . 11.8 mtt180 -103.06 -88.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.69 -1.256 . . . . 0.0 111.744 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . -138.18 151.79 21.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 90' ' ' MET . 9.9 p -143.78 -53.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.273 . . . . 0.0 111.143 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.564 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 57.5 mmm -107.69 -98.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 111.362 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.587 HG21 ' CE1' ' A' ' 120' ' ' PHE . 5.4 t -129.23 174.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.909 -1.119 . . . . 0.0 111.448 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.515 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -42.23 -54.16 4.67 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.746 -0.596 . . . . 0.0 112.284 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 97' ' ' ALA . 43.5 Cg_endo -67.7 -19.75 47.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.459 1.242 . . . . 0.0 111.712 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HB2' ' A' ' 90' ' ' MET . 42.6 t80 -79.6 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.797 -1.19 . . . . 0.0 110.107 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.527 ' NE2' ' HE3' ' A' ' 85' ' ' MET . 28.4 mm100 -70.99 -38.23 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 4.7 mm-40 -70.75 -33.98 71.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -69.7 -48.15 60.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.148 -0.97 . . . . 0.0 110.574 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.0 97.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 111.291 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.82 0.3 57.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.013 -1.054 . . . . 0.0 111.563 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -127.04 4.89 6.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.771 -1.206 . . . . 0.0 111.186 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.556 ' CD2' ' CG2' ' A' ' 103' ' ' VAL . 41.4 tp -82.08 116.75 65.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.906 -1.121 . . . . 0.0 109.842 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.61 -18.97 25.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.862 1.454 . . . . 0.0 111.591 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 101' ' ' LEU . 3.9 m -76.19 -21.83 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.866 -1.146 . . . . 0.0 110.559 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.54 ' N ' HG23 ' A' ' 103' ' ' VAL . 73.4 m -109.34 107.94 18.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.807 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -161.7 9.83 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.313 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.2 ttt -76.01 -21.83 56.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.961 . . . . 0.0 110.954 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 53.9 t0 -113.45 -14.78 12.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.052 -1.03 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.26 73.6 73.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.966 -1.084 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.467 ' O ' HG11 ' A' ' 110' ' ' VAL . 51.5 Cg_endo -78.28 123.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.071 1.564 . . . . 0.0 110.042 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 109' ' ' PRO . 17.5 m -143.31 -147.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.096 -1.002 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CZ ' ' CE ' ' A' ' 126' ' ' MET . 19.1 m-30 -101.42 171.18 7.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.519 -0.738 . . . . 0.0 110.039 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.525 ' OG1' HG12 ' A' ' 125' ' ' ILE . 65.0 m -65.18 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 111.802 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.66 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 99.0 m-20 -93.39 -24.93 0.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 42.5 Cg_endo -71.04 -27.36 7.5 Favored 'Cis proline' 0 N--CA 1.493 1.442 0 C-N-CA 124.306 -1.122 . . . . 0.0 114.484 1.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 51.5 Cg_endo -80.92 130.68 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 122.404 0.686 . . . . 0.0 112.576 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 60.6 t -98.66 143.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.479 ' O ' ' CG ' ' A' ' 117' ' ' LYS . 11.9 ptpt -102.51 108.55 19.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.53 -0.731 . . . . 0.0 111.065 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.629 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 19.4 p -136.84 158.37 44.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -65.82 -13.62 59.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.629 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.6 p90 -100.41 21.56 12.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.78 -1.2 . . . . 0.0 110.039 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 112.66 -169.9 13.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.527 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 33.7 m-85 -105.68 156.61 18.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 109.25 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 60.8 m-70 -135.16 128.57 32.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 112.199 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.537 ' CG2' HD23 ' A' ' 58' ' ' LEU . 95.7 mt -117.93 102.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.525 HG12 ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -106.78 152.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.468 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.634 ' CE ' ' CZ ' ' A' ' 111' ' ' PHE . 20.3 mtt -124.17 136.21 54.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.69 139.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.888 -1.133 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -117.39 -37.57 3.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 110.46 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -145.64 121.6 1.53 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 41.5 ttt180 -110.25 149.4 30.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -1.132 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.128 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.288 0.566 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' CB ' ' OG1' ' A' ' 86' ' ' THR . . . -90.63 -170.54 2.75 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 85' ' ' MET . 1.6 p -143.46 151.62 16.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.724 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HG3' ' CE3' ' A' ' 84' ' ' TRP . 49.7 mtmt -99.27 129.6 45.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 109.257 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 82' ' ' LEU . 5.0 p -139.34 139.39 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.02 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.1 mtt-85 -110.74 122.5 47.97 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 80' ' ' GLY . 3.7 p80 -138.27 148.25 44.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.821 -1.174 . . . . 0.0 111.501 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.569 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 19.4 mt -102.7 119.35 50.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 120' ' ' PHE . 4.4 tt -101.79 116.31 32.44 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 41.8 t -129.0 163.56 25.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.546 -0.721 . . . . 0.0 109.642 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 32.0 mt-10 -71.55 -178.91 2.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.598 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . 22.7 tttm -97.0 104.27 16.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.024 -1.048 . . . . 0.0 112.639 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.61 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.9 m-70 -133.13 0.42 3.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.254 -0.904 . . . . 0.0 110.504 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 122' ' ' TYR . . . 94.03 11.77 57.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' ILE . 98.0 mttt -85.56 3.85 38.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.253 -1.145 . . . . 0.0 110.739 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 122' ' ' TYR . 67.8 mt -42.28 -53.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 98.5 mmm -66.01 -45.19 82.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.144 -0.972 . . . . 0.0 110.637 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.28 -48.1 81.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.781 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.452 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -59.0 -61.19 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.539 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.526 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 3.9 ppp? -63.19 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 110.712 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 52' ' ' MET . 39.5 tp10 -71.54 -28.25 63.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.073 -1.017 . . . . 0.0 110.016 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -74.65 -34.77 62.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 110.372 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 3.7 pp -91.56 -16.98 26.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.3 mtpt 43.45 -135.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.551 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 100.0 p -57.26 -24.98 58.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.138 -0.976 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.03 9.92 2.94 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtp -50.73 -44.79 58.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.892 -1.357 . . . . 0.0 109.723 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 65.0 mtt-85 -114.24 38.82 2.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.455 -0.778 . . . . 0.0 109.702 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -52.55 -49.98 63.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.371 -0.831 . . . . 0.0 110.341 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 16.9 p30 -61.88 -42.26 98.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 39.5 mm-40 -59.25 -50.93 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.052 -1.03 . . . . 0.0 108.993 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 58' ' ' LEU . 92.4 t -57.5 -52.42 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 0.0 109.817 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.485 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -60.12 -40.57 90.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -49.89 -44.99 50.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.483 -0.761 . . . . 0.0 110.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 14.7 mm-40 -94.89 -11.79 28.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.529 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 32.9 m-85 -117.81 25.75 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 111.1 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 t -103.68 115.43 30.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.927 -1.108 . . . . 0.0 110.214 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -100.34 -7.51 24.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.488 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 m-20 -104.92 23.7 13.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.491 -0.755 . . . . 0.0 109.065 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -49.89 -32.17 13.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.63 88.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 16.4 mtt-85 -112.09 -45.22 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.125 -0.984 . . . . 0.0 110.274 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mp0 -118.91 149.56 41.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.09 13.23 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 101.58 -5.91 54.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 36.5 p-10 -124.84 140.5 52.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -1.204 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 63.3 tp -110.6 127.8 55.39 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.06 -1.025 . . . . 0.0 109.484 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -59.3 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 39' ' ' LYS . 98.3 m95 -80.31 142.21 34.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -1.017 . . . . 0.0 110.727 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.541 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 19.2 ttt -128.89 121.81 28.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.619 -0.676 . . . . 0.0 109.269 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.511 ' OG1' ' CB ' ' A' ' 37' ' ' ALA . 1.1 m -118.28 -46.65 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.732 -1.23 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -100.41 -54.48 2.85 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.005 . . . . 0.0 110.502 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA2' ' HE2' ' A' ' 85' ' ' MET . . . 160.74 -165.73 35.22 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -133.19 -75.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.513 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 41.7 mtp -140.37 -80.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.081 -1.012 . . . . 0.0 110.74 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.47 HG12 ' HD2' ' A' ' 93' ' ' PRO . 97.3 t -50.69 127.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.62 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.58 -51.48 30.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 38.9 Cg_endo -65.15 -8.78 19.49 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.461 1.243 . . . . 0.0 110.817 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.454 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 46.9 t80 -80.56 -46.17 16.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.04 . . . . 0.0 109.014 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.45 ' NE2' ' HA3' ' A' ' 88' ' ' GLY . 19.9 mt-30 -68.52 -30.72 69.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 92' ' ' GLY . 79.9 mm-40 -54.41 -40.73 68.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -77.75 -51.08 11.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.55 -53.0 15.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -77.03 -17.48 58.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.407 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' ALA . . . -58.76 -44.68 90.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.99 -1.069 . . . . 0.0 109.253 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.468 HD13 HG23 ' A' ' 127' ' ' VAL . 69.4 mt -59.07 122.79 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.367 -0.833 . . . . 0.0 109.396 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -77.93 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.888 1.467 . . . . 0.0 112.013 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.0 141.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.178 . . . . 0.0 111.594 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.2 p -126.55 89.73 3.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.598 -0.689 . . . . 0.0 109.421 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.16 142.06 48.31 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -70.44 -12.46 61.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -100.6 -17.35 17.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 62.6 mttt -131.19 57.1 28.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.757 . . . . 0.0 109.596 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.448 ' O ' HG21 ' A' ' 110' ' ' VAL . 44.9 Cg_endo -70.87 138.43 34.28 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.117 1.588 . . . . 0.0 110.69 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 45.6 t -140.74 170.29 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 113' ' ' ASP . 50.5 p90 -123.21 157.06 33.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 0.0 110.139 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.452 ' CG2' ' HB ' ' A' ' 125' ' ' ILE . 77.3 p -56.86 109.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 110.642 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 22.3 p-10 -132.33 124.14 19.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.763 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 44.8 Cg_endo -70.79 164.74 81.43 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.208 0.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.436 ' HB3' HG23 ' A' ' 124' ' ' ILE . 46.3 Cg_endo -72.55 -178.5 3.41 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.085 1.571 . . . . 0.0 109.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.573 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 3.7 m -99.61 146.3 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.053 . . . . 0.0 109.396 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HG3' ' CD1' ' A' ' 122' ' ' TYR . 40.1 ttpt -120.83 134.58 55.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.006 -1.059 . . . . 0.0 110.46 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.32 -164.29 1.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -0.88 . . . . 0.0 109.75 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -73.37 -45.91 52.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.992 . . . . 0.0 112.059 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.757 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 6.8 p90 -53.6 -41.62 66.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.065 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.673 ' N ' ' CG ' ' A' ' 120' ' ' PHE . . . 164.81 -124.4 1.25 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -177.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' OH ' ' HG3' ' A' ' 47' ' ' LYS . 15.7 m-85 -133.41 162.53 31.59 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.81 -1.406 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.757 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 97.6 m-70 -137.58 110.63 7.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.308 -0.87 . . . . 0.0 111.071 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.569 ' CG1' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.05 118.57 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 3.4 mp -105.78 134.89 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.902 -1.124 . . . . 0.0 113.505 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 tpt -118.23 121.76 41.27 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.468 HG23 HD13 ' A' ' 101' ' ' LEU . 17.0 t -92.8 144.14 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.808 -1.183 . . . . 0.0 111.389 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.2 -48.25 3.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.8 . . . . 0.0 110.234 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.14 149.25 16.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.18 157.2 44.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -1.134 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 pttt . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.083 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.368 0.604 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -99.44 155.37 17.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 30.4 m -138.63 158.16 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -100.54 122.48 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.724 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 7.9 p -124.22 162.62 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.917 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 126' ' ' MET . 41.1 ttm180 -143.17 128.2 18.52 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 1.9 p80 -140.29 175.15 9.83 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.151 -1.593 . . . . 0.0 113.173 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 36.0 mt -128.55 125.15 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.581 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.3 tt -105.56 131.38 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 110.566 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 20.0 m -142.85 162.33 35.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.914 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.585 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 85.4 mt-10 -75.91 161.44 28.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 79.5 tttt -72.58 119.5 16.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.195 -0.941 . . . . 0.0 111.692 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.585 ' CE1' ' CB ' ' A' ' 46' ' ' GLU . 12.3 m-70 -133.32 -1.57 3.19 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.42 -0.8 . . . . 0.0 110.45 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.58 81.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HG2' ' HB2' ' A' ' 48' ' ' HIS . 21.7 ptmt -107.34 15.46 24.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.478 -1.013 . . . . 0.0 109.948 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.475 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 3.9 mp -46.66 -52.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.386 -0.822 . . . . 0.0 110.44 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.3 ttp -53.95 -38.29 64.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 88.6 mt-10 -70.4 -39.13 74.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -59.04 6.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.454 ' HA ' HD22 ' A' ' 58' ' ' LEU . 22.9 ptm -59.01 -33.26 70.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.918 . . . . 0.0 110.171 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' O ' ' CD ' ' A' ' 59' ' ' LYS . 33.8 tp10 -72.93 -32.96 65.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 110.189 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 24.4 mmtp -63.54 -50.74 68.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 55' ' ' MET . 3.2 pp -73.65 -20.26 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' CD ' ' O ' ' A' ' 56' ' ' GLU . 28.9 mmmt 53.66 -137.31 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.878 . . . . 0.0 110.781 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -52.35 -39.14 60.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.485 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.45 2.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.429 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 16.1 ptp -51.88 -35.44 45.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' N ' ' CG ' ' A' ' 62' ' ' MET . 25.8 mtt180 -101.5 9.19 41.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 110.163 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -44.35 -48.73 9.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.05 -39.22 77.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.233 -0.917 . . . . 0.0 109.849 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.23 -40.84 74.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.602 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 71' ' ' TYR . 42.2 t -67.17 -49.16 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.443 -0.786 . . . . 0.0 110.044 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -58.22 -54.74 43.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.138 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.68 -51.26 16.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.4 mm-40 -75.7 -15.58 60.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 110.101 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' CD2' HG11 ' A' ' 67' ' ' VAL . 15.1 m-30 -111.14 18.32 19.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.454 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ALA . 19.4 p -79.48 93.56 5.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.015 -1.053 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 45' ' ' CYS . 3.5 mp0 -108.95 8.26 26.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 4.3 p30 -112.12 37.08 3.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -48.81 -31.05 6.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.01 -39.21 51.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -91.19 4.91 51.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.306 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 51.18 51.41 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.958 . . . . 0.0 109.592 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.454 ' HA3' ' CG ' ' A' ' 74' ' ' ASP . . . -78.06 115.32 4.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.66 -122.79 0.64 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 40.4 p-10 -86.71 131.55 34.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.128 -1.219 . . . . 0.0 109.007 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.596 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 7.2 mp -102.91 162.77 12.66 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.987 -1.071 . . . . 0.0 110.226 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -93.37 -135.39 7.43 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 13.3 m-90 -96.38 133.03 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.968 -0.725 . . . . 0.0 110.8 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -140.52 168.35 20.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.738 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.8 p -128.02 -125.48 0.22 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.301 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -113.91 174.76 5.77 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.915 -1.116 . . . . 0.0 109.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.89 56.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 t -110.36 -29.51 8.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -1.125 . . . . 0.0 110.098 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 95' ' ' GLN . 2.1 ptt? -126.35 176.7 6.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.409 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 19.3 m -68.44 -174.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.354 -0.841 . . . . 0.0 110.76 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.606 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -77.61 -47.38 8.85 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 121.468 -0.77 . . . . 0.0 111.897 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.9 Cg_endo -65.52 -46.77 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.064 1.033 . . . . 0.0 110.986 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.56 -39.88 88.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.938 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 34.9 tt0 -69.64 -44.39 70.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 34.2 tt0 -51.36 -26.83 8.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.38 -38.25 13.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.247 -0.908 . . . . 0.0 110.479 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.57 99.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.399 -0.813 . . . . 0.0 111.642 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -101.39 -12.85 18.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.162 . . . . 0.0 111.788 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -113.1 8.91 18.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.734 -1.229 . . . . 0.0 111.021 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 2.6 pt? -42.66 135.53 2.68 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.038 . . . . 0.0 109.575 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 -15.52 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.841 1.442 . . . . 0.0 111.692 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 109' ' ' PRO . 15.7 m -97.21 115.92 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 110.286 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -126.36 24.29 6.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.893 . . . . 0.0 110.297 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 109' ' ' PRO . . . 108.9 -10.37 34.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 73.4 mtp -82.65 -29.4 30.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -1.071 . . . . 0.0 110.695 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD1' ' HG3' ' A' ' 108' ' ' LYS . 67.8 t0 -128.52 -94.45 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.964 -1.085 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 107' ' ' ASP . 18.0 mttm -130.69 86.2 53.44 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.849 -1.157 . . . . 0.0 110.741 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.505 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . 49.6 Cg_endo -75.67 55.21 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.503 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 111' ' ' PHE . 62.2 t -104.32 -102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 110.36 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 46.3 p90 -108.52 169.39 8.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 110.962 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 125' ' ' ILE . 25.3 m -70.07 116.45 10.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.506 -0.746 . . . . 0.0 110.919 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.564 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 22.7 p-10 -133.85 112.78 12.59 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.33 160.2 94.23 Favored 'Cis proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.153 -2.02 . . . . 0.0 110.36 -0.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 46.0 Cg_endo -72.86 -175.86 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.957 1.504 . . . . 0.0 109.908 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.1 m -102.25 146.53 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.274 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -114.53 138.05 51.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 108.975 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.602 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 81.1 p -136.39 -173.9 3.54 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.708 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.36 -11.23 59.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -104.38 11.01 35.15 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.736 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.79 -167.1 12.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 45.6 p90 -108.86 157.91 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.315 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.604 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 12.2 m-70 -133.72 140.54 47.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 111.419 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 19.9 tt -128.04 111.21 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 28.8 pt -108.62 161.2 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.789 -1.194 . . . . 0.0 111.836 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.548 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 39.5 mtm -128.05 143.88 51.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.37 128.59 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.981 -1.074 . . . . 0.0 110.552 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -144.26 -38.08 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.985 -1.072 . . . . 0.0 111.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . -89.26 88.32 1.51 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.418 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -118.66 135.89 54.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -1.167 . . . . 0.0 110.04 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.289 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 57.9 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.16 0.505 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 86' ' ' THR . . . -59.9 139.43 57.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.534 ' CB ' ' HA2' ' A' ' 129' ' ' GLY . 28.8 m -147.02 165.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.507 -0.746 . . . . 0.0 111.298 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -97.06 126.32 42.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.11 134.05 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.867 -1.145 . . . . 0.0 112.226 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 48.2 mtm-85 -114.15 126.03 54.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -133.51 151.47 51.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.535 -1.353 . . . . 0.0 112.231 -178.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 71' ' ' TYR . 86.3 mt -113.4 126.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -113.99 121.17 43.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 110.934 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 19.4 p -132.95 177.52 7.59 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.635 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 74.3 mm-40 -64.14 158.16 23.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.573 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.626 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 5.0 ttmt -101.84 73.17 1.4 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.942 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 30.0 m80 -135.12 51.55 2.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 111.728 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.52 -10.35 55.82 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.759 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -71.15 -15.15 62.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.336 . . . . 0.0 110.675 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.586 HD13 ' CD1' ' A' ' 122' ' ' TYR . 7.3 tt -52.95 -36.16 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.427 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 26.0 ttt -67.23 -40.14 86.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 110.143 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -67.56 -34.63 77.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.909 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 58' ' ' LEU . . . -61.65 -63.06 1.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 18.5 ptt? -56.32 -34.75 66.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.797 . . . . 0.0 111.0 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 55' ' ' MET . 87.6 tt0 -69.91 -42.02 73.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 111.288 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 62' ' ' MET . 53.0 mtpt -80.27 -24.95 39.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.978 . . . . 0.0 111.246 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 54' ' ' ALA . 2.3 pp -104.35 2.87 31.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 58' ' ' LEU . 6.2 mttt -49.46 178.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.07 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -52.47 139.48 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 110.095 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.05 -10.95 69.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 29.5 mmt -100.9 163.71 12.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -1.049 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.476 ' CG ' ' HG3' ' A' ' 66' ' ' GLU . 4.9 ttm180 -93.77 95.04 8.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -46.24 -31.43 2.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 0.0 110.337 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 51.3 t30 -65.61 -41.24 92.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.127 -0.983 . . . . 0.0 110.011 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HG3' ' CG ' ' A' ' 63' ' ' ARG . 3.4 mt-10 -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG12 ' CE2' ' A' ' 71' ' ' TYR . 53.6 t -68.94 -38.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.897 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -70.9 -51.38 26.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 110.465 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -57.12 -31.34 65.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.672 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.527 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 8.1 mm-40 -91.42 -19.75 22.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.031 -1.043 . . . . 0.0 110.735 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.545 ' CE2' HG12 ' A' ' 67' ' ' VAL . 17.2 m-30 -108.71 10.44 26.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 0.0 111.078 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 16.7 m -76.44 116.76 17.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.937 -1.102 . . . . 0.0 110.154 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 25.3 tp10 -104.5 10.41 35.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 22.0 t70 -114.9 108.29 16.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.158 -0.964 . . . . 0.0 110.543 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 78' ' ' GLN . 17.1 ptpt -61.3 -25.18 66.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.04 -21.72 29.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.474 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -129.51 25.54 5.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.385 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.484 ' HG3' ' HA ' ' A' ' 75' ' ' LYS . 52.6 mt-30 -43.53 -28.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.93 -15.61 14.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . 61.39 24.03 63.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 55.4 t0 -130.74 142.84 50.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -1.116 . . . . 0.0 110.493 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 82' ' ' LEU . 8.7 mp -104.04 -20.5 13.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.68 -170.06 34.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 28.9 m-90 -84.26 127.75 34.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -1.016 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 19.2 ptp -140.37 137.48 34.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 49.1 m -76.53 -54.64 6.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -111.14 -173.55 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.385 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . -149.62 146.07 14.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.6 p -137.9 16.07 2.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -1.182 . . . . 0.0 110.759 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.508 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 6.4 mmt -100.8 108.4 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.241 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 11.4 t 64.84 117.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -51.81 -53.05 31.44 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.49 -0.756 . . . . 0.0 111.461 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -65.66 -32.7 47.13 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.438 1.231 . . . . 0.0 111.705 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.561 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 42.1 t80 -63.77 -52.46 60.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.851 -1.156 . . . . 0.0 109.932 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' HA3' ' A' ' 88' ' ' GLY . 39.5 tt0 -55.12 -46.05 75.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 62.4 mt-10 -58.62 -48.63 80.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.12 77.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.343 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.23 91.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 36' ' ' ASN . 6.5 m-85 -103.63 13.23 33.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.957 . . . . 0.0 110.906 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' O ' ' CG2' ' A' ' 103' ' ' VAL . . . -130.76 3.33 4.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.133 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 61.0 tp -69.35 -39.24 12.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 101' ' ' LEU . 45.4 Cg_endo -76.44 2.11 7.68 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.308 1.162 . . . . 0.0 111.976 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 100' ' ' ALA . 8.7 m -79.68 -27.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.276 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.6 m -106.54 18.82 21.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.17 123.92 6.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.456 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 89.7 mmm -56.52 -34.24 66.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -1.117 . . . . 0.0 109.98 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 106' ' ' MET . 93.4 m-20 -140.46 -59.08 0.53 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.999 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -128.3 158.84 70.1 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.867 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 44.3 Cg_endo -72.82 158.37 50.27 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.935 1.492 . . . . 0.0 111.699 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 4.5 p -141.75 -138.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.534 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 31.4 p90 -102.56 158.06 16.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.828 -1.17 . . . . 0.0 110.134 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.464 ' OG1' HG12 ' A' ' 125' ' ' ILE . 22.4 m -40.61 121.98 1.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.8 p-10 -133.51 104.76 12.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.909 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.506 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 49.5 Cg_endo -76.78 176.91 41.88 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.198 -2.001 . . . . 0.0 110.471 0.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 114' ' ' PRO . 41.7 Cg_endo -69.32 166.67 26.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.764 1.402 . . . . 0.0 109.686 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 123' ' ' HIS . 34.2 m -110.3 139.18 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.01 . . . . 0.0 110.656 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . 1.2 pttp -114.03 131.39 56.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.474 -0.766 . . . . 0.0 108.934 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 69.8 p -134.75 176.21 8.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.965 -1.084 . . . . 0.0 110.822 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -61.49 -8.73 4.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.74 -0.6 . . . . 0.0 111.369 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 11.0 p90 -112.73 37.95 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.705 -1.247 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . 99.65 -173.38 25.84 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 20.5 m-85 -99.01 158.62 15.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -1.05 . . . . 0.0 108.417 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.68 ' CE1' ' CD2' ' A' ' 120' ' ' PHE . 73.0 m-70 -141.35 137.71 32.54 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.063 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.432 HD11 HD23 ' A' ' 58' ' ' LEU . 69.9 mt -128.29 96.38 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 15.4 pt -103.79 137.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.942 -1.099 . . . . 0.0 112.029 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.489 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 48.9 mtp -107.42 142.08 37.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.435 HG23 HD21 ' A' ' 101' ' ' LEU . 30.0 t -119.83 125.2 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.719 -1.238 . . . . 0.0 111.576 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -107.82 -47.62 3.55 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 119.54 176.83 16.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 46.3 tpt85 -116.96 -48.48 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.968 . . . . 0.0 109.117 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.235 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.835 0.35 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 131' ' ' LYS . . . -117.99 176.62 5.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.5 OUTLIER -120.98 151.24 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' HG3' ' CZ2' ' A' ' 84' ' ' TRP . 1.9 tmmt? -100.42 121.85 42.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.106 -0.996 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 10.2 p -142.44 147.94 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 119.344 -0.943 . . . . 0.0 112.876 -178.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' NE ' ' HB2' ' A' ' 81' ' ' ASP . 65.8 mtp180 -130.06 137.38 50.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 0.4 OUTLIER -142.69 167.75 21.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.162 -1.587 . . . . 0.0 113.061 -177.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CD1' HG11 ' A' ' 67' ' ' VAL . 5.1 mt -127.55 130.36 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.7 tt -113.91 118.86 35.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 48.1 t -129.68 154.22 47.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 35.0 tp10 -60.24 163.83 4.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 0.0 109.86 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 18.2 ttpt -97.58 96.74 8.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 0.0 110.38 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 1.8 p-80 -132.07 21.89 4.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.48 19.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 120.107 -1.044 . . . . 0.0 110.603 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' HD3' ' CE2' ' A' ' 71' ' ' TYR . 8.9 tttt -114.65 18.35 16.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.889 -1.359 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.583 HG13 ' CD2' ' A' ' 122' ' ' TYR . 4.2 mt -57.41 -42.39 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.488 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 62.8 ttp -65.86 -46.96 76.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.888 . . . . 0.0 110.869 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 50' ' ' LYS . 72.1 mm-40 -59.89 -47.41 85.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -0.985 . . . . 0.0 110.641 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.0 -60.73 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.529 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' LYS . 3.7 tmm? -62.47 -33.33 74.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 110.088 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.5 tt0 -59.15 -46.13 89.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -60.21 -46.64 89.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.76 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 111' ' ' PHE . 4.1 pp -101.26 25.33 8.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 110.365 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' MET . 7.9 tptt -35.09 -70.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.744 -0.598 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.4 m -91.3 25.0 2.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.77 32.78 66.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.78 40.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -1.05 . . . . 0.0 110.568 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' HG21 ' A' ' 67' ' ' VAL . 71.5 mtt180 -117.71 37.36 3.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 111.715 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CE2' ' CZ ' ' A' ' 111' ' ' PHE . 25.7 t80 -49.28 -46.92 47.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.707 -1.245 . . . . 0.0 109.988 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -63.97 -45.96 86.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 110.73 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 38.9 tt0 -64.94 -45.2 86.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 110.426 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 58' ' ' LEU . 67.2 t -55.1 -41.81 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.749 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -64.13 -59.2 4.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.0 109.638 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.49 -40.21 1.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 0.0 111.688 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.649 ' NE2' ' CD1' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -101.18 -30.27 11.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 112.002 -178.696 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.649 ' CD1' ' NE2' ' A' ' 70' ' ' GLN . 8.3 m-85 -100.79 28.36 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.641 -1.287 . . . . 0.0 109.945 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 41.0 t -115.82 123.27 47.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -101.83 -8.14 21.9 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' GLN . 46.6 p30 -108.04 32.43 4.77 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -60.03 -37.01 78.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.4 71.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.383 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' C ' ' HG3' ' A' ' 78' ' ' GLN . 13.7 ptp180 -87.58 -47.64 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.8 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' ASP . 20.2 mt-30 -138.6 -127.15 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.256 -0.903 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.56 25.8 8.48 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.22 -135.43 1.81 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.018 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 82' ' ' LEU . 59.8 t0 -73.98 150.18 40.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -1.099 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 8.0 mp -100.9 -15.47 17.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.47 -0.769 . . . . 0.0 108.941 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 82.39 -145.34 24.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.6 m-90 -109.08 133.3 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.667 -0.902 . . . . 0.0 110.101 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 82' ' ' LEU . 25.0 ptp -141.1 154.37 45.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.404 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 32.8 p -115.81 -66.05 1.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 110.371 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -104.35 37.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.879 . . . . 0.0 110.709 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.2 97.59 1.8 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 25.2 t -101.69 114.89 29.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.368 -1.078 . . . . 0.0 109.93 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 30.5 mmt -100.42 -106.35 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.436 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 70.1 t -64.42 -51.33 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.911 -1.118 . . . . 0.0 110.397 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.64 -67.19 0.45 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 45.1 Cg_endo -70.49 -25.08 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.105 1.581 . . . . 0.0 109.612 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.53 ' CE1' HD13 ' A' ' 125' ' ' ILE . 58.7 t80 -70.61 -33.92 71.57 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.468 -0.77 . . . . 0.0 109.567 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 65.4 tt0 -73.04 -54.88 7.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 110.154 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 29.2 tp10 -48.02 -61.9 1.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -62.13 -66.55 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.422 -0.799 . . . . 0.0 111.504 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' PHE . . . -54.3 -63.46 1.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 112.206 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 18.5 t80 -41.71 -42.91 2.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.528 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -96.86 -89.55 0.27 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.495 HD12 ' HD2' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -119.43 119.46 31.63 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 111.484 -178.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.495 ' HD2' HD12 ' A' ' 101' ' ' LEU . 43.7 Cg_endo -71.18 -32.71 12.56 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.419 1.221 . . . . 0.0 110.453 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.561 ' CG1' ' HA ' ' A' ' 112' ' ' THR . 28.1 m -120.67 -152.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.145 -0.972 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.2 m -104.93 11.96 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.929 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.81 121.74 6.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.2 ptm -102.29 -0.2 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -101.9 -35.68 8.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.733 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 48.0 pttt -130.49 55.75 20.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.781 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 44.9 Cg_endo -71.16 115.05 4.11 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -130.38 -93.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.596 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.665 ' CZ ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -100.34 149.56 23.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.251 179.792 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.561 ' HA ' ' CG1' ' A' ' 103' ' ' VAL . 21.2 m -75.1 101.63 4.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.48 111.94 13.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.146 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.33 160.45 94.32 Favored 'Cis proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.849 -2.146 . . . . 0.0 110.271 0.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 112' ' ' THR . 45.0 Cg_endo -72.46 -168.92 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.964 1.508 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.21 131.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.529 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 122' ' ' TYR . 8.4 mtmm -102.03 123.14 45.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.312 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.581 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 41.4 p -134.62 -178.03 4.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -73.02 -16.48 61.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 111.369 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 3.8 p90 -97.1 1.6 50.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.738 -1.226 . . . . 0.0 110.983 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 131.52 -171.92 21.02 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.168 -1.491 . . . . 0.0 111.357 178.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.583 ' CE1' ' HG3' ' A' ' 47' ' ' LYS . 26.2 m-85 -101.23 150.54 22.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.742 -0.858 . . . . 0.0 109.34 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 15.0 m-70 -136.31 122.67 20.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.895 -1.128 . . . . 0.0 112.11 -179.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.609 ' CG2' ' CE1' ' A' ' 111' ' ' PHE . 25.8 mt -102.06 120.89 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.53 HD13 ' CE1' ' A' ' 94' ' ' PHE . 20.3 mt -108.88 126.87 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.777 -1.202 . . . . 0.0 112.54 -177.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 13.5 tpt -110.3 99.01 8.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 t -107.77 138.04 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.955 . . . . 0.0 111.471 -178.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -143.1 3.72 1.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -0.834 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -125.52 139.78 11.79 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -132.59 133.05 43.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -1.21 . . . . 0.0 110.199 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.965 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 8.9 p-10 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.409 0.623 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.25 -177.02 4.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 39' ' ' LYS . 7.7 p -144.74 156.11 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HE2' ' CZ2' ' A' ' 84' ' ' TRP . 42.1 mttt -98.23 136.18 38.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.08 -1.012 . . . . 0.0 109.411 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 59.7 t -133.53 146.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.874 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 126' ' ' MET . 84.0 mtt180 -141.62 123.34 15.18 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.585 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -136.72 -176.55 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.671 -1.268 . . . . 0.0 112.597 -178.342 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 ' HB ' HG21 ' A' ' 124' ' ' ILE . 82.5 mt -126.75 131.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' HG ' ' ND1' ' A' ' 123' ' ' HIS . 1.3 tt -106.7 126.38 52.21 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 110.68 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 48' ' ' HIS . 16.4 t -137.54 149.89 47.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 6.6 mm-40 -73.27 -155.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HA ' ' CE1' ' A' ' 122' ' ' TYR . 83.9 tttt -98.09 102.81 14.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.881 -1.137 . . . . 0.0 112.231 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.608 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.5 m-70 -132.56 -19.83 2.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.383 -0.823 . . . . 0.0 110.469 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.63 24.99 22.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 19.1 mttt -97.78 14.1 28.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.48 -1.012 . . . . 0.0 110.43 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.533 HG23 ' CG ' ' A' ' 115' ' ' PRO . 2.7 mp -44.37 -62.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.988 . . . . 0.0 109.997 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 22.1 ptm -66.33 -34.5 78.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.0 110.948 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -65.13 -39.71 93.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.612 ' CB ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.07 -56.68 9.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.833 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.538 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -62.46 -31.84 72.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.894 -1.129 . . . . 0.0 110.385 -179.559 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 55' ' ' MET . 18.3 tp10 -62.58 -38.75 91.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.489 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HD2' ' OH ' ' A' ' 71' ' ' TYR . 44.8 mttm -76.86 -37.8 54.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 4.2 pp -83.7 -2.28 55.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.911 -1.118 . . . . 0.0 111.128 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 56' ' ' GLU . 12.1 mttt -48.93 178.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 109.986 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -54.33 139.83 35.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.9 -23.55 29.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.484 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -110.45 149.04 30.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.116 . . . . 0.0 110.283 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.532 ' HG3' ' CG ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -87.16 107.39 18.45 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.043 0.925 . . . . 0.0 110.515 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 63' ' ' ARG . 72.7 t80 -39.28 -40.92 0.83 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.493 0.663 . . . . 0.0 109.906 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -48.99 -46.98 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.251 -0.906 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' CG ' ' HG3' ' A' ' 63' ' ' ARG . 80.2 mm-40 -65.35 -43.39 90.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 58' ' ' LEU . 44.2 t -59.95 -41.05 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -55.38 -46.72 76.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.689 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.56 55.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 5.4 mm-40 -64.92 -23.79 67.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 54' ' ' ALA . 12.3 m-85 -118.39 26.38 9.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 109.744 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ALA . 7.1 t -88.24 87.3 7.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 110.942 -179.078 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 1.1 tm-20 -101.79 5.27 41.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -0.975 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 44' ' ' LEU . 48.6 p30 -126.07 12.86 7.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.366 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -53.9 -18.6 3.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.538 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.03 -26.17 56.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.9 mmm180 -127.44 -2.3 6.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.05 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 77' ' ' ARG . 6.7 tt0 -178.63 150.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.62 38.32 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 42' ' ' HIS . . . 65.24 18.95 65.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -128.3 118.34 23.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.126 . . . . 0.0 110.119 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 42' ' ' HIS . 4.4 mp -101.69 150.91 22.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.928 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.72 -122.24 0.61 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.559 ' CZ2' ' HE2' ' A' ' 39' ' ' LYS . 61.8 m95 -95.3 143.32 26.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.765 -0.844 . . . . 0.0 110.525 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 38' ' ' VAL . 8.5 mmt -125.64 139.29 53.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.028 179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.51 HG21 ' N ' ' A' ' 87' ' ' ARG . 11.9 t -134.02 -37.59 0.89 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG21 ' A' ' 86' ' ' THR . 15.0 mtp85 -119.67 151.79 38.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 111.849 -177.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . -100.92 113.86 4.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p -139.16 12.49 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.324 . . . . 0.0 111.722 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.539 ' CG ' HG11 ' A' ' 91' ' ' VAL . 6.8 ptp -105.26 -26.59 11.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.78 -1.2 . . . . 0.0 110.077 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG11 ' CG ' ' A' ' 90' ' ' MET . 11.5 p -167.36 -46.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 132.93 -63.28 0.62 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.63 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.503 ' HD2' HG13 ' A' ' 91' ' ' VAL . 38.7 Cg_endo -63.55 -37.68 46.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.907 1.478 . . . . 0.0 112.13 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.72 -45.94 91.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.619 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HG3' ' CA ' ' A' ' 88' ' ' GLY . 1.5 tm0? -74.55 -42.04 59.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.15 -0.969 . . . . 0.0 110.791 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -64.75 -39.71 94.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 111.572 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.5 18.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.9 -1.125 . . . . 0.0 110.27 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.63 -42.28 23.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 110.399 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -70.42 -39.4 74.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.351 -0.843 . . . . 0.0 111.659 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.496 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . -137.11 51.53 1.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 113.067 -177.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 tt -80.63 111.42 22.92 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.482 -1.386 . . . . 0.0 109.453 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 48.5 Cg_endo -73.03 121.82 7.6 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.692 1.364 . . . . 0.0 110.801 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.531 HG23 ' N ' ' A' ' 104' ' ' SER . 1.0 OUTLIER -130.88 -78.22 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.531 ' N ' HG23 ' A' ' 103' ' ' VAL . 80.3 p -116.19 -2.27 12.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.23 175.06 30.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.5 mmm -77.54 -26.66 51.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -1.22 . . . . 0.0 110.266 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.434 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 53.5 t0 -108.95 15.23 23.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 0.0 110.754 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 98.6 mttt -124.43 45.72 1.36 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.086 -1.009 . . . . 0.0 110.433 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 53.1 Cg_endo -77.17 144.23 23.29 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.718 1.378 . . . . 0.0 110.769 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' MET . 86.0 t -140.74 -96.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.354 -0.841 . . . . 0.0 109.171 178.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 26.4 p90 -131.77 161.13 33.62 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.95 -1.094 . . . . 0.0 109.966 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 114' ' ' PRO . 18.9 m -68.12 118.18 10.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 111.543 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.608 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 32.3 p-10 -133.93 108.34 11.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 0.0 110.447 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 48.6 Cg_endo -75.28 176.17 44.73 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.093 -2.044 . . . . 0.0 110.344 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.533 ' CG ' HG23 ' A' ' 51' ' ' ILE . 44.2 Cg_endo -69.65 -175.03 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.877 1.462 . . . . 0.0 109.702 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.07 137.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 0.0 110.111 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -102.11 125.54 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 109.064 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 38.7 p -142.04 -175.98 4.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.631 -1.293 . . . . 0.0 111.68 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 1.8 tttt -74.36 -10.67 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.768 -0.582 . . . . 0.0 110.132 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.61 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -103.55 37.92 1.91 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.065 -1.022 . . . . 0.0 109.605 179.117 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.6 -167.71 37.28 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.639 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 6.9 m-85 -103.72 144.13 31.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -1.084 . . . . 0.0 108.879 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 120' ' ' PHE . 10.1 m-70 -137.94 135.29 35.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.666 -1.272 . . . . 0.0 112.32 -178.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 124' ' ' ILE . 11.5 tt -120.64 116.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 125' ' ' ILE . 12.1 pt -114.46 158.28 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.571 -1.33 . . . . 0.0 112.651 -177.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.522 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 44.9 mtp -118.87 151.07 38.77 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 126' ' ' MET . 18.3 t -126.91 121.36 57.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.55 -1.344 . . . . 0.0 111.822 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.8 pt-20 -133.67 157.41 45.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 61.45 82.65 0.07 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.539 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 10.1 ttm180 -116.77 154.1 31.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.992 . . . . 0.0 110.173 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.539 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.9 mtpt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.184 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.174 0.511 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' CB ' ' CG2' ' A' ' 86' ' ' THR . . . -129.65 -170.35 2.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 85' ' ' MET . 1.5 p -128.76 150.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.576 -0.703 . . . . 0.0 109.244 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.677 ' HD2' ' CD2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -101.0 113.93 27.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.637 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 82' ' ' LEU . 38.6 t -127.14 152.31 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.836 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 93.5 mtt180 -133.73 121.93 22.62 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.585 ' CD2' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -131.06 159.23 38.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.638 -1.289 . . . . 0.0 113.008 -177.763 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.539 HD11 ' CE1' ' A' ' 64' ' ' PHE . 24.9 mt -122.82 123.21 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -104.63 120.97 42.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.503 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.6 p -133.09 -168.81 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.892 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 92.4 mt-10 -70.98 176.61 4.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.0 111.419 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 28.1 pttt -118.66 56.77 0.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.356 -0.84 . . . . 0.0 110.947 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.543 ' N ' ' CE2' ' A' ' 122' ' ' TYR . 19.3 m80 -134.6 64.04 1.61 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 111.576 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 -0.95 34.05 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.88 178.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.78 -10.78 59.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.984 -1.304 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.601 ' HB ' ' CD2' ' A' ' 122' ' ' TYR . 3.1 tt -62.15 -36.81 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 53' ' ' GLU . 23.3 ptm -74.54 -42.97 57.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.957 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' N ' ' CG ' ' A' ' 52' ' ' MET . 19.1 mm-40 -68.12 -38.82 82.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.675 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . . . -65.73 -49.38 68.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.893 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.539 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 27.1 ptm -61.68 -35.39 77.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.916 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 55' ' ' MET . 91.7 mt-10 -68.44 -33.44 74.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.062 -1.024 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -68.72 -46.01 70.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -74.45 -27.77 60.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.977 -1.077 . . . . 0.0 110.446 -179.454 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.504 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 91.1 mttt 49.82 -126.98 2.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 62' ' ' MET . 55.7 p -65.45 -28.5 69.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 110.587 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . 130.73 -5.82 5.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.427 ' HG3' ' OG ' ' A' ' 60' ' ' SER . 60.0 mtt -49.47 -31.43 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -1.225 . . . . 0.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.72 29.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.565 ' CD1' ' HE3' ' A' ' 126' ' ' MET . 30.9 t80 -54.71 -40.99 69.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.904 . . . . 0.0 110.477 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 20.6 p-10 -58.59 -44.48 89.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -69.21 -44.13 72.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 97.2 t -69.75 -26.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 110.413 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -74.16 -57.59 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.11 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.89 62.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.619 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -29.81 33.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.173 -0.954 . . . . 0.0 111.124 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 23.4 m-85 -114.57 26.71 10.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.034 -1.041 . . . . 0.0 111.049 -179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 26.7 t -102.28 116.93 33.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.911 -1.118 . . . . 0.0 110.68 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.32 -7.42 24.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.404 ' OD2' ' NE2' ' A' ' 42' ' ' HIS . 49.8 p-10 -111.86 21.22 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.508 -0.745 . . . . 0.0 109.212 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 6.4 tmtt? -53.8 -31.3 48.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.625 -0.672 . . . . 0.0 110.68 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.28 81.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.173 -0.955 . . . . 0.0 110.927 -179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.27 9.27 36.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.097 -1.002 . . . . 0.0 110.795 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 2.1 tt0 -169.07 172.62 7.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.054 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.69 27.49 6.83 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 72.66 11.5 77.4 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 41.2 p-10 -133.08 129.46 38.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -1.182 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 42' ' ' HIS . 7.9 mp -110.09 109.29 19.78 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 110.159 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -60.12 -123.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.081 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.677 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 78.2 m95 -76.45 130.26 37.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.795 -0.826 . . . . 0.0 110.808 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.534 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 10.8 tpt -137.28 136.04 37.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 0.0 109.767 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.592 ' CG2' ' CB ' ' A' ' 37' ' ' ALA . 19.0 p -122.78 -57.98 1.69 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.827 -1.171 . . . . 0.0 110.675 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' A' ' 86' ' ' THR . 21.9 ttm-85 -68.22 -48.99 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.739 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 46.65 64.79 2.46 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -122.93 43.59 2.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -1.06 . . . . 0.0 110.634 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.477 ' O ' HG21 ' A' ' 91' ' ' VAL . 16.2 mtp -99.78 -32.04 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.768 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 89.9 t -142.96 112.38 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.524 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -43.04 -53.93 5.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.514 -0.741 . . . . 0.0 111.874 -178.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 42.8 Cg_endo -69.33 -19.66 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.511 1.269 . . . . 0.0 111.765 -178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.576 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 23.4 t80 -76.56 -54.09 7.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 110.771 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -66.52 -41.76 88.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.972 . . . . 0.0 110.897 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 14.1 pt-20 -60.23 -25.15 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.894 -1.128 . . . . 0.0 110.42 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -79.61 -50.74 10.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.773 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.32 -54.63 7.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.755 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 58.4 m-85 -56.42 -47.0 79.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 0.0 110.975 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -66.17 -39.69 89.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.202 -0.937 . . . . 0.0 111.196 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD23 HG21 ' A' ' 112' ' ' THR . 27.3 tp -57.15 127.82 76.86 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.985 -1.072 . . . . 0.0 110.802 -179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.25 157.35 50.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.848 1.446 . . . . 0.0 109.864 179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 109' ' ' PRO . 20.3 m -105.64 -1.61 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.824 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 105' ' ' GLY . 46.4 m -101.82 -48.02 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.906 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 104' ' ' SER . . . 40.79 -140.41 1.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.404 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 82.8 mmm -57.17 -47.5 81.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.99 . . . . 0.0 111.038 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 106' ' ' MET . 78.6 m-20 -143.19 -60.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 110.953 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . 50.7 mtpt -131.72 168.79 15.88 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.374 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 108' ' ' LYS . 38.2 Cg_endo -65.36 149.03 88.66 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.823 1.433 . . . . 0.0 109.543 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 4.1 p -143.4 -137.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.988 -1.07 . . . . 0.0 111.397 -178.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' CD2' ' HG2' ' A' ' 126' ' ' MET . 8.2 t80 -103.62 163.12 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 111.185 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.507 ' OG1' HG12 ' A' ' 125' ' ' ILE . 1.7 p -84.47 29.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 38.1 p-10 -71.73 130.17 87.42 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.986 -1.071 . . . . 0.0 110.389 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 112' ' ' THR . 49.0 Cg_endo -76.16 146.33 84.72 Favored 'Cis proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.949 -2.105 . . . . 0.0 110.082 -0.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HG2' ' CG1' ' A' ' 51' ' ' ILE . 40.8 Cg_endo -66.34 -174.24 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.097 1.577 . . . . 0.0 110.902 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 28.5 m -101.68 158.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 110.248 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' C ' HG22 ' A' ' 118' ' ' THR . 42.3 mttm -113.57 142.07 46.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.608 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 24.8 p -143.12 177.12 8.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.758 -1.214 . . . . 0.0 111.078 -179.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -80.85 -11.6 59.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.678 -0.639 . . . . 0.0 109.533 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.3 p90 -104.82 20.96 17.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 110.01 179.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.13 -173.04 14.52 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 16.4 m-85 -100.25 160.87 13.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -1.033 . . . . 0.0 108.729 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.58 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 63.9 m-70 -141.98 122.48 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.708 -1.245 . . . . 0.0 112.061 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.598 ' HB ' ' CE1' ' A' ' 111' ' ' PHE . 30.9 pt -118.46 125.06 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 18.2 pt -123.88 173.03 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.684 -1.26 . . . . 0.0 112.944 -176.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.614 ' HG2' ' CD2' ' A' ' 111' ' ' PHE . 73.1 mtm -133.4 146.71 51.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m -121.32 120.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.867 -1.145 . . . . 0.0 109.974 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -107.12 -20.86 13.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 111.331 -178.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.492 ' HA3' ' NZ ' ' A' ' 39' ' ' LYS . . . -161.62 156.09 27.5 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.101 -1.523 . . . . 0.0 110.637 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.461 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 7.0 ttt180 -126.05 145.51 50.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.922 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 58.9 pttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 53.5 p30 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.724 0.773 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' A' ' 86' ' ' THR . . . -103.71 168.39 9.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 -178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 129' ' ' GLY . 1.3 p -128.78 153.63 38.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 110.022 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 2.9 mtpm? -98.87 132.99 43.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 109.084 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 82.5 t -130.36 143.12 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.292 -178.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -125.34 120.88 32.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -144.78 164.95 29.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.738 -1.227 . . . . 0.0 112.256 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' CD1' HD11 ' A' ' 124' ' ' ILE . 13.5 pt -126.47 144.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -101.34 122.36 43.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.881 -1.137 . . . . 0.0 110.041 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 36.5 m -111.51 170.07 8.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 110.275 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.593 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 27.8 mt-10 -88.45 -158.63 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 110.318 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.1 mtmm -128.04 92.63 3.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.923 -1.111 . . . . 0.0 111.142 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.593 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 6.3 m-70 -132.88 17.26 4.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.95 2.25 81.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 5.0 ttmt -83.81 -12.95 54.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -1.079 . . . . 0.0 110.089 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.564 HG12 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -43.22 -41.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 110.298 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.503 ' O ' ' HG2' ' A' ' 55' ' ' MET . 41.7 ttm -60.94 -44.77 96.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.063 -1.023 . . . . 0.0 109.841 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -72.16 -31.73 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.05 -1.031 . . . . 0.0 109.385 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -59.6 -54.68 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.757 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 52' ' ' MET . 25.5 ptm -65.97 -23.91 66.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 24.1 tp10 -64.35 -41.98 96.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.042 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -79.79 -38.42 33.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 0.0 109.057 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD22 ' CZ ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -65.96 -49.14 68.94 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.616 -0.677 . . . . 0.0 109.218 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 33.4 mtmt 50.09 -124.66 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 0.0 110.384 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -70.66 -31.72 68.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.0 -1.062 . . . . 0.0 109.932 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.94 7.26 5.61 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 ttt -47.73 -42.07 24.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.861 -1.376 . . . . 0.0 109.247 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 27.3 mtt-85 -108.5 30.51 6.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.524 -0.735 . . . . 0.0 109.255 179.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -46.94 -47.8 21.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.886 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -57.74 -39.05 76.45 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 77.4 mt-10 -67.67 -42.65 81.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 71' ' ' TYR . 96.5 t -70.11 -52.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.56 -40.25 51.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.092 -1.005 . . . . 0.0 110.331 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.72 91.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 7.6 mm-40 -89.77 8.31 32.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.683 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 54' ' ' ALA . 33.1 m-85 -134.25 4.37 3.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.916 -1.115 . . . . 0.0 111.289 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -67.86 111.25 4.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 16.7 tt0 -102.06 5.59 40.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.748 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 79' ' ' GLY . 29.3 t70 -132.98 45.33 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.975 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -66.65 -32.59 74.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.032 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.94 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 108.842 179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.4 mmm-85 -104.74 8.25 34.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.65 -0.656 . . . . 0.0 109.408 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 52.86 42.35 31.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.775 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 74' ' ' ASP . . . -79.79 108.5 2.75 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -160.42 -92.45 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -90.39 140.67 29.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -1.149 . . . . 0.0 109.771 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -124.61 169.57 11.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -82.04 -122.99 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.466 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.629 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 18.4 m-90 -96.48 144.83 26.22 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.786 0.803 . . . . 0.0 112.116 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 40' ' ' VAL . 23.2 ptm -139.88 155.54 47.15 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 37' ' ' ALA . 31.3 p -129.84 -72.95 0.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.554 -1.341 . . . . 0.0 110.315 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 86' ' ' THR . 4.2 ttp85 -116.76 136.57 52.86 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.311 -0.955 . . . . 0.0 111.598 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' ARG . . . 58.34 144.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 90' ' ' MET . 53.2 p -142.37 -66.45 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.042 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.502 ' N ' ' OG ' ' A' ' 89' ' ' SER . 20.0 ptm -142.06 -39.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.541 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 38.4 t -153.01 157.55 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 110.085 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.52 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -37.99 -60.67 1.26 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 37.9 Cg_endo -63.62 -175.55 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.759 1.399 . . . . 0.0 110.334 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.577 ' CE1' HG21 ' A' ' 125' ' ' ILE . 59.9 t80 68.48 -78.03 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.611 -0.68 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.459 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 12.0 tm0? -66.51 -47.93 71.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 81.8 mt-10 -61.68 -38.75 88.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.05 70.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 0.0 109.003 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.5 83.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.086 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 15.2 m-85 -69.51 -21.48 63.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' C ' ' HD2' ' A' ' 102' ' ' PRO . . . -86.25 -12.8 48.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.468 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.566 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 9.8 tt -49.99 -45.66 81.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 101' ' ' LEU . 51.1 Cg_endo -75.65 77.64 3.28 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.299 1.157 . . . . 0.0 110.366 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.44 -32.05 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.7 p -128.19 -10.94 5.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.78 0.55 85.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 76.6 mtm -77.52 -28.37 52.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 110.208 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -128.6 70.84 1.39 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 38.0 tptt -77.61 -42.46 2.38 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.061 -1.024 . . . . 0.0 110.105 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 52.9 Cg_endo -81.66 59.53 7.26 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.452 1.238 . . . . 0.0 109.521 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.78 -166.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.029 . . . . 0.0 111.524 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.615 ' CZ ' HG23 ' A' ' 124' ' ' ILE . 7.5 t80 -114.34 153.8 29.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.77 -0.581 . . . . 0.0 110.409 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.548 ' CG2' HG12 ' A' ' 125' ' ' ILE . 66.2 p -72.85 119.38 17.0 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.352 -0.842 . . . . 0.0 110.732 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 111' ' ' PHE . 81.3 m-20 -133.45 121.9 16.64 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.257 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 48.8 Cg_endo -78.81 174.59 50.36 Favored 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.188 -2.005 . . . . 0.0 110.396 -0.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -70.83 175.78 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.957 1.504 . . . . 0.0 109.926 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 32.6 m -103.19 155.44 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -123.08 136.11 54.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.603 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 36.4 p -139.02 168.02 20.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.103 -0.998 . . . . 0.0 110.645 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -64.89 -17.28 64.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.796 . . . . 0.0 110.017 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.603 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -97.38 19.62 12.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.985 -1.072 . . . . 0.0 110.366 179.526 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.549 ' HA2' ' CG ' ' A' ' 47' ' ' LYS . . . 117.72 -176.91 16.37 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-30 -97.82 158.8 15.31 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . 75.9 m-70 -138.09 140.19 39.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.403 -1.436 . . . . 0.0 112.302 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.615 HG23 ' CZ ' ' A' ' 111' ' ' PHE . 84.2 mt -123.0 114.49 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG21 ' CE1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -122.43 149.49 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 0.0 112.102 -178.725 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' A' ' 111' ' ' PHE . 89.8 mtp -128.5 150.75 50.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.503 HG13 ' CG2' ' A' ' 38' ' ' VAL . 15.2 t -124.62 138.86 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.75 -1.219 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -114.9 -24.61 8.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 110.93 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.547 ' O ' ' CG2' ' A' ' 38' ' ' VAL . . . -150.27 132.67 4.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.461 ' HB2' ' HE2' ' A' ' 108' ' ' LYS . 23.4 ttm180 -76.97 -42.67 38.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.969 . . . . 0.0 110.949 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 38.0 mtmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.229 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 49.8 p30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.411 0.624 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -107.47 164.69 11.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 130' ' ' ARG . 5.9 m -136.72 161.46 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.917 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HD3' ' NE1' ' A' ' 84' ' ' TRP . 7.3 mmmt -99.71 112.09 24.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.415 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 4.0 p -127.88 128.4 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.949 . . . . 0.0 111.465 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 126' ' ' MET . 46.6 mtm180 -118.42 134.0 55.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . 3.7 p80 -135.81 162.86 31.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.59 -1.319 . . . . 0.0 111.704 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 124' ' ' ILE . 23.6 mt -116.64 121.86 68.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.608 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.8 tt -101.83 101.0 11.39 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.909 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' SG ' HG21 ' A' ' 43' ' ' ILE . 35.2 m -101.36 162.49 12.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.4 mt-10 -63.35 165.75 7.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.82 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 21.2 tttt -89.7 59.09 4.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.133 -0.979 . . . . 0.0 111.419 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 20.3 m80 -135.87 66.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.66 -1.275 . . . . 0.0 111.584 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.44 28.47 44.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.02 7.22 45.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.992 -1.299 . . . . 0.0 109.445 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.506 HG13 ' CD2' ' A' ' 122' ' ' TYR . 43.2 mt -62.51 -50.81 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.541 -0.725 . . . . 0.0 110.581 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.451 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 49.2 mtm -69.15 -32.26 71.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.451 -0.781 . . . . 0.0 110.617 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.54 -49.37 75.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.457 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -69.86 -51.32 34.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 111.479 -179.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 28.6 ptm -65.69 -43.9 87.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.315 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 55' ' ' MET . 64.3 tt0 -65.09 -41.23 95.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.956 -1.09 . . . . 0.0 110.686 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 55.3 mmtt -60.23 -56.14 25.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' HD11 ' A' ' 124' ' ' ILE . 1.2 pp -68.1 -14.04 62.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.62 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 21.0 mtpt 45.66 -133.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.795 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -57.87 -21.66 44.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.846 -1.159 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 123.45 10.73 5.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.4 ttm -51.16 -45.55 61.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -1.232 . . . . 0.0 109.927 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 10.7 mtp180 -109.66 31.6 5.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.903 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.61 -49.1 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -58.28 -46.86 85.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 109.374 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 51.4 mp0 -62.37 -41.53 98.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.299 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 54.3 t -65.54 -44.38 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.553 -0.717 . . . . 0.0 109.294 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -57.76 -51.88 67.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.925 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -46.74 88.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 6.0 mm-40 -73.29 -28.06 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.315 -0.866 . . . . 0.0 111.27 -179.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 63.5 m-85 -108.76 13.82 24.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.057 . . . . 0.0 110.86 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 8.4 t -78.9 105.23 10.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.876 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 31.9 tp10 -101.4 1.34 38.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.734 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 74' ' ' ASP . 20.4 p30 -103.4 24.56 10.82 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 110.112 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 43.8 tttm -46.96 -49.25 21.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.87 -50.38 10.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.0 109.734 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 7.1 tpm_? -80.4 -11.55 59.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.605 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 75' ' ' LYS . 84.5 mm-40 54.4 47.9 21.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.531 -0.731 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -81.61 -76.42 1.07 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.32 -84.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' GLY . 62.9 m-20 -109.25 150.61 27.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.579 -0.953 . . . . 0.0 109.632 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 2.9 mp -102.67 2.76 36.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 49.88 -139.53 18.06 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.1 m95 -89.94 114.8 26.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.395 -1.062 . . . . 0.0 110.574 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.513 ' HE2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -126.09 152.21 46.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.209 -0.932 . . . . 0.0 110.186 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.7 p -100.58 -89.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 110.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.506 ' N ' ' OG1' ' A' ' 86' ' ' THR . 39.3 ptt180 -116.61 138.71 51.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.375 -1.453 . . . . 0.0 110.901 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . -131.56 164.45 23.52 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -137.71 34.24 2.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.842 -1.387 . . . . 0.0 111.209 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.47 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 43.3 mmm -100.65 123.94 45.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.536 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 30.2 t 60.11 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 109.97 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.602 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -55.31 -43.95 84.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 43.7 Cg_endo -71.89 -12.12 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.369 1.194 . . . . 0.0 111.243 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.536 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 53.0 t80 -88.65 -54.48 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.0 110.18 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 2.0 tt0 -64.7 -43.64 92.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 110.677 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 47.1 tp10 -59.36 -42.97 92.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.973 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -60.35 -58.13 9.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.5 -56.33 2.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.473 -0.767 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HZ ' ' O ' ' A' ' 86' ' ' THR . 38.0 m-85 -83.16 3.68 29.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.524 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . . . -80.69 -29.74 36.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.193 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -107.99 94.09 12.08 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.165 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 50.0 Cg_endo -80.71 -33.89 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.939 1.494 . . . . 0.0 111.205 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.46 -173.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.737 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -113.77 84.31 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.782 . . . . 0.0 109.572 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.58 171.77 3.15 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.3 ttt -60.56 -28.53 68.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.566 -0.961 . . . . 0.0 110.544 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -117.15 23.35 11.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.039 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -121.33 130.79 24.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.001 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.25 -164.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.955 1.503 . . . . 0.0 110.5 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 126' ' ' MET . 7.2 p -106.83 -11.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -118.52 172.37 7.53 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.105 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.556 ' O ' ' O ' ' A' ' 114' ' ' PRO . 2.1 m -76.97 -4.83 46.02 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.58 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 65.6 m-20 -48.44 122.48 10.35 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.344 -1.473 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' A' ' 112' ' ' THR . 43.4 Cg_endo -66.38 128.08 8.81 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.359 1.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.507 ' HB3' ' CB ' ' A' ' 124' ' ' ILE . 38.4 Cg_endo -63.65 -179.3 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.086 1.572 . . . . 0.0 111.616 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 116' ' ' VAL . 31.5 m -102.47 144.87 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.568 -0.707 . . . . 0.0 109.86 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 34.1 pttt -110.28 130.14 55.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.045 -1.035 . . . . 0.0 110.296 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.599 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 71.8 p -137.35 173.1 12.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.059 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -19.31 65.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.179 -0.95 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 2.8 p90 -93.46 19.32 8.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.803 -1.185 . . . . 0.0 110.369 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 114.88 -174.11 15.17 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.512 178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-85 -104.12 153.22 21.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.702 -0.881 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 13.1 m-70 -141.34 133.48 27.84 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.684 -1.26 . . . . 0.0 112.948 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.56 ' O ' ' CG1' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -125.36 106.14 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.375 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.567 ' CG2' ' HB2' ' A' ' 42' ' ' HIS . 35.1 pt -105.11 157.0 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.857 -1.152 . . . . 0.0 111.864 -177.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.612 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 16.3 ptm -133.36 160.86 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.996 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 126' ' ' MET . 14.5 t -133.74 131.79 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.928 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.09 -4.51 16.55 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.486 -0.759 . . . . 0.0 110.225 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 38' ' ' VAL . . . -172.18 126.75 1.31 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.521 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.2 ttt-85 -127.22 152.6 47.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -1.121 . . . . 0.0 109.857 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 36' ' ' ASN . 30.5 tttm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.063 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.506 ' HA ' ' HG3' ' A' ' 131' ' ' LYS . 19.9 p30 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -125.93 173.73 8.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 2.5 p -132.52 154.58 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 110.065 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 84' ' ' TRP . 37.7 mtpt -100.05 115.18 29.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 82' ' ' LEU . 69.9 t -120.04 125.54 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 111.497 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -124.98 109.62 13.2 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.808 ' HB3' HG22 ' A' ' 125' ' ' ILE . 4.0 p80 -134.96 166.97 21.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.701 -1.249 . . . . 0.0 112.427 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.666 HG21 ' CB ' ' A' ' 68' ' ' ALA . 17.9 pt -118.56 134.04 63.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.761 HD23 ' N ' ' A' ' 45' ' ' CYS . 5.0 tt -107.44 132.15 53.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.549 -0.719 . . . . 0.0 111.097 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.761 ' N ' HD23 ' A' ' 44' ' ' LEU . 42.8 t -140.26 163.57 32.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 109.088 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 59.5 mm-40 -72.54 158.31 35.94 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.153 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.58 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.6 tttp -78.38 122.69 26.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.248 -0.907 . . . . 0.0 111.333 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 9.2 m-70 -129.79 -13.74 4.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 0.0 110.416 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.38 2.95 50.79 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -88.59 18.39 4.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.177 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.533 HD11 ' HG3' ' A' ' 117' ' ' LYS . 53.5 mt -45.68 -46.78 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 109.293 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 55' ' ' MET . 23.5 ptt? -65.74 -35.32 80.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.412 -0.805 . . . . 0.0 109.52 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 34.9 tt0 -75.19 -27.5 59.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.289 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.2 -45.99 44.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 21.0 ptm -64.92 -44.91 87.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 77.6 tt0 -65.44 -41.32 93.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.451 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 28.5 mmtt -67.42 -31.21 71.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 108.524 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 124' ' ' ILE . 24.3 tp -73.93 -29.36 61.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.748 -0.595 . . . . 0.0 109.83 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 20.0 mttm 39.46 -92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 58' ' ' LEU . 83.0 p -129.48 -158.03 0.86 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . -73.17 -1.92 57.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.8 ttp -65.0 -46.15 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 110.463 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 81.6 mtt180 -106.21 11.36 31.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.765 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.444 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 73.7 t80 -50.23 -43.96 53.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 109.748 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.84 -38.7 80.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 109.897 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 64.9 mt-10 -61.64 -51.07 69.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.892 . . . . 0.0 109.841 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 71' ' ' TYR . 93.6 t -69.65 -39.44 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' HG21 ' A' ' 43' ' ' ILE . . . -60.51 -53.25 59.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.71 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 7.9 mm100 -70.73 -28.0 64.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' HG13 ' A' ' 67' ' ' VAL . 12.0 m-30 -102.62 9.25 39.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 68' ' ' ALA . 47.4 t -79.07 88.18 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -104.33 7.66 35.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' ' CB ' ' A' ' 44' ' ' LEU . 43.0 p30 -132.01 40.49 3.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.468 -0.77 . . . . 0.0 109.982 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -64.89 -43.97 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.0 110.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.2 64.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -74.91 -33.09 61.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' ASP . 60.5 mt-30 -137.02 157.4 46.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.973 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.94 14.92 37.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.21 2.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 34.9 p-10 -121.3 137.37 54.72 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.318 -1.107 . . . . 0.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -104.35 -9.17 18.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 78.29 -143.98 27.81 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 39' ' ' LYS . 89.5 m95 -79.99 140.33 36.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.589 -0.948 . . . . 0.0 111.302 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.807 ' HG3' HD12 ' A' ' 82' ' ' LEU . 68.7 mmm -131.66 114.6 15.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.6 -0.688 . . . . 0.0 109.171 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.576 HG22 ' HB2' ' A' ' 37' ' ' ALA . 51.4 p -74.6 -43.38 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.979 -1.076 . . . . 0.0 109.896 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 8.6 mtt180 -107.55 -62.58 1.41 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.833 . . . . 0.0 110.015 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 89.6 111.01 1.31 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -141.94 86.3 1.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -1.165 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 91' ' ' VAL . 49.4 mtt -121.71 -37.26 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.095 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.03 -88.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.254 -0.904 . . . . 0.0 110.142 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -170.55 -69.45 0.04 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 -37.92 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.874 1.46 . . . . 0.0 110.571 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 125' ' ' ILE . 60.5 t80 -60.92 -49.99 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 3.5 tm0? -74.54 -55.25 6.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 110.094 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 3.1 tp10 -42.05 -45.65 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.54 -39.7 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.68 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.36 74.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 87' ' ' ARG . 34.8 m-85 -89.5 -5.47 57.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 110.156 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.43 8.73 14.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.32 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 127' ' ' VAL . 56.8 tp . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 111' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.071 0.462 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.576 ' H ' HG23 ' A' ' 110' ' ' VAL . 73.6 m-85 -106.55 146.89 30.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.635 HG21 HG13 ' A' ' 125' ' ' ILE . 13.3 p -72.04 86.87 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.002 -1.061 . . . . 0.0 109.065 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.1 125.77 38.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.446 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.3 Cg_endo -75.12 165.47 85.79 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 -2.147 . . . . 0.0 110.08 -0.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 -179.44 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.896 1.472 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 23.9 m -102.95 139.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.011 . . . . 0.0 110.558 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 51' ' ' ILE . 12.0 ttmt -112.08 123.81 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.598 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 73.7 p -130.65 176.1 8.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.981 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -72.03 -16.75 62.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.77 . . . . 0.0 110.551 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.598 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.1 p90 -98.18 19.4 14.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 0.0 110.187 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.58 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 111.29 -179.11 19.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 54.7 p90 -101.53 160.37 14.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -1.224 . . . . 0.0 110.034 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.581 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.3 m-70 -138.67 138.17 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 111.819 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.797 HG21 HD22 ' A' ' 58' ' ' LEU . 87.2 mt -115.27 111.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -103.23 143.86 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.066 . . . . 0.0 111.807 -178.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.8 tmm? -118.61 119.81 35.6 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 101' ' ' LEU . 46.8 t -97.56 121.2 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -110.53 -8.13 14.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.481 -0.762 . . . . 0.0 109.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.502 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -144.44 149.96 22.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.02 149.31 52.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.922 -1.34 . . . . 0.0 110.653 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 36' ' ' ASN . 71.6 tttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.081 0.944 . . . . 0.0 110.368 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -133.8 156.45 48.0 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.785 -1.197 . . . . 0.0 111.263 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.896 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.5 m -116.86 152.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HG3' ' CH2' ' A' ' 84' ' ' TRP . 5.5 mtmt -98.49 113.08 24.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.884 -1.135 . . . . 0.0 108.815 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.817 HG13 ' CG2' ' A' ' 125' ' ' ILE . 70.3 t -113.94 130.81 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.118 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -134.41 129.95 36.1 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.504 ' CE1' HD11 ' A' ' 82' ' ' LEU . 8.9 p-80 -145.04 168.7 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.448 -1.407 . . . . 0.0 112.565 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 67' ' ' VAL . 89.4 mt -108.88 131.86 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -118.49 125.12 49.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 111.838 -178.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 19.1 t -137.62 136.22 37.31 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.4 mm-40 -55.23 -157.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.502 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 92.8 mttt -97.91 105.04 17.12 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.47 -1.394 . . . . 0.0 112.509 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -133.02 16.7 4.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.242 -0.911 . . . . 0.0 109.897 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.28 23.49 73.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 91.7 mttt -94.51 6.18 49.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -1.006 . . . . 0.0 110.808 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 3.0 mp -51.27 -50.1 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.029 . . . . 0.0 110.392 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 39.5 ttp -69.62 -40.13 76.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -0.757 . . . . 0.0 111.288 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 54.1 tp10 -70.62 -41.09 72.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.656 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -61.49 -54.51 42.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 111.18 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 4.9 ptt? -61.79 -44.12 97.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.085 -1.009 . . . . 0.0 111.178 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.525 ' N ' ' CG ' ' A' ' 55' ' ' MET . 10.2 pt-20 -72.04 -23.61 61.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.929 -1.107 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.7 tptt -70.26 -45.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.805 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' HB3' HG21 ' A' ' 67' ' ' VAL . 1.3 pp -81.02 -23.06 38.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 61.5 mmtt 52.2 -133.62 1.77 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.116 -0.99 . . . . 0.0 111.178 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -36.28 66.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 110.622 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.2 -0.3 3.54 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.221 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.4 mtm -47.86 -36.87 12.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.007 -1.29 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 7.1 mtp180 -110.3 29.28 7.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.703 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.96 -47.78 43.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.527 -0.733 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.18 -37.55 78.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.881 . . . . 0.0 109.945 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 8.3 tp10 -65.48 -47.67 75.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 43' ' ' ILE . 41.0 t -63.52 -47.42 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.319 -0.863 . . . . 0.0 109.639 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -53.4 -51.06 63.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 110.127 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.97 67.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.687 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -29.94 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 m-85 -106.94 11.12 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.009 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ALA . 79.7 p -76.58 69.67 3.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.398 -0.813 . . . . 0.0 109.741 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 11.7 pt-20 -111.24 26.79 10.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.638 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.702 ' HB3' HD13 ' A' ' 44' ' ' LEU . 47.9 p-10 -100.66 14.45 31.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 74' ' ' ASP . 21.9 tttm -38.32 -35.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 110.166 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.15 -37.63 47.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.565 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 41.8 ttt85 -121.82 17.74 11.04 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.462 -0.774 . . . . 0.0 109.744 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.8 tp60 62.61 -77.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 110.612 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . 53.62 -116.14 5.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 66.74 -84.15 0.11 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' C ' HD12 ' A' ' 82' ' ' LEU . 13.5 p-10 -132.69 136.5 46.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -1.117 . . . . 0.0 110.389 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.79 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.0 mp -102.09 147.44 26.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.77 -125.14 0.19 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.776 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 94.2 m95 -93.79 131.61 38.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.549 -0.971 . . . . 0.0 111.001 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.705 ' O ' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -127.6 122.24 32.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.104 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.0 p -72.14 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 111.04 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -87.19 -37.9 16.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' GLN . . . 57.66 77.82 0.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . 90.1 p -123.91 103.24 8.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -1.135 . . . . 0.0 109.718 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -141.65 -86.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.37 -41.39 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 111.25 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . 132.03 -77.41 0.39 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.301 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -24.17 44.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.759 1.4 . . . . 0.0 112.03 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -62.68 -47.82 81.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.759 -1.213 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 26.4 pt20 -78.2 -38.12 43.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.531 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.89 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 89.6 mt-10 -55.35 -32.17 62.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.89 -40.24 16.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.036 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.37 7.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.841 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -70.56 -32.38 69.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.0 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -50.04 -35.36 24.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 127' ' ' VAL . 7.0 tt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 111' ' ' PHE . 95.7 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.699 0.761 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 110' ' ' VAL . 52.8 p90 -120.19 163.87 17.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 6.4 m -48.87 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.485 -0.759 . . . . 0.0 110.533 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.5 p-10 -127.05 120.36 22.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.097 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 45.3 Cg_endo -72.91 165.77 83.09 Favored 'Cis proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.623 -2.24 . . . . 0.0 109.736 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.8 Cg_endo -71.09 178.55 5.27 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.784 1.413 . . . . 0.0 109.765 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 26.8 m -101.43 161.99 3.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -124.54 118.55 26.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 109.208 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -136.6 171.78 13.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.734 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -65.37 -9.07 21.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.549 -0.72 . . . . 0.0 110.277 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -89.54 -20.18 24.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 109.043 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.17 -160.97 25.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 16.3 m-30 -100.72 134.54 43.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -1.077 . . . . 0.0 109.247 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.532 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 61.6 m-70 -125.39 121.75 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.011 -1.055 . . . . 0.0 112.556 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.645 HG22 ' HB ' ' A' ' 43' ' ' ILE . 4.8 tt -115.71 114.62 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.817 ' CG2' HG13 ' A' ' 40' ' ' VAL . 7.1 mt -107.13 125.56 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.942 -1.099 . . . . 0.0 113.543 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 9.8 tpt -100.09 114.12 27.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 101' ' ' LEU . 5.7 p -107.43 156.83 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.677 -1.265 . . . . 0.0 112.071 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -103.85 -29.29 11.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.493 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.79 -175.42 23.04 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.896 ' HB2' HG12 ' A' ' 38' ' ' VAL . 17.8 ttp180 -132.41 -85.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 50.6 tttm . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.538 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.172 0.511 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.968 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -127.24 -172.89 2.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.672 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.1 m -135.92 145.67 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 110.337 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -98.73 137.15 37.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.822 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.768 HG23 ' HB3' ' A' ' 82' ' ' LEU . 3.6 m -138.43 157.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.3 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HB2' ' HE2' ' A' ' 126' ' ' MET . 7.7 mmt85 -123.1 115.8 22.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -125.52 157.61 36.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.715 -1.24 . . . . 0.0 112.633 -177.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 16.3 pt -130.57 125.49 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.5 tt -106.42 123.84 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.16 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 1.4 t -143.26 -171.47 3.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.906 -1.121 . . . . 0.0 111.8 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.714 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 4.4 mt-10 -77.41 117.15 18.61 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.595 -0.69 . . . . 0.0 111.403 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HG3' HD11 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -82.58 77.28 9.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.711 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.714 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 30.0 m-70 -134.61 71.05 1.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.983 -1.073 . . . . 0.0 110.155 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.18 78.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.184 -1.567 . . . . 0.0 109.184 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 59.6 tttt -108.7 -11.55 15.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -1.044 . . . . 0.0 110.385 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.622 HD13 ' HE2' ' A' ' 117' ' ' LYS . 34.2 mt -47.58 -53.11 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 73.1 mtm -59.21 -37.34 77.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.446 -0.784 . . . . 0.0 110.598 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 75.0 mm-40 -61.41 -39.8 92.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.928 . . . . 0.0 110.568 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -66.38 -60.7 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.458 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.471 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 22.6 ptm -58.93 -44.44 91.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.026 . . . . 0.0 110.336 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 55' ' ' MET . 32.4 mm-40 -59.1 -42.98 91.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' MET . 66.2 tttt -72.07 -38.0 69.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 111.0 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.8 ' CB ' HG21 ' A' ' 67' ' ' VAL . 2.3 pp -93.98 10.81 31.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.956 -1.09 . . . . 0.0 110.807 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.9 ptmt -42.55 161.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.145 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -52.09 115.99 1.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.004 . . . . 0.0 110.087 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.11 -44.05 1.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 7.5 tpt -77.3 162.72 27.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -1.098 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -80.36 100.25 8.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CD1' ' SD ' ' A' ' 126' ' ' MET . 76.9 t80 -50.64 -32.54 19.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.966 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 54.8 t30 -55.38 -43.64 75.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.558 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.22 -44.1 84.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.696 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.8 HG21 ' CB ' ' A' ' 58' ' ' LEU . 59.3 t -55.81 -57.54 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -46.13 -58.02 3.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.54 -38.7 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.375 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -78.77 -32.36 46.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.212 -0.93 . . . . 0.0 110.584 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.78 23.15 13.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -1.0 . . . . 0.0 110.616 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 m -83.86 100.27 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.385 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.51 ' OE1' ' HG3' ' A' ' 46' ' ' GLU . 28.7 tt0 -100.66 4.62 43.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.506 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLN . 85.3 m-20 -102.07 72.1 1.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.459 -0.776 . . . . 0.0 109.357 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -50.55 -35.49 30.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.467 -0.77 . . . . 0.0 110.87 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.41 -54.41 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -73.3 -15.7 61.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.102 -0.999 . . . . 0.0 110.589 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.603 ' CG ' ' O ' ' A' ' 78' ' ' GLN . 1.6 pt20 33.92 99.94 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.249 1.023 . . . . 0.0 111.431 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -70.38 -90.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . 46.73 -91.63 0.01 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 79' ' ' GLY . 19.9 p-10 -106.13 132.45 52.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.589 -0.948 . . . . 0.0 110.075 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 40' ' ' VAL . 50.4 tp -116.88 135.08 54.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -56.48 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.8 m-90 -88.56 138.69 31.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.972 . . . . 0.0 110.466 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.5 mmm -101.41 119.45 38.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 108.999 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.968 HG22 ' CB ' ' A' ' 37' ' ' ALA . 3.6 p -119.36 -29.42 5.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 7.2 ptp180 -63.61 -33.67 76.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.429 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.508 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . 52.85 20.7 8.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -130.36 78.71 1.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -1.166 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 92' ' ' GLY . 7.9 ttt -136.9 153.23 50.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.618 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.884 HG12 ' HD2' ' A' ' 93' ' ' PRO . 57.0 t 34.51 -91.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.368 0.604 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.621 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 178.44 -74.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.884 ' HD2' HG12 ' A' ' 91' ' ' VAL . 43.9 Cg_endo -70.14 -11.8 31.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.137 1.598 . . . . 0.0 110.391 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -73.94 -66.63 0.69 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' HA2' ' A' ' 88' ' ' GLY . 13.3 mm-40 -65.4 -40.2 93.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 110.944 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.864 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 9.8 pt-20 -55.07 -38.5 68.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.749 -1.219 . . . . 0.0 109.848 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -68.12 -55.13 13.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.989 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.34 -49.57 12.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 7.3 m-30 -88.58 0.78 56.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.33 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -83.23 -25.76 31.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.151 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 101' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.51 0.672 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 54.3 p90 -123.65 172.56 8.71 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.611 ' CG2' HG12 ' A' ' 125' ' ' ILE . 3.1 p -58.26 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.607 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 10.5 p-10 -120.24 113.87 33.7 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.956 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.8 Cg_endo -73.4 164.53 86.89 Favored 'Cis proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.971 -2.095 . . . . 0.0 110.563 0.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 1.029 ' HB3' HG22 ' A' ' 124' ' ' ILE . 44.4 Cg_endo -73.02 -175.83 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.019 1.536 . . . . 0.0 110.385 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 123' ' ' HIS . 16.5 m -105.63 146.55 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.622 ' HE2' HD13 ' A' ' 51' ' ' ILE . 64.7 mttt -112.61 130.53 56.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 73.8 p -142.31 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.889 -1.132 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.24 -29.73 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 109.997 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 3.5 p90 -88.6 43.26 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.533 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.6 -157.75 27.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p90 -130.61 160.18 34.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -1.037 . . . . 0.0 108.476 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 1.4 m-70 -140.32 133.24 29.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.666 -1.271 . . . . 0.0 112.135 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.029 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -112.66 136.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -126.52 133.71 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.598 -1.314 . . . . 0.0 112.278 -176.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.675 ' HE2' ' HB2' ' A' ' 41' ' ' ARG . 31.2 mtm -94.42 99.01 11.28 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.78 110.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.429 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -139.4 151.09 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.17 60.26 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.18 169.23 14.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.58 -0.953 . . . . 0.0 110.392 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.328 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.4 t30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.748 0.785 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -136.36 164.2 28.67 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.645 -1.285 . . . . 0.0 110.648 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 85' ' ' MET . 17.9 m -139.48 146.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 33.0 tttm -100.57 130.34 46.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.918 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -130.78 149.68 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.863 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 45.6 mtt180 -140.17 126.32 19.81 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.026 ' CB ' HG22 ' A' ' 125' ' ' ILE . 2.3 p80 -144.9 -178.65 6.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.612 -1.305 . . . . 0.0 112.206 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 71' ' ' TYR . 9.2 pt -138.37 138.47 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -103.47 126.81 50.84 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.273 0.558 . . . . 0.0 110.386 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.8 p -134.38 171.09 14.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.063 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' NE2' ' A' ' 48' ' ' HIS . 73.3 mm-40 -61.69 171.17 1.65 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.261 -0.899 . . . . 0.0 110.623 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 6.0 tttt -116.56 80.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.988 . . . . 0.0 110.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.569 ' NE2' ' HB3' ' A' ' 46' ' ' GLU . 18.4 m-70 -134.78 63.21 1.63 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.936 -1.103 . . . . 0.0 111.966 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.97 9.95 12.53 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.241 -0.912 . . . . 0.0 111.114 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 37.4 ttmt -89.2 13.29 13.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.973 -1.31 . . . . 0.0 110.482 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.635 HG13 ' CE2' ' A' ' 122' ' ' TYR . 82.0 mt -64.29 -42.58 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.569 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.45 ' HE2' ' SD ' ' A' ' 55' ' ' MET . 38.6 mmt -69.26 -44.4 71.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.895 . . . . 0.0 111.273 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -70.65 -38.92 73.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.08 . . . . 0.0 110.746 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.5 -52.73 56.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.45 ' SD ' ' HE2' ' A' ' 52' ' ' MET . 5.7 ptt? -65.39 -34.39 78.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.887 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 16.0 tp10 -58.03 -46.41 85.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' CG ' HG22 ' A' ' 67' ' ' VAL . 22.2 tttt -67.57 -32.86 73.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 109.181 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.871 HD21 ' CE2' ' A' ' 111' ' ' PHE . 2.0 tp -74.41 -13.02 60.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 109.253 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 39.9 tptt -40.4 144.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.746 . . . . 0.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -50.4 149.43 3.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.235 -0.916 . . . . 0.0 108.953 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.88 -44.25 1.6 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.6 mmt -78.36 165.77 23.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.509 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -71.69 99.16 2.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.108 -0.995 . . . . 0.0 110.811 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 60.9 t80 -48.47 -29.54 4.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 109.304 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -77.79 -40.23 41.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 11.2 tp10 -56.54 -46.21 80.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.866 . . . . 0.0 109.67 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 58' ' ' LEU . 69.5 t -67.07 -44.06 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 109.558 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -54.89 -50.89 67.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.92 57.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -63.1 -29.08 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.807 ' HB2' HD12 ' A' ' 43' ' ' ILE . 21.9 m-85 -108.99 18.77 20.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.46 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.3 t -91.25 96.06 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -99.77 0.03 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.233 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 75' ' ' LYS . 41.2 t0 -105.97 15.26 26.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.464 -0.772 . . . . 0.0 109.953 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 14.4 pttm -41.81 -35.15 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -86.02 134.75 33.83 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 81.14 -18.39 0.5 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.683 -0.636 . . . . 0.0 109.962 -178.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.3 tt0 70.38 177.33 0.27 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 110.982 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 82' ' ' LEU . . . 154.8 -20.81 0.59 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 42' ' ' HIS . . . -48.29 -44.99 28.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.61 ' C ' HD12 ' A' ' 82' ' ' LEU . 34.6 p-10 -115.01 126.43 54.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -1.016 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.0 mp -101.35 7.8 42.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 60.26 -147.66 44.63 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 35.3 m95 -96.73 132.29 42.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.743 -0.857 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 38' ' ' VAL . 9.0 ptp -135.87 149.77 49.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.58 -0.7 . . . . 0.0 109.206 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 36' ' ' ASN . 26.4 p -111.47 -64.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.375 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' ' OG1' ' A' ' 86' ' ' THR . 7.3 mtp180 -71.69 -38.23 70.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 109.758 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 95' ' ' GLN . . . 60.03 55.38 30.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.8 m -103.67 106.23 16.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.251 . . . . 0.0 109.522 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.0 mmt -130.16 -83.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 111.107 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 93' ' ' PRO . 4.0 p -96.46 -28.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.235 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.46 -73.12 0.47 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.025 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 91' ' ' VAL . 44.0 Cg_endo -69.84 -41.67 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.849 1.447 . . . . 0.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -53.91 -38.41 64.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.071 -1.018 . . . . 0.0 109.393 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 88' ' ' GLY . 44.9 tt0 -67.33 -52.35 41.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.776 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 38.3 tt0 -54.45 -44.45 72.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -59.67 -56.12 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.07 -54.9 6.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.346 -0.846 . . . . 0.0 110.264 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.435 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 61.1 m-85 -85.08 11.29 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 0.0 110.478 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -102.15 -19.9 14.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.736 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.91 . . . . 0.0 112.638 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 111' ' ' PHE . 2.7 m . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD21 ' A' ' 58' ' ' LEU . 40.6 t80 -116.58 152.19 34.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.896 -1.127 . . . . 0.0 110.806 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.643 HG21 ' CG1' ' A' ' 125' ' ' ILE . 7.3 p -74.84 110.43 9.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 110.936 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 88.3 m-20 -133.81 121.69 16.12 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.8 Cg_endo -79.32 172.7 58.49 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.164 -2.015 . . . . 0.0 110.362 -0.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HG3' HD12 ' A' ' 124' ' ' ILE . 47.2 Cg_endo -73.15 178.12 6.95 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.956 1.503 . . . . 0.0 109.725 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 123' ' ' HIS . 16.2 m -99.91 155.11 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.008 -1.058 . . . . 0.0 109.378 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -125.26 130.43 52.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.58 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.593 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.2 p -134.04 178.23 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -72.89 -15.83 61.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -0.955 . . . . 0.0 110.617 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 1.8 p90 -95.84 24.62 5.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.174 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 109.97 -176.41 19.19 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.4 m-85 -100.02 154.04 18.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 53.4 m-70 -129.91 122.52 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.872 -1.143 . . . . 0.0 110.487 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.829 HD12 ' HG3' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -117.92 108.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.026 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -109.01 157.47 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.69 -1.256 . . . . 0.0 112.959 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.476 ' HA ' ' CD1' ' A' ' 111' ' ' PHE . 3.7 ttt -116.26 119.29 35.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.95 115.52 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.814 -1.179 . . . . 0.0 111.947 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -106.0 -18.28 14.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 70.7 -163.64 53.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG3' ' CZ3' ' A' ' 84' ' ' TRP . 66.1 ttt180 -132.77 -35.69 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.943 . . . . 0.0 110.003 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.288 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' THR . 38.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.26 0.553 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CA ' ' OG1' ' A' ' 86' ' ' THR . . . -113.14 168.73 9.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.0 110.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 14.3 m -130.3 169.5 21.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.558 -0.714 . . . . 0.0 109.882 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CG ' ' CE2' ' A' ' 84' ' ' TRP . 19.0 mtpt -98.53 119.61 37.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.095 -1.003 . . . . 0.0 109.193 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.719 HG21 ' CE ' ' A' ' 85' ' ' MET . 95.9 t -111.72 126.39 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.023 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NH1' ' OE1' ' A' ' 128' ' ' GLU . 71.0 mtm180 -119.77 125.67 49.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB3' HG23 ' A' ' 125' ' ' ILE . 2.1 p80 -143.92 178.81 7.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.392 -1.442 . . . . 0.0 112.416 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 88.6 mt -121.61 135.48 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.45 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -111.75 119.42 38.57 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.681 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 43' ' ' ILE . 15.4 m -130.22 168.31 17.05 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 67.6 mt-10 -88.5 -172.6 3.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 110.283 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 35.9 mtmt -102.83 101.66 11.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.962 -1.086 . . . . 0.0 111.442 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.414 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 29.1 m-70 -134.57 6.56 3.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.888 . . . . 0.0 111.459 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.6 44.05 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.427 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 27.9 mttt -96.88 6.79 47.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.26 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' A' ' 122' ' ' TYR . 69.5 mt -46.14 -57.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' MET . 51.1 mtt -65.08 -40.24 94.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.482 -0.761 . . . . 0.0 109.842 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 tp10 -67.37 -22.01 65.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.192 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -75.56 -60.51 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.167 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.546 ' HB2' ' HG2' ' A' ' 114' ' ' PRO . 11.6 ptt? -56.93 -32.52 66.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -71.09 -42.55 69.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 39.3 mmtm -64.37 -50.64 66.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.807 ' HB3' HG21 ' A' ' 67' ' ' VAL . 2.5 pp -78.17 -14.88 59.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 109.522 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 60' ' ' SER . 4.5 ptmm? 23.41 -134.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 41.3 t -52.0 -22.1 3.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.938 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 126.77 2.46 6.71 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 58.3 ttm -56.86 -39.27 74.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -1.179 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 mtt180 -108.86 13.26 24.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.0 110.132 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 77.3 t80 -51.1 -48.87 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 49.5 m-80 -57.76 -43.38 85.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.35 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' CD ' ' HG2' ' A' ' 63' ' ' ARG . 41.4 mt-10 -68.09 -38.24 82.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.807 HG21 ' HB3' ' A' ' 58' ' ' LEU . 97.4 t -62.74 -71.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.416 -0.803 . . . . 0.0 109.134 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -48.65 -50.8 31.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -42.92 -42.24 3.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.822 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 70' ' ' GLN . 4.7 tp-100 -106.02 -6.61 18.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.378 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-85 -103.42 11.74 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.6 p -83.27 100.5 10.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 110.383 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -106.03 20.12 19.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.953 . . . . 0.0 110.067 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 30.2 t0 -137.85 39.84 2.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -59.84 -24.29 64.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.857 . . . . 0.0 110.189 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.93 81.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -103.26 -57.6 2.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.138 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ASP . 1.2 pt20 -135.19 164.83 26.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.84 23.21 31.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 97.76 1.32 58.77 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.558 ' C ' HD12 ' A' ' 82' ' ' LEU . 76.1 m-20 -134.15 132.01 39.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.799 -1.412 . . . . 0.0 110.929 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.3 mp -109.58 151.87 26.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.795 . . . . 0.0 109.368 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -77.56 -132.5 0.6 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.619 ' CE2' ' CG ' ' A' ' 39' ' ' LYS . 86.0 m95 -95.08 122.71 38.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.928 -0.748 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.719 ' CE ' HG21 ' A' ' 40' ' ' VAL . 6.6 ptt? -141.54 137.47 32.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 36' ' ' ASN . 89.1 m -103.38 -45.13 4.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.762 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -73.27 -32.22 64.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.0 -145.66 16.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -120.96 -62.16 1.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.147 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 85.9 mmm -137.44 -86.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.394 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 92' ' ' GLY . 9.9 p -174.61 176.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG22 ' A' ' 91' ' ' VAL . . . 93.93 -151.14 20.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HG13 ' A' ' 116' ' ' VAL . 43.0 Cg_endo -69.3 -8.34 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.245 1.656 . . . . 0.0 110.093 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.53 ' CE1' HD13 ' A' ' 125' ' ' ILE . 1.1 t80 -76.71 -48.52 18.58 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.514 -0.741 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -78.87 -47.6 16.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.129 -0.982 . . . . 0.0 110.835 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.97 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -62.43 -20.65 64.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 112' ' ' THR . . . -93.16 -55.02 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.786 -1.196 . . . . 0.0 110.545 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.31 -54.51 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.967 . . . . 0.0 111.388 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 38.8 m-85 -89.81 -21.85 22.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.158 -0.964 . . . . 0.0 111.609 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.97 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -119.05 32.43 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.823 -1.173 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.525 HD11 ' C ' ' A' ' 112' ' ' THR . 14.4 tp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 111' ' ' PHE . 48.9 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.559 ' CB ' ' HB3' ' A' ' 114' ' ' PRO . 92.8 m-85 -98.37 167.29 10.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 113' ' ' ASP . 96.8 m -62.15 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 112.558 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.815 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 54.2 t0 -70.33 -34.08 3.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.815 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 52.9 Cg_endo -76.16 -25.76 10.25 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.466 -1.056 . . . . 0.0 114.729 1.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 42.0 Cg_endo -71.14 115.56 4.32 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 122.341 0.653 . . . . 0.0 112.895 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 93' ' ' PRO . 32.3 t -111.39 153.08 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 14.6 ptmm? -143.06 117.93 9.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.795 -1.191 . . . . 0.0 110.697 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.827 HG21 ' CD2' ' A' ' 120' ' ' PHE . 1.3 t -145.37 179.65 7.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -64.12 -11.97 35.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.827 ' CD2' HG21 ' A' ' 118' ' ' THR . 0.0 OUTLIER -87.78 -17.99 30.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 108.673 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 129.08 -149.84 18.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.95 142.85 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -1.092 . . . . 0.0 108.446 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.642 ' CE1' ' CG2' ' A' ' 118' ' ' THR . 43.7 m80 -132.32 144.09 50.32 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.229 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.591 HD11 ' HB1' ' A' ' 54' ' ' ALA . 7.6 mt -132.72 109.96 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.052 HG23 ' HB3' ' A' ' 42' ' ' HIS . 1.2 mt -115.32 129.66 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.735 -1.228 . . . . 0.0 112.271 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.523 ' HG2' ' CD1' ' A' ' 111' ' ' PHE . 88.1 mtp -99.55 135.19 41.33 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.8 125.4 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.949 -1.095 . . . . 0.0 111.141 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.52 ' OE1' ' NH1' ' A' ' 41' ' ' ARG . 79.7 tt0 -142.21 147.75 37.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.08 76.47 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 38' ' ' VAL . 76.2 ttt180 -122.34 131.89 54.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -1.119 . . . . 0.0 110.179 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.751 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.164 0.507 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -128.92 172.03 11.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 110.7 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.6 p -141.45 156.94 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.357 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -100.13 119.72 38.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.66 HG21 HD21 ' A' ' 82' ' ' LEU . 4.5 m -127.31 157.36 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.7 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 37.9 mtt-85 -139.8 118.84 12.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.011 ' HB3' HG23 ' A' ' 125' ' ' ILE . 9.8 p-80 -132.03 161.96 31.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.838 -1.164 . . . . 0.0 112.262 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 3.4 mt -115.81 128.15 73.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.652 HD13 ' OD2' ' A' ' 74' ' ' ASP . 5.1 tt -110.36 129.37 55.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.226 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' N ' HD23 ' A' ' 44' ' ' LEU . 45.1 t -132.33 152.5 51.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 33.8 mt-10 -64.76 -171.64 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.716 -1.24 . . . . 0.0 109.463 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.666 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 48.0 tttt -97.94 106.66 18.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.587 -1.32 . . . . 0.0 113.312 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 2.8 m-70 -131.63 -5.9 3.67 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.161 -0.962 . . . . 0.0 110.032 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.6 30.29 10.84 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' GLU . 82.3 mttt -109.63 -2.75 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 111.111 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.569 ' HB ' ' CG ' ' A' ' 122' ' ' TYR . 11.3 tt -45.64 -40.94 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 51' ' ' ILE . 16.6 ttt -65.66 -34.4 78.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.334 -0.854 . . . . 0.0 109.001 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' LYS . 79.5 tt0 -72.24 -41.75 66.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 108.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.94 -57.03 13.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.716 . . . . 0.0 110.12 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.698 ' HA ' HD23 ' A' ' 58' ' ' LEU . 28.3 ptm -68.83 -28.13 66.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.862 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.3 tt0 -74.57 -26.25 59.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB3' HG12 ' A' ' 67' ' ' VAL . 17.2 mmtm -81.41 -36.84 29.03 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.538 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.812 ' N ' HG11 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -83.96 -19.04 35.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.453 -0.78 . . . . 0.0 109.259 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 56' ' ' GLU . 60.8 mmtt 44.57 -138.75 0.38 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.48 -0.762 . . . . 0.0 110.052 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.8 t -54.86 -25.91 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 110.912 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 139.7 -11.47 3.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.4 mtp -48.21 -35.39 11.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 67' ' ' VAL . 9.7 mtt180 -112.91 26.64 10.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.154 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 79.6 t80 -55.49 -37.51 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -75.37 -39.56 59.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.339 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 61.1 mm-40 -62.43 -58.15 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.794 . . . . 0.0 109.534 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.812 HG11 ' N ' ' A' ' 58' ' ' LEU . 16.6 m -50.92 -44.7 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.242 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -62.72 -37.26 85.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.602 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -55.66 -36.9 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.176 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -105.74 -10.83 16.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 110.794 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 67' ' ' VAL . 24.8 m-85 -114.23 18.94 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.247 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 36.6 t -111.77 113.24 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.831 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.94 -5.3 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.655 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.652 ' OD2' HD13 ' A' ' 44' ' ' LEU . 96.2 m-20 -104.43 59.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.452 -0.78 . . . . 0.0 109.607 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -55.43 -28.88 57.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.343 -0.848 . . . . 0.0 111.773 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.15 -36.12 6.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.729 -1.232 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -65.12 -55.54 18.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.12 . . . . 0.0 110.307 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HG3' ' C ' ' A' ' 77' ' ' ARG . 19.7 mt-30 -143.45 -72.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 110.696 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.84 -107.83 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -99.35 -37.97 3.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 39.2 p30 -128.5 134.65 48.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.076 -1.249 . . . . 0.0 110.959 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 85' ' ' MET . 2.1 pp -103.3 1.33 32.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.5 -134.81 11.84 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.6 m-90 -99.23 155.41 17.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.552 -0.97 . . . . 0.0 110.915 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -126.87 133.63 50.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.442 -0.786 . . . . 0.0 109.471 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.6 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.5 p -128.77 -37.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.035 -1.04 . . . . 0.0 111.011 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 3.1 mtm105 -116.63 -14.96 10.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.907 -1.121 . . . . 0.0 111.507 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.451 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . 126.92 -176.66 17.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 9.5 t -141.8 -32.09 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.45 -1.029 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 3.7 mmt -104.33 -145.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.913 -1.117 . . . . 0.0 110.956 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.709 HG23 ' HD2' ' A' ' 93' ' ' PRO . 13.3 m -86.53 -29.41 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.073 -1.017 . . . . 0.0 112.467 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 177.04 -54.44 0.1 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 118.451 -1.833 . . . . 0.0 111.877 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.709 ' HD2' HG23 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -62.23 -27.04 77.97 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.352 1.185 . . . . 0.0 111.856 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 90' ' ' MET . 78.1 t80 -70.79 -52.39 20.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.749 -1.219 . . . . 0.0 109.948 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 2.6 tt0 -73.25 -29.42 62.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 109.548 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.959 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 83.0 mt-10 -70.42 -25.86 63.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 109.832 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -87.09 -53.88 4.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.67 -50.62 60.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -76.05 -14.69 60.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.253 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -67.7 -58.01 5.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.694 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 101' ' ' LEU . 11.2 mp . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.755 HG22 ' N ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.842 0.353 . . . . 0.0 111.76 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.755 ' N ' HG22 ' A' ' 110' ' ' VAL . 9.3 t80 -133.95 156.11 48.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 111.109 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 114' ' ' PRO . 23.2 p -70.63 63.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.407 -0.808 . . . . 0.0 109.712 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 24.7 p-10 -97.88 130.73 28.17 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.5 Cg_endo -74.9 168.8 76.28 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.773 -2.178 . . . . 0.0 110.033 -0.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.985 ' HB3' HG22 ' A' ' 124' ' ' ILE . 41.6 Cg_endo -70.75 171.51 15.4 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.049 1.552 . . . . 0.0 110.407 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.33 150.32 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.494 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HG2' ' CD1' ' A' ' 51' ' ' ILE . 50.4 mtmt -113.33 133.32 55.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 75.5 p -139.28 -178.7 5.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.804 -1.185 . . . . 0.0 111.485 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -81.43 -18.03 46.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.449 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.3 OUTLIER -91.23 -0.77 57.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.062 -1.024 . . . . 0.0 109.455 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 132.46 -176.38 19.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 94.8 m-85 -100.95 153.77 19.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.489 -1.007 . . . . 0.0 109.426 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.597 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 5.0 m-70 -141.6 141.35 33.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 112.286 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.985 HG22 ' HB3' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -124.55 114.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 176.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -103.38 157.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.225 1.012 . . . . 0.0 112.175 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 19.5 ttt -136.94 134.07 36.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.71 136.55 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.74 -1.225 . . . . 0.0 111.353 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.02 109.19 7.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 109.669 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.66 115.24 0.26 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -130.07 150.5 51.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 pttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.269 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' THR . 26.4 p30 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.434 0.635 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 131' ' ' LYS . . . -90.31 129.19 36.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 110.309 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 129' ' ' GLY . 13.9 p -141.63 164.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HD3' ' CZ2' ' A' ' 84' ' ' TRP . 12.1 mtmm -98.76 121.31 40.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.221 -0.925 . . . . 0.0 108.773 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.968 ' HB ' HD11 ' A' ' 82' ' ' LEU . 91.2 t -130.15 143.84 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.934 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 31.1 mtt85 -140.4 107.17 5.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 3.8 p80 -132.45 179.33 6.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.615 -1.303 . . . . 0.0 112.149 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 6.7 mt -127.81 133.66 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -117.33 121.44 41.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.988 . . . . 0.0 111.149 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 54.0 t -142.07 137.25 30.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.143 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 71.5 mm-40 -58.28 162.03 3.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.467 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 2.9 tttm -72.68 113.28 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.033 -1.042 . . . . 0.0 112.674 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.612 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 7.2 m-70 -132.06 14.41 4.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.28 76.23 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 12.4 mtpt -93.92 -5.66 47.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.984 . . . . 0.0 110.475 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.609 HG13 ' CD2' ' A' ' 122' ' ' TYR . 2.8 mp -40.13 -58.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.225 -0.922 . . . . 0.0 110.426 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 6.0 ttt -69.12 -45.29 70.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.99 -46.94 78.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -59.84 -62.63 1.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.551 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.746 ' SD ' HD12 ' A' ' 124' ' ' ILE . 0.4 OUTLIER -61.19 -39.86 91.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.12 -179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 4.5 tp10 -52.82 -54.98 26.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.794 -1.191 . . . . 0.0 109.54 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -57.55 -38.2 74.36 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.506 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.92 -68.83 0.14 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 25.9 mmtt 39.17 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.588 -0.695 . . . . 0.0 110.281 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -110.08 133.64 53.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.05 -1.031 . . . . 0.0 110.725 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.86 -12.22 59.19 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.406 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 tpt -81.49 161.22 23.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.32 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -82.79 99.34 9.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.344 -0.848 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -49.17 -29.37 5.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 110.379 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -63.37 -35.12 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -77.19 -41.02 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 58' ' ' LEU . 23.3 t -68.69 -38.11 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.955 -1.091 . . . . 0.0 110.195 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -68.68 -41.92 78.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.95 -1.094 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.11 81.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.862 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 70' ' ' GLN . 4.8 tp-100 -70.25 -34.81 73.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 110.757 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' HB2' HG21 ' A' ' 43' ' ' ILE . 54.1 m-85 -104.42 21.81 16.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.023 -1.048 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -86.01 90.91 8.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.1 tp10 -100.33 -2.42 33.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.336 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 32.0 p-10 -136.25 12.33 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' H ' ' A' ' 79' ' ' GLY . 81.4 tttt -56.46 -34.17 66.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.416 -0.802 . . . . 0.0 110.386 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.5 94.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 5.9 ptp180 -98.81 -12.9 20.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.044 -1.035 . . . . 0.0 110.967 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -129.05 -38.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.911 -1.118 . . . . 0.0 110.241 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' H ' ' HA ' ' A' ' 75' ' ' LYS . . . 93.23 -12.66 69.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 90.83 -43.79 2.86 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.8 p-10 -124.56 142.74 51.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -1.207 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 40' ' ' VAL . 2.9 pp -136.59 156.08 49.05 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.02 -119.16 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.802 -1.189 . . . . 0.0 111.047 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.601 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 19.0 m-90 -90.7 121.42 32.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.065 -0.668 . . . . 0.0 110.802 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.561 ' SD ' HD13 ' A' ' 82' ' ' LEU . 23.3 ptm -144.38 155.12 43.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 1.5 p -87.0 134.85 33.45 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.907 ' HE ' HG21 ' A' ' 40' ' ' VAL . 50.8 mtt-85 -98.96 46.11 0.99 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.178 . . . . 0.0 112.48 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.08 36.27 4.38 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 106.586 -2.606 . . . . 0.0 106.586 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -137.08 -7.93 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.874 -0.78 . . . . 0.0 111.792 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.93 -166.15 1.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.719 -1.238 . . . . 0.0 110.391 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.27 178.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.883 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.74 -151.54 19.64 Favored Glycine 0 N--CA 1.483 1.799 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.933 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 47.4 Cg_endo -75.16 -24.17 12.83 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.717 1.904 . . . . 0.0 110.664 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 44.6 t80 -45.71 -65.85 0.48 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 87' ' ' ARG . 4.0 tm0? -79.56 -32.04 42.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 41.0 tt0 -56.15 -39.77 72.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.952 -1.092 . . . . 0.0 110.403 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.64 -39.76 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' CB ' ' NH1' ' A' ' 87' ' ' ARG . . . -44.99 -59.25 2.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 110.774 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -81.69 -41.02 21.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 111.373 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -51.33 -21.22 2.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 101' ' ' LEU . 14.5 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.276 0.56 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 37.4 p90 -122.85 158.87 29.35 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.094 -1.003 . . . . 0.0 110.147 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 116' ' ' VAL . 14.8 m -50.43 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.362 -0.836 . . . . 0.0 112.197 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 46.4 t0 -132.36 118.64 16.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 41.4 Cg_endo -66.82 176.42 23.35 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.315 -1.952 . . . . 0.0 111.011 1.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD3' ' HE2' ' A' ' 55' ' ' MET . 47.5 Cg_endo -81.89 -178.76 4.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.16 1.611 . . . . 0.0 110.398 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 112' ' ' THR . 25.2 m -104.49 142.9 16.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.839 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -115.33 124.99 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 109.246 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 69.5 p -137.01 -179.38 5.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.621 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 3.9 tttm -68.07 -11.72 59.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.588 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 0.4 OUTLIER -107.56 22.5 15.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.82 -1.175 . . . . 0.0 110.816 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 46' ' ' GLU . . . 104.35 -179.32 24.67 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' HG13 ' A' ' 51' ' ' ILE . 32.7 p90 -101.58 155.28 18.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.942 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.727 ' CE1' HD21 ' A' ' 44' ' ' LEU . 3.0 m-70 -134.25 147.35 50.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 111.881 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.746 HD12 ' SD ' ' A' ' 55' ' ' MET . 3.0 tt -126.83 115.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.9 mp -104.68 141.57 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 112.354 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 1.3 mmm -113.63 102.69 10.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.76 132.5 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.177 -0.952 . . . . 0.0 111.194 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.13 70.84 1.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 128.14 127.32 2.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -126.64 148.74 49.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 1.7 tttp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.155 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.88 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -130.61 164.46 24.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 127' ' ' VAL . 7.3 p -143.33 156.01 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 8.2 tttm -101.05 126.5 47.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.256 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.7 HG23 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -131.05 152.91 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.585 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -136.32 123.26 21.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.617 ' HD1' HD11 ' A' ' 82' ' ' LEU . 5.8 p-80 -130.01 157.46 42.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.747 -1.22 . . . . 0.0 112.192 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 124' ' ' ILE . 1.4 pt -112.66 131.94 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.736 ' HG ' ' CD2' ' A' ' 123' ' ' HIS . 1.6 tt -104.77 131.46 52.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.913 -1.117 . . . . 0.0 111.852 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 48.7 t -136.17 156.18 49.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -112.96 -12.68 13.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.044 -1.035 . . . . 0.0 111.774 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 14.9 mmtm -64.72 114.33 4.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -89.71 144.07 26.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.855 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 -15.99 58.9 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' NZ ' ' CE1' ' A' ' 71' ' ' TYR . 27.9 tttm -97.37 -9.76 26.82 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.616 HG12 ' CD2' ' A' ' 122' ' ' TYR . 38.9 mt -46.29 -44.86 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.48 ' O ' ' HG2' ' A' ' 55' ' ' MET . 21.2 ptt? -62.45 -36.52 82.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 110.7 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' A' ' 52' ' ' MET . 59.2 tt0 -72.44 -37.46 68.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.318 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.33 -49.2 72.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' MET . 13.8 ptt? -65.29 -31.89 73.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.008 . . . . 0.0 110.385 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -70.96 -44.02 66.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.042 -1.036 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -58.79 -53.45 58.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.021 HD21 ' CE2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -76.57 -27.53 55.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 108.8 179.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 55' ' ' MET . 33.0 tttt 45.83 -99.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -0.789 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 p -98.41 -12.47 21.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.897 -1.127 . . . . 0.0 110.561 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 64' ' ' PHE . . . 124.47 2.05 8.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.1 mmm -50.28 -49.86 52.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.029 -1.277 . . . . 0.0 109.745 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -103.82 32.64 3.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.349 -0.845 . . . . 0.0 109.491 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.766 ' HD1' HD12 ' A' ' 58' ' ' LEU . 9.8 t80 -52.22 -48.67 65.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.431 -0.793 . . . . 0.0 110.72 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.91 -47.52 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.73 -42.49 77.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 71' ' ' TYR . 45.1 t -65.42 -53.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -59.96 -52.62 64.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 110.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.37 -18.43 61.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 111.353 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.02 -24.61 11.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 110.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.711 ' CD2' HG13 ' A' ' 67' ' ' VAL . 45.4 m-85 -100.31 6.47 44.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.075 -1.016 . . . . 0.0 109.517 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 28.7 t -72.16 103.74 3.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.386 -0.822 . . . . 0.0 110.575 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 45' ' ' CYS . 11.0 mt-10 -101.01 5.49 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.953 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 78' ' ' GLN . 17.6 t0 -111.8 24.61 12.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HG2' ' OG ' ' A' ' 72' ' ' SER . 20.3 mmtt -62.83 -36.25 82.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.116 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.06 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.26 -59.96 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.258 -0.902 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.468 ' O ' ' OD2' ' A' ' 74' ' ' ASP . 8.5 pt20 -169.52 105.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.765 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 74' ' ' ASP . . . -129.45 91.36 0.31 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.84 -96.94 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 82' ' ' LEU . 56.1 p30 -114.76 160.61 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 110.951 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.754 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.5 mp -103.99 -11.55 17.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 85.65 -143.48 19.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.5 m-90 -106.96 129.59 54.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.567 -0.96 . . . . 0.0 110.349 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 14.3 ptp -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.049 -1.032 . . . . 0.0 109.924 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.88 HG22 ' HB2' ' A' ' 37' ' ' ALA . 24.4 p -101.63 -67.6 0.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 111.457 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 84.8 mtt85 -80.83 -29.19 35.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.961 . . . . 0.0 111.24 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 95' ' ' GLN . . . 168.31 -170.28 42.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -142.87 -50.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -1.195 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -117.63 -95.59 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 111.578 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 6.1 m -114.91 -175.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.875 -1.141 . . . . 0.0 111.941 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.638 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -63.86 -46.36 91.87 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.613 -0.68 . . . . 0.0 111.922 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.6 Cg_endo -66.35 -40.76 13.77 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.066 1.035 . . . . 0.0 110.755 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 87.8 t80 -75.44 -37.22 60.51 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 45.6 tt0 -76.38 -51.73 11.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.773 . . . . 0.0 110.433 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -57.4 -40.19 77.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.979 . . . . 0.0 110.409 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -63.82 -63.52 1.14 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -37.61 -58.57 0.87 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.296 0.57 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.29 -15.34 63.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 111.118 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -135.15 40.66 2.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.748 -1.22 . . . . 0.0 111.951 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 O-C-N 120.848 -1.158 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 126' ' ' MET . 6.4 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 1.021 ' CE2' HD21 ' A' ' 58' ' ' LEU . 6.3 t80 -142.91 151.53 41.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.582 ' O ' ' CE1' ' A' ' 111' ' ' PHE . 40.3 m -86.06 111.38 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.672 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -133.23 117.66 14.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.0 Cg_endo -78.19 173.67 55.59 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.014 -2.078 . . . . 0.0 110.066 0.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 51' ' ' ILE . 42.4 Cg_endo -71.32 177.3 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.848 1.446 . . . . 0.0 110.014 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -105.02 150.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.846 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -116.13 121.1 41.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 67.4 p -135.51 176.01 9.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.666 -1.271 . . . . 0.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.29 -14.48 62.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 110.426 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -105.28 33.31 3.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.293 -0.88 . . . . 0.0 108.706 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 89.47 174.22 46.01 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 51' ' ' ILE . 35.3 p90 -100.85 151.72 21.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.16 -1.2 . . . . 0.0 108.681 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.736 ' CD2' ' HG ' ' A' ' 44' ' ' LEU . 1.8 m80 -130.75 160.22 34.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.893 -1.13 . . . . 0.0 112.532 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.875 HD13 HD11 ' A' ' 43' ' ' ILE . 1.8 mp -126.04 124.96 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 1.7 mt -107.04 136.14 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.821 -1.175 . . . . 0.0 112.759 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.567 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 38.1 tpp -122.89 102.75 8.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.63 HG23 HG12 ' A' ' 40' ' ' VAL . 14.7 p -103.09 129.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.022 -1.049 . . . . 0.0 112.189 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -142.48 135.65 28.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.672 -0.642 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.48 121.51 1.55 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -108.79 151.87 25.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 0.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 67.8 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.131 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 36' ' ' ASN . 23.5 t30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.578 0.704 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.02 134.6 44.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 85' ' ' MET . 4.4 p -127.31 153.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.985 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 11.8 tttp -101.64 133.14 46.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.939 . . . . 0.0 109.995 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 82' ' ' LEU . 3.6 t -128.29 139.12 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.09 -1.006 . . . . 0.0 111.342 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 90.2 mtt180 -120.98 121.97 39.14 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -135.5 150.51 49.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.757 -1.214 . . . . 0.0 111.406 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.825 HD13 HG13 ' A' ' 67' ' ' VAL . 32.9 pt -121.19 133.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.637 ' HG ' ' CD2' ' A' ' 123' ' ' HIS . 1.1 tt -104.93 134.58 47.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.916 -1.115 . . . . 0.0 112.087 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 7.6 p -139.49 168.01 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 109.523 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.3 mm-40 -73.44 -159.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.007 . . . . 0.0 110.747 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 4.4 mtmt -122.9 99.52 6.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 110.623 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 8.3 m-70 -132.35 30.9 4.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.857 . . . . 0.0 110.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.07 21.38 75.5 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 48' ' ' HIS . 94.4 mttt -93.14 15.91 14.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.652 HG23 ' HG2' ' A' ' 115' ' ' PRO . 56.4 mt -61.89 -43.95 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.075 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.498 ' O ' ' HG2' ' A' ' 55' ' ' MET . 8.0 ttt -70.59 -40.64 73.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.518 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 52.2 mp0 -70.42 -37.2 74.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.872 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . -59.72 -60.73 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.701 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 15.5 ptt? -52.73 -38.09 60.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 55' ' ' MET . 96.8 mt-10 -73.61 -11.94 60.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 67' ' ' VAL . 29.8 tptt -80.83 -40.0 25.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.761 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.17 -22.28 18.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.601 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 58.6 mttp 49.3 -142.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -52.95 -34.26 54.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.432 -0.792 . . . . 0.0 110.935 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.98 -11.66 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 36.3 ttm -50.64 -34.85 27.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.14 -1.212 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 89.3 mtt180 -112.7 31.12 6.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.974 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 78.3 t80 -51.98 -40.46 60.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 110.083 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -70.69 -33.37 70.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 13.4 tp10 -63.26 -52.4 62.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.825 HG13 HD13 ' A' ' 43' ' ' ILE . 9.4 p -62.28 -36.46 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 109.57 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -65.31 -35.44 81.0 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.243 -0.911 . . . . 0.0 109.111 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.62 68.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.826 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -71.61 -19.65 62.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.606 ' HD2' HG22 ' A' ' 67' ' ' VAL . 29.1 m-85 -116.22 23.92 11.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.44 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' ALA . 55.9 p -78.12 76.22 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.023 -1.048 . . . . 0.0 109.767 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 80.8 mm-40 -105.76 1.47 27.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.25 13.92 9.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HA ' ' CA ' ' A' ' 79' ' ' GLY . 12.5 tmtt? -48.57 -34.72 11.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.534 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.26 96.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -94.7 -61.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 110.233 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -121.36 -61.56 1.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.893 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 75' ' ' LYS . . . 92.25 -104.19 3.14 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -103.04 -73.78 0.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.812 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.8 p-10 -81.19 153.27 27.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.29 -1.124 . . . . 0.0 110.781 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 81' ' ' ASP . 9.0 mp -113.82 -12.34 12.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.83 . . . . 0.0 109.794 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.38 -165.36 24.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 93.6 m95 -93.87 136.8 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.981 . . . . 0.0 110.091 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.517 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.5 ptp -140.52 135.56 32.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.89 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 18.1 p -83.83 -37.63 22.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.482 -0.761 . . . . 0.0 110.443 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -113.41 -38.54 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 95' ' ' GLN . . . 58.69 66.2 2.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 31.3 t -113.08 105.63 13.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -1.171 . . . . 0.0 109.437 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.2 tpt -125.69 -60.38 1.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 111.291 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.829 HG13 ' HD2' ' A' ' 93' ' ' PRO . 11.8 p -114.63 -30.22 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.882 -1.137 . . . . 0.0 111.312 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.64 -65.83 0.59 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.006 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 91' ' ' VAL . 49.0 Cg_endo -71.1 -24.76 23.28 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.811 1.427 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -35.47 63.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.445 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 64.5 tt0 -78.62 -39.76 36.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.42 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 17.5 pt-20 -63.42 -25.04 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.779 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -88.45 -46.15 9.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.123 -0.986 . . . . 0.0 111.174 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.37 -35.21 75.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.465 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG11 ' A' ' 38' ' ' VAL . 27.2 m-85 -100.85 -1.04 35.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.85 -1.156 . . . . 0.0 111.818 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -99.45 -26.12 14.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.706 -1.246 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 127' ' ' VAL . 14.4 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.013 . . . . 0.0 110.001 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 127' ' ' VAL . 33.7 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.878 0.371 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.621 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 3.6 p90 -128.68 177.63 6.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.723 -1.236 . . . . 0.0 111.472 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.545 ' C ' ' HA ' ' A' ' 114' ' ' PRO . 3.2 p -71.58 -105.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.46 -0.775 . . . . 0.0 111.708 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.909 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 28.0 m-20 -79.8 -29.11 0.55 Allowed Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.909 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 38.2 Cg_endo -76.78 -26.04 10.1 Favored 'Cis proline' 0 N--CA 1.487 1.129 0 C-N-CA 124.169 -1.179 . . . . 0.0 115.075 2.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.2 Cg_endo -69.18 121.39 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-O 121.69 0.621 . . . . 0.0 112.422 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 2.9 t -97.5 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HD3' HD13 ' A' ' 51' ' ' ILE . 37.5 mtmm -103.91 112.96 26.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.027 . . . . 0.0 110.253 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.648 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 14.6 p -138.36 166.36 24.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 110.663 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -66.43 -9.35 33.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.2 OUTLIER -105.78 21.88 16.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.839 -1.163 . . . . 0.0 110.312 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.59 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 108.71 -173.51 17.68 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.855 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.97 150.55 21.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.637 ' CD2' ' HG ' ' A' ' 44' ' ' LEU . 33.9 m80 -138.31 127.45 24.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.534 -1.354 . . . . 0.0 112.631 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mp -106.83 105.2 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.052 HG22 ' HB2' ' A' ' 42' ' ' HIS . 34.3 pt -108.76 141.47 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 16.7 ttt -119.07 141.87 48.37 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 127' ' ' VAL . 23.3 m -113.5 105.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.846 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 63.2 tt0 -111.44 132.98 54.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.782 . . . . 0.0 109.674 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 73.31 80.21 0.46 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -110.23 146.64 35.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.99 . . . . 0.0 109.712 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 1.3 mmmm . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 0.0 110.288 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 10.4 p30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.532 0.682 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -112.32 166.59 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.403 -0.81 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 26.8 m -138.72 148.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.709 -0.62 . . . . 0.0 109.808 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' CE ' ' HD2' ' A' ' 130' ' ' ARG . 26.5 mttt -98.64 114.3 26.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 108.74 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 78.5 t -114.61 136.36 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 45.7 ttp180 -130.82 118.35 20.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.919 ' HB2' HG22 ' A' ' 125' ' ' ILE . 4.3 p80 -128.15 177.65 6.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.713 -1.242 . . . . 0.0 112.068 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG21 ' HB3' ' A' ' 71' ' ' TYR . 46.1 mt -126.49 140.69 48.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.3 tt -112.32 127.05 55.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.48 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 56.8 m -132.06 138.79 48.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 109.859 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 72.1 mt-10 -59.63 155.58 15.28 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.003 -1.061 . . . . 0.0 108.786 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 4.1 tttt -80.42 118.77 22.34 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.027 -1.046 . . . . 0.0 113.101 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.626 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 8.0 m80 -135.2 1.75 2.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.697 . . . . 0.0 110.384 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.16 5.38 73.08 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 18.4 ptpt -99.71 22.17 11.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.745 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 69.6 mt -49.28 -53.1 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.419 -0.801 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.54 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 44.0 ttm -59.38 -34.39 72.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 81.2 mm-40 -63.15 -41.84 99.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.75 -52.35 57.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 0.0 110.67 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' ' CB ' ' A' ' 58' ' ' LEU . 2.6 ppp? -69.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 52' ' ' MET . 32.9 mm-40 -68.13 -33.03 73.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 108.909 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HG2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -87.55 -14.82 39.2 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.91 -29.64 61.03 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.746 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 58' ' ' LEU . 13.0 ptpt -30.9 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.43 0.633 . . . . 0.0 111.385 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -52.4 -42.92 64.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.356 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.97 -26.57 2.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 6.5 tpt -106.44 150.33 26.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -1.137 . . . . 0.0 110.296 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 66' ' ' GLU . 3.3 ptm180 -75.23 109.61 8.88 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.306 1.051 . . . . 0.0 110.72 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.681 ' CE1' HD21 ' A' ' 58' ' ' LEU . 84.2 t80 -41.96 -36.31 1.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.743 -0.598 . . . . 0.0 109.665 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -58.64 -44.62 90.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 110.664 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 35.7 tt0 -65.04 -48.68 72.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.052 . . . . 0.0 110.812 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 58' ' ' LEU . 27.4 m -63.68 -44.12 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.081 -1.448 . . . . 0.0 109.493 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -63.31 -39.42 94.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 109.571 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.69 71.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.436 -0.79 . . . . 0.0 109.699 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -80.31 -7.14 58.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.594 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m-30 -108.79 9.0 26.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.858 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.7 t -80.8 83.52 6.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.174 -0.954 . . . . 0.0 111.251 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -99.54 7.02 45.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ARG . 18.8 p30 -104.1 41.46 1.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.686 -0.634 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -50.4 -42.04 53.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 110.586 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 9.38 28.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.6 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 74' ' ' ASP . 2.6 ttt180 -105.29 -15.12 15.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 55.58 55.98 6.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -116.48 25.43 9.16 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -82.74 -60.0 2.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 9.5 p-10 -133.5 133.57 42.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.29 . . . . 0.0 111.059 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.1 mp -104.04 157.07 17.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 109.212 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 -127.92 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.177 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 23.5 m-90 -90.92 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.872 -0.781 . . . . 0.0 110.611 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 38' ' ' VAL . 13.9 mmt -132.14 140.82 48.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.9 t -110.37 -45.49 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.314 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 86' ' ' THR . 2.2 mmp_? -117.4 1.9 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.443 -0.786 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.557 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 72.8 146.47 0.71 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 38.8 p -146.37 40.67 1.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.594 -1.533 . . . . 0.0 111.541 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.616 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 2.1 tpt -125.48 137.02 53.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.033 -1.042 . . . . 0.0 110.123 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' C ' ' A' ' 90' ' ' MET . 5.8 m 35.0 -110.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.748 -0.595 . . . . 0.0 111.149 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 93' ' ' PRO . . . -148.78 -67.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.432 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 92' ' ' GLY . 38.2 Cg_endo -64.08 -14.07 41.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.709 1.373 . . . . 0.0 110.813 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 90' ' ' MET . 68.5 t80 -68.27 -47.03 68.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.56 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 14.5 mt-30 -71.05 -41.48 70.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 109.285 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.9 mm-40 -58.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.491 -0.756 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -41.41 81.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.449 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -50.19 -51.8 40.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.702 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.41 -1.39 57.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 0.0 111.118 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -116.92 12.2 14.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.85 -1.156 . . . . 0.0 110.891 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.932 HD22 HG22 ' A' ' 112' ' ' THR . 52.5 mt . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.564 -0.71 . . . . 0.0 110.66 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.57 HG12 ' HD1' ' A' ' 111' ' ' PHE . 2.1 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.087 0.47 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' A' ' 110' ' ' VAL . 33.8 p90 -124.86 156.11 38.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.012 -1.055 . . . . 0.0 110.425 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.932 HG22 HD22 ' A' ' 101' ' ' LEU . 24.8 p -46.16 124.51 5.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.0 111.08 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 34.1 t0 -133.35 119.75 15.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 50.7 Cg_endo -79.11 174.33 51.2 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.12 -2.033 . . . . 0.0 110.163 -0.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 124' ' ' ILE . 46.5 Cg_endo -72.12 177.33 7.31 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.863 1.454 . . . . 0.0 109.993 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.32 158.98 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 10.9 ptmm? -119.64 136.23 54.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.587 ' HB ' ' CE2' ' A' ' 120' ' ' PHE . 74.3 p -142.13 168.62 19.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.62 -23.69 59.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 15.2 p90 -98.81 46.22 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 84.08 175.65 50.9 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 41.8 p90 -98.53 166.12 11.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -1.112 . . . . 0.0 108.844 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 22.8 m-70 -141.77 140.49 33.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.802 -1.186 . . . . 0.0 112.624 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.9 HD11 HD23 ' A' ' 58' ' ' LEU . 5.1 pt -128.1 110.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 42' ' ' HIS . 12.0 pt -106.98 149.61 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.055 -1.028 . . . . 0.0 112.867 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 49.5 mtp -107.0 124.43 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.46 107.78 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 111.319 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.35 -3.36 27.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.422 -0.799 . . . . 0.0 109.4 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 58.39 -164.54 8.34 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.498 ' HD2' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tpm_? -134.26 -35.45 0.93 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.776 -0.838 . . . . 0.0 109.894 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' A' ' 36' ' ' ASN . 23.7 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.35 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 23.2 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.082 0.468 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -86.86 129.46 34.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.986 -1.071 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 22.9 m -144.1 151.12 16.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.917 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 2.3 tmtt? -96.11 124.27 40.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.049 -1.032 . . . . 0.0 108.858 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 82' ' ' LEU . 42.9 t -119.75 132.55 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.022 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 53.0 mtm180 -120.25 112.35 18.94 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.081 ' HB2' HG22 ' A' ' 125' ' ' ILE . 8.3 p-80 -134.86 158.82 43.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.518 -1.364 . . . . 0.0 113.047 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.765 HG21 ' HA ' ' A' ' 68' ' ' ALA . 7.8 pt -119.82 133.42 66.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -106.28 136.09 46.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.462 0.649 . . . . 0.0 111.719 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 26.0 m -142.57 144.88 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.975 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.644 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt-10 -59.0 172.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.062 -1.024 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.1 ttmt -105.48 113.18 26.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.686 -1.259 . . . . 0.0 113.29 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.644 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 1.5 m80 -134.3 26.56 3.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.56 9.21 82.02 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 ttmt -90.76 -10.65 42.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.622 -0.928 . . . . 0.0 109.975 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.57 HG23 ' N ' ' A' ' 52' ' ' MET . 16.4 tt -44.2 -42.72 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.464 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.57 ' N ' HG23 ' A' ' 51' ' ' ILE . 11.9 ttt -67.09 -29.73 69.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.0 109.139 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' LYS . 65.7 tt0 -72.2 -42.92 65.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.356 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . . . -56.81 -49.85 74.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.787 . . . . 0.0 110.164 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 22.1 ptm -74.1 -22.43 59.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 32.2 tp10 -69.92 -38.03 76.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -80.78 -25.65 37.75 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 124' ' ' ILE . 35.4 tp -76.2 -44.34 38.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.564 0.697 . . . . 0.0 109.275 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 32.1 mtmt 48.43 -112.51 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.598 -0.689 . . . . 0.0 111.081 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.7 p -78.79 -14.37 59.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.954 -1.091 . . . . 0.0 110.261 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 103.33 0.32 47.17 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 61' ' ' GLY . 56.8 ttp -44.72 -34.65 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.268 . . . . 0.0 109.641 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' PHE . 10.6 mtp180 -112.89 19.38 17.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.56 ' HD1' HD11 ' A' ' 58' ' ' LEU . 87.1 t80 -43.72 -40.36 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 28.9 p-10 -66.12 -40.37 90.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 43.5 mm-40 -70.59 -43.36 69.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 109.491 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 18.4 t -69.79 -41.02 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.573 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.765 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -63.68 -43.33 96.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 110.226 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.45 94.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.56 -9.1 59.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 43' ' ' ILE . 8.5 m-85 -111.82 5.51 19.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.942 . . . . 0.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.2 m -73.86 87.44 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 2.6 tm-20 -101.41 32.04 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.59 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 78.6 m-20 -100.13 83.55 2.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 14.8 tptt -70.79 -52.21 22.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 111.087 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 77' ' ' ARG . . . -77.05 -13.14 60.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.111 -0.993 . . . . 0.0 110.599 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.543 ' N ' ' CD ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -102.42 -48.6 4.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.129 -0.982 . . . . 0.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 8.2 mm100 51.56 34.73 13.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 110.035 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -93.64 -55.87 1.49 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 67.86 -64.41 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.595 ' C ' HD12 ' A' ' 82' ' ' LEU . 75.5 m-20 -116.47 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.693 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 81' ' ' ASP . 8.3 mp -102.78 139.86 37.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -71.8 -138.47 0.23 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 1.5 m95 -91.58 134.18 34.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -1.02 . . . . 0.0 110.343 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.509 ' CE ' ' HA3' ' A' ' 88' ' ' GLY . 21.2 ptm -134.01 150.75 51.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 47.3 p -101.56 -38.67 7.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.953 -1.092 . . . . 0.0 110.126 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -114.01 -92.58 0.49 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' HA3' ' CE ' ' A' ' 85' ' ' MET . . . 73.14 75.12 0.75 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.1 m -110.86 93.28 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -31.15 8.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -150.6 -171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.044 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.491 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -88.33 -56.5 2.02 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.314 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -66.55 -29.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.372 1.196 . . . . 0.0 112.343 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 91' ' ' VAL . 32.5 t80 -69.18 -43.4 74.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.71 -1.244 . . . . 0.0 110.756 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' OE1' ' CD1' ' A' ' 99' ' ' PHE . 7.7 tp-100 -72.52 -52.07 17.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.904 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.988 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 mt-10 -59.94 -20.97 60.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.149 -0.969 . . . . 0.0 110.912 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -82.76 -59.24 2.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.905 -1.122 . . . . 0.0 110.557 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.84 -59.31 5.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CD1' ' OE1' ' A' ' 95' ' ' GLN . 29.2 m-85 -74.3 -28.32 61.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -118.11 34.97 4.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.909 -1.119 . . . . 0.0 110.764 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 112' ' ' THR . 8.8 tp . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.113 -0.992 . . . . 0.0 110.345 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.311 0.577 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 58' ' ' LEU . 29.2 p90 -119.08 165.03 14.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.527 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.967 HG22 HD13 ' A' ' 101' ' ' LEU . 46.0 p -48.22 113.62 0.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 110.776 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.3 p-10 -132.26 120.61 17.15 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.765 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.3 Cg_endo -68.77 165.26 74.1 Favored 'Cis proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.769 -2.179 . . . . 0.0 110.248 0.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 1.083 ' HB3' HG22 ' A' ' 124' ' ' ILE . 45.1 Cg_endo -70.46 -179.88 3.56 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.926 1.487 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.8 134.33 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.895 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HB2' ' CE ' ' A' ' 47' ' ' LYS . 10.0 ptpt -109.65 126.99 54.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 0.0 109.187 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.604 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 44.0 p -130.33 -177.6 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.039 -1.038 . . . . 0.0 111.013 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -69.53 -18.8 63.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -0.772 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 p90 -100.36 32.58 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.044 . . . . 0.0 109.88 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.578 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 97.68 177.04 33.96 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 53.8 p90 -99.74 162.21 13.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -1.179 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.6 m-70 -141.69 151.49 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.001 -1.062 . . . . 0.0 112.238 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.083 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.8 pt -133.94 118.92 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.081 HG22 ' HB2' ' A' ' 42' ' ' HIS . 8.2 pt -121.56 142.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.673 -1.267 . . . . 0.0 112.83 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 34.8 mmm -97.43 125.04 41.83 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.16 121.36 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.664 -1.273 . . . . 0.0 111.889 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 39' ' ' LYS . 8.7 pt-20 -115.16 -22.17 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.527 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 80.9 -167.47 49.9 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.608 ' HD3' ' CE3' ' A' ' 84' ' ' TRP . 12.7 tpt180 -132.66 -75.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.983 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 3.6 p30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.459 0.647 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 86' ' ' THR . . . -130.84 150.98 51.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -111.39 164.93 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HD3' ' CE2' ' A' ' 84' ' ' TRP . 30.0 mtmt -99.05 117.35 33.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 109.544 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 13.1 t -116.67 133.25 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 110.763 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -141.49 113.04 7.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.96 ' CB ' HG22 ' A' ' 125' ' ' ILE . 21.9 p-80 -132.16 -179.29 5.33 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.98 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 124' ' ' ILE . 5.2 mt -124.31 117.43 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -102.15 120.19 40.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.864 -1.147 . . . . 0.0 110.596 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.578 ' SG ' HG22 ' A' ' 43' ' ' ILE . 5.4 m -133.54 155.59 49.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.042 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.62 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.27 -163.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.835 -1.165 . . . . 0.0 110.561 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -92.48 106.43 18.42 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.739 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 17.9 m-70 -123.27 -2.83 8.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.7 27.89 73.52 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -107.17 8.97 30.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.54 -0.976 . . . . 0.0 110.11 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 115' ' ' PRO . 75.9 mt -41.23 -43.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.02 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -31.94 72.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 2.1 tp10 -76.18 -37.36 57.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.412 -0.805 . . . . 0.0 110.109 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.83 -52.69 64.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.433 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 14.0 ptm -66.55 -35.46 80.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.387 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 55' ' ' MET . 26.8 tt0 -70.15 -36.06 74.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.55 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -71.0 -35.7 72.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.778 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 59' ' ' LYS . 4.6 pp -97.14 -46.12 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 110.823 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.918 ' N ' HD12 ' A' ' 58' ' ' LEU . 13.4 mttt 37.87 -157.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.0 t -103.01 7.8 39.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.029 -1.044 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.89 -40.07 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 33.7 mmt -67.44 166.79 13.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -1.149 . . . . 0.0 110.37 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.3 mtt85 -72.02 97.97 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 110.715 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -52.33 -31.48 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.25 -35.71 71.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.346 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 43.7 tt0 -63.62 -39.1 93.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.567 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.869 HG21 ' HB3' ' A' ' 58' ' ' LEU . 30.5 t -68.61 -45.75 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -59.18 -47.98 83.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.36 79.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 111.013 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -83.92 -23.54 31.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.026 -1.046 . . . . 0.0 111.395 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' CD2' HG13 ' A' ' 67' ' ' VAL . 21.9 m-30 -112.86 18.79 17.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.933 -1.104 . . . . 0.0 110.677 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -89.15 112.59 23.63 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.75 -4.95 29.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 80' ' ' GLY . 58.5 p30 -104.67 33.77 3.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.708 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -52.89 -41.01 63.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 110.21 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.56 90.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 mtt85 -85.61 -11.33 54.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.158 -0.964 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 74' ' ' ASP . 3.6 tp60 58.21 30.58 19.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.747 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.748 ' O ' HD11 ' A' ' 82' ' ' LEU . . . -68.83 -25.6 75.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 74' ' ' ASP . . . -49.73 -34.3 21.12 Favored Glycine 0 N--CA 1.489 2.19 0 O-C-N 121.127 -1.219 . . . . 0.0 110.391 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 82' ' ' LEU . 7.5 t0 -134.59 109.21 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.784 -1.421 . . . . 0.0 111.483 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.825 ' N ' HD12 ' A' ' 82' ' ' LEU . 5.3 mp -100.48 145.06 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.65 -141.27 4.54 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.536 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CE2' ' HD3' ' A' ' 39' ' ' LYS . 77.5 m95 -81.82 100.67 9.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.899 -0.765 . . . . 0.0 109.678 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' MET . 1.8 ptp -139.04 146.66 41.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.011 -1.056 . . . . 0.0 111.149 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -126.3 -0.0 7.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.564 -0.71 . . . . 0.0 109.301 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -90.43 -175.48 4.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.05 124.73 8.32 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.45 -9.98 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.084 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.736 ' HE2' ' CE2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -136.28 -165.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.77 151.74 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.982 -1.074 . . . . 0.0 111.05 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -169.14 19.81 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 40.5 Cg_endo -66.96 -11.23 31.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.161 1.611 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.736 ' CE2' ' HE2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -57.39 -58.38 8.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.107 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 5.8 tt0 -72.1 -40.61 68.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.737 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 31.8 tt0 -64.05 -40.53 96.5 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -66.26 -56.03 13.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.124 -0.985 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.72 -47.47 5.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 99' ' ' PHE . 10.5 m-30 -94.87 17.94 12.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.134 -0.978 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -111.24 -21.9 11.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 127' ' ' VAL . 72.4 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 111' ' ' PHE . 64.1 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.505 0.669 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 23.9 p90 -114.31 164.42 13.94 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.333 -0.854 . . . . 0.0 109.687 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 125' ' ' ILE . 30.4 p -63.5 109.42 1.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 111.654 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.592 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 25.8 p-10 -132.66 113.11 13.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.1 Cg_endo -68.07 166.55 67.19 Favored 'Cis proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.343 0.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -71.45 -174.79 1.33 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.086 1.572 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 118' ' ' THR . 66.6 t -101.66 136.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.753 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -110.21 120.12 41.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.855 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.659 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -130.69 170.64 14.05 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -70.25 -14.65 62.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.408 -0.807 . . . . 0.0 110.554 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.659 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -91.57 5.15 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.834 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 126.91 -169.84 18.78 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.555 ' CE2' HG13 ' A' ' 51' ' ' ILE . 18.1 m-30 -99.59 159.26 15.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -1.083 . . . . 0.0 108.609 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.432 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 67.0 m-70 -143.44 110.13 5.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.783 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 43' ' ' ILE . 4.4 mp -100.52 111.71 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.96 HG22 ' CB ' ' A' ' 42' ' ' HIS . 33.6 pt -115.67 142.76 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.557 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 tpt -115.11 124.02 50.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 101' ' ' LEU . 22.1 t -105.96 131.08 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.107 -0.996 . . . . 0.0 111.373 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 71.1 mt-10 -141.98 143.56 33.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.51 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 56.9 117.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -113.68 156.68 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -1.216 . . . . 0.0 110.137 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.587 ' H ' HG12 ' A' ' 38' ' ' VAL . 13.0 pttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.326 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB3' ' CB ' ' A' ' 131' ' ' LYS . . . -79.13 115.5 18.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.852 -1.155 . . . . 0.0 109.596 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -127.97 160.91 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 8.7 mttt -98.82 128.96 45.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.373 -0.83 . . . . 0.0 109.61 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 72.8 t -109.82 129.97 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.372 -0.83 . . . . 0.0 111.45 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 83.2 mtt180 -120.69 125.14 46.92 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 4.9 p-80 -134.98 172.61 12.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 0.0 112.351 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' ' 71' ' ' TYR . 58.9 mt -126.79 116.58 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.723 HD22 ' OD2' ' A' ' 74' ' ' ASP . 4.6 tt -102.56 124.07 47.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.901 -1.124 . . . . 0.0 111.629 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 19.0 m -142.77 160.42 40.35 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.591 ' O ' ' CE2' ' A' ' 122' ' ' TYR . 87.1 mt-10 -71.7 172.31 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.903 -1.123 . . . . 0.0 109.789 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 74.6 tttt -93.12 111.4 23.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.851 -1.156 . . . . 0.0 112.547 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.584 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 5.8 m-70 -132.43 9.61 4.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.47 -8.79 77.96 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 51' ' ' ILE . 7.6 tttp -73.81 -15.44 61.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.708 -0.878 . . . . 0.0 109.611 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 52' ' ' MET . 10.8 tt -40.5 -44.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.798 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.587 ' N ' HG23 ' A' ' 51' ' ' ILE . 50.8 ttp -65.38 -42.61 92.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 67.0 tt0 -56.49 -44.19 80.43 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.268 -0.895 . . . . 0.0 109.147 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.37 -60.76 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.592 ' HA ' HD11 ' A' ' 58' ' ' LEU . 52.7 ttp -59.93 -33.38 71.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.557 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 45.1 tt0 -62.93 -33.92 76.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 108.793 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.85 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.9 tptt -62.55 -45.68 91.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.493 -0.754 . . . . 0.0 109.185 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 pp -108.76 27.61 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.384 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 56' ' ' GLU . 36.4 tttp -54.74 -60.13 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.398 0.618 . . . . 0.0 110.722 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.4 m -81.37 33.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 74.16 25.59 70.66 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.555 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 3.7 ttm -53.79 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.837 -1.39 . . . . 0.0 109.572 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CG ' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -70.69 78.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.998 -1.064 . . . . 0.0 111.288 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' ' SD ' ' A' ' 126' ' ' MET . 5.2 t80 -46.65 -27.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.865 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.565 ' OD1' ' CG ' ' A' ' 63' ' ' ARG . 33.9 p-10 -67.68 -46.91 70.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.219 . . . . 0.0 110.092 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 83.9 mt-10 -63.27 -32.47 73.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 109.496 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 57' ' ' LYS . 45.8 t -61.55 -53.63 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -51.11 -60.5 3.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.952 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.48 19.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.802 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.32 -26.71 62.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.571 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 48.6 m-85 -111.04 30.05 7.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.385 -0.822 . . . . 0.0 110.282 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 68' ' ' ALA . 43.4 t -100.21 101.95 13.11 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.095 -1.003 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -101.72 2.25 38.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.723 ' OD2' HD22 ' A' ' 44' ' ' LEU . 15.3 m-20 -116.69 30.75 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.741 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -67.42 -23.86 65.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.78 . . . . 0.0 110.255 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.4 -56.34 21.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.143 -0.973 . . . . 0.0 109.181 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 4.2 ttm180 -96.31 -52.01 4.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.482 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 8.2 pt20 179.96 133.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.656 -0.653 . . . . 0.0 109.866 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.39 96.72 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.96 -85.96 0.1 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 95.5 m-20 -121.19 137.2 54.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -1.169 . . . . 0.0 110.731 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.9 mp -100.56 163.55 12.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.822 . . . . 0.0 109.577 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -73.17 -143.68 0.61 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 94.1 m95 -82.78 160.53 22.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.496 -1.002 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -138.13 143.8 40.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.0 109.799 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.598 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.4 t -131.34 -46.43 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.941 -1.099 . . . . 0.0 111.689 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.598 ' N ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -117.48 -5.98 11.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.667 -1.271 . . . . 0.0 112.807 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . 118.65 -168.31 13.21 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 118.949 -1.595 . . . . 0.0 110.611 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 90' ' ' MET . 26.2 t -125.68 -88.8 0.58 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.614 -0.933 . . . . 0.0 110.708 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' GLY . 65.9 mtm -147.43 -85.49 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.046 -1.034 . . . . 0.0 112.87 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -9.0 -58.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' MET . . . 125.34 -72.43 0.44 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.538 -1.351 . . . . 0.0 109.811 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 38.1 Cg_endo -63.42 -37.14 50.94 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.851 1.448 . . . . 0.0 109.333 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.492 ' H ' HG12 ' A' ' 91' ' ' VAL . 74.9 t80 -60.09 -33.78 72.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.561 0.696 . . . . 0.0 109.259 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 38.0 tt0 -75.64 -45.06 39.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.562 -0.711 . . . . 0.0 110.148 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.793 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 46.6 mt-10 -55.62 -42.68 75.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.0 110.566 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -81.02 -58.7 2.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.509 -1.37 . . . . 0.0 110.711 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.41 27.09 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.83 -1.169 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 85' ' ' MET . 2.4 t80 -117.9 -46.92 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.558 -1.339 . . . . 0.0 112.435 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -76.26 -11.18 59.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.841 -1.162 . . . . 0.0 111.575 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 4.2 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 120.826 -1.171 . . . . 0.0 109.425 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.514 0.674 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 21.0 t80 -108.72 134.41 51.47 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 115' ' ' PRO . 6.5 m -53.65 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 110.418 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 26.3 p-10 -133.03 113.52 13.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.58 163.3 90.07 Favored 'Cis proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.073 -2.053 . . . . 0.0 110.382 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.72 ' HA ' HG22 ' A' ' 112' ' ' THR . 46.7 Cg_endo -72.87 -179.66 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.99 1.521 . . . . 0.0 110.054 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.6 161.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.005 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 13.8 ptmt -129.93 119.46 23.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.578 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 39.5 p -122.94 -177.16 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.84 -1.162 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -71.49 -16.69 62.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 0.0 110.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -98.87 27.13 5.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.909 -1.119 . . . . 0.0 109.301 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 103.18 179.69 26.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 52.6 p90 -99.22 159.22 15.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.302 . . . . 0.0 109.797 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.59 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 34.8 m-70 -132.66 140.17 48.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.692 ' N ' HD12 ' A' ' 124' ' ' ILE . 3.7 mp -115.55 136.99 50.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.42 ' HB ' ' OG1' ' A' ' 112' ' ' THR . 0.7 OUTLIER -132.98 147.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.32 -1.488 . . . . 0.0 112.066 -177.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.569 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 13.6 ttt -127.17 135.09 50.19 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.55 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.938 -1.101 . . . . 0.0 111.077 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -141.69 160.82 39.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.674 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 78.62 81.38 0.69 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.496 ' HD2' ' OXT' ' A' ' 131' ' ' LYS . 8.5 tmm_? -97.1 142.73 28.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 110.402 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.787 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . 9.6 tttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' THR . 12.3 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.083 0.468 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . . . -131.86 143.42 50.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 0.0 110.684 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 39' ' ' LYS . 7.4 p -142.7 176.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.91 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.04 121.97 39.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.919 -1.113 . . . . 0.0 108.353 178.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 77.2 t -108.2 138.27 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.05 0.929 . . . . 0.0 112.946 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -140.76 117.0 10.63 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.105 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 6.1 p-80 -138.61 -175.04 3.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.446 -1.409 . . . . 0.0 112.565 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 67' ' ' VAL . 73.8 mt -130.91 114.31 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 123' ' ' HIS . 5.3 tt -104.54 117.27 33.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 110.555 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 41.7 t -142.52 152.06 42.27 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.223 -0.923 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.635 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 18.9 pt-20 -52.5 153.63 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 109.372 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.562 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 3.1 tptt -127.24 113.44 16.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.84 -1.163 . . . . 0.0 111.79 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.7 m-70 -133.29 -60.74 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.063 0.935 . . . . 0.0 108.584 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.33 25.71 0.23 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -116.14 -10.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.555 -0.968 . . . . 0.0 110.148 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -51.08 -32.61 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -0.799 . . . . 0.0 110.444 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.516 ' O ' ' HG2' ' A' ' 55' ' ' MET . 40.0 mtp -72.01 -34.02 68.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.975 -1.078 . . . . 0.0 109.553 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -74.51 -32.5 62.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.331 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.02 -39.94 87.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.643 -0.661 . . . . 0.0 109.986 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.605 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 4.0 ptt? -70.8 -34.19 71.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -0.968 . . . . 0.0 109.676 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 70.4 tt0 -57.72 -50.48 73.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.603 ' C ' HG21 ' A' ' 67' ' ' VAL . 34.0 mmtt -71.16 -21.16 62.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.903 . . . . 0.0 108.943 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.048 HD22 HD13 ' A' ' 124' ' ' ILE . 39.5 tp -75.77 -15.49 60.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.647 -0.658 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 29.1 mmmt -40.0 136.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.816 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -50.01 -30.4 10.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.98 -21.81 25.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.25 157.51 20.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 0.0 110.036 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 24.3 ttm180 -66.45 105.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 111.192 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 58' ' ' LEU . 34.6 t80 -46.82 -30.42 2.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.62 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 38.9 t30 -64.11 -43.37 95.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -62.21 -43.21 99.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 57' ' ' LYS . 1.9 t -63.14 -42.73 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.914 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -64.91 -43.62 92.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.46 -48.73 76.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 0.0 110.993 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.1 -30.03 64.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.001 -1.062 . . . . 0.0 111.044 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 22.2 m-85 -100.35 15.3 28.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.514 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.1 p -73.93 91.9 2.05 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 50.4 tt0 -101.41 10.62 40.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.11 . . . . 0.0 110.283 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' O ' ' CA ' ' A' ' 78' ' ' GLN . 51.7 t0 -110.91 104.9 13.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.13 -42.66 31.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.359 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -38.49 78.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.558 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -111.42 0.42 16.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.334 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER 54.26 91.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 78' ' ' GLN . . . -44.69 100.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 78' ' ' GLN . . . -174.66 -115.5 0.4 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.744 ' C ' HD12 ' A' ' 82' ' ' LEU . 46.8 p-10 -117.62 142.34 47.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -1.05 . . . . 0.0 110.861 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.814 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.7 mp -110.47 175.84 5.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.49 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.96 -147.63 9.12 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 23.5 m-90 -98.78 117.3 32.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.724 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 20.6 ptm -130.71 171.72 12.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.036 -1.04 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' N ' ' A' ' 87' ' ' ARG . 14.8 t -101.2 -147.95 0.36 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.513 ' N ' HG23 ' A' ' 86' ' ' THR . 33.7 ptt-85 -115.39 119.73 37.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.346 -0.846 . . . . 0.0 110.579 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' ' NE2' ' A' ' 95' ' ' GLN . . . -92.7 -157.06 33.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -141.58 52.26 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -1.151 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.6 tpt -100.96 -90.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 109.041 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.638 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -77.84 132.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 108.799 178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.553 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.95 -53.49 18.79 Favored Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.654 -0.654 . . . . 0.0 112.997 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.4 Cg_endo -65.01 -42.09 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.276 1.146 . . . . 0.0 111.669 -177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 91' ' ' VAL . 56.4 t80 -65.46 -49.18 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.103 -0.998 . . . . 0.0 110.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.426 ' NE2' ' H ' ' A' ' 88' ' ' GLY . 12.6 mm100 -72.89 -58.84 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 111.251 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 13.1 mm-40 -53.17 -49.84 65.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.958 -1.089 . . . . 0.0 111.199 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -59.24 -57.98 10.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 0.0 110.35 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.11 -52.76 4.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.647 -0.658 . . . . 0.0 111.183 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.42 10.36 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 110.555 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -87.65 -48.07 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.981 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 111' ' ' PHE . 11.9 t . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.705 ' H ' HG12 ' A' ' 110' ' ' VAL . 5.4 p90 -114.02 168.8 9.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.012 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 114' ' ' PRO . 26.5 m -56.78 -5.73 0.26 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 111' ' ' PHE . 9.2 p-10 -50.74 126.59 24.27 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.027 -1.671 . . . . 0.0 109.378 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' THR . 45.5 Cg_endo -70.1 134.78 31.5 Favored 'Cis proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.287 -1.964 . . . . 0.0 111.124 0.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.662 ' HG2' HD11 ' A' ' 51' ' ' ILE . 40.3 Cg_endo -66.22 -174.69 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.054 1.555 . . . . 0.0 111.289 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.3 m -108.12 157.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.648 . . . . 0.0 109.899 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -113.56 118.21 33.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 30.0 p -130.73 170.98 13.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 110.623 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.35 -17.69 63.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 110.224 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.6 OUTLIER -98.26 24.36 7.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.215 -0.928 . . . . 0.0 109.357 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 98.06 174.43 33.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 5.3 p90 -98.49 152.0 20.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.378 -1.072 . . . . 0.0 108.567 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.579 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 1.6 m80 -131.28 141.48 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.825 -1.172 . . . . 0.0 113.053 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.048 HD13 HD22 ' A' ' 58' ' ' LEU . 57.9 mt -115.51 112.93 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 111' ' ' PHE . 25.0 mt -102.01 144.88 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.665 -1.272 . . . . 0.0 111.065 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ARG . 7.6 tpt -121.12 111.66 17.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.9 t -94.96 102.19 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.036 -1.04 . . . . 0.0 111.65 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 88.3 tt0 -144.66 135.02 24.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 132.84 7.08 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.12 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -107.74 169.25 8.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.386 -1.067 . . . . 0.0 110.323 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.534 ' CD ' ' HB3' ' A' ' 37' ' ' ALA . 45.2 mtmt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.354 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.395 0.617 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' THR . . . -109.13 155.47 20.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.361 -0.837 . . . . 0.0 109.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 85' ' ' MET . 7.7 p -140.65 156.69 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.024 -1.048 . . . . 0.0 110.517 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD2' ' NE1' ' A' ' 84' ' ' TRP . 1.5 mppt? -100.06 126.27 46.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.098 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -125.38 113.49 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.009 . . . . 0.0 111.57 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HA ' ' CB ' ' A' ' 81' ' ' ASP . 15.3 mtp180 -114.33 115.75 27.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.839 . . . . 0.0 108.819 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.993 ' HB2' HG22 ' A' ' 125' ' ' ILE . 13.5 p-80 -138.14 160.81 38.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.968 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.704 ' CG1' HG22 ' A' ' 124' ' ' ILE . 27.3 pt -116.89 124.53 73.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 45' ' ' CYS . 6.2 tt -108.53 129.96 55.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.585 . . . . 0.0 111.055 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.642 ' N ' HD23 ' A' ' 44' ' ' LEU . 32.6 t -142.62 165.42 27.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 83.0 mt-10 -69.13 154.1 42.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 26.9 tttm -87.88 116.62 26.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.76 -1.212 . . . . 0.0 112.834 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.5 m-70 -131.32 9.08 4.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.502 -0.749 . . . . 0.0 109.268 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.14 41.91 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -88.52 9.09 25.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.489 -1.006 . . . . 0.0 110.378 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.7 HG23 ' HG2' ' A' ' 115' ' ' PRO . 5.5 mt -48.8 -59.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.906 -1.121 . . . . 0.0 110.0 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' SD ' ' A' ' 55' ' ' MET . 72.3 mtm -69.06 -28.12 66.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.771 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -73.98 -42.47 60.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.784 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.31 79.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.506 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 25.2 ptm -63.7 -46.18 86.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.995 . . . . 0.0 110.467 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 79.0 tt0 -56.6 -33.46 66.26 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.041 -1.037 . . . . 0.0 110.161 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.695 ' HG2' HG22 ' A' ' 67' ' ' VAL . 66.1 tttt -77.72 -27.78 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.738 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 124' ' ' ILE . 1.0 OUTLIER -104.59 16.18 26.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.871 -1.143 . . . . 0.0 110.582 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 58' ' ' LEU . 38.5 mttm -50.65 -161.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.507 -0.745 . . . . 0.0 110.438 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.2 m -87.0 154.49 20.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.574 -1.329 . . . . 0.0 110.931 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.41 -3.83 86.32 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -113.89 -168.39 1.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.065 -1.256 . . . . 0.0 110.862 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 13.5 mtm180 -95.71 95.34 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.411 -0.805 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -50.65 -35.51 31.07 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.121 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 21.8 p-10 -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.797 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.7 tt0 -58.52 -49.02 78.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 57' ' ' LYS . 59.1 t -62.94 -52.27 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.922 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -45.2 -50.09 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.44 76.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 110.399 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -74.38 -26.05 59.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.995 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -109.89 17.47 21.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.109 . . . . 0.0 110.483 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.5 t -82.1 97.5 8.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.998 -1.064 . . . . 0.0 110.4 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -100.52 1.39 40.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.378 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' HD22 ' A' ' 44' ' ' LEU . 4.0 m-20 -114.07 23.28 13.08 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.459 -0.776 . . . . 0.0 109.538 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -56.6 -35.49 68.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -39.24 68.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.891 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -106.4 -53.3 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.851 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . 54.3 mm-40 -141.01 -80.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 110.05 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.46 24.43 76.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -144.32 -104.8 0.48 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.614 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.3 p-10 -128.13 171.77 11.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -1.133 . . . . 0.0 110.322 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.1 mp -100.51 16.91 23.11 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.358 -0.838 . . . . 0.0 109.092 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.29 -134.12 33.26 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.532 ' NE1' ' HD2' ' A' ' 39' ' ' LYS . 3.4 m-90 -87.37 125.99 34.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.842 -0.799 . . . . 0.0 109.542 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.78 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.6 ttm -137.65 140.86 41.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 37' ' ' ALA . 76.5 p -111.4 -33.03 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.438 -0.789 . . . . 0.0 109.979 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -66.71 -31.32 71.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.435 -0.791 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 99' ' ' PHE . . . 147.79 -107.01 0.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.609 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -143.22 -65.78 0.38 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.403 -1.057 . . . . 0.0 109.502 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 23.0 mtp -144.08 -77.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.762 . . . . 0.0 110.951 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -175.09 166.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 0.0 110.936 -179.138 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . 68.36 -143.65 41.2 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 92' ' ' GLY . 40.8 Cg_endo -67.16 -35.92 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.104 1.581 . . . . 0.0 109.284 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 125' ' ' ILE . 50.5 t80 -51.17 -30.52 17.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.476 ' OE1' ' HA3' ' A' ' 88' ' ' GLY . 16.7 tp60 -83.01 -54.68 4.88 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.597 0.713 . . . . 0.0 109.225 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.61 -45.26 92.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.615 -0.678 . . . . 0.0 110.215 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.44 -52.4 53.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 110.161 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.639 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -41.7 -53.88 3.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 88' ' ' GLY . 4.0 m-30 -81.43 -0.84 43.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.412 -0.805 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.25 21.15 6.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.87 -1.144 . . . . 0.0 111.927 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 101' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.576 -1.327 . . . . 0.0 110.861 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.405 0.621 . . . . 0.0 109.779 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.644 ' N ' HG13 ' A' ' 110' ' ' VAL . 38.0 p90 -114.57 164.39 14.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.8 p -74.43 117.4 16.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.515 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.5 p-10 -132.58 122.98 18.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 109.574 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.5 Cg_endo -69.07 170.27 56.31 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.232 0.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.7 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -73.57 -175.93 2.29 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.146 1.603 . . . . 0.0 110.081 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 123' ' ' HIS . 11.4 m -100.94 147.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 109.503 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -118.02 128.59 54.92 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.614 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 77.1 p -131.63 174.4 10.15 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -67.96 -16.95 64.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 1.2 p90 -96.67 28.19 3.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 105.38 -166.13 14.35 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 31.6 p90 -116.57 152.79 33.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.39 -1.065 . . . . 0.0 109.905 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.623 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -134.74 136.23 42.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.966 -1.084 . . . . 0.0 112.346 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.074 HD13 HD21 ' A' ' 58' ' ' LEU . 19.0 tt -121.17 108.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.993 HG22 ' HB2' ' A' ' 42' ' ' HIS . 24.9 pt -107.4 157.34 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.935 -1.103 . . . . 0.0 113.289 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 3.9 ttt -121.46 124.6 44.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 101' ' ' LEU . 16.3 m -109.74 120.88 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.649 -1.282 . . . . 0.0 111.903 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 129' ' ' GLY . 46.3 tt0 -115.29 149.21 38.19 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 48.22 95.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -131.56 150.7 52.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -1.0 . . . . 0.0 109.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.081 . . . . 0.0 110.16 -179.783 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.727 ' O ' HG23 ' A' ' 86' ' ' THR . 45.7 t30 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -100.69 159.2 15.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.52 -0.737 . . . . 0.0 109.282 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.7 p -143.3 154.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.8 ttpt -98.49 125.4 43.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 74.5 t -121.97 132.56 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.833 -177.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.2 mtt180 -120.16 130.91 54.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.977 ' HB2' HG22 ' A' ' 125' ' ' ILE . 11.2 p-80 -143.81 170.34 16.06 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.971 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.995 ' CD1' HG12 ' A' ' 67' ' ' VAL . 2.5 tt -124.32 113.77 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 8.1 tt -107.64 119.43 39.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 53.8 t -141.36 150.64 42.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.573 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 30.2 mt-10 -53.68 168.25 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 108.888 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' C ' ' CD2' ' A' ' 48' ' ' HIS . 8.6 ttmt -99.03 115.22 28.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.594 -1.316 . . . . 0.0 113.021 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 2.7 m80 -134.73 20.57 3.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.607 . . . . 0.0 109.651 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.14 11.92 83.84 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 tttm -81.2 5.22 17.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.958 . . . . 0.0 110.401 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.695 HD11 ' CB ' ' A' ' 122' ' ' TYR . 14.3 mm -51.22 -44.58 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 96.7 mtp -69.25 -43.16 74.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.818 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.77 -57.35 13.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 0.0 110.526 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' OH ' ' A' ' 71' ' ' TYR . . . -55.53 -55.82 27.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 9.8 ptt? -60.84 -41.25 95.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.049 . . . . 0.0 110.3 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' MET . 81.9 tt0 -52.86 -50.18 64.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.925 -1.109 . . . . 0.0 109.173 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 67' ' ' VAL . 12.9 ttmt -74.13 -28.64 61.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -0.768 . . . . 0.0 109.466 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.847 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.98 -24.52 58.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.401 -0.812 . . . . 0.0 109.229 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 58' ' ' LEU . 16.3 tptt -22.37 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.41 0.624 . . . . 0.0 112.082 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLY . 53.9 p -50.68 -52.29 41.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.394 -0.816 . . . . 0.0 109.63 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 60' ' ' SER . . . -45.0 -36.12 4.9 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 33.8 mmt -82.68 149.86 27.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -1.098 . . . . 0.0 110.315 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' HG3' ' CB ' ' A' ' 66' ' ' GLU . 1.3 ptm180 -73.55 106.54 5.37 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.961 0.886 . . . . 0.0 110.583 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 58' ' ' LEU . 9.0 t80 -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.484 0.659 . . . . 0.0 110.484 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.91 -56.88 16.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 111.075 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CB ' ' HG3' ' A' ' 63' ' ' ARG . 10.5 tp10 -55.81 -41.14 73.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.118 -0.989 . . . . 0.0 110.966 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.995 HG12 ' CD1' ' A' ' 43' ' ' ILE . 71.4 t -52.61 -59.09 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.748 -1.22 . . . . 0.0 109.803 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.584 ' CA ' HD11 ' A' ' 43' ' ' ILE . . . -64.94 -54.87 23.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -42.07 -27.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.413 -0.804 . . . . 0.0 109.838 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 68' ' ' ALA . 4.2 tp-100 -80.59 -62.85 1.55 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 109.992 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.768 ' OH ' ' HB1' ' A' ' 54' ' ' ALA . 50.9 p90 -109.96 51.16 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.606 -1.308 . . . . 0.0 111.084 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 31.1 t -89.83 131.14 35.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.248 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 68.4 mm-40 -102.4 -3.15 27.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.886 -1.134 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 78' ' ' GLN . 84.6 m-20 -104.6 26.89 8.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.922 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.77 -19.96 64.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.895 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -75.14 -29.82 60.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.092 -1.005 . . . . 0.0 110.802 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 55.9 mtt180 -118.62 -25.33 6.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.534 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 170.07 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.04 98.95 0.81 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.9 -103.8 0.25 Allowed Glycine 0 N--CA 1.491 2.333 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.2 m-20 -97.21 162.2 13.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -1.092 . . . . 0.0 110.739 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 42' ' ' HIS . 1.3 mp -101.64 -35.69 9.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 117.84 -161.99 13.2 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 17.1 m-90 -98.6 115.64 29.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.891 -0.77 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 ptm -134.78 138.24 44.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 110.208 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.787 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 93.3 m -104.14 -14.08 16.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.473 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 88' ' ' GLY . 27.6 ttt180 -100.0 -72.29 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 111.125 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . 44.83 66.41 1.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.6 p -120.44 66.3 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -1.092 . . . . 0.0 110.432 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 37.1 mmt -107.95 -49.06 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 94' ' ' PHE . 72.0 t -114.02 153.96 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.912 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -72.81 -64.77 2.47 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 121.2 -0.937 . . . . 0.0 111.062 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 37.0 Cg_endo -60.89 -30.9 90.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.71 1.374 . . . . 0.0 112.104 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 51.1 t80 -68.93 -40.67 78.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.738 -1.226 . . . . 0.0 110.426 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -72.86 -30.99 64.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.298 -0.876 . . . . 0.0 110.651 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 1.039 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 7.5 mm-40 -62.24 -26.51 68.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.82 . . . . 0.0 111.025 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.02 -54.63 3.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 111.315 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.41 -47.02 76.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.125 -0.984 . . . . 0.0 111.594 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.04 -8.63 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 111.544 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 1.039 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -130.33 25.88 5.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.698 -1.251 . . . . 0.0 111.89 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.712 -1.243 . . . . 0.0 109.373 179.241 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.646 0.736 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 39.3 p90 -123.2 164.33 18.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.6 p -50.43 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 67.3 t0 -122.32 116.85 29.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.931 . . . . 0.0 109.756 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.9 Cg_endo -70.72 164.33 82.27 Favored 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.987 -2.089 . . . . 0.0 110.535 0.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.638 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.5 Cg_endo -70.85 -176.25 1.72 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.967 1.509 . . . . 0.0 110.291 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.69 155.08 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.988 . . . . 0.0 110.402 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HE2' HG13 ' A' ' 51' ' ' ILE . 38.8 ttmt -124.03 127.4 47.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.53 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 38.9 p -138.81 -175.85 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.945 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -71.74 -35.09 70.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 118' ' ' THR . 1.4 p90 -80.03 7.54 8.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.014 -1.054 . . . . 0.0 109.956 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . . . 117.48 175.82 17.24 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.695 ' CB ' HD11 ' A' ' 51' ' ' ILE . 55.6 p90 -101.67 151.72 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -1.056 . . . . 0.0 109.453 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -132.23 140.68 48.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.867 -1.146 . . . . 0.0 111.95 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.888 HG22 HG22 ' A' ' 43' ' ' ILE . 8.0 tt -118.46 106.22 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.977 HG22 ' HB2' ' A' ' 42' ' ' HIS . 14.8 pt -115.07 149.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.492 -1.38 . . . . 0.0 112.695 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 41' ' ' ARG . 26.1 ptm -122.46 145.53 48.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.3 m -114.78 101.16 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.951 -1.093 . . . . 0.0 111.272 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 76.3 tt0 -143.59 87.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 110.486 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 39' ' ' LYS . . . 162.27 115.68 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.546 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 72.3 ttt180 -130.35 157.3 42.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -1.037 . . . . 0.0 109.533 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 56.5 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.129 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.688 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -105.01 -156.53 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.281 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 85' ' ' MET . 2.4 p -139.21 161.15 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 84' ' ' TRP . 47.1 mttt -99.61 111.55 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.885 -1.135 . . . . 0.0 109.309 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.48 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 46.3 mtt-85 -111.86 125.73 54.34 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.777 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -138.47 162.63 34.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.441 -1.412 . . . . 0.0 112.609 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.701 HD11 HD12 ' A' ' 124' ' ' ILE . 10.0 pt -129.85 137.64 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.012 HD13 ' OD2' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -107.74 131.56 54.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 111.1 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 71' ' ' TYR . 62.5 m -126.76 168.73 14.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 73.4 tt0 -74.04 158.91 33.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.0 ttpt -96.41 96.02 8.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.043 -1.036 . . . . 0.0 110.565 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 2.2 p-80 -132.71 6.82 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.554 -0.716 . . . . 0.0 110.009 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.77 2.37 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -114.72 10.87 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -1.185 . . . . 0.0 110.271 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG23 ' CG ' ' A' ' 115' ' ' PRO . 60.0 mt -53.63 -49.33 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.454 -0.779 . . . . 0.0 111.026 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.6 mmm -65.31 -50.68 64.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.987 . . . . 0.0 110.989 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.02 -42.88 99.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.948 . . . . 0.0 111.334 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . . . -61.38 -50.41 72.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.372 -0.83 . . . . 0.0 112.198 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.559 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 3.5 ptt? -65.48 -37.74 87.73 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.802 -1.186 . . . . 0.0 111.718 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 55' ' ' MET . 60.7 tt0 -65.39 -46.09 81.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -63.58 -34.19 77.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.962 -1.086 . . . . 0.0 108.594 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 124' ' ' ILE . 13.6 tp -71.59 -35.5 70.56 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.558 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 12.9 mttp 46.38 -92.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.504 -0.747 . . . . 0.0 111.161 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' LEU . 75.6 p -122.59 -3.61 8.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.147 -0.971 . . . . 0.0 110.976 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 -9.06 13.8 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 38.6 mmt -50.8 -34.95 29.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -1.159 . . . . 0.0 110.056 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -113.45 27.02 9.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.115 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' CE1' ' HE3' ' A' ' 126' ' ' MET . 8.9 t80 -53.11 -46.1 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 0.0 109.841 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 47.9 t30 -60.31 -40.3 90.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.601 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -65.25 -58.36 6.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 71.1 t -60.44 -63.23 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -46.29 -42.46 14.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -49.5 -56.15 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 109.935 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.04 -0.01 57.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 5.7 m-85 -104.33 3.16 32.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 110.382 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.2 t -99.89 93.65 5.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 0.0 109.729 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 24.6 mp0 -106.27 9.78 31.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.19 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 1.012 ' OD2' HD13 ' A' ' 44' ' ' LEU . 80.8 m-20 -117.29 46.17 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -66.15 -14.71 62.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.72 -37.07 42.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 111.363 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -121.99 15.66 10.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 111.599 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' CD ' ' NE2' ' A' ' 42' ' ' HIS . 0.5 OUTLIER -159.99 154.77 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.792 -1.193 . . . . 0.0 110.687 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.93 9.84 13.98 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 103.39 -52.98 0.75 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 41' ' ' ARG . 93.2 m-20 -115.44 137.94 51.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -1.085 . . . . 0.0 109.68 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 85' ' ' MET . 0.7 OUTLIER -100.52 -13.96 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 109.986 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 89.95 -115.62 4.6 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.356 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.625 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 79.5 m95 -89.46 133.56 34.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.989 . . . . 0.0 111.502 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 38' ' ' VAL . 22.8 ttt -122.59 124.81 44.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.2 m -134.92 -47.22 0.73 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.974 -1.079 . . . . 0.0 112.172 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 86' ' ' THR . 11.8 mtt180 -103.06 -88.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.69 -1.256 . . . . 0.0 111.744 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . -138.18 151.79 21.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 90' ' ' MET . 9.9 p -143.78 -53.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.273 . . . . 0.0 111.143 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 57.5 mmm -107.69 -98.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 111.362 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 120' ' ' PHE . 5.4 t -129.23 174.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.909 -1.119 . . . . 0.0 111.448 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -42.23 -54.16 4.67 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.746 -0.596 . . . . 0.0 112.284 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 43.5 Cg_endo -67.7 -19.75 47.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.459 1.242 . . . . 0.0 111.712 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 90' ' ' MET . 42.6 t80 -79.6 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.797 -1.19 . . . . 0.0 110.107 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.539 ' OE1' ' HE3' ' A' ' 85' ' ' MET . 28.4 mm100 -70.99 -38.23 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.769 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 4.7 mm-40 -70.75 -33.98 71.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' PRO . . . -69.7 -48.15 60.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.148 -0.97 . . . . 0.0 110.574 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.0 97.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 111.291 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.82 0.3 57.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.013 -1.054 . . . . 0.0 111.563 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -127.04 4.89 6.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.771 -1.206 . . . . 0.0 111.186 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 112' ' ' THR . 41.4 tp . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.906 -1.121 . . . . 0.0 109.842 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 111' ' ' PHE . 17.5 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.412 0.625 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CZ ' ' CE ' ' A' ' 126' ' ' MET . 19.1 m-30 -101.42 171.18 7.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.519 -0.738 . . . . 0.0 110.039 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.719 HG21 ' CG2' ' A' ' 116' ' ' VAL . 65.0 m -65.18 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 111.802 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.771 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 99.0 m-20 -93.39 -24.93 0.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 42.5 Cg_endo -71.04 -27.36 7.5 Favored 'Cis proline' 0 N--CA 1.493 1.442 0 C-N-CA 124.306 -1.122 . . . . 0.0 114.484 1.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.624 ' HD3' ' CD ' ' A' ' 114' ' ' PRO . 51.5 Cg_endo -80.92 130.68 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 122.404 0.686 . . . . 0.0 112.576 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.719 ' CG2' HG21 ' A' ' 112' ' ' THR . 60.6 t -98.66 143.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 11.9 ptpt -102.51 108.55 19.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.53 -0.731 . . . . 0.0 111.065 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.645 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 19.4 p -136.84 158.37 44.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -65.82 -13.62 59.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.645 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.6 p90 -100.41 21.56 12.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.78 -1.2 . . . . 0.0 110.039 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 112.66 -169.9 13.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 33.7 m-85 -105.68 156.61 18.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 109.25 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 60.8 m-70 -135.16 128.57 32.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 112.199 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.836 HG21 HD22 ' A' ' 58' ' ' LEU . 95.7 mt -117.93 102.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -106.78 152.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.468 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.634 ' CE ' ' CZ ' ' A' ' 111' ' ' PHE . 20.3 mtt -124.17 136.21 54.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.69 139.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.888 -1.133 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -117.39 -37.57 3.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 110.46 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -145.64 121.6 1.53 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 41.5 ttt180 -110.25 149.4 30.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -1.132 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.128 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.288 0.566 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -90.63 -170.54 2.75 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 85' ' ' MET . 1.6 p -143.46 151.62 16.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.724 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.551 ' HG3' ' CE3' ' A' ' 84' ' ' TRP . 49.7 mtmt -99.27 129.6 45.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 109.257 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 82' ' ' LEU . 5.0 p -139.34 139.39 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.02 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.1 mtt-85 -110.74 122.5 47.97 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 80' ' ' GLY . 13.7 p-80 -138.27 148.25 44.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.821 -1.174 . . . . 0.0 111.501 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 19.4 mt -102.7 119.35 50.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 120' ' ' PHE . 4.4 tt -101.79 116.31 32.44 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 41.8 t -129.0 163.56 25.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.546 -0.721 . . . . 0.0 109.642 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 32.0 mt-10 -71.55 -178.91 2.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.598 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . 22.7 tttm -97.0 104.27 16.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.024 -1.048 . . . . 0.0 112.639 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.649 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.9 m-70 -133.13 0.42 3.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.254 -0.904 . . . . 0.0 110.504 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 122' ' ' TYR . . . 94.03 11.77 57.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' ILE . 98.0 mttt -85.56 3.85 38.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.253 -1.145 . . . . 0.0 110.739 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG23 ' HG2' ' A' ' 115' ' ' PRO . 67.8 mt -42.28 -53.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 98.5 mmm -66.01 -45.19 82.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.144 -0.972 . . . . 0.0 110.637 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.28 -48.1 81.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.781 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.0 -61.19 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.539 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.679 ' HA ' HD21 ' A' ' 58' ' ' LEU . 3.9 ppp? -63.19 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 110.712 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 52' ' ' MET . 39.5 tp10 -71.54 -28.25 63.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.073 -1.017 . . . . 0.0 110.016 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 67' ' ' VAL . 9.3 tptt -74.65 -34.77 62.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.846 ' HB3' HG21 ' A' ' 67' ' ' VAL . 3.7 pp -91.56 -16.98 26.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.817 ' O ' HD12 ' A' ' 58' ' ' LEU . 19.3 mtpt 43.45 -135.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.551 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 100.0 p -57.26 -24.98 58.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.138 -0.976 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.03 9.92 2.94 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtp -50.73 -44.79 58.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.892 -1.357 . . . . 0.0 109.723 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 67' ' ' VAL . 65.0 mtt-85 -114.24 38.82 2.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.455 -0.778 . . . . 0.0 109.702 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -52.55 -49.98 63.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.371 -0.831 . . . . 0.0 110.341 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 16.9 p30 -61.88 -42.26 98.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.5 mm-40 -59.25 -50.93 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.052 -1.03 . . . . 0.0 108.993 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 58' ' ' LEU . 92.4 t -57.5 -52.42 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 0.0 109.817 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -60.12 -40.57 90.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -49.89 -44.99 50.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.483 -0.761 . . . . 0.0 110.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -94.89 -11.79 28.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.529 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 43' ' ' ILE . 32.9 m-85 -117.81 25.75 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 111.1 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 t -103.68 115.43 30.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.927 -1.108 . . . . 0.0 110.214 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -100.34 -7.51 24.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.488 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 2.1 m-20 -104.92 23.7 13.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.491 -0.755 . . . . 0.0 109.065 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -49.89 -32.17 13.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.63 88.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -112.09 -45.22 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.125 -0.984 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.91 149.56 41.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.09 13.23 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 101.58 -5.91 54.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 36.5 p-10 -124.84 140.5 52.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -1.204 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 40' ' ' VAL . 63.3 tp -110.6 127.8 55.39 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.06 -1.025 . . . . 0.0 109.484 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -59.3 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE3' ' HG3' ' A' ' 39' ' ' LYS . 98.3 m95 -80.31 142.21 34.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -1.017 . . . . 0.0 110.727 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.877 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.2 ttt -128.89 121.81 28.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.619 -0.676 . . . . 0.0 109.269 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.1 m -118.28 -46.65 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.732 -1.23 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -100.41 -54.48 2.85 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.005 . . . . 0.0 110.502 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' NE2' ' A' ' 95' ' ' GLN . . . 160.74 -165.73 35.22 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -133.19 -75.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.513 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 41.7 mtp -140.37 -80.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.081 -1.012 . . . . 0.0 110.74 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 118' ' ' THR . 97.3 t -50.69 127.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.639 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.58 -51.48 30.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 38.9 Cg_endo -65.15 -8.78 19.49 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.461 1.243 . . . . 0.0 110.817 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.462 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 46.9 t80 -80.56 -46.17 16.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.04 . . . . 0.0 109.014 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' NE2' ' HA3' ' A' ' 88' ' ' GLY . 19.9 mt-30 -68.52 -30.72 69.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 79.9 mm-40 -54.41 -40.73 68.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -77.75 -51.08 11.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.55 -53.0 15.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -77.03 -17.48 58.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.407 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -58.76 -44.68 90.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.99 -1.069 . . . . 0.0 109.253 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 127' ' ' VAL . 69.4 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.367 -0.833 . . . . 0.0 109.396 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 111' ' ' PHE . 45.6 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.255 0.55 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' N ' HG12 ' A' ' 110' ' ' VAL . 50.5 p90 -123.21 157.06 33.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 0.0 110.139 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.456 ' CG2' ' HB ' ' A' ' 125' ' ' ILE . 77.3 p -56.86 109.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 110.642 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.548 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 22.3 p-10 -132.33 124.14 19.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.763 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 44.8 Cg_endo -70.79 164.74 81.43 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.208 0.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.614 ' HG2' HG23 ' A' ' 51' ' ' ILE . 46.3 Cg_endo -72.55 -178.5 3.41 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.085 1.571 . . . . 0.0 109.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' A' ' 123' ' ' HIS . 3.7 m -99.61 146.3 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.053 . . . . 0.0 109.396 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HD3' HD11 ' A' ' 51' ' ' ILE . 40.1 ttpt -120.83 134.58 55.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.006 -1.059 . . . . 0.0 110.46 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.583 HG21 HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -141.32 -164.29 1.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -0.88 . . . . 0.0 109.75 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -73.37 -45.91 52.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.992 . . . . 0.0 112.059 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.757 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 6.8 p90 -53.6 -41.62 66.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.065 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.673 ' N ' ' CG ' ' A' ' 120' ' ' PHE . . . 164.81 -124.4 1.25 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.563 ' OH ' ' HG3' ' A' ' 47' ' ' LYS . 15.7 m-85 -133.41 162.53 31.59 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.81 -1.406 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.787 ' HB2' HG22 ' A' ' 116' ' ' VAL . 97.6 m-70 -137.58 110.63 7.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.308 -0.87 . . . . 0.0 111.071 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -99.05 118.57 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 125' ' ' ILE . 3.4 mp -105.78 134.89 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.902 -1.124 . . . . 0.0 113.505 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 tpt -118.23 121.76 41.27 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 101' ' ' LEU . 17.0 t -92.8 144.14 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.808 -1.183 . . . . 0.0 111.389 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.2 -48.25 3.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.8 . . . . 0.0 110.234 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.14 149.25 16.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.18 157.2 44.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -1.134 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 pttt . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.083 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.368 0.604 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -99.44 155.37 17.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 30.4 m -138.63 158.16 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -100.54 122.48 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.724 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 82' ' ' LEU . 7.9 p -124.22 162.62 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.917 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 126' ' ' MET . 41.1 ttm180 -143.17 128.2 18.52 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.963 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.9 p80 -140.29 175.15 9.83 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.151 -1.593 . . . . 0.0 113.173 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.684 ' HB ' HG22 ' A' ' 124' ' ' ILE . 36.0 mt -128.55 125.15 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 45' ' ' CYS . 3.3 tt -105.56 131.38 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 110.566 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.765 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.0 m -142.85 162.33 35.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.914 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 85.4 mt-10 -75.91 161.44 28.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 79.5 tttt -72.58 119.5 16.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.195 -0.941 . . . . 0.0 111.692 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 12.3 m-70 -133.32 -1.57 3.19 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.42 -0.8 . . . . 0.0 110.45 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.58 81.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' HB2' ' A' ' 48' ' ' HIS . 21.7 ptmt -107.34 15.46 24.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.478 -1.013 . . . . 0.0 109.948 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.755 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -46.66 -52.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.386 -0.822 . . . . 0.0 110.44 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.3 ttp -53.95 -38.29 64.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 88.6 mt-10 -70.4 -39.13 74.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -59.04 6.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.655 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.9 ptm -59.01 -33.26 70.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.918 . . . . 0.0 110.171 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' O ' ' CD ' ' A' ' 59' ' ' LYS . 33.8 tp10 -72.93 -32.96 65.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 110.189 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 24.4 mmtp -63.54 -50.74 68.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 59' ' ' LYS . 3.2 pp -73.65 -20.26 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.79 ' O ' HD12 ' A' ' 58' ' ' LEU . 28.9 mmmt 53.66 -137.31 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.878 . . . . 0.0 110.781 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.44 ' O ' HG11 ' A' ' 110' ' ' VAL . 26.2 t -52.35 -39.14 60.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.45 2.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.429 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 16.1 ptp -51.88 -35.44 45.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' N ' ' CG ' ' A' ' 62' ' ' MET . 25.8 mtt180 -101.5 9.19 41.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 110.163 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -44.35 -48.73 9.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.05 -39.22 77.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.233 -0.917 . . . . 0.0 109.849 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.23 -40.84 74.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.602 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 58' ' ' LEU . 42.2 t -67.17 -49.16 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.443 -0.786 . . . . 0.0 110.044 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -58.22 -54.74 43.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.138 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.68 -51.26 16.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -75.7 -15.58 60.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 110.101 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.663 ' CE2' HG13 ' A' ' 67' ' ' VAL . 15.1 m-30 -111.14 18.32 19.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.454 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ALA . 19.4 p -79.48 93.56 5.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.015 -1.053 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 45' ' ' CYS . 3.5 mp0 -108.95 8.26 26.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' HB3' HD13 ' A' ' 44' ' ' LEU . 4.3 p30 -112.12 37.08 3.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -48.81 -31.05 6.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.01 -39.21 51.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -91.19 4.91 51.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.306 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 51.18 51.41 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.958 . . . . 0.0 109.592 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 74' ' ' ASP . . . -78.06 115.32 4.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.66 -122.79 0.64 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' C ' HD12 ' A' ' 82' ' ' LEU . 40.4 p-10 -86.71 131.55 34.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.128 -1.219 . . . . 0.0 109.007 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.814 ' HB2' HG13 ' A' ' 40' ' ' VAL . 7.2 mp -102.91 162.77 12.66 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.987 -1.071 . . . . 0.0 110.226 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -93.37 -135.39 7.43 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 13.3 m-90 -96.38 133.03 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.968 -0.725 . . . . 0.0 110.8 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -140.52 168.35 20.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.738 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . 31.8 p -128.02 -125.48 0.22 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.301 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -113.91 174.76 5.77 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.915 -1.116 . . . . 0.0 109.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.89 56.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 t -110.36 -29.51 8.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -1.125 . . . . 0.0 110.098 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 95' ' ' GLN . 2.1 ptt? -126.35 176.7 6.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 94' ' ' PHE . 19.3 m -68.44 -174.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.354 -0.841 . . . . 0.0 110.76 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.629 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -77.61 -47.38 8.85 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 121.468 -0.77 . . . . 0.0 111.897 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.9 Cg_endo -65.52 -46.77 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.064 1.033 . . . . 0.0 110.986 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.552 ' H ' HG23 ' A' ' 91' ' ' VAL . 1.6 t80 -66.56 -39.88 88.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.938 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 8.6 tt0 -69.64 -44.39 70.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 1.011 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 34.2 tt0 -51.36 -26.83 8.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.38 -38.25 13.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.247 -0.908 . . . . 0.0 110.479 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.57 99.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.399 -0.813 . . . . 0.0 111.642 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 86' ' ' THR . 10.5 m-85 -101.39 -12.85 18.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.162 . . . . 0.0 111.788 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 1.011 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -113.1 8.91 18.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.734 -1.229 . . . . 0.0 111.021 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.711 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.6 pt? . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.038 . . . . 0.0 109.575 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 111' ' ' PHE . 62.2 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.879 0.371 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 124' ' ' ILE . 46.3 p90 -108.52 169.39 8.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 110.962 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.576 ' OG1' HG12 ' A' ' 125' ' ' ILE . 25.3 m -70.07 116.45 10.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.506 -0.746 . . . . 0.0 110.919 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 22.7 p-10 -133.85 112.78 12.59 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.7 Cg_endo -77.33 160.2 94.23 Favored 'Cis proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.153 -2.02 . . . . 0.0 110.36 -0.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 46.0 Cg_endo -72.86 -175.86 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.957 1.504 . . . . 0.0 109.908 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 116' ' ' VAL . 22.1 m -102.25 146.53 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.274 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -114.53 138.05 51.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 108.975 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.6 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 81.1 p -136.39 -173.9 3.54 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.708 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 120' ' ' PHE . 15.0 ptpt -76.36 -11.23 59.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -104.38 11.01 35.15 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.736 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.79 -167.1 12.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 45.6 p90 -108.86 157.91 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.315 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.604 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 12.2 m-70 -133.72 140.54 47.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 111.419 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 124' ' ' ILE . 19.9 tt -128.04 111.21 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.963 HG22 ' CB ' ' A' ' 42' ' ' HIS . 28.8 pt -108.62 161.2 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.789 -1.194 . . . . 0.0 111.836 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.561 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 39.5 mtm -128.05 143.88 51.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 101' ' ' LEU . 16.7 t -118.37 128.59 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.981 -1.074 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -144.26 -38.08 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.985 -1.072 . . . . 0.0 111.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . -89.26 88.32 1.51 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.418 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -118.66 135.89 54.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -1.167 . . . . 0.0 110.04 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.289 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.9 t-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.16 0.505 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -59.9 139.43 57.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG12 ' HA2' ' A' ' 129' ' ' GLY . 28.8 m -147.02 165.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.507 -0.746 . . . . 0.0 111.298 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -97.06 126.32 42.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.023 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.11 134.05 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.867 -1.145 . . . . 0.0 112.226 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 48.2 mtm-85 -114.15 126.03 54.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.099 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.3 p-80 -133.51 151.47 51.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.535 -1.353 . . . . 0.0 112.231 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 67' ' ' VAL . 86.3 mt -113.4 126.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.623 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -113.99 121.17 43.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 110.934 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 19.4 p -132.95 177.52 7.59 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.721 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 74.3 mm-40 -64.14 158.16 23.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.573 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.69 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 5.0 ttmt -101.84 73.17 1.4 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.942 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.721 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 75.8 m-70 -135.12 51.55 2.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 111.728 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.52 -10.35 55.82 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.759 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -71.15 -15.15 62.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.336 . . . . 0.0 110.675 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 122' ' ' TYR . 7.3 tt -52.95 -36.16 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 55' ' ' MET . 26.0 ttt -67.23 -40.14 86.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 110.143 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -67.56 -34.63 77.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.909 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 124' ' ' ILE . . . -61.65 -63.06 1.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 18.5 ptt? -56.32 -34.75 66.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.797 . . . . 0.0 111.0 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 55' ' ' MET . 87.6 tt0 -69.91 -42.02 73.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 111.288 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 62' ' ' MET . 53.0 mtpt -80.27 -24.95 39.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.978 . . . . 0.0 111.246 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 124' ' ' ILE . 2.3 pp -104.35 2.87 31.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 58' ' ' LEU . 6.2 mttt -49.46 178.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.07 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -52.47 139.48 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 110.095 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.05 -10.95 69.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 29.5 mmt -100.9 163.71 12.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -1.049 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.497 ' CG ' ' HG3' ' A' ' 66' ' ' GLU . 4.9 ttm180 -93.77 95.04 8.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -46.24 -31.43 2.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 0.0 110.337 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.61 -41.24 92.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.127 -0.983 . . . . 0.0 110.011 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.497 ' HG3' ' CG ' ' A' ' 63' ' ' ARG . 3.4 mt-10 -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.826 HG13 ' CE2' ' A' ' 71' ' ' TYR . 53.6 t -68.94 -38.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.897 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -70.9 -51.38 26.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 110.465 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.34 65.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.672 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 10.9 mm100 -91.42 -19.75 22.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.031 -1.043 . . . . 0.0 110.735 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.826 ' CE2' HG13 ' A' ' 67' ' ' VAL . 17.2 m-30 -108.71 10.44 26.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 0.0 111.078 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 16.7 m -76.44 116.76 17.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.937 -1.102 . . . . 0.0 110.154 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 25.3 tp10 -104.5 10.41 35.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 22.0 t70 -114.9 108.29 16.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.158 -0.964 . . . . 0.0 110.543 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HA ' ' HG3' ' A' ' 78' ' ' GLN . 17.1 ptpt -61.3 -25.18 66.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.04 -21.72 29.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -129.51 25.54 5.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.385 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.557 ' HG3' ' HA ' ' A' ' 75' ' ' LYS . 52.6 mt-30 -43.53 -28.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.93 -15.61 14.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . 61.39 24.03 63.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 55.4 t0 -130.74 142.84 50.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -1.116 . . . . 0.0 110.493 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.7 mp -104.04 -20.5 13.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.68 -170.06 34.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 28.9 m-90 -84.26 127.75 34.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -1.016 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 19.2 ptp -140.37 137.48 34.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 49.1 m -76.53 -54.64 6.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -111.14 -173.55 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.385 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . -149.62 146.07 14.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.6 p -137.9 16.07 2.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -1.182 . . . . 0.0 110.759 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 6.4 mmt -100.8 108.4 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.241 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.57 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 11.4 t 64.84 117.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.6 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -51.81 -53.05 31.44 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.49 -0.756 . . . . 0.0 111.461 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -65.66 -32.7 47.13 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.438 1.231 . . . . 0.0 111.705 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 125' ' ' ILE . 42.1 t80 -63.77 -52.46 60.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.851 -1.156 . . . . 0.0 109.932 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HG3' ' HA3' ' A' ' 88' ' ' GLY . 39.5 tt0 -55.12 -46.05 75.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.4 mt-10 -58.62 -48.63 80.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.12 77.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.343 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.23 91.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 36' ' ' ASN . 6.5 m-85 -103.63 13.23 33.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.957 . . . . 0.0 110.906 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -130.76 3.33 4.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.133 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 110' ' ' VAL . 61.0 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 111.34 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.815 ' N ' HG13 ' A' ' 110' ' ' VAL . 31.4 p90 -102.56 158.06 16.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.828 -1.17 . . . . 0.0 110.134 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 1.009 HG21 HG13 ' A' ' 116' ' ' VAL . 22.4 m -40.61 121.98 1.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 37.8 p-10 -133.51 104.76 12.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.909 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.963 ' O ' HG22 ' A' ' 112' ' ' THR . 49.5 Cg_endo -76.78 176.91 41.88 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.198 -2.001 . . . . 0.0 110.471 0.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 114' ' ' PRO . 41.7 Cg_endo -69.32 166.67 26.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.764 1.402 . . . . 0.0 109.686 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 112' ' ' THR . 34.2 m -110.3 139.18 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.01 . . . . 0.0 110.656 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . 1.2 pttp -114.03 131.39 56.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.474 -0.766 . . . . 0.0 108.934 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 69.8 p -134.75 176.21 8.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.965 -1.084 . . . . 0.0 110.822 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -61.49 -8.73 4.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.74 -0.6 . . . . 0.0 111.369 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 11.0 p90 -112.73 37.95 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.705 -1.247 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . 99.65 -173.38 25.84 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 51' ' ' ILE . 20.5 m-85 -99.01 158.62 15.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -1.05 . . . . 0.0 108.417 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.68 ' CE1' ' CD2' ' A' ' 120' ' ' PHE . 73.0 m-70 -141.35 137.71 32.54 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.063 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.881 HD13 HD21 ' A' ' 58' ' ' LEU . 69.9 mt -128.29 96.38 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.099 HG22 ' HB2' ' A' ' 42' ' ' HIS . 15.4 pt -103.79 137.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.942 -1.099 . . . . 0.0 112.029 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 48.9 mtp -107.42 142.08 37.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.407 HG23 HD23 ' A' ' 101' ' ' LEU . 30.0 t -119.83 125.2 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.719 -1.238 . . . . 0.0 111.576 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -107.82 -47.62 3.55 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 38' ' ' VAL . . . 119.54 176.83 16.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 46.3 tpt85 -116.96 -48.48 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.968 . . . . 0.0 109.117 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.235 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' HG22 ' A' ' 86' ' ' THR . 35.6 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.835 0.35 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.79 ' HB1' ' N ' ' A' ' 85' ' ' MET . . . -117.99 176.62 5.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.5 OUTLIER -120.98 151.24 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HG3' ' CZ2' ' A' ' 84' ' ' TRP . 1.9 tmmt? -100.42 121.85 42.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.106 -0.996 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.981 HG23 HG22 ' A' ' 127' ' ' VAL . 10.2 p -142.44 147.94 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 119.344 -0.943 . . . . 0.0 112.876 -178.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' NE ' ' HB2' ' A' ' 81' ' ' ASP . 65.8 mtp180 -130.06 137.38 50.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 2.4 p-80 -142.69 167.75 21.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.162 -1.587 . . . . 0.0 113.061 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.49 HD13 ' CG1' ' A' ' 67' ' ' VAL . 5.1 mt -127.55 130.36 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 73' ' ' GLU . 6.7 tt -113.91 118.86 35.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 48.1 t -129.68 154.22 47.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 35.0 tp10 -60.24 163.83 4.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 0.0 109.86 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 18.2 ttpt -97.58 96.74 8.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 0.0 110.38 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.565 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 1.4 p80 -132.07 21.89 4.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.48 19.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 120.107 -1.044 . . . . 0.0 110.603 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 71' ' ' TYR . 8.9 tttt -114.65 18.35 16.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.889 -1.359 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 4.2 mt -57.41 -42.39 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.488 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 62.8 ttp -65.86 -46.96 76.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.888 . . . . 0.0 110.869 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 50' ' ' LYS . 72.1 mm-40 -59.89 -47.41 85.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -0.985 . . . . 0.0 110.641 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -55.0 -60.73 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.529 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' LYS . 3.7 tmm? -62.47 -33.33 74.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 110.088 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.5 tt0 -59.15 -46.13 89.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -60.21 -46.64 89.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.76 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 111' ' ' PHE . 4.1 pp -101.26 25.33 8.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 110.365 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' MET . 7.9 tptt -35.09 -70.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.744 -0.598 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.4 m -91.3 25.0 2.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.77 32.78 66.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.78 40.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -1.05 . . . . 0.0 110.568 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 71.5 mtt180 -117.71 37.36 3.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 111.715 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CE2' ' CZ ' ' A' ' 111' ' ' PHE . 25.7 t80 -49.28 -46.92 47.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.707 -1.245 . . . . 0.0 109.988 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -63.97 -45.96 86.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 110.73 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 38.9 tt0 -64.94 -45.2 86.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 110.426 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.893 HG11 HD23 ' A' ' 58' ' ' LEU . 67.2 t -55.1 -41.81 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.749 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -64.13 -59.2 4.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.0 109.638 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.49 -40.21 1.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 0.0 111.688 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.507 ' CD ' ' CE1' ' A' ' 71' ' ' TYR . 0.5 OUTLIER -101.18 -30.27 11.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 112.002 -178.696 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.532 ' CE2' ' HD3' ' A' ' 50' ' ' LYS . 8.3 m-85 -100.79 28.36 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.641 -1.287 . . . . 0.0 109.945 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 41.0 t -115.82 123.27 47.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 44' ' ' LEU . 64.8 tt0 -101.83 -8.14 21.9 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' GLN . 46.6 p30 -108.04 32.43 4.77 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -60.03 -37.01 78.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.4 71.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.383 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' C ' ' HG3' ' A' ' 78' ' ' GLN . 13.7 ptp180 -87.58 -47.64 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.8 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' ASP . 20.2 mt-30 -138.6 -127.15 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.256 -0.903 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.56 25.8 8.48 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.22 -135.43 1.81 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.018 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.623 ' C ' HD12 ' A' ' 82' ' ' LEU . 59.8 t0 -73.98 150.18 40.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -1.099 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.736 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.0 mp -100.9 -15.47 17.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.47 -0.769 . . . . 0.0 108.941 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 82.39 -145.34 24.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.6 m-90 -109.08 133.3 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.667 -0.902 . . . . 0.0 110.101 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.79 ' N ' ' HB1' ' A' ' 37' ' ' ALA . 25.0 ptp -141.1 154.37 45.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.404 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 36' ' ' ASN . 32.8 p -115.81 -66.05 1.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 110.371 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -104.35 37.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.879 . . . . 0.0 110.709 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.2 97.59 1.8 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.424 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 25.2 t -101.69 114.89 29.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.368 -1.078 . . . . 0.0 109.93 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 30.5 mmt -100.42 -106.35 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' A' ' 93' ' ' PRO . 70.1 t -64.42 -51.33 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.911 -1.118 . . . . 0.0 110.397 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.64 -67.19 0.45 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' A' ' 91' ' ' VAL . 45.1 Cg_endo -70.49 -25.08 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.105 1.581 . . . . 0.0 109.612 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.82 ' CE1' HD11 ' A' ' 125' ' ' ILE . 58.7 t80 -70.61 -33.92 71.57 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.468 -0.77 . . . . 0.0 109.567 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 65.4 tt0 -73.04 -54.88 7.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 110.154 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -48.02 -61.9 1.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -62.13 -66.55 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.422 -0.799 . . . . 0.0 111.504 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -54.3 -63.46 1.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 112.206 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 18.5 t80 -41.71 -42.91 2.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.528 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.86 -89.55 0.27 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 111.484 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 1.014 ' CE1' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.34 149.56 23.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.251 179.792 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 115' ' ' PRO . 21.2 m -75.1 101.63 4.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 55.3 t0 -132.48 111.94 13.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.146 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.6 Cg_endo -72.33 160.45 94.32 Favored 'Cis proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.849 -2.146 . . . . 0.0 110.271 0.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.682 ' HA ' HG22 ' A' ' 112' ' ' THR . 45.0 Cg_endo -72.46 -168.92 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.964 1.508 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.43 HG12 HG23 ' A' ' 118' ' ' THR . 19.4 t -101.21 131.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.529 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 51' ' ' ILE . 8.4 mtmm -102.03 123.14 45.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.312 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.569 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 41.4 p -134.62 -178.03 4.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -73.02 -16.48 61.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 111.369 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 3.8 p90 -97.1 1.6 50.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.738 -1.226 . . . . 0.0 110.983 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 131.52 -171.92 21.02 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.168 -1.491 . . . . 0.0 111.357 178.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 26.2 m-85 -101.23 150.54 22.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.742 -0.858 . . . . 0.0 109.34 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 15.0 m-70 -136.31 122.67 20.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.895 -1.128 . . . . 0.0 112.11 -179.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.014 HG22 ' CE1' ' A' ' 111' ' ' PHE . 25.8 mt -102.06 120.89 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.82 HD11 ' CE1' ' A' ' 94' ' ' PHE . 20.3 mt -108.88 126.87 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.777 -1.202 . . . . 0.0 112.54 -177.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 13.5 tpt -110.3 99.01 8.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.981 HG22 HG23 ' A' ' 40' ' ' VAL . 11.6 t -107.77 138.04 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.955 . . . . 0.0 111.471 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -143.1 3.72 1.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -0.834 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -125.52 139.78 11.79 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -132.59 133.05 43.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -1.21 . . . . 0.0 110.199 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.965 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.409 0.623 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -131.25 -177.02 4.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 7.7 p -144.74 156.11 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HE2' ' CZ2' ' A' ' 84' ' ' TRP . 42.1 mttt -98.23 136.18 38.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.08 -1.012 . . . . 0.0 109.411 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 59.7 t -133.53 146.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.874 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 126' ' ' MET . 84.0 mtt180 -141.62 123.34 15.18 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.99 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.72 -176.55 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.671 -1.268 . . . . 0.0 112.597 -178.342 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.83 ' HB ' HG22 ' A' ' 124' ' ' ILE . 82.5 mt -126.75 131.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 1.3 tt -106.7 126.38 52.21 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 110.68 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.438 ' N ' HD23 ' A' ' 44' ' ' LEU . 16.4 t -137.54 149.89 47.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.639 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 6.6 mm-40 -73.27 -155.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 122' ' ' TYR . 83.9 tttt -98.09 102.81 14.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.881 -1.137 . . . . 0.0 112.231 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.5 m-70 -132.56 -19.83 2.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.383 -0.823 . . . . 0.0 110.469 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.63 24.99 22.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 19.1 mttt -97.78 14.1 28.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.48 -1.012 . . . . 0.0 110.43 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.943 HG23 ' HG2' ' A' ' 115' ' ' PRO . 2.7 mp -44.37 -62.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.988 . . . . 0.0 109.997 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 22.1 ptm -66.33 -34.5 78.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.0 110.948 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -65.13 -39.71 93.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.69 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -67.07 -56.68 9.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.833 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.562 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -62.46 -31.84 72.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.894 -1.129 . . . . 0.0 110.385 -179.559 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 55' ' ' MET . 18.3 tp10 -62.58 -38.75 91.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.489 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD2' ' OH ' ' A' ' 71' ' ' TYR . 44.8 mttm -76.86 -37.8 54.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.799 ' CB ' HG21 ' A' ' 67' ' ' VAL . 4.2 pp -83.7 -2.28 55.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.911 -1.118 . . . . 0.0 111.128 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HG3' ' HA ' ' A' ' 56' ' ' GLU . 12.1 mttt -48.93 178.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 109.986 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -54.33 139.83 35.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.9 -23.55 29.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.487 ' HA ' ' CE ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -110.45 149.04 30.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.116 . . . . 0.0 110.283 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HG3' ' CG ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -87.16 107.39 18.45 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.043 0.925 . . . . 0.0 110.515 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD11 ' A' ' 43' ' ' ILE . 72.7 t80 -39.28 -40.92 0.83 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.493 0.663 . . . . 0.0 109.906 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -48.99 -46.98 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.251 -0.906 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CG ' ' HG3' ' A' ' 63' ' ' ARG . 80.2 mm-40 -65.35 -43.39 90.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 58' ' ' LEU . 44.2 t -59.95 -41.05 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -55.38 -46.72 76.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.689 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.56 55.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -64.92 -23.79 67.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 0.0 110.593 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 54' ' ' ALA . 12.3 m-85 -118.39 26.38 9.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 109.744 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ALA . 7.1 t -88.24 87.3 7.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 110.942 -179.078 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 1.1 tm-20 -101.79 5.27 41.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -0.975 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -126.07 12.86 7.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.366 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -53.9 -18.6 3.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.538 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.03 -26.17 56.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.9 mmm180 -127.44 -2.3 6.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.05 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 77' ' ' ARG . 6.7 tt0 -178.63 150.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.62 38.32 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 42' ' ' HIS . . . 65.24 18.95 65.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -128.3 118.34 23.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.126 . . . . 0.0 110.119 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.881 HD11 ' CD2' ' A' ' 42' ' ' HIS . 4.4 mp -101.69 150.91 22.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.928 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.72 -122.24 0.61 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 61.8 m95 -95.3 143.32 26.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.765 -0.844 . . . . 0.0 110.525 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.5 mmt -125.64 139.29 53.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.028 179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.9 t -134.02 -37.59 0.89 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' THR . 15.0 mtp85 -119.67 151.79 38.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 111.849 -177.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . -100.92 113.86 4.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p -139.16 12.49 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.324 . . . . 0.0 111.722 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.591 ' CG ' HG12 ' A' ' 91' ' ' VAL . 6.8 ptp -105.26 -26.59 11.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.78 -1.2 . . . . 0.0 110.077 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.61 HG22 ' HD2' ' A' ' 93' ' ' PRO . 11.5 p -167.36 -46.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.579 ' N ' HG13 ' A' ' 91' ' ' VAL . . . 132.93 -63.28 0.62 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.63 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 91' ' ' VAL . 38.7 Cg_endo -63.55 -37.68 46.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.907 1.478 . . . . 0.0 112.13 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.72 -45.94 91.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.619 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.513 ' HG3' ' CA ' ' A' ' 88' ' ' GLY . 1.5 tm0? -74.55 -42.04 59.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.15 -0.969 . . . . 0.0 110.791 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -64.75 -39.71 94.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 111.572 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.5 18.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.9 -1.125 . . . . 0.0 110.27 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.63 -42.28 23.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 110.399 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -70.42 -39.4 74.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.351 -0.843 . . . . 0.0 111.659 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.11 51.53 1.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 113.067 -177.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.494 1.731 0 O-C-N 120.482 -1.386 . . . . 0.0 109.453 178.57 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.607 HG12 ' HD2' ' A' ' 111' ' ' PHE . 86.0 t . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.625 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 26.4 p90 -131.77 161.13 33.62 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.95 -1.094 . . . . 0.0 109.966 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 114' ' ' PRO . 18.9 m -68.12 118.18 10.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 111.543 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.625 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 32.3 p-10 -133.93 108.34 11.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 0.0 110.447 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 112' ' ' THR . 48.6 Cg_endo -75.28 176.17 44.73 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.093 -2.044 . . . . 0.0 110.344 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.943 ' HG2' HG23 ' A' ' 51' ' ' ILE . 44.2 Cg_endo -69.65 -175.03 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.877 1.462 . . . . 0.0 109.702 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 HG23 ' A' ' 118' ' ' THR . 46.6 t -102.07 137.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 0.0 110.111 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -102.11 125.54 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 109.064 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 38.7 p -142.04 -175.98 4.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.631 -1.293 . . . . 0.0 111.68 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.8 tttt -74.36 -10.67 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.768 -0.582 . . . . 0.0 110.132 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -103.55 37.92 1.91 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.065 -1.022 . . . . 0.0 109.605 179.117 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.6 -167.71 37.28 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.74 ' CE2' HD11 ' A' ' 51' ' ' ILE . 6.9 m-85 -103.72 144.13 31.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -1.084 . . . . 0.0 108.879 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 120' ' ' PHE . 10.1 m-70 -137.94 135.29 35.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.666 -1.272 . . . . 0.0 112.32 -178.515 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.83 HG22 ' HB ' ' A' ' 43' ' ' ILE . 11.5 tt -120.64 116.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.99 HG22 ' CB ' ' A' ' 42' ' ' HIS . 12.1 pt -114.46 158.28 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.571 -1.33 . . . . 0.0 112.651 -177.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.534 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 44.9 mtp -118.87 151.07 38.77 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.3 t -126.91 121.36 57.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.55 -1.344 . . . . 0.0 111.822 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.8 pt-20 -133.67 157.41 45.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 61.45 82.65 0.07 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 10.1 ttm180 -116.77 154.1 31.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.992 . . . . 0.0 110.173 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.546 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.9 mtpt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.184 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.174 0.511 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.811 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -129.65 -170.35 2.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 85' ' ' MET . 1.5 p -128.76 150.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.576 -0.703 . . . . 0.0 109.244 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HD2' ' CD2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -101.0 113.93 27.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.637 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 38' ' ' VAL . 38.6 t -127.14 152.31 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.836 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 93.5 mtt180 -133.73 121.93 22.62 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.114 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -131.06 159.23 38.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.638 -1.289 . . . . 0.0 113.008 -177.763 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 24.9 mt -122.82 123.21 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -104.63 120.97 42.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.6 p -133.09 -168.81 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.892 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 92.4 mt-10 -70.98 176.61 4.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.0 111.419 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.693 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 28.1 pttt -118.66 56.77 0.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.356 -0.84 . . . . 0.0 110.947 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.543 ' N ' ' CE2' ' A' ' 122' ' ' TYR . 19.3 m80 -134.6 64.04 1.61 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 111.576 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 -0.95 34.05 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.88 178.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.78 -10.78 59.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.984 -1.304 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.721 HD12 ' HB3' ' A' ' 122' ' ' TYR . 3.1 tt -62.15 -36.81 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.543 ' HG3' ' N ' ' A' ' 53' ' ' GLU . 23.3 ptm -74.54 -42.97 57.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.957 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' N ' ' HG3' ' A' ' 52' ' ' MET . 19.1 mm-40 -68.12 -38.82 82.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.675 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.38 68.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.893 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.846 ' HA ' HD23 ' A' ' 58' ' ' LEU . 27.1 ptm -61.68 -35.39 77.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.916 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 55' ' ' MET . 91.7 mt-10 -68.44 -33.44 74.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.062 -1.024 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -68.72 -46.01 70.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -74.45 -27.77 60.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.977 -1.077 . . . . 0.0 110.446 -179.454 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 91.1 mttt 49.82 -126.98 2.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 62' ' ' MET . 55.7 p -65.45 -28.5 69.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 110.587 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 130.73 -5.82 5.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.434 ' HG3' ' OG ' ' A' ' 60' ' ' SER . 60.0 mtt -49.47 -31.43 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -1.225 . . . . 0.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.72 29.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 30.9 t80 -54.71 -40.99 69.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.904 . . . . 0.0 110.477 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 20.6 p-10 -58.59 -44.48 89.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -69.21 -44.13 72.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 58' ' ' LEU . 97.2 t -69.75 -26.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 110.413 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -74.16 -57.59 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.11 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.89 62.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.619 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.65 -29.81 33.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.173 -0.954 . . . . 0.0 111.124 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 23.4 m-85 -114.57 26.71 10.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.034 -1.041 . . . . 0.0 111.049 -179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 26.7 t -102.28 116.93 33.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.911 -1.118 . . . . 0.0 110.68 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.32 -7.42 24.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -111.86 21.22 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.508 -0.745 . . . . 0.0 109.212 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 6.4 tmtt? -53.8 -31.3 48.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.625 -0.672 . . . . 0.0 110.68 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.28 81.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.173 -0.955 . . . . 0.0 110.927 -179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.27 9.27 36.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.097 -1.002 . . . . 0.0 110.795 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 2.1 tt0 -169.07 172.62 7.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.054 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.69 27.49 6.83 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 72.66 11.5 77.4 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.657 ' C ' HD12 ' A' ' 82' ' ' LEU . 41.2 p-10 -133.08 129.46 38.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -1.182 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.9 mp -110.09 109.29 19.78 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 110.159 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -60.12 -123.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.081 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.692 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 78.2 m95 -76.45 130.26 37.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.795 -0.826 . . . . 0.0 110.808 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.921 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.8 tpt -137.28 136.04 37.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 0.0 109.767 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.811 HG22 ' CB ' ' A' ' 37' ' ' ALA . 19.0 p -122.78 -57.98 1.69 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.827 -1.171 . . . . 0.0 110.675 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' A' ' 86' ' ' THR . 21.9 ttm-85 -68.22 -48.99 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.739 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 46.65 64.79 2.46 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -122.93 43.59 2.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -1.06 . . . . 0.0 110.634 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.2 mtp -99.78 -32.04 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.768 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 89.9 t -142.96 112.38 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -43.04 -53.93 5.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.514 -0.741 . . . . 0.0 111.874 -178.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 42.8 Cg_endo -69.33 -19.66 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.511 1.269 . . . . 0.0 111.765 -178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.59 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 23.4 t80 -76.56 -54.09 7.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 110.771 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -66.52 -41.76 88.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.972 . . . . 0.0 110.897 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 14.1 pt-20 -60.23 -25.15 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.894 -1.128 . . . . 0.0 110.42 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -79.61 -50.74 10.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.773 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.32 -54.63 7.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.755 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 58.4 m-85 -56.42 -47.0 79.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 0.0 110.975 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -66.17 -39.69 89.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.202 -0.937 . . . . 0.0 111.196 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 tp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.985 -1.072 . . . . 0.0 110.802 -179.395 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.1 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.155 0.502 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.828 ' N ' HG13 ' A' ' 110' ' ' VAL . 8.2 t80 -103.62 163.12 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 111.185 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.698 HG21 HD11 ' A' ' 125' ' ' ILE . 1.7 p -84.47 29.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 38.1 p-10 -71.73 130.17 87.42 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.986 -1.071 . . . . 0.0 110.389 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 112' ' ' THR . 49.0 Cg_endo -76.16 146.33 84.72 Favored 'Cis proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.949 -2.105 . . . . 0.0 110.082 -0.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.751 ' CB ' HG22 ' A' ' 124' ' ' ILE . 40.8 Cg_endo -66.34 -174.24 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.097 1.577 . . . . 0.0 110.902 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 28.5 m -101.68 158.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 110.248 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 51' ' ' ILE . 42.3 mttm -113.57 142.07 46.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.619 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 24.8 p -143.12 177.12 8.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.758 -1.214 . . . . 0.0 111.078 -179.471 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -80.85 -11.6 59.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.678 -0.639 . . . . 0.0 109.533 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.619 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.3 p90 -104.82 20.96 17.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 110.01 179.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.13 -173.04 14.52 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 51' ' ' ILE . 16.4 m-85 -100.25 160.87 13.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -1.033 . . . . 0.0 108.729 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.583 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 63.9 m-70 -141.98 122.48 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.708 -1.245 . . . . 0.0 112.061 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.814 HD12 HD22 ' A' ' 58' ' ' LEU . 30.9 pt -118.46 125.06 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.114 HG22 ' HB2' ' A' ' 42' ' ' HIS . 18.2 pt -123.88 173.03 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.684 -1.26 . . . . 0.0 112.944 -176.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.638 ' HG2' ' CD2' ' A' ' 111' ' ' PHE . 73.1 mtm -133.4 146.71 51.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m -121.32 120.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.867 -1.145 . . . . 0.0 109.974 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -107.12 -20.86 13.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 111.331 -178.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.481 ' HA3' ' NZ ' ' A' ' 39' ' ' LYS . . . -161.62 156.09 27.5 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.101 -1.523 . . . . 0.0 110.637 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.461 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 7.0 ttt180 -126.05 145.51 50.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.922 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 58.9 pttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 53.5 p30 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.724 0.773 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . -103.71 168.39 9.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 -178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 129' ' ' GLY . 1.3 p -128.78 153.63 38.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 110.022 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 2.9 mtpm? -98.87 132.99 43.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 109.084 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 82.5 t -130.36 143.12 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.292 -178.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 76.4 mtt180 -125.34 120.88 32.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.202 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.808 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -144.78 164.95 29.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.738 -1.227 . . . . 0.0 112.256 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.909 HD11 HD12 ' A' ' 124' ' ' ILE . 13.5 pt -126.47 144.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -101.34 122.36 43.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.881 -1.137 . . . . 0.0 110.041 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 36.5 m -111.51 170.07 8.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 110.275 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 27.8 mt-10 -88.45 -158.63 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 110.318 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.1 mtmm -128.04 92.63 3.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.923 -1.111 . . . . 0.0 111.142 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.594 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -132.88 17.26 4.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.95 2.25 81.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 5.0 ttmt -83.81 -12.95 54.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -1.079 . . . . 0.0 110.089 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -43.22 -41.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 110.298 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' MET . 41.7 ttm -60.94 -44.77 96.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.063 -1.023 . . . . 0.0 109.841 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -72.16 -31.73 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.05 -1.031 . . . . 0.0 109.385 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.68 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.757 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' HD23 ' A' ' 58' ' ' LEU . 25.5 ptm -65.97 -23.91 66.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 24.1 tp10 -64.35 -41.98 96.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.042 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -79.79 -38.42 33.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 0.0 109.057 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -65.96 -49.14 68.94 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.616 -0.677 . . . . 0.0 109.218 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 33.4 mtmt 50.09 -124.66 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 0.0 110.384 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -70.66 -31.72 68.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.0 -1.062 . . . . 0.0 109.932 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.94 7.26 5.61 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 ttt -47.73 -42.07 24.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.861 -1.376 . . . . 0.0 109.247 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 27.3 mtt-85 -108.5 30.51 6.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.524 -0.735 . . . . 0.0 109.255 179.178 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -46.94 -47.8 21.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.886 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -57.74 -39.05 76.45 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 77.4 mt-10 -67.67 -42.65 81.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 58' ' ' LEU . 96.5 t -70.11 -52.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.56 -40.25 51.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.092 -1.005 . . . . 0.0 110.331 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.72 91.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -89.77 8.31 32.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.683 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.556 ' HB3' HD12 ' A' ' 43' ' ' ILE . 33.1 m-85 -134.25 4.37 3.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.916 -1.115 . . . . 0.0 111.289 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -67.86 111.25 4.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 16.7 tt0 -102.06 5.59 40.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.748 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 29.3 t70 -132.98 45.33 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.975 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -66.65 -32.59 74.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.032 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.94 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 108.842 179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.456 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.4 mmm-85 -104.74 8.25 34.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.65 -0.656 . . . . 0.0 109.408 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 52.86 42.35 31.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.775 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.447 ' HA3' ' OD2' ' A' ' 74' ' ' ASP . . . -79.79 108.5 2.75 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -160.42 -92.45 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 78.1 m-20 -90.39 140.67 29.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -1.149 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -124.61 169.57 11.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -82.04 -122.99 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.466 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.629 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 18.4 m-90 -96.48 144.83 26.22 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.786 0.803 . . . . 0.0 112.116 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.2 ptm -139.88 155.54 47.15 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.3 p -129.84 -72.95 0.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.554 -1.341 . . . . 0.0 110.315 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 86' ' ' THR . 4.2 ttp85 -116.76 136.57 52.86 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.311 -0.955 . . . . 0.0 111.598 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' ARG . . . 58.34 144.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 90' ' ' MET . 53.2 p -142.37 -66.45 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.042 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.568 ' C ' HG23 ' A' ' 91' ' ' VAL . 20.0 ptm -142.06 -39.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.992 HG12 ' HD2' ' A' ' 93' ' ' PRO . 38.4 t -153.01 157.55 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 110.085 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -37.99 -60.67 1.26 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.992 ' HD2' HG12 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -63.62 -175.55 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.759 1.399 . . . . 0.0 110.334 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 125' ' ' ILE . 59.9 t80 68.48 -78.03 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.611 -0.68 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 12.0 tm0? -66.51 -47.93 71.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 81.8 mt-10 -61.68 -38.75 88.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.05 70.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 0.0 109.003 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.5 83.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.086 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -69.51 -21.48 63.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.25 -12.8 48.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.468 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 110' ' ' VAL . 9.8 tt . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 110.641 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.87 HG12 HD21 ' A' ' 101' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.632 0.73 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.933 ' CE1' HG23 ' A' ' 124' ' ' ILE . 7.5 t80 -114.34 153.8 29.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.77 -0.581 . . . . 0.0 110.409 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 101' ' ' LEU . 66.2 p -72.85 119.38 17.0 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.352 -0.842 . . . . 0.0 110.732 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 111' ' ' PHE . 81.3 m-20 -133.45 121.9 16.64 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.257 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 48.8 Cg_endo -78.81 174.59 50.36 Favored 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.188 -2.005 . . . . 0.0 110.396 -0.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HG2' HD12 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -70.83 175.78 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.957 1.504 . . . . 0.0 109.926 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 32.6 m -103.19 155.44 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -123.08 136.11 54.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 36.4 p -139.02 168.02 20.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.103 -0.998 . . . . 0.0 110.645 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -64.89 -17.28 64.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.796 . . . . 0.0 110.017 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -97.38 19.62 12.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.985 -1.072 . . . . 0.0 110.366 179.526 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.552 ' HA2' ' CG ' ' A' ' 47' ' ' LYS . . . 117.72 -176.91 16.37 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-30 -97.82 158.8 15.31 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CE1' HD21 ' A' ' 44' ' ' LEU . 75.9 m-70 -138.09 140.19 39.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.403 -1.436 . . . . 0.0 112.302 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.933 HG23 ' CE1' ' A' ' 111' ' ' PHE . 84.2 mt -123.0 114.49 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -122.43 149.49 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 0.0 112.102 -178.725 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.455 ' HE3' ' HB2' ' A' ' 111' ' ' PHE . 89.8 mtp -128.5 150.75 50.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 38' ' ' VAL . 15.2 t -124.62 138.86 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.75 -1.219 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -114.9 -24.61 8.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 110.93 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -150.27 132.67 4.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -76.97 -42.67 38.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.969 . . . . 0.0 110.949 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 38.0 mtmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.229 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 49.8 p30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.411 0.624 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -107.47 164.69 11.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 130' ' ' ARG . 5.9 m -136.72 161.46 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.917 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HD3' ' NE1' ' A' ' 84' ' ' TRP . 7.3 mmmt -99.71 112.09 24.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.415 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.114 HG13 ' HB2' ' A' ' 82' ' ' LEU . 4.0 p -127.88 128.4 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.949 . . . . 0.0 111.465 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 46.6 mtm180 -118.42 134.0 55.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.995 ' HB2' HG22 ' A' ' 125' ' ' ILE . 13.7 p-80 -135.81 162.86 31.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.59 -1.319 . . . . 0.0 111.704 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' SG ' ' A' ' 45' ' ' CYS . 23.6 mt -116.64 121.86 68.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.247 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.616 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.8 tt -101.83 101.0 11.39 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.909 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.612 ' SG ' HG22 ' A' ' 43' ' ' ILE . 35.2 m -101.36 162.49 12.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.637 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.4 mt-10 -63.35 165.75 7.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.82 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 21.2 tttt -89.7 59.09 4.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.133 -0.979 . . . . 0.0 111.419 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 20.3 m80 -135.87 66.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.66 -1.275 . . . . 0.0 111.584 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.44 28.47 44.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.02 7.22 45.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.992 -1.299 . . . . 0.0 109.445 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 115' ' ' PRO . 43.2 mt -62.51 -50.81 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.541 -0.725 . . . . 0.0 110.581 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 49.2 mtm -69.15 -32.26 71.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.451 -0.781 . . . . 0.0 110.617 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 14.2 tt0 -62.54 -49.37 75.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.518 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -69.86 -51.32 34.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 111.479 -179.076 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 28.6 ptm -65.69 -43.9 87.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.315 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' MET . 64.3 tt0 -65.09 -41.23 95.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.956 -1.09 . . . . 0.0 110.686 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 55.3 mmtt -60.23 -56.14 25.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.655 ' CB ' HG21 ' A' ' 67' ' ' VAL . 1.2 pp -68.1 -14.04 62.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.62 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.0 mtpt 45.66 -133.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.795 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -57.87 -21.66 44.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.846 -1.159 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 123.45 10.73 5.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.4 ttm -51.16 -45.55 61.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -1.232 . . . . 0.0 109.927 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 10.7 mtp180 -109.66 31.6 5.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.903 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.61 -49.1 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -58.28 -46.86 85.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 109.374 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 51.4 mp0 -62.37 -41.53 98.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.299 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 58' ' ' LEU . 54.3 t -65.54 -44.38 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.553 -0.717 . . . . 0.0 109.294 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -57.76 -51.88 67.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.925 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -46.74 88.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 7.1 mm100 -73.29 -28.06 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.315 -0.866 . . . . 0.0 111.27 -179.215 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 63.5 m-85 -108.76 13.82 24.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.057 . . . . 0.0 110.86 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 8.4 t -78.9 105.23 10.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.876 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 31.9 tp10 -101.4 1.34 38.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.734 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB3' HD13 ' A' ' 44' ' ' LEU . 20.4 p30 -103.4 24.56 10.82 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 110.112 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' GLN . 43.8 tttm -46.96 -49.25 21.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.87 -50.38 10.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.0 109.734 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 7.1 tpm_? -80.4 -11.55 59.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.605 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . 14.6 mm100 54.4 47.9 21.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.531 -0.731 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -81.61 -76.42 1.07 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.32 -84.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' GLY . 62.9 m-20 -109.25 150.61 27.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.579 -0.953 . . . . 0.0 109.632 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.114 ' HB2' HG13 ' A' ' 40' ' ' VAL . 2.9 mp -102.67 2.76 36.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 49.88 -139.53 18.06 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.1 m95 -89.94 114.8 26.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.395 -1.062 . . . . 0.0 110.574 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.496 ' CE ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.09 152.21 46.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.209 -0.932 . . . . 0.0 110.186 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.7 p -100.58 -89.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 110.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.536 ' N ' ' OG1' ' A' ' 86' ' ' THR . 39.3 ptt180 -116.61 138.71 51.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.375 -1.453 . . . . 0.0 110.901 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . -131.56 164.45 23.52 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -137.71 34.24 2.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.842 -1.387 . . . . 0.0 111.209 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.476 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 43.3 mmm -100.65 123.94 45.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 30.2 t 60.11 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 109.97 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.627 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -55.31 -43.95 84.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 43.7 Cg_endo -71.89 -12.12 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.369 1.194 . . . . 0.0 111.243 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 53.0 t80 -88.65 -54.48 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.0 110.18 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 2.0 tt0 -64.7 -43.64 92.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 110.677 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.653 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 47.1 tp10 -59.36 -42.97 92.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.973 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -60.35 -58.13 9.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.5 -56.33 2.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.473 -0.767 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.483 ' HZ ' ' O ' ' A' ' 86' ' ' THR . 38.0 m-85 -83.16 3.68 29.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.524 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -80.69 -29.74 36.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.193 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.165 179.492 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' MET . 7.2 p . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 0.6 OUTLIER -118.52 172.37 7.53 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.105 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.557 ' OG1' HG12 ' A' ' 125' ' ' ILE . 2.1 m -76.97 -4.83 46.02 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 65.6 m-20 -48.44 122.48 10.35 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.344 -1.473 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' A' ' 112' ' ' THR . 43.4 Cg_endo -66.38 128.08 8.81 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.359 1.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HG2' HG23 ' A' ' 51' ' ' ILE . 38.4 Cg_endo -63.65 -179.3 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.086 1.572 . . . . 0.0 111.616 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.5 m -102.47 144.87 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.568 -0.707 . . . . 0.0 109.86 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 34.1 pttt -110.28 130.14 55.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.045 -1.035 . . . . 0.0 110.296 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.581 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.8 p -137.35 173.1 12.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.059 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -19.31 65.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.179 -0.95 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.8 p90 -93.46 19.32 8.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.803 -1.185 . . . . 0.0 110.369 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 114.88 -174.11 15.17 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.512 178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-85 -104.12 153.22 21.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.702 -0.881 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.616 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 13.1 m-70 -141.34 133.48 27.84 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.684 -1.26 . . . . 0.0 112.948 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -125.36 106.14 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.375 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.995 HG22 ' HB2' ' A' ' 42' ' ' HIS . 35.1 pt -105.11 157.0 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.857 -1.152 . . . . 0.0 111.864 -177.174 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 16.3 ptm -133.36 160.86 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.996 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.74 131.79 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.928 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.09 -4.51 16.55 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.486 -0.759 . . . . 0.0 110.225 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 38' ' ' VAL . . . -172.18 126.75 1.31 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 38' ' ' VAL . 2.2 ttt-85 -127.22 152.6 47.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -1.121 . . . . 0.0 109.857 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 36' ' ' ASN . 30.5 tttm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.063 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.506 ' HA ' ' HG3' ' A' ' 131' ' ' LYS . 19.9 p30 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -125.93 173.73 8.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 2.5 p -132.52 154.58 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 110.065 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 84' ' ' TRP . 37.7 mtpt -100.05 115.18 29.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 82' ' ' LEU . 69.9 t -120.04 125.54 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 111.497 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -124.98 109.62 13.2 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.808 ' HB3' HG22 ' A' ' 125' ' ' ILE . 4.0 p80 -134.96 166.97 21.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.701 -1.249 . . . . 0.0 112.427 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.666 HG21 ' CB ' ' A' ' 68' ' ' ALA . 17.9 pt -118.56 134.04 63.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.761 HD23 ' N ' ' A' ' 45' ' ' CYS . 5.0 tt -107.44 132.15 53.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.549 -0.719 . . . . 0.0 111.097 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.761 ' N ' HD23 ' A' ' 44' ' ' LEU . 42.8 t -140.26 163.57 32.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 109.088 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 59.5 mm-40 -72.54 158.31 35.94 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.153 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.58 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.6 tttp -78.38 122.69 26.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.248 -0.907 . . . . 0.0 111.333 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 9.2 m-70 -129.79 -13.74 4.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 0.0 110.416 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.38 2.95 50.79 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -88.59 18.39 4.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.177 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.533 HD11 ' HG3' ' A' ' 117' ' ' LYS . 53.5 mt -45.68 -46.78 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 109.293 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 55' ' ' MET . 23.5 ptt? -65.74 -35.32 80.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.412 -0.805 . . . . 0.0 109.52 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 34.9 tt0 -75.19 -27.5 59.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.289 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.2 -45.99 44.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 21.0 ptm -64.92 -44.91 87.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 77.6 tt0 -65.44 -41.32 93.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.451 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 28.5 mmtt -67.42 -31.21 71.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 108.524 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 124' ' ' ILE . 24.3 tp -73.93 -29.36 61.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.748 -0.595 . . . . 0.0 109.83 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 20.0 mttm 39.46 -92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 58' ' ' LEU . 83.0 p -129.48 -158.03 0.86 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . -73.17 -1.92 57.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.8 ttp -65.0 -46.15 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 110.463 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 81.6 mtt180 -106.21 11.36 31.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.765 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.444 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 73.7 t80 -50.23 -43.96 53.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 109.748 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.84 -38.7 80.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 109.897 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 64.9 mt-10 -61.64 -51.07 69.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.892 . . . . 0.0 109.841 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 71' ' ' TYR . 93.6 t -69.65 -39.44 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' HG21 ' A' ' 43' ' ' ILE . . . -60.51 -53.25 59.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.71 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 7.9 mm100 -70.73 -28.0 64.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' HG13 ' A' ' 67' ' ' VAL . 12.0 m-30 -102.62 9.25 39.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 68' ' ' ALA . 47.4 t -79.07 88.18 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -104.33 7.66 35.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' ' CB ' ' A' ' 44' ' ' LEU . 43.0 p30 -132.01 40.49 3.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.468 -0.77 . . . . 0.0 109.982 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -64.89 -43.97 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.0 110.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.2 64.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -74.91 -33.09 61.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' ASP . 60.5 mt-30 -137.02 157.4 46.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.973 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.94 14.92 37.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.21 2.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 34.9 p-10 -121.3 137.37 54.72 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.318 -1.107 . . . . 0.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -104.35 -9.17 18.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 78.29 -143.98 27.81 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 39' ' ' LYS . 89.5 m95 -79.99 140.33 36.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.589 -0.948 . . . . 0.0 111.302 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.807 ' HG3' HD12 ' A' ' 82' ' ' LEU . 68.7 mmm -131.66 114.6 15.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.6 -0.688 . . . . 0.0 109.171 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.576 HG22 ' HB2' ' A' ' 37' ' ' ALA . 51.4 p -74.6 -43.38 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.979 -1.076 . . . . 0.0 109.896 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 8.6 mtt180 -107.55 -62.58 1.41 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.833 . . . . 0.0 110.015 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 89.6 111.01 1.31 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -141.94 86.3 1.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -1.165 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 91' ' ' VAL . 49.4 mtt -121.71 -37.26 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.095 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.03 -88.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.254 -0.904 . . . . 0.0 110.142 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -170.55 -69.45 0.04 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 -37.92 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.874 1.46 . . . . 0.0 110.571 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 125' ' ' ILE . 60.5 t80 -60.92 -49.99 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 3.5 tm0? -74.54 -55.25 6.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 110.094 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 3.1 tp10 -42.05 -45.65 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.54 -39.7 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.68 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.36 74.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 87' ' ' ARG . 34.8 m-85 -89.5 -5.47 57.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 110.156 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.43 8.73 14.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.32 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.945 HD12 ' HD2' ' A' ' 102' ' ' PRO . 56.8 tp -52.75 127.48 43.33 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.159 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.945 ' HD2' HD12 ' A' ' 101' ' ' LEU . 41.1 Cg_endo -67.61 149.77 79.55 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.913 1.481 . . . . 0.0 110.376 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 m -87.38 -10.51 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 111.073 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.1 p -111.51 112.55 24.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.403 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . -167.82 136.11 3.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 107' ' ' ASP . 5.5 ptt? -62.6 -40.38 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -1.12 . . . . 0.0 110.348 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' N ' ' CG ' ' A' ' 106' ' ' MET . 50.6 t0 -125.09 25.42 7.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.713 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 24.1 mttp -93.96 -18.5 0.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.429 -0.794 . . . . 0.0 112.671 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 45.6 Cg_endo -75.33 4.21 5.1 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 O-C-N 122.432 0.701 . . . . 0.0 110.56 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.28 -77.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 110.046 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.576 ' H ' HG23 ' A' ' 110' ' ' VAL . 73.6 m-85 -106.55 146.89 30.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.635 HG21 HG13 ' A' ' 125' ' ' ILE . 13.3 p -72.04 86.87 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.002 -1.061 . . . . 0.0 109.065 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.1 125.77 38.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.446 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.3 Cg_endo -75.12 165.47 85.79 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 -2.147 . . . . 0.0 110.08 -0.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 -179.44 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.896 1.472 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 23.9 m -102.95 139.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.011 . . . . 0.0 110.558 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 51' ' ' ILE . 12.0 ttmt -112.08 123.81 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.598 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 73.7 p -130.65 176.1 8.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.981 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -72.03 -16.75 62.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.77 . . . . 0.0 110.551 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.598 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.1 p90 -98.18 19.4 14.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 0.0 110.187 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.58 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 111.29 -179.11 19.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 54.7 p90 -101.53 160.37 14.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -1.224 . . . . 0.0 110.034 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.581 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.3 m-70 -138.67 138.17 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 111.819 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.797 HG21 HD22 ' A' ' 58' ' ' LEU . 87.2 mt -115.27 111.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -103.23 143.86 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.066 . . . . 0.0 111.807 -178.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.8 tmm? -118.61 119.81 35.6 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 101' ' ' LEU . 46.8 t -97.56 121.2 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -110.53 -8.13 14.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.481 -0.762 . . . . 0.0 109.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.502 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -144.44 149.96 22.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.02 149.31 52.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.922 -1.34 . . . . 0.0 110.653 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 36' ' ' ASN . 71.6 tttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.081 0.944 . . . . 0.0 110.368 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -133.8 156.45 48.0 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.785 -1.197 . . . . 0.0 111.263 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.896 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.5 m -116.86 152.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HG3' ' CH2' ' A' ' 84' ' ' TRP . 5.5 mtmt -98.49 113.08 24.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.884 -1.135 . . . . 0.0 108.815 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.817 HG13 ' CG2' ' A' ' 125' ' ' ILE . 70.3 t -113.94 130.81 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.118 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -134.41 129.95 36.1 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.504 ' CE1' HD11 ' A' ' 82' ' ' LEU . 8.9 p-80 -145.04 168.7 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.448 -1.407 . . . . 0.0 112.565 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 67' ' ' VAL . 89.4 mt -108.88 131.86 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -118.49 125.12 49.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 111.838 -178.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 19.1 t -137.62 136.22 37.31 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.4 mm-40 -55.23 -157.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.502 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 92.8 mttt -97.91 105.04 17.12 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.47 -1.394 . . . . 0.0 112.509 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -133.02 16.7 4.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.242 -0.911 . . . . 0.0 109.897 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.28 23.49 73.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 91.7 mttt -94.51 6.18 49.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -1.006 . . . . 0.0 110.808 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 3.0 mp -51.27 -50.1 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.029 . . . . 0.0 110.392 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 39.5 ttp -69.62 -40.13 76.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -0.757 . . . . 0.0 111.288 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 54.1 tp10 -70.62 -41.09 72.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.656 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -61.49 -54.51 42.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 111.18 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 4.9 ptt? -61.79 -44.12 97.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.085 -1.009 . . . . 0.0 111.178 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.525 ' N ' ' CG ' ' A' ' 55' ' ' MET . 10.2 pt-20 -72.04 -23.61 61.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.929 -1.107 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.7 tptt -70.26 -45.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.805 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' HB3' HG21 ' A' ' 67' ' ' VAL . 1.3 pp -81.02 -23.06 38.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 61.5 mmtt 52.2 -133.62 1.77 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.116 -0.99 . . . . 0.0 111.178 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -36.28 66.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 110.622 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.2 -0.3 3.54 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.221 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.4 mtm -47.86 -36.87 12.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.007 -1.29 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 7.1 mtp180 -110.3 29.28 7.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.703 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.96 -47.78 43.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.527 -0.733 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.18 -37.55 78.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.881 . . . . 0.0 109.945 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 8.3 tp10 -65.48 -47.67 75.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 43' ' ' ILE . 41.0 t -63.52 -47.42 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.319 -0.863 . . . . 0.0 109.639 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -53.4 -51.06 63.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 110.127 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.97 67.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.687 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -29.94 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 m-85 -106.94 11.12 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.009 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ALA . 79.7 p -76.58 69.67 3.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.398 -0.813 . . . . 0.0 109.741 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 11.7 pt-20 -111.24 26.79 10.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.638 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.702 ' HB3' HD13 ' A' ' 44' ' ' LEU . 47.9 p-10 -100.66 14.45 31.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 74' ' ' ASP . 21.9 tttm -38.32 -35.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 110.166 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.15 -37.63 47.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.565 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 41.8 ttt85 -121.82 17.74 11.04 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.462 -0.774 . . . . 0.0 109.744 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.8 tp60 62.61 -77.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 110.612 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . 53.62 -116.14 5.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 66.74 -84.15 0.11 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' C ' HD12 ' A' ' 82' ' ' LEU . 13.5 p-10 -132.69 136.5 46.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -1.117 . . . . 0.0 110.389 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.79 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.0 mp -102.09 147.44 26.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.77 -125.14 0.19 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.776 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 94.2 m95 -93.79 131.61 38.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.549 -0.971 . . . . 0.0 111.001 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.705 ' O ' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -127.6 122.24 32.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.104 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.0 p -72.14 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 111.04 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -87.19 -37.9 16.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' GLN . . . 57.66 77.82 0.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . 90.1 p -123.91 103.24 8.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -1.135 . . . . 0.0 109.718 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -141.65 -86.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.37 -41.39 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 111.25 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . 132.03 -77.41 0.39 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.301 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -24.17 44.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.759 1.4 . . . . 0.0 112.03 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -62.68 -47.82 81.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.759 -1.213 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 26.4 pt20 -78.2 -38.12 43.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.531 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.89 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 89.6 mt-10 -55.35 -32.17 62.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.89 -40.24 16.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.036 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.37 7.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.841 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -70.56 -32.38 69.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.0 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -50.04 -35.36 24.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 127' ' ' VAL . 7.0 tt -61.17 144.09 91.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.702 ' O ' HD23 ' A' ' 101' ' ' LEU . 38.9 Cg_endo -65.25 159.57 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.707 1.372 . . . . 0.0 110.059 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 104' ' ' SER . 3.1 p -74.19 -44.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 111.568 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 77.6 p -130.09 4.5 4.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 104' ' ' SER . . . 48.27 -170.93 0.06 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 82.3 mmm -67.02 -31.91 72.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 107' ' ' ASP . 46.2 t0 -144.23 -86.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . 24.1 mtmm -82.99 166.67 34.2 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 110.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 108' ' ' LYS . 41.9 Cg_endo -69.89 171.96 13.64 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.84 1.442 . . . . 0.0 109.657 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 111' ' ' PHE . 95.7 t -139.96 172.7 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.076 -1.015 . . . . 0.0 110.934 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 110' ' ' VAL . 52.8 p90 -120.19 163.87 17.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 6.4 m -48.87 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.485 -0.759 . . . . 0.0 110.533 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.5 p-10 -127.05 120.36 22.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.097 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 45.3 Cg_endo -72.91 165.77 83.09 Favored 'Cis proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.623 -2.24 . . . . 0.0 109.736 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.8 Cg_endo -71.09 178.55 5.27 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.784 1.413 . . . . 0.0 109.765 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 26.8 m -101.43 161.99 3.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -124.54 118.55 26.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 109.208 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -136.6 171.78 13.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.734 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -65.37 -9.07 21.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.549 -0.72 . . . . 0.0 110.277 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -89.54 -20.18 24.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 109.043 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.17 -160.97 25.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 16.3 m-30 -100.72 134.54 43.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -1.077 . . . . 0.0 109.247 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.532 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 61.6 m-70 -125.39 121.75 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.011 -1.055 . . . . 0.0 112.556 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.645 HG22 ' HB ' ' A' ' 43' ' ' ILE . 4.8 tt -115.71 114.62 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.817 ' CG2' HG13 ' A' ' 40' ' ' VAL . 7.1 mt -107.13 125.56 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.942 -1.099 . . . . 0.0 113.543 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 9.8 tpt -100.09 114.12 27.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 101' ' ' LEU . 5.7 p -107.43 156.83 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.677 -1.265 . . . . 0.0 112.071 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -103.85 -29.29 11.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.493 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.79 -175.42 23.04 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.896 ' HB2' HG12 ' A' ' 38' ' ' VAL . 17.8 ttp180 -132.41 -85.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 50.6 tttm . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.538 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.172 0.511 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.968 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -127.24 -172.89 2.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.672 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.1 m -135.92 145.67 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 110.337 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -98.73 137.15 37.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.822 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.768 HG23 ' HB3' ' A' ' 82' ' ' LEU . 3.6 m -138.43 157.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.3 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HB2' ' HE2' ' A' ' 126' ' ' MET . 7.7 mmt85 -123.1 115.8 22.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -125.52 157.61 36.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.715 -1.24 . . . . 0.0 112.633 -177.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 16.3 pt -130.57 125.49 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.5 tt -106.42 123.84 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.16 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 1.4 t -143.26 -171.47 3.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.906 -1.121 . . . . 0.0 111.8 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.714 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 4.4 mt-10 -77.41 117.15 18.61 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.595 -0.69 . . . . 0.0 111.403 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HG3' HD11 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -82.58 77.28 9.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.711 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.714 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 30.0 m-70 -134.61 71.05 1.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.983 -1.073 . . . . 0.0 110.155 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.18 78.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.184 -1.567 . . . . 0.0 109.184 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 59.6 tttt -108.7 -11.55 15.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -1.044 . . . . 0.0 110.385 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.622 HD13 ' HE2' ' A' ' 117' ' ' LYS . 34.2 mt -47.58 -53.11 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 73.1 mtm -59.21 -37.34 77.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.446 -0.784 . . . . 0.0 110.598 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 75.0 mm-40 -61.41 -39.8 92.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.928 . . . . 0.0 110.568 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -66.38 -60.7 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.458 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.471 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 22.6 ptm -58.93 -44.44 91.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.026 . . . . 0.0 110.336 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 55' ' ' MET . 32.4 mm-40 -59.1 -42.98 91.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' MET . 66.2 tttt -72.07 -38.0 69.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 111.0 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.8 ' CB ' HG21 ' A' ' 67' ' ' VAL . 2.3 pp -93.98 10.81 31.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.956 -1.09 . . . . 0.0 110.807 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.9 ptmt -42.55 161.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.145 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -52.09 115.99 1.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.004 . . . . 0.0 110.087 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.11 -44.05 1.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 7.5 tpt -77.3 162.72 27.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -1.098 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -80.36 100.25 8.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CD1' ' SD ' ' A' ' 126' ' ' MET . 76.9 t80 -50.64 -32.54 19.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.966 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 54.8 t30 -55.38 -43.64 75.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.558 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.22 -44.1 84.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.696 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.8 HG21 ' CB ' ' A' ' 58' ' ' LEU . 59.3 t -55.81 -57.54 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -46.13 -58.02 3.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.54 -38.7 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.375 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -78.77 -32.36 46.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.212 -0.93 . . . . 0.0 110.584 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.78 23.15 13.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -1.0 . . . . 0.0 110.616 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 m -83.86 100.27 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.385 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' OE1' ' HG3' ' A' ' 46' ' ' GLU . 28.7 tt0 -100.66 4.62 43.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.506 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLN . 85.3 m-20 -102.07 72.1 1.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.459 -0.776 . . . . 0.0 109.357 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -50.55 -35.49 30.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.467 -0.77 . . . . 0.0 110.87 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.41 -54.41 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -73.3 -15.7 61.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.102 -0.999 . . . . 0.0 110.589 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' CG ' ' O ' ' A' ' 78' ' ' GLN . 1.6 pt20 33.92 99.94 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.249 1.023 . . . . 0.0 111.431 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -70.38 -90.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . 46.73 -91.63 0.01 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 79' ' ' GLY . 19.9 p-10 -106.13 132.45 52.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.589 -0.948 . . . . 0.0 110.075 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 40' ' ' VAL . 50.4 tp -116.88 135.08 54.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -56.48 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.8 m-90 -88.56 138.69 31.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.972 . . . . 0.0 110.466 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.5 mmm -101.41 119.45 38.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 108.999 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.968 HG22 ' CB ' ' A' ' 37' ' ' ALA . 3.6 p -119.36 -29.42 5.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 7.2 ptp180 -63.61 -33.67 76.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.429 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.508 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . 52.85 20.7 8.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -130.36 78.71 1.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -1.166 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 92' ' ' GLY . 7.9 ttt -136.9 153.23 50.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.618 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.884 HG12 ' HD2' ' A' ' 93' ' ' PRO . 57.0 t 34.51 -91.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.368 0.604 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.621 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 178.44 -74.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.884 ' HD2' HG12 ' A' ' 91' ' ' VAL . 43.9 Cg_endo -70.14 -11.8 31.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.137 1.598 . . . . 0.0 110.391 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -73.94 -66.63 0.69 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' HA2' ' A' ' 88' ' ' GLY . 13.3 mm-40 -65.4 -40.2 93.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 110.944 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.864 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 9.8 pt-20 -55.07 -38.5 68.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.749 -1.219 . . . . 0.0 109.848 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -68.12 -55.13 13.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.989 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.34 -49.57 12.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 7.3 m-30 -88.58 0.78 56.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.33 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -83.23 -25.76 31.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.151 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 101' ' ' LEU . 9.5 mp -106.03 65.77 0.17 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 111.267 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 100' ' ' ALA . 50.0 Cg_endo -72.17 -21.33 23.76 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.729 1.384 . . . . 0.0 110.616 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.66 -13.39 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.9 m -101.22 116.54 33.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.108 -0.995 . . . . 0.0 109.111 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.31 -135.44 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.607 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 106' ' ' MET . 3.2 ttt -85.06 13.4 6.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -1.023 . . . . 0.0 110.959 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -102.68 -40.43 6.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.825 -1.172 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -133.81 98.17 14.9 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.06 126.44 10.56 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.918 1.483 . . . . 0.0 109.835 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.71 -178.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.668 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 54.3 p90 -123.65 172.56 8.71 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.611 ' CG2' HG12 ' A' ' 125' ' ' ILE . 3.1 p -58.26 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.607 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 10.5 p-10 -120.24 113.87 33.7 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.956 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.8 Cg_endo -73.4 164.53 86.89 Favored 'Cis proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.971 -2.095 . . . . 0.0 110.563 0.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 1.029 ' HB3' HG22 ' A' ' 124' ' ' ILE . 44.4 Cg_endo -73.02 -175.83 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.019 1.536 . . . . 0.0 110.385 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 123' ' ' HIS . 16.5 m -105.63 146.55 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.622 ' HE2' HD13 ' A' ' 51' ' ' ILE . 64.7 mttt -112.61 130.53 56.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 73.8 p -142.31 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.889 -1.132 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.24 -29.73 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 109.997 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 3.5 p90 -88.6 43.26 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.533 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.6 -157.75 27.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p90 -130.61 160.18 34.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -1.037 . . . . 0.0 108.476 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 1.4 m-70 -140.32 133.24 29.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.666 -1.271 . . . . 0.0 112.135 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.029 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -112.66 136.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -126.52 133.71 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.598 -1.314 . . . . 0.0 112.278 -176.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.675 ' HE2' ' HB2' ' A' ' 41' ' ' ARG . 31.2 mtm -94.42 99.01 11.28 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.78 110.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.429 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -139.4 151.09 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.17 60.26 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.18 169.23 14.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.58 -0.953 . . . . 0.0 110.392 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.328 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.4 t30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.748 0.785 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -136.36 164.2 28.67 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.645 -1.285 . . . . 0.0 110.648 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 85' ' ' MET . 17.9 m -139.48 146.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 33.0 tttm -100.57 130.34 46.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.918 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -130.78 149.68 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.863 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 45.6 mtt180 -140.17 126.32 19.81 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.026 ' CB ' HG22 ' A' ' 125' ' ' ILE . 2.3 p80 -144.9 -178.65 6.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.612 -1.305 . . . . 0.0 112.206 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 71' ' ' TYR . 9.2 pt -138.37 138.47 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -103.47 126.81 50.84 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.273 0.558 . . . . 0.0 110.386 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.8 p -134.38 171.09 14.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.063 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' NE2' ' A' ' 48' ' ' HIS . 73.3 mm-40 -61.69 171.17 1.65 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.261 -0.899 . . . . 0.0 110.623 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 6.0 tttt -116.56 80.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.988 . . . . 0.0 110.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.569 ' NE2' ' HB3' ' A' ' 46' ' ' GLU . 18.4 m-70 -134.78 63.21 1.63 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.936 -1.103 . . . . 0.0 111.966 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.97 9.95 12.53 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.241 -0.912 . . . . 0.0 111.114 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 37.4 ttmt -89.2 13.29 13.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.973 -1.31 . . . . 0.0 110.482 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.635 HG13 ' CE2' ' A' ' 122' ' ' TYR . 82.0 mt -64.29 -42.58 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.569 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.45 ' HE2' ' SD ' ' A' ' 55' ' ' MET . 38.6 mmt -69.26 -44.4 71.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.895 . . . . 0.0 111.273 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -70.65 -38.92 73.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.08 . . . . 0.0 110.746 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.5 -52.73 56.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.45 ' SD ' ' HE2' ' A' ' 52' ' ' MET . 5.7 ptt? -65.39 -34.39 78.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.887 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 16.0 tp10 -58.03 -46.41 85.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' CG ' HG22 ' A' ' 67' ' ' VAL . 22.2 tttt -67.57 -32.86 73.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 109.181 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.871 HD21 ' CE2' ' A' ' 111' ' ' PHE . 2.0 tp -74.41 -13.02 60.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 109.253 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 39.9 tptt -40.4 144.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.746 . . . . 0.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -50.4 149.43 3.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.235 -0.916 . . . . 0.0 108.953 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.88 -44.25 1.6 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.6 mmt -78.36 165.77 23.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.509 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -71.69 99.16 2.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.108 -0.995 . . . . 0.0 110.811 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 60.9 t80 -48.47 -29.54 4.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 109.304 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -77.79 -40.23 41.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 11.2 tp10 -56.54 -46.21 80.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.866 . . . . 0.0 109.67 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 58' ' ' LEU . 69.5 t -67.07 -44.06 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 109.558 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -54.89 -50.89 67.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.92 57.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -63.1 -29.08 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.807 ' HB2' HD12 ' A' ' 43' ' ' ILE . 21.9 m-85 -108.99 18.77 20.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.46 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.3 t -91.25 96.06 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -99.77 0.03 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.233 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 75' ' ' LYS . 41.2 t0 -105.97 15.26 26.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.464 -0.772 . . . . 0.0 109.953 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 14.4 pttm -41.81 -35.15 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -86.02 134.75 33.83 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 81.14 -18.39 0.5 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.683 -0.636 . . . . 0.0 109.962 -178.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.3 tt0 70.38 177.33 0.27 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 110.982 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 82' ' ' LEU . . . 154.8 -20.81 0.59 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 42' ' ' HIS . . . -48.29 -44.99 28.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.61 ' C ' HD12 ' A' ' 82' ' ' LEU . 34.6 p-10 -115.01 126.43 54.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -1.016 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.0 mp -101.35 7.8 42.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 60.26 -147.66 44.63 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 35.3 m95 -96.73 132.29 42.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.743 -0.857 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 38' ' ' VAL . 9.0 ptp -135.87 149.77 49.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.58 -0.7 . . . . 0.0 109.206 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 36' ' ' ASN . 26.4 p -111.47 -64.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.375 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' ' OG1' ' A' ' 86' ' ' THR . 7.3 mtp180 -71.69 -38.23 70.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 109.758 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 95' ' ' GLN . . . 60.03 55.38 30.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.8 m -103.67 106.23 16.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.251 . . . . 0.0 109.522 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.0 mmt -130.16 -83.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 111.107 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 93' ' ' PRO . 4.0 p -96.46 -28.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.235 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.46 -73.12 0.47 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.025 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 91' ' ' VAL . 44.0 Cg_endo -69.84 -41.67 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.849 1.447 . . . . 0.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -53.91 -38.41 64.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.071 -1.018 . . . . 0.0 109.393 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 88' ' ' GLY . 44.9 tt0 -67.33 -52.35 41.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.776 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 38.3 tt0 -54.45 -44.45 72.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -59.67 -56.12 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.07 -54.9 6.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.346 -0.846 . . . . 0.0 110.264 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 102' ' ' PRO . 61.1 m-85 -85.08 11.29 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 0.0 110.478 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -102.15 -19.9 14.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.736 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.69 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -109.05 21.94 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.91 . . . . 0.0 112.638 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 101' ' ' LEU . 52.1 Cg_endo -78.05 -8.51 16.57 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 m -107.04 25.4 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.49 -0.757 . . . . 0.0 110.081 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB2' HD23 ' A' ' 101' ' ' LEU . 18.6 m -101.26 -1.49 33.52 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.746 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.27 137.66 10.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 ttp -55.39 -44.87 76.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -1.221 . . . . 0.0 110.393 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -103.9 -62.93 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.49 162.63 49.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 110.158 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 47.8 Cg_endo -74.27 142.15 29.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.144 1.602 . . . . 0.0 110.083 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 111' ' ' PHE . 2.7 m -106.87 -99.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD21 ' A' ' 58' ' ' LEU . 40.6 t80 -116.58 152.19 34.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.896 -1.127 . . . . 0.0 110.806 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.643 HG21 ' CG1' ' A' ' 125' ' ' ILE . 7.3 p -74.84 110.43 9.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 110.936 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 88.3 m-20 -133.81 121.69 16.12 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.8 Cg_endo -79.32 172.7 58.49 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.164 -2.015 . . . . 0.0 110.362 -0.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HG3' HD12 ' A' ' 124' ' ' ILE . 47.2 Cg_endo -73.15 178.12 6.95 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.956 1.503 . . . . 0.0 109.725 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 123' ' ' HIS . 16.2 m -99.91 155.11 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.008 -1.058 . . . . 0.0 109.378 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -125.26 130.43 52.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.58 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.593 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.2 p -134.04 178.23 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -72.89 -15.83 61.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -0.955 . . . . 0.0 110.617 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 1.8 p90 -95.84 24.62 5.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.174 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 109.97 -176.41 19.19 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.4 m-85 -100.02 154.04 18.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 53.4 m-70 -129.91 122.52 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.872 -1.143 . . . . 0.0 110.487 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.829 HD12 ' HG3' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -117.92 108.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.026 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -109.01 157.47 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.69 -1.256 . . . . 0.0 112.959 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.476 ' HA ' ' CD1' ' A' ' 111' ' ' PHE . 3.7 ttt -116.26 119.29 35.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' PRO . 21.3 t -107.95 115.52 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.814 -1.179 . . . . 0.0 111.947 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -106.0 -18.28 14.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 70.7 -163.64 53.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG3' ' CZ3' ' A' ' 84' ' ' TRP . 66.1 ttt180 -132.77 -35.69 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.943 . . . . 0.0 110.003 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.288 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' THR . 38.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.26 0.553 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CA ' ' OG1' ' A' ' 86' ' ' THR . . . -113.14 168.73 9.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.0 110.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 14.3 m -130.3 169.5 21.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.558 -0.714 . . . . 0.0 109.882 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CG ' ' CE2' ' A' ' 84' ' ' TRP . 19.0 mtpt -98.53 119.61 37.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.095 -1.003 . . . . 0.0 109.193 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.719 HG21 ' CE ' ' A' ' 85' ' ' MET . 95.9 t -111.72 126.39 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.023 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NH1' ' OE1' ' A' ' 128' ' ' GLU . 71.0 mtm180 -119.77 125.67 49.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB3' HG23 ' A' ' 125' ' ' ILE . 2.1 p80 -143.92 178.81 7.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.392 -1.442 . . . . 0.0 112.416 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 88.6 mt -121.61 135.48 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -111.75 119.42 38.57 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.681 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 43' ' ' ILE . 15.4 m -130.22 168.31 17.05 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 67.6 mt-10 -88.5 -172.6 3.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 110.283 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 35.9 mtmt -102.83 101.66 11.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.962 -1.086 . . . . 0.0 111.442 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.414 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 29.1 m-70 -134.57 6.56 3.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.888 . . . . 0.0 111.459 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.6 44.05 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.427 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 27.9 mttt -96.88 6.79 47.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.26 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' A' ' 122' ' ' TYR . 69.5 mt -46.14 -57.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' MET . 51.1 mtt -65.08 -40.24 94.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.482 -0.761 . . . . 0.0 109.842 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 tp10 -67.37 -22.01 65.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.192 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -75.56 -60.51 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.167 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.546 ' HB2' ' HG2' ' A' ' 114' ' ' PRO . 11.6 ptt? -56.93 -32.52 66.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -71.09 -42.55 69.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 39.3 mmtm -64.37 -50.64 66.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.807 ' HB3' HG21 ' A' ' 67' ' ' VAL . 2.5 pp -78.17 -14.88 59.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 109.522 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 60' ' ' SER . 4.5 ptmm? 23.41 -134.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 41.3 t -52.0 -22.1 3.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.938 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 126.77 2.46 6.71 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 58.3 ttm -56.86 -39.27 74.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -1.179 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 mtt180 -108.86 13.26 24.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.0 110.132 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 77.3 t80 -51.1 -48.87 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 49.5 m-80 -57.76 -43.38 85.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.35 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' CD ' ' HG2' ' A' ' 63' ' ' ARG . 41.4 mt-10 -68.09 -38.24 82.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.807 HG21 ' HB3' ' A' ' 58' ' ' LEU . 97.4 t -62.74 -71.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.416 -0.803 . . . . 0.0 109.134 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -48.65 -50.8 31.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -42.92 -42.24 3.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.822 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 70' ' ' GLN . 4.7 tp-100 -106.02 -6.61 18.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.378 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-85 -103.42 11.74 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.6 p -83.27 100.5 10.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 110.383 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -106.03 20.12 19.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.953 . . . . 0.0 110.067 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 30.2 t0 -137.85 39.84 2.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -59.84 -24.29 64.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.857 . . . . 0.0 110.189 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.93 81.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -103.26 -57.6 2.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.138 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ASP . 1.2 pt20 -135.19 164.83 26.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.84 23.21 31.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 97.76 1.32 58.77 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' C ' HD12 ' A' ' 82' ' ' LEU . 76.1 m-20 -134.15 132.01 39.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.799 -1.412 . . . . 0.0 110.929 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.3 mp -109.58 151.87 26.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.795 . . . . 0.0 109.368 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -77.56 -132.5 0.6 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.619 ' CE2' ' CG ' ' A' ' 39' ' ' LYS . 86.0 m95 -95.08 122.71 38.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.928 -0.748 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.719 ' CE ' HG21 ' A' ' 40' ' ' VAL . 6.6 ptt? -141.54 137.47 32.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 36' ' ' ASN . 89.1 m -103.38 -45.13 4.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.762 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -73.27 -32.22 64.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.0 -145.66 16.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -120.96 -62.16 1.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.147 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 85.9 mmm -137.44 -86.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.394 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 92' ' ' GLY . 9.9 p -174.61 176.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG22 ' A' ' 91' ' ' VAL . . . 93.93 -151.14 20.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HG13 ' A' ' 116' ' ' VAL . 43.0 Cg_endo -69.3 -8.34 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.245 1.656 . . . . 0.0 110.093 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.53 ' CE1' HD13 ' A' ' 125' ' ' ILE . 1.1 t80 -76.71 -48.52 18.58 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.514 -0.741 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -78.87 -47.6 16.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.129 -0.982 . . . . 0.0 110.835 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.97 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -62.43 -20.65 64.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 112' ' ' THR . . . -93.16 -55.02 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.786 -1.196 . . . . 0.0 110.545 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.31 -54.51 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.967 . . . . 0.0 111.388 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 38.8 m-85 -89.81 -21.85 22.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.158 -0.964 . . . . 0.0 111.609 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.97 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -119.05 32.43 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.823 -1.173 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.525 HD11 ' C ' ' A' ' 112' ' ' THR . 14.4 tp -56.1 140.71 70.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD2' ' HG ' ' A' ' 101' ' ' LEU . 43.8 Cg_endo -70.45 150.72 64.41 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.946 1.498 . . . . 0.0 110.036 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 103' ' ' VAL . 7.1 p -68.78 90.98 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 110.522 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 p -100.33 -10.57 21.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.061 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.69 145.08 18.65 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.33 -28.97 69.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 111.298 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 31.9 p-10 -140.3 -46.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.886 -1.134 . . . . 0.0 110.951 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 4.0 mttp -128.04 126.49 23.75 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.571 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.52 162.16 36.2 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.938 1.494 . . . . 0.0 110.491 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 111' ' ' PHE . 48.9 t -121.33 -74.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.241 -0.912 . . . . 0.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.559 ' CB ' ' HB3' ' A' ' 114' ' ' PRO . 92.8 m-85 -98.37 167.29 10.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 113' ' ' ASP . 96.8 m -62.15 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 112.558 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.815 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 54.2 t0 -70.33 -34.08 3.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.815 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 52.9 Cg_endo -76.16 -25.76 10.25 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.466 -1.056 . . . . 0.0 114.729 1.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 42.0 Cg_endo -71.14 115.56 4.32 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 122.341 0.653 . . . . 0.0 112.895 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 93' ' ' PRO . 32.3 t -111.39 153.08 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 14.6 ptmm? -143.06 117.93 9.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.795 -1.191 . . . . 0.0 110.697 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.827 HG21 ' CD2' ' A' ' 120' ' ' PHE . 1.3 t -145.37 179.65 7.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -64.12 -11.97 35.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.827 ' CD2' HG21 ' A' ' 118' ' ' THR . 0.0 OUTLIER -87.78 -17.99 30.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 108.673 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 129.08 -149.84 18.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.95 142.85 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -1.092 . . . . 0.0 108.446 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.642 ' CE1' ' CG2' ' A' ' 118' ' ' THR . 43.7 m80 -132.32 144.09 50.32 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.229 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.591 HD11 ' HB1' ' A' ' 54' ' ' ALA . 7.6 mt -132.72 109.96 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.052 HG23 ' HB3' ' A' ' 42' ' ' HIS . 1.2 mt -115.32 129.66 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.735 -1.228 . . . . 0.0 112.271 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.523 ' HG2' ' CD1' ' A' ' 111' ' ' PHE . 88.1 mtp -99.55 135.19 41.33 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.8 125.4 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.949 -1.095 . . . . 0.0 111.141 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.52 ' OE1' ' NH1' ' A' ' 41' ' ' ARG . 79.7 tt0 -142.21 147.75 37.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.08 76.47 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 38' ' ' VAL . 76.2 ttt180 -122.34 131.89 54.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -1.119 . . . . 0.0 110.179 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.751 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.164 0.507 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -128.92 172.03 11.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 110.7 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.6 p -141.45 156.94 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.357 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -100.13 119.72 38.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.66 HG21 HD21 ' A' ' 82' ' ' LEU . 4.5 m -127.31 157.36 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.7 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 37.9 mtt-85 -139.8 118.84 12.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.011 ' HB3' HG23 ' A' ' 125' ' ' ILE . 9.8 p-80 -132.03 161.96 31.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.838 -1.164 . . . . 0.0 112.262 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 3.4 mt -115.81 128.15 73.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.652 HD13 ' OD2' ' A' ' 74' ' ' ASP . 5.1 tt -110.36 129.37 55.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.226 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' N ' HD23 ' A' ' 44' ' ' LEU . 45.1 t -132.33 152.5 51.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 33.8 mt-10 -64.76 -171.64 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.716 -1.24 . . . . 0.0 109.463 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.666 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 48.0 tttt -97.94 106.66 18.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.587 -1.32 . . . . 0.0 113.312 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 2.8 m-70 -131.63 -5.9 3.67 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.161 -0.962 . . . . 0.0 110.032 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.6 30.29 10.84 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' GLU . 82.3 mttt -109.63 -2.75 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 111.111 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.569 ' HB ' ' CG ' ' A' ' 122' ' ' TYR . 11.3 tt -45.64 -40.94 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 51' ' ' ILE . 16.6 ttt -65.66 -34.4 78.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.334 -0.854 . . . . 0.0 109.001 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' LYS . 79.5 tt0 -72.24 -41.75 66.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 108.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.94 -57.03 13.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.716 . . . . 0.0 110.12 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.698 ' HA ' HD23 ' A' ' 58' ' ' LEU . 28.3 ptm -68.83 -28.13 66.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.862 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.3 tt0 -74.57 -26.25 59.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB3' HG12 ' A' ' 67' ' ' VAL . 17.2 mmtm -81.41 -36.84 29.03 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.538 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.812 ' N ' HG11 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -83.96 -19.04 35.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.453 -0.78 . . . . 0.0 109.259 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 56' ' ' GLU . 60.8 mmtt 44.57 -138.75 0.38 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.48 -0.762 . . . . 0.0 110.052 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.8 t -54.86 -25.91 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 110.912 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 139.7 -11.47 3.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.4 mtp -48.21 -35.39 11.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 67' ' ' VAL . 9.7 mtt180 -112.91 26.64 10.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.154 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 79.6 t80 -55.49 -37.51 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -75.37 -39.56 59.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.339 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 61.1 mm-40 -62.43 -58.15 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.794 . . . . 0.0 109.534 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.812 HG11 ' N ' ' A' ' 58' ' ' LEU . 16.6 m -50.92 -44.7 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.242 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -62.72 -37.26 85.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.602 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -55.66 -36.9 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.176 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -105.74 -10.83 16.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 110.794 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 67' ' ' VAL . 24.8 m-85 -114.23 18.94 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.247 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 36.6 t -111.77 113.24 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.831 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.94 -5.3 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.655 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.652 ' OD2' HD13 ' A' ' 44' ' ' LEU . 96.2 m-20 -104.43 59.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.452 -0.78 . . . . 0.0 109.607 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -55.43 -28.88 57.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.343 -0.848 . . . . 0.0 111.773 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.15 -36.12 6.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.729 -1.232 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -65.12 -55.54 18.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.12 . . . . 0.0 110.307 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HG3' ' C ' ' A' ' 77' ' ' ARG . 19.7 mt-30 -143.45 -72.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 110.696 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.84 -107.83 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -99.35 -37.97 3.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 39.2 p30 -128.5 134.65 48.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.076 -1.249 . . . . 0.0 110.959 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 85' ' ' MET . 2.1 pp -103.3 1.33 32.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.5 -134.81 11.84 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.6 m-90 -99.23 155.41 17.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.552 -0.97 . . . . 0.0 110.915 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -126.87 133.63 50.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.442 -0.786 . . . . 0.0 109.471 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.6 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.5 p -128.77 -37.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.035 -1.04 . . . . 0.0 111.011 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 3.1 mtm105 -116.63 -14.96 10.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.907 -1.121 . . . . 0.0 111.507 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . 126.92 -176.66 17.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 9.5 t -141.8 -32.09 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.45 -1.029 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 3.7 mmt -104.33 -145.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.913 -1.117 . . . . 0.0 110.956 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.709 HG23 ' HD2' ' A' ' 93' ' ' PRO . 13.3 m -86.53 -29.41 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.073 -1.017 . . . . 0.0 112.467 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 177.04 -54.44 0.1 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 118.451 -1.833 . . . . 0.0 111.877 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.709 ' HD2' HG23 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -62.23 -27.04 77.97 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.352 1.185 . . . . 0.0 111.856 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 90' ' ' MET . 78.1 t80 -70.79 -52.39 20.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.749 -1.219 . . . . 0.0 109.948 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 2.6 tt0 -73.25 -29.42 62.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 109.548 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.959 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 83.0 mt-10 -70.42 -25.86 63.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 109.832 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -87.09 -53.88 4.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.67 -50.62 60.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -76.05 -14.69 60.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.253 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -67.7 -58.01 5.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.694 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 101' ' ' LEU . 11.2 mp -41.07 120.5 1.84 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.36 164.97 30.09 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.802 1.422 . . . . 0.0 110.606 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.555 HG21 ' HD3' ' A' ' 130' ' ' ARG . 52.9 t -133.06 107.92 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.873 . . . . 0.0 109.849 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.7 p -102.13 3.82 38.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -159.15 178.09 35.44 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.9 ttt -73.98 -31.53 63.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.309 -1.112 . . . . 0.0 110.243 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -122.14 23.47 9.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 110.186 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.655 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 28.4 mmtt -71.04 -40.07 9.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 110.8 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 45.7 Cg_endo -73.7 155.98 49.09 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.167 1.088 . . . . 0.0 110.135 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.755 HG22 ' N ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -144.86 -85.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.119 -0.988 . . . . 0.0 111.76 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.755 ' N ' HG22 ' A' ' 110' ' ' VAL . 9.3 t80 -133.95 156.11 48.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 111.109 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 114' ' ' PRO . 23.2 p -70.63 63.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.407 -0.808 . . . . 0.0 109.712 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 24.7 p-10 -97.88 130.73 28.17 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.5 Cg_endo -74.9 168.8 76.28 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.773 -2.178 . . . . 0.0 110.033 -0.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.985 ' HB3' HG22 ' A' ' 124' ' ' ILE . 41.6 Cg_endo -70.75 171.51 15.4 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.049 1.552 . . . . 0.0 110.407 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.33 150.32 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.494 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HG2' ' CD1' ' A' ' 51' ' ' ILE . 50.4 mtmt -113.33 133.32 55.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 75.5 p -139.28 -178.7 5.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.804 -1.185 . . . . 0.0 111.485 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -81.43 -18.03 46.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.449 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.3 OUTLIER -91.23 -0.77 57.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.062 -1.024 . . . . 0.0 109.455 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 132.46 -176.38 19.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 94.8 m-85 -100.95 153.77 19.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.489 -1.007 . . . . 0.0 109.426 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.597 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 5.0 m-70 -141.6 141.35 33.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 112.286 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.985 HG22 ' HB3' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -124.55 114.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 176.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -103.38 157.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.225 1.012 . . . . 0.0 112.175 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 19.5 ttt -136.94 134.07 36.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.71 136.55 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.74 -1.225 . . . . 0.0 111.353 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.02 109.19 7.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 109.669 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.66 115.24 0.26 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.555 ' HD3' HG21 ' A' ' 103' ' ' VAL . 5.2 ttp180 -130.07 150.5 51.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 pttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.269 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' THR . 26.4 p30 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.434 0.635 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 131' ' ' LYS . . . -90.31 129.19 36.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 110.309 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 129' ' ' GLY . 13.9 p -141.63 164.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HD3' ' CZ2' ' A' ' 84' ' ' TRP . 12.1 mtmm -98.76 121.31 40.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.221 -0.925 . . . . 0.0 108.773 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.968 ' HB ' HD11 ' A' ' 82' ' ' LEU . 91.2 t -130.15 143.84 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.934 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 31.1 mtt85 -140.4 107.17 5.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 3.8 p80 -132.45 179.33 6.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.615 -1.303 . . . . 0.0 112.149 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 6.7 mt -127.81 133.66 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -117.33 121.44 41.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.988 . . . . 0.0 111.149 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 54.0 t -142.07 137.25 30.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.143 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 71.5 mm-40 -58.28 162.03 3.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 2.9 tttm -72.68 113.28 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.033 -1.042 . . . . 0.0 112.674 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.612 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 7.2 m-70 -132.06 14.41 4.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.28 76.23 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 12.4 mtpt -93.92 -5.66 47.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.984 . . . . 0.0 110.475 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.609 HG13 ' CD2' ' A' ' 122' ' ' TYR . 2.8 mp -40.13 -58.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.225 -0.922 . . . . 0.0 110.426 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 6.0 ttt -69.12 -45.29 70.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.99 -46.94 78.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -59.84 -62.63 1.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.551 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.746 ' SD ' HD12 ' A' ' 124' ' ' ILE . 0.4 OUTLIER -61.19 -39.86 91.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.12 -179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 4.5 tp10 -52.82 -54.98 26.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.794 -1.191 . . . . 0.0 109.54 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -57.55 -38.2 74.36 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.506 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.92 -68.83 0.14 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 25.9 mmtt 39.17 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.588 -0.695 . . . . 0.0 110.281 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -110.08 133.64 53.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.05 -1.031 . . . . 0.0 110.725 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.86 -12.22 59.19 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.406 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 tpt -81.49 161.22 23.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.32 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -82.79 99.34 9.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.344 -0.848 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -49.17 -29.37 5.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 110.379 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -63.37 -35.12 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -77.19 -41.02 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 58' ' ' LEU . 23.3 t -68.69 -38.11 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.955 -1.091 . . . . 0.0 110.195 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -68.68 -41.92 78.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.95 -1.094 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.11 81.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.862 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 70' ' ' GLN . 4.8 tp-100 -70.25 -34.81 73.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 110.757 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' HB2' HG21 ' A' ' 43' ' ' ILE . 54.1 m-85 -104.42 21.81 16.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.023 -1.048 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -86.01 90.91 8.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.1 tp10 -100.33 -2.42 33.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.336 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 32.0 p-10 -136.25 12.33 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' H ' ' A' ' 79' ' ' GLY . 81.4 tttt -56.46 -34.17 66.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.416 -0.802 . . . . 0.0 110.386 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.5 94.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 5.9 ptp180 -98.81 -12.9 20.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.044 -1.035 . . . . 0.0 110.967 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -129.05 -38.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.911 -1.118 . . . . 0.0 110.241 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' H ' ' HA ' ' A' ' 75' ' ' LYS . . . 93.23 -12.66 69.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 90.83 -43.79 2.86 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.8 p-10 -124.56 142.74 51.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -1.207 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 40' ' ' VAL . 2.9 pp -136.59 156.08 49.05 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.02 -119.16 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.802 -1.189 . . . . 0.0 111.047 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.601 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 19.0 m-90 -90.7 121.42 32.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.065 -0.668 . . . . 0.0 110.802 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.561 ' SD ' HD13 ' A' ' 82' ' ' LEU . 23.3 ptm -144.38 155.12 43.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 1.5 p -87.0 134.85 33.45 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.907 ' HE ' HG21 ' A' ' 40' ' ' VAL . 50.8 mtt-85 -98.96 46.11 0.99 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.178 . . . . 0.0 112.48 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.08 36.27 4.38 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 106.586 -2.606 . . . . 0.0 106.586 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -137.08 -7.93 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.874 -0.78 . . . . 0.0 111.792 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.93 -166.15 1.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.719 -1.238 . . . . 0.0 110.391 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.27 178.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.883 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.74 -151.54 19.64 Favored Glycine 0 N--CA 1.483 1.799 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.933 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 47.4 Cg_endo -75.16 -24.17 12.83 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.717 1.904 . . . . 0.0 110.664 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 44.6 t80 -45.71 -65.85 0.48 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 87' ' ' ARG . 4.0 tm0? -79.56 -32.04 42.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 41.0 tt0 -56.15 -39.77 72.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.952 -1.092 . . . . 0.0 110.403 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.64 -39.76 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' CB ' ' NH1' ' A' ' 87' ' ' ARG . . . -44.99 -59.25 2.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 110.774 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -81.69 -41.02 21.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 111.373 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -51.33 -21.22 2.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 101' ' ' LEU . 14.5 tp -45.38 127.4 6.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 110.008 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -27.3 16.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.944 1.497 . . . . 0.0 110.895 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 103' ' ' VAL . 30.4 m -124.11 125.92 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.112 -0.993 . . . . 0.0 110.629 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 130' ' ' ARG . 69.3 m -131.58 66.79 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.63 65.73 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.7 ttm -52.02 -39.6 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.179 -1.189 . . . . 0.0 110.092 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -137.84 -59.09 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.275 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 19.5 tptm -132.53 143.04 47.11 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 108' ' ' LYS . 42.6 Cg_endo -69.94 130.62 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.882 1.464 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -134.44 157.49 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.251 -0.905 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 37.4 p90 -122.85 158.87 29.35 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.094 -1.003 . . . . 0.0 110.147 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 116' ' ' VAL . 14.8 m -50.43 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.362 -0.836 . . . . 0.0 112.197 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 46.4 t0 -132.36 118.64 16.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 41.4 Cg_endo -66.82 176.42 23.35 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.315 -1.952 . . . . 0.0 111.011 1.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD3' ' HE2' ' A' ' 55' ' ' MET . 47.5 Cg_endo -81.89 -178.76 4.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.16 1.611 . . . . 0.0 110.398 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 112' ' ' THR . 25.2 m -104.49 142.9 16.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.839 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -115.33 124.99 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 109.246 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 69.5 p -137.01 -179.38 5.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.621 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 3.9 tttm -68.07 -11.72 59.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.588 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 0.4 OUTLIER -107.56 22.5 15.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.82 -1.175 . . . . 0.0 110.816 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 46' ' ' GLU . . . 104.35 -179.32 24.67 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' HG13 ' A' ' 51' ' ' ILE . 32.7 p90 -101.58 155.28 18.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.942 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.727 ' CE1' HD21 ' A' ' 44' ' ' LEU . 3.0 m-70 -134.25 147.35 50.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 111.881 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.746 HD12 ' SD ' ' A' ' 55' ' ' MET . 3.0 tt -126.83 115.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.9 mp -104.68 141.57 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 112.354 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 1.3 mmm -113.63 102.69 10.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.76 132.5 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.177 -0.952 . . . . 0.0 111.194 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.13 70.84 1.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 128.14 127.32 2.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 104' ' ' SER . 3.6 ptp180 -126.64 148.74 49.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 1.7 tttp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.155 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.88 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -130.61 164.46 24.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 127' ' ' VAL . 7.3 p -143.33 156.01 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 8.2 tttm -101.05 126.5 47.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.256 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.7 HG23 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -131.05 152.91 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.585 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -136.32 123.26 21.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.617 ' HD1' HD11 ' A' ' 82' ' ' LEU . 5.8 p-80 -130.01 157.46 42.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.747 -1.22 . . . . 0.0 112.192 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 124' ' ' ILE . 1.4 pt -112.66 131.94 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.736 ' HG ' ' CD2' ' A' ' 123' ' ' HIS . 1.6 tt -104.77 131.46 52.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.913 -1.117 . . . . 0.0 111.852 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 48.7 t -136.17 156.18 49.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -112.96 -12.68 13.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.044 -1.035 . . . . 0.0 111.774 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 14.9 mmtm -64.72 114.33 4.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -89.71 144.07 26.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.855 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 -15.99 58.9 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' NZ ' ' CE1' ' A' ' 71' ' ' TYR . 27.9 tttm -97.37 -9.76 26.82 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.616 HG12 ' CD2' ' A' ' 122' ' ' TYR . 38.9 mt -46.29 -44.86 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.48 ' O ' ' HG2' ' A' ' 55' ' ' MET . 21.2 ptt? -62.45 -36.52 82.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 110.7 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' A' ' 52' ' ' MET . 59.2 tt0 -72.44 -37.46 68.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.318 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.33 -49.2 72.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' MET . 13.8 ptt? -65.29 -31.89 73.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.008 . . . . 0.0 110.385 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -70.96 -44.02 66.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.042 -1.036 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -58.79 -53.45 58.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.021 HD21 ' CE2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -76.57 -27.53 55.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 108.8 179.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 55' ' ' MET . 33.0 tttt 45.83 -99.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -0.789 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 p -98.41 -12.47 21.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.897 -1.127 . . . . 0.0 110.561 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 64' ' ' PHE . . . 124.47 2.05 8.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.1 mmm -50.28 -49.86 52.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.029 -1.277 . . . . 0.0 109.745 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -103.82 32.64 3.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.349 -0.845 . . . . 0.0 109.491 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.766 ' HD1' HD12 ' A' ' 58' ' ' LEU . 9.8 t80 -52.22 -48.67 65.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.431 -0.793 . . . . 0.0 110.72 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.91 -47.52 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.73 -42.49 77.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 71' ' ' TYR . 45.1 t -65.42 -53.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -59.96 -52.62 64.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 110.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.37 -18.43 61.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 111.353 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.02 -24.61 11.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 110.89 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.711 ' CD2' HG13 ' A' ' 67' ' ' VAL . 45.4 m-85 -100.31 6.47 44.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.075 -1.016 . . . . 0.0 109.517 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 28.7 t -72.16 103.74 3.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.386 -0.822 . . . . 0.0 110.575 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 45' ' ' CYS . 11.0 mt-10 -101.01 5.49 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.953 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 78' ' ' GLN . 17.6 t0 -111.8 24.61 12.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HG2' ' OG ' ' A' ' 72' ' ' SER . 20.3 mmtt -62.83 -36.25 82.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.116 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.06 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.26 -59.96 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.258 -0.902 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.468 ' O ' ' OD2' ' A' ' 74' ' ' ASP . 8.5 pt20 -169.52 105.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.765 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 74' ' ' ASP . . . -129.45 91.36 0.31 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.84 -96.94 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 82' ' ' LEU . 56.1 p30 -114.76 160.61 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 110.951 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.754 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.5 mp -103.99 -11.55 17.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 85.65 -143.48 19.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.5 m-90 -106.96 129.59 54.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.567 -0.96 . . . . 0.0 110.349 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 14.3 ptp -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.049 -1.032 . . . . 0.0 109.924 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.88 HG22 ' HB2' ' A' ' 37' ' ' ALA . 24.4 p -101.63 -67.6 0.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 111.457 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 84.8 mtt85 -80.83 -29.19 35.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.961 . . . . 0.0 111.24 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 95' ' ' GLN . . . 168.31 -170.28 42.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -142.87 -50.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -1.195 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -117.63 -95.59 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 111.578 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 6.1 m -114.91 -175.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.875 -1.141 . . . . 0.0 111.941 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.638 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -63.86 -46.36 91.87 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.613 -0.68 . . . . 0.0 111.922 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.6 Cg_endo -66.35 -40.76 13.77 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.066 1.035 . . . . 0.0 110.755 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 87.8 t80 -75.44 -37.22 60.51 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 45.6 tt0 -76.38 -51.73 11.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.773 . . . . 0.0 110.433 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -57.4 -40.19 77.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.979 . . . . 0.0 110.409 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -63.82 -63.52 1.14 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -37.61 -58.57 0.87 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.296 0.57 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.29 -15.34 63.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 111.118 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 102' ' ' PRO . . . -135.15 40.66 2.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.748 -1.22 . . . . 0.0 111.951 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -105.67 67.52 0.17 Allowed Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.848 -1.158 . . . . 0.0 111.015 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 42.4 Cg_endo -68.14 93.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.616 1.324 . . . . 0.0 110.974 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.566 HG13 ' N ' ' A' ' 104' ' ' SER . 11.2 p -66.24 -40.41 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 109.851 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 103' ' ' VAL . 84.3 p -138.81 -36.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.853 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.95 155.87 15.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.0 ttt -65.11 -37.33 87.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -1.17 . . . . 0.0 110.456 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.463 ' C ' ' CD ' ' A' ' 109' ' ' PRO . 6.8 p-10 -127.31 13.27 7.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.578 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 86.8 mttt -118.19 39.13 0.29 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.0 111.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 51.4 Cg_endo -77.55 149.32 26.99 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.223 1.117 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 126' ' ' MET . 6.4 p -132.18 -21.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.43 -0.794 . . . . 0.0 110.481 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.021 ' CE2' HD21 ' A' ' 58' ' ' LEU . 6.3 t80 -142.91 151.53 41.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.582 ' O ' ' CE1' ' A' ' 111' ' ' PHE . 40.3 m -86.06 111.38 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.672 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -133.23 117.66 14.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.0 Cg_endo -78.19 173.67 55.59 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.014 -2.078 . . . . 0.0 110.066 0.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 51' ' ' ILE . 42.4 Cg_endo -71.32 177.3 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.848 1.446 . . . . 0.0 110.014 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -105.02 150.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.846 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -116.13 121.1 41.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 67.4 p -135.51 176.01 9.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.666 -1.271 . . . . 0.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.29 -14.48 62.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 110.426 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -105.28 33.31 3.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.293 -0.88 . . . . 0.0 108.706 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 89.47 174.22 46.01 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 51' ' ' ILE . 35.3 p90 -100.85 151.72 21.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.16 -1.2 . . . . 0.0 108.681 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.736 ' CD2' ' HG ' ' A' ' 44' ' ' LEU . 1.8 m80 -130.75 160.22 34.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.893 -1.13 . . . . 0.0 112.532 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.875 HD13 HD11 ' A' ' 43' ' ' ILE . 1.8 mp -126.04 124.96 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 1.7 mt -107.04 136.14 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.821 -1.175 . . . . 0.0 112.759 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.567 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 38.1 tpp -122.89 102.75 8.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.63 HG23 HG12 ' A' ' 40' ' ' VAL . 14.7 p -103.09 129.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.022 -1.049 . . . . 0.0 112.189 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -142.48 135.65 28.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.672 -0.642 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.48 121.51 1.55 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -108.79 151.87 25.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 0.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 67.8 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.131 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 36' ' ' ASN . 23.5 t30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.578 0.704 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.02 134.6 44.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 85' ' ' MET . 4.4 p -127.31 153.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.985 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 11.8 tttp -101.64 133.14 46.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.939 . . . . 0.0 109.995 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 82' ' ' LEU . 3.6 t -128.29 139.12 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.09 -1.006 . . . . 0.0 111.342 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 90.2 mtt180 -120.98 121.97 39.14 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -135.5 150.51 49.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.757 -1.214 . . . . 0.0 111.406 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.825 HD13 HG13 ' A' ' 67' ' ' VAL . 32.9 pt -121.19 133.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.637 ' HG ' ' CD2' ' A' ' 123' ' ' HIS . 1.1 tt -104.93 134.58 47.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.916 -1.115 . . . . 0.0 112.087 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 7.6 p -139.49 168.01 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 109.523 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.3 mm-40 -73.44 -159.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.007 . . . . 0.0 110.747 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 4.4 mtmt -122.9 99.52 6.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 110.623 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 8.3 m-70 -132.35 30.9 4.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.857 . . . . 0.0 110.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.07 21.38 75.5 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 48' ' ' HIS . 94.4 mttt -93.14 15.91 14.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.652 HG23 ' HG2' ' A' ' 115' ' ' PRO . 56.4 mt -61.89 -43.95 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.075 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.498 ' O ' ' HG2' ' A' ' 55' ' ' MET . 8.0 ttt -70.59 -40.64 73.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.518 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 52.2 mp0 -70.42 -37.2 74.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.872 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . -59.72 -60.73 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.701 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 15.5 ptt? -52.73 -38.09 60.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 55' ' ' MET . 96.8 mt-10 -73.61 -11.94 60.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 67' ' ' VAL . 29.8 tptt -80.83 -40.0 25.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.761 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.17 -22.28 18.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.601 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 58.6 mttp 49.3 -142.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -52.95 -34.26 54.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.432 -0.792 . . . . 0.0 110.935 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.98 -11.66 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 36.3 ttm -50.64 -34.85 27.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.14 -1.212 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 89.3 mtt180 -112.7 31.12 6.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.974 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 78.3 t80 -51.98 -40.46 60.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 110.083 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -70.69 -33.37 70.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 13.4 tp10 -63.26 -52.4 62.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.825 HG13 HD13 ' A' ' 43' ' ' ILE . 9.4 p -62.28 -36.46 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 109.57 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -65.31 -35.44 81.0 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.243 -0.911 . . . . 0.0 109.111 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.62 68.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.826 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -71.61 -19.65 62.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.606 ' HD2' HG22 ' A' ' 67' ' ' VAL . 29.1 m-85 -116.22 23.92 11.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.44 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' ALA . 55.9 p -78.12 76.22 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.023 -1.048 . . . . 0.0 109.767 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 80.8 mm-40 -105.76 1.47 27.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.25 13.92 9.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HA ' ' CA ' ' A' ' 79' ' ' GLY . 12.5 tmtt? -48.57 -34.72 11.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.534 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.26 96.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -94.7 -61.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 110.233 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -121.36 -61.56 1.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.893 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 75' ' ' LYS . . . 92.25 -104.19 3.14 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -103.04 -73.78 0.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.812 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.8 p-10 -81.19 153.27 27.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.29 -1.124 . . . . 0.0 110.781 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 81' ' ' ASP . 9.0 mp -113.82 -12.34 12.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.83 . . . . 0.0 109.794 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.38 -165.36 24.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 93.6 m95 -93.87 136.8 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.981 . . . . 0.0 110.091 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.517 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.5 ptp -140.52 135.56 32.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.89 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 18.1 p -83.83 -37.63 22.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.482 -0.761 . . . . 0.0 110.443 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -113.41 -38.54 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 95' ' ' GLN . . . 58.69 66.2 2.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 31.3 t -113.08 105.63 13.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -1.171 . . . . 0.0 109.437 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.2 tpt -125.69 -60.38 1.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 111.291 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.829 HG13 ' HD2' ' A' ' 93' ' ' PRO . 11.8 p -114.63 -30.22 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.882 -1.137 . . . . 0.0 111.312 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.64 -65.83 0.59 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.006 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 91' ' ' VAL . 49.0 Cg_endo -71.1 -24.76 23.28 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.811 1.427 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -35.47 63.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.445 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 64.5 tt0 -78.62 -39.76 36.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.42 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 17.5 pt-20 -63.42 -25.04 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.779 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -88.45 -46.15 9.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.123 -0.986 . . . . 0.0 111.174 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.37 -35.21 75.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.465 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG11 ' A' ' 38' ' ' VAL . 27.2 m-85 -100.85 -1.04 35.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.85 -1.156 . . . . 0.0 111.818 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -99.45 -26.12 14.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.706 -1.246 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 127' ' ' VAL . 14.4 tp -45.37 135.35 5.61 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.013 . . . . 0.0 110.001 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.44 141.29 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.974 1.513 . . . . 0.0 110.47 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 103' ' ' VAL . 6.6 p -131.0 101.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' OG ' ' HG2' ' A' ' 108' ' ' LYS . 96.6 p -119.12 8.94 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.38 -123.85 5.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.81 16.74 25.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -1.228 . . . . 0.0 110.388 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -104.32 8.98 36.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HG2' ' OG ' ' A' ' 104' ' ' SER . 74.8 mmtt -122.53 157.58 58.8 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.71 166.23 30.11 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.97 1.51 . . . . 0.0 110.017 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 127' ' ' VAL . 33.7 m -106.74 -14.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.542 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.621 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 3.6 p90 -128.68 177.63 6.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.723 -1.236 . . . . 0.0 111.472 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.545 ' C ' ' HA ' ' A' ' 114' ' ' PRO . 3.2 p -71.58 -105.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.46 -0.775 . . . . 0.0 111.708 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.909 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 28.0 m-20 -79.8 -29.11 0.55 Allowed Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.909 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 38.2 Cg_endo -76.78 -26.04 10.1 Favored 'Cis proline' 0 N--CA 1.487 1.129 0 C-N-CA 124.169 -1.179 . . . . 0.0 115.075 2.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.2 Cg_endo -69.18 121.39 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-O 121.69 0.621 . . . . 0.0 112.422 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 2.9 t -97.5 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HD3' HD13 ' A' ' 51' ' ' ILE . 37.5 mtmm -103.91 112.96 26.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.027 . . . . 0.0 110.253 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.648 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 14.6 p -138.36 166.36 24.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 110.663 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -66.43 -9.35 33.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.2 OUTLIER -105.78 21.88 16.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.839 -1.163 . . . . 0.0 110.312 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.59 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 108.71 -173.51 17.68 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.855 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.97 150.55 21.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.637 ' CD2' ' HG ' ' A' ' 44' ' ' LEU . 33.9 m80 -138.31 127.45 24.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.534 -1.354 . . . . 0.0 112.631 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mp -106.83 105.2 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.052 HG22 ' HB2' ' A' ' 42' ' ' HIS . 34.3 pt -108.76 141.47 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 16.7 ttt -119.07 141.87 48.37 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 127' ' ' VAL . 23.3 m -113.5 105.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.846 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 63.2 tt0 -111.44 132.98 54.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.782 . . . . 0.0 109.674 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 73.31 80.21 0.46 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -110.23 146.64 35.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.99 . . . . 0.0 109.712 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 1.3 mmmm . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 0.0 110.288 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 10.4 p30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.532 0.682 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -112.32 166.59 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.403 -0.81 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 26.8 m -138.72 148.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.709 -0.62 . . . . 0.0 109.808 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' CE ' ' HD2' ' A' ' 130' ' ' ARG . 26.5 mttt -98.64 114.3 26.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 108.74 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 78.5 t -114.61 136.36 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 45.7 ttp180 -130.82 118.35 20.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.919 ' HB2' HG22 ' A' ' 125' ' ' ILE . 4.3 p80 -128.15 177.65 6.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.713 -1.242 . . . . 0.0 112.068 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG21 ' HB3' ' A' ' 71' ' ' TYR . 46.1 mt -126.49 140.69 48.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.3 tt -112.32 127.05 55.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.48 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 56.8 m -132.06 138.79 48.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 109.859 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 72.1 mt-10 -59.63 155.58 15.28 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.003 -1.061 . . . . 0.0 108.786 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 4.1 tttt -80.42 118.77 22.34 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.027 -1.046 . . . . 0.0 113.101 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.626 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 8.0 m80 -135.2 1.75 2.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.697 . . . . 0.0 110.384 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.16 5.38 73.08 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 18.4 ptpt -99.71 22.17 11.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.745 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 69.6 mt -49.28 -53.1 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.419 -0.801 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.54 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 44.0 ttm -59.38 -34.39 72.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 81.2 mm-40 -63.15 -41.84 99.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.75 -52.35 57.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 0.0 110.67 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' ' CB ' ' A' ' 58' ' ' LEU . 2.6 ppp? -69.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 52' ' ' MET . 32.9 mm-40 -68.13 -33.03 73.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 108.909 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HG2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -87.55 -14.82 39.2 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.91 -29.64 61.03 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.746 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 58' ' ' LEU . 13.0 ptpt -30.9 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.43 0.633 . . . . 0.0 111.385 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -52.4 -42.92 64.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.356 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.97 -26.57 2.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 6.5 tpt -106.44 150.33 26.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -1.137 . . . . 0.0 110.296 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 66' ' ' GLU . 3.3 ptm180 -75.23 109.61 8.88 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.306 1.051 . . . . 0.0 110.72 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.681 ' CE1' HD21 ' A' ' 58' ' ' LEU . 84.2 t80 -41.96 -36.31 1.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.743 -0.598 . . . . 0.0 109.665 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -58.64 -44.62 90.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 110.664 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 35.7 tt0 -65.04 -48.68 72.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.052 . . . . 0.0 110.812 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 58' ' ' LEU . 27.4 m -63.68 -44.12 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.081 -1.448 . . . . 0.0 109.493 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -63.31 -39.42 94.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 109.571 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.69 71.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.436 -0.79 . . . . 0.0 109.699 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -80.31 -7.14 58.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.594 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m-30 -108.79 9.0 26.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.858 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.7 t -80.8 83.52 6.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.174 -0.954 . . . . 0.0 111.251 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -99.54 7.02 45.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ARG . 18.8 p30 -104.1 41.46 1.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.686 -0.634 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -50.4 -42.04 53.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 110.586 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 9.38 28.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.6 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 74' ' ' ASP . 2.6 ttt180 -105.29 -15.12 15.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 55.58 55.98 6.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -116.48 25.43 9.16 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -82.74 -60.0 2.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 9.5 p-10 -133.5 133.57 42.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.29 . . . . 0.0 111.059 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.1 mp -104.04 157.07 17.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 109.212 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 -127.92 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.177 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 23.5 m-90 -90.92 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.872 -0.781 . . . . 0.0 110.611 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 38' ' ' VAL . 13.9 mmt -132.14 140.82 48.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.9 t -110.37 -45.49 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.314 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 86' ' ' THR . 2.2 mmp_? -117.4 1.9 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.443 -0.786 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.557 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 72.8 146.47 0.71 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 38.8 p -146.37 40.67 1.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.594 -1.533 . . . . 0.0 111.541 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.616 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 2.1 tpt -125.48 137.02 53.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.033 -1.042 . . . . 0.0 110.123 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' C ' ' A' ' 90' ' ' MET . 5.8 m 35.0 -110.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.748 -0.595 . . . . 0.0 111.149 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 93' ' ' PRO . . . -148.78 -67.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.432 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 92' ' ' GLY . 38.2 Cg_endo -64.08 -14.07 41.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.709 1.373 . . . . 0.0 110.813 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 90' ' ' MET . 68.5 t80 -68.27 -47.03 68.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.56 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 14.5 mt-30 -71.05 -41.48 70.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 109.285 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.9 mm-40 -58.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.491 -0.756 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -41.41 81.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.449 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -50.19 -51.8 40.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.702 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.41 -1.39 57.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 0.0 111.118 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -116.92 12.2 14.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.85 -1.156 . . . . 0.0 110.891 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.932 HD22 HG22 ' A' ' 112' ' ' THR . 52.5 mt -37.53 97.66 0.14 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.564 -0.71 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.462 ' N ' ' O ' ' A' ' 100' ' ' ALA . 49.6 Cg_endo -77.09 -2.15 12.37 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.041 1.548 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 104' ' ' SER . 11.7 p -69.56 -44.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.681 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.591 ' N ' HG13 ' A' ' 103' ' ' VAL . 44.1 m -142.54 -42.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 110.282 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.3 -80.27 0.87 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 79.1 mtp -63.96 -42.63 97.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -1.189 . . . . 0.0 109.953 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' C ' ' CD ' ' A' ' 109' ' ' PRO . 94.5 m-20 -107.1 81.86 1.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -116.73 42.9 0.38 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.364 -0.835 . . . . 0.0 111.225 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 50.0 Cg_endo -75.09 -6.85 18.51 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.468 1.247 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.57 HG12 ' HD1' ' A' ' 111' ' ' PHE . 2.1 t -102.33 -140.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 0.0 109.905 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' A' ' 110' ' ' VAL . 33.8 p90 -124.86 156.11 38.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.012 -1.055 . . . . 0.0 110.425 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.932 HG22 HD22 ' A' ' 101' ' ' LEU . 24.8 p -46.16 124.51 5.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.0 111.08 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 34.1 t0 -133.35 119.75 15.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 50.7 Cg_endo -79.11 174.33 51.2 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.12 -2.033 . . . . 0.0 110.163 -0.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 124' ' ' ILE . 46.5 Cg_endo -72.12 177.33 7.31 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.863 1.454 . . . . 0.0 109.993 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.32 158.98 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 10.9 ptmm? -119.64 136.23 54.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.587 ' HB ' ' CE2' ' A' ' 120' ' ' PHE . 74.3 p -142.13 168.62 19.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.62 -23.69 59.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 15.2 p90 -98.81 46.22 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 84.08 175.65 50.9 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 41.8 p90 -98.53 166.12 11.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -1.112 . . . . 0.0 108.844 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 22.8 m-70 -141.77 140.49 33.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.802 -1.186 . . . . 0.0 112.624 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.9 HD11 HD23 ' A' ' 58' ' ' LEU . 5.1 pt -128.1 110.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 42' ' ' HIS . 12.0 pt -106.98 149.61 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.055 -1.028 . . . . 0.0 112.867 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 49.5 mtp -107.0 124.43 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.46 107.78 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 111.319 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.35 -3.36 27.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.422 -0.799 . . . . 0.0 109.4 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 58.39 -164.54 8.34 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.498 ' HD2' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tpm_? -134.26 -35.45 0.93 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.776 -0.838 . . . . 0.0 109.894 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' A' ' 36' ' ' ASN . 23.7 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.35 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 23.2 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.082 0.468 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -86.86 129.46 34.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.986 -1.071 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 22.9 m -144.1 151.12 16.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.917 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 2.3 tmtt? -96.11 124.27 40.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.049 -1.032 . . . . 0.0 108.858 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 82' ' ' LEU . 42.9 t -119.75 132.55 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.022 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 53.0 mtm180 -120.25 112.35 18.94 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.081 ' HB2' HG22 ' A' ' 125' ' ' ILE . 8.3 p-80 -134.86 158.82 43.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.518 -1.364 . . . . 0.0 113.047 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.765 HG21 ' HA ' ' A' ' 68' ' ' ALA . 7.8 pt -119.82 133.42 66.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -106.28 136.09 46.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.462 0.649 . . . . 0.0 111.719 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 26.0 m -142.57 144.88 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.975 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.644 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt-10 -59.0 172.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.062 -1.024 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.1 ttmt -105.48 113.18 26.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.686 -1.259 . . . . 0.0 113.29 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.644 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 1.5 m80 -134.3 26.56 3.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.56 9.21 82.02 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 ttmt -90.76 -10.65 42.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.622 -0.928 . . . . 0.0 109.975 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.57 HG23 ' N ' ' A' ' 52' ' ' MET . 16.4 tt -44.2 -42.72 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.464 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.57 ' N ' HG23 ' A' ' 51' ' ' ILE . 11.9 ttt -67.09 -29.73 69.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.0 109.139 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' LYS . 65.7 tt0 -72.2 -42.92 65.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.356 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . . . -56.81 -49.85 74.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.787 . . . . 0.0 110.164 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 22.1 ptm -74.1 -22.43 59.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 32.2 tp10 -69.92 -38.03 76.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -80.78 -25.65 37.75 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 124' ' ' ILE . 35.4 tp -76.2 -44.34 38.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.564 0.697 . . . . 0.0 109.275 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 32.1 mtmt 48.43 -112.51 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.598 -0.689 . . . . 0.0 111.081 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.7 p -78.79 -14.37 59.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.954 -1.091 . . . . 0.0 110.261 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 103.33 0.32 47.17 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 61' ' ' GLY . 56.8 ttp -44.72 -34.65 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.268 . . . . 0.0 109.641 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' PHE . 10.6 mtp180 -112.89 19.38 17.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.56 ' HD1' HD11 ' A' ' 58' ' ' LEU . 87.1 t80 -43.72 -40.36 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 28.9 p-10 -66.12 -40.37 90.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 43.5 mm-40 -70.59 -43.36 69.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 109.491 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 18.4 t -69.79 -41.02 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.573 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.765 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -63.68 -43.33 96.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 110.226 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.45 94.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.56 -9.1 59.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 43' ' ' ILE . 8.5 m-85 -111.82 5.51 19.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.942 . . . . 0.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.2 m -73.86 87.44 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 2.6 tm-20 -101.41 32.04 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.59 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 78.6 m-20 -100.13 83.55 2.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 14.8 tptt -70.79 -52.21 22.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 111.087 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 77' ' ' ARG . . . -77.05 -13.14 60.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.111 -0.993 . . . . 0.0 110.599 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.543 ' N ' ' CD ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -102.42 -48.6 4.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.129 -0.982 . . . . 0.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 8.2 mm100 51.56 34.73 13.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 110.035 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -93.64 -55.87 1.49 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 67.86 -64.41 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.595 ' C ' HD12 ' A' ' 82' ' ' LEU . 75.5 m-20 -116.47 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.693 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 81' ' ' ASP . 8.3 mp -102.78 139.86 37.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -71.8 -138.47 0.23 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 1.5 m95 -91.58 134.18 34.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -1.02 . . . . 0.0 110.343 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.509 ' CE ' ' HA3' ' A' ' 88' ' ' GLY . 21.2 ptm -134.01 150.75 51.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 47.3 p -101.56 -38.67 7.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.953 -1.092 . . . . 0.0 110.126 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -114.01 -92.58 0.49 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' HA3' ' CE ' ' A' ' 85' ' ' MET . . . 73.14 75.12 0.75 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.1 m -110.86 93.28 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -31.15 8.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -150.6 -171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.044 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.491 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -88.33 -56.5 2.02 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.314 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -66.55 -29.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.372 1.196 . . . . 0.0 112.343 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 91' ' ' VAL . 32.5 t80 -69.18 -43.4 74.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.71 -1.244 . . . . 0.0 110.756 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' OE1' ' CD1' ' A' ' 99' ' ' PHE . 7.7 tp-100 -72.52 -52.07 17.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.904 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.988 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 mt-10 -59.94 -20.97 60.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.149 -0.969 . . . . 0.0 110.912 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -82.76 -59.24 2.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.905 -1.122 . . . . 0.0 110.557 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.84 -59.31 5.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CD1' ' OE1' ' A' ' 95' ' ' GLN . 29.2 m-85 -74.3 -28.32 61.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -118.11 34.97 4.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.909 -1.119 . . . . 0.0 110.764 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 112' ' ' THR . 8.8 tp -56.68 142.69 70.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.113 -0.992 . . . . 0.0 110.345 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.591 ' HD2' HD12 ' A' ' 101' ' ' LEU . 46.1 Cg_endo -71.31 -178.11 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.819 1.431 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.7 t -53.75 122.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' HD21 ' A' ' 101' ' ' LEU . 20.1 m -136.61 84.35 2.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.374 -0.829 . . . . 0.0 109.683 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.82 -149.54 33.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 37.4 ttm -66.27 -45.09 81.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.031 -1.276 . . . . 0.0 108.52 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -141.55 -96.32 0.13 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 34.7 mttm -134.15 42.29 0.79 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 47.5 Cg_endo -73.49 -0.93 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.491 1.259 . . . . 0.0 110.792 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' CG2' ' HB3' ' A' ' 104' ' ' SER . 34.5 m -128.65 -156.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.568 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 58' ' ' LEU . 29.2 p90 -119.08 165.03 14.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.527 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.967 HG22 HD13 ' A' ' 101' ' ' LEU . 46.0 p -48.22 113.62 0.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 110.776 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.3 p-10 -132.26 120.61 17.15 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.765 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.3 Cg_endo -68.77 165.26 74.1 Favored 'Cis proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.769 -2.179 . . . . 0.0 110.248 0.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 1.083 ' HB3' HG22 ' A' ' 124' ' ' ILE . 45.1 Cg_endo -70.46 -179.88 3.56 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.926 1.487 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.8 134.33 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.895 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HB2' ' CE ' ' A' ' 47' ' ' LYS . 10.0 ptpt -109.65 126.99 54.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 0.0 109.187 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.604 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 44.0 p -130.33 -177.6 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.039 -1.038 . . . . 0.0 111.013 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -69.53 -18.8 63.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -0.772 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 p90 -100.36 32.58 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.044 . . . . 0.0 109.88 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.578 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 97.68 177.04 33.96 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 53.8 p90 -99.74 162.21 13.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -1.179 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.6 m-70 -141.69 151.49 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.001 -1.062 . . . . 0.0 112.238 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.083 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.8 pt -133.94 118.92 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.081 HG22 ' HB2' ' A' ' 42' ' ' HIS . 8.2 pt -121.56 142.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.673 -1.267 . . . . 0.0 112.83 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 34.8 mmm -97.43 125.04 41.83 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 108' ' ' LYS . 42.9 t -113.16 121.36 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.664 -1.273 . . . . 0.0 111.889 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 39' ' ' LYS . 8.7 pt-20 -115.16 -22.17 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.527 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 80.9 -167.47 49.9 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.608 ' HD3' ' CE3' ' A' ' 84' ' ' TRP . 12.7 tpt180 -132.66 -75.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.983 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 3.6 p30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.459 0.647 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 86' ' ' THR . . . -130.84 150.98 51.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -111.39 164.93 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HD3' ' CE2' ' A' ' 84' ' ' TRP . 30.0 mtmt -99.05 117.35 33.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 109.544 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 13.1 t -116.67 133.25 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 110.763 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -141.49 113.04 7.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.96 ' CB ' HG22 ' A' ' 125' ' ' ILE . 21.9 p-80 -132.16 -179.29 5.33 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.98 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 124' ' ' ILE . 5.2 mt -124.31 117.43 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -102.15 120.19 40.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.864 -1.147 . . . . 0.0 110.596 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.578 ' SG ' HG22 ' A' ' 43' ' ' ILE . 5.4 m -133.54 155.59 49.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.042 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.62 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.27 -163.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.835 -1.165 . . . . 0.0 110.561 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -92.48 106.43 18.42 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.739 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 17.9 m-70 -123.27 -2.83 8.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.7 27.89 73.52 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -107.17 8.97 30.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.54 -0.976 . . . . 0.0 110.11 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 115' ' ' PRO . 75.9 mt -41.23 -43.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.02 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -31.94 72.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 2.1 tp10 -76.18 -37.36 57.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.412 -0.805 . . . . 0.0 110.109 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.83 -52.69 64.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.433 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 14.0 ptm -66.55 -35.46 80.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.387 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 55' ' ' MET . 26.8 tt0 -70.15 -36.06 74.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.55 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -71.0 -35.7 72.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.778 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 59' ' ' LYS . 4.6 pp -97.14 -46.12 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 110.823 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.918 ' N ' HD12 ' A' ' 58' ' ' LEU . 13.4 mttt 37.87 -157.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.0 t -103.01 7.8 39.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.029 -1.044 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.89 -40.07 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 33.7 mmt -67.44 166.79 13.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -1.149 . . . . 0.0 110.37 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.3 mtt85 -72.02 97.97 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 110.715 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -52.33 -31.48 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.25 -35.71 71.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.346 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 43.7 tt0 -63.62 -39.1 93.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.567 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.869 HG21 ' HB3' ' A' ' 58' ' ' LEU . 30.5 t -68.61 -45.75 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -59.18 -47.98 83.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.36 79.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 111.013 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -83.92 -23.54 31.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.026 -1.046 . . . . 0.0 111.395 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' CD2' HG13 ' A' ' 67' ' ' VAL . 21.9 m-30 -112.86 18.79 17.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.933 -1.104 . . . . 0.0 110.677 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -89.15 112.59 23.63 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.75 -4.95 29.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 80' ' ' GLY . 58.5 p30 -104.67 33.77 3.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.708 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -52.89 -41.01 63.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 110.21 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.56 90.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 mtt85 -85.61 -11.33 54.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.158 -0.964 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 74' ' ' ASP . 3.6 tp60 58.21 30.58 19.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.747 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.748 ' O ' HD11 ' A' ' 82' ' ' LEU . . . -68.83 -25.6 75.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 74' ' ' ASP . . . -49.73 -34.3 21.12 Favored Glycine 0 N--CA 1.489 2.19 0 O-C-N 121.127 -1.219 . . . . 0.0 110.391 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 82' ' ' LEU . 7.5 t0 -134.59 109.21 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.784 -1.421 . . . . 0.0 111.483 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.825 ' N ' HD12 ' A' ' 82' ' ' LEU . 5.3 mp -100.48 145.06 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.65 -141.27 4.54 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.536 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CE2' ' HD3' ' A' ' 39' ' ' LYS . 77.5 m95 -81.82 100.67 9.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.899 -0.765 . . . . 0.0 109.678 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' MET . 1.8 ptp -139.04 146.66 41.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.011 -1.056 . . . . 0.0 111.149 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -126.3 -0.0 7.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.564 -0.71 . . . . 0.0 109.301 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -90.43 -175.48 4.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.05 124.73 8.32 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.45 -9.98 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.084 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.736 ' HE2' ' CE2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -136.28 -165.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.77 151.74 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.982 -1.074 . . . . 0.0 111.05 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -169.14 19.81 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 40.5 Cg_endo -66.96 -11.23 31.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.161 1.611 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.736 ' CE2' ' HE2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -57.39 -58.38 8.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.107 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 5.8 tt0 -72.1 -40.61 68.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.737 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 31.8 tt0 -64.05 -40.53 96.5 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -66.26 -56.03 13.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.124 -0.985 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.72 -47.47 5.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 99' ' ' PHE . 10.5 m-30 -94.87 17.94 12.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.134 -0.978 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -111.24 -21.9 11.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 103' ' ' VAL . 72.4 mt -49.0 131.32 15.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.03 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.77 -17.84 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.92 1.484 . . . . 0.0 110.507 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 101' ' ' LEU . 29.0 m -67.51 129.18 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 61.9 p -126.1 16.36 7.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.009 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 140.16 15.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -93.25 -5.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -1.102 . . . . 0.0 110.279 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' OD1' ' HG3' ' A' ' 108' ' ' LYS . 44.6 p-10 -101.35 6.25 42.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.76 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HG3' ' OD1' ' A' ' 107' ' ' ASP . 28.8 mtmt -127.11 62.03 50.64 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.983 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.504 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 46.6 Cg_endo -71.06 124.55 10.65 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.949 1.499 . . . . 0.0 110.344 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 111' ' ' PHE . 64.1 t -142.5 164.43 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 23.9 p90 -114.31 164.42 13.94 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.333 -0.854 . . . . 0.0 109.687 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 125' ' ' ILE . 30.4 p -63.5 109.42 1.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 111.654 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.592 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 25.8 p-10 -132.66 113.11 13.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.1 Cg_endo -68.07 166.55 67.19 Favored 'Cis proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.343 0.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -71.45 -174.79 1.33 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.086 1.572 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 118' ' ' THR . 66.6 t -101.66 136.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.753 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -110.21 120.12 41.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.855 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.659 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -130.69 170.64 14.05 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -70.25 -14.65 62.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.408 -0.807 . . . . 0.0 110.554 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.659 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -91.57 5.15 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.834 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 126.91 -169.84 18.78 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.555 ' CE2' HG13 ' A' ' 51' ' ' ILE . 18.1 m-30 -99.59 159.26 15.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -1.083 . . . . 0.0 108.609 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.432 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 67.0 m-70 -143.44 110.13 5.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.783 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 43' ' ' ILE . 4.4 mp -100.52 111.71 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.96 HG22 ' CB ' ' A' ' 42' ' ' HIS . 33.6 pt -115.67 142.76 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.557 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.504 ' HE3' ' HB2' ' A' ' 109' ' ' PRO . 12.4 tpt -115.11 124.02 50.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 101' ' ' LEU . 22.1 t -105.96 131.08 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.107 -0.996 . . . . 0.0 111.373 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 71.1 mt-10 -141.98 143.56 33.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.51 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 56.9 117.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -113.68 156.68 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -1.216 . . . . 0.0 110.137 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.587 ' H ' HG12 ' A' ' 38' ' ' VAL . 13.0 pttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.326 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB3' ' CB ' ' A' ' 131' ' ' LYS . . . -79.13 115.5 18.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.852 -1.155 . . . . 0.0 109.596 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -127.97 160.91 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 8.7 mttt -98.82 128.96 45.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.373 -0.83 . . . . 0.0 109.61 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 72.8 t -109.82 129.97 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.372 -0.83 . . . . 0.0 111.45 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 83.2 mtt180 -120.69 125.14 46.92 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 4.9 p-80 -134.98 172.61 12.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 0.0 112.351 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' ' 71' ' ' TYR . 58.9 mt -126.79 116.58 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.723 HD22 ' OD2' ' A' ' 74' ' ' ASP . 4.6 tt -102.56 124.07 47.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.901 -1.124 . . . . 0.0 111.629 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 19.0 m -142.77 160.42 40.35 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.591 ' O ' ' CE2' ' A' ' 122' ' ' TYR . 87.1 mt-10 -71.7 172.31 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.903 -1.123 . . . . 0.0 109.789 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 74.6 tttt -93.12 111.4 23.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.851 -1.156 . . . . 0.0 112.547 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.584 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 5.8 m-70 -132.43 9.61 4.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.47 -8.79 77.96 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 51' ' ' ILE . 7.6 tttp -73.81 -15.44 61.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.708 -0.878 . . . . 0.0 109.611 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 52' ' ' MET . 10.8 tt -40.5 -44.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.798 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.587 ' N ' HG23 ' A' ' 51' ' ' ILE . 50.8 ttp -65.38 -42.61 92.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 67.0 tt0 -56.49 -44.19 80.43 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.268 -0.895 . . . . 0.0 109.147 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.37 -60.76 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.592 ' HA ' HD11 ' A' ' 58' ' ' LEU . 52.7 ttp -59.93 -33.38 71.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.557 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 45.1 tt0 -62.93 -33.92 76.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 108.793 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.85 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.9 tptt -62.55 -45.68 91.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.493 -0.754 . . . . 0.0 109.185 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 pp -108.76 27.61 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.384 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 56' ' ' GLU . 36.4 tttp -54.74 -60.13 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.398 0.618 . . . . 0.0 110.722 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.4 m -81.37 33.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 74.16 25.59 70.66 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.555 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 3.7 ttm -53.79 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.837 -1.39 . . . . 0.0 109.572 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CG ' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -70.69 78.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.998 -1.064 . . . . 0.0 111.288 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' ' SD ' ' A' ' 126' ' ' MET . 5.2 t80 -46.65 -27.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.865 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.565 ' OD1' ' CG ' ' A' ' 63' ' ' ARG . 33.9 p-10 -67.68 -46.91 70.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.219 . . . . 0.0 110.092 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 83.9 mt-10 -63.27 -32.47 73.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 109.496 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 57' ' ' LYS . 45.8 t -61.55 -53.63 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -51.11 -60.5 3.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.952 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.48 19.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.802 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.32 -26.71 62.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 48.6 m-85 -111.04 30.05 7.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.385 -0.822 . . . . 0.0 110.282 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 68' ' ' ALA . 43.4 t -100.21 101.95 13.11 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.095 -1.003 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -101.72 2.25 38.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.723 ' OD2' HD22 ' A' ' 44' ' ' LEU . 15.3 m-20 -116.69 30.75 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.741 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -67.42 -23.86 65.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.78 . . . . 0.0 110.255 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.4 -56.34 21.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.143 -0.973 . . . . 0.0 109.181 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 4.2 ttm180 -96.31 -52.01 4.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.482 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 8.2 pt20 179.96 133.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.656 -0.653 . . . . 0.0 109.866 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.39 96.72 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.96 -85.96 0.1 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 95.5 m-20 -121.19 137.2 54.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -1.169 . . . . 0.0 110.731 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.9 mp -100.56 163.55 12.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.822 . . . . 0.0 109.577 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -73.17 -143.68 0.61 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 94.1 m95 -82.78 160.53 22.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.496 -1.002 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -138.13 143.8 40.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.0 109.799 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.598 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.4 t -131.34 -46.43 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.941 -1.099 . . . . 0.0 111.689 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' N ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -117.48 -5.98 11.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.667 -1.271 . . . . 0.0 112.807 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . 118.65 -168.31 13.21 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 118.949 -1.595 . . . . 0.0 110.611 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 90' ' ' MET . 26.2 t -125.68 -88.8 0.58 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.614 -0.933 . . . . 0.0 110.708 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' GLY . 65.9 mtm -147.43 -85.49 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.046 -1.034 . . . . 0.0 112.87 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -9.0 -58.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' MET . . . 125.34 -72.43 0.44 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.538 -1.351 . . . . 0.0 109.811 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 38.1 Cg_endo -63.42 -37.14 50.94 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.851 1.448 . . . . 0.0 109.333 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.492 ' H ' HG12 ' A' ' 91' ' ' VAL . 74.9 t80 -60.09 -33.78 72.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.561 0.696 . . . . 0.0 109.259 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 38.0 tt0 -75.64 -45.06 39.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.562 -0.711 . . . . 0.0 110.148 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.793 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 46.6 mt-10 -55.62 -42.68 75.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.0 110.566 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -81.02 -58.7 2.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.509 -1.37 . . . . 0.0 110.711 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.41 27.09 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.83 -1.169 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 85' ' ' MET . 2.4 t80 -117.9 -46.92 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.558 -1.339 . . . . 0.0 112.435 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -76.26 -11.18 59.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.841 -1.162 . . . . 0.0 111.575 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 4.2 tp -55.6 141.61 63.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.826 -1.171 . . . . 0.0 109.425 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.433 ' HD2' ' HG ' ' A' ' 101' ' ' LEU . 42.2 Cg_endo -68.88 134.56 30.2 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.948 1.499 . . . . 0.0 110.947 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 103' ' ' VAL . 28.3 m -112.37 117.42 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 110.025 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.4 m -138.88 76.57 1.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.72 -24.72 13.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mmm -75.34 -22.96 57.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -1.212 . . . . 0.0 110.447 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -113.98 -56.02 2.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 110.787 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.472 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 6.0 pttm -131.98 164.2 44.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.401 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 108' ' ' LYS . 47.3 Cg_endo -71.57 175.06 10.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.968 1.509 . . . . 0.0 110.357 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.06 33.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 21.0 t80 -108.72 134.41 51.47 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 115' ' ' PRO . 6.5 m -53.65 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 110.418 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 26.3 p-10 -133.03 113.52 13.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.58 163.3 90.07 Favored 'Cis proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.073 -2.053 . . . . 0.0 110.382 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.72 ' HA ' HG22 ' A' ' 112' ' ' THR . 46.7 Cg_endo -72.87 -179.66 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.99 1.521 . . . . 0.0 110.054 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.6 161.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.005 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 13.8 ptmt -129.93 119.46 23.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.578 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 39.5 p -122.94 -177.16 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.84 -1.162 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -71.49 -16.69 62.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 0.0 110.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -98.87 27.13 5.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.909 -1.119 . . . . 0.0 109.301 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 103.18 179.69 26.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 52.6 p90 -99.22 159.22 15.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.302 . . . . 0.0 109.797 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.59 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 34.8 m-70 -132.66 140.17 48.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.692 ' N ' HD12 ' A' ' 124' ' ' ILE . 3.7 mp -115.55 136.99 50.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.42 ' HB ' ' OG1' ' A' ' 112' ' ' THR . 0.7 OUTLIER -132.98 147.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.32 -1.488 . . . . 0.0 112.066 -177.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.569 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 13.6 ttt -127.17 135.09 50.19 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.55 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.938 -1.101 . . . . 0.0 111.077 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -141.69 160.82 39.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.674 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 78.62 81.38 0.69 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.496 ' HD2' ' OXT' ' A' ' 131' ' ' LYS . 8.5 tmm_? -97.1 142.73 28.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 110.402 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.787 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . 9.6 tttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' THR . 12.3 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.083 0.468 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . . . -131.86 143.42 50.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 0.0 110.684 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 39' ' ' LYS . 7.4 p -142.7 176.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.91 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.04 121.97 39.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.919 -1.113 . . . . 0.0 108.353 178.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 77.2 t -108.2 138.27 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.05 0.929 . . . . 0.0 112.946 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -140.76 117.0 10.63 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.105 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 6.1 p-80 -138.61 -175.04 3.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.446 -1.409 . . . . 0.0 112.565 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 67' ' ' VAL . 73.8 mt -130.91 114.31 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 123' ' ' HIS . 5.3 tt -104.54 117.27 33.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 110.555 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 41.7 t -142.52 152.06 42.27 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.223 -0.923 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.635 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 18.9 pt-20 -52.5 153.63 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 109.372 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.562 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 3.1 tptt -127.24 113.44 16.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.84 -1.163 . . . . 0.0 111.79 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.7 m-70 -133.29 -60.74 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.063 0.935 . . . . 0.0 108.584 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.33 25.71 0.23 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -116.14 -10.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.555 -0.968 . . . . 0.0 110.148 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -51.08 -32.61 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -0.799 . . . . 0.0 110.444 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.516 ' O ' ' HG2' ' A' ' 55' ' ' MET . 40.0 mtp -72.01 -34.02 68.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.975 -1.078 . . . . 0.0 109.553 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -74.51 -32.5 62.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.331 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.02 -39.94 87.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.643 -0.661 . . . . 0.0 109.986 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.605 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 4.0 ptt? -70.8 -34.19 71.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -0.968 . . . . 0.0 109.676 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 70.4 tt0 -57.72 -50.48 73.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.603 ' C ' HG21 ' A' ' 67' ' ' VAL . 34.0 mmtt -71.16 -21.16 62.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.903 . . . . 0.0 108.943 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.048 HD22 HD13 ' A' ' 124' ' ' ILE . 39.5 tp -75.77 -15.49 60.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.647 -0.658 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 29.1 mmmt -40.0 136.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.816 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -50.01 -30.4 10.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.98 -21.81 25.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.25 157.51 20.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 0.0 110.036 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 24.3 ttm180 -66.45 105.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 111.192 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 58' ' ' LEU . 34.6 t80 -46.82 -30.42 2.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.62 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 38.9 t30 -64.11 -43.37 95.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -62.21 -43.21 99.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 57' ' ' LYS . 1.9 t -63.14 -42.73 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.914 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -64.91 -43.62 92.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.46 -48.73 76.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 0.0 110.993 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.1 -30.03 64.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.001 -1.062 . . . . 0.0 111.044 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 22.2 m-85 -100.35 15.3 28.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.514 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.1 p -73.93 91.9 2.05 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 50.4 tt0 -101.41 10.62 40.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.11 . . . . 0.0 110.283 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' O ' ' CA ' ' A' ' 78' ' ' GLN . 51.7 t0 -110.91 104.9 13.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.13 -42.66 31.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.359 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -38.49 78.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.558 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -111.42 0.42 16.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.334 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER 54.26 91.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 78' ' ' GLN . . . -44.69 100.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 78' ' ' GLN . . . -174.66 -115.5 0.4 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.744 ' C ' HD12 ' A' ' 82' ' ' LEU . 46.8 p-10 -117.62 142.34 47.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -1.05 . . . . 0.0 110.861 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.814 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.7 mp -110.47 175.84 5.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.49 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.96 -147.63 9.12 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 23.5 m-90 -98.78 117.3 32.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.724 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 20.6 ptm -130.71 171.72 12.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.036 -1.04 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' N ' ' A' ' 87' ' ' ARG . 14.8 t -101.2 -147.95 0.36 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.513 ' N ' HG23 ' A' ' 86' ' ' THR . 33.7 ptt-85 -115.39 119.73 37.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.346 -0.846 . . . . 0.0 110.579 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' ' NE2' ' A' ' 95' ' ' GLN . . . -92.7 -157.06 33.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -141.58 52.26 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -1.151 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.6 tpt -100.96 -90.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 109.041 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.638 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -77.84 132.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 108.799 178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.553 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.95 -53.49 18.79 Favored Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.654 -0.654 . . . . 0.0 112.997 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.4 Cg_endo -65.01 -42.09 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.276 1.146 . . . . 0.0 111.669 -177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 91' ' ' VAL . 56.4 t80 -65.46 -49.18 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.103 -0.998 . . . . 0.0 110.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.426 ' NE2' ' H ' ' A' ' 88' ' ' GLY . 12.6 mm100 -72.89 -58.84 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 111.251 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 13.1 mm-40 -53.17 -49.84 65.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.958 -1.089 . . . . 0.0 111.199 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -59.24 -57.98 10.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 0.0 110.35 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.11 -52.76 4.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.647 -0.658 . . . . 0.0 111.183 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.42 10.36 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 110.555 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -87.65 -48.07 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.981 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -62.54 134.14 95.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.5 -58.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.446 1.235 . . . . 0.0 110.048 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.04 134.9 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.459 -0.776 . . . . 0.0 109.885 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 110' ' ' VAL . 83.9 p -101.84 -7.93 22.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 110.0 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 108' ' ' LYS . . . -156.72 148.16 17.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 75.5 mtm -61.93 -41.14 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -1.146 . . . . 0.0 110.881 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 59.4 p30 -130.35 -10.89 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.0 111.104 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 10.5 pttm -132.2 153.26 81.23 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 0.0 110.3 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.451 ' HG3' ' HG3' ' A' ' 128' ' ' GLU . 45.7 Cg_endo -73.0 146.64 41.95 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.936 1.493 . . . . 0.0 110.582 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 111' ' ' PHE . 11.9 t -134.28 -175.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 109.69 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.705 ' H ' HG12 ' A' ' 110' ' ' VAL . 5.4 p90 -114.02 168.8 9.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.012 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 114' ' ' PRO . 26.5 m -56.78 -5.73 0.26 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 111' ' ' PHE . 9.2 p-10 -50.74 126.59 24.27 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.027 -1.671 . . . . 0.0 109.378 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' THR . 45.5 Cg_endo -70.1 134.78 31.5 Favored 'Cis proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.287 -1.964 . . . . 0.0 111.124 0.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.662 ' HG2' HD11 ' A' ' 51' ' ' ILE . 40.3 Cg_endo -66.22 -174.69 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.054 1.555 . . . . 0.0 111.289 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.3 m -108.12 157.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.648 . . . . 0.0 109.899 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -113.56 118.21 33.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 30.0 p -130.73 170.98 13.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 110.623 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.35 -17.69 63.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 110.224 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.6 OUTLIER -98.26 24.36 7.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.215 -0.928 . . . . 0.0 109.357 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 98.06 174.43 33.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 5.3 p90 -98.49 152.0 20.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.378 -1.072 . . . . 0.0 108.567 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.579 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 1.6 m80 -131.28 141.48 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.825 -1.172 . . . . 0.0 113.053 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.048 HD13 HD22 ' A' ' 58' ' ' LEU . 57.9 mt -115.51 112.93 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 111' ' ' PHE . 25.0 mt -102.01 144.88 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.665 -1.272 . . . . 0.0 111.065 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ARG . 7.6 tpt -121.12 111.66 17.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.9 t -94.96 102.19 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.036 -1.04 . . . . 0.0 111.65 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 88.3 tt0 -144.66 135.02 24.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 132.84 7.08 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.12 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -107.74 169.25 8.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.386 -1.067 . . . . 0.0 110.323 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.534 ' CD ' ' HB3' ' A' ' 37' ' ' ALA . 45.2 mtmt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.354 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.395 0.617 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' THR . . . -109.13 155.47 20.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.361 -0.837 . . . . 0.0 109.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 85' ' ' MET . 7.7 p -140.65 156.69 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.024 -1.048 . . . . 0.0 110.517 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD2' ' NE1' ' A' ' 84' ' ' TRP . 1.5 mppt? -100.06 126.27 46.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.098 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -125.38 113.49 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.009 . . . . 0.0 111.57 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HA ' ' CB ' ' A' ' 81' ' ' ASP . 15.3 mtp180 -114.33 115.75 27.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.839 . . . . 0.0 108.819 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.993 ' HB2' HG22 ' A' ' 125' ' ' ILE . 13.5 p-80 -138.14 160.81 38.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.968 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.704 ' CG1' HG22 ' A' ' 124' ' ' ILE . 27.3 pt -116.89 124.53 73.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 45' ' ' CYS . 6.2 tt -108.53 129.96 55.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.585 . . . . 0.0 111.055 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.642 ' N ' HD23 ' A' ' 44' ' ' LEU . 32.6 t -142.62 165.42 27.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 83.0 mt-10 -69.13 154.1 42.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 26.9 tttm -87.88 116.62 26.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.76 -1.212 . . . . 0.0 112.834 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.5 m-70 -131.32 9.08 4.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.502 -0.749 . . . . 0.0 109.268 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.14 41.91 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -88.52 9.09 25.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.489 -1.006 . . . . 0.0 110.378 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.7 HG23 ' HG2' ' A' ' 115' ' ' PRO . 5.5 mt -48.8 -59.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.906 -1.121 . . . . 0.0 110.0 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' SD ' ' A' ' 55' ' ' MET . 72.3 mtm -69.06 -28.12 66.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.771 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -73.98 -42.47 60.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.784 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.31 79.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.506 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 25.2 ptm -63.7 -46.18 86.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.995 . . . . 0.0 110.467 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 79.0 tt0 -56.6 -33.46 66.26 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.041 -1.037 . . . . 0.0 110.161 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.695 ' HG2' HG22 ' A' ' 67' ' ' VAL . 66.1 tttt -77.72 -27.78 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.738 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 124' ' ' ILE . 1.0 OUTLIER -104.59 16.18 26.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.871 -1.143 . . . . 0.0 110.582 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 58' ' ' LEU . 38.5 mttm -50.65 -161.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.507 -0.745 . . . . 0.0 110.438 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.2 m -87.0 154.49 20.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.574 -1.329 . . . . 0.0 110.931 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.41 -3.83 86.32 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -113.89 -168.39 1.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.065 -1.256 . . . . 0.0 110.862 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 13.5 mtm180 -95.71 95.34 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.411 -0.805 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -50.65 -35.51 31.07 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.121 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 21.8 p-10 -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.797 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.7 tt0 -58.52 -49.02 78.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 57' ' ' LYS . 59.1 t -62.94 -52.27 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.922 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -45.2 -50.09 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.44 76.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 110.399 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -74.38 -26.05 59.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.995 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -109.89 17.47 21.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.109 . . . . 0.0 110.483 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.5 t -82.1 97.5 8.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.998 -1.064 . . . . 0.0 110.4 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -100.52 1.39 40.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.378 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' HD22 ' A' ' 44' ' ' LEU . 4.0 m-20 -114.07 23.28 13.08 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.459 -0.776 . . . . 0.0 109.538 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -56.6 -35.49 68.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -39.24 68.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.891 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -106.4 -53.3 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.851 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . 54.3 mm-40 -141.01 -80.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 110.05 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.46 24.43 76.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -144.32 -104.8 0.48 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.614 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.3 p-10 -128.13 171.77 11.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -1.133 . . . . 0.0 110.322 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.1 mp -100.51 16.91 23.11 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.358 -0.838 . . . . 0.0 109.092 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.29 -134.12 33.26 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.532 ' NE1' ' HD2' ' A' ' 39' ' ' LYS . 3.4 m-90 -87.37 125.99 34.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.842 -0.799 . . . . 0.0 109.542 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.78 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.6 ttm -137.65 140.86 41.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 37' ' ' ALA . 76.5 p -111.4 -33.03 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.438 -0.789 . . . . 0.0 109.979 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -66.71 -31.32 71.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.435 -0.791 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 99' ' ' PHE . . . 147.79 -107.01 0.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.609 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -143.22 -65.78 0.38 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.403 -1.057 . . . . 0.0 109.502 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 23.0 mtp -144.08 -77.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.762 . . . . 0.0 110.951 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -175.09 166.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 0.0 110.936 -179.138 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . 68.36 -143.65 41.2 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 92' ' ' GLY . 40.8 Cg_endo -67.16 -35.92 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.104 1.581 . . . . 0.0 109.284 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 125' ' ' ILE . 50.5 t80 -51.17 -30.52 17.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.476 ' OE1' ' HA3' ' A' ' 88' ' ' GLY . 16.7 tp60 -83.01 -54.68 4.88 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.597 0.713 . . . . 0.0 109.225 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.61 -45.26 92.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.615 -0.678 . . . . 0.0 110.215 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.44 -52.4 53.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 110.161 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.639 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -41.7 -53.88 3.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 88' ' ' GLY . 4.0 m-30 -81.43 -0.84 43.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.412 -0.805 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.505 ' C ' ' HD3' ' A' ' 102' ' ' PRO . . . -128.25 21.15 6.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.87 -1.144 . . . . 0.0 111.927 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -107.31 67.69 0.25 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.576 -1.327 . . . . 0.0 110.861 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD3' ' C ' ' A' ' 100' ' ' ALA . 47.8 Cg_endo -70.81 127.43 13.75 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.57 1.3 . . . . 0.0 110.364 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.62 142.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.178 -0.951 . . . . 0.0 110.083 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.3 p -120.85 -83.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.86 -124.34 17.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.4 ptm -113.01 -27.07 8.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -105.15 -144.04 0.37 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.614 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 13.3 mtpt -138.68 -68.75 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.876 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.701 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 48.0 Cg_endo -71.49 117.99 5.43 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 O-C-N 123.356 1.187 . . . . 0.0 111.581 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -141.86 -175.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.779 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.644 ' N ' HG13 ' A' ' 110' ' ' VAL . 38.0 p90 -114.57 164.39 14.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.8 p -74.43 117.4 16.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.515 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.5 p-10 -132.58 122.98 18.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 109.574 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.5 Cg_endo -69.07 170.27 56.31 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.232 0.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.7 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -73.57 -175.93 2.29 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.146 1.603 . . . . 0.0 110.081 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 123' ' ' HIS . 11.4 m -100.94 147.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 109.503 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -118.02 128.59 54.92 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.614 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 77.1 p -131.63 174.4 10.15 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -67.96 -16.95 64.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 1.2 p90 -96.67 28.19 3.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 105.38 -166.13 14.35 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 31.6 p90 -116.57 152.79 33.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.39 -1.065 . . . . 0.0 109.905 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.623 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -134.74 136.23 42.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.966 -1.084 . . . . 0.0 112.346 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.074 HD13 HD21 ' A' ' 58' ' ' LEU . 19.0 tt -121.17 108.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.993 HG22 ' HB2' ' A' ' 42' ' ' HIS . 24.9 pt -107.4 157.34 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.935 -1.103 . . . . 0.0 113.289 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 3.9 ttt -121.46 124.6 44.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 101' ' ' LEU . 16.3 m -109.74 120.88 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.649 -1.282 . . . . 0.0 111.903 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 129' ' ' GLY . 46.3 tt0 -115.29 149.21 38.19 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 48.22 95.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -131.56 150.7 52.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -1.0 . . . . 0.0 109.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.081 . . . . 0.0 110.16 -179.783 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.727 ' O ' HG23 ' A' ' 86' ' ' THR . 45.7 t30 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -100.69 159.2 15.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.52 -0.737 . . . . 0.0 109.282 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.7 p -143.3 154.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.8 ttpt -98.49 125.4 43.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 74.5 t -121.97 132.56 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.833 -177.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.2 mtt180 -120.16 130.91 54.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.977 ' HB2' HG22 ' A' ' 125' ' ' ILE . 11.2 p-80 -143.81 170.34 16.06 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.971 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.995 ' CD1' HG12 ' A' ' 67' ' ' VAL . 2.5 tt -124.32 113.77 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 8.1 tt -107.64 119.43 39.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 53.8 t -141.36 150.64 42.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.573 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 30.2 mt-10 -53.68 168.25 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 108.888 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' C ' ' CD2' ' A' ' 48' ' ' HIS . 8.6 ttmt -99.03 115.22 28.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.594 -1.316 . . . . 0.0 113.021 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 2.7 m80 -134.73 20.57 3.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.607 . . . . 0.0 109.651 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.14 11.92 83.84 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 tttm -81.2 5.22 17.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.958 . . . . 0.0 110.401 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.695 HD11 ' CB ' ' A' ' 122' ' ' TYR . 14.3 mm -51.22 -44.58 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 96.7 mtp -69.25 -43.16 74.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.818 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.77 -57.35 13.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 0.0 110.526 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' OH ' ' A' ' 71' ' ' TYR . . . -55.53 -55.82 27.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 9.8 ptt? -60.84 -41.25 95.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.049 . . . . 0.0 110.3 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' MET . 81.9 tt0 -52.86 -50.18 64.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.925 -1.109 . . . . 0.0 109.173 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 67' ' ' VAL . 12.9 ttmt -74.13 -28.64 61.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -0.768 . . . . 0.0 109.466 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.847 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.98 -24.52 58.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.401 -0.812 . . . . 0.0 109.229 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 58' ' ' LEU . 16.3 tptt -22.37 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.41 0.624 . . . . 0.0 112.082 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLY . 53.9 p -50.68 -52.29 41.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.394 -0.816 . . . . 0.0 109.63 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 60' ' ' SER . . . -45.0 -36.12 4.9 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 33.8 mmt -82.68 149.86 27.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -1.098 . . . . 0.0 110.315 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' HG3' ' CB ' ' A' ' 66' ' ' GLU . 1.3 ptm180 -73.55 106.54 5.37 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.961 0.886 . . . . 0.0 110.583 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 58' ' ' LEU . 9.0 t80 -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.484 0.659 . . . . 0.0 110.484 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.91 -56.88 16.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 111.075 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CB ' ' HG3' ' A' ' 63' ' ' ARG . 10.5 tp10 -55.81 -41.14 73.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.118 -0.989 . . . . 0.0 110.966 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.995 HG12 ' CD1' ' A' ' 43' ' ' ILE . 71.4 t -52.61 -59.09 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.748 -1.22 . . . . 0.0 109.803 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.584 ' CA ' HD11 ' A' ' 43' ' ' ILE . . . -64.94 -54.87 23.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -42.07 -27.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.413 -0.804 . . . . 0.0 109.838 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 68' ' ' ALA . 4.2 tp-100 -80.59 -62.85 1.55 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 109.992 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.768 ' OH ' ' HB1' ' A' ' 54' ' ' ALA . 50.9 p90 -109.96 51.16 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.606 -1.308 . . . . 0.0 111.084 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 31.1 t -89.83 131.14 35.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.248 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 68.4 mm-40 -102.4 -3.15 27.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.886 -1.134 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 78' ' ' GLN . 84.6 m-20 -104.6 26.89 8.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.922 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.77 -19.96 64.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.895 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -75.14 -29.82 60.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.092 -1.005 . . . . 0.0 110.802 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 55.9 mtt180 -118.62 -25.33 6.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.534 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 170.07 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.04 98.95 0.81 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.9 -103.8 0.25 Allowed Glycine 0 N--CA 1.491 2.333 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.2 m-20 -97.21 162.2 13.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -1.092 . . . . 0.0 110.739 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 42' ' ' HIS . 1.3 mp -101.64 -35.69 9.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 117.84 -161.99 13.2 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 17.1 m-90 -98.6 115.64 29.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.891 -0.77 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 ptm -134.78 138.24 44.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 110.208 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.787 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 93.3 m -104.14 -14.08 16.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.473 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 88' ' ' GLY . 27.6 ttt180 -100.0 -72.29 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 111.125 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . 44.83 66.41 1.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.6 p -120.44 66.3 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -1.092 . . . . 0.0 110.432 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 37.1 mmt -107.95 -49.06 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 94' ' ' PHE . 72.0 t -114.02 153.96 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.912 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -72.81 -64.77 2.47 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 121.2 -0.937 . . . . 0.0 111.062 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 37.0 Cg_endo -60.89 -30.9 90.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.71 1.374 . . . . 0.0 112.104 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 51.1 t80 -68.93 -40.67 78.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.738 -1.226 . . . . 0.0 110.426 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -72.86 -30.99 64.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.298 -0.876 . . . . 0.0 110.651 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 1.039 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 7.5 mm-40 -62.24 -26.51 68.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.82 . . . . 0.0 111.025 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.02 -54.63 3.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 111.315 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.41 -47.02 76.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.125 -0.984 . . . . 0.0 111.594 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.04 -8.63 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 111.544 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 1.039 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -130.33 25.88 5.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.698 -1.251 . . . . 0.0 111.89 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.81 135.54 83.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.712 -1.243 . . . . 0.0 109.373 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.82 -27.53 26.05 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.837 1.44 . . . . 0.0 110.991 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 103' ' ' VAL . 14.9 m -102.54 112.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.016 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.4 m -143.73 32.71 1.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.575 -0.703 . . . . 0.0 110.211 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.508 ' HA3' ' CG ' ' A' ' 108' ' ' LYS . . . -61.27 154.39 37.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -71.45 -24.86 62.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -1.152 . . . . 0.0 110.335 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -111.31 0.11 16.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.388 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 14.8 ptpt -132.74 43.61 1.11 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 45.8 Cg_endo -73.45 131.77 16.72 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.623 1.328 . . . . 0.0 109.39 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -143.65 -157.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.972 -1.08 . . . . 0.0 111.094 -178.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 39.3 p90 -123.2 164.33 18.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.6 p -50.43 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 67.3 t0 -122.32 116.85 29.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.931 . . . . 0.0 109.756 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.9 Cg_endo -70.72 164.33 82.27 Favored 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.987 -2.089 . . . . 0.0 110.535 0.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.638 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.5 Cg_endo -70.85 -176.25 1.72 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.967 1.509 . . . . 0.0 110.291 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.69 155.08 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.988 . . . . 0.0 110.402 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HE2' HG13 ' A' ' 51' ' ' ILE . 38.8 ttmt -124.03 127.4 47.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.53 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 38.9 p -138.81 -175.85 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.945 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -71.74 -35.09 70.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 118' ' ' THR . 1.4 p90 -80.03 7.54 8.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.014 -1.054 . . . . 0.0 109.956 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . . . 117.48 175.82 17.24 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.695 ' CB ' HD11 ' A' ' 51' ' ' ILE . 55.6 p90 -101.67 151.72 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -1.056 . . . . 0.0 109.453 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -132.23 140.68 48.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.867 -1.146 . . . . 0.0 111.95 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.888 HG22 HG22 ' A' ' 43' ' ' ILE . 8.0 tt -118.46 106.22 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.977 HG22 ' HB2' ' A' ' 42' ' ' HIS . 14.8 pt -115.07 149.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.492 -1.38 . . . . 0.0 112.695 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 41' ' ' ARG . 26.1 ptm -122.46 145.53 48.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.3 m -114.78 101.16 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.951 -1.093 . . . . 0.0 111.272 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 76.3 tt0 -143.59 87.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 110.486 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 39' ' ' LYS . . . 162.27 115.68 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.546 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 72.3 ttt180 -130.35 157.3 42.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -1.037 . . . . 0.0 109.533 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 56.5 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.129 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.688 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -105.01 -156.53 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.281 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 85' ' ' MET . 2.4 p -139.21 161.15 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 84' ' ' TRP . 47.1 mttt -99.61 111.55 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.885 -1.135 . . . . 0.0 109.309 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.48 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 46.3 mtt-85 -111.86 125.73 54.34 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.777 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -138.47 162.63 34.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.441 -1.412 . . . . 0.0 112.609 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.701 HD11 HD12 ' A' ' 124' ' ' ILE . 10.0 pt -129.85 137.64 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.012 HD13 ' OD2' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -107.74 131.56 54.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 111.1 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 71' ' ' TYR . 62.5 m -126.76 168.73 14.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 73.4 tt0 -74.04 158.91 33.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.0 ttpt -96.41 96.02 8.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.043 -1.036 . . . . 0.0 110.565 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 2.2 p-80 -132.71 6.82 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.554 -0.716 . . . . 0.0 110.009 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.77 2.37 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -114.72 10.87 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -1.185 . . . . 0.0 110.271 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG23 ' CG ' ' A' ' 115' ' ' PRO . 60.0 mt -53.63 -49.33 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.454 -0.779 . . . . 0.0 111.026 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.6 mmm -65.31 -50.68 64.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.987 . . . . 0.0 110.989 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.02 -42.88 99.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.948 . . . . 0.0 111.334 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . . . -61.38 -50.41 72.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.372 -0.83 . . . . 0.0 112.198 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.559 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 3.5 ptt? -65.48 -37.74 87.73 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.802 -1.186 . . . . 0.0 111.718 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 55' ' ' MET . 60.7 tt0 -65.39 -46.09 81.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -63.58 -34.19 77.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.962 -1.086 . . . . 0.0 108.594 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 124' ' ' ILE . 13.6 tp -71.59 -35.5 70.56 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.558 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 12.9 mttp 46.38 -92.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.504 -0.747 . . . . 0.0 111.161 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' LEU . 75.6 p -122.59 -3.61 8.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.147 -0.971 . . . . 0.0 110.976 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 -9.06 13.8 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 38.6 mmt -50.8 -34.95 29.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -1.159 . . . . 0.0 110.056 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -113.45 27.02 9.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.115 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' CE1' ' HE3' ' A' ' 126' ' ' MET . 8.9 t80 -53.11 -46.1 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 0.0 109.841 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 47.9 t30 -60.31 -40.3 90.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.601 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -65.25 -58.36 6.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 71.1 t -60.44 -63.23 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -46.29 -42.46 14.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -49.5 -56.15 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 109.935 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.04 -0.01 57.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 5.7 m-85 -104.33 3.16 32.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 110.382 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.2 t -99.89 93.65 5.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 0.0 109.729 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 24.6 mp0 -106.27 9.78 31.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.19 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 1.012 ' OD2' HD13 ' A' ' 44' ' ' LEU . 80.8 m-20 -117.29 46.17 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -66.15 -14.71 62.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.72 -37.07 42.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 111.363 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -121.99 15.66 10.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 111.599 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' CD ' ' NE2' ' A' ' 42' ' ' HIS . 0.5 OUTLIER -159.99 154.77 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.792 -1.193 . . . . 0.0 110.687 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.93 9.84 13.98 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 103.39 -52.98 0.75 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 41' ' ' ARG . 93.2 m-20 -115.44 137.94 51.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -1.085 . . . . 0.0 109.68 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 85' ' ' MET . 0.7 OUTLIER -100.52 -13.96 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 109.986 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 89.95 -115.62 4.6 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.356 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.625 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 79.5 m95 -89.46 133.56 34.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.989 . . . . 0.0 111.502 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 38' ' ' VAL . 22.8 ttt -122.59 124.81 44.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.2 m -134.92 -47.22 0.73 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.974 -1.079 . . . . 0.0 112.172 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 86' ' ' THR . 11.8 mtt180 -103.06 -88.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.69 -1.256 . . . . 0.0 111.744 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . -138.18 151.79 21.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 90' ' ' MET . 9.9 p -143.78 -53.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.273 . . . . 0.0 111.143 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 57.5 mmm -107.69 -98.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 111.362 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 120' ' ' PHE . 5.4 t -129.23 174.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.909 -1.119 . . . . 0.0 111.448 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -42.23 -54.16 4.67 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.746 -0.596 . . . . 0.0 112.284 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 43.5 Cg_endo -67.7 -19.75 47.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.459 1.242 . . . . 0.0 111.712 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 90' ' ' MET . 42.6 t80 -79.6 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.797 -1.19 . . . . 0.0 110.107 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.539 ' OE1' ' HE3' ' A' ' 85' ' ' MET . 28.4 mm100 -70.99 -38.23 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.769 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 4.7 mm-40 -70.75 -33.98 71.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' PRO . . . -69.7 -48.15 60.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.148 -0.97 . . . . 0.0 110.574 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.0 97.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 111.291 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.82 0.3 57.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.013 -1.054 . . . . 0.0 111.563 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -127.04 4.89 6.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.771 -1.206 . . . . 0.0 111.186 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.02 ' HG ' HG22 ' A' ' 103' ' ' VAL . 41.4 tp -82.08 116.75 65.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.906 -1.121 . . . . 0.0 109.842 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' HD2' HD12 ' A' ' 101' ' ' LEU . 47.2 Cg_endo -72.61 -18.97 25.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.862 1.454 . . . . 0.0 111.591 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.02 HG22 ' HG ' ' A' ' 101' ' ' LEU . 3.9 m -76.19 -21.83 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.866 -1.146 . . . . 0.0 110.559 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -109.34 107.94 18.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.807 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -161.7 9.83 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.313 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.2 ttt -76.01 -21.83 56.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.961 . . . . 0.0 110.954 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 107' ' ' ASP . 53.9 t0 -113.45 -14.78 12.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.052 -1.03 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.26 73.6 73.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.966 -1.084 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.28 123.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.071 1.564 . . . . 0.0 110.042 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 111' ' ' PHE . 17.5 m -143.31 -147.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.096 -1.002 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CZ ' ' CE ' ' A' ' 126' ' ' MET . 19.1 m-30 -101.42 171.18 7.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.519 -0.738 . . . . 0.0 110.039 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.719 HG21 ' CG2' ' A' ' 116' ' ' VAL . 65.0 m -65.18 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 111.802 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.771 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 99.0 m-20 -93.39 -24.93 0.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 42.5 Cg_endo -71.04 -27.36 7.5 Favored 'Cis proline' 0 N--CA 1.493 1.442 0 C-N-CA 124.306 -1.122 . . . . 0.0 114.484 1.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.624 ' HD3' ' CD ' ' A' ' 114' ' ' PRO . 51.5 Cg_endo -80.92 130.68 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 122.404 0.686 . . . . 0.0 112.576 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.719 ' CG2' HG21 ' A' ' 112' ' ' THR . 60.6 t -98.66 143.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 11.9 ptpt -102.51 108.55 19.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.53 -0.731 . . . . 0.0 111.065 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.645 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 19.4 p -136.84 158.37 44.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -65.82 -13.62 59.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.645 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.6 p90 -100.41 21.56 12.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.78 -1.2 . . . . 0.0 110.039 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 112.66 -169.9 13.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 33.7 m-85 -105.68 156.61 18.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 109.25 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 60.8 m-70 -135.16 128.57 32.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 112.199 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.836 HG21 HD22 ' A' ' 58' ' ' LEU . 95.7 mt -117.93 102.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -106.78 152.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.468 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.634 ' CE ' ' CZ ' ' A' ' 111' ' ' PHE . 20.3 mtt -124.17 136.21 54.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.69 139.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.888 -1.133 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -117.39 -37.57 3.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 110.46 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -145.64 121.6 1.53 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 41.5 ttt180 -110.25 149.4 30.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -1.132 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.128 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.288 0.566 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -90.63 -170.54 2.75 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 85' ' ' MET . 1.6 p -143.46 151.62 16.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.724 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.551 ' HG3' ' CE3' ' A' ' 84' ' ' TRP . 49.7 mtmt -99.27 129.6 45.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 109.257 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 82' ' ' LEU . 5.0 p -139.34 139.39 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.02 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.1 mtt-85 -110.74 122.5 47.97 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 80' ' ' GLY . 13.7 p-80 -138.27 148.25 44.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.821 -1.174 . . . . 0.0 111.501 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 19.4 mt -102.7 119.35 50.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 120' ' ' PHE . 4.4 tt -101.79 116.31 32.44 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 41.8 t -129.0 163.56 25.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.546 -0.721 . . . . 0.0 109.642 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 32.0 mt-10 -71.55 -178.91 2.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.598 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . 22.7 tttm -97.0 104.27 16.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.024 -1.048 . . . . 0.0 112.639 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.649 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.9 m-70 -133.13 0.42 3.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.254 -0.904 . . . . 0.0 110.504 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 122' ' ' TYR . . . 94.03 11.77 57.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' ILE . 98.0 mttt -85.56 3.85 38.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.253 -1.145 . . . . 0.0 110.739 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG23 ' HG2' ' A' ' 115' ' ' PRO . 67.8 mt -42.28 -53.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 98.5 mmm -66.01 -45.19 82.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.144 -0.972 . . . . 0.0 110.637 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.28 -48.1 81.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.781 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.0 -61.19 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.539 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.679 ' HA ' HD21 ' A' ' 58' ' ' LEU . 3.9 ppp? -63.19 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 110.712 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 52' ' ' MET . 39.5 tp10 -71.54 -28.25 63.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.073 -1.017 . . . . 0.0 110.016 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 67' ' ' VAL . 9.3 tptt -74.65 -34.77 62.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.846 ' HB3' HG21 ' A' ' 67' ' ' VAL . 3.7 pp -91.56 -16.98 26.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.817 ' O ' HD12 ' A' ' 58' ' ' LEU . 19.3 mtpt 43.45 -135.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.551 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 100.0 p -57.26 -24.98 58.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.138 -0.976 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.03 9.92 2.94 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtp -50.73 -44.79 58.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.892 -1.357 . . . . 0.0 109.723 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 67' ' ' VAL . 65.0 mtt-85 -114.24 38.82 2.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.455 -0.778 . . . . 0.0 109.702 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -52.55 -49.98 63.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.371 -0.831 . . . . 0.0 110.341 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 16.9 p30 -61.88 -42.26 98.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.5 mm-40 -59.25 -50.93 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.052 -1.03 . . . . 0.0 108.993 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 58' ' ' LEU . 92.4 t -57.5 -52.42 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 0.0 109.817 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -60.12 -40.57 90.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -49.89 -44.99 50.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.483 -0.761 . . . . 0.0 110.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -94.89 -11.79 28.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.529 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 43' ' ' ILE . 32.9 m-85 -117.81 25.75 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 111.1 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 t -103.68 115.43 30.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.927 -1.108 . . . . 0.0 110.214 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -100.34 -7.51 24.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.488 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 2.1 m-20 -104.92 23.7 13.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.491 -0.755 . . . . 0.0 109.065 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -49.89 -32.17 13.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.63 88.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -112.09 -45.22 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.125 -0.984 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.91 149.56 41.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.09 13.23 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 101.58 -5.91 54.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 36.5 p-10 -124.84 140.5 52.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -1.204 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 40' ' ' VAL . 63.3 tp -110.6 127.8 55.39 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.06 -1.025 . . . . 0.0 109.484 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -59.3 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE3' ' HG3' ' A' ' 39' ' ' LYS . 98.3 m95 -80.31 142.21 34.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -1.017 . . . . 0.0 110.727 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.877 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.2 ttt -128.89 121.81 28.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.619 -0.676 . . . . 0.0 109.269 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.1 m -118.28 -46.65 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.732 -1.23 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -100.41 -54.48 2.85 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.005 . . . . 0.0 110.502 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' NE2' ' A' ' 95' ' ' GLN . . . 160.74 -165.73 35.22 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -133.19 -75.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.513 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 41.7 mtp -140.37 -80.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.081 -1.012 . . . . 0.0 110.74 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 118' ' ' THR . 97.3 t -50.69 127.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.639 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.58 -51.48 30.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 38.9 Cg_endo -65.15 -8.78 19.49 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.461 1.243 . . . . 0.0 110.817 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.462 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 46.9 t80 -80.56 -46.17 16.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.04 . . . . 0.0 109.014 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' NE2' ' HA3' ' A' ' 88' ' ' GLY . 19.9 mt-30 -68.52 -30.72 69.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 79.9 mm-40 -54.41 -40.73 68.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -77.75 -51.08 11.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.55 -53.0 15.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -77.03 -17.48 58.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.407 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -58.76 -44.68 90.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.99 -1.069 . . . . 0.0 109.253 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 127' ' ' VAL . 69.4 mt -59.07 122.79 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.367 -0.833 . . . . 0.0 109.396 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -77.93 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.888 1.467 . . . . 0.0 112.013 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.0 141.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.178 . . . . 0.0 111.594 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.2 p -126.55 89.73 3.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.598 -0.689 . . . . 0.0 109.421 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.16 142.06 48.31 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -70.44 -12.46 61.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -100.6 -17.35 17.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 62.6 mttt -131.19 57.1 28.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.757 . . . . 0.0 109.596 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 44.9 Cg_endo -70.87 138.43 34.28 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.117 1.588 . . . . 0.0 110.69 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 111' ' ' PHE . 45.6 t -140.74 170.29 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' N ' HG12 ' A' ' 110' ' ' VAL . 50.5 p90 -123.21 157.06 33.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 0.0 110.139 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.456 ' CG2' ' HB ' ' A' ' 125' ' ' ILE . 77.3 p -56.86 109.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 110.642 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.548 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 22.3 p-10 -132.33 124.14 19.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.763 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 44.8 Cg_endo -70.79 164.74 81.43 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.208 0.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.614 ' HG2' HG23 ' A' ' 51' ' ' ILE . 46.3 Cg_endo -72.55 -178.5 3.41 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.085 1.571 . . . . 0.0 109.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' A' ' 123' ' ' HIS . 3.7 m -99.61 146.3 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.053 . . . . 0.0 109.396 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HD3' HD11 ' A' ' 51' ' ' ILE . 40.1 ttpt -120.83 134.58 55.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.006 -1.059 . . . . 0.0 110.46 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.583 HG21 HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -141.32 -164.29 1.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -0.88 . . . . 0.0 109.75 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -73.37 -45.91 52.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.992 . . . . 0.0 112.059 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.757 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 6.8 p90 -53.6 -41.62 66.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.065 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.673 ' N ' ' CG ' ' A' ' 120' ' ' PHE . . . 164.81 -124.4 1.25 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.563 ' OH ' ' HG3' ' A' ' 47' ' ' LYS . 15.7 m-85 -133.41 162.53 31.59 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.81 -1.406 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.787 ' HB2' HG22 ' A' ' 116' ' ' VAL . 97.6 m-70 -137.58 110.63 7.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.308 -0.87 . . . . 0.0 111.071 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -99.05 118.57 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 125' ' ' ILE . 3.4 mp -105.78 134.89 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.902 -1.124 . . . . 0.0 113.505 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 tpt -118.23 121.76 41.27 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 101' ' ' LEU . 17.0 t -92.8 144.14 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.808 -1.183 . . . . 0.0 111.389 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.2 -48.25 3.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.8 . . . . 0.0 110.234 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.14 149.25 16.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.18 157.2 44.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -1.134 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 pttt . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.083 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.368 0.604 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -99.44 155.37 17.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 30.4 m -138.63 158.16 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -100.54 122.48 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.724 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 82' ' ' LEU . 7.9 p -124.22 162.62 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.917 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 126' ' ' MET . 41.1 ttm180 -143.17 128.2 18.52 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.963 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.9 p80 -140.29 175.15 9.83 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.151 -1.593 . . . . 0.0 113.173 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.684 ' HB ' HG22 ' A' ' 124' ' ' ILE . 36.0 mt -128.55 125.15 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 45' ' ' CYS . 3.3 tt -105.56 131.38 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 110.566 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.765 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.0 m -142.85 162.33 35.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.914 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 85.4 mt-10 -75.91 161.44 28.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 79.5 tttt -72.58 119.5 16.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.195 -0.941 . . . . 0.0 111.692 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 12.3 m-70 -133.32 -1.57 3.19 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.42 -0.8 . . . . 0.0 110.45 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.58 81.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' HB2' ' A' ' 48' ' ' HIS . 21.7 ptmt -107.34 15.46 24.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.478 -1.013 . . . . 0.0 109.948 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.755 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -46.66 -52.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.386 -0.822 . . . . 0.0 110.44 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.3 ttp -53.95 -38.29 64.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 88.6 mt-10 -70.4 -39.13 74.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -59.04 6.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.655 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.9 ptm -59.01 -33.26 70.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.918 . . . . 0.0 110.171 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' O ' ' CD ' ' A' ' 59' ' ' LYS . 33.8 tp10 -72.93 -32.96 65.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 110.189 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 24.4 mmtp -63.54 -50.74 68.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 59' ' ' LYS . 3.2 pp -73.65 -20.26 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.79 ' O ' HD12 ' A' ' 58' ' ' LEU . 28.9 mmmt 53.66 -137.31 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.878 . . . . 0.0 110.781 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.44 ' O ' HG11 ' A' ' 110' ' ' VAL . 26.2 t -52.35 -39.14 60.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.45 2.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.429 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 16.1 ptp -51.88 -35.44 45.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' N ' ' CG ' ' A' ' 62' ' ' MET . 25.8 mtt180 -101.5 9.19 41.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 110.163 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -44.35 -48.73 9.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.05 -39.22 77.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.233 -0.917 . . . . 0.0 109.849 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.23 -40.84 74.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.602 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 58' ' ' LEU . 42.2 t -67.17 -49.16 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.443 -0.786 . . . . 0.0 110.044 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -58.22 -54.74 43.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.138 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.68 -51.26 16.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -75.7 -15.58 60.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 110.101 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.663 ' CE2' HG13 ' A' ' 67' ' ' VAL . 15.1 m-30 -111.14 18.32 19.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.454 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ALA . 19.4 p -79.48 93.56 5.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.015 -1.053 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 45' ' ' CYS . 3.5 mp0 -108.95 8.26 26.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' HB3' HD13 ' A' ' 44' ' ' LEU . 4.3 p30 -112.12 37.08 3.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -48.81 -31.05 6.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.01 -39.21 51.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -91.19 4.91 51.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.306 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 51.18 51.41 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.958 . . . . 0.0 109.592 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 74' ' ' ASP . . . -78.06 115.32 4.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.66 -122.79 0.64 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' C ' HD12 ' A' ' 82' ' ' LEU . 40.4 p-10 -86.71 131.55 34.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.128 -1.219 . . . . 0.0 109.007 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.814 ' HB2' HG13 ' A' ' 40' ' ' VAL . 7.2 mp -102.91 162.77 12.66 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.987 -1.071 . . . . 0.0 110.226 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -93.37 -135.39 7.43 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 13.3 m-90 -96.38 133.03 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.968 -0.725 . . . . 0.0 110.8 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -140.52 168.35 20.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.738 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . 31.8 p -128.02 -125.48 0.22 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.301 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -113.91 174.76 5.77 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.915 -1.116 . . . . 0.0 109.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.89 56.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 t -110.36 -29.51 8.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -1.125 . . . . 0.0 110.098 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 95' ' ' GLN . 2.1 ptt? -126.35 176.7 6.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 94' ' ' PHE . 19.3 m -68.44 -174.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.354 -0.841 . . . . 0.0 110.76 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.629 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -77.61 -47.38 8.85 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 121.468 -0.77 . . . . 0.0 111.897 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.9 Cg_endo -65.52 -46.77 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.064 1.033 . . . . 0.0 110.986 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.552 ' H ' HG23 ' A' ' 91' ' ' VAL . 1.6 t80 -66.56 -39.88 88.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.938 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 8.6 tt0 -69.64 -44.39 70.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 1.011 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 34.2 tt0 -51.36 -26.83 8.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.38 -38.25 13.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.247 -0.908 . . . . 0.0 110.479 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.57 99.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.399 -0.813 . . . . 0.0 111.642 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 86' ' ' THR . 10.5 m-85 -101.39 -12.85 18.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.162 . . . . 0.0 111.788 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 1.011 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -113.1 8.91 18.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.734 -1.229 . . . . 0.0 111.021 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.711 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.6 pt? -42.66 135.53 2.68 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.038 . . . . 0.0 109.575 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 -15.52 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.841 1.442 . . . . 0.0 111.692 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 109' ' ' PRO . 15.7 m -97.21 115.92 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 110.286 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -126.36 24.29 6.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.893 . . . . 0.0 110.297 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.497 ' HA2' ' HG3' ' A' ' 109' ' ' PRO . . . 108.9 -10.37 34.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 73.4 mtp -82.65 -29.4 30.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -1.071 . . . . 0.0 110.695 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD1' ' HG3' ' A' ' 108' ' ' LYS . 67.8 t0 -128.52 -94.45 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.964 -1.085 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 107' ' ' ASP . 18.0 mttm -130.69 86.2 53.44 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.849 -1.157 . . . . 0.0 110.741 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.497 ' HG3' ' HA2' ' A' ' 105' ' ' GLY . 49.6 Cg_endo -75.67 55.21 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.503 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 111' ' ' PHE . 62.2 t -104.32 -102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 110.36 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 124' ' ' ILE . 46.3 p90 -108.52 169.39 8.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 110.962 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.576 ' OG1' HG12 ' A' ' 125' ' ' ILE . 25.3 m -70.07 116.45 10.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.506 -0.746 . . . . 0.0 110.919 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 22.7 p-10 -133.85 112.78 12.59 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.7 Cg_endo -77.33 160.2 94.23 Favored 'Cis proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.153 -2.02 . . . . 0.0 110.36 -0.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 46.0 Cg_endo -72.86 -175.86 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.957 1.504 . . . . 0.0 109.908 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 116' ' ' VAL . 22.1 m -102.25 146.53 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.274 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -114.53 138.05 51.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 108.975 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.6 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 81.1 p -136.39 -173.9 3.54 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.708 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 120' ' ' PHE . 15.0 ptpt -76.36 -11.23 59.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -104.38 11.01 35.15 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.736 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.79 -167.1 12.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 45.6 p90 -108.86 157.91 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.315 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.604 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 12.2 m-70 -133.72 140.54 47.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 111.419 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 124' ' ' ILE . 19.9 tt -128.04 111.21 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.963 HG22 ' CB ' ' A' ' 42' ' ' HIS . 28.8 pt -108.62 161.2 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.789 -1.194 . . . . 0.0 111.836 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.561 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 39.5 mtm -128.05 143.88 51.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 101' ' ' LEU . 16.7 t -118.37 128.59 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.981 -1.074 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -144.26 -38.08 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.985 -1.072 . . . . 0.0 111.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . -89.26 88.32 1.51 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.418 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -118.66 135.89 54.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -1.167 . . . . 0.0 110.04 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.289 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.9 t-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.16 0.505 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -59.9 139.43 57.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG12 ' HA2' ' A' ' 129' ' ' GLY . 28.8 m -147.02 165.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.507 -0.746 . . . . 0.0 111.298 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -97.06 126.32 42.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.023 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.11 134.05 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.867 -1.145 . . . . 0.0 112.226 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 48.2 mtm-85 -114.15 126.03 54.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.099 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.3 p-80 -133.51 151.47 51.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.535 -1.353 . . . . 0.0 112.231 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 67' ' ' VAL . 86.3 mt -113.4 126.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.623 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -113.99 121.17 43.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 110.934 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 19.4 p -132.95 177.52 7.59 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.721 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 74.3 mm-40 -64.14 158.16 23.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.573 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.69 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 5.0 ttmt -101.84 73.17 1.4 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.942 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.721 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 75.8 m-70 -135.12 51.55 2.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 111.728 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.52 -10.35 55.82 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.759 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -71.15 -15.15 62.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.336 . . . . 0.0 110.675 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 122' ' ' TYR . 7.3 tt -52.95 -36.16 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 55' ' ' MET . 26.0 ttt -67.23 -40.14 86.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 110.143 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -67.56 -34.63 77.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.909 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 124' ' ' ILE . . . -61.65 -63.06 1.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 18.5 ptt? -56.32 -34.75 66.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.797 . . . . 0.0 111.0 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 55' ' ' MET . 87.6 tt0 -69.91 -42.02 73.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 111.288 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 62' ' ' MET . 53.0 mtpt -80.27 -24.95 39.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.978 . . . . 0.0 111.246 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 124' ' ' ILE . 2.3 pp -104.35 2.87 31.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 58' ' ' LEU . 6.2 mttt -49.46 178.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.07 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -52.47 139.48 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 110.095 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.05 -10.95 69.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 29.5 mmt -100.9 163.71 12.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -1.049 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.497 ' CG ' ' HG3' ' A' ' 66' ' ' GLU . 4.9 ttm180 -93.77 95.04 8.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -46.24 -31.43 2.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 0.0 110.337 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.61 -41.24 92.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.127 -0.983 . . . . 0.0 110.011 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.497 ' HG3' ' CG ' ' A' ' 63' ' ' ARG . 3.4 mt-10 -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.826 HG13 ' CE2' ' A' ' 71' ' ' TYR . 53.6 t -68.94 -38.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.897 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -70.9 -51.38 26.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 110.465 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.34 65.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.672 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 10.9 mm100 -91.42 -19.75 22.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.031 -1.043 . . . . 0.0 110.735 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.826 ' CE2' HG13 ' A' ' 67' ' ' VAL . 17.2 m-30 -108.71 10.44 26.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 0.0 111.078 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 16.7 m -76.44 116.76 17.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.937 -1.102 . . . . 0.0 110.154 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 25.3 tp10 -104.5 10.41 35.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 22.0 t70 -114.9 108.29 16.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.158 -0.964 . . . . 0.0 110.543 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HA ' ' HG3' ' A' ' 78' ' ' GLN . 17.1 ptpt -61.3 -25.18 66.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.04 -21.72 29.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -129.51 25.54 5.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.385 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.557 ' HG3' ' HA ' ' A' ' 75' ' ' LYS . 52.6 mt-30 -43.53 -28.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.93 -15.61 14.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . 61.39 24.03 63.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 55.4 t0 -130.74 142.84 50.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -1.116 . . . . 0.0 110.493 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.7 mp -104.04 -20.5 13.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.68 -170.06 34.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 28.9 m-90 -84.26 127.75 34.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -1.016 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 19.2 ptp -140.37 137.48 34.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 49.1 m -76.53 -54.64 6.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -111.14 -173.55 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.385 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . -149.62 146.07 14.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.6 p -137.9 16.07 2.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -1.182 . . . . 0.0 110.759 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 6.4 mmt -100.8 108.4 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.241 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.57 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 11.4 t 64.84 117.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.6 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -51.81 -53.05 31.44 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.49 -0.756 . . . . 0.0 111.461 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -65.66 -32.7 47.13 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.438 1.231 . . . . 0.0 111.705 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 125' ' ' ILE . 42.1 t80 -63.77 -52.46 60.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.851 -1.156 . . . . 0.0 109.932 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HG3' ' HA3' ' A' ' 88' ' ' GLY . 39.5 tt0 -55.12 -46.05 75.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.4 mt-10 -58.62 -48.63 80.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.12 77.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.343 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.23 91.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 36' ' ' ASN . 6.5 m-85 -103.63 13.23 33.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.957 . . . . 0.0 110.906 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' ' 103' ' ' VAL . . . -130.76 3.33 4.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.133 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 61.0 tp -69.35 -39.24 12.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 101' ' ' LEU . 45.4 Cg_endo -76.44 2.11 7.68 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.308 1.162 . . . . 0.0 111.976 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 100' ' ' ALA . 8.7 m -79.68 -27.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.276 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.6 m -106.54 18.82 21.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.17 123.92 6.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.456 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 89.7 mmm -56.52 -34.24 66.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -1.117 . . . . 0.0 109.98 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 106' ' ' MET . 93.4 m-20 -140.46 -59.08 0.53 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.999 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -128.3 158.84 70.1 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.867 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 44.3 Cg_endo -72.82 158.37 50.27 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.935 1.492 . . . . 0.0 111.699 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.5 p -141.75 -138.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.815 ' N ' HG13 ' A' ' 110' ' ' VAL . 31.4 p90 -102.56 158.06 16.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.828 -1.17 . . . . 0.0 110.134 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 1.009 HG21 HG13 ' A' ' 116' ' ' VAL . 22.4 m -40.61 121.98 1.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 37.8 p-10 -133.51 104.76 12.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.909 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.963 ' O ' HG22 ' A' ' 112' ' ' THR . 49.5 Cg_endo -76.78 176.91 41.88 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.198 -2.001 . . . . 0.0 110.471 0.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 114' ' ' PRO . 41.7 Cg_endo -69.32 166.67 26.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.764 1.402 . . . . 0.0 109.686 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 112' ' ' THR . 34.2 m -110.3 139.18 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.01 . . . . 0.0 110.656 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . 1.2 pttp -114.03 131.39 56.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.474 -0.766 . . . . 0.0 108.934 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 69.8 p -134.75 176.21 8.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.965 -1.084 . . . . 0.0 110.822 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -61.49 -8.73 4.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.74 -0.6 . . . . 0.0 111.369 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 11.0 p90 -112.73 37.95 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.705 -1.247 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . 99.65 -173.38 25.84 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 51' ' ' ILE . 20.5 m-85 -99.01 158.62 15.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -1.05 . . . . 0.0 108.417 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.68 ' CE1' ' CD2' ' A' ' 120' ' ' PHE . 73.0 m-70 -141.35 137.71 32.54 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.063 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.881 HD13 HD21 ' A' ' 58' ' ' LEU . 69.9 mt -128.29 96.38 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.099 HG22 ' HB2' ' A' ' 42' ' ' HIS . 15.4 pt -103.79 137.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.942 -1.099 . . . . 0.0 112.029 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 48.9 mtp -107.42 142.08 37.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.407 HG23 HD23 ' A' ' 101' ' ' LEU . 30.0 t -119.83 125.2 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.719 -1.238 . . . . 0.0 111.576 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -107.82 -47.62 3.55 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 38' ' ' VAL . . . 119.54 176.83 16.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 46.3 tpt85 -116.96 -48.48 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.968 . . . . 0.0 109.117 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.235 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' HG22 ' A' ' 86' ' ' THR . 35.6 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.835 0.35 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.79 ' HB1' ' N ' ' A' ' 85' ' ' MET . . . -117.99 176.62 5.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.5 OUTLIER -120.98 151.24 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HG3' ' CZ2' ' A' ' 84' ' ' TRP . 1.9 tmmt? -100.42 121.85 42.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.106 -0.996 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.981 HG23 HG22 ' A' ' 127' ' ' VAL . 10.2 p -142.44 147.94 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 119.344 -0.943 . . . . 0.0 112.876 -178.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' NE ' ' HB2' ' A' ' 81' ' ' ASP . 65.8 mtp180 -130.06 137.38 50.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 2.4 p-80 -142.69 167.75 21.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.162 -1.587 . . . . 0.0 113.061 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.49 HD13 ' CG1' ' A' ' 67' ' ' VAL . 5.1 mt -127.55 130.36 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 73' ' ' GLU . 6.7 tt -113.91 118.86 35.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 48.1 t -129.68 154.22 47.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 35.0 tp10 -60.24 163.83 4.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 0.0 109.86 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 18.2 ttpt -97.58 96.74 8.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 0.0 110.38 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.565 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 1.4 p80 -132.07 21.89 4.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.48 19.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 120.107 -1.044 . . . . 0.0 110.603 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 71' ' ' TYR . 8.9 tttt -114.65 18.35 16.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.889 -1.359 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 4.2 mt -57.41 -42.39 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.488 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 62.8 ttp -65.86 -46.96 76.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.888 . . . . 0.0 110.869 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 50' ' ' LYS . 72.1 mm-40 -59.89 -47.41 85.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -0.985 . . . . 0.0 110.641 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -55.0 -60.73 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.529 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' LYS . 3.7 tmm? -62.47 -33.33 74.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 110.088 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.5 tt0 -59.15 -46.13 89.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -60.21 -46.64 89.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.76 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 111' ' ' PHE . 4.1 pp -101.26 25.33 8.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 110.365 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' MET . 7.9 tptt -35.09 -70.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.744 -0.598 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.4 m -91.3 25.0 2.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.77 32.78 66.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.78 40.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -1.05 . . . . 0.0 110.568 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 71.5 mtt180 -117.71 37.36 3.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 111.715 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CE2' ' CZ ' ' A' ' 111' ' ' PHE . 25.7 t80 -49.28 -46.92 47.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.707 -1.245 . . . . 0.0 109.988 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -63.97 -45.96 86.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 110.73 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 38.9 tt0 -64.94 -45.2 86.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 110.426 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.893 HG11 HD23 ' A' ' 58' ' ' LEU . 67.2 t -55.1 -41.81 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.749 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -64.13 -59.2 4.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.0 109.638 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.49 -40.21 1.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 0.0 111.688 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.507 ' CD ' ' CE1' ' A' ' 71' ' ' TYR . 0.5 OUTLIER -101.18 -30.27 11.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 112.002 -178.696 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.532 ' CE2' ' HD3' ' A' ' 50' ' ' LYS . 8.3 m-85 -100.79 28.36 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.641 -1.287 . . . . 0.0 109.945 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 41.0 t -115.82 123.27 47.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 44' ' ' LEU . 64.8 tt0 -101.83 -8.14 21.9 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' GLN . 46.6 p30 -108.04 32.43 4.77 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -60.03 -37.01 78.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.4 71.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.383 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.431 ' C ' ' HG3' ' A' ' 78' ' ' GLN . 13.7 ptp180 -87.58 -47.64 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.8 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' ASP . 20.2 mt-30 -138.6 -127.15 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.256 -0.903 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.56 25.8 8.48 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.22 -135.43 1.81 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.018 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.623 ' C ' HD12 ' A' ' 82' ' ' LEU . 59.8 t0 -73.98 150.18 40.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -1.099 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.736 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.0 mp -100.9 -15.47 17.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.47 -0.769 . . . . 0.0 108.941 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 82.39 -145.34 24.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.6 m-90 -109.08 133.3 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.667 -0.902 . . . . 0.0 110.101 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.79 ' N ' ' HB1' ' A' ' 37' ' ' ALA . 25.0 ptp -141.1 154.37 45.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.404 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 36' ' ' ASN . 32.8 p -115.81 -66.05 1.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 110.371 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -104.35 37.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.879 . . . . 0.0 110.709 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.2 97.59 1.8 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.424 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 25.2 t -101.69 114.89 29.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.368 -1.078 . . . . 0.0 109.93 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 30.5 mmt -100.42 -106.35 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' A' ' 93' ' ' PRO . 70.1 t -64.42 -51.33 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.911 -1.118 . . . . 0.0 110.397 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.64 -67.19 0.45 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' A' ' 91' ' ' VAL . 45.1 Cg_endo -70.49 -25.08 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.105 1.581 . . . . 0.0 109.612 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.82 ' CE1' HD11 ' A' ' 125' ' ' ILE . 58.7 t80 -70.61 -33.92 71.57 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.468 -0.77 . . . . 0.0 109.567 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 65.4 tt0 -73.04 -54.88 7.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 110.154 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -48.02 -61.9 1.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -62.13 -66.55 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.422 -0.799 . . . . 0.0 111.504 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -54.3 -63.46 1.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 112.206 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 18.5 t80 -41.71 -42.91 2.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.528 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.86 -89.55 0.27 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' HD2' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -119.43 119.46 31.63 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 111.484 -178.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.876 ' HD2' HD13 ' A' ' 101' ' ' LEU . 43.7 Cg_endo -71.18 -32.71 12.56 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.419 1.221 . . . . 0.0 110.453 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 105' ' ' GLY . 28.1 m -120.67 -152.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.145 -0.972 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.2 m -104.93 11.96 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.929 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.77 ' H ' HG23 ' A' ' 103' ' ' VAL . . . -108.81 121.74 6.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.527 ' HA ' HD21 ' A' ' 101' ' ' LEU . 19.2 ptm -102.29 -0.2 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -101.9 -35.68 8.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.733 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 48.0 pttt -130.49 55.75 20.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.781 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 44.9 Cg_endo -71.16 115.05 4.11 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -130.38 -93.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.596 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.014 ' CE1' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.34 149.56 23.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.251 179.792 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 115' ' ' PRO . 21.2 m -75.1 101.63 4.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 55.3 t0 -132.48 111.94 13.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.146 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.6 Cg_endo -72.33 160.45 94.32 Favored 'Cis proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.849 -2.146 . . . . 0.0 110.271 0.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.682 ' HA ' HG22 ' A' ' 112' ' ' THR . 45.0 Cg_endo -72.46 -168.92 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.964 1.508 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.43 HG12 HG23 ' A' ' 118' ' ' THR . 19.4 t -101.21 131.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.529 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 51' ' ' ILE . 8.4 mtmm -102.03 123.14 45.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.312 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.569 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 41.4 p -134.62 -178.03 4.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -73.02 -16.48 61.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 111.369 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 3.8 p90 -97.1 1.6 50.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.738 -1.226 . . . . 0.0 110.983 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 131.52 -171.92 21.02 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.168 -1.491 . . . . 0.0 111.357 178.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 26.2 m-85 -101.23 150.54 22.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.742 -0.858 . . . . 0.0 109.34 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 15.0 m-70 -136.31 122.67 20.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.895 -1.128 . . . . 0.0 112.11 -179.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.014 HG22 ' CE1' ' A' ' 111' ' ' PHE . 25.8 mt -102.06 120.89 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.82 HD11 ' CE1' ' A' ' 94' ' ' PHE . 20.3 mt -108.88 126.87 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.777 -1.202 . . . . 0.0 112.54 -177.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 13.5 tpt -110.3 99.01 8.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.981 HG22 HG23 ' A' ' 40' ' ' VAL . 11.6 t -107.77 138.04 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.955 . . . . 0.0 111.471 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -143.1 3.72 1.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -0.834 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -125.52 139.78 11.79 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -132.59 133.05 43.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -1.21 . . . . 0.0 110.199 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.965 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.409 0.623 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -131.25 -177.02 4.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 7.7 p -144.74 156.11 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HE2' ' CZ2' ' A' ' 84' ' ' TRP . 42.1 mttt -98.23 136.18 38.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.08 -1.012 . . . . 0.0 109.411 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 59.7 t -133.53 146.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.874 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 126' ' ' MET . 84.0 mtt180 -141.62 123.34 15.18 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.99 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.72 -176.55 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.671 -1.268 . . . . 0.0 112.597 -178.342 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.83 ' HB ' HG22 ' A' ' 124' ' ' ILE . 82.5 mt -126.75 131.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 1.3 tt -106.7 126.38 52.21 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 110.68 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.438 ' N ' HD23 ' A' ' 44' ' ' LEU . 16.4 t -137.54 149.89 47.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.639 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 6.6 mm-40 -73.27 -155.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 122' ' ' TYR . 83.9 tttt -98.09 102.81 14.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.881 -1.137 . . . . 0.0 112.231 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.5 m-70 -132.56 -19.83 2.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.383 -0.823 . . . . 0.0 110.469 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.63 24.99 22.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 19.1 mttt -97.78 14.1 28.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.48 -1.012 . . . . 0.0 110.43 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.943 HG23 ' HG2' ' A' ' 115' ' ' PRO . 2.7 mp -44.37 -62.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.988 . . . . 0.0 109.997 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 22.1 ptm -66.33 -34.5 78.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.0 110.948 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -65.13 -39.71 93.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.69 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -67.07 -56.68 9.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.833 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.562 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -62.46 -31.84 72.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.894 -1.129 . . . . 0.0 110.385 -179.559 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 55' ' ' MET . 18.3 tp10 -62.58 -38.75 91.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.489 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD2' ' OH ' ' A' ' 71' ' ' TYR . 44.8 mttm -76.86 -37.8 54.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.799 ' CB ' HG21 ' A' ' 67' ' ' VAL . 4.2 pp -83.7 -2.28 55.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.911 -1.118 . . . . 0.0 111.128 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HG3' ' HA ' ' A' ' 56' ' ' GLU . 12.1 mttt -48.93 178.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 109.986 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -54.33 139.83 35.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.9 -23.55 29.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.487 ' HA ' ' CE ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -110.45 149.04 30.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.116 . . . . 0.0 110.283 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HG3' ' CG ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -87.16 107.39 18.45 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.043 0.925 . . . . 0.0 110.515 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD11 ' A' ' 43' ' ' ILE . 72.7 t80 -39.28 -40.92 0.83 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.493 0.663 . . . . 0.0 109.906 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -48.99 -46.98 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.251 -0.906 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CG ' ' HG3' ' A' ' 63' ' ' ARG . 80.2 mm-40 -65.35 -43.39 90.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 58' ' ' LEU . 44.2 t -59.95 -41.05 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -55.38 -46.72 76.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.689 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.56 55.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -64.92 -23.79 67.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 0.0 110.593 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 54' ' ' ALA . 12.3 m-85 -118.39 26.38 9.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 109.744 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ALA . 7.1 t -88.24 87.3 7.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 110.942 -179.078 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 1.1 tm-20 -101.79 5.27 41.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -0.975 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -126.07 12.86 7.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.366 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -53.9 -18.6 3.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.538 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.03 -26.17 56.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.9 mmm180 -127.44 -2.3 6.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.05 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 77' ' ' ARG . 6.7 tt0 -178.63 150.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.62 38.32 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 42' ' ' HIS . . . 65.24 18.95 65.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -128.3 118.34 23.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.126 . . . . 0.0 110.119 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.881 HD11 ' CD2' ' A' ' 42' ' ' HIS . 4.4 mp -101.69 150.91 22.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.928 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.72 -122.24 0.61 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 61.8 m95 -95.3 143.32 26.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.765 -0.844 . . . . 0.0 110.525 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.5 mmt -125.64 139.29 53.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.028 179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.9 t -134.02 -37.59 0.89 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' THR . 15.0 mtp85 -119.67 151.79 38.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 111.849 -177.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . -100.92 113.86 4.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p -139.16 12.49 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.324 . . . . 0.0 111.722 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.591 ' CG ' HG12 ' A' ' 91' ' ' VAL . 6.8 ptp -105.26 -26.59 11.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.78 -1.2 . . . . 0.0 110.077 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.61 HG22 ' HD2' ' A' ' 93' ' ' PRO . 11.5 p -167.36 -46.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' N ' HG13 ' A' ' 91' ' ' VAL . . . 132.93 -63.28 0.62 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.63 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 91' ' ' VAL . 38.7 Cg_endo -63.55 -37.68 46.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.907 1.478 . . . . 0.0 112.13 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.72 -45.94 91.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.619 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.513 ' HG3' ' CA ' ' A' ' 88' ' ' GLY . 1.5 tm0? -74.55 -42.04 59.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.15 -0.969 . . . . 0.0 110.791 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -64.75 -39.71 94.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 111.572 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.5 18.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.9 -1.125 . . . . 0.0 110.27 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.63 -42.28 23.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 110.399 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -70.42 -39.4 74.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.351 -0.843 . . . . 0.0 111.659 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . -137.11 51.53 1.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 113.067 -177.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 tt -80.63 111.42 22.92 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.482 -1.386 . . . . 0.0 109.453 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 48.5 Cg_endo -73.03 121.82 7.6 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.692 1.364 . . . . 0.0 110.801 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.707 HG13 ' H ' ' A' ' 104' ' ' SER . 1.0 OUTLIER -130.88 -78.22 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.707 ' H ' HG13 ' A' ' 103' ' ' VAL . 80.3 p -116.19 -2.27 12.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.23 175.06 30.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.5 mmm -77.54 -26.66 51.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -1.22 . . . . 0.0 110.266 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 53.5 t0 -108.95 15.23 23.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 0.0 110.754 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 98.6 mttt -124.43 45.72 1.36 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.086 -1.009 . . . . 0.0 110.433 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 53.1 Cg_endo -77.17 144.23 23.29 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.718 1.378 . . . . 0.0 110.769 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.607 HG12 ' HD2' ' A' ' 111' ' ' PHE . 86.0 t -140.74 -96.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.354 -0.841 . . . . 0.0 109.171 178.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.625 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 26.4 p90 -131.77 161.13 33.62 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.95 -1.094 . . . . 0.0 109.966 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 114' ' ' PRO . 18.9 m -68.12 118.18 10.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 111.543 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.625 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 32.3 p-10 -133.93 108.34 11.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 0.0 110.447 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 112' ' ' THR . 48.6 Cg_endo -75.28 176.17 44.73 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.093 -2.044 . . . . 0.0 110.344 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.943 ' HG2' HG23 ' A' ' 51' ' ' ILE . 44.2 Cg_endo -69.65 -175.03 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.877 1.462 . . . . 0.0 109.702 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 HG23 ' A' ' 118' ' ' THR . 46.6 t -102.07 137.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 0.0 110.111 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -102.11 125.54 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 109.064 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 38.7 p -142.04 -175.98 4.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.631 -1.293 . . . . 0.0 111.68 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.8 tttt -74.36 -10.67 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.768 -0.582 . . . . 0.0 110.132 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -103.55 37.92 1.91 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.065 -1.022 . . . . 0.0 109.605 179.117 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.6 -167.71 37.28 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.74 ' CE2' HD11 ' A' ' 51' ' ' ILE . 6.9 m-85 -103.72 144.13 31.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -1.084 . . . . 0.0 108.879 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 120' ' ' PHE . 10.1 m-70 -137.94 135.29 35.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.666 -1.272 . . . . 0.0 112.32 -178.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.83 HG22 ' HB ' ' A' ' 43' ' ' ILE . 11.5 tt -120.64 116.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.99 HG22 ' CB ' ' A' ' 42' ' ' HIS . 12.1 pt -114.46 158.28 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.571 -1.33 . . . . 0.0 112.651 -177.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.534 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 44.9 mtp -118.87 151.07 38.77 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.3 t -126.91 121.36 57.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.55 -1.344 . . . . 0.0 111.822 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.8 pt-20 -133.67 157.41 45.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 61.45 82.65 0.07 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 10.1 ttm180 -116.77 154.1 31.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.992 . . . . 0.0 110.173 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.546 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.9 mtpt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.184 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.174 0.511 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.811 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -129.65 -170.35 2.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 85' ' ' MET . 1.5 p -128.76 150.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.576 -0.703 . . . . 0.0 109.244 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HD2' ' CD2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -101.0 113.93 27.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.637 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 38' ' ' VAL . 38.6 t -127.14 152.31 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.836 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 93.5 mtt180 -133.73 121.93 22.62 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.114 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -131.06 159.23 38.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.638 -1.289 . . . . 0.0 113.008 -177.763 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 24.9 mt -122.82 123.21 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -104.63 120.97 42.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.6 p -133.09 -168.81 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.892 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 92.4 mt-10 -70.98 176.61 4.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.0 111.419 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.693 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 28.1 pttt -118.66 56.77 0.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.356 -0.84 . . . . 0.0 110.947 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.543 ' N ' ' CE2' ' A' ' 122' ' ' TYR . 19.3 m80 -134.6 64.04 1.61 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 111.576 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 -0.95 34.05 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.88 178.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.78 -10.78 59.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.984 -1.304 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.721 HD12 ' HB3' ' A' ' 122' ' ' TYR . 3.1 tt -62.15 -36.81 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HG3' ' N ' ' A' ' 53' ' ' GLU . 23.3 ptm -74.54 -42.97 57.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.957 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' N ' ' HG3' ' A' ' 52' ' ' MET . 19.1 mm-40 -68.12 -38.82 82.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.675 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.38 68.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.893 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.846 ' HA ' HD23 ' A' ' 58' ' ' LEU . 27.1 ptm -61.68 -35.39 77.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.916 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 55' ' ' MET . 91.7 mt-10 -68.44 -33.44 74.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.062 -1.024 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -68.72 -46.01 70.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -74.45 -27.77 60.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.977 -1.077 . . . . 0.0 110.446 -179.454 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 91.1 mttt 49.82 -126.98 2.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 62' ' ' MET . 55.7 p -65.45 -28.5 69.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 110.587 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 130.73 -5.82 5.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.434 ' HG3' ' OG ' ' A' ' 60' ' ' SER . 60.0 mtt -49.47 -31.43 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -1.225 . . . . 0.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.72 29.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 30.9 t80 -54.71 -40.99 69.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.904 . . . . 0.0 110.477 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 20.6 p-10 -58.59 -44.48 89.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -69.21 -44.13 72.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 58' ' ' LEU . 97.2 t -69.75 -26.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 110.413 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -74.16 -57.59 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.11 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.89 62.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.619 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.65 -29.81 33.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.173 -0.954 . . . . 0.0 111.124 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 23.4 m-85 -114.57 26.71 10.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.034 -1.041 . . . . 0.0 111.049 -179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 26.7 t -102.28 116.93 33.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.911 -1.118 . . . . 0.0 110.68 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.32 -7.42 24.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -111.86 21.22 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.508 -0.745 . . . . 0.0 109.212 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 6.4 tmtt? -53.8 -31.3 48.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.625 -0.672 . . . . 0.0 110.68 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.28 81.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.173 -0.955 . . . . 0.0 110.927 -179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.27 9.27 36.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.097 -1.002 . . . . 0.0 110.795 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 2.1 tt0 -169.07 172.62 7.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.054 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.69 27.49 6.83 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 72.66 11.5 77.4 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.657 ' C ' HD12 ' A' ' 82' ' ' LEU . 41.2 p-10 -133.08 129.46 38.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -1.182 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.9 mp -110.09 109.29 19.78 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 110.159 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -60.12 -123.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.081 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.692 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 78.2 m95 -76.45 130.26 37.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.795 -0.826 . . . . 0.0 110.808 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.921 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.8 tpt -137.28 136.04 37.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 0.0 109.767 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.811 HG22 ' CB ' ' A' ' 37' ' ' ALA . 19.0 p -122.78 -57.98 1.69 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.827 -1.171 . . . . 0.0 110.675 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' A' ' 86' ' ' THR . 21.9 ttm-85 -68.22 -48.99 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.739 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 46.65 64.79 2.46 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -122.93 43.59 2.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -1.06 . . . . 0.0 110.634 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.2 mtp -99.78 -32.04 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.768 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 89.9 t -142.96 112.38 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -43.04 -53.93 5.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.514 -0.741 . . . . 0.0 111.874 -178.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 42.8 Cg_endo -69.33 -19.66 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.511 1.269 . . . . 0.0 111.765 -178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.59 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 23.4 t80 -76.56 -54.09 7.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 110.771 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -66.52 -41.76 88.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.972 . . . . 0.0 110.897 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 14.1 pt-20 -60.23 -25.15 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.894 -1.128 . . . . 0.0 110.42 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -79.61 -50.74 10.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.773 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.32 -54.63 7.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.755 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 58.4 m-85 -56.42 -47.0 79.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 0.0 110.975 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -66.17 -39.69 89.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.202 -0.937 . . . . 0.0 111.196 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 102' ' ' PRO . 27.3 tp -57.15 127.82 76.86 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.985 -1.072 . . . . 0.0 110.802 -179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.734 ' HD2' HD12 ' A' ' 101' ' ' LEU . 45.5 Cg_endo -73.25 157.35 50.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.848 1.446 . . . . 0.0 109.864 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 130' ' ' ARG . 20.3 m -105.64 -1.61 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.824 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 105' ' ' GLY . 46.4 m -101.82 -48.02 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.906 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 104' ' ' SER . . . 40.79 -140.41 1.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.404 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 82.8 mmm -57.17 -47.5 81.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.99 . . . . 0.0 111.038 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 106' ' ' MET . 78.6 m-20 -143.19 -60.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 110.953 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . 50.7 mtpt -131.72 168.79 15.88 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.374 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 108' ' ' LYS . 38.2 Cg_endo -65.36 149.03 88.66 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.823 1.433 . . . . 0.0 109.543 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.1 p -143.4 -137.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.988 -1.07 . . . . 0.0 111.397 -178.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.828 ' N ' HG13 ' A' ' 110' ' ' VAL . 8.2 t80 -103.62 163.12 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 111.185 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.698 HG21 HD11 ' A' ' 125' ' ' ILE . 1.7 p -84.47 29.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 38.1 p-10 -71.73 130.17 87.42 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.986 -1.071 . . . . 0.0 110.389 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 112' ' ' THR . 49.0 Cg_endo -76.16 146.33 84.72 Favored 'Cis proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.949 -2.105 . . . . 0.0 110.082 -0.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.751 ' CB ' HG22 ' A' ' 124' ' ' ILE . 40.8 Cg_endo -66.34 -174.24 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.097 1.577 . . . . 0.0 110.902 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 28.5 m -101.68 158.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 110.248 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 51' ' ' ILE . 42.3 mttm -113.57 142.07 46.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.619 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 24.8 p -143.12 177.12 8.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.758 -1.214 . . . . 0.0 111.078 -179.471 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -80.85 -11.6 59.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.678 -0.639 . . . . 0.0 109.533 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.619 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.3 p90 -104.82 20.96 17.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 110.01 179.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.13 -173.04 14.52 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 51' ' ' ILE . 16.4 m-85 -100.25 160.87 13.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -1.033 . . . . 0.0 108.729 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.583 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 63.9 m-70 -141.98 122.48 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.708 -1.245 . . . . 0.0 112.061 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.814 HD12 HD22 ' A' ' 58' ' ' LEU . 30.9 pt -118.46 125.06 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.114 HG22 ' HB2' ' A' ' 42' ' ' HIS . 18.2 pt -123.88 173.03 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.684 -1.26 . . . . 0.0 112.944 -176.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.638 ' HG2' ' CD2' ' A' ' 111' ' ' PHE . 73.1 mtm -133.4 146.71 51.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 109' ' ' PRO . 7.9 m -121.32 120.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.867 -1.145 . . . . 0.0 109.974 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -107.12 -20.86 13.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 111.331 -178.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.481 ' HA3' ' NZ ' ' A' ' 39' ' ' LYS . . . -161.62 156.09 27.5 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.101 -1.523 . . . . 0.0 110.637 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.526 ' HB2' HG11 ' A' ' 103' ' ' VAL . 7.0 ttt180 -126.05 145.51 50.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.922 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 58.9 pttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 53.5 p30 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.724 0.773 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . -103.71 168.39 9.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 -178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 129' ' ' GLY . 1.3 p -128.78 153.63 38.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 110.022 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 2.9 mtpm? -98.87 132.99 43.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 109.084 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 82.5 t -130.36 143.12 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.292 -178.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 76.4 mtt180 -125.34 120.88 32.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.202 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.808 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -144.78 164.95 29.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.738 -1.227 . . . . 0.0 112.256 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.909 HD11 HD12 ' A' ' 124' ' ' ILE . 13.5 pt -126.47 144.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -101.34 122.36 43.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.881 -1.137 . . . . 0.0 110.041 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 36.5 m -111.51 170.07 8.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 110.275 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 27.8 mt-10 -88.45 -158.63 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 110.318 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.1 mtmm -128.04 92.63 3.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.923 -1.111 . . . . 0.0 111.142 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.594 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -132.88 17.26 4.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.95 2.25 81.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 5.0 ttmt -83.81 -12.95 54.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -1.079 . . . . 0.0 110.089 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -43.22 -41.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 110.298 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' MET . 41.7 ttm -60.94 -44.77 96.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.063 -1.023 . . . . 0.0 109.841 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -72.16 -31.73 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.05 -1.031 . . . . 0.0 109.385 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.68 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.757 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' HD23 ' A' ' 58' ' ' LEU . 25.5 ptm -65.97 -23.91 66.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 24.1 tp10 -64.35 -41.98 96.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.042 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -79.79 -38.42 33.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 0.0 109.057 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -65.96 -49.14 68.94 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.616 -0.677 . . . . 0.0 109.218 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 33.4 mtmt 50.09 -124.66 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 0.0 110.384 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -70.66 -31.72 68.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.0 -1.062 . . . . 0.0 109.932 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.94 7.26 5.61 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 ttt -47.73 -42.07 24.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.861 -1.376 . . . . 0.0 109.247 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 27.3 mtt-85 -108.5 30.51 6.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.524 -0.735 . . . . 0.0 109.255 179.178 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -46.94 -47.8 21.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.886 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -57.74 -39.05 76.45 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 77.4 mt-10 -67.67 -42.65 81.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 58' ' ' LEU . 96.5 t -70.11 -52.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.56 -40.25 51.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.092 -1.005 . . . . 0.0 110.331 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.72 91.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -89.77 8.31 32.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.683 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.556 ' HB3' HD12 ' A' ' 43' ' ' ILE . 33.1 m-85 -134.25 4.37 3.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.916 -1.115 . . . . 0.0 111.289 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -67.86 111.25 4.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 16.7 tt0 -102.06 5.59 40.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.748 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 29.3 t70 -132.98 45.33 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.975 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -66.65 -32.59 74.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.032 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.94 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 108.842 179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.456 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.4 mmm-85 -104.74 8.25 34.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.65 -0.656 . . . . 0.0 109.408 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 52.86 42.35 31.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.775 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.447 ' HA3' ' OD2' ' A' ' 74' ' ' ASP . . . -79.79 108.5 2.75 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -160.42 -92.45 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 78.1 m-20 -90.39 140.67 29.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -1.149 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -124.61 169.57 11.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -82.04 -122.99 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.466 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.629 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 18.4 m-90 -96.48 144.83 26.22 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.786 0.803 . . . . 0.0 112.116 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.2 ptm -139.88 155.54 47.15 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.3 p -129.84 -72.95 0.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.554 -1.341 . . . . 0.0 110.315 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 86' ' ' THR . 4.2 ttp85 -116.76 136.57 52.86 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.311 -0.955 . . . . 0.0 111.598 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' ARG . . . 58.34 144.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 90' ' ' MET . 53.2 p -142.37 -66.45 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.042 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.568 ' C ' HG23 ' A' ' 91' ' ' VAL . 20.0 ptm -142.06 -39.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.992 HG12 ' HD2' ' A' ' 93' ' ' PRO . 38.4 t -153.01 157.55 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 110.085 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -37.99 -60.67 1.26 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.992 ' HD2' HG12 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -63.62 -175.55 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.759 1.399 . . . . 0.0 110.334 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 125' ' ' ILE . 59.9 t80 68.48 -78.03 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.611 -0.68 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 12.0 tm0? -66.51 -47.93 71.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 81.8 mt-10 -61.68 -38.75 88.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.05 70.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 0.0 109.003 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.5 83.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.086 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 15.2 m-85 -69.51 -21.48 63.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' C ' ' HD2' ' A' ' 102' ' ' PRO . . . -86.25 -12.8 48.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.468 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 110' ' ' VAL . 9.8 tt -49.99 -45.66 81.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 101' ' ' LEU . 51.1 Cg_endo -75.65 77.64 3.28 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.299 1.157 . . . . 0.0 110.366 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.44 -32.05 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.7 p -128.19 -10.94 5.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.78 0.55 85.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.418 ' HB2' ' HE3' ' A' ' 106' ' ' MET . 76.6 mtm -77.52 -28.37 52.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -128.6 70.84 1.39 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 38.0 tptt -77.61 -42.46 2.38 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.061 -1.024 . . . . 0.0 110.105 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 52.9 Cg_endo -81.66 59.53 7.26 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.452 1.238 . . . . 0.0 109.521 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.87 HG12 HD21 ' A' ' 101' ' ' LEU . 1.4 p -133.78 -166.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.029 . . . . 0.0 111.524 -178.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.933 ' CE1' HG23 ' A' ' 124' ' ' ILE . 7.5 t80 -114.34 153.8 29.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.77 -0.581 . . . . 0.0 110.409 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 101' ' ' LEU . 66.2 p -72.85 119.38 17.0 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.352 -0.842 . . . . 0.0 110.732 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 111' ' ' PHE . 81.3 m-20 -133.45 121.9 16.64 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.257 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 48.8 Cg_endo -78.81 174.59 50.36 Favored 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.188 -2.005 . . . . 0.0 110.396 -0.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HG2' HD12 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -70.83 175.78 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.957 1.504 . . . . 0.0 109.926 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 32.6 m -103.19 155.44 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -123.08 136.11 54.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 36.4 p -139.02 168.02 20.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.103 -0.998 . . . . 0.0 110.645 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -64.89 -17.28 64.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.796 . . . . 0.0 110.017 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -97.38 19.62 12.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.985 -1.072 . . . . 0.0 110.366 179.526 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.552 ' HA2' ' CG ' ' A' ' 47' ' ' LYS . . . 117.72 -176.91 16.37 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-30 -97.82 158.8 15.31 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CE1' HD21 ' A' ' 44' ' ' LEU . 75.9 m-70 -138.09 140.19 39.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.403 -1.436 . . . . 0.0 112.302 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.933 HG23 ' CE1' ' A' ' 111' ' ' PHE . 84.2 mt -123.0 114.49 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -122.43 149.49 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 0.0 112.102 -178.725 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.455 ' HE3' ' HB2' ' A' ' 111' ' ' PHE . 89.8 mtp -128.5 150.75 50.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 38' ' ' VAL . 15.2 t -124.62 138.86 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.75 -1.219 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -114.9 -24.61 8.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 110.93 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -150.27 132.67 4.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.436 ' HB2' ' HE2' ' A' ' 108' ' ' LYS . 23.4 ttm180 -76.97 -42.67 38.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.969 . . . . 0.0 110.949 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 38.0 mtmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.229 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 49.8 p30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.411 0.624 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -107.47 164.69 11.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 130' ' ' ARG . 5.9 m -136.72 161.46 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.917 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HD3' ' NE1' ' A' ' 84' ' ' TRP . 7.3 mmmt -99.71 112.09 24.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.415 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.114 HG13 ' HB2' ' A' ' 82' ' ' LEU . 4.0 p -127.88 128.4 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.949 . . . . 0.0 111.465 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 46.6 mtm180 -118.42 134.0 55.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.995 ' HB2' HG22 ' A' ' 125' ' ' ILE . 13.7 p-80 -135.81 162.86 31.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.59 -1.319 . . . . 0.0 111.704 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' SG ' ' A' ' 45' ' ' CYS . 23.6 mt -116.64 121.86 68.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.247 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.616 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.8 tt -101.83 101.0 11.39 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.909 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.612 ' SG ' HG22 ' A' ' 43' ' ' ILE . 35.2 m -101.36 162.49 12.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.637 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.4 mt-10 -63.35 165.75 7.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.82 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 21.2 tttt -89.7 59.09 4.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.133 -0.979 . . . . 0.0 111.419 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 20.3 m80 -135.87 66.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.66 -1.275 . . . . 0.0 111.584 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.44 28.47 44.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.02 7.22 45.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.992 -1.299 . . . . 0.0 109.445 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 115' ' ' PRO . 43.2 mt -62.51 -50.81 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.541 -0.725 . . . . 0.0 110.581 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 49.2 mtm -69.15 -32.26 71.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.451 -0.781 . . . . 0.0 110.617 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 14.2 tt0 -62.54 -49.37 75.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.518 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -69.86 -51.32 34.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 111.479 -179.076 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 28.6 ptm -65.69 -43.9 87.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.315 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' MET . 64.3 tt0 -65.09 -41.23 95.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.956 -1.09 . . . . 0.0 110.686 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 55.3 mmtt -60.23 -56.14 25.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.655 ' CB ' HG21 ' A' ' 67' ' ' VAL . 1.2 pp -68.1 -14.04 62.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.62 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.0 mtpt 45.66 -133.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.795 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -57.87 -21.66 44.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.846 -1.159 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 123.45 10.73 5.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.4 ttm -51.16 -45.55 61.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -1.232 . . . . 0.0 109.927 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 10.7 mtp180 -109.66 31.6 5.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.903 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.61 -49.1 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -58.28 -46.86 85.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 109.374 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 51.4 mp0 -62.37 -41.53 98.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.299 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 58' ' ' LEU . 54.3 t -65.54 -44.38 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.553 -0.717 . . . . 0.0 109.294 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -57.76 -51.88 67.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.925 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -46.74 88.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 66' ' ' GLU . 7.1 mm100 -73.29 -28.06 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.315 -0.866 . . . . 0.0 111.27 -179.215 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 63.5 m-85 -108.76 13.82 24.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.057 . . . . 0.0 110.86 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 8.4 t -78.9 105.23 10.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.876 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 31.9 tp10 -101.4 1.34 38.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.734 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB3' HD13 ' A' ' 44' ' ' LEU . 20.4 p30 -103.4 24.56 10.82 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 110.112 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' GLN . 43.8 tttm -46.96 -49.25 21.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.87 -50.38 10.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.0 109.734 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 7.1 tpm_? -80.4 -11.55 59.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.605 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . 14.6 mm100 54.4 47.9 21.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.531 -0.731 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -81.61 -76.42 1.07 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.32 -84.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' GLY . 62.9 m-20 -109.25 150.61 27.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.579 -0.953 . . . . 0.0 109.632 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.114 ' HB2' HG13 ' A' ' 40' ' ' VAL . 2.9 mp -102.67 2.76 36.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 49.88 -139.53 18.06 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.1 m95 -89.94 114.8 26.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.395 -1.062 . . . . 0.0 110.574 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.496 ' CE ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.09 152.21 46.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.209 -0.932 . . . . 0.0 110.186 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.7 p -100.58 -89.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 110.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.536 ' N ' ' OG1' ' A' ' 86' ' ' THR . 39.3 ptt180 -116.61 138.71 51.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.375 -1.453 . . . . 0.0 110.901 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . -131.56 164.45 23.52 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -137.71 34.24 2.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.842 -1.387 . . . . 0.0 111.209 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.476 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 43.3 mmm -100.65 123.94 45.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 30.2 t 60.11 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 109.97 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.627 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -55.31 -43.95 84.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 43.7 Cg_endo -71.89 -12.12 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.369 1.194 . . . . 0.0 111.243 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 53.0 t80 -88.65 -54.48 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.0 110.18 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 2.0 tt0 -64.7 -43.64 92.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 110.677 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.653 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 47.1 tp10 -59.36 -42.97 92.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.973 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -60.35 -58.13 9.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.5 -56.33 2.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.473 -0.767 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.483 ' HZ ' ' O ' ' A' ' 86' ' ' THR . 38.0 m-85 -83.16 3.68 29.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.524 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -80.69 -29.74 36.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.193 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -107.99 94.09 12.08 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.165 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 50.0 Cg_endo -80.71 -33.89 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.939 1.494 . . . . 0.0 111.205 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.46 -173.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.737 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -113.77 84.31 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.782 . . . . 0.0 109.572 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.58 171.77 3.15 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.3 ttt -60.56 -28.53 68.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.566 -0.961 . . . . 0.0 110.544 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -117.15 23.35 11.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.039 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -121.33 130.79 24.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.001 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.25 -164.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.955 1.503 . . . . 0.0 110.5 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' MET . 7.2 p -106.83 -11.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 0.6 OUTLIER -118.52 172.37 7.53 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.105 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.557 ' OG1' HG12 ' A' ' 125' ' ' ILE . 2.1 m -76.97 -4.83 46.02 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 65.6 m-20 -48.44 122.48 10.35 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.344 -1.473 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' A' ' 112' ' ' THR . 43.4 Cg_endo -66.38 128.08 8.81 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.359 1.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HG2' HG23 ' A' ' 51' ' ' ILE . 38.4 Cg_endo -63.65 -179.3 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.086 1.572 . . . . 0.0 111.616 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.5 m -102.47 144.87 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.568 -0.707 . . . . 0.0 109.86 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 34.1 pttt -110.28 130.14 55.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.045 -1.035 . . . . 0.0 110.296 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.581 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.8 p -137.35 173.1 12.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.059 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -19.31 65.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.179 -0.95 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.8 p90 -93.46 19.32 8.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.803 -1.185 . . . . 0.0 110.369 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 114.88 -174.11 15.17 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.512 178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-85 -104.12 153.22 21.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.702 -0.881 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.616 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 13.1 m-70 -141.34 133.48 27.84 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.684 -1.26 . . . . 0.0 112.948 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -125.36 106.14 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.375 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.995 HG22 ' HB2' ' A' ' 42' ' ' HIS . 35.1 pt -105.11 157.0 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.857 -1.152 . . . . 0.0 111.864 -177.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 16.3 ptm -133.36 160.86 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.996 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.74 131.79 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.928 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.09 -4.51 16.55 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.486 -0.759 . . . . 0.0 110.225 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 38' ' ' VAL . . . -172.18 126.75 1.31 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 38' ' ' VAL . 2.2 ttt-85 -127.22 152.6 47.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -1.121 . . . . 0.0 109.857 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 36' ' ' ASN . 30.5 tttm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.063 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.506 ' HA ' ' HG3' ' A' ' 131' ' ' LYS . 19.9 p30 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -125.93 173.73 8.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 2.5 p -132.52 154.58 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 110.065 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 84' ' ' TRP . 37.7 mtpt -100.05 115.18 29.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 82' ' ' LEU . 69.9 t -120.04 125.54 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 111.497 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -124.98 109.62 13.2 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.808 ' HB3' HG22 ' A' ' 125' ' ' ILE . 4.0 p80 -134.96 166.97 21.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.701 -1.249 . . . . 0.0 112.427 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.666 HG21 ' CB ' ' A' ' 68' ' ' ALA . 17.9 pt -118.56 134.04 63.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.761 HD23 ' N ' ' A' ' 45' ' ' CYS . 5.0 tt -107.44 132.15 53.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.549 -0.719 . . . . 0.0 111.097 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.761 ' N ' HD23 ' A' ' 44' ' ' LEU . 42.8 t -140.26 163.57 32.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 109.088 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 59.5 mm-40 -72.54 158.31 35.94 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.153 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.58 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.6 tttp -78.38 122.69 26.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.248 -0.907 . . . . 0.0 111.333 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 9.2 m-70 -129.79 -13.74 4.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 0.0 110.416 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.38 2.95 50.79 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -88.59 18.39 4.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.177 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.533 HD11 ' HG3' ' A' ' 117' ' ' LYS . 53.5 mt -45.68 -46.78 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 109.293 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 55' ' ' MET . 23.5 ptt? -65.74 -35.32 80.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.412 -0.805 . . . . 0.0 109.52 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 34.9 tt0 -75.19 -27.5 59.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.289 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.2 -45.99 44.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 21.0 ptm -64.92 -44.91 87.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 77.6 tt0 -65.44 -41.32 93.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.451 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 28.5 mmtt -67.42 -31.21 71.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 108.524 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 124' ' ' ILE . 24.3 tp -73.93 -29.36 61.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.748 -0.595 . . . . 0.0 109.83 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 20.0 mttm 39.46 -92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 58' ' ' LEU . 83.0 p -129.48 -158.03 0.86 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . -73.17 -1.92 57.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.8 ttp -65.0 -46.15 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 110.463 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 81.6 mtt180 -106.21 11.36 31.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.765 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.444 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 73.7 t80 -50.23 -43.96 53.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 109.748 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.84 -38.7 80.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 109.897 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 64.9 mt-10 -61.64 -51.07 69.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.892 . . . . 0.0 109.841 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 71' ' ' TYR . 93.6 t -69.65 -39.44 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' HG21 ' A' ' 43' ' ' ILE . . . -60.51 -53.25 59.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.71 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.9 mm-40 -70.73 -28.0 64.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' HG13 ' A' ' 67' ' ' VAL . 12.0 m-30 -102.62 9.25 39.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 68' ' ' ALA . 47.4 t -79.07 88.18 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -104.33 7.66 35.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' ' CB ' ' A' ' 44' ' ' LEU . 43.0 p30 -132.01 40.49 3.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.468 -0.77 . . . . 0.0 109.982 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -64.89 -43.97 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.0 110.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.2 64.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -74.91 -33.09 61.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' ASP . 60.5 mt-30 -137.02 157.4 46.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.973 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.94 14.92 37.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.21 2.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 34.9 p-10 -121.3 137.37 54.72 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.318 -1.107 . . . . 0.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -104.35 -9.17 18.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 78.29 -143.98 27.81 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 39' ' ' LYS . 89.5 m95 -79.99 140.33 36.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.589 -0.948 . . . . 0.0 111.302 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.807 ' HG3' HD12 ' A' ' 82' ' ' LEU . 68.7 mmm -131.66 114.6 15.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.6 -0.688 . . . . 0.0 109.171 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.576 HG22 ' HB2' ' A' ' 37' ' ' ALA . 51.4 p -74.6 -43.38 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.979 -1.076 . . . . 0.0 109.896 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 8.6 mtt180 -107.55 -62.58 1.41 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.833 . . . . 0.0 110.015 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 89.6 111.01 1.31 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -141.94 86.3 1.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -1.165 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 91' ' ' VAL . 49.4 mtt -121.71 -37.26 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.095 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.03 -88.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.254 -0.904 . . . . 0.0 110.142 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -170.55 -69.45 0.04 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 -37.92 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.874 1.46 . . . . 0.0 110.571 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 125' ' ' ILE . 60.5 t80 -60.92 -49.99 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 3.5 tm0? -74.54 -55.25 6.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 110.094 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 3.1 tp10 -42.05 -45.65 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.54 -39.7 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.68 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.36 74.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 87' ' ' ARG . 34.8 m-85 -89.5 -5.47 57.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 110.156 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.43 8.73 14.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.32 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 127' ' ' VAL . 56.8 tp . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 111' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.071 0.462 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.576 ' H ' HG23 ' A' ' 110' ' ' VAL . 73.6 m-85 -106.55 146.89 30.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.635 HG21 HG13 ' A' ' 125' ' ' ILE . 13.3 p -72.04 86.87 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.002 -1.061 . . . . 0.0 109.065 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.1 125.77 38.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.446 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.3 Cg_endo -75.12 165.47 85.79 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 -2.147 . . . . 0.0 110.08 -0.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 -179.44 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.896 1.472 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 23.9 m -102.95 139.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.011 . . . . 0.0 110.558 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 51' ' ' ILE . 12.0 ttmt -112.08 123.81 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.598 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 73.7 p -130.65 176.1 8.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.981 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -72.03 -16.75 62.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.77 . . . . 0.0 110.551 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.598 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.1 p90 -98.18 19.4 14.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 0.0 110.187 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.58 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 111.29 -179.11 19.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 54.7 p90 -101.53 160.37 14.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -1.224 . . . . 0.0 110.034 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.581 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.3 m-70 -138.67 138.17 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 111.819 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.797 HG21 HD22 ' A' ' 58' ' ' LEU . 87.2 mt -115.27 111.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -103.23 143.86 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.066 . . . . 0.0 111.807 -178.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.8 tmm? -118.61 119.81 35.6 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 101' ' ' LEU . 46.8 t -97.56 121.2 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -110.53 -8.13 14.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.481 -0.762 . . . . 0.0 109.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.502 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -144.44 149.96 22.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.02 149.31 52.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.922 -1.34 . . . . 0.0 110.653 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 36' ' ' ASN . 71.6 tttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.081 0.944 . . . . 0.0 110.368 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -133.8 156.45 48.0 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.785 -1.197 . . . . 0.0 111.263 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.896 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.5 m -116.86 152.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HG3' ' CH2' ' A' ' 84' ' ' TRP . 5.5 mtmt -98.49 113.08 24.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.884 -1.135 . . . . 0.0 108.815 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.817 HG13 ' CG2' ' A' ' 125' ' ' ILE . 70.3 t -113.94 130.81 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.118 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -134.41 129.95 36.1 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.531 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.0 p80 -145.04 168.7 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.448 -1.407 . . . . 0.0 112.565 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 67' ' ' VAL . 89.4 mt -108.88 131.86 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -118.49 125.12 49.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 111.838 -178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 19.1 t -137.62 136.22 37.31 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.4 mm-40 -55.23 -157.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.502 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 92.8 mttt -97.91 105.04 17.12 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.47 -1.394 . . . . 0.0 112.509 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -133.02 16.7 4.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.242 -0.911 . . . . 0.0 109.897 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.28 23.49 73.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 91.7 mttt -94.51 6.18 49.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -1.006 . . . . 0.0 110.808 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 3.0 mp -51.27 -50.1 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.029 . . . . 0.0 110.392 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 39.5 ttp -69.62 -40.13 76.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -0.757 . . . . 0.0 111.288 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 54.1 tp10 -70.62 -41.09 72.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.656 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -61.49 -54.51 42.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 111.18 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 4.9 ptt? -61.79 -44.12 97.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.085 -1.009 . . . . 0.0 111.178 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.525 ' N ' ' CG ' ' A' ' 55' ' ' MET . 10.2 pt-20 -72.04 -23.61 61.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.929 -1.107 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.7 tptt -70.26 -45.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.805 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' HB3' HG21 ' A' ' 67' ' ' VAL . 1.3 pp -81.02 -23.06 38.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 61.5 mmtt 52.2 -133.62 1.77 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.116 -0.99 . . . . 0.0 111.178 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -36.28 66.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 110.622 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.2 -0.3 3.54 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.221 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.4 mtm -47.86 -36.87 12.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.007 -1.29 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 7.1 mtp180 -110.3 29.28 7.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.703 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.96 -47.78 43.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.527 -0.733 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.18 -37.55 78.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.881 . . . . 0.0 109.945 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 8.3 tp10 -65.48 -47.67 75.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 43' ' ' ILE . 41.0 t -63.52 -47.42 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.319 -0.863 . . . . 0.0 109.639 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -53.4 -51.06 63.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 110.127 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.97 67.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.687 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -70.81 -29.94 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 m-85 -106.94 11.12 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.009 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ALA . 79.7 p -76.58 69.67 3.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.398 -0.813 . . . . 0.0 109.741 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 11.7 pt-20 -111.24 26.79 10.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.638 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.702 ' HB3' HD13 ' A' ' 44' ' ' LEU . 47.9 p-10 -100.66 14.45 31.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 74' ' ' ASP . 21.9 tttm -38.32 -35.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 110.166 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.15 -37.63 47.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.565 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 41.8 ttt85 -121.82 17.74 11.04 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.462 -0.774 . . . . 0.0 109.744 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 62.61 -77.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 110.612 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . 53.62 -116.14 5.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 66.74 -84.15 0.11 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' C ' HD12 ' A' ' 82' ' ' LEU . 13.5 p-10 -132.69 136.5 46.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -1.117 . . . . 0.0 110.389 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.79 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.0 mp -102.09 147.44 26.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.77 -125.14 0.19 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.776 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 94.2 m95 -93.79 131.61 38.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.549 -0.971 . . . . 0.0 111.001 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.705 ' O ' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -127.6 122.24 32.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.104 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.0 p -72.14 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 111.04 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -87.19 -37.9 16.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' GLN . . . 57.66 77.82 0.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . 90.1 p -123.91 103.24 8.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -1.135 . . . . 0.0 109.718 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -141.65 -86.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.37 -41.39 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 111.25 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . 132.03 -77.41 0.39 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.301 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -24.17 44.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.759 1.4 . . . . 0.0 112.03 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -62.68 -47.82 81.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.759 -1.213 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -78.2 -38.12 43.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.531 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.89 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 89.6 mt-10 -55.35 -32.17 62.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.89 -40.24 16.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.036 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.37 7.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.841 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -70.56 -32.38 69.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.0 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -50.04 -35.36 24.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 127' ' ' VAL . 7.0 tt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 111' ' ' PHE . 95.7 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.699 0.761 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 110' ' ' VAL . 52.8 p90 -120.19 163.87 17.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 6.4 m -48.87 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.485 -0.759 . . . . 0.0 110.533 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.5 p-10 -127.05 120.36 22.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.097 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 45.3 Cg_endo -72.91 165.77 83.09 Favored 'Cis proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.623 -2.24 . . . . 0.0 109.736 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.8 Cg_endo -71.09 178.55 5.27 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.784 1.413 . . . . 0.0 109.765 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 26.8 m -101.43 161.99 3.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -124.54 118.55 26.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 109.208 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -136.6 171.78 13.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.734 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -65.37 -9.07 21.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.549 -0.72 . . . . 0.0 110.277 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -89.54 -20.18 24.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 109.043 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.17 -160.97 25.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 16.3 m-30 -100.72 134.54 43.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -1.077 . . . . 0.0 109.247 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.532 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 61.6 m-70 -125.39 121.75 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.011 -1.055 . . . . 0.0 112.556 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.645 HG22 ' HB ' ' A' ' 43' ' ' ILE . 4.8 tt -115.71 114.62 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.817 ' CG2' HG13 ' A' ' 40' ' ' VAL . 7.1 mt -107.13 125.56 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.942 -1.099 . . . . 0.0 113.543 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 9.8 tpt -100.09 114.12 27.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 101' ' ' LEU . 5.7 p -107.43 156.83 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.677 -1.265 . . . . 0.0 112.071 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -103.85 -29.29 11.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.493 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.79 -175.42 23.04 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.896 ' HB2' HG12 ' A' ' 38' ' ' VAL . 17.8 ttp180 -132.41 -85.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 50.6 tttm . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.538 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.172 0.511 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.968 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -127.24 -172.89 2.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.672 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.1 m -135.92 145.67 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 110.337 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -98.73 137.15 37.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.822 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.768 HG23 ' HB3' ' A' ' 82' ' ' LEU . 3.6 m -138.43 157.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.3 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HB2' ' HE2' ' A' ' 126' ' ' MET . 7.7 mmt85 -123.1 115.8 22.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -125.52 157.61 36.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.715 -1.24 . . . . 0.0 112.633 -177.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 16.3 pt -130.57 125.49 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.5 tt -106.42 123.84 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.16 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 1.4 t -143.26 -171.47 3.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.906 -1.121 . . . . 0.0 111.8 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 4.4 mt-10 -77.41 117.15 18.61 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.595 -0.69 . . . . 0.0 111.403 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -82.58 77.28 9.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.711 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 19.3 m80 -134.61 71.05 1.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.983 -1.073 . . . . 0.0 110.155 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.18 78.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.184 -1.567 . . . . 0.0 109.184 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 59.6 tttt -108.7 -11.55 15.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -1.044 . . . . 0.0 110.385 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.622 HD13 ' HE2' ' A' ' 117' ' ' LYS . 34.2 mt -47.58 -53.11 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 73.1 mtm -59.21 -37.34 77.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.446 -0.784 . . . . 0.0 110.598 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 75.0 mm-40 -61.41 -39.8 92.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.928 . . . . 0.0 110.568 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -66.38 -60.7 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.458 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.471 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 22.6 ptm -58.93 -44.44 91.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.026 . . . . 0.0 110.336 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 55' ' ' MET . 32.4 mm-40 -59.1 -42.98 91.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' MET . 66.2 tttt -72.07 -38.0 69.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 111.0 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.8 ' CB ' HG21 ' A' ' 67' ' ' VAL . 2.3 pp -93.98 10.81 31.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.956 -1.09 . . . . 0.0 110.807 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.9 ptmt -42.55 161.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.145 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -52.09 115.99 1.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.004 . . . . 0.0 110.087 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.11 -44.05 1.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 7.5 tpt -77.3 162.72 27.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -1.098 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -80.36 100.25 8.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CD1' ' SD ' ' A' ' 126' ' ' MET . 76.9 t80 -50.64 -32.54 19.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.966 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 54.8 t30 -55.38 -43.64 75.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.558 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.22 -44.1 84.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.696 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.8 HG21 ' CB ' ' A' ' 58' ' ' LEU . 59.3 t -55.81 -57.54 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -46.13 -58.02 3.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.54 -38.7 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.375 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.6 mm-40 -78.77 -32.36 46.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.212 -0.93 . . . . 0.0 110.584 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.78 23.15 13.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -1.0 . . . . 0.0 110.616 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 m -83.86 100.27 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.385 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.51 ' OE1' ' HG3' ' A' ' 46' ' ' GLU . 28.7 tt0 -100.66 4.62 43.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.506 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLN . 85.3 m-20 -102.07 72.1 1.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.459 -0.776 . . . . 0.0 109.357 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -50.55 -35.49 30.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.467 -0.77 . . . . 0.0 110.87 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.41 -54.41 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -73.3 -15.7 61.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.102 -0.999 . . . . 0.0 110.589 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.603 ' CG ' ' O ' ' A' ' 78' ' ' GLN . 1.6 pt20 33.92 99.94 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.249 1.023 . . . . 0.0 111.431 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -70.38 -90.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . 46.73 -91.63 0.01 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 79' ' ' GLY . 19.9 p-10 -106.13 132.45 52.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.589 -0.948 . . . . 0.0 110.075 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 40' ' ' VAL . 50.4 tp -116.88 135.08 54.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -56.48 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.8 m-90 -88.56 138.69 31.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.972 . . . . 0.0 110.466 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.5 mmm -101.41 119.45 38.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 108.999 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.968 HG22 ' CB ' ' A' ' 37' ' ' ALA . 3.6 p -119.36 -29.42 5.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 7.2 ptp180 -63.61 -33.67 76.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.429 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.508 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . 52.85 20.7 8.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -130.36 78.71 1.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -1.166 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 92' ' ' GLY . 7.9 ttt -136.9 153.23 50.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.618 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.884 HG12 ' HD2' ' A' ' 93' ' ' PRO . 57.0 t 34.51 -91.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.368 0.604 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.621 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 178.44 -74.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.884 ' HD2' HG12 ' A' ' 91' ' ' VAL . 43.9 Cg_endo -70.14 -11.8 31.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.137 1.598 . . . . 0.0 110.391 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -73.94 -66.63 0.69 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' HA2' ' A' ' 88' ' ' GLY . 13.3 mm-40 -65.4 -40.2 93.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 110.944 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.864 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 9.8 pt-20 -55.07 -38.5 68.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.749 -1.219 . . . . 0.0 109.848 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -68.12 -55.13 13.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.989 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.34 -49.57 12.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 7.3 m-30 -88.58 0.78 56.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.33 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -83.23 -25.76 31.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.151 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 101' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 111.267 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.51 0.672 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 54.3 p90 -123.65 172.56 8.71 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.611 ' CG2' HG12 ' A' ' 125' ' ' ILE . 3.1 p -58.26 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.607 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 10.5 p-10 -120.24 113.87 33.7 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.956 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.8 Cg_endo -73.4 164.53 86.89 Favored 'Cis proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.971 -2.095 . . . . 0.0 110.563 0.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 1.029 ' HB3' HG22 ' A' ' 124' ' ' ILE . 44.4 Cg_endo -73.02 -175.83 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.019 1.536 . . . . 0.0 110.385 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 123' ' ' HIS . 16.5 m -105.63 146.55 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.622 ' HE2' HD13 ' A' ' 51' ' ' ILE . 64.7 mttt -112.61 130.53 56.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 73.8 p -142.31 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.889 -1.132 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.24 -29.73 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 109.997 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 3.5 p90 -88.6 43.26 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.533 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.6 -157.75 27.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p90 -130.61 160.18 34.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -1.037 . . . . 0.0 108.476 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 1.4 m-70 -140.32 133.24 29.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.666 -1.271 . . . . 0.0 112.135 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.029 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -112.66 136.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -126.52 133.71 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.598 -1.314 . . . . 0.0 112.278 -176.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.675 ' HE2' ' HB2' ' A' ' 41' ' ' ARG . 31.2 mtm -94.42 99.01 11.28 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.78 110.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.429 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -139.4 151.09 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.17 60.26 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.18 169.23 14.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.58 -0.953 . . . . 0.0 110.392 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.328 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.4 t30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.748 0.785 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -136.36 164.2 28.67 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.645 -1.285 . . . . 0.0 110.648 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 85' ' ' MET . 17.9 m -139.48 146.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 33.0 tttm -100.57 130.34 46.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.918 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -130.78 149.68 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.863 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 45.6 mtt180 -140.17 126.32 19.81 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.026 ' CB ' HG22 ' A' ' 125' ' ' ILE . 2.3 p80 -144.9 -178.65 6.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.612 -1.305 . . . . 0.0 112.206 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 71' ' ' TYR . 9.2 pt -138.37 138.47 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -103.47 126.81 50.84 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.273 0.558 . . . . 0.0 110.386 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.8 p -134.38 171.09 14.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.063 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' NE2' ' A' ' 48' ' ' HIS . 73.3 mm-40 -61.69 171.17 1.65 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.261 -0.899 . . . . 0.0 110.623 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 6.0 tttt -116.56 80.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.988 . . . . 0.0 110.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.569 ' NE2' ' HB3' ' A' ' 46' ' ' GLU . 18.4 m-70 -134.78 63.21 1.63 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.936 -1.103 . . . . 0.0 111.966 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.97 9.95 12.53 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.241 -0.912 . . . . 0.0 111.114 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 37.4 ttmt -89.2 13.29 13.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.973 -1.31 . . . . 0.0 110.482 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.635 HG13 ' CE2' ' A' ' 122' ' ' TYR . 82.0 mt -64.29 -42.58 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.569 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.45 ' HE2' ' SD ' ' A' ' 55' ' ' MET . 38.6 mmt -69.26 -44.4 71.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.895 . . . . 0.0 111.273 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -70.65 -38.92 73.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.08 . . . . 0.0 110.746 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.5 -52.73 56.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.45 ' SD ' ' HE2' ' A' ' 52' ' ' MET . 5.7 ptt? -65.39 -34.39 78.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.887 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 16.0 tp10 -58.03 -46.41 85.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' CG ' HG22 ' A' ' 67' ' ' VAL . 22.2 tttt -67.57 -32.86 73.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 109.181 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.871 HD21 ' CE2' ' A' ' 111' ' ' PHE . 2.0 tp -74.41 -13.02 60.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 109.253 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 39.9 tptt -40.4 144.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.746 . . . . 0.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -50.4 149.43 3.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.235 -0.916 . . . . 0.0 108.953 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.88 -44.25 1.6 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.6 mmt -78.36 165.77 23.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.509 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -71.69 99.16 2.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.108 -0.995 . . . . 0.0 110.811 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 60.9 t80 -48.47 -29.54 4.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 109.304 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -77.79 -40.23 41.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 11.2 tp10 -56.54 -46.21 80.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.866 . . . . 0.0 109.67 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 58' ' ' LEU . 69.5 t -67.07 -44.06 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 109.558 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -54.89 -50.89 67.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.92 57.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.466 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.2 mm-40 -63.1 -29.08 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.807 ' HB2' HD12 ' A' ' 43' ' ' ILE . 21.9 m-85 -108.99 18.77 20.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.46 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.3 t -91.25 96.06 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -99.77 0.03 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.233 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 75' ' ' LYS . 41.2 t0 -105.97 15.26 26.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.464 -0.772 . . . . 0.0 109.953 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 14.4 pttm -41.81 -35.15 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -86.02 134.75 33.83 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 81.14 -18.39 0.5 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.683 -0.636 . . . . 0.0 109.962 -178.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.3 tt0 70.38 177.33 0.27 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 110.982 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 82' ' ' LEU . . . 154.8 -20.81 0.59 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 42' ' ' HIS . . . -48.29 -44.99 28.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.61 ' C ' HD12 ' A' ' 82' ' ' LEU . 34.6 p-10 -115.01 126.43 54.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -1.016 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.0 mp -101.35 7.8 42.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 60.26 -147.66 44.63 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 35.3 m95 -96.73 132.29 42.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.743 -0.857 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 38' ' ' VAL . 9.0 ptp -135.87 149.77 49.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.58 -0.7 . . . . 0.0 109.206 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 36' ' ' ASN . 26.4 p -111.47 -64.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.375 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' ' OG1' ' A' ' 86' ' ' THR . 7.3 mtp180 -71.69 -38.23 70.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 109.758 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 95' ' ' GLN . . . 60.03 55.38 30.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.8 m -103.67 106.23 16.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.251 . . . . 0.0 109.522 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.0 mmt -130.16 -83.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 111.107 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 93' ' ' PRO . 4.0 p -96.46 -28.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.235 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.46 -73.12 0.47 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.025 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 91' ' ' VAL . 44.0 Cg_endo -69.84 -41.67 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.849 1.447 . . . . 0.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -53.91 -38.41 64.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.071 -1.018 . . . . 0.0 109.393 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 88' ' ' GLY . 44.9 tt0 -67.33 -52.35 41.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.776 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 38.3 tt0 -54.45 -44.45 72.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -59.67 -56.12 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.07 -54.9 6.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.346 -0.846 . . . . 0.0 110.264 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.435 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 61.1 m-85 -85.08 11.29 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 0.0 110.478 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -102.15 -19.9 14.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.736 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.91 . . . . 0.0 112.638 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 111' ' ' PHE . 2.7 m . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD21 ' A' ' 58' ' ' LEU . 40.6 t80 -116.58 152.19 34.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.896 -1.127 . . . . 0.0 110.806 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.643 HG21 ' CG1' ' A' ' 125' ' ' ILE . 7.3 p -74.84 110.43 9.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 110.936 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 88.3 m-20 -133.81 121.69 16.12 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.8 Cg_endo -79.32 172.7 58.49 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.164 -2.015 . . . . 0.0 110.362 -0.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HG3' HD12 ' A' ' 124' ' ' ILE . 47.2 Cg_endo -73.15 178.12 6.95 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.956 1.503 . . . . 0.0 109.725 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 123' ' ' HIS . 16.2 m -99.91 155.11 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.008 -1.058 . . . . 0.0 109.378 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -125.26 130.43 52.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.58 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.593 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.2 p -134.04 178.23 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -72.89 -15.83 61.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -0.955 . . . . 0.0 110.617 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 1.8 p90 -95.84 24.62 5.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.174 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 109.97 -176.41 19.19 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.4 m-85 -100.02 154.04 18.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 53.4 m-70 -129.91 122.52 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.872 -1.143 . . . . 0.0 110.487 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.829 HD12 ' HG3' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -117.92 108.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.026 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -109.01 157.47 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.69 -1.256 . . . . 0.0 112.959 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.476 ' HA ' ' CD1' ' A' ' 111' ' ' PHE . 3.7 ttt -116.26 119.29 35.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.95 115.52 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.814 -1.179 . . . . 0.0 111.947 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -106.0 -18.28 14.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 70.7 -163.64 53.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG3' ' CZ3' ' A' ' 84' ' ' TRP . 66.1 ttt180 -132.77 -35.69 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.943 . . . . 0.0 110.003 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.288 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' THR . 38.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.26 0.553 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CA ' ' OG1' ' A' ' 86' ' ' THR . . . -113.14 168.73 9.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.0 110.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 14.3 m -130.3 169.5 21.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.558 -0.714 . . . . 0.0 109.882 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CG ' ' CE2' ' A' ' 84' ' ' TRP . 19.0 mtpt -98.53 119.61 37.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.095 -1.003 . . . . 0.0 109.193 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.719 HG21 ' CE ' ' A' ' 85' ' ' MET . 95.9 t -111.72 126.39 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.023 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NH1' ' OE1' ' A' ' 128' ' ' GLU . 71.0 mtm180 -119.77 125.67 49.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB3' HG23 ' A' ' 125' ' ' ILE . 2.1 p80 -143.92 178.81 7.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.392 -1.442 . . . . 0.0 112.416 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 88.6 mt -121.61 135.48 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.576 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -111.75 119.42 38.57 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.681 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 43' ' ' ILE . 15.4 m -130.22 168.31 17.05 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 67.6 mt-10 -88.5 -172.6 3.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 110.283 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 35.9 mtmt -102.83 101.66 11.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.962 -1.086 . . . . 0.0 111.442 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.607 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 28.7 m170 -134.57 6.56 3.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.888 . . . . 0.0 111.459 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.6 44.05 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.427 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 27.9 mttt -96.88 6.79 47.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.26 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' A' ' 122' ' ' TYR . 69.5 mt -46.14 -57.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' MET . 51.1 mtt -65.08 -40.24 94.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.482 -0.761 . . . . 0.0 109.842 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 tp10 -67.37 -22.01 65.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.192 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -75.56 -60.51 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.167 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.546 ' HB2' ' HG2' ' A' ' 114' ' ' PRO . 11.6 ptt? -56.93 -32.52 66.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -71.09 -42.55 69.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 39.3 mmtm -64.37 -50.64 66.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.807 ' HB3' HG21 ' A' ' 67' ' ' VAL . 2.5 pp -78.17 -14.88 59.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 109.522 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 60' ' ' SER . 4.5 ptmm? 23.41 -134.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 41.3 t -52.0 -22.1 3.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.938 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 126.77 2.46 6.71 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 58.3 ttm -56.86 -39.27 74.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -1.179 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 mtt180 -108.86 13.26 24.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.0 110.132 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 77.3 t80 -51.1 -48.87 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 49.5 m-80 -57.76 -43.38 85.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.35 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' CD ' ' HG2' ' A' ' 63' ' ' ARG . 41.4 mt-10 -68.09 -38.24 82.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.807 HG21 ' HB3' ' A' ' 58' ' ' LEU . 97.4 t -62.74 -71.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.416 -0.803 . . . . 0.0 109.134 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -48.65 -50.8 31.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -42.92 -42.24 3.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.822 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.549 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.1 tp60 -106.02 -6.61 18.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.378 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-85 -103.42 11.74 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.6 p -83.27 100.5 10.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 110.383 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -106.03 20.12 19.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.953 . . . . 0.0 110.067 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 30.2 t0 -137.85 39.84 2.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -59.84 -24.29 64.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.857 . . . . 0.0 110.189 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.93 81.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -103.26 -57.6 2.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.138 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ASP . 1.2 pt20 -135.19 164.83 26.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.84 23.21 31.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 97.76 1.32 58.77 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.558 ' C ' HD12 ' A' ' 82' ' ' LEU . 76.1 m-20 -134.15 132.01 39.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.799 -1.412 . . . . 0.0 110.929 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.3 mp -109.58 151.87 26.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.795 . . . . 0.0 109.368 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -77.56 -132.5 0.6 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.619 ' CE2' ' CG ' ' A' ' 39' ' ' LYS . 86.0 m95 -95.08 122.71 38.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.928 -0.748 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.719 ' CE ' HG21 ' A' ' 40' ' ' VAL . 6.6 ptt? -141.54 137.47 32.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 36' ' ' ASN . 89.1 m -103.38 -45.13 4.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.762 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -73.27 -32.22 64.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.0 -145.66 16.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -120.96 -62.16 1.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.147 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 85.9 mmm -137.44 -86.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.394 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 92' ' ' GLY . 9.9 p -174.61 176.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG22 ' A' ' 91' ' ' VAL . . . 93.93 -151.14 20.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HG13 ' A' ' 116' ' ' VAL . 43.0 Cg_endo -69.3 -8.34 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.245 1.656 . . . . 0.0 110.093 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.53 ' CE1' HD13 ' A' ' 125' ' ' ILE . 1.1 t80 -76.71 -48.52 18.58 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.514 -0.741 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -78.87 -47.6 16.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.129 -0.982 . . . . 0.0 110.835 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.97 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -62.43 -20.65 64.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 112' ' ' THR . . . -93.16 -55.02 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.786 -1.196 . . . . 0.0 110.545 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.31 -54.51 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.967 . . . . 0.0 111.388 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 38.8 m-85 -89.81 -21.85 22.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.158 -0.964 . . . . 0.0 111.609 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.97 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -119.05 32.43 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.823 -1.173 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.525 HD11 ' C ' ' A' ' 112' ' ' THR . 14.4 tp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 111' ' ' PHE . 48.9 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.559 ' CB ' ' HB3' ' A' ' 114' ' ' PRO . 92.8 m-85 -98.37 167.29 10.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 113' ' ' ASP . 96.8 m -62.15 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 112.558 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.815 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 54.2 t0 -70.33 -34.08 3.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.815 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 52.9 Cg_endo -76.16 -25.76 10.25 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.466 -1.056 . . . . 0.0 114.729 1.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 42.0 Cg_endo -71.14 115.56 4.32 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 122.341 0.653 . . . . 0.0 112.895 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 93' ' ' PRO . 32.3 t -111.39 153.08 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 14.6 ptmm? -143.06 117.93 9.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.795 -1.191 . . . . 0.0 110.697 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.827 HG21 ' CD2' ' A' ' 120' ' ' PHE . 1.3 t -145.37 179.65 7.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -64.12 -11.97 35.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.827 ' CD2' HG21 ' A' ' 118' ' ' THR . 0.0 OUTLIER -87.78 -17.99 30.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 108.673 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 129.08 -149.84 18.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.95 142.85 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -1.092 . . . . 0.0 108.446 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.576 ' CE1' HD21 ' A' ' 44' ' ' LEU . 35.2 m-70 -132.32 144.09 50.32 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.229 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.591 HD11 ' HB1' ' A' ' 54' ' ' ALA . 7.6 mt -132.72 109.96 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.052 HG23 ' HB3' ' A' ' 42' ' ' HIS . 1.2 mt -115.32 129.66 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.735 -1.228 . . . . 0.0 112.271 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.523 ' HG2' ' CD1' ' A' ' 111' ' ' PHE . 88.1 mtp -99.55 135.19 41.33 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.8 125.4 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.949 -1.095 . . . . 0.0 111.141 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.52 ' OE1' ' NH1' ' A' ' 41' ' ' ARG . 79.7 tt0 -142.21 147.75 37.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.08 76.47 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 38' ' ' VAL . 76.2 ttt180 -122.34 131.89 54.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -1.119 . . . . 0.0 110.179 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.164 0.507 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -128.92 172.03 11.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 110.7 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.6 p -141.45 156.94 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.357 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -100.13 119.72 38.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.66 HG21 HD21 ' A' ' 82' ' ' LEU . 4.5 m -127.31 157.36 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.7 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 37.9 mtt-85 -139.8 118.84 12.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.011 ' HB3' HG23 ' A' ' 125' ' ' ILE . 2.8 p80 -132.03 161.96 31.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.838 -1.164 . . . . 0.0 112.262 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 3.4 mt -115.81 128.15 73.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.652 HD13 ' OD2' ' A' ' 74' ' ' ASP . 5.1 tt -110.36 129.37 55.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.226 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' N ' HD23 ' A' ' 44' ' ' LEU . 45.1 t -132.33 152.5 51.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 33.8 mt-10 -64.76 -171.64 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.716 -1.24 . . . . 0.0 109.463 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.666 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 48.0 tttt -97.94 106.66 18.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.587 -1.32 . . . . 0.0 113.312 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 2.8 m-70 -131.63 -5.9 3.67 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.161 -0.962 . . . . 0.0 110.032 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.6 30.29 10.84 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' GLU . 82.3 mttt -109.63 -2.75 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 111.111 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.569 ' HB ' ' CG ' ' A' ' 122' ' ' TYR . 11.3 tt -45.64 -40.94 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 51' ' ' ILE . 16.6 ttt -65.66 -34.4 78.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.334 -0.854 . . . . 0.0 109.001 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' LYS . 79.5 tt0 -72.24 -41.75 66.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 108.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.94 -57.03 13.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.716 . . . . 0.0 110.12 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.698 ' HA ' HD23 ' A' ' 58' ' ' LEU . 28.3 ptm -68.83 -28.13 66.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.862 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.3 tt0 -74.57 -26.25 59.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB3' HG12 ' A' ' 67' ' ' VAL . 17.2 mmtm -81.41 -36.84 29.03 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.538 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.812 ' N ' HG11 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -83.96 -19.04 35.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.453 -0.78 . . . . 0.0 109.259 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 56' ' ' GLU . 60.8 mmtt 44.57 -138.75 0.38 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.48 -0.762 . . . . 0.0 110.052 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.8 t -54.86 -25.91 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 110.912 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 139.7 -11.47 3.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.4 mtp -48.21 -35.39 11.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 67' ' ' VAL . 9.7 mtt180 -112.91 26.64 10.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.154 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 79.6 t80 -55.49 -37.51 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -75.37 -39.56 59.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.339 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 61.1 mm-40 -62.43 -58.15 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.794 . . . . 0.0 109.534 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.812 HG11 ' N ' ' A' ' 58' ' ' LEU . 16.6 m -50.92 -44.7 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.242 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -62.72 -37.26 85.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.602 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -55.66 -36.9 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.176 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.53 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 4.1 tp60 -105.74 -10.83 16.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 110.794 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 67' ' ' VAL . 24.8 m-85 -114.23 18.94 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.247 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 36.6 t -111.77 113.24 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.831 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.94 -5.3 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.655 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.652 ' OD2' HD13 ' A' ' 44' ' ' LEU . 96.2 m-20 -104.43 59.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.452 -0.78 . . . . 0.0 109.607 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -55.43 -28.88 57.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.343 -0.848 . . . . 0.0 111.773 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.15 -36.12 6.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.729 -1.232 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -65.12 -55.54 18.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.12 . . . . 0.0 110.307 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HG3' ' C ' ' A' ' 77' ' ' ARG . 19.7 mt-30 -143.45 -72.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 110.696 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.84 -107.83 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -99.35 -37.97 3.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 39.2 p30 -128.5 134.65 48.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.076 -1.249 . . . . 0.0 110.959 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 85' ' ' MET . 2.1 pp -103.3 1.33 32.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.5 -134.81 11.84 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.6 m-90 -99.23 155.41 17.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.552 -0.97 . . . . 0.0 110.915 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -126.87 133.63 50.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.442 -0.786 . . . . 0.0 109.471 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.6 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.5 p -128.77 -37.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.035 -1.04 . . . . 0.0 111.011 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 3.1 mtm105 -116.63 -14.96 10.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.907 -1.121 . . . . 0.0 111.507 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.451 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . 126.92 -176.66 17.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 9.5 t -141.8 -32.09 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.45 -1.029 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 3.7 mmt -104.33 -145.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.913 -1.117 . . . . 0.0 110.956 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.709 HG23 ' HD2' ' A' ' 93' ' ' PRO . 13.3 m -86.53 -29.41 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.073 -1.017 . . . . 0.0 112.467 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 177.04 -54.44 0.1 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 118.451 -1.833 . . . . 0.0 111.877 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.709 ' HD2' HG23 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -62.23 -27.04 77.97 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.352 1.185 . . . . 0.0 111.856 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 90' ' ' MET . 78.1 t80 -70.79 -52.39 20.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.749 -1.219 . . . . 0.0 109.948 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 2.6 tt0 -73.25 -29.42 62.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 109.548 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.959 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 83.0 mt-10 -70.42 -25.86 63.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 109.832 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -87.09 -53.88 4.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.67 -50.62 60.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -76.05 -14.69 60.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.253 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -67.7 -58.01 5.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.694 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 101' ' ' LEU . 11.2 mp . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.755 HG22 ' N ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.842 0.353 . . . . 0.0 111.76 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.755 ' N ' HG22 ' A' ' 110' ' ' VAL . 9.3 t80 -133.95 156.11 48.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 111.109 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 114' ' ' PRO . 23.2 p -70.63 63.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.407 -0.808 . . . . 0.0 109.712 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 24.7 p-10 -97.88 130.73 28.17 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.5 Cg_endo -74.9 168.8 76.28 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.773 -2.178 . . . . 0.0 110.033 -0.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.985 ' HB3' HG22 ' A' ' 124' ' ' ILE . 41.6 Cg_endo -70.75 171.51 15.4 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.049 1.552 . . . . 0.0 110.407 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.33 150.32 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.494 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HG2' ' CD1' ' A' ' 51' ' ' ILE . 50.4 mtmt -113.33 133.32 55.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 75.5 p -139.28 -178.7 5.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.804 -1.185 . . . . 0.0 111.485 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -81.43 -18.03 46.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.449 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.3 OUTLIER -91.23 -0.77 57.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.062 -1.024 . . . . 0.0 109.455 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 132.46 -176.38 19.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 94.8 m-85 -100.95 153.77 19.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.489 -1.007 . . . . 0.0 109.426 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.597 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 5.0 m-70 -141.6 141.35 33.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 112.286 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.985 HG22 ' HB3' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -124.55 114.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 176.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -103.38 157.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.225 1.012 . . . . 0.0 112.175 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 19.5 ttt -136.94 134.07 36.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.71 136.55 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.74 -1.225 . . . . 0.0 111.353 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.02 109.19 7.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 109.669 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.66 115.24 0.26 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -130.07 150.5 51.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 pttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.269 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' THR . 26.4 p30 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.434 0.635 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 131' ' ' LYS . . . -90.31 129.19 36.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 110.309 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 129' ' ' GLY . 13.9 p -141.63 164.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HD3' ' CZ2' ' A' ' 84' ' ' TRP . 12.1 mtmm -98.76 121.31 40.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.221 -0.925 . . . . 0.0 108.773 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.968 ' HB ' HD11 ' A' ' 82' ' ' LEU . 91.2 t -130.15 143.84 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.934 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 31.1 mtt85 -140.4 107.17 5.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 3.8 p80 -132.45 179.33 6.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.615 -1.303 . . . . 0.0 112.149 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 6.7 mt -127.81 133.66 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -117.33 121.44 41.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.988 . . . . 0.0 111.149 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 54.0 t -142.07 137.25 30.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.143 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 71.5 mm-40 -58.28 162.03 3.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.467 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 2.9 tttm -72.68 113.28 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.033 -1.042 . . . . 0.0 112.674 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.612 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 7.2 m-70 -132.06 14.41 4.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.28 76.23 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 12.4 mtpt -93.92 -5.66 47.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.984 . . . . 0.0 110.475 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.609 HG13 ' CD2' ' A' ' 122' ' ' TYR . 2.8 mp -40.13 -58.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.225 -0.922 . . . . 0.0 110.426 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 6.0 ttt -69.12 -45.29 70.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.99 -46.94 78.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -59.84 -62.63 1.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.551 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.746 ' SD ' HD12 ' A' ' 124' ' ' ILE . 0.4 OUTLIER -61.19 -39.86 91.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.12 -179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 4.5 tp10 -52.82 -54.98 26.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.794 -1.191 . . . . 0.0 109.54 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -57.55 -38.2 74.36 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.506 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.92 -68.83 0.14 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 25.9 mmtt 39.17 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.588 -0.695 . . . . 0.0 110.281 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -110.08 133.64 53.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.05 -1.031 . . . . 0.0 110.725 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.86 -12.22 59.19 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.406 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 tpt -81.49 161.22 23.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.32 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -82.79 99.34 9.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.344 -0.848 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -49.17 -29.37 5.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 110.379 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -63.37 -35.12 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -77.19 -41.02 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 58' ' ' LEU . 23.3 t -68.69 -38.11 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.955 -1.091 . . . . 0.0 110.195 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -68.68 -41.92 78.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.95 -1.094 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.11 81.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.862 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.551 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.9 tp60 -70.25 -34.81 73.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 110.757 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' HB2' HG21 ' A' ' 43' ' ' ILE . 54.1 m-85 -104.42 21.81 16.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.023 -1.048 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -86.01 90.91 8.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.1 tp10 -100.33 -2.42 33.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.336 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 32.0 p-10 -136.25 12.33 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' H ' ' A' ' 79' ' ' GLY . 81.4 tttt -56.46 -34.17 66.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.416 -0.802 . . . . 0.0 110.386 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.5 94.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 5.9 ptp180 -98.81 -12.9 20.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.044 -1.035 . . . . 0.0 110.967 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.496 HE22 HD12 ' A' ' 44' ' ' LEU . 53.4 mt-30 -129.05 -38.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.911 -1.118 . . . . 0.0 110.241 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' H ' ' HA ' ' A' ' 75' ' ' LYS . . . 93.23 -12.66 69.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 90.83 -43.79 2.86 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.8 p-10 -124.56 142.74 51.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -1.207 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 40' ' ' VAL . 2.9 pp -136.59 156.08 49.05 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.02 -119.16 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.802 -1.189 . . . . 0.0 111.047 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.601 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 19.0 m-90 -90.7 121.42 32.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.065 -0.668 . . . . 0.0 110.802 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.561 ' SD ' HD13 ' A' ' 82' ' ' LEU . 23.3 ptm -144.38 155.12 43.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 1.5 p -87.0 134.85 33.45 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.907 ' HE ' HG21 ' A' ' 40' ' ' VAL . 50.8 mtt-85 -98.96 46.11 0.99 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.178 . . . . 0.0 112.48 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.08 36.27 4.38 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 106.586 -2.606 . . . . 0.0 106.586 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -137.08 -7.93 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.874 -0.78 . . . . 0.0 111.792 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.93 -166.15 1.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.719 -1.238 . . . . 0.0 110.391 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.27 178.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.883 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.74 -151.54 19.64 Favored Glycine 0 N--CA 1.483 1.799 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.933 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 47.4 Cg_endo -75.16 -24.17 12.83 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.717 1.904 . . . . 0.0 110.664 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 44.6 t80 -45.71 -65.85 0.48 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 87' ' ' ARG . 4.0 tm0? -79.56 -32.04 42.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 41.0 tt0 -56.15 -39.77 72.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.952 -1.092 . . . . 0.0 110.403 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.64 -39.76 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' CB ' ' NH1' ' A' ' 87' ' ' ARG . . . -44.99 -59.25 2.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 110.774 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -81.69 -41.02 21.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 111.373 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -51.33 -21.22 2.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 101' ' ' LEU . 14.5 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.276 0.56 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 37.4 p90 -122.85 158.87 29.35 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.094 -1.003 . . . . 0.0 110.147 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 116' ' ' VAL . 14.8 m -50.43 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.362 -0.836 . . . . 0.0 112.197 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 46.4 t0 -132.36 118.64 16.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 41.4 Cg_endo -66.82 176.42 23.35 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.315 -1.952 . . . . 0.0 111.011 1.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD3' ' HE2' ' A' ' 55' ' ' MET . 47.5 Cg_endo -81.89 -178.76 4.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.16 1.611 . . . . 0.0 110.398 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 112' ' ' THR . 25.2 m -104.49 142.9 16.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.839 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -115.33 124.99 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 109.246 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 69.5 p -137.01 -179.38 5.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.621 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 3.9 tttm -68.07 -11.72 59.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.588 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 0.4 OUTLIER -107.56 22.5 15.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.82 -1.175 . . . . 0.0 110.816 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 46' ' ' GLU . . . 104.35 -179.32 24.67 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' HG13 ' A' ' 51' ' ' ILE . 32.7 p90 -101.58 155.28 18.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.942 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.727 ' CE1' HD21 ' A' ' 44' ' ' LEU . 3.0 m-70 -134.25 147.35 50.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 111.881 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.746 HD12 ' SD ' ' A' ' 55' ' ' MET . 3.0 tt -126.83 115.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.9 mp -104.68 141.57 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 112.354 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 1.3 mmm -113.63 102.69 10.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.76 132.5 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.177 -0.952 . . . . 0.0 111.194 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.13 70.84 1.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 128.14 127.32 2.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -126.64 148.74 49.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 1.7 tttp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.155 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.88 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -130.61 164.46 24.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 127' ' ' VAL . 7.3 p -143.33 156.01 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 8.2 tttm -101.05 126.5 47.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.256 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.7 HG23 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -131.05 152.91 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.585 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -136.32 123.26 21.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.712 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.7 p80 -130.01 157.46 42.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.747 -1.22 . . . . 0.0 112.192 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 124' ' ' ILE . 1.4 pt -112.66 131.94 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.681 HD11 ' HE1' ' A' ' 123' ' ' HIS . 1.6 tt -104.77 131.46 52.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.913 -1.117 . . . . 0.0 111.852 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 48.7 t -136.17 156.18 49.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 48' ' ' HIS . 97.5 mt-10 -112.96 -12.68 13.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.044 -1.035 . . . . 0.0 111.774 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 14.9 mmtm -64.72 114.33 4.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 46' ' ' GLU . 7.1 m-70 -89.71 144.07 26.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.855 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 -15.99 58.9 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' NZ ' ' CE1' ' A' ' 71' ' ' TYR . 27.9 tttm -97.37 -9.76 26.82 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.616 HG12 ' CD2' ' A' ' 122' ' ' TYR . 38.9 mt -46.29 -44.86 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.48 ' O ' ' HG2' ' A' ' 55' ' ' MET . 21.2 ptt? -62.45 -36.52 82.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 110.7 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' A' ' 52' ' ' MET . 59.2 tt0 -72.44 -37.46 68.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.318 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.33 -49.2 72.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' MET . 13.8 ptt? -65.29 -31.89 73.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.008 . . . . 0.0 110.385 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -70.96 -44.02 66.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.042 -1.036 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -58.79 -53.45 58.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.021 HD21 ' CE2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -76.57 -27.53 55.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 108.8 179.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 55' ' ' MET . 33.0 tttt 45.83 -99.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -0.789 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 p -98.41 -12.47 21.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.897 -1.127 . . . . 0.0 110.561 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 64' ' ' PHE . . . 124.47 2.05 8.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.1 mmm -50.28 -49.86 52.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.029 -1.277 . . . . 0.0 109.745 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -103.82 32.64 3.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.349 -0.845 . . . . 0.0 109.491 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.766 ' HD1' HD12 ' A' ' 58' ' ' LEU . 9.8 t80 -52.22 -48.67 65.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.431 -0.793 . . . . 0.0 110.72 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.91 -47.52 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.73 -42.49 77.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 71' ' ' TYR . 45.1 t -65.42 -53.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -59.96 -52.62 64.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 110.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.37 -18.43 61.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 111.353 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -24.61 11.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 110.89 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.711 ' CD2' HG13 ' A' ' 67' ' ' VAL . 45.4 m-85 -100.31 6.47 44.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.075 -1.016 . . . . 0.0 109.517 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 28.7 t -72.16 103.74 3.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.386 -0.822 . . . . 0.0 110.575 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 45' ' ' CYS . 11.0 mt-10 -101.01 5.49 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.953 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 78' ' ' GLN . 17.6 t0 -111.8 24.61 12.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HG2' ' OG ' ' A' ' 72' ' ' SER . 20.3 mmtt -62.83 -36.25 82.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.116 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.06 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.26 -59.96 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.258 -0.902 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.468 ' O ' ' OD2' ' A' ' 74' ' ' ASP . 8.5 pt20 -169.52 105.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.765 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 74' ' ' ASP . . . -129.45 91.36 0.31 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.84 -96.94 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 82' ' ' LEU . 56.1 p30 -114.76 160.61 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 110.951 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.754 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.5 mp -103.99 -11.55 17.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 85.65 -143.48 19.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.5 m-90 -106.96 129.59 54.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.567 -0.96 . . . . 0.0 110.349 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 14.3 ptp -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.049 -1.032 . . . . 0.0 109.924 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.88 HG22 ' HB2' ' A' ' 37' ' ' ALA . 24.4 p -101.63 -67.6 0.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 111.457 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 84.8 mtt85 -80.83 -29.19 35.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.961 . . . . 0.0 111.24 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 95' ' ' GLN . . . 168.31 -170.28 42.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -142.87 -50.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -1.195 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -117.63 -95.59 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 111.578 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 6.1 m -114.91 -175.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.875 -1.141 . . . . 0.0 111.941 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.638 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -63.86 -46.36 91.87 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.613 -0.68 . . . . 0.0 111.922 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.6 Cg_endo -66.35 -40.76 13.77 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.066 1.035 . . . . 0.0 110.755 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 87.8 t80 -75.44 -37.22 60.51 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 45.6 tt0 -76.38 -51.73 11.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.773 . . . . 0.0 110.433 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -57.4 -40.19 77.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.979 . . . . 0.0 110.409 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -63.82 -63.52 1.14 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -37.61 -58.57 0.87 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.296 0.57 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.29 -15.34 63.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 111.118 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -135.15 40.66 2.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.748 -1.22 . . . . 0.0 111.951 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 O-C-N 120.848 -1.158 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 126' ' ' MET . 6.4 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.855 0.359 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 1.021 ' CE2' HD21 ' A' ' 58' ' ' LEU . 6.3 t80 -142.91 151.53 41.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.582 ' O ' ' CE1' ' A' ' 111' ' ' PHE . 40.3 m -86.06 111.38 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.672 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -133.23 117.66 14.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.0 Cg_endo -78.19 173.67 55.59 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.014 -2.078 . . . . 0.0 110.066 0.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 51' ' ' ILE . 42.4 Cg_endo -71.32 177.3 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.848 1.446 . . . . 0.0 110.014 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -105.02 150.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.846 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -116.13 121.1 41.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 67.4 p -135.51 176.01 9.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.666 -1.271 . . . . 0.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.29 -14.48 62.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 110.426 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -105.28 33.31 3.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.293 -0.88 . . . . 0.0 108.706 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA2' ' HE1' ' A' ' 48' ' ' HIS . . . 89.47 174.22 46.01 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 51' ' ' ILE . 35.3 p90 -100.85 151.72 21.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.16 -1.2 . . . . 0.0 108.681 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.681 ' HE1' HD11 ' A' ' 44' ' ' LEU . 3.7 m-70 -130.75 160.22 34.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.893 -1.13 . . . . 0.0 112.532 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.875 HD13 HD11 ' A' ' 43' ' ' ILE . 1.8 mp -126.04 124.96 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 1.7 mt -107.04 136.14 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.821 -1.175 . . . . 0.0 112.759 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.567 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 38.1 tpp -122.89 102.75 8.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.63 HG23 HG12 ' A' ' 40' ' ' VAL . 14.7 p -103.09 129.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.022 -1.049 . . . . 0.0 112.189 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -142.48 135.65 28.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.672 -0.642 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.48 121.51 1.55 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -108.79 151.87 25.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 0.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 67.8 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.131 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.0 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.578 0.704 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.02 134.6 44.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 85' ' ' MET . 4.4 p -127.31 153.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.985 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 11.8 tttp -101.64 133.14 46.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.939 . . . . 0.0 109.995 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 82' ' ' LEU . 3.6 t -128.29 139.12 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.09 -1.006 . . . . 0.0 111.342 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 90.2 mtt180 -120.98 121.97 39.14 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -135.5 150.51 49.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.757 -1.214 . . . . 0.0 111.406 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.825 HD13 HG13 ' A' ' 67' ' ' VAL . 32.9 pt -121.19 133.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.615 HD11 ' HE1' ' A' ' 123' ' ' HIS . 1.1 tt -104.93 134.58 47.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.916 -1.115 . . . . 0.0 112.087 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 7.6 p -139.49 168.01 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 109.523 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.3 mm-40 -73.44 -159.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.007 . . . . 0.0 110.747 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 4.4 mtmt -122.9 99.52 6.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 110.623 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 8.3 m-70 -132.35 30.9 4.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.857 . . . . 0.0 110.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.07 21.38 75.5 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 48' ' ' HIS . 94.4 mttt -93.14 15.91 14.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.652 HG23 ' HG2' ' A' ' 115' ' ' PRO . 56.4 mt -61.89 -43.95 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.075 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.498 ' O ' ' HG2' ' A' ' 55' ' ' MET . 8.0 ttt -70.59 -40.64 73.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.518 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 52.2 mp0 -70.42 -37.2 74.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.872 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . -59.72 -60.73 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.701 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 15.5 ptt? -52.73 -38.09 60.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 55' ' ' MET . 96.8 mt-10 -73.61 -11.94 60.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 67' ' ' VAL . 29.8 tptt -80.83 -40.0 25.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.761 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.17 -22.28 18.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.601 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 58.6 mttp 49.3 -142.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -52.95 -34.26 54.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.432 -0.792 . . . . 0.0 110.935 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.98 -11.66 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 36.3 ttm -50.64 -34.85 27.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.14 -1.212 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 89.3 mtt180 -112.7 31.12 6.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.974 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 78.3 t80 -51.98 -40.46 60.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 110.083 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -70.69 -33.37 70.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 13.4 tp10 -63.26 -52.4 62.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.825 HG13 HD13 ' A' ' 43' ' ' ILE . 9.4 p -62.28 -36.46 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 109.57 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -65.31 -35.44 81.0 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.243 -0.911 . . . . 0.0 109.111 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.62 68.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.826 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.469 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 7.0 mm-40 -71.61 -19.65 62.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.003 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.606 ' HD2' HG22 ' A' ' 67' ' ' VAL . 29.1 m-85 -116.22 23.92 11.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.44 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' ALA . 55.9 p -78.12 76.22 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.023 -1.048 . . . . 0.0 109.767 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 80.8 mm-40 -105.76 1.47 27.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.25 13.92 9.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HA ' ' CA ' ' A' ' 79' ' ' GLY . 12.5 tmtt? -48.57 -34.72 11.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.534 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.26 96.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -94.7 -61.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 110.233 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -121.36 -61.56 1.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.893 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 75' ' ' LYS . . . 92.25 -104.19 3.14 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -103.04 -73.78 0.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.812 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.8 p-10 -81.19 153.27 27.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.29 -1.124 . . . . 0.0 110.781 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 81' ' ' ASP . 9.0 mp -113.82 -12.34 12.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.83 . . . . 0.0 109.794 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.38 -165.36 24.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 93.6 m95 -93.87 136.8 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.981 . . . . 0.0 110.091 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.517 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.5 ptp -140.52 135.56 32.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.89 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.41 ' HB ' ' ND2' ' A' ' 36' ' ' ASN . 18.1 p -83.83 -37.63 22.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.482 -0.761 . . . . 0.0 110.443 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -113.41 -38.54 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 95' ' ' GLN . . . 58.69 66.2 2.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 31.3 t -113.08 105.63 13.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -1.171 . . . . 0.0 109.437 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.2 tpt -125.69 -60.38 1.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 111.291 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.829 HG13 ' HD2' ' A' ' 93' ' ' PRO . 11.8 p -114.63 -30.22 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.882 -1.137 . . . . 0.0 111.312 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.64 -65.83 0.59 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.006 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 91' ' ' VAL . 49.0 Cg_endo -71.1 -24.76 23.28 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.811 1.427 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -35.47 63.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.445 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 64.5 tt0 -78.62 -39.76 36.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.42 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 17.5 pt-20 -63.42 -25.04 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.779 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -88.45 -46.15 9.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.123 -0.986 . . . . 0.0 111.174 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.37 -35.21 75.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.465 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG11 ' A' ' 38' ' ' VAL . 27.2 m-85 -100.85 -1.04 35.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.85 -1.156 . . . . 0.0 111.818 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -99.45 -26.12 14.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.706 -1.246 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 127' ' ' VAL . 14.4 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.013 . . . . 0.0 110.001 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 127' ' ' VAL . 33.7 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.878 0.371 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.621 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 3.6 p90 -128.68 177.63 6.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.723 -1.236 . . . . 0.0 111.472 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.545 ' C ' ' HA ' ' A' ' 114' ' ' PRO . 3.2 p -71.58 -105.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.46 -0.775 . . . . 0.0 111.708 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.909 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 28.0 m-20 -79.8 -29.11 0.55 Allowed Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.909 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 38.2 Cg_endo -76.78 -26.04 10.1 Favored 'Cis proline' 0 N--CA 1.487 1.129 0 C-N-CA 124.169 -1.179 . . . . 0.0 115.075 2.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.2 Cg_endo -69.18 121.39 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-O 121.69 0.621 . . . . 0.0 112.422 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 2.9 t -97.5 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HD3' HD13 ' A' ' 51' ' ' ILE . 37.5 mtmm -103.91 112.96 26.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.027 . . . . 0.0 110.253 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.648 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 14.6 p -138.36 166.36 24.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 110.663 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -66.43 -9.35 33.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.2 OUTLIER -105.78 21.88 16.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.839 -1.163 . . . . 0.0 110.312 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.59 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 108.71 -173.51 17.68 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.855 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.97 150.55 21.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.615 ' HE1' HD11 ' A' ' 44' ' ' LEU . 33.3 m-70 -138.31 127.45 24.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.534 -1.354 . . . . 0.0 112.631 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mp -106.83 105.2 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.052 HG22 ' HB2' ' A' ' 42' ' ' HIS . 34.3 pt -108.76 141.47 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 16.7 ttt -119.07 141.87 48.37 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 127' ' ' VAL . 23.3 m -113.5 105.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.846 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 63.2 tt0 -111.44 132.98 54.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.782 . . . . 0.0 109.674 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 73.31 80.21 0.46 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -110.23 146.64 35.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.99 . . . . 0.0 109.712 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 1.3 mmmm . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 0.0 110.288 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 10.4 p30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.532 0.682 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -112.32 166.59 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.403 -0.81 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 26.8 m -138.72 148.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.709 -0.62 . . . . 0.0 109.808 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' CE ' ' HD2' ' A' ' 130' ' ' ARG . 26.5 mttt -98.64 114.3 26.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 108.74 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 78.5 t -114.61 136.36 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 45.7 ttp180 -130.82 118.35 20.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.919 ' HB2' HG22 ' A' ' 125' ' ' ILE . 4.3 p80 -128.15 177.65 6.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.713 -1.242 . . . . 0.0 112.068 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG21 ' HB3' ' A' ' 71' ' ' TYR . 46.1 mt -126.49 140.69 48.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.3 tt -112.32 127.05 55.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.48 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 56.8 m -132.06 138.79 48.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 109.859 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 72.1 mt-10 -59.63 155.58 15.28 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.003 -1.061 . . . . 0.0 108.786 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 4.1 tttt -80.42 118.77 22.34 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.027 -1.046 . . . . 0.0 113.101 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.626 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 8.0 m80 -135.2 1.75 2.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.697 . . . . 0.0 110.384 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.16 5.38 73.08 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 18.4 ptpt -99.71 22.17 11.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.745 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 69.6 mt -49.28 -53.1 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.419 -0.801 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.54 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 44.0 ttm -59.38 -34.39 72.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 81.2 mm-40 -63.15 -41.84 99.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.75 -52.35 57.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 0.0 110.67 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' ' CB ' ' A' ' 58' ' ' LEU . 2.6 ppp? -69.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 52' ' ' MET . 32.9 mm-40 -68.13 -33.03 73.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 108.909 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HG2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -87.55 -14.82 39.2 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.91 -29.64 61.03 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.746 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 58' ' ' LEU . 13.0 ptpt -30.9 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.43 0.633 . . . . 0.0 111.385 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -52.4 -42.92 64.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.356 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.97 -26.57 2.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 6.5 tpt -106.44 150.33 26.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -1.137 . . . . 0.0 110.296 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 66' ' ' GLU . 3.3 ptm180 -75.23 109.61 8.88 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.306 1.051 . . . . 0.0 110.72 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.681 ' CE1' HD21 ' A' ' 58' ' ' LEU . 84.2 t80 -41.96 -36.31 1.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.743 -0.598 . . . . 0.0 109.665 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -58.64 -44.62 90.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 110.664 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 35.7 tt0 -65.04 -48.68 72.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.052 . . . . 0.0 110.812 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 58' ' ' LEU . 27.4 m -63.68 -44.12 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.081 -1.448 . . . . 0.0 109.493 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -63.31 -39.42 94.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 109.571 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.69 71.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.436 -0.79 . . . . 0.0 109.699 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -80.31 -7.14 58.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.594 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m-30 -108.79 9.0 26.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.858 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.7 t -80.8 83.52 6.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.174 -0.954 . . . . 0.0 111.251 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -99.54 7.02 45.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ARG . 18.8 p30 -104.1 41.46 1.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.686 -0.634 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -50.4 -42.04 53.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 110.586 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 9.38 28.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.6 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 74' ' ' ASP . 2.6 ttt180 -105.29 -15.12 15.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 55.58 55.98 6.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -116.48 25.43 9.16 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -82.74 -60.0 2.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 9.5 p-10 -133.5 133.57 42.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.29 . . . . 0.0 111.059 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.1 mp -104.04 157.07 17.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 109.212 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 -127.92 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.177 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 23.5 m-90 -90.92 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.872 -0.781 . . . . 0.0 110.611 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 38' ' ' VAL . 13.9 mmt -132.14 140.82 48.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.9 t -110.37 -45.49 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.314 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 86' ' ' THR . 2.2 mmp_? -117.4 1.9 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.443 -0.786 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.557 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 72.8 146.47 0.71 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 38.8 p -146.37 40.67 1.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.594 -1.533 . . . . 0.0 111.541 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.616 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 2.1 tpt -125.48 137.02 53.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.033 -1.042 . . . . 0.0 110.123 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' C ' ' A' ' 90' ' ' MET . 5.8 m 35.0 -110.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.748 -0.595 . . . . 0.0 111.149 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 93' ' ' PRO . . . -148.78 -67.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.432 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 92' ' ' GLY . 38.2 Cg_endo -64.08 -14.07 41.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.709 1.373 . . . . 0.0 110.813 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 90' ' ' MET . 68.5 t80 -68.27 -47.03 68.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.56 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 14.5 mt-30 -71.05 -41.48 70.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 109.285 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.9 mm-40 -58.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.491 -0.756 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -41.41 81.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.449 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -50.19 -51.8 40.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.702 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.41 -1.39 57.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 0.0 111.118 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -116.92 12.2 14.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.85 -1.156 . . . . 0.0 110.891 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.932 HD22 HG22 ' A' ' 112' ' ' THR . 52.5 mt . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.564 -0.71 . . . . 0.0 110.66 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.57 HG12 ' HD1' ' A' ' 111' ' ' PHE . 2.1 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.087 0.47 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' A' ' 110' ' ' VAL . 33.8 p90 -124.86 156.11 38.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.012 -1.055 . . . . 0.0 110.425 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.932 HG22 HD22 ' A' ' 101' ' ' LEU . 24.8 p -46.16 124.51 5.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.0 111.08 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 34.1 t0 -133.35 119.75 15.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 50.7 Cg_endo -79.11 174.33 51.2 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.12 -2.033 . . . . 0.0 110.163 -0.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 124' ' ' ILE . 46.5 Cg_endo -72.12 177.33 7.31 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.863 1.454 . . . . 0.0 109.993 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.32 158.98 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 10.9 ptmm? -119.64 136.23 54.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.587 ' HB ' ' CE2' ' A' ' 120' ' ' PHE . 74.3 p -142.13 168.62 19.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.62 -23.69 59.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 15.2 p90 -98.81 46.22 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 84.08 175.65 50.9 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 41.8 p90 -98.53 166.12 11.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -1.112 . . . . 0.0 108.844 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 22.8 m-70 -141.77 140.49 33.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.802 -1.186 . . . . 0.0 112.624 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.9 HD11 HD23 ' A' ' 58' ' ' LEU . 5.1 pt -128.1 110.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 42' ' ' HIS . 12.0 pt -106.98 149.61 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.055 -1.028 . . . . 0.0 112.867 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 49.5 mtp -107.0 124.43 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.46 107.78 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 111.319 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.35 -3.36 27.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.422 -0.799 . . . . 0.0 109.4 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 58.39 -164.54 8.34 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.498 ' HD2' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tpm_? -134.26 -35.45 0.93 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.776 -0.838 . . . . 0.0 109.894 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' A' ' 36' ' ' ASN . 23.7 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.35 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 23.2 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.082 0.468 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -86.86 129.46 34.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.986 -1.071 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 22.9 m -144.1 151.12 16.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.917 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 2.3 tmtt? -96.11 124.27 40.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.049 -1.032 . . . . 0.0 108.858 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 82' ' ' LEU . 42.9 t -119.75 132.55 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.022 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 53.0 mtm180 -120.25 112.35 18.94 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.081 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.7 p80 -134.86 158.82 43.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.518 -1.364 . . . . 0.0 113.047 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.765 HG21 ' HA ' ' A' ' 68' ' ' ALA . 7.8 pt -119.82 133.42 66.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -106.28 136.09 46.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.462 0.649 . . . . 0.0 111.719 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 26.0 m -142.57 144.88 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.975 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.644 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt-10 -59.0 172.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.062 -1.024 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.1 ttmt -105.48 113.18 26.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.686 -1.259 . . . . 0.0 113.29 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.644 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 1.5 m80 -134.3 26.56 3.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.56 9.21 82.02 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 ttmt -90.76 -10.65 42.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.622 -0.928 . . . . 0.0 109.975 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.57 HG23 ' N ' ' A' ' 52' ' ' MET . 16.4 tt -44.2 -42.72 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.464 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.57 ' N ' HG23 ' A' ' 51' ' ' ILE . 11.9 ttt -67.09 -29.73 69.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.0 109.139 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' LYS . 65.7 tt0 -72.2 -42.92 65.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.356 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . . . -56.81 -49.85 74.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.787 . . . . 0.0 110.164 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 22.1 ptm -74.1 -22.43 59.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 32.2 tp10 -69.92 -38.03 76.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -80.78 -25.65 37.75 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 124' ' ' ILE . 35.4 tp -76.2 -44.34 38.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.564 0.697 . . . . 0.0 109.275 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 32.1 mtmt 48.43 -112.51 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.598 -0.689 . . . . 0.0 111.081 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.7 p -78.79 -14.37 59.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.954 -1.091 . . . . 0.0 110.261 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 103.33 0.32 47.17 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 61' ' ' GLY . 56.8 ttp -44.72 -34.65 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.268 . . . . 0.0 109.641 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' PHE . 10.6 mtp180 -112.89 19.38 17.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.56 ' HD1' HD11 ' A' ' 58' ' ' LEU . 87.1 t80 -43.72 -40.36 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 28.9 p-10 -66.12 -40.37 90.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 43.5 mm-40 -70.59 -43.36 69.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 109.491 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 18.4 t -69.79 -41.02 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.573 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.765 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -63.68 -43.33 96.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 110.226 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.45 94.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.56 -9.1 59.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 43' ' ' ILE . 8.5 m-85 -111.82 5.51 19.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.942 . . . . 0.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.2 m -73.86 87.44 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 2.6 tm-20 -101.41 32.04 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.59 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 78.6 m-20 -100.13 83.55 2.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 14.8 tptt -70.79 -52.21 22.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 111.087 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 77' ' ' ARG . . . -77.05 -13.14 60.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.111 -0.993 . . . . 0.0 110.599 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.543 ' N ' ' CD ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -102.42 -48.6 4.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.129 -0.982 . . . . 0.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 38.1 mm-40 51.56 34.73 13.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 110.035 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -93.64 -55.87 1.49 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 67.86 -64.41 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.595 ' C ' HD12 ' A' ' 82' ' ' LEU . 75.5 m-20 -116.47 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.693 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 81' ' ' ASP . 8.3 mp -102.78 139.86 37.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -71.8 -138.47 0.23 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 1.5 m95 -91.58 134.18 34.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -1.02 . . . . 0.0 110.343 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.509 ' CE ' ' HA3' ' A' ' 88' ' ' GLY . 21.2 ptm -134.01 150.75 51.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 47.3 p -101.56 -38.67 7.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.953 -1.092 . . . . 0.0 110.126 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -114.01 -92.58 0.49 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' HA3' ' CE ' ' A' ' 85' ' ' MET . . . 73.14 75.12 0.75 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.1 m -110.86 93.28 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -31.15 8.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -150.6 -171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.044 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.491 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -88.33 -56.5 2.02 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.314 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -66.55 -29.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.372 1.196 . . . . 0.0 112.343 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 91' ' ' VAL . 32.5 t80 -69.18 -43.4 74.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.71 -1.244 . . . . 0.0 110.756 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' OE1' ' CD1' ' A' ' 99' ' ' PHE . 7.7 tp-100 -72.52 -52.07 17.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.904 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.988 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 mt-10 -59.94 -20.97 60.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.149 -0.969 . . . . 0.0 110.912 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -82.76 -59.24 2.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.905 -1.122 . . . . 0.0 110.557 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.84 -59.31 5.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CD1' ' OE1' ' A' ' 95' ' ' GLN . 29.2 m-85 -74.3 -28.32 61.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -118.11 34.97 4.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.909 -1.119 . . . . 0.0 110.764 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 112' ' ' THR . 8.8 tp . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.113 -0.992 . . . . 0.0 110.345 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.311 0.577 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 58' ' ' LEU . 29.2 p90 -119.08 165.03 14.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.527 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.967 HG22 HD13 ' A' ' 101' ' ' LEU . 46.0 p -48.22 113.62 0.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 110.776 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.3 p-10 -132.26 120.61 17.15 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.765 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.3 Cg_endo -68.77 165.26 74.1 Favored 'Cis proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.769 -2.179 . . . . 0.0 110.248 0.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 1.083 ' HB3' HG22 ' A' ' 124' ' ' ILE . 45.1 Cg_endo -70.46 -179.88 3.56 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.926 1.487 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.8 134.33 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.895 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HB2' ' CE ' ' A' ' 47' ' ' LYS . 10.0 ptpt -109.65 126.99 54.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 0.0 109.187 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.604 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 44.0 p -130.33 -177.6 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.039 -1.038 . . . . 0.0 111.013 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -69.53 -18.8 63.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -0.772 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 p90 -100.36 32.58 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.044 . . . . 0.0 109.88 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.578 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 97.68 177.04 33.96 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 53.8 p90 -99.74 162.21 13.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -1.179 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.6 m-70 -141.69 151.49 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.001 -1.062 . . . . 0.0 112.238 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.083 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.8 pt -133.94 118.92 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.081 HG22 ' HB2' ' A' ' 42' ' ' HIS . 8.2 pt -121.56 142.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.673 -1.267 . . . . 0.0 112.83 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 34.8 mmm -97.43 125.04 41.83 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.16 121.36 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.664 -1.273 . . . . 0.0 111.889 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 39' ' ' LYS . 8.7 pt-20 -115.16 -22.17 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.527 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 80.9 -167.47 49.9 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.608 ' HD3' ' CE3' ' A' ' 84' ' ' TRP . 12.7 tpt180 -132.66 -75.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.983 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 3.6 p30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.459 0.647 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 86' ' ' THR . . . -130.84 150.98 51.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -111.39 164.93 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HD3' ' CE2' ' A' ' 84' ' ' TRP . 30.0 mtmt -99.05 117.35 33.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 109.544 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 13.1 t -116.67 133.25 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 110.763 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -141.49 113.04 7.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.96 ' CB ' HG22 ' A' ' 125' ' ' ILE . 5.0 p80 -132.16 -179.29 5.33 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.98 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 124' ' ' ILE . 5.2 mt -124.31 117.43 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -102.15 120.19 40.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.864 -1.147 . . . . 0.0 110.596 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.578 ' SG ' HG22 ' A' ' 43' ' ' ILE . 5.4 m -133.54 155.59 49.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.042 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.62 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.27 -163.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.835 -1.165 . . . . 0.0 110.561 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -92.48 106.43 18.42 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.739 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 17.9 m-70 -123.27 -2.83 8.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.7 27.89 73.52 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -107.17 8.97 30.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.54 -0.976 . . . . 0.0 110.11 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 115' ' ' PRO . 75.9 mt -41.23 -43.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.02 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -31.94 72.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 2.1 tp10 -76.18 -37.36 57.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.412 -0.805 . . . . 0.0 110.109 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.83 -52.69 64.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.433 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 14.0 ptm -66.55 -35.46 80.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.387 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 55' ' ' MET . 26.8 tt0 -70.15 -36.06 74.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.55 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -71.0 -35.7 72.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.778 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 59' ' ' LYS . 4.6 pp -97.14 -46.12 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 110.823 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.918 ' N ' HD12 ' A' ' 58' ' ' LEU . 13.4 mttt 37.87 -157.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.0 t -103.01 7.8 39.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.029 -1.044 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.89 -40.07 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 33.7 mmt -67.44 166.79 13.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -1.149 . . . . 0.0 110.37 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.3 mtt85 -72.02 97.97 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 110.715 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -52.33 -31.48 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.25 -35.71 71.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.346 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 43.7 tt0 -63.62 -39.1 93.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.567 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.869 HG21 ' HB3' ' A' ' 58' ' ' LEU . 30.5 t -68.61 -45.75 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -59.18 -47.98 83.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.36 79.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 111.013 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.1 mm-40 -83.92 -23.54 31.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.026 -1.046 . . . . 0.0 111.395 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' CD2' HG13 ' A' ' 67' ' ' VAL . 21.9 m-30 -112.86 18.79 17.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.933 -1.104 . . . . 0.0 110.677 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -89.15 112.59 23.63 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.75 -4.95 29.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 80' ' ' GLY . 58.5 p30 -104.67 33.77 3.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.708 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -52.89 -41.01 63.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 110.21 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.56 90.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 mtt85 -85.61 -11.33 54.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.158 -0.964 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 58.21 30.58 19.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.747 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.748 ' O ' HD11 ' A' ' 82' ' ' LEU . . . -68.83 -25.6 75.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 74' ' ' ASP . . . -49.73 -34.3 21.12 Favored Glycine 0 N--CA 1.489 2.19 0 O-C-N 121.127 -1.219 . . . . 0.0 110.391 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 82' ' ' LEU . 7.5 t0 -134.59 109.21 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.784 -1.421 . . . . 0.0 111.483 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.825 ' N ' HD12 ' A' ' 82' ' ' LEU . 5.3 mp -100.48 145.06 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.65 -141.27 4.54 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.536 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CE2' ' HD3' ' A' ' 39' ' ' LYS . 77.5 m95 -81.82 100.67 9.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.899 -0.765 . . . . 0.0 109.678 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' MET . 1.8 ptp -139.04 146.66 41.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.011 -1.056 . . . . 0.0 111.149 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -126.3 -0.0 7.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.564 -0.71 . . . . 0.0 109.301 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -90.43 -175.48 4.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.473 ' CA ' ' NE2' ' A' ' 95' ' ' GLN . . . -99.05 124.73 8.32 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.45 -9.98 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.084 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.736 ' HE2' ' CE2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -136.28 -165.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.77 151.74 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.982 -1.074 . . . . 0.0 111.05 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -169.14 19.81 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 40.5 Cg_endo -66.96 -11.23 31.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.161 1.611 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.736 ' CE2' ' HE2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -57.39 -58.38 8.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.107 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 46.4 tt0 -72.1 -40.61 68.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.737 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 31.8 tt0 -64.05 -40.53 96.5 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -66.26 -56.03 13.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.124 -0.985 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.72 -47.47 5.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 99' ' ' PHE . 10.5 m-30 -94.87 17.94 12.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.134 -0.978 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -111.24 -21.9 11.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 127' ' ' VAL . 72.4 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 111' ' ' PHE . 64.1 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.505 0.669 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 23.9 p90 -114.31 164.42 13.94 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.333 -0.854 . . . . 0.0 109.687 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 125' ' ' ILE . 30.4 p -63.5 109.42 1.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 111.654 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.592 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 25.8 p-10 -132.66 113.11 13.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.1 Cg_endo -68.07 166.55 67.19 Favored 'Cis proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.343 0.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -71.45 -174.79 1.33 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.086 1.572 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 118' ' ' THR . 66.6 t -101.66 136.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.753 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -110.21 120.12 41.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.855 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.659 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -130.69 170.64 14.05 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -70.25 -14.65 62.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.408 -0.807 . . . . 0.0 110.554 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.659 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -91.57 5.15 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.834 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 126.91 -169.84 18.78 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.555 ' CE2' HG13 ' A' ' 51' ' ' ILE . 18.1 m-30 -99.59 159.26 15.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -1.083 . . . . 0.0 108.609 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.432 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 67.0 m-70 -143.44 110.13 5.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.783 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 43' ' ' ILE . 4.4 mp -100.52 111.71 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.96 HG22 ' CB ' ' A' ' 42' ' ' HIS . 33.6 pt -115.67 142.76 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.557 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 tpt -115.11 124.02 50.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 101' ' ' LEU . 22.1 t -105.96 131.08 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.107 -0.996 . . . . 0.0 111.373 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 71.1 mt-10 -141.98 143.56 33.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.51 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 56.9 117.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -113.68 156.68 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -1.216 . . . . 0.0 110.137 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.587 ' H ' HG12 ' A' ' 38' ' ' VAL . 13.0 pttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.326 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB3' ' CB ' ' A' ' 131' ' ' LYS . . . -79.13 115.5 18.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.852 -1.155 . . . . 0.0 109.596 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -127.97 160.91 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 8.7 mttt -98.82 128.96 45.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.373 -0.83 . . . . 0.0 109.61 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 72.8 t -109.82 129.97 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.372 -0.83 . . . . 0.0 111.45 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 83.2 mtt180 -120.69 125.14 46.92 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.621 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -134.98 172.61 12.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 0.0 112.351 -178.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' ' 71' ' ' TYR . 58.9 mt -126.79 116.58 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.723 HD22 ' OD2' ' A' ' 74' ' ' ASP . 4.6 tt -102.56 124.07 47.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.901 -1.124 . . . . 0.0 111.629 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 19.0 m -142.77 160.42 40.35 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.591 ' O ' ' CE2' ' A' ' 122' ' ' TYR . 87.1 mt-10 -71.7 172.31 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.903 -1.123 . . . . 0.0 109.789 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 74.6 tttt -93.12 111.4 23.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.851 -1.156 . . . . 0.0 112.547 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.584 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 5.8 m-70 -132.43 9.61 4.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.47 -8.79 77.96 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 51' ' ' ILE . 7.6 tttp -73.81 -15.44 61.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.708 -0.878 . . . . 0.0 109.611 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 52' ' ' MET . 10.8 tt -40.5 -44.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.798 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.587 ' N ' HG23 ' A' ' 51' ' ' ILE . 50.8 ttp -65.38 -42.61 92.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 67.0 tt0 -56.49 -44.19 80.43 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.268 -0.895 . . . . 0.0 109.147 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.37 -60.76 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.592 ' HA ' HD11 ' A' ' 58' ' ' LEU . 52.7 ttp -59.93 -33.38 71.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.557 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 45.1 tt0 -62.93 -33.92 76.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 108.793 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.85 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.9 tptt -62.55 -45.68 91.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.493 -0.754 . . . . 0.0 109.185 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 pp -108.76 27.61 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.384 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 56' ' ' GLU . 36.4 tttp -54.74 -60.13 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.398 0.618 . . . . 0.0 110.722 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.4 m -81.37 33.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 74.16 25.59 70.66 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.555 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 3.7 ttm -53.79 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.837 -1.39 . . . . 0.0 109.572 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CG ' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -70.69 78.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.998 -1.064 . . . . 0.0 111.288 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' ' SD ' ' A' ' 126' ' ' MET . 5.2 t80 -46.65 -27.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.865 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.565 ' OD1' ' CG ' ' A' ' 63' ' ' ARG . 33.9 p-10 -67.68 -46.91 70.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.219 . . . . 0.0 110.092 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 83.9 mt-10 -63.27 -32.47 73.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 109.496 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 57' ' ' LYS . 45.8 t -61.55 -53.63 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -51.11 -60.5 3.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.952 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.48 19.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.802 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' N ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -71.32 -26.71 62.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.571 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 48.6 m-85 -111.04 30.05 7.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.385 -0.822 . . . . 0.0 110.282 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 68' ' ' ALA . 43.4 t -100.21 101.95 13.11 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.095 -1.003 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -101.72 2.25 38.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.723 ' OD2' HD22 ' A' ' 44' ' ' LEU . 15.3 m-20 -116.69 30.75 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.741 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -67.42 -23.86 65.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.78 . . . . 0.0 110.255 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.4 -56.34 21.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.143 -0.973 . . . . 0.0 109.181 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 4.2 ttm180 -96.31 -52.01 4.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.482 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 9.6 pt20 179.96 133.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.656 -0.653 . . . . 0.0 109.866 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.39 96.72 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.96 -85.96 0.1 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 95.5 m-20 -121.19 137.2 54.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -1.169 . . . . 0.0 110.731 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.9 mp -100.56 163.55 12.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.822 . . . . 0.0 109.577 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -73.17 -143.68 0.61 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 94.1 m95 -82.78 160.53 22.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.496 -1.002 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -138.13 143.8 40.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.0 109.799 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.598 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.4 t -131.34 -46.43 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.941 -1.099 . . . . 0.0 111.689 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.598 ' N ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -117.48 -5.98 11.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.667 -1.271 . . . . 0.0 112.807 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . 118.65 -168.31 13.21 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 118.949 -1.595 . . . . 0.0 110.611 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 90' ' ' MET . 26.2 t -125.68 -88.8 0.58 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.614 -0.933 . . . . 0.0 110.708 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' GLY . 65.9 mtm -147.43 -85.49 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.046 -1.034 . . . . 0.0 112.87 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -9.0 -58.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' MET . . . 125.34 -72.43 0.44 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.538 -1.351 . . . . 0.0 109.811 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 38.1 Cg_endo -63.42 -37.14 50.94 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.851 1.448 . . . . 0.0 109.333 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.492 ' H ' HG12 ' A' ' 91' ' ' VAL . 74.9 t80 -60.09 -33.78 72.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.561 0.696 . . . . 0.0 109.259 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 38.0 tt0 -75.64 -45.06 39.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.562 -0.711 . . . . 0.0 110.148 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.793 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 46.6 mt-10 -55.62 -42.68 75.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.0 110.566 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -81.02 -58.7 2.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.509 -1.37 . . . . 0.0 110.711 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.41 27.09 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.83 -1.169 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 85' ' ' MET . 2.4 t80 -117.9 -46.92 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.558 -1.339 . . . . 0.0 112.435 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -76.26 -11.18 59.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.841 -1.162 . . . . 0.0 111.575 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 4.2 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 120.826 -1.171 . . . . 0.0 109.425 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.514 0.674 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 21.0 t80 -108.72 134.41 51.47 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 115' ' ' PRO . 6.5 m -53.65 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 110.418 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 26.3 p-10 -133.03 113.52 13.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.58 163.3 90.07 Favored 'Cis proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.073 -2.053 . . . . 0.0 110.382 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.72 ' HA ' HG22 ' A' ' 112' ' ' THR . 46.7 Cg_endo -72.87 -179.66 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.99 1.521 . . . . 0.0 110.054 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.6 161.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.005 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 13.8 ptmt -129.93 119.46 23.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.578 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 39.5 p -122.94 -177.16 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.84 -1.162 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -71.49 -16.69 62.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 0.0 110.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -98.87 27.13 5.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.909 -1.119 . . . . 0.0 109.301 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 103.18 179.69 26.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 52.6 p90 -99.22 159.22 15.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.302 . . . . 0.0 109.797 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.59 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 34.8 m-70 -132.66 140.17 48.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.692 ' N ' HD12 ' A' ' 124' ' ' ILE . 3.7 mp -115.55 136.99 50.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.42 ' HB ' ' OG1' ' A' ' 112' ' ' THR . 0.7 OUTLIER -132.98 147.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.32 -1.488 . . . . 0.0 112.066 -177.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.569 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 13.6 ttt -127.17 135.09 50.19 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.55 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.938 -1.101 . . . . 0.0 111.077 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -141.69 160.82 39.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.674 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 78.62 81.38 0.69 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.496 ' HD2' ' OXT' ' A' ' 131' ' ' LYS . 8.5 tmm_? -97.1 142.73 28.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 110.402 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.787 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . 9.6 tttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' THR . 12.3 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.083 0.468 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . . . -131.86 143.42 50.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 0.0 110.684 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 39' ' ' LYS . 7.4 p -142.7 176.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.91 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.04 121.97 39.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.919 -1.113 . . . . 0.0 108.353 178.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 77.2 t -108.2 138.27 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.05 0.929 . . . . 0.0 112.946 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -140.76 117.0 10.63 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 1.2 p80 -138.61 -175.04 3.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.446 -1.409 . . . . 0.0 112.565 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 67' ' ' VAL . 73.8 mt -130.91 114.31 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.621 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.3 tt -104.54 117.27 33.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 110.555 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 41.7 t -142.52 152.06 42.27 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.223 -0.923 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.635 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 18.9 pt-20 -52.5 153.63 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 109.372 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.562 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 3.1 tptt -127.24 113.44 16.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.84 -1.163 . . . . 0.0 111.79 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.7 m-70 -133.29 -60.74 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.063 0.935 . . . . 0.0 108.584 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.33 25.71 0.23 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -116.14 -10.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.555 -0.968 . . . . 0.0 110.148 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -51.08 -32.61 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -0.799 . . . . 0.0 110.444 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.516 ' O ' ' HG2' ' A' ' 55' ' ' MET . 40.0 mtp -72.01 -34.02 68.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.975 -1.078 . . . . 0.0 109.553 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -74.51 -32.5 62.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.331 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.02 -39.94 87.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.643 -0.661 . . . . 0.0 109.986 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.605 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 4.0 ptt? -70.8 -34.19 71.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -0.968 . . . . 0.0 109.676 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 70.4 tt0 -57.72 -50.48 73.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.603 ' C ' HG21 ' A' ' 67' ' ' VAL . 34.0 mmtt -71.16 -21.16 62.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.903 . . . . 0.0 108.943 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.048 HD22 HD13 ' A' ' 124' ' ' ILE . 39.5 tp -75.77 -15.49 60.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.647 -0.658 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 29.1 mmmt -40.0 136.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.816 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -50.01 -30.4 10.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.98 -21.81 25.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.25 157.51 20.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 0.0 110.036 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 24.3 ttm180 -66.45 105.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 111.192 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 58' ' ' LEU . 34.6 t80 -46.82 -30.42 2.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.62 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 38.9 t30 -64.11 -43.37 95.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -62.21 -43.21 99.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 57' ' ' LYS . 1.9 t -63.14 -42.73 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.914 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -64.91 -43.62 92.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.46 -48.73 76.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 0.0 110.993 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.429 ' CA ' HE21 ' A' ' 70' ' ' GLN . 0.0 OUTLIER -72.1 -30.03 64.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.001 -1.062 . . . . 0.0 111.044 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 22.2 m-85 -100.35 15.3 28.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.514 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.1 p -73.93 91.9 2.05 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 50.4 tt0 -101.41 10.62 40.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.11 . . . . 0.0 110.283 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' O ' ' CA ' ' A' ' 78' ' ' GLN . 51.7 t0 -110.91 104.9 13.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.13 -42.66 31.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.359 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -38.49 78.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.558 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -111.42 0.42 16.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.334 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER 54.26 91.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 78' ' ' GLN . . . -44.69 100.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 78' ' ' GLN . . . -174.66 -115.5 0.4 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.744 ' C ' HD12 ' A' ' 82' ' ' LEU . 46.8 p-10 -117.62 142.34 47.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -1.05 . . . . 0.0 110.861 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.814 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.7 mp -110.47 175.84 5.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.49 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.96 -147.63 9.12 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 23.5 m-90 -98.78 117.3 32.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.724 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 20.6 ptm -130.71 171.72 12.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.036 -1.04 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' N ' ' A' ' 87' ' ' ARG . 14.8 t -101.2 -147.95 0.36 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.513 ' N ' HG23 ' A' ' 86' ' ' THR . 33.7 ptt-85 -115.39 119.73 37.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.346 -0.846 . . . . 0.0 110.579 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' ' NE2' ' A' ' 95' ' ' GLN . . . -92.7 -157.06 33.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -141.58 52.26 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -1.151 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.6 tpt -100.96 -90.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 109.041 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.638 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -77.84 132.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 108.799 178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.553 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.95 -53.49 18.79 Favored Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.654 -0.654 . . . . 0.0 112.997 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.4 Cg_endo -65.01 -42.09 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.276 1.146 . . . . 0.0 111.669 -177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 91' ' ' VAL . 56.4 t80 -65.46 -49.18 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.103 -0.998 . . . . 0.0 110.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.426 ' NE2' ' H ' ' A' ' 88' ' ' GLY . 12.6 mm100 -72.89 -58.84 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 111.251 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 13.1 mm-40 -53.17 -49.84 65.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.958 -1.089 . . . . 0.0 111.199 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -59.24 -57.98 10.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 0.0 110.35 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.11 -52.76 4.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.647 -0.658 . . . . 0.0 111.183 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.42 10.36 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 110.555 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -87.65 -48.07 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.981 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 111' ' ' PHE . 11.9 t . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.705 ' H ' HG12 ' A' ' 110' ' ' VAL . 5.4 p90 -114.02 168.8 9.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.012 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 114' ' ' PRO . 26.5 m -56.78 -5.73 0.26 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 111' ' ' PHE . 9.2 p-10 -50.74 126.59 24.27 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.027 -1.671 . . . . 0.0 109.378 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' THR . 45.5 Cg_endo -70.1 134.78 31.5 Favored 'Cis proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.287 -1.964 . . . . 0.0 111.124 0.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.662 ' HG2' HD11 ' A' ' 51' ' ' ILE . 40.3 Cg_endo -66.22 -174.69 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.054 1.555 . . . . 0.0 111.289 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.3 m -108.12 157.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.648 . . . . 0.0 109.899 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -113.56 118.21 33.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 30.0 p -130.73 170.98 13.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 110.623 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.35 -17.69 63.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 110.224 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.6 OUTLIER -98.26 24.36 7.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.215 -0.928 . . . . 0.0 109.357 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 98.06 174.43 33.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 5.3 p90 -98.49 152.0 20.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.378 -1.072 . . . . 0.0 108.567 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 3.4 m-70 -131.28 141.48 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.825 -1.172 . . . . 0.0 113.053 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.048 HD13 HD22 ' A' ' 58' ' ' LEU . 57.9 mt -115.51 112.93 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 111' ' ' PHE . 25.0 mt -102.01 144.88 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.665 -1.272 . . . . 0.0 111.065 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ARG . 7.6 tpt -121.12 111.66 17.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.9 t -94.96 102.19 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.036 -1.04 . . . . 0.0 111.65 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 88.3 tt0 -144.66 135.02 24.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 132.84 7.08 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.12 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -107.74 169.25 8.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.386 -1.067 . . . . 0.0 110.323 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.534 ' CD ' ' HB3' ' A' ' 37' ' ' ALA . 45.2 mtmt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.354 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' ND2' ' HB ' ' A' ' 86' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.395 0.617 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' THR . . . -109.13 155.47 20.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.361 -0.837 . . . . 0.0 109.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 85' ' ' MET . 7.7 p -140.65 156.69 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.024 -1.048 . . . . 0.0 110.517 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD2' ' NE1' ' A' ' 84' ' ' TRP . 1.5 mppt? -100.06 126.27 46.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.098 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -125.38 113.49 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.009 . . . . 0.0 111.57 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HA ' ' CB ' ' A' ' 81' ' ' ASP . 15.3 mtp180 -114.33 115.75 27.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.839 . . . . 0.0 108.819 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.993 ' HB2' HG22 ' A' ' 125' ' ' ILE . 3.7 p80 -138.14 160.81 38.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.968 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.704 ' CG1' HG22 ' A' ' 124' ' ' ILE . 27.3 pt -116.89 124.53 73.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 45' ' ' CYS . 6.2 tt -108.53 129.96 55.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.585 . . . . 0.0 111.055 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.642 ' N ' HD23 ' A' ' 44' ' ' LEU . 32.6 t -142.62 165.42 27.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 83.0 mt-10 -69.13 154.1 42.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 26.9 tttm -87.88 116.62 26.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.76 -1.212 . . . . 0.0 112.834 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.5 m-70 -131.32 9.08 4.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.502 -0.749 . . . . 0.0 109.268 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.14 41.91 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -88.52 9.09 25.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.489 -1.006 . . . . 0.0 110.378 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.7 HG23 ' HG2' ' A' ' 115' ' ' PRO . 5.5 mt -48.8 -59.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.906 -1.121 . . . . 0.0 110.0 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' SD ' ' A' ' 55' ' ' MET . 72.3 mtm -69.06 -28.12 66.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.771 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -73.98 -42.47 60.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.784 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.31 79.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.506 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 25.2 ptm -63.7 -46.18 86.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.995 . . . . 0.0 110.467 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 79.0 tt0 -56.6 -33.46 66.26 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.041 -1.037 . . . . 0.0 110.161 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.695 ' HG2' HG22 ' A' ' 67' ' ' VAL . 66.1 tttt -77.72 -27.78 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.738 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 124' ' ' ILE . 1.0 OUTLIER -104.59 16.18 26.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.871 -1.143 . . . . 0.0 110.582 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 58' ' ' LEU . 38.5 mttm -50.65 -161.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.507 -0.745 . . . . 0.0 110.438 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.2 m -87.0 154.49 20.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.574 -1.329 . . . . 0.0 110.931 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.41 -3.83 86.32 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -113.89 -168.39 1.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.065 -1.256 . . . . 0.0 110.862 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 13.5 mtm180 -95.71 95.34 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.411 -0.805 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -50.65 -35.51 31.07 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.121 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 21.8 p-10 -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.797 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.7 tt0 -58.52 -49.02 78.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 57' ' ' LYS . 59.1 t -62.94 -52.27 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.922 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -45.2 -50.09 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.44 76.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 110.399 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.48 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.4 tp60 -74.38 -26.05 59.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.995 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -109.89 17.47 21.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.109 . . . . 0.0 110.483 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.5 t -82.1 97.5 8.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.998 -1.064 . . . . 0.0 110.4 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -100.52 1.39 40.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.378 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' HD22 ' A' ' 44' ' ' LEU . 4.0 m-20 -114.07 23.28 13.08 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.459 -0.776 . . . . 0.0 109.538 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -56.6 -35.49 68.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -39.24 68.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.891 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -106.4 -53.3 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.851 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . 54.3 mm-40 -141.01 -80.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 110.05 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.46 24.43 76.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -144.32 -104.8 0.48 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.614 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.3 p-10 -128.13 171.77 11.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -1.133 . . . . 0.0 110.322 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.1 mp -100.51 16.91 23.11 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.358 -0.838 . . . . 0.0 109.092 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.29 -134.12 33.26 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.532 ' NE1' ' HD2' ' A' ' 39' ' ' LYS . 3.4 m-90 -87.37 125.99 34.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.842 -0.799 . . . . 0.0 109.542 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.78 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.6 ttm -137.65 140.86 41.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.548 ' HB ' ' ND2' ' A' ' 36' ' ' ASN . 76.5 p -111.4 -33.03 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.438 -0.789 . . . . 0.0 109.979 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -66.71 -31.32 71.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.435 -0.791 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 99' ' ' PHE . . . 147.79 -107.01 0.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.609 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -143.22 -65.78 0.38 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.403 -1.057 . . . . 0.0 109.502 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 23.0 mtp -144.08 -77.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.762 . . . . 0.0 110.951 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -175.09 166.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 0.0 110.936 -179.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . 68.36 -143.65 41.2 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 92' ' ' GLY . 40.8 Cg_endo -67.16 -35.92 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.104 1.581 . . . . 0.0 109.284 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 125' ' ' ILE . 50.5 t80 -51.17 -30.52 17.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.476 ' OE1' ' HA3' ' A' ' 88' ' ' GLY . 16.7 tp60 -83.01 -54.68 4.88 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.597 0.713 . . . . 0.0 109.225 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.61 -45.26 92.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.615 -0.678 . . . . 0.0 110.215 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.44 -52.4 53.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 110.161 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.639 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -41.7 -53.88 3.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 88' ' ' GLY . 4.0 m-30 -81.43 -0.84 43.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.412 -0.805 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.25 21.15 6.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.87 -1.144 . . . . 0.0 111.927 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 101' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.576 -1.327 . . . . 0.0 110.861 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.405 0.621 . . . . 0.0 109.779 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.644 ' N ' HG13 ' A' ' 110' ' ' VAL . 38.0 p90 -114.57 164.39 14.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.8 p -74.43 117.4 16.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.515 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.5 p-10 -132.58 122.98 18.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 109.574 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.5 Cg_endo -69.07 170.27 56.31 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.232 0.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.7 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -73.57 -175.93 2.29 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.146 1.603 . . . . 0.0 110.081 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 123' ' ' HIS . 11.4 m -100.94 147.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 109.503 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -118.02 128.59 54.92 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.614 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 77.1 p -131.63 174.4 10.15 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -67.96 -16.95 64.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 1.2 p90 -96.67 28.19 3.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 105.38 -166.13 14.35 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 31.6 p90 -116.57 152.79 33.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.39 -1.065 . . . . 0.0 109.905 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.623 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -134.74 136.23 42.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.966 -1.084 . . . . 0.0 112.346 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.074 HD13 HD21 ' A' ' 58' ' ' LEU . 19.0 tt -121.17 108.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.993 HG22 ' HB2' ' A' ' 42' ' ' HIS . 24.9 pt -107.4 157.34 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.935 -1.103 . . . . 0.0 113.289 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 3.9 ttt -121.46 124.6 44.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 101' ' ' LEU . 16.3 m -109.74 120.88 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.649 -1.282 . . . . 0.0 111.903 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 129' ' ' GLY . 46.3 tt0 -115.29 149.21 38.19 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 48.22 95.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -131.56 150.7 52.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -1.0 . . . . 0.0 109.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.081 . . . . 0.0 110.16 -179.783 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.727 ' O ' HG23 ' A' ' 86' ' ' THR . 45.7 t30 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -100.69 159.2 15.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.52 -0.737 . . . . 0.0 109.282 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.7 p -143.3 154.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.8 ttpt -98.49 125.4 43.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 74.5 t -121.97 132.56 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.833 -177.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.2 mtt180 -120.16 130.91 54.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.977 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.7 p80 -143.81 170.34 16.06 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.971 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.995 ' CD1' HG12 ' A' ' 67' ' ' VAL . 2.5 tt -124.32 113.77 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 8.1 tt -107.64 119.43 39.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 53.8 t -141.36 150.64 42.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.573 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 30.2 mt-10 -53.68 168.25 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 108.888 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' C ' ' CD2' ' A' ' 48' ' ' HIS . 8.6 ttmt -99.03 115.22 28.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.594 -1.316 . . . . 0.0 113.021 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 2.7 m80 -134.73 20.57 3.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.607 . . . . 0.0 109.651 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.14 11.92 83.84 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 tttm -81.2 5.22 17.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.958 . . . . 0.0 110.401 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.695 HD11 ' CB ' ' A' ' 122' ' ' TYR . 14.3 mm -51.22 -44.58 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 96.7 mtp -69.25 -43.16 74.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.818 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.77 -57.35 13.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 0.0 110.526 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' OH ' ' A' ' 71' ' ' TYR . . . -55.53 -55.82 27.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 9.8 ptt? -60.84 -41.25 95.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.049 . . . . 0.0 110.3 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' MET . 81.9 tt0 -52.86 -50.18 64.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.925 -1.109 . . . . 0.0 109.173 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 67' ' ' VAL . 12.9 ttmt -74.13 -28.64 61.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -0.768 . . . . 0.0 109.466 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.847 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.98 -24.52 58.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.401 -0.812 . . . . 0.0 109.229 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 58' ' ' LEU . 16.3 tptt -22.37 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.41 0.624 . . . . 0.0 112.082 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLY . 53.9 p -50.68 -52.29 41.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.394 -0.816 . . . . 0.0 109.63 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 60' ' ' SER . . . -45.0 -36.12 4.9 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 33.8 mmt -82.68 149.86 27.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -1.098 . . . . 0.0 110.315 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' HG3' ' CB ' ' A' ' 66' ' ' GLU . 1.3 ptm180 -73.55 106.54 5.37 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.961 0.886 . . . . 0.0 110.583 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 58' ' ' LEU . 9.0 t80 -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.484 0.659 . . . . 0.0 110.484 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.91 -56.88 16.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 111.075 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CB ' ' HG3' ' A' ' 63' ' ' ARG . 10.5 tp10 -55.81 -41.14 73.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.118 -0.989 . . . . 0.0 110.966 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.995 HG12 ' CD1' ' A' ' 43' ' ' ILE . 71.4 t -52.61 -59.09 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.748 -1.22 . . . . 0.0 109.803 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.584 ' CA ' HD11 ' A' ' 43' ' ' ILE . . . -64.94 -54.87 23.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -42.07 -27.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.413 -0.804 . . . . 0.0 109.838 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.582 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 3.7 tp60 -80.59 -62.85 1.55 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 109.992 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.768 ' OH ' ' HB1' ' A' ' 54' ' ' ALA . 50.9 p90 -109.96 51.16 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.606 -1.308 . . . . 0.0 111.084 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 31.1 t -89.83 131.14 35.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.248 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 68.4 mm-40 -102.4 -3.15 27.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.886 -1.134 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 78' ' ' GLN . 84.6 m-20 -104.6 26.89 8.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.922 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.77 -19.96 64.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.895 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -75.14 -29.82 60.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.092 -1.005 . . . . 0.0 110.802 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 55.9 mtt180 -118.62 -25.33 6.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.534 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 170.07 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.04 98.95 0.81 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.9 -103.8 0.25 Allowed Glycine 0 N--CA 1.491 2.333 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.2 m-20 -97.21 162.2 13.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -1.092 . . . . 0.0 110.739 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.615 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 1.3 mp -101.64 -35.69 9.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 117.84 -161.99 13.2 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 17.1 m-90 -98.6 115.64 29.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.891 -0.77 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 ptm -134.78 138.24 44.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 110.208 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.787 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 93.3 m -104.14 -14.08 16.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.473 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 88' ' ' GLY . 27.6 ttt180 -100.0 -72.29 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 111.125 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . 44.83 66.41 1.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.6 p -120.44 66.3 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -1.092 . . . . 0.0 110.432 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 37.1 mmt -107.95 -49.06 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 94' ' ' PHE . 72.0 t -114.02 153.96 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.912 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -72.81 -64.77 2.47 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 121.2 -0.937 . . . . 0.0 111.062 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 37.0 Cg_endo -60.89 -30.9 90.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.71 1.374 . . . . 0.0 112.104 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 51.1 t80 -68.93 -40.67 78.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.738 -1.226 . . . . 0.0 110.426 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 42.1 tt0 -72.86 -30.99 64.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.298 -0.876 . . . . 0.0 110.651 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 1.039 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 7.5 mm-40 -62.24 -26.51 68.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.82 . . . . 0.0 111.025 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.02 -54.63 3.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 111.315 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.41 -47.02 76.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.125 -0.984 . . . . 0.0 111.594 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.04 -8.63 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 111.544 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 1.039 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -130.33 25.88 5.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.698 -1.251 . . . . 0.0 111.89 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.712 -1.243 . . . . 0.0 109.373 179.241 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.646 0.736 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 39.3 p90 -123.2 164.33 18.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.6 p -50.43 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 67.3 t0 -122.32 116.85 29.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.931 . . . . 0.0 109.756 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.9 Cg_endo -70.72 164.33 82.27 Favored 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.987 -2.089 . . . . 0.0 110.535 0.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.638 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.5 Cg_endo -70.85 -176.25 1.72 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.967 1.509 . . . . 0.0 110.291 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.69 155.08 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.988 . . . . 0.0 110.402 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HE2' HG13 ' A' ' 51' ' ' ILE . 38.8 ttmt -124.03 127.4 47.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.53 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 38.9 p -138.81 -175.85 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.945 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -71.74 -35.09 70.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 118' ' ' THR . 1.4 p90 -80.03 7.54 8.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.014 -1.054 . . . . 0.0 109.956 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . . . 117.48 175.82 17.24 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.695 ' CB ' HD11 ' A' ' 51' ' ' ILE . 55.6 p90 -101.67 151.72 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -1.056 . . . . 0.0 109.453 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -132.23 140.68 48.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.867 -1.146 . . . . 0.0 111.95 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.888 HG22 HG22 ' A' ' 43' ' ' ILE . 8.0 tt -118.46 106.22 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.977 HG22 ' HB2' ' A' ' 42' ' ' HIS . 14.8 pt -115.07 149.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.492 -1.38 . . . . 0.0 112.695 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 41' ' ' ARG . 26.1 ptm -122.46 145.53 48.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.3 m -114.78 101.16 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.951 -1.093 . . . . 0.0 111.272 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 76.3 tt0 -143.59 87.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 110.486 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 39' ' ' LYS . . . 162.27 115.68 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.546 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 72.3 ttt180 -130.35 157.3 42.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -1.037 . . . . 0.0 109.533 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 56.5 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.129 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.688 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -105.01 -156.53 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.281 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 85' ' ' MET . 2.4 p -139.21 161.15 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 84' ' ' TRP . 47.1 mttt -99.61 111.55 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.885 -1.135 . . . . 0.0 109.309 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.48 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 46.3 mtt-85 -111.86 125.73 54.34 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.777 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -138.47 162.63 34.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.441 -1.412 . . . . 0.0 112.609 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.701 HD11 HD12 ' A' ' 124' ' ' ILE . 10.0 pt -129.85 137.64 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.012 HD13 ' OD2' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -107.74 131.56 54.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 111.1 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 71' ' ' TYR . 62.5 m -126.76 168.73 14.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 73.4 tt0 -74.04 158.91 33.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.0 ttpt -96.41 96.02 8.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.043 -1.036 . . . . 0.0 110.565 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 2.2 p-80 -132.71 6.82 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.554 -0.716 . . . . 0.0 110.009 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.77 2.37 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -114.72 10.87 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -1.185 . . . . 0.0 110.271 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG23 ' CG ' ' A' ' 115' ' ' PRO . 60.0 mt -53.63 -49.33 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.454 -0.779 . . . . 0.0 111.026 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.6 mmm -65.31 -50.68 64.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.987 . . . . 0.0 110.989 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.02 -42.88 99.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.948 . . . . 0.0 111.334 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . . . -61.38 -50.41 72.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.372 -0.83 . . . . 0.0 112.198 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.559 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 3.5 ptt? -65.48 -37.74 87.73 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.802 -1.186 . . . . 0.0 111.718 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 55' ' ' MET . 60.7 tt0 -65.39 -46.09 81.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -63.58 -34.19 77.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.962 -1.086 . . . . 0.0 108.594 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 124' ' ' ILE . 13.6 tp -71.59 -35.5 70.56 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.558 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 12.9 mttp 46.38 -92.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.504 -0.747 . . . . 0.0 111.161 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' LEU . 75.6 p -122.59 -3.61 8.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.147 -0.971 . . . . 0.0 110.976 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 -9.06 13.8 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 38.6 mmt -50.8 -34.95 29.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -1.159 . . . . 0.0 110.056 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -113.45 27.02 9.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.115 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' CE1' ' HE3' ' A' ' 126' ' ' MET . 8.9 t80 -53.11 -46.1 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 0.0 109.841 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 47.9 t30 -60.31 -40.3 90.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.601 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -65.25 -58.36 6.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 71.1 t -60.44 -63.23 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -46.29 -42.46 14.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -49.5 -56.15 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 109.935 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 8.2 mm-40 -90.04 -0.01 57.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 5.7 m-85 -104.33 3.16 32.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 110.382 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.2 t -99.89 93.65 5.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 0.0 109.729 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 24.6 mp0 -106.27 9.78 31.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.19 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 1.012 ' OD2' HD13 ' A' ' 44' ' ' LEU . 80.8 m-20 -117.29 46.17 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -66.15 -14.71 62.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.72 -37.07 42.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 111.363 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -121.99 15.66 10.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 111.599 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' CD ' ' NE2' ' A' ' 42' ' ' HIS . 0.5 OUTLIER -159.99 154.77 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.792 -1.193 . . . . 0.0 110.687 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.93 9.84 13.98 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 103.39 -52.98 0.75 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 41' ' ' ARG . 93.2 m-20 -115.44 137.94 51.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -1.085 . . . . 0.0 109.68 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 85' ' ' MET . 0.7 OUTLIER -100.52 -13.96 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 109.986 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 89.95 -115.62 4.6 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.356 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.625 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 79.5 m95 -89.46 133.56 34.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.989 . . . . 0.0 111.502 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 38' ' ' VAL . 22.8 ttt -122.59 124.81 44.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.2 m -134.92 -47.22 0.73 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.974 -1.079 . . . . 0.0 112.172 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 86' ' ' THR . 11.8 mtt180 -103.06 -88.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.69 -1.256 . . . . 0.0 111.744 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . -138.18 151.79 21.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 90' ' ' MET . 9.9 p -143.78 -53.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.273 . . . . 0.0 111.143 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 57.5 mmm -107.69 -98.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 111.362 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 120' ' ' PHE . 5.4 t -129.23 174.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.909 -1.119 . . . . 0.0 111.448 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -42.23 -54.16 4.67 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.746 -0.596 . . . . 0.0 112.284 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 43.5 Cg_endo -67.7 -19.75 47.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.459 1.242 . . . . 0.0 111.712 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 90' ' ' MET . 42.6 t80 -79.6 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.797 -1.19 . . . . 0.0 110.107 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.539 ' OE1' ' HE3' ' A' ' 85' ' ' MET . 28.4 mm100 -70.99 -38.23 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.769 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 4.7 mm-40 -70.75 -33.98 71.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' PRO . . . -69.7 -48.15 60.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.148 -0.97 . . . . 0.0 110.574 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.0 97.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 111.291 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.82 0.3 57.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.013 -1.054 . . . . 0.0 111.563 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -127.04 4.89 6.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.771 -1.206 . . . . 0.0 111.186 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 112' ' ' THR . 41.4 tp . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.906 -1.121 . . . . 0.0 109.842 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 111' ' ' PHE . 17.5 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.412 0.625 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CZ ' ' CE ' ' A' ' 126' ' ' MET . 19.1 m-30 -101.42 171.18 7.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.519 -0.738 . . . . 0.0 110.039 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.719 HG21 ' CG2' ' A' ' 116' ' ' VAL . 65.0 m -65.18 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 111.802 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.771 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 99.0 m-20 -93.39 -24.93 0.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 42.5 Cg_endo -71.04 -27.36 7.5 Favored 'Cis proline' 0 N--CA 1.493 1.442 0 C-N-CA 124.306 -1.122 . . . . 0.0 114.484 1.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.624 ' HD3' ' CD ' ' A' ' 114' ' ' PRO . 51.5 Cg_endo -80.92 130.68 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 122.404 0.686 . . . . 0.0 112.576 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.719 ' CG2' HG21 ' A' ' 112' ' ' THR . 60.6 t -98.66 143.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 11.9 ptpt -102.51 108.55 19.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.53 -0.731 . . . . 0.0 111.065 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.645 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 19.4 p -136.84 158.37 44.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -65.82 -13.62 59.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.645 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.6 p90 -100.41 21.56 12.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.78 -1.2 . . . . 0.0 110.039 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 112.66 -169.9 13.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 33.7 m-85 -105.68 156.61 18.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 109.25 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 60.8 m-70 -135.16 128.57 32.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 112.199 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.836 HG21 HD22 ' A' ' 58' ' ' LEU . 95.7 mt -117.93 102.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -106.78 152.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.468 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.634 ' CE ' ' CZ ' ' A' ' 111' ' ' PHE . 20.3 mtt -124.17 136.21 54.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.69 139.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.888 -1.133 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -117.39 -37.57 3.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 110.46 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -145.64 121.6 1.53 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 41.5 ttt180 -110.25 149.4 30.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -1.132 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.128 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.288 0.566 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -90.63 -170.54 2.75 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 85' ' ' MET . 1.6 p -143.46 151.62 16.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.724 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.551 ' HG3' ' CE3' ' A' ' 84' ' ' TRP . 49.7 mtmt -99.27 129.6 45.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 109.257 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 82' ' ' LEU . 5.0 p -139.34 139.39 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.02 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.1 mtt-85 -110.74 122.5 47.97 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 80' ' ' GLY . 3.7 p80 -138.27 148.25 44.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.821 -1.174 . . . . 0.0 111.501 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 19.4 mt -102.7 119.35 50.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 120' ' ' PHE . 4.4 tt -101.79 116.31 32.44 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 41.8 t -129.0 163.56 25.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.546 -0.721 . . . . 0.0 109.642 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 32.0 mt-10 -71.55 -178.91 2.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.598 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . 22.7 tttm -97.0 104.27 16.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.024 -1.048 . . . . 0.0 112.639 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.649 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.9 m-70 -133.13 0.42 3.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.254 -0.904 . . . . 0.0 110.504 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 122' ' ' TYR . . . 94.03 11.77 57.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' ILE . 98.0 mttt -85.56 3.85 38.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.253 -1.145 . . . . 0.0 110.739 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG23 ' HG2' ' A' ' 115' ' ' PRO . 67.8 mt -42.28 -53.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 98.5 mmm -66.01 -45.19 82.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.144 -0.972 . . . . 0.0 110.637 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.28 -48.1 81.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.781 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.0 -61.19 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.539 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.679 ' HA ' HD21 ' A' ' 58' ' ' LEU . 3.9 ppp? -63.19 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 110.712 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 52' ' ' MET . 39.5 tp10 -71.54 -28.25 63.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.073 -1.017 . . . . 0.0 110.016 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 67' ' ' VAL . 9.3 tptt -74.65 -34.77 62.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.846 ' HB3' HG21 ' A' ' 67' ' ' VAL . 3.7 pp -91.56 -16.98 26.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.817 ' O ' HD12 ' A' ' 58' ' ' LEU . 19.3 mtpt 43.45 -135.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.551 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 100.0 p -57.26 -24.98 58.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.138 -0.976 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.03 9.92 2.94 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtp -50.73 -44.79 58.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.892 -1.357 . . . . 0.0 109.723 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 67' ' ' VAL . 65.0 mtt-85 -114.24 38.82 2.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.455 -0.778 . . . . 0.0 109.702 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -52.55 -49.98 63.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.371 -0.831 . . . . 0.0 110.341 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 16.9 p30 -61.88 -42.26 98.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.5 mm-40 -59.25 -50.93 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.052 -1.03 . . . . 0.0 108.993 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 58' ' ' LEU . 92.4 t -57.5 -52.42 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 0.0 109.817 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -60.12 -40.57 90.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -49.89 -44.99 50.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.483 -0.761 . . . . 0.0 110.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -94.89 -11.79 28.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.529 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 43' ' ' ILE . 32.9 m-85 -117.81 25.75 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 111.1 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 t -103.68 115.43 30.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.927 -1.108 . . . . 0.0 110.214 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -100.34 -7.51 24.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.488 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 2.1 m-20 -104.92 23.7 13.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.491 -0.755 . . . . 0.0 109.065 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -49.89 -32.17 13.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.63 88.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.473 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 16.4 mtt-85 -112.09 -45.22 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.125 -0.984 . . . . 0.0 110.274 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 mp0 -118.91 149.56 41.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.09 13.23 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 101.58 -5.91 54.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 36.5 p-10 -124.84 140.5 52.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -1.204 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 40' ' ' VAL . 63.3 tp -110.6 127.8 55.39 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.06 -1.025 . . . . 0.0 109.484 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -59.3 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE3' ' HG3' ' A' ' 39' ' ' LYS . 98.3 m95 -80.31 142.21 34.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -1.017 . . . . 0.0 110.727 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.877 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.2 ttt -128.89 121.81 28.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.619 -0.676 . . . . 0.0 109.269 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.1 m -118.28 -46.65 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.732 -1.23 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -100.41 -54.48 2.85 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.005 . . . . 0.0 110.502 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' NE2' ' A' ' 95' ' ' GLN . . . 160.74 -165.73 35.22 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -133.19 -75.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.513 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 41.7 mtp -140.37 -80.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.081 -1.012 . . . . 0.0 110.74 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 118' ' ' THR . 97.3 t -50.69 127.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.639 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.58 -51.48 30.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 38.9 Cg_endo -65.15 -8.78 19.49 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.461 1.243 . . . . 0.0 110.817 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.462 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 46.9 t80 -80.56 -46.17 16.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.04 . . . . 0.0 109.014 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' NE2' ' HA3' ' A' ' 88' ' ' GLY . 19.9 mt-30 -68.52 -30.72 69.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 79.9 mm-40 -54.41 -40.73 68.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -77.75 -51.08 11.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.55 -53.0 15.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -77.03 -17.48 58.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.407 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -58.76 -44.68 90.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.99 -1.069 . . . . 0.0 109.253 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 127' ' ' VAL . 69.4 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.367 -0.833 . . . . 0.0 109.396 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 111' ' ' PHE . 45.6 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.255 0.55 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' N ' HG12 ' A' ' 110' ' ' VAL . 50.5 p90 -123.21 157.06 33.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 0.0 110.139 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.456 ' CG2' ' HB ' ' A' ' 125' ' ' ILE . 77.3 p -56.86 109.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 110.642 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.548 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 22.3 p-10 -132.33 124.14 19.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.763 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 44.8 Cg_endo -70.79 164.74 81.43 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.208 0.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.614 ' HG2' HG23 ' A' ' 51' ' ' ILE . 46.3 Cg_endo -72.55 -178.5 3.41 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.085 1.571 . . . . 0.0 109.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' A' ' 123' ' ' HIS . 3.7 m -99.61 146.3 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.053 . . . . 0.0 109.396 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HD3' HD11 ' A' ' 51' ' ' ILE . 40.1 ttpt -120.83 134.58 55.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.006 -1.059 . . . . 0.0 110.46 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.583 HG21 HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -141.32 -164.29 1.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -0.88 . . . . 0.0 109.75 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -73.37 -45.91 52.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.992 . . . . 0.0 112.059 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.757 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 6.8 p90 -53.6 -41.62 66.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.065 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.673 ' N ' ' CG ' ' A' ' 120' ' ' PHE . . . 164.81 -124.4 1.25 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -177.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.563 ' OH ' ' HG3' ' A' ' 47' ' ' LYS . 15.7 m-85 -133.41 162.53 31.59 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.81 -1.406 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.787 ' HB2' HG22 ' A' ' 116' ' ' VAL . 97.6 m-70 -137.58 110.63 7.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.308 -0.87 . . . . 0.0 111.071 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -99.05 118.57 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 125' ' ' ILE . 3.4 mp -105.78 134.89 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.902 -1.124 . . . . 0.0 113.505 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 tpt -118.23 121.76 41.27 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 101' ' ' LEU . 17.0 t -92.8 144.14 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.808 -1.183 . . . . 0.0 111.389 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.2 -48.25 3.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.8 . . . . 0.0 110.234 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.14 149.25 16.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.18 157.2 44.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -1.134 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 pttt . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.083 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.368 0.604 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -99.44 155.37 17.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 30.4 m -138.63 158.16 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -100.54 122.48 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.724 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 82' ' ' LEU . 7.9 p -124.22 162.62 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.917 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 126' ' ' MET . 41.1 ttm180 -143.17 128.2 18.52 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.963 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.9 p80 -140.29 175.15 9.83 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.151 -1.593 . . . . 0.0 113.173 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.684 ' HB ' HG22 ' A' ' 124' ' ' ILE . 36.0 mt -128.55 125.15 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 45' ' ' CYS . 3.3 tt -105.56 131.38 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 110.566 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.765 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.0 m -142.85 162.33 35.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.914 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 85.4 mt-10 -75.91 161.44 28.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 79.5 tttt -72.58 119.5 16.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.195 -0.941 . . . . 0.0 111.692 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 12.3 m-70 -133.32 -1.57 3.19 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.42 -0.8 . . . . 0.0 110.45 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.58 81.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' HB2' ' A' ' 48' ' ' HIS . 21.7 ptmt -107.34 15.46 24.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.478 -1.013 . . . . 0.0 109.948 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.755 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -46.66 -52.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.386 -0.822 . . . . 0.0 110.44 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.3 ttp -53.95 -38.29 64.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 88.6 mt-10 -70.4 -39.13 74.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -59.04 6.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.655 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.9 ptm -59.01 -33.26 70.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.918 . . . . 0.0 110.171 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' O ' ' CD ' ' A' ' 59' ' ' LYS . 33.8 tp10 -72.93 -32.96 65.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 110.189 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 24.4 mmtp -63.54 -50.74 68.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 59' ' ' LYS . 3.2 pp -73.65 -20.26 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.79 ' O ' HD12 ' A' ' 58' ' ' LEU . 28.9 mmmt 53.66 -137.31 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.878 . . . . 0.0 110.781 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.44 ' O ' HG11 ' A' ' 110' ' ' VAL . 26.2 t -52.35 -39.14 60.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.45 2.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.429 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 16.1 ptp -51.88 -35.44 45.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' N ' ' CG ' ' A' ' 62' ' ' MET . 25.8 mtt180 -101.5 9.19 41.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 110.163 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -44.35 -48.73 9.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.05 -39.22 77.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.233 -0.917 . . . . 0.0 109.849 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.23 -40.84 74.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.602 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 58' ' ' LEU . 42.2 t -67.17 -49.16 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.443 -0.786 . . . . 0.0 110.044 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -58.22 -54.74 43.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.138 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.68 -51.26 16.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.464 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.4 mm-40 -75.7 -15.58 60.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 110.101 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.663 ' CE2' HG13 ' A' ' 67' ' ' VAL . 15.1 m-30 -111.14 18.32 19.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.454 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ALA . 19.4 p -79.48 93.56 5.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.015 -1.053 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 45' ' ' CYS . 3.5 mp0 -108.95 8.26 26.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' HB3' HD13 ' A' ' 44' ' ' LEU . 4.3 p30 -112.12 37.08 3.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -48.81 -31.05 6.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.01 -39.21 51.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -91.19 4.91 51.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.306 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 51.18 51.41 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.958 . . . . 0.0 109.592 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 74' ' ' ASP . . . -78.06 115.32 4.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.66 -122.79 0.64 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' C ' HD12 ' A' ' 82' ' ' LEU . 40.4 p-10 -86.71 131.55 34.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.128 -1.219 . . . . 0.0 109.007 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.814 ' HB2' HG13 ' A' ' 40' ' ' VAL . 7.2 mp -102.91 162.77 12.66 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.987 -1.071 . . . . 0.0 110.226 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -93.37 -135.39 7.43 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 13.3 m-90 -96.38 133.03 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.968 -0.725 . . . . 0.0 110.8 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -140.52 168.35 20.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.738 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . 31.8 p -128.02 -125.48 0.22 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.301 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -113.91 174.76 5.77 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.915 -1.116 . . . . 0.0 109.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.89 56.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 t -110.36 -29.51 8.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -1.125 . . . . 0.0 110.098 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 95' ' ' GLN . 2.1 ptt? -126.35 176.7 6.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 94' ' ' PHE . 19.3 m -68.44 -174.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.354 -0.841 . . . . 0.0 110.76 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.629 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -77.61 -47.38 8.85 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 121.468 -0.77 . . . . 0.0 111.897 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.9 Cg_endo -65.52 -46.77 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.064 1.033 . . . . 0.0 110.986 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.552 ' H ' HG23 ' A' ' 91' ' ' VAL . 1.6 t80 -66.56 -39.88 88.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.938 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 34.9 tt0 -69.64 -44.39 70.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 1.011 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 34.2 tt0 -51.36 -26.83 8.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.38 -38.25 13.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.247 -0.908 . . . . 0.0 110.479 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.57 99.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.399 -0.813 . . . . 0.0 111.642 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 86' ' ' THR . 10.5 m-85 -101.39 -12.85 18.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.162 . . . . 0.0 111.788 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 1.011 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -113.1 8.91 18.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.734 -1.229 . . . . 0.0 111.021 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.711 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.6 pt? . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.038 . . . . 0.0 109.575 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 111' ' ' PHE . 62.2 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.879 0.371 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 124' ' ' ILE . 46.3 p90 -108.52 169.39 8.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 110.962 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.576 ' OG1' HG12 ' A' ' 125' ' ' ILE . 25.3 m -70.07 116.45 10.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.506 -0.746 . . . . 0.0 110.919 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 22.7 p-10 -133.85 112.78 12.59 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.7 Cg_endo -77.33 160.2 94.23 Favored 'Cis proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.153 -2.02 . . . . 0.0 110.36 -0.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 46.0 Cg_endo -72.86 -175.86 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.957 1.504 . . . . 0.0 109.908 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 116' ' ' VAL . 22.1 m -102.25 146.53 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.274 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -114.53 138.05 51.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 108.975 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.6 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 81.1 p -136.39 -173.9 3.54 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.708 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 120' ' ' PHE . 15.0 ptpt -76.36 -11.23 59.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -104.38 11.01 35.15 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.736 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.79 -167.1 12.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 45.6 p90 -108.86 157.91 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.315 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.604 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 12.2 m-70 -133.72 140.54 47.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 111.419 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 124' ' ' ILE . 19.9 tt -128.04 111.21 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.963 HG22 ' CB ' ' A' ' 42' ' ' HIS . 28.8 pt -108.62 161.2 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.789 -1.194 . . . . 0.0 111.836 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.561 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 39.5 mtm -128.05 143.88 51.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 101' ' ' LEU . 16.7 t -118.37 128.59 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.981 -1.074 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -144.26 -38.08 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.985 -1.072 . . . . 0.0 111.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . -89.26 88.32 1.51 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.418 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -118.66 135.89 54.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -1.167 . . . . 0.0 110.04 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.289 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' HG13 ' A' ' 38' ' ' VAL . 57.9 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.16 0.505 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -59.9 139.43 57.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG12 ' HA2' ' A' ' 129' ' ' GLY . 28.8 m -147.02 165.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.507 -0.746 . . . . 0.0 111.298 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -97.06 126.32 42.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.11 134.05 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.867 -1.145 . . . . 0.0 112.226 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 48.2 mtm-85 -114.15 126.03 54.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.099 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -133.51 151.47 51.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.535 -1.353 . . . . 0.0 112.231 -178.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 67' ' ' VAL . 86.3 mt -113.4 126.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.623 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -113.99 121.17 43.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 110.934 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 19.4 p -132.95 177.52 7.59 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.655 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 74.3 mm-40 -64.14 158.16 23.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.573 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.69 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 5.0 ttmt -101.84 73.17 1.4 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.942 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.655 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 30.0 m80 -135.12 51.55 2.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 111.728 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.52 -10.35 55.82 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.759 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -71.15 -15.15 62.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.336 . . . . 0.0 110.675 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 122' ' ' TYR . 7.3 tt -52.95 -36.16 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 55' ' ' MET . 26.0 ttt -67.23 -40.14 86.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 110.143 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -67.56 -34.63 77.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.909 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 124' ' ' ILE . . . -61.65 -63.06 1.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 18.5 ptt? -56.32 -34.75 66.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.797 . . . . 0.0 111.0 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 55' ' ' MET . 87.6 tt0 -69.91 -42.02 73.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 111.288 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 62' ' ' MET . 53.0 mtpt -80.27 -24.95 39.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.978 . . . . 0.0 111.246 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 124' ' ' ILE . 2.3 pp -104.35 2.87 31.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 58' ' ' LEU . 6.2 mttt -49.46 178.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.07 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -52.47 139.48 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 110.095 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.05 -10.95 69.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 29.5 mmt -100.9 163.71 12.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -1.049 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.497 ' CG ' ' HG3' ' A' ' 66' ' ' GLU . 4.9 ttm180 -93.77 95.04 8.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -46.24 -31.43 2.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 0.0 110.337 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.61 -41.24 92.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.127 -0.983 . . . . 0.0 110.011 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.497 ' HG3' ' CG ' ' A' ' 63' ' ' ARG . 3.4 mt-10 -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.826 HG13 ' CE2' ' A' ' 71' ' ' TYR . 53.6 t -68.94 -38.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.897 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -70.9 -51.38 26.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 110.465 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.34 65.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.672 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.473 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 8.1 mm-40 -91.42 -19.75 22.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.031 -1.043 . . . . 0.0 110.735 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.826 ' CE2' HG13 ' A' ' 67' ' ' VAL . 17.2 m-30 -108.71 10.44 26.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 0.0 111.078 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 16.7 m -76.44 116.76 17.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.937 -1.102 . . . . 0.0 110.154 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 25.3 tp10 -104.5 10.41 35.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 22.0 t70 -114.9 108.29 16.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.158 -0.964 . . . . 0.0 110.543 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HA ' ' HG3' ' A' ' 78' ' ' GLN . 17.1 ptpt -61.3 -25.18 66.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.04 -21.72 29.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -129.51 25.54 5.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.385 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.557 ' HG3' ' HA ' ' A' ' 75' ' ' LYS . 52.6 mt-30 -43.53 -28.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.93 -15.61 14.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . 61.39 24.03 63.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 55.4 t0 -130.74 142.84 50.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -1.116 . . . . 0.0 110.493 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.739 HD11 ' CD2' ' A' ' 42' ' ' HIS . 8.7 mp -104.04 -20.5 13.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.68 -170.06 34.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 28.9 m-90 -84.26 127.75 34.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -1.016 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 19.2 ptp -140.37 137.48 34.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 49.1 m -76.53 -54.64 6.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -111.14 -173.55 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.385 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . -149.62 146.07 14.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.6 p -137.9 16.07 2.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -1.182 . . . . 0.0 110.759 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 6.4 mmt -100.8 108.4 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.241 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.57 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 11.4 t 64.84 117.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.6 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -51.81 -53.05 31.44 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.49 -0.756 . . . . 0.0 111.461 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -65.66 -32.7 47.13 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.438 1.231 . . . . 0.0 111.705 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 125' ' ' ILE . 42.1 t80 -63.77 -52.46 60.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.851 -1.156 . . . . 0.0 109.932 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HG3' ' HA3' ' A' ' 88' ' ' GLY . 39.5 tt0 -55.12 -46.05 75.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.4 mt-10 -58.62 -48.63 80.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.12 77.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.343 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.23 91.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 36' ' ' ASN . 6.5 m-85 -103.63 13.23 33.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.957 . . . . 0.0 110.906 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -130.76 3.33 4.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.133 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 110' ' ' VAL . 61.0 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 111.34 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.815 ' N ' HG13 ' A' ' 110' ' ' VAL . 31.4 p90 -102.56 158.06 16.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.828 -1.17 . . . . 0.0 110.134 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 1.009 HG21 HG13 ' A' ' 116' ' ' VAL . 22.4 m -40.61 121.98 1.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 37.8 p-10 -133.51 104.76 12.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.909 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.963 ' O ' HG22 ' A' ' 112' ' ' THR . 49.5 Cg_endo -76.78 176.91 41.88 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.198 -2.001 . . . . 0.0 110.471 0.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 114' ' ' PRO . 41.7 Cg_endo -69.32 166.67 26.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.764 1.402 . . . . 0.0 109.686 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 112' ' ' THR . 34.2 m -110.3 139.18 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.01 . . . . 0.0 110.656 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . 1.2 pttp -114.03 131.39 56.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.474 -0.766 . . . . 0.0 108.934 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 69.8 p -134.75 176.21 8.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.965 -1.084 . . . . 0.0 110.822 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -61.49 -8.73 4.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.74 -0.6 . . . . 0.0 111.369 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 11.0 p90 -112.73 37.95 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.705 -1.247 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . 99.65 -173.38 25.84 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 51' ' ' ILE . 20.5 m-85 -99.01 158.62 15.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -1.05 . . . . 0.0 108.417 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.68 ' CE1' ' CD2' ' A' ' 120' ' ' PHE . 73.0 m-70 -141.35 137.71 32.54 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.063 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.881 HD13 HD21 ' A' ' 58' ' ' LEU . 69.9 mt -128.29 96.38 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.099 HG22 ' HB2' ' A' ' 42' ' ' HIS . 15.4 pt -103.79 137.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.942 -1.099 . . . . 0.0 112.029 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 48.9 mtp -107.42 142.08 37.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.407 HG23 HD23 ' A' ' 101' ' ' LEU . 30.0 t -119.83 125.2 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.719 -1.238 . . . . 0.0 111.576 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -107.82 -47.62 3.55 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 38' ' ' VAL . . . 119.54 176.83 16.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 46.3 tpt85 -116.96 -48.48 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.968 . . . . 0.0 109.117 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.235 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' HG22 ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.835 0.35 . . . . 0.0 111.912 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.79 ' HB1' ' N ' ' A' ' 85' ' ' MET . . . -117.99 176.62 5.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.5 OUTLIER -120.98 151.24 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HG3' ' CZ2' ' A' ' 84' ' ' TRP . 1.9 tmmt? -100.42 121.85 42.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.106 -0.996 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.981 HG23 HG22 ' A' ' 127' ' ' VAL . 10.2 p -142.44 147.94 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 119.344 -0.943 . . . . 0.0 112.876 -178.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' NE ' ' HB2' ' A' ' 81' ' ' ASP . 65.8 mtp180 -130.06 137.38 50.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.556 ' HD2' HD11 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -142.69 167.75 21.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.162 -1.587 . . . . 0.0 113.061 -177.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.49 HD13 ' CG1' ' A' ' 67' ' ' VAL . 5.1 mt -127.55 130.36 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 73' ' ' GLU . 6.7 tt -113.91 118.86 35.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 48.1 t -129.68 154.22 47.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 35.0 tp10 -60.24 163.83 4.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 0.0 109.86 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 18.2 ttpt -97.58 96.74 8.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 0.0 110.38 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 1.8 p-80 -132.07 21.89 4.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.48 19.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 120.107 -1.044 . . . . 0.0 110.603 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 71' ' ' TYR . 8.9 tttt -114.65 18.35 16.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.889 -1.359 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 4.2 mt -57.41 -42.39 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.488 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 62.8 ttp -65.86 -46.96 76.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.888 . . . . 0.0 110.869 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 50' ' ' LYS . 72.1 mm-40 -59.89 -47.41 85.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -0.985 . . . . 0.0 110.641 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -55.0 -60.73 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.529 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' LYS . 3.7 tmm? -62.47 -33.33 74.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 110.088 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.5 tt0 -59.15 -46.13 89.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -60.21 -46.64 89.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.76 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 111' ' ' PHE . 4.1 pp -101.26 25.33 8.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 110.365 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' MET . 7.9 tptt -35.09 -70.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.744 -0.598 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.4 m -91.3 25.0 2.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.77 32.78 66.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.78 40.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -1.05 . . . . 0.0 110.568 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 71.5 mtt180 -117.71 37.36 3.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 111.715 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CE2' ' CZ ' ' A' ' 111' ' ' PHE . 25.7 t80 -49.28 -46.92 47.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.707 -1.245 . . . . 0.0 109.988 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -63.97 -45.96 86.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 110.73 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 38.9 tt0 -64.94 -45.2 86.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 110.426 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.893 HG11 HD23 ' A' ' 58' ' ' LEU . 67.2 t -55.1 -41.81 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.749 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -64.13 -59.2 4.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.0 109.638 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.49 -40.21 1.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 0.0 111.688 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.649 ' NE2' ' CD1' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -101.18 -30.27 11.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 112.002 -178.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.649 ' CD1' ' NE2' ' A' ' 70' ' ' GLN . 8.3 m-85 -100.79 28.36 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.641 -1.287 . . . . 0.0 109.945 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 41.0 t -115.82 123.27 47.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 44' ' ' LEU . 64.8 tt0 -101.83 -8.14 21.9 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' GLN . 46.6 p30 -108.04 32.43 4.77 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -60.03 -37.01 78.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.4 71.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.383 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' C ' ' HG3' ' A' ' 78' ' ' GLN . 13.7 ptp180 -87.58 -47.64 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.8 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' ASP . 20.2 mt-30 -138.6 -127.15 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.256 -0.903 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.56 25.8 8.48 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.22 -135.43 1.81 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.018 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.623 ' C ' HD12 ' A' ' 82' ' ' LEU . 59.8 t0 -73.98 150.18 40.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -1.099 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.736 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.0 mp -100.9 -15.47 17.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.47 -0.769 . . . . 0.0 108.941 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 82.39 -145.34 24.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.6 m-90 -109.08 133.3 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.667 -0.902 . . . . 0.0 110.101 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.79 ' N ' ' HB1' ' A' ' 37' ' ' ALA . 25.0 ptp -141.1 154.37 45.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.404 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 36' ' ' ASN . 32.8 p -115.81 -66.05 1.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 110.371 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -104.35 37.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.879 . . . . 0.0 110.709 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.2 97.59 1.8 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.424 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 25.2 t -101.69 114.89 29.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.368 -1.078 . . . . 0.0 109.93 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 30.5 mmt -100.42 -106.35 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' A' ' 93' ' ' PRO . 70.1 t -64.42 -51.33 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.911 -1.118 . . . . 0.0 110.397 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.64 -67.19 0.45 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' A' ' 91' ' ' VAL . 45.1 Cg_endo -70.49 -25.08 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.105 1.581 . . . . 0.0 109.612 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.82 ' CE1' HD11 ' A' ' 125' ' ' ILE . 58.7 t80 -70.61 -33.92 71.57 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.468 -0.77 . . . . 0.0 109.567 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 65.4 tt0 -73.04 -54.88 7.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 110.154 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -48.02 -61.9 1.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -62.13 -66.55 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.422 -0.799 . . . . 0.0 111.504 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -54.3 -63.46 1.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 112.206 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 18.5 t80 -41.71 -42.91 2.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.528 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.86 -89.55 0.27 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 111.484 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 1.014 ' CE1' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.34 149.56 23.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.251 179.792 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 115' ' ' PRO . 21.2 m -75.1 101.63 4.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 55.3 t0 -132.48 111.94 13.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.146 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.6 Cg_endo -72.33 160.45 94.32 Favored 'Cis proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.849 -2.146 . . . . 0.0 110.271 0.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.682 ' HA ' HG22 ' A' ' 112' ' ' THR . 45.0 Cg_endo -72.46 -168.92 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.964 1.508 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.43 HG12 HG23 ' A' ' 118' ' ' THR . 19.4 t -101.21 131.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.529 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 51' ' ' ILE . 8.4 mtmm -102.03 123.14 45.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.312 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.569 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 41.4 p -134.62 -178.03 4.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -73.02 -16.48 61.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 111.369 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 3.8 p90 -97.1 1.6 50.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.738 -1.226 . . . . 0.0 110.983 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 131.52 -171.92 21.02 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.168 -1.491 . . . . 0.0 111.357 178.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 26.2 m-85 -101.23 150.54 22.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.742 -0.858 . . . . 0.0 109.34 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 15.0 m-70 -136.31 122.67 20.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.895 -1.128 . . . . 0.0 112.11 -179.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.014 HG22 ' CE1' ' A' ' 111' ' ' PHE . 25.8 mt -102.06 120.89 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.82 HD11 ' CE1' ' A' ' 94' ' ' PHE . 20.3 mt -108.88 126.87 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.777 -1.202 . . . . 0.0 112.54 -177.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 13.5 tpt -110.3 99.01 8.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.981 HG22 HG23 ' A' ' 40' ' ' VAL . 11.6 t -107.77 138.04 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.955 . . . . 0.0 111.471 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -143.1 3.72 1.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -0.834 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -125.52 139.78 11.79 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -132.59 133.05 43.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -1.21 . . . . 0.0 110.199 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.965 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.409 0.623 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -131.25 -177.02 4.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 7.7 p -144.74 156.11 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HE2' ' CZ2' ' A' ' 84' ' ' TRP . 42.1 mttt -98.23 136.18 38.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.08 -1.012 . . . . 0.0 109.411 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 59.7 t -133.53 146.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.874 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 126' ' ' MET . 84.0 mtt180 -141.62 123.34 15.18 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.99 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.72 -176.55 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.671 -1.268 . . . . 0.0 112.597 -178.342 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.83 ' HB ' HG22 ' A' ' 124' ' ' ILE . 82.5 mt -126.75 131.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 1.3 tt -106.7 126.38 52.21 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 110.68 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.438 ' N ' HD23 ' A' ' 44' ' ' LEU . 16.4 t -137.54 149.89 47.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.639 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 6.6 mm-40 -73.27 -155.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 122' ' ' TYR . 83.9 tttt -98.09 102.81 14.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.881 -1.137 . . . . 0.0 112.231 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.5 m-70 -132.56 -19.83 2.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.383 -0.823 . . . . 0.0 110.469 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.63 24.99 22.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 19.1 mttt -97.78 14.1 28.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.48 -1.012 . . . . 0.0 110.43 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.943 HG23 ' HG2' ' A' ' 115' ' ' PRO . 2.7 mp -44.37 -62.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.988 . . . . 0.0 109.997 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 22.1 ptm -66.33 -34.5 78.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.0 110.948 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -65.13 -39.71 93.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.69 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -67.07 -56.68 9.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.833 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.562 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -62.46 -31.84 72.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.894 -1.129 . . . . 0.0 110.385 -179.559 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 55' ' ' MET . 18.3 tp10 -62.58 -38.75 91.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.489 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD2' ' OH ' ' A' ' 71' ' ' TYR . 44.8 mttm -76.86 -37.8 54.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.799 ' CB ' HG21 ' A' ' 67' ' ' VAL . 4.2 pp -83.7 -2.28 55.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.911 -1.118 . . . . 0.0 111.128 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HG3' ' HA ' ' A' ' 56' ' ' GLU . 12.1 mttt -48.93 178.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 109.986 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -54.33 139.83 35.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.9 -23.55 29.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.487 ' HA ' ' CE ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -110.45 149.04 30.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.116 . . . . 0.0 110.283 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HG3' ' CG ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -87.16 107.39 18.45 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.043 0.925 . . . . 0.0 110.515 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD11 ' A' ' 43' ' ' ILE . 72.7 t80 -39.28 -40.92 0.83 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.493 0.663 . . . . 0.0 109.906 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -48.99 -46.98 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.251 -0.906 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CG ' ' HG3' ' A' ' 63' ' ' ARG . 80.2 mm-40 -65.35 -43.39 90.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 58' ' ' LEU . 44.2 t -59.95 -41.05 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -55.38 -46.72 76.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.689 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.56 55.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.4 mm-40 -64.92 -23.79 67.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 54' ' ' ALA . 12.3 m-85 -118.39 26.38 9.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 109.744 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ALA . 7.1 t -88.24 87.3 7.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 110.942 -179.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 1.1 tm-20 -101.79 5.27 41.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -0.975 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -126.07 12.86 7.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.366 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -53.9 -18.6 3.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.538 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.03 -26.17 56.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.9 mmm180 -127.44 -2.3 6.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.05 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 77' ' ' ARG . 6.7 tt0 -178.63 150.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.62 38.32 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 42' ' ' HIS . . . 65.24 18.95 65.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -128.3 118.34 23.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.126 . . . . 0.0 110.119 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.881 HD11 ' CD2' ' A' ' 42' ' ' HIS . 4.4 mp -101.69 150.91 22.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.928 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.72 -122.24 0.61 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 61.8 m95 -95.3 143.32 26.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.765 -0.844 . . . . 0.0 110.525 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.5 mmt -125.64 139.29 53.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.028 179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.9 t -134.02 -37.59 0.89 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' THR . 15.0 mtp85 -119.67 151.79 38.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 111.849 -177.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . -100.92 113.86 4.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p -139.16 12.49 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.324 . . . . 0.0 111.722 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.591 ' CG ' HG12 ' A' ' 91' ' ' VAL . 6.8 ptp -105.26 -26.59 11.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.78 -1.2 . . . . 0.0 110.077 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.61 HG22 ' HD2' ' A' ' 93' ' ' PRO . 11.5 p -167.36 -46.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.579 ' N ' HG13 ' A' ' 91' ' ' VAL . . . 132.93 -63.28 0.62 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.63 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 91' ' ' VAL . 38.7 Cg_endo -63.55 -37.68 46.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.907 1.478 . . . . 0.0 112.13 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.72 -45.94 91.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.619 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.513 ' HG3' ' CA ' ' A' ' 88' ' ' GLY . 1.5 tm0? -74.55 -42.04 59.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.15 -0.969 . . . . 0.0 110.791 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -64.75 -39.71 94.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 111.572 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.5 18.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.9 -1.125 . . . . 0.0 110.27 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.63 -42.28 23.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 110.399 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -70.42 -39.4 74.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.351 -0.843 . . . . 0.0 111.659 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.11 51.53 1.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 113.067 -177.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.494 1.731 0 O-C-N 120.482 -1.386 . . . . 0.0 109.453 178.57 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.607 HG12 ' HD2' ' A' ' 111' ' ' PHE . 86.0 t . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.625 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 26.4 p90 -131.77 161.13 33.62 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.95 -1.094 . . . . 0.0 109.966 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 114' ' ' PRO . 18.9 m -68.12 118.18 10.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 111.543 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.625 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 32.3 p-10 -133.93 108.34 11.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 0.0 110.447 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 112' ' ' THR . 48.6 Cg_endo -75.28 176.17 44.73 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.093 -2.044 . . . . 0.0 110.344 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.943 ' HG2' HG23 ' A' ' 51' ' ' ILE . 44.2 Cg_endo -69.65 -175.03 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.877 1.462 . . . . 0.0 109.702 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 HG23 ' A' ' 118' ' ' THR . 46.6 t -102.07 137.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 0.0 110.111 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -102.11 125.54 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 109.064 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 38.7 p -142.04 -175.98 4.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.631 -1.293 . . . . 0.0 111.68 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.8 tttt -74.36 -10.67 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.768 -0.582 . . . . 0.0 110.132 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -103.55 37.92 1.91 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.065 -1.022 . . . . 0.0 109.605 179.117 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.6 -167.71 37.28 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.74 ' CE2' HD11 ' A' ' 51' ' ' ILE . 6.9 m-85 -103.72 144.13 31.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -1.084 . . . . 0.0 108.879 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 120' ' ' PHE . 10.1 m-70 -137.94 135.29 35.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.666 -1.272 . . . . 0.0 112.32 -178.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.83 HG22 ' HB ' ' A' ' 43' ' ' ILE . 11.5 tt -120.64 116.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.99 HG22 ' CB ' ' A' ' 42' ' ' HIS . 12.1 pt -114.46 158.28 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.571 -1.33 . . . . 0.0 112.651 -177.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.534 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 44.9 mtp -118.87 151.07 38.77 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.3 t -126.91 121.36 57.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.55 -1.344 . . . . 0.0 111.822 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.8 pt-20 -133.67 157.41 45.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 61.45 82.65 0.07 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 10.1 ttm180 -116.77 154.1 31.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.992 . . . . 0.0 110.173 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.546 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.9 mtpt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.184 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.174 0.511 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.811 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -129.65 -170.35 2.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 85' ' ' MET . 1.5 p -128.76 150.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.576 -0.703 . . . . 0.0 109.244 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HD2' ' CD2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -101.0 113.93 27.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.637 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 38' ' ' VAL . 38.6 t -127.14 152.31 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.836 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 93.5 mtt180 -133.73 121.93 22.62 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.114 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -131.06 159.23 38.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.638 -1.289 . . . . 0.0 113.008 -177.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 24.9 mt -122.82 123.21 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -104.63 120.97 42.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.6 p -133.09 -168.81 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.892 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 92.4 mt-10 -70.98 176.61 4.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.0 111.419 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.693 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 28.1 pttt -118.66 56.77 0.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.356 -0.84 . . . . 0.0 110.947 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.543 ' N ' ' CE2' ' A' ' 122' ' ' TYR . 19.3 m80 -134.6 64.04 1.61 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 111.576 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 -0.95 34.05 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.88 178.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.78 -10.78 59.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.984 -1.304 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.721 HD12 ' HB3' ' A' ' 122' ' ' TYR . 3.1 tt -62.15 -36.81 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.543 ' HG3' ' N ' ' A' ' 53' ' ' GLU . 23.3 ptm -74.54 -42.97 57.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.957 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' N ' ' HG3' ' A' ' 52' ' ' MET . 19.1 mm-40 -68.12 -38.82 82.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.675 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.38 68.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.893 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.846 ' HA ' HD23 ' A' ' 58' ' ' LEU . 27.1 ptm -61.68 -35.39 77.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.916 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 55' ' ' MET . 91.7 mt-10 -68.44 -33.44 74.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.062 -1.024 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -68.72 -46.01 70.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -74.45 -27.77 60.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.977 -1.077 . . . . 0.0 110.446 -179.454 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 91.1 mttt 49.82 -126.98 2.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 62' ' ' MET . 55.7 p -65.45 -28.5 69.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 110.587 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 130.73 -5.82 5.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.434 ' HG3' ' OG ' ' A' ' 60' ' ' SER . 60.0 mtt -49.47 -31.43 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -1.225 . . . . 0.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.72 29.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 30.9 t80 -54.71 -40.99 69.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.904 . . . . 0.0 110.477 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 20.6 p-10 -58.59 -44.48 89.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -69.21 -44.13 72.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 58' ' ' LEU . 97.2 t -69.75 -26.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 110.413 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -74.16 -57.59 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.11 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.89 62.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.619 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -29.81 33.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.173 -0.954 . . . . 0.0 111.124 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 23.4 m-85 -114.57 26.71 10.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.034 -1.041 . . . . 0.0 111.049 -179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 26.7 t -102.28 116.93 33.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.911 -1.118 . . . . 0.0 110.68 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.32 -7.42 24.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -111.86 21.22 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.508 -0.745 . . . . 0.0 109.212 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 6.4 tmtt? -53.8 -31.3 48.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.625 -0.672 . . . . 0.0 110.68 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.28 81.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.173 -0.955 . . . . 0.0 110.927 -179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.27 9.27 36.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.097 -1.002 . . . . 0.0 110.795 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 2.1 tt0 -169.07 172.62 7.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.054 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.69 27.49 6.83 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 72.66 11.5 77.4 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.657 ' C ' HD12 ' A' ' 82' ' ' LEU . 41.2 p-10 -133.08 129.46 38.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -1.182 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.9 mp -110.09 109.29 19.78 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 110.159 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -60.12 -123.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.081 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.692 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 78.2 m95 -76.45 130.26 37.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.795 -0.826 . . . . 0.0 110.808 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.921 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.8 tpt -137.28 136.04 37.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 0.0 109.767 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.811 HG22 ' CB ' ' A' ' 37' ' ' ALA . 19.0 p -122.78 -57.98 1.69 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.827 -1.171 . . . . 0.0 110.675 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' A' ' 86' ' ' THR . 21.9 ttm-85 -68.22 -48.99 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.739 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 46.65 64.79 2.46 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -122.93 43.59 2.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -1.06 . . . . 0.0 110.634 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.2 mtp -99.78 -32.04 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.768 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 89.9 t -142.96 112.38 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -43.04 -53.93 5.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.514 -0.741 . . . . 0.0 111.874 -178.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 42.8 Cg_endo -69.33 -19.66 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.511 1.269 . . . . 0.0 111.765 -178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.59 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 23.4 t80 -76.56 -54.09 7.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 110.771 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -66.52 -41.76 88.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.972 . . . . 0.0 110.897 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 14.1 pt-20 -60.23 -25.15 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.894 -1.128 . . . . 0.0 110.42 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -79.61 -50.74 10.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.773 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.32 -54.63 7.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.755 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 58.4 m-85 -56.42 -47.0 79.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 0.0 110.975 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -66.17 -39.69 89.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.202 -0.937 . . . . 0.0 111.196 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 tp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.985 -1.072 . . . . 0.0 110.802 -179.395 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.1 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.155 0.502 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.828 ' N ' HG13 ' A' ' 110' ' ' VAL . 8.2 t80 -103.62 163.12 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 111.185 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.698 HG21 HD11 ' A' ' 125' ' ' ILE . 1.7 p -84.47 29.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 38.1 p-10 -71.73 130.17 87.42 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.986 -1.071 . . . . 0.0 110.389 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 112' ' ' THR . 49.0 Cg_endo -76.16 146.33 84.72 Favored 'Cis proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.949 -2.105 . . . . 0.0 110.082 -0.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.751 ' CB ' HG22 ' A' ' 124' ' ' ILE . 40.8 Cg_endo -66.34 -174.24 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.097 1.577 . . . . 0.0 110.902 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 28.5 m -101.68 158.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 110.248 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 51' ' ' ILE . 42.3 mttm -113.57 142.07 46.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.619 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 24.8 p -143.12 177.12 8.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.758 -1.214 . . . . 0.0 111.078 -179.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -80.85 -11.6 59.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.678 -0.639 . . . . 0.0 109.533 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.619 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.3 p90 -104.82 20.96 17.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 110.01 179.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.13 -173.04 14.52 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 51' ' ' ILE . 16.4 m-85 -100.25 160.87 13.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -1.033 . . . . 0.0 108.729 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.583 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 63.9 m-70 -141.98 122.48 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.708 -1.245 . . . . 0.0 112.061 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.814 HD12 HD22 ' A' ' 58' ' ' LEU . 30.9 pt -118.46 125.06 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.114 HG22 ' HB2' ' A' ' 42' ' ' HIS . 18.2 pt -123.88 173.03 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.684 -1.26 . . . . 0.0 112.944 -176.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.638 ' HG2' ' CD2' ' A' ' 111' ' ' PHE . 73.1 mtm -133.4 146.71 51.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m -121.32 120.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.867 -1.145 . . . . 0.0 109.974 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -107.12 -20.86 13.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 111.331 -178.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.481 ' HA3' ' NZ ' ' A' ' 39' ' ' LYS . . . -161.62 156.09 27.5 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.101 -1.523 . . . . 0.0 110.637 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.461 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 7.0 ttt180 -126.05 145.51 50.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.922 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 58.9 pttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 53.5 p30 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.724 0.773 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . -103.71 168.39 9.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 -178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 129' ' ' GLY . 1.3 p -128.78 153.63 38.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 110.022 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 2.9 mtpm? -98.87 132.99 43.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 109.084 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 82.5 t -130.36 143.12 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.292 -178.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 76.4 mtt180 -125.34 120.88 32.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.808 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -144.78 164.95 29.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.738 -1.227 . . . . 0.0 112.256 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.909 HD11 HD12 ' A' ' 124' ' ' ILE . 13.5 pt -126.47 144.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -101.34 122.36 43.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.881 -1.137 . . . . 0.0 110.041 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 36.5 m -111.51 170.07 8.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 110.275 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 27.8 mt-10 -88.45 -158.63 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 110.318 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.1 mtmm -128.04 92.63 3.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.923 -1.111 . . . . 0.0 111.142 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.594 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -132.88 17.26 4.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.95 2.25 81.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 5.0 ttmt -83.81 -12.95 54.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -1.079 . . . . 0.0 110.089 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -43.22 -41.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 110.298 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' MET . 41.7 ttm -60.94 -44.77 96.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.063 -1.023 . . . . 0.0 109.841 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -72.16 -31.73 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.05 -1.031 . . . . 0.0 109.385 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.68 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.757 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' HD23 ' A' ' 58' ' ' LEU . 25.5 ptm -65.97 -23.91 66.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 24.1 tp10 -64.35 -41.98 96.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.042 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -79.79 -38.42 33.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 0.0 109.057 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -65.96 -49.14 68.94 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.616 -0.677 . . . . 0.0 109.218 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 33.4 mtmt 50.09 -124.66 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 0.0 110.384 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -70.66 -31.72 68.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.0 -1.062 . . . . 0.0 109.932 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.94 7.26 5.61 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 ttt -47.73 -42.07 24.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.861 -1.376 . . . . 0.0 109.247 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 27.3 mtt-85 -108.5 30.51 6.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.524 -0.735 . . . . 0.0 109.255 179.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -46.94 -47.8 21.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.886 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -57.74 -39.05 76.45 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 77.4 mt-10 -67.67 -42.65 81.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 58' ' ' LEU . 96.5 t -70.11 -52.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.56 -40.25 51.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.092 -1.005 . . . . 0.0 110.331 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.72 91.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.463 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 7.6 mm-40 -89.77 8.31 32.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.683 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.556 ' HB3' HD12 ' A' ' 43' ' ' ILE . 33.1 m-85 -134.25 4.37 3.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.916 -1.115 . . . . 0.0 111.289 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -67.86 111.25 4.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 16.7 tt0 -102.06 5.59 40.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.748 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 29.3 t70 -132.98 45.33 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.975 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -66.65 -32.59 74.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.032 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.94 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 108.842 179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.456 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.4 mmm-85 -104.74 8.25 34.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.65 -0.656 . . . . 0.0 109.408 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 52.86 42.35 31.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.775 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.447 ' HA3' ' OD2' ' A' ' 74' ' ' ASP . . . -79.79 108.5 2.75 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -160.42 -92.45 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 78.1 m-20 -90.39 140.67 29.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -1.149 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -124.61 169.57 11.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -82.04 -122.99 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.466 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.629 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 18.4 m-90 -96.48 144.83 26.22 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.786 0.803 . . . . 0.0 112.116 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.2 ptm -139.88 155.54 47.15 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.3 p -129.84 -72.95 0.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.554 -1.341 . . . . 0.0 110.315 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 86' ' ' THR . 4.2 ttp85 -116.76 136.57 52.86 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.311 -0.955 . . . . 0.0 111.598 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' ARG . . . 58.34 144.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 90' ' ' MET . 53.2 p -142.37 -66.45 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.042 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.568 ' C ' HG23 ' A' ' 91' ' ' VAL . 20.0 ptm -142.06 -39.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.992 HG12 ' HD2' ' A' ' 93' ' ' PRO . 38.4 t -153.01 157.55 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 110.085 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -37.99 -60.67 1.26 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.992 ' HD2' HG12 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -63.62 -175.55 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.759 1.399 . . . . 0.0 110.334 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 125' ' ' ILE . 59.9 t80 68.48 -78.03 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.611 -0.68 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 12.0 tm0? -66.51 -47.93 71.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 81.8 mt-10 -61.68 -38.75 88.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.05 70.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 0.0 109.003 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.5 83.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.086 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -69.51 -21.48 63.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.25 -12.8 48.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.468 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 110' ' ' VAL . 9.8 tt . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 110.641 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.87 HG12 HD21 ' A' ' 101' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.632 0.73 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.933 ' CE1' HG23 ' A' ' 124' ' ' ILE . 7.5 t80 -114.34 153.8 29.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.77 -0.581 . . . . 0.0 110.409 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 101' ' ' LEU . 66.2 p -72.85 119.38 17.0 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.352 -0.842 . . . . 0.0 110.732 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 111' ' ' PHE . 81.3 m-20 -133.45 121.9 16.64 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.257 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 48.8 Cg_endo -78.81 174.59 50.36 Favored 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.188 -2.005 . . . . 0.0 110.396 -0.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HG2' HD12 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -70.83 175.78 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.957 1.504 . . . . 0.0 109.926 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 32.6 m -103.19 155.44 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -123.08 136.11 54.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 36.4 p -139.02 168.02 20.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.103 -0.998 . . . . 0.0 110.645 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -64.89 -17.28 64.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.796 . . . . 0.0 110.017 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -97.38 19.62 12.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.985 -1.072 . . . . 0.0 110.366 179.526 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.552 ' HA2' ' CG ' ' A' ' 47' ' ' LYS . . . 117.72 -176.91 16.37 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-30 -97.82 158.8 15.31 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CE1' HD21 ' A' ' 44' ' ' LEU . 75.9 m-70 -138.09 140.19 39.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.403 -1.436 . . . . 0.0 112.302 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.933 HG23 ' CE1' ' A' ' 111' ' ' PHE . 84.2 mt -123.0 114.49 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -122.43 149.49 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 0.0 112.102 -178.725 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.455 ' HE3' ' HB2' ' A' ' 111' ' ' PHE . 89.8 mtp -128.5 150.75 50.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 38' ' ' VAL . 15.2 t -124.62 138.86 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.75 -1.219 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -114.9 -24.61 8.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 110.93 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -150.27 132.67 4.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -76.97 -42.67 38.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.969 . . . . 0.0 110.949 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 38.0 mtmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.229 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 49.8 p30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.411 0.624 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -107.47 164.69 11.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 130' ' ' ARG . 5.9 m -136.72 161.46 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.917 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HD3' ' NE1' ' A' ' 84' ' ' TRP . 7.3 mmmt -99.71 112.09 24.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.415 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.114 HG13 ' HB2' ' A' ' 82' ' ' LEU . 4.0 p -127.88 128.4 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.949 . . . . 0.0 111.465 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 46.6 mtm180 -118.42 134.0 55.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.995 ' HB2' HG22 ' A' ' 125' ' ' ILE . 3.7 p80 -135.81 162.86 31.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.59 -1.319 . . . . 0.0 111.704 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' SG ' ' A' ' 45' ' ' CYS . 23.6 mt -116.64 121.86 68.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.616 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.8 tt -101.83 101.0 11.39 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.909 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.612 ' SG ' HG22 ' A' ' 43' ' ' ILE . 35.2 m -101.36 162.49 12.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.637 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.4 mt-10 -63.35 165.75 7.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.82 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 21.2 tttt -89.7 59.09 4.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.133 -0.979 . . . . 0.0 111.419 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 20.3 m80 -135.87 66.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.66 -1.275 . . . . 0.0 111.584 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.44 28.47 44.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.02 7.22 45.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.992 -1.299 . . . . 0.0 109.445 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 115' ' ' PRO . 43.2 mt -62.51 -50.81 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.541 -0.725 . . . . 0.0 110.581 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 49.2 mtm -69.15 -32.26 71.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.451 -0.781 . . . . 0.0 110.617 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 14.2 tt0 -62.54 -49.37 75.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.518 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -69.86 -51.32 34.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 111.479 -179.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 28.6 ptm -65.69 -43.9 87.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.315 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' MET . 64.3 tt0 -65.09 -41.23 95.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.956 -1.09 . . . . 0.0 110.686 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 55.3 mmtt -60.23 -56.14 25.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.655 ' CB ' HG21 ' A' ' 67' ' ' VAL . 1.2 pp -68.1 -14.04 62.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.62 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.0 mtpt 45.66 -133.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.795 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -57.87 -21.66 44.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.846 -1.159 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 123.45 10.73 5.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.4 ttm -51.16 -45.55 61.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -1.232 . . . . 0.0 109.927 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 10.7 mtp180 -109.66 31.6 5.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.903 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.61 -49.1 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -58.28 -46.86 85.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 109.374 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 51.4 mp0 -62.37 -41.53 98.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.299 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 58' ' ' LEU . 54.3 t -65.54 -44.38 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.553 -0.717 . . . . 0.0 109.294 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -57.76 -51.88 67.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.925 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -46.74 88.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.0 mm-40 -73.29 -28.06 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.315 -0.866 . . . . 0.0 111.27 -179.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 63.5 m-85 -108.76 13.82 24.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.057 . . . . 0.0 110.86 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 8.4 t -78.9 105.23 10.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.876 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 31.9 tp10 -101.4 1.34 38.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.734 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB3' HD13 ' A' ' 44' ' ' LEU . 20.4 p30 -103.4 24.56 10.82 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 110.112 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 43.8 tttm -46.96 -49.25 21.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.87 -50.38 10.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.0 109.734 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 7.1 tpm_? -80.4 -11.55 59.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.605 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 75' ' ' LYS . 84.5 mm-40 54.4 47.9 21.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.531 -0.731 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -81.61 -76.42 1.07 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.32 -84.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' GLY . 62.9 m-20 -109.25 150.61 27.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.579 -0.953 . . . . 0.0 109.632 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.114 ' HB2' HG13 ' A' ' 40' ' ' VAL . 2.9 mp -102.67 2.76 36.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 49.88 -139.53 18.06 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.1 m95 -89.94 114.8 26.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.395 -1.062 . . . . 0.0 110.574 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.496 ' CE ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.09 152.21 46.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.209 -0.932 . . . . 0.0 110.186 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.7 p -100.58 -89.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 110.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.536 ' N ' ' OG1' ' A' ' 86' ' ' THR . 39.3 ptt180 -116.61 138.71 51.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.375 -1.453 . . . . 0.0 110.901 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . -131.56 164.45 23.52 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -137.71 34.24 2.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.842 -1.387 . . . . 0.0 111.209 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.476 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 43.3 mmm -100.65 123.94 45.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 30.2 t 60.11 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 109.97 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.627 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -55.31 -43.95 84.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 43.7 Cg_endo -71.89 -12.12 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.369 1.194 . . . . 0.0 111.243 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 53.0 t80 -88.65 -54.48 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.0 110.18 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 2.0 tt0 -64.7 -43.64 92.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 110.677 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.653 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 47.1 tp10 -59.36 -42.97 92.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.973 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -60.35 -58.13 9.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.5 -56.33 2.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.473 -0.767 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.483 ' HZ ' ' O ' ' A' ' 86' ' ' THR . 38.0 m-85 -83.16 3.68 29.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.524 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -80.69 -29.74 36.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.193 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.165 179.492 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' MET . 7.2 p . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 0.6 OUTLIER -118.52 172.37 7.53 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.105 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.557 ' OG1' HG12 ' A' ' 125' ' ' ILE . 2.1 m -76.97 -4.83 46.02 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 65.6 m-20 -48.44 122.48 10.35 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.344 -1.473 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' A' ' 112' ' ' THR . 43.4 Cg_endo -66.38 128.08 8.81 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.359 1.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HG2' HG23 ' A' ' 51' ' ' ILE . 38.4 Cg_endo -63.65 -179.3 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.086 1.572 . . . . 0.0 111.616 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.5 m -102.47 144.87 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.568 -0.707 . . . . 0.0 109.86 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 34.1 pttt -110.28 130.14 55.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.045 -1.035 . . . . 0.0 110.296 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.581 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.8 p -137.35 173.1 12.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.059 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -19.31 65.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.179 -0.95 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.8 p90 -93.46 19.32 8.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.803 -1.185 . . . . 0.0 110.369 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 114.88 -174.11 15.17 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.512 178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-85 -104.12 153.22 21.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.702 -0.881 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.616 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 13.1 m-70 -141.34 133.48 27.84 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.684 -1.26 . . . . 0.0 112.948 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -125.36 106.14 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.375 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.995 HG22 ' HB2' ' A' ' 42' ' ' HIS . 35.1 pt -105.11 157.0 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.857 -1.152 . . . . 0.0 111.864 -177.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 16.3 ptm -133.36 160.86 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.996 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.74 131.79 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.928 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.09 -4.51 16.55 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.486 -0.759 . . . . 0.0 110.225 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 38' ' ' VAL . . . -172.18 126.75 1.31 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 38' ' ' VAL . 2.2 ttt-85 -127.22 152.6 47.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -1.121 . . . . 0.0 109.857 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 36' ' ' ASN . 30.5 tttm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.063 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.506 ' HA ' ' HG3' ' A' ' 131' ' ' LYS . 19.9 p30 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -125.93 173.73 8.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 2.5 p -132.52 154.58 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 110.065 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' A' ' 84' ' ' TRP . 37.7 mtpt -100.05 115.18 29.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 82' ' ' LEU . 69.9 t -120.04 125.54 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 111.497 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -124.98 109.62 13.2 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.808 ' HB3' HG22 ' A' ' 125' ' ' ILE . 4.0 p80 -134.96 166.97 21.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.701 -1.249 . . . . 0.0 112.427 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.666 HG21 ' CB ' ' A' ' 68' ' ' ALA . 17.9 pt -118.56 134.04 63.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.761 HD23 ' N ' ' A' ' 45' ' ' CYS . 5.0 tt -107.44 132.15 53.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.549 -0.719 . . . . 0.0 111.097 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.761 ' N ' HD23 ' A' ' 44' ' ' LEU . 42.8 t -140.26 163.57 32.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.456 -0.778 . . . . 0.0 109.088 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 59.5 mm-40 -72.54 158.31 35.94 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.153 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.58 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.6 tttp -78.38 122.69 26.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.248 -0.907 . . . . 0.0 111.333 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 9.2 m-70 -129.79 -13.74 4.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.396 -0.815 . . . . 0.0 110.416 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.38 2.95 50.79 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -88.59 18.39 4.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.177 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.533 HD11 ' HG3' ' A' ' 117' ' ' LYS . 53.5 mt -45.68 -46.78 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 109.293 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 55' ' ' MET . 23.5 ptt? -65.74 -35.32 80.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.412 -0.805 . . . . 0.0 109.52 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 34.9 tt0 -75.19 -27.5 59.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.289 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.2 -45.99 44.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 21.0 ptm -64.92 -44.91 87.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 77.6 tt0 -65.44 -41.32 93.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.451 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 28.5 mmtt -67.42 -31.21 71.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 108.524 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 124' ' ' ILE . 24.3 tp -73.93 -29.36 61.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.748 -0.595 . . . . 0.0 109.83 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 20.0 mttm 39.46 -92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 58' ' ' LEU . 83.0 p -129.48 -158.03 0.86 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . -73.17 -1.92 57.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.8 ttp -65.0 -46.15 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 110.463 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' HG2' ' CD ' ' A' ' 66' ' ' GLU . 81.6 mtt180 -106.21 11.36 31.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.765 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.444 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 73.7 t80 -50.23 -43.96 53.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 109.748 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.84 -38.7 80.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 109.897 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 64.9 mt-10 -61.64 -51.07 69.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.892 . . . . 0.0 109.841 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 71' ' ' TYR . 93.6 t -69.65 -39.44 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' HG21 ' A' ' 43' ' ' ILE . . . -60.51 -53.25 59.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 0.0 110.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.71 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.202 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.9 mm-40 -70.73 -28.0 64.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' HG13 ' A' ' 67' ' ' VAL . 12.0 m-30 -102.62 9.25 39.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 68' ' ' ALA . 47.4 t -79.07 88.18 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 111.005 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -104.33 7.66 35.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.198 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' ' CB ' ' A' ' 44' ' ' LEU . 43.0 p30 -132.01 40.49 3.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.468 -0.77 . . . . 0.0 109.982 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -64.89 -43.97 91.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.0 110.035 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.2 64.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -74.91 -33.09 61.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 74' ' ' ASP . 60.5 mt-30 -137.02 157.4 46.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.973 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.94 14.92 37.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 -44.21 2.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 34.9 p-10 -121.3 137.37 54.72 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.318 -1.107 . . . . 0.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -104.35 -9.17 18.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.406 -0.809 . . . . 0.0 109.821 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 78.29 -143.98 27.81 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.578 ' CE2' ' HD2' ' A' ' 39' ' ' LYS . 89.5 m95 -79.99 140.33 36.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.589 -0.948 . . . . 0.0 111.302 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.807 ' HG3' HD12 ' A' ' 82' ' ' LEU . 68.7 mmm -131.66 114.6 15.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.6 -0.688 . . . . 0.0 109.171 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.576 HG22 ' HB2' ' A' ' 37' ' ' ALA . 51.4 p -74.6 -43.38 55.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.979 -1.076 . . . . 0.0 109.896 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' O ' ' CE1' ' A' ' 99' ' ' PHE . 8.6 mtt180 -107.55 -62.58 1.41 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.833 . . . . 0.0 110.015 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 89.6 111.01 1.31 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -141.94 86.3 1.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -1.165 . . . . 0.0 110.342 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 91' ' ' VAL . 49.4 mtt -121.71 -37.26 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.255 -0.903 . . . . 0.0 110.095 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.03 -88.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.254 -0.904 . . . . 0.0 110.142 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -170.55 -69.45 0.04 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 -37.92 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.874 1.46 . . . . 0.0 110.571 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 125' ' ' ILE . 60.5 t80 -60.92 -49.99 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 110.032 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 3.5 tm0? -74.54 -55.25 6.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 110.094 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 3.1 tp10 -42.05 -45.65 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.54 -39.7 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.68 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.36 74.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.823 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 87' ' ' ARG . 34.8 m-85 -89.5 -5.47 57.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 110.156 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.43 8.73 14.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.32 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.945 HD12 ' HD2' ' A' ' 102' ' ' PRO . 56.8 tp -52.75 127.48 43.33 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.159 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.945 ' HD2' HD12 ' A' ' 101' ' ' LEU . 41.1 Cg_endo -67.61 149.77 79.55 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.913 1.481 . . . . 0.0 110.376 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 m -87.38 -10.51 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 111.073 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.1 p -111.51 112.55 24.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.403 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . -167.82 136.11 3.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 107' ' ' ASP . 5.5 ptt? -62.6 -40.38 96.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -1.12 . . . . 0.0 110.348 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' N ' ' CG ' ' A' ' 106' ' ' MET . 50.6 t0 -125.09 25.42 7.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.713 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 24.1 mttp -93.96 -18.5 0.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.429 -0.794 . . . . 0.0 112.671 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 45.6 Cg_endo -75.33 4.21 5.1 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 O-C-N 122.432 0.701 . . . . 0.0 110.56 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.28 -77.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 110.046 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.576 ' H ' HG23 ' A' ' 110' ' ' VAL . 73.6 m-85 -106.55 146.89 30.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.635 HG21 HG13 ' A' ' 125' ' ' ILE . 13.3 p -72.04 86.87 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.002 -1.061 . . . . 0.0 109.065 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.1 125.77 38.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.446 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.3 Cg_endo -75.12 165.47 85.79 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 -2.147 . . . . 0.0 110.08 -0.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 -179.44 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.896 1.472 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 23.9 m -102.95 139.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.011 . . . . 0.0 110.558 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 51' ' ' ILE . 12.0 ttmt -112.08 123.81 51.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.598 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 73.7 p -130.65 176.1 8.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.981 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -72.03 -16.75 62.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.77 . . . . 0.0 110.551 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.598 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.1 p90 -98.18 19.4 14.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 0.0 110.187 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.58 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 111.29 -179.11 19.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 54.7 p90 -101.53 160.37 14.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -1.224 . . . . 0.0 110.034 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.581 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.3 m-70 -138.67 138.17 37.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.059 -1.026 . . . . 0.0 111.819 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.797 HG21 HD22 ' A' ' 58' ' ' LEU . 87.2 mt -115.27 111.26 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -103.23 143.86 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.066 . . . . 0.0 111.807 -178.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.8 tmm? -118.61 119.81 35.6 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 101' ' ' LEU . 46.8 t -97.56 121.2 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.001 -1.062 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -110.53 -8.13 14.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.481 -0.762 . . . . 0.0 109.451 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.502 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -144.44 149.96 22.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.02 149.31 52.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.922 -1.34 . . . . 0.0 110.653 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 36' ' ' ASN . 71.6 tttt . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.081 0.944 . . . . 0.0 110.368 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -133.8 156.45 48.0 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.785 -1.197 . . . . 0.0 111.263 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.896 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.5 m -116.86 152.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HG3' ' CH2' ' A' ' 84' ' ' TRP . 5.5 mtmt -98.49 113.08 24.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.884 -1.135 . . . . 0.0 108.815 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.817 HG13 ' CG2' ' A' ' 125' ' ' ILE . 70.3 t -113.94 130.81 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.118 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -134.41 129.95 36.1 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.531 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.0 p80 -145.04 168.7 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.448 -1.407 . . . . 0.0 112.565 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 67' ' ' VAL . 89.4 mt -108.88 131.86 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -118.49 125.12 49.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 111.838 -178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 19.1 t -137.62 136.22 37.31 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.4 mm-40 -55.23 -157.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.502 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 92.8 mttt -97.91 105.04 17.12 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.47 -1.394 . . . . 0.0 112.509 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -133.02 16.7 4.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.242 -0.911 . . . . 0.0 109.897 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.28 23.49 73.28 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 91.7 mttt -94.51 6.18 49.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -1.006 . . . . 0.0 110.808 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 3.0 mp -51.27 -50.1 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.029 . . . . 0.0 110.392 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 39.5 ttp -69.62 -40.13 76.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.49 -0.757 . . . . 0.0 111.288 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 54.1 tp10 -70.62 -41.09 72.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.656 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -61.49 -54.51 42.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 111.18 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 4.9 ptt? -61.79 -44.12 97.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.085 -1.009 . . . . 0.0 111.178 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.525 ' N ' ' CG ' ' A' ' 55' ' ' MET . 10.2 pt-20 -72.04 -23.61 61.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.929 -1.107 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 21.7 tptt -70.26 -45.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.805 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' HB3' HG21 ' A' ' 67' ' ' VAL . 1.3 pp -81.02 -23.06 38.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.066 -1.021 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 61.5 mmtt 52.2 -133.62 1.77 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.116 -0.99 . . . . 0.0 111.178 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -55.34 -36.28 66.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 110.622 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.2 -0.3 3.54 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.221 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.4 mtm -47.86 -36.87 12.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.007 -1.29 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 7.1 mtp180 -110.3 29.28 7.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.703 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.96 -47.78 43.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.527 -0.733 . . . . 0.0 110.174 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.18 -37.55 78.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.881 . . . . 0.0 109.945 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 8.3 tp10 -65.48 -47.67 75.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 43' ' ' ILE . 41.0 t -63.52 -47.42 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.319 -0.863 . . . . 0.0 109.639 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -53.4 -51.06 63.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 110.127 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.97 67.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.687 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -70.81 -29.94 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.495 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 m-85 -106.94 11.12 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.009 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ALA . 79.7 p -76.58 69.67 3.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.398 -0.813 . . . . 0.0 109.741 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 11.7 pt-20 -111.24 26.79 10.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.638 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.702 ' HB3' HD13 ' A' ' 44' ' ' LEU . 47.9 p-10 -100.66 14.45 31.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 74' ' ' ASP . 21.9 tttm -38.32 -35.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.314 0.578 . . . . 0.0 110.166 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.15 -37.63 47.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -0.798 . . . . 0.0 109.565 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 41.8 ttt85 -121.82 17.74 11.04 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.462 -0.774 . . . . 0.0 109.744 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 62.61 -77.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 110.612 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . 53.62 -116.14 5.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 66.74 -84.15 0.11 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' C ' HD12 ' A' ' 82' ' ' LEU . 13.5 p-10 -132.69 136.5 46.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -1.117 . . . . 0.0 110.389 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.79 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.0 mp -102.09 147.44 26.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.77 -125.14 0.19 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.776 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 94.2 m95 -93.79 131.61 38.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.549 -0.971 . . . . 0.0 111.001 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.705 ' O ' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -127.6 122.24 32.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.104 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.0 p -72.14 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 111.04 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -87.19 -37.9 16.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' GLN . . . 57.66 77.82 0.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . 90.1 p -123.91 103.24 8.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -1.135 . . . . 0.0 109.718 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -141.65 -86.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.37 -41.39 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 0.0 111.25 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . 132.03 -77.41 0.39 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.301 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.26 -24.17 44.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.759 1.4 . . . . 0.0 112.03 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -62.68 -47.82 81.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.759 -1.213 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -78.2 -38.12 43.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.531 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.89 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 89.6 mt-10 -55.35 -32.17 62.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.89 -40.24 16.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.036 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.37 7.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.841 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -70.56 -32.38 69.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.893 . . . . 0.0 110.0 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -50.04 -35.36 24.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 127' ' ' VAL . 7.0 tt -61.17 144.09 91.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.702 ' O ' HD23 ' A' ' 101' ' ' LEU . 38.9 Cg_endo -65.25 159.57 46.5 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.707 1.372 . . . . 0.0 110.059 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 104' ' ' SER . 3.1 p -74.19 -44.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 111.568 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 77.6 p -130.09 4.5 4.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 104' ' ' SER . . . 48.27 -170.93 0.06 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 82.3 mmm -67.02 -31.91 72.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 107' ' ' ASP . 46.2 t0 -144.23 -86.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . 24.1 mtmm -82.99 166.67 34.2 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 110.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 108' ' ' LYS . 41.9 Cg_endo -69.89 171.96 13.64 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.84 1.442 . . . . 0.0 109.657 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 111' ' ' PHE . 95.7 t -139.96 172.7 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.076 -1.015 . . . . 0.0 110.934 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 110' ' ' VAL . 52.8 p90 -120.19 163.87 17.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 125' ' ' ILE . 6.4 m -48.87 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.485 -0.759 . . . . 0.0 110.533 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.5 p-10 -127.05 120.36 22.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.097 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 45.3 Cg_endo -72.91 165.77 83.09 Favored 'Cis proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.623 -2.24 . . . . 0.0 109.736 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.8 Cg_endo -71.09 178.55 5.27 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.784 1.413 . . . . 0.0 109.765 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 26.8 m -101.43 161.99 3.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -124.54 118.55 26.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.506 -0.746 . . . . 0.0 109.208 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -136.6 171.78 13.99 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.734 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -65.37 -9.07 21.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.549 -0.72 . . . . 0.0 110.277 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.617 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -89.54 -20.18 24.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 109.043 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.17 -160.97 25.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.72 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 16.3 m-30 -100.72 134.54 43.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -1.077 . . . . 0.0 109.247 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.532 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 61.6 m-70 -125.39 121.75 34.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.011 -1.055 . . . . 0.0 112.556 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.645 HG22 ' HB ' ' A' ' 43' ' ' ILE . 4.8 tt -115.71 114.62 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.817 ' CG2' HG13 ' A' ' 40' ' ' VAL . 7.1 mt -107.13 125.56 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.942 -1.099 . . . . 0.0 113.543 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 9.8 tpt -100.09 114.12 27.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 101' ' ' LEU . 5.7 p -107.43 156.83 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.677 -1.265 . . . . 0.0 112.071 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -103.85 -29.29 11.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.493 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.79 -175.42 23.04 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.896 ' HB2' HG12 ' A' ' 38' ' ' VAL . 17.8 ttp180 -132.41 -85.55 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 50.6 tttm . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.538 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.172 0.511 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.968 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -127.24 -172.89 2.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.672 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.1 m -135.92 145.67 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 0.0 110.337 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB2' ' NE1' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -98.73 137.15 37.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.822 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.768 HG23 ' HB3' ' A' ' 82' ' ' LEU . 3.6 m -138.43 157.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.3 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HB2' ' HE2' ' A' ' 126' ' ' MET . 7.7 mmt85 -123.1 115.8 22.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -125.52 157.61 36.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.715 -1.24 . . . . 0.0 112.633 -177.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.631 ' CG1' ' CG1' ' A' ' 124' ' ' ILE . 16.3 pt -130.57 125.49 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 6.5 tt -106.42 123.84 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.16 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 1.4 t -143.26 -171.47 3.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.906 -1.121 . . . . 0.0 111.8 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 4.4 mt-10 -77.41 117.15 18.61 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.595 -0.69 . . . . 0.0 111.403 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -82.58 77.28 9.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.711 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 19.3 m80 -134.61 71.05 1.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.983 -1.073 . . . . 0.0 110.155 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.18 78.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.184 -1.567 . . . . 0.0 109.184 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 59.6 tttt -108.7 -11.55 15.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -1.044 . . . . 0.0 110.385 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.622 HD13 ' HE2' ' A' ' 117' ' ' LYS . 34.2 mt -47.58 -53.11 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 73.1 mtm -59.21 -37.34 77.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.446 -0.784 . . . . 0.0 110.598 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 75.0 mm-40 -61.41 -39.8 92.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.928 . . . . 0.0 110.568 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -66.38 -60.7 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.458 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.471 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 22.6 ptm -58.93 -44.44 91.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.059 -1.026 . . . . 0.0 110.336 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 55' ' ' MET . 32.4 mm-40 -59.1 -42.98 91.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.535 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' MET . 66.2 tttt -72.07 -38.0 69.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 111.0 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.8 ' CB ' HG21 ' A' ' 67' ' ' VAL . 2.3 pp -93.98 10.81 31.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.956 -1.09 . . . . 0.0 110.807 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.9 ptmt -42.55 161.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.172 -0.955 . . . . 0.0 110.145 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -52.09 115.99 1.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.004 . . . . 0.0 110.087 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.11 -44.05 1.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 7.5 tpt -77.3 162.72 27.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -1.098 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -80.36 100.25 8.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CD1' ' SD ' ' A' ' 126' ' ' MET . 76.9 t80 -50.64 -32.54 19.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.961 . . . . 0.0 109.966 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 54.8 t30 -55.38 -43.64 75.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.558 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.22 -44.1 84.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.696 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.8 HG21 ' CB ' ' A' ' 58' ' ' LEU . 59.3 t -55.81 -57.54 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -46.13 -58.02 3.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -45.54 -38.7 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.375 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.6 mm-40 -78.77 -32.36 46.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.212 -0.93 . . . . 0.0 110.584 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.78 23.15 13.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -1.0 . . . . 0.0 110.616 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 m -83.86 100.27 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.385 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' OE1' ' HG3' ' A' ' 46' ' ' GLU . 28.7 tt0 -100.66 4.62 43.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.506 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 78' ' ' GLN . 85.3 m-20 -102.07 72.1 1.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.459 -0.776 . . . . 0.0 109.357 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -50.55 -35.49 30.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.467 -0.77 . . . . 0.0 110.87 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.41 -54.41 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -73.3 -15.7 61.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.102 -0.999 . . . . 0.0 110.589 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' CG ' ' O ' ' A' ' 78' ' ' GLN . 1.6 pt20 33.92 99.94 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.249 1.023 . . . . 0.0 111.431 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -70.38 -90.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . 46.73 -91.63 0.01 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 79' ' ' GLY . 19.9 p-10 -106.13 132.45 52.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.589 -0.948 . . . . 0.0 110.075 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 40' ' ' VAL . 50.4 tp -116.88 135.08 54.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -56.48 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.8 m-90 -88.56 138.69 31.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.972 . . . . 0.0 110.466 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.5 mmm -101.41 119.45 38.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 108.999 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.968 HG22 ' CB ' ' A' ' 37' ' ' ALA . 3.6 p -119.36 -29.42 5.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 7.2 ptp180 -63.61 -33.67 76.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.429 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.508 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . 52.85 20.7 8.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -130.36 78.71 1.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -1.166 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 92' ' ' GLY . 7.9 ttt -136.9 153.23 50.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.618 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.884 HG12 ' HD2' ' A' ' 93' ' ' PRO . 57.0 t 34.51 -91.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.368 0.604 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.621 ' N ' HG12 ' A' ' 91' ' ' VAL . . . 178.44 -74.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.884 ' HD2' HG12 ' A' ' 91' ' ' VAL . 43.9 Cg_endo -70.14 -11.8 31.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.137 1.598 . . . . 0.0 110.391 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -73.94 -66.63 0.69 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' HA2' ' A' ' 88' ' ' GLY . 13.3 mm-40 -65.4 -40.2 93.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 110.944 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.864 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 9.8 pt-20 -55.07 -38.5 68.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.749 -1.219 . . . . 0.0 109.848 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.521 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -68.12 -55.13 13.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.989 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.34 -49.57 12.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 7.3 m-30 -88.58 0.78 56.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.33 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -83.23 -25.76 31.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.151 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 101' ' ' LEU . 9.5 mp -106.03 65.77 0.17 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 111.267 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 100' ' ' ALA . 50.0 Cg_endo -72.17 -21.33 23.76 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.729 1.384 . . . . 0.0 110.616 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.66 -13.39 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.9 m -101.22 116.54 33.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.108 -0.995 . . . . 0.0 109.111 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.31 -135.44 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.607 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 106' ' ' MET . 3.2 ttt -85.06 13.4 6.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -1.023 . . . . 0.0 110.959 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -102.68 -40.43 6.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.825 -1.172 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -133.81 98.17 14.9 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.06 126.44 10.56 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.918 1.483 . . . . 0.0 109.835 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.71 -178.53 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.668 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 54.3 p90 -123.65 172.56 8.71 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.611 ' CG2' HG12 ' A' ' 125' ' ' ILE . 3.1 p -58.26 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.607 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 10.5 p-10 -120.24 113.87 33.7 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.956 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.8 Cg_endo -73.4 164.53 86.89 Favored 'Cis proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.971 -2.095 . . . . 0.0 110.563 0.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 1.029 ' HB3' HG22 ' A' ' 124' ' ' ILE . 44.4 Cg_endo -73.02 -175.83 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.019 1.536 . . . . 0.0 110.385 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 123' ' ' HIS . 16.5 m -105.63 146.55 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.622 ' HE2' HD13 ' A' ' 51' ' ' ILE . 64.7 mttt -112.61 130.53 56.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 73.8 p -142.31 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.889 -1.132 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.24 -29.73 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 109.997 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 3.5 p90 -88.6 43.26 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.533 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.6 -157.75 27.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p90 -130.61 160.18 34.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -1.037 . . . . 0.0 108.476 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 1.4 m-70 -140.32 133.24 29.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.666 -1.271 . . . . 0.0 112.135 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.029 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -112.66 136.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -126.52 133.71 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.598 -1.314 . . . . 0.0 112.278 -176.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.675 ' HE2' ' HB2' ' A' ' 41' ' ' ARG . 31.2 mtm -94.42 99.01 11.28 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.78 110.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.429 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -139.4 151.09 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.17 60.26 3.37 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.18 169.23 14.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.58 -0.953 . . . . 0.0 110.392 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.328 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.4 t30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.748 0.785 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -136.36 164.2 28.67 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.645 -1.285 . . . . 0.0 110.648 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 85' ' ' MET . 17.9 m -139.48 146.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 33.0 tttm -100.57 130.34 46.62 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.918 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -130.78 149.68 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.863 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 45.6 mtt180 -140.17 126.32 19.81 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.026 ' CB ' HG22 ' A' ' 125' ' ' ILE . 2.3 p80 -144.9 -178.65 6.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.612 -1.305 . . . . 0.0 112.206 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 71' ' ' TYR . 9.2 pt -138.37 138.47 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -103.47 126.81 50.84 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.273 0.558 . . . . 0.0 110.386 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.8 p -134.38 171.09 14.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 110.063 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' NE2' ' A' ' 48' ' ' HIS . 73.3 mm-40 -61.69 171.17 1.65 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.261 -0.899 . . . . 0.0 110.623 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 6.0 tttt -116.56 80.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.988 . . . . 0.0 110.704 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.569 ' NE2' ' HB3' ' A' ' 46' ' ' GLU . 18.4 m-70 -134.78 63.21 1.63 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.936 -1.103 . . . . 0.0 111.966 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.97 9.95 12.53 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.241 -0.912 . . . . 0.0 111.114 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 37.4 ttmt -89.2 13.29 13.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.973 -1.31 . . . . 0.0 110.482 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.635 HG13 ' CE2' ' A' ' 122' ' ' TYR . 82.0 mt -64.29 -42.58 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.569 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.45 ' HE2' ' SD ' ' A' ' 55' ' ' MET . 38.6 mmt -69.26 -44.4 71.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.895 . . . . 0.0 111.273 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -70.65 -38.92 73.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.08 . . . . 0.0 110.746 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.5 -52.73 56.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.45 ' SD ' ' HE2' ' A' ' 52' ' ' MET . 5.7 ptt? -65.39 -34.39 78.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.887 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 16.0 tp10 -58.03 -46.41 85.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' CG ' HG22 ' A' ' 67' ' ' VAL . 22.2 tttt -67.57 -32.86 73.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 109.181 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.871 HD21 ' CE2' ' A' ' 111' ' ' PHE . 2.0 tp -74.41 -13.02 60.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 109.253 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 39.9 tptt -40.4 144.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.746 . . . . 0.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -50.4 149.43 3.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.235 -0.916 . . . . 0.0 108.953 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.88 -44.25 1.6 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.6 mmt -78.36 165.77 23.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.509 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -71.69 99.16 2.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.108 -0.995 . . . . 0.0 110.811 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 60.9 t80 -48.47 -29.54 4.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.975 -1.078 . . . . 0.0 109.304 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -77.79 -40.23 41.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 11.2 tp10 -56.54 -46.21 80.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.866 . . . . 0.0 109.67 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 58' ' ' LEU . 69.5 t -67.07 -44.06 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 109.558 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -54.89 -50.89 67.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.92 57.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.466 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.2 mm-40 -63.1 -29.08 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.477 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.807 ' HB2' HD12 ' A' ' 43' ' ' ILE . 21.9 m-85 -108.99 18.77 20.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.46 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.3 t -91.25 96.06 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -99.77 0.03 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.233 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' C ' ' A' ' 75' ' ' LYS . 41.2 t0 -105.97 15.26 26.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.464 -0.772 . . . . 0.0 109.953 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 14.4 pttm -41.81 -35.15 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -86.02 134.75 33.83 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 81.14 -18.39 0.5 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.683 -0.636 . . . . 0.0 109.962 -178.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 5.3 tt0 70.38 177.33 0.27 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 110.982 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 82' ' ' LEU . . . 154.8 -20.81 0.59 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 42' ' ' HIS . . . -48.29 -44.99 28.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.61 ' C ' HD12 ' A' ' 82' ' ' LEU . 34.6 p-10 -115.01 126.43 54.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -1.016 . . . . 0.0 109.669 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.0 mp -101.35 7.8 42.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 60.26 -147.66 44.63 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 35.3 m95 -96.73 132.29 42.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.743 -0.857 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 38' ' ' VAL . 9.0 ptp -135.87 149.77 49.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.58 -0.7 . . . . 0.0 109.206 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 36' ' ' ASN . 26.4 p -111.47 -64.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.375 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' N ' ' OG1' ' A' ' 86' ' ' THR . 7.3 mtp180 -71.69 -38.23 70.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 109.758 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 95' ' ' GLN . . . 60.03 55.38 30.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.8 m -103.67 106.23 16.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.251 . . . . 0.0 109.522 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.0 mmt -130.16 -83.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 111.107 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 93' ' ' PRO . 4.0 p -96.46 -28.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.235 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.46 -73.12 0.47 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.025 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.505 ' HD2' HG22 ' A' ' 91' ' ' VAL . 44.0 Cg_endo -69.84 -41.67 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.849 1.447 . . . . 0.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -53.91 -38.41 64.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.071 -1.018 . . . . 0.0 109.393 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 88' ' ' GLY . 44.9 tt0 -67.33 -52.35 41.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.776 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 38.3 tt0 -54.45 -44.45 72.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -59.67 -56.12 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.07 -54.9 6.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.346 -0.846 . . . . 0.0 110.264 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 102' ' ' PRO . 61.1 m-85 -85.08 11.29 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 0.0 110.478 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -102.15 -19.9 14.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.736 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.69 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -109.05 21.94 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.91 . . . . 0.0 112.638 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 101' ' ' LEU . 52.1 Cg_endo -78.05 -8.51 16.57 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 m -107.04 25.4 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.49 -0.757 . . . . 0.0 110.081 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB2' HD23 ' A' ' 101' ' ' LEU . 18.6 m -101.26 -1.49 33.52 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.746 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.27 137.66 10.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 ttp -55.39 -44.87 76.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -1.221 . . . . 0.0 110.393 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -103.9 -62.93 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.49 162.63 49.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 110.158 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 47.8 Cg_endo -74.27 142.15 29.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.144 1.602 . . . . 0.0 110.083 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 111' ' ' PHE . 2.7 m -106.87 -99.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD21 ' A' ' 58' ' ' LEU . 40.6 t80 -116.58 152.19 34.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.896 -1.127 . . . . 0.0 110.806 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.643 HG21 ' CG1' ' A' ' 125' ' ' ILE . 7.3 p -74.84 110.43 9.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 110.936 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 88.3 m-20 -133.81 121.69 16.12 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.8 Cg_endo -79.32 172.7 58.49 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.164 -2.015 . . . . 0.0 110.362 -0.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.829 ' HG3' HD12 ' A' ' 124' ' ' ILE . 47.2 Cg_endo -73.15 178.12 6.95 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.956 1.503 . . . . 0.0 109.725 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 123' ' ' HIS . 16.2 m -99.91 155.11 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.008 -1.058 . . . . 0.0 109.378 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -125.26 130.43 52.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.58 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.593 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.2 p -134.04 178.23 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -72.89 -15.83 61.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -0.955 . . . . 0.0 110.617 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 1.8 p90 -95.84 24.62 5.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.174 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 109.97 -176.41 19.19 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.4 m-85 -100.02 154.04 18.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 53.4 m-70 -129.91 122.52 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.872 -1.143 . . . . 0.0 110.487 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.829 HD12 ' HG3' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -117.92 108.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.026 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -109.01 157.47 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.69 -1.256 . . . . 0.0 112.959 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.476 ' HA ' ' CD1' ' A' ' 111' ' ' PHE . 3.7 ttt -116.26 119.29 35.27 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' PRO . 21.3 t -107.95 115.52 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.814 -1.179 . . . . 0.0 111.947 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -106.0 -18.28 14.09 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 70.7 -163.64 53.38 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG3' ' CZ3' ' A' ' 84' ' ' TRP . 66.1 ttt180 -132.77 -35.69 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.943 . . . . 0.0 110.003 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.288 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' THR . 38.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.26 0.553 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CA ' ' OG1' ' A' ' 86' ' ' THR . . . -113.14 168.73 9.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.05 -1.031 . . . . 0.0 110.52 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 14.3 m -130.3 169.5 21.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.558 -0.714 . . . . 0.0 109.882 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CG ' ' CE2' ' A' ' 84' ' ' TRP . 19.0 mtpt -98.53 119.61 37.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.095 -1.003 . . . . 0.0 109.193 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.719 HG21 ' CE ' ' A' ' 85' ' ' MET . 95.9 t -111.72 126.39 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.281 -0.968 . . . . 0.0 112.023 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NH1' ' OE1' ' A' ' 128' ' ' GLU . 71.0 mtm180 -119.77 125.67 49.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB3' HG23 ' A' ' 125' ' ' ILE . 2.1 p80 -143.92 178.81 7.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.392 -1.442 . . . . 0.0 112.416 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 88.6 mt -121.61 135.48 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.576 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -111.75 119.42 38.57 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.681 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 43' ' ' ILE . 15.4 m -130.22 168.31 17.05 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 67.6 mt-10 -88.5 -172.6 3.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 110.283 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 122' ' ' TYR . 35.9 mtmt -102.83 101.66 11.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.962 -1.086 . . . . 0.0 111.442 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.607 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 28.7 m170 -134.57 6.56 3.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.888 . . . . 0.0 111.459 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.17 15.6 44.05 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.427 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 27.9 mttt -96.88 6.79 47.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.26 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' A' ' 122' ' ' TYR . 69.5 mt -46.14 -57.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' MET . 51.1 mtt -65.08 -40.24 94.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.482 -0.761 . . . . 0.0 109.842 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 1.7 tp10 -67.37 -22.01 65.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.192 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -75.56 -60.51 2.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.167 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.546 ' HB2' ' HG2' ' A' ' 114' ' ' PRO . 11.6 ptt? -56.93 -32.52 66.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -71.09 -42.55 69.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 39.3 mmtm -64.37 -50.64 66.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.807 ' HB3' HG21 ' A' ' 67' ' ' VAL . 2.5 pp -78.17 -14.88 59.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 109.522 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 60' ' ' SER . 4.5 ptmm? 23.41 -134.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 41.3 t -52.0 -22.1 3.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.938 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 126.77 2.46 6.71 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 58.3 ttm -56.86 -39.27 74.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -1.179 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.69 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 mtt180 -108.86 13.26 24.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.376 -0.827 . . . . 0.0 110.132 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 77.3 t80 -51.1 -48.87 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 49.5 m-80 -57.76 -43.38 85.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.35 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' CD ' ' HG2' ' A' ' 63' ' ' ARG . 41.4 mt-10 -68.09 -38.24 82.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.807 HG21 ' HB3' ' A' ' 58' ' ' LEU . 97.4 t -62.74 -71.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.416 -0.803 . . . . 0.0 109.134 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -48.65 -50.8 31.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -42.92 -42.24 3.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.822 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.549 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.1 tp60 -106.02 -6.61 18.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.378 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-85 -103.42 11.74 36.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.6 p -83.27 100.5 10.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 110.383 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -106.03 20.12 19.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.174 -0.953 . . . . 0.0 110.067 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 30.2 t0 -137.85 39.84 2.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -59.84 -24.29 64.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.857 . . . . 0.0 110.189 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.93 81.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -103.26 -57.6 2.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.138 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ASP . 1.2 pt20 -135.19 164.83 26.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.84 23.21 31.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 97.76 1.32 58.77 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' C ' HD12 ' A' ' 82' ' ' LEU . 76.1 m-20 -134.15 132.01 39.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.799 -1.412 . . . . 0.0 110.929 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.3 mp -109.58 151.87 26.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.795 . . . . 0.0 109.368 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -77.56 -132.5 0.6 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.619 ' CE2' ' CG ' ' A' ' 39' ' ' LYS . 86.0 m95 -95.08 122.71 38.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.928 -0.748 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.719 ' CE ' HG21 ' A' ' 40' ' ' VAL . 6.6 ptt? -141.54 137.47 32.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 36' ' ' ASN . 89.1 m -103.38 -45.13 4.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 110.762 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -73.27 -32.22 64.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.0 -145.66 16.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -120.96 -62.16 1.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.147 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 85.9 mmm -137.44 -86.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.394 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 92' ' ' GLY . 9.9 p -174.61 176.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG22 ' A' ' 91' ' ' VAL . . . 93.93 -151.14 20.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HG13 ' A' ' 116' ' ' VAL . 43.0 Cg_endo -69.3 -8.34 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.245 1.656 . . . . 0.0 110.093 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.53 ' CE1' HD13 ' A' ' 125' ' ' ILE . 1.1 t80 -76.71 -48.52 18.58 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.514 -0.741 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -78.87 -47.6 16.24 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.129 -0.982 . . . . 0.0 110.835 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.97 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -62.43 -20.65 64.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 112' ' ' THR . . . -93.16 -55.02 3.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.786 -1.196 . . . . 0.0 110.545 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.31 -54.51 25.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.967 . . . . 0.0 111.388 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CZ ' ' O ' ' A' ' 86' ' ' THR . 38.8 m-85 -89.81 -21.85 22.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.158 -0.964 . . . . 0.0 111.609 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.97 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -119.05 32.43 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.823 -1.173 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.525 HD11 ' C ' ' A' ' 112' ' ' THR . 14.4 tp -56.1 140.71 70.0 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD2' ' HG ' ' A' ' 101' ' ' LEU . 43.8 Cg_endo -70.45 150.72 64.41 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.946 1.498 . . . . 0.0 110.036 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 103' ' ' VAL . 7.1 p -68.78 90.98 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 110.522 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 p -100.33 -10.57 21.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.061 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.69 145.08 18.65 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.3 mtm -61.33 -28.97 69.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 111.298 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 31.9 p-10 -140.3 -46.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.886 -1.134 . . . . 0.0 110.951 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 4.0 mttp -128.04 126.49 23.75 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.571 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.52 162.16 36.2 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.938 1.494 . . . . 0.0 110.491 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 111' ' ' PHE . 48.9 t -121.33 -74.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.241 -0.912 . . . . 0.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.559 ' CB ' ' HB3' ' A' ' 114' ' ' PRO . 92.8 m-85 -98.37 167.29 10.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 113' ' ' ASP . 96.8 m -62.15 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 112.558 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.815 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 54.2 t0 -70.33 -34.08 3.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.815 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 52.9 Cg_endo -76.16 -25.76 10.25 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.466 -1.056 . . . . 0.0 114.729 1.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 114' ' ' PRO . 42.0 Cg_endo -71.14 115.56 4.32 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 O-C-N 122.341 0.653 . . . . 0.0 112.895 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 93' ' ' PRO . 32.3 t -111.39 153.08 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 14.6 ptmm? -143.06 117.93 9.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.795 -1.191 . . . . 0.0 110.697 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.827 HG21 ' CD2' ' A' ' 120' ' ' PHE . 1.3 t -145.37 179.65 7.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.355 -0.84 . . . . 0.0 110.695 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -64.12 -11.97 35.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.827 ' CD2' HG21 ' A' ' 118' ' ' THR . 0.0 OUTLIER -87.78 -17.99 30.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 108.673 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 129.08 -149.84 18.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.95 142.85 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -1.092 . . . . 0.0 108.446 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.576 ' CE1' HD21 ' A' ' 44' ' ' LEU . 35.2 m-70 -132.32 144.09 50.32 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.229 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.591 HD11 ' HB1' ' A' ' 54' ' ' ALA . 7.6 mt -132.72 109.96 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.052 HG23 ' HB3' ' A' ' 42' ' ' HIS . 1.2 mt -115.32 129.66 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.735 -1.228 . . . . 0.0 112.271 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.523 ' HG2' ' CD1' ' A' ' 111' ' ' PHE . 88.1 mtp -99.55 135.19 41.33 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.8 125.4 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.949 -1.095 . . . . 0.0 111.141 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.52 ' OE1' ' NH1' ' A' ' 41' ' ' ARG . 79.7 tt0 -142.21 147.75 37.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 60.08 76.47 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HA ' HG12 ' A' ' 38' ' ' VAL . 76.2 ttt180 -122.34 131.89 54.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -1.119 . . . . 0.0 110.179 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.164 0.507 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -128.92 172.03 11.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 110.7 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 3.6 p -141.45 156.94 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.357 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -100.13 119.72 38.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.66 HG21 HD21 ' A' ' 82' ' ' LEU . 4.5 m -127.31 157.36 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.7 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 37.9 mtt-85 -139.8 118.84 12.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.011 ' HB3' HG23 ' A' ' 125' ' ' ILE . 2.8 p80 -132.03 161.96 31.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.838 -1.164 . . . . 0.0 112.262 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.707 HG12 ' HB2' ' A' ' 68' ' ' ALA . 3.4 mt -115.81 128.15 73.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.652 HD13 ' OD2' ' A' ' 74' ' ' ASP . 5.1 tt -110.36 129.37 55.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.226 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' N ' HD23 ' A' ' 44' ' ' LEU . 45.1 t -132.33 152.5 51.38 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 33.8 mt-10 -64.76 -171.64 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.716 -1.24 . . . . 0.0 109.463 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.666 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 48.0 tttt -97.94 106.66 18.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.587 -1.32 . . . . 0.0 113.312 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 2.8 m-70 -131.63 -5.9 3.67 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.161 -0.962 . . . . 0.0 110.032 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.6 30.29 10.84 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' GLU . 82.3 mttt -109.63 -2.75 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 111.111 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.569 ' HB ' ' CG ' ' A' ' 122' ' ' TYR . 11.3 tt -45.64 -40.94 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.737 -1.227 . . . . 0.0 109.276 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.509 ' N ' HG23 ' A' ' 51' ' ' ILE . 16.6 ttt -65.66 -34.4 78.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.334 -0.854 . . . . 0.0 109.001 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' LYS . 79.5 tt0 -72.24 -41.75 66.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 108.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.94 -57.03 13.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.716 . . . . 0.0 110.12 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.698 ' HA ' HD23 ' A' ' 58' ' ' LEU . 28.3 ptm -68.83 -28.13 66.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.862 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.3 tt0 -74.57 -26.25 59.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB3' HG12 ' A' ' 67' ' ' VAL . 17.2 mmtm -81.41 -36.84 29.03 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.538 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.812 ' N ' HG11 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -83.96 -19.04 35.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.453 -0.78 . . . . 0.0 109.259 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 56' ' ' GLU . 60.8 mmtt 44.57 -138.75 0.38 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.48 -0.762 . . . . 0.0 110.052 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.8 t -54.86 -25.91 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 110.912 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 139.7 -11.47 3.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.4 mtp -48.21 -35.39 11.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 110.2 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 67' ' ' VAL . 9.7 mtt180 -112.91 26.64 10.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.154 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 79.6 t80 -55.49 -37.51 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -75.37 -39.56 59.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.339 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 61.1 mm-40 -62.43 -58.15 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.429 -0.794 . . . . 0.0 109.534 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.812 HG11 ' N ' ' A' ' 58' ' ' LEU . 16.6 m -50.92 -44.7 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.242 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.707 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . -62.72 -37.26 85.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.602 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -55.66 -36.9 67.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.176 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.53 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 4.1 tp60 -105.74 -10.83 16.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 110.794 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 67' ' ' VAL . 24.8 m-85 -114.23 18.94 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.247 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 36.6 t -111.77 113.24 25.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.831 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.94 -5.3 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.655 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.652 ' OD2' HD13 ' A' ' 44' ' ' LEU . 96.2 m-20 -104.43 59.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.452 -0.78 . . . . 0.0 109.607 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -55.43 -28.88 57.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.343 -0.848 . . . . 0.0 111.773 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.15 -36.12 6.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.729 -1.232 . . . . 0.0 111.402 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -65.12 -55.54 18.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.908 -1.12 . . . . 0.0 110.307 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HG3' ' C ' ' A' ' 77' ' ' ARG . 19.7 mt-30 -143.45 -72.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 0.0 110.696 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.84 -107.83 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -99.35 -37.97 3.89 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 39.2 p30 -128.5 134.65 48.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.076 -1.249 . . . . 0.0 110.959 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 85' ' ' MET . 2.1 pp -103.3 1.33 32.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.5 -134.81 11.84 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.6 m-90 -99.23 155.41 17.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.552 -0.97 . . . . 0.0 110.915 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -126.87 133.63 50.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.442 -0.786 . . . . 0.0 109.471 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.6 HG22 ' HB2' ' A' ' 37' ' ' ALA . 30.5 p -128.77 -37.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.035 -1.04 . . . . 0.0 111.011 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 3.1 mtm105 -116.63 -14.96 10.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.907 -1.121 . . . . 0.0 111.507 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . 126.92 -176.66 17.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 9.5 t -141.8 -32.09 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.45 -1.029 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 3.7 mmt -104.33 -145.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.913 -1.117 . . . . 0.0 110.956 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.709 HG23 ' HD2' ' A' ' 93' ' ' PRO . 13.3 m -86.53 -29.41 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.073 -1.017 . . . . 0.0 112.467 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . 177.04 -54.44 0.1 Allowed Glycine 0 N--CA 1.493 2.491 0 C-N-CA 118.451 -1.833 . . . . 0.0 111.877 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.709 ' HD2' HG23 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -62.23 -27.04 77.97 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.352 1.185 . . . . 0.0 111.856 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 90' ' ' MET . 78.1 t80 -70.79 -52.39 20.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.749 -1.219 . . . . 0.0 109.948 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 2.6 tt0 -73.25 -29.42 62.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 109.548 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.959 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 83.0 mt-10 -70.42 -25.86 63.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 109.832 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -87.09 -53.88 4.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.67 -50.62 60.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -76.05 -14.69 60.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.253 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -67.7 -58.01 5.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.694 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 101' ' ' LEU . 11.2 mp -41.07 120.5 1.84 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.13 -0.981 . . . . 0.0 109.892 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.36 164.97 30.09 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.802 1.422 . . . . 0.0 110.606 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.555 HG21 ' HD3' ' A' ' 130' ' ' ARG . 52.9 t -133.06 107.92 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.873 . . . . 0.0 109.849 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.7 p -102.13 3.82 38.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -159.15 178.09 35.44 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.9 ttt -73.98 -31.53 63.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.309 -1.112 . . . . 0.0 110.243 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -122.14 23.47 9.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 110.186 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.655 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 28.4 mmtt -71.04 -40.07 9.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 110.8 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 108' ' ' LYS . 45.7 Cg_endo -73.7 155.98 49.09 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.167 1.088 . . . . 0.0 110.135 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.755 HG22 ' N ' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -144.86 -85.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.119 -0.988 . . . . 0.0 111.76 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.755 ' N ' HG22 ' A' ' 110' ' ' VAL . 9.3 t80 -133.95 156.11 48.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 111.109 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 114' ' ' PRO . 23.2 p -70.63 63.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.407 -0.808 . . . . 0.0 109.712 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 24.7 p-10 -97.88 130.73 28.17 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 112' ' ' THR . 48.5 Cg_endo -74.9 168.8 76.28 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 121.773 -2.178 . . . . 0.0 110.033 -0.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.985 ' HB3' HG22 ' A' ' 124' ' ' ILE . 41.6 Cg_endo -70.75 171.51 15.4 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.049 1.552 . . . . 0.0 110.407 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.33 150.32 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.494 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HG2' ' CD1' ' A' ' 51' ' ' ILE . 50.4 mtmt -113.33 133.32 55.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 75.5 p -139.28 -178.7 5.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.804 -1.185 . . . . 0.0 111.485 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -81.43 -18.03 46.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.449 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.3 OUTLIER -91.23 -0.77 57.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.062 -1.024 . . . . 0.0 109.455 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 132.46 -176.38 19.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 94.8 m-85 -100.95 153.77 19.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.489 -1.007 . . . . 0.0 109.426 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.597 ' ND1' ' HG ' ' A' ' 44' ' ' LEU . 5.0 m-70 -141.6 141.35 33.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 112.286 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.985 HG22 ' HB3' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -124.55 114.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 176.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -103.38 157.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 122.225 1.012 . . . . 0.0 112.175 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 19.5 ttt -136.94 134.07 36.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.71 136.55 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.74 -1.225 . . . . 0.0 111.353 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.02 109.19 7.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 109.669 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.66 115.24 0.26 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.555 ' HD3' HG21 ' A' ' 103' ' ' VAL . 5.2 ttp180 -130.07 150.5 51.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 pttm . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.269 -179.856 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' THR . 26.4 p30 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.434 0.635 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 131' ' ' LYS . . . -90.31 129.19 36.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 110.309 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 129' ' ' GLY . 13.9 p -141.63 164.08 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HD3' ' CZ2' ' A' ' 84' ' ' TRP . 12.1 mtmm -98.76 121.31 40.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.221 -0.925 . . . . 0.0 108.773 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.968 ' HB ' HD11 ' A' ' 82' ' ' LEU . 91.2 t -130.15 143.84 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.934 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 31.1 mtt85 -140.4 107.17 5.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 125' ' ' ILE . 3.8 p80 -132.45 179.33 6.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.615 -1.303 . . . . 0.0 112.149 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 124' ' ' ILE . 6.7 mt -127.81 133.66 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -117.33 121.44 41.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.988 . . . . 0.0 111.149 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 54.0 t -142.07 137.25 30.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.143 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 71.5 mm-40 -58.28 162.03 3.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 2.9 tttm -72.68 113.28 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.033 -1.042 . . . . 0.0 112.674 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.612 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 7.2 m-70 -132.06 14.41 4.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.28 76.23 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 12.4 mtpt -93.92 -5.66 47.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.984 . . . . 0.0 110.475 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.609 HG13 ' CD2' ' A' ' 122' ' ' TYR . 2.8 mp -40.13 -58.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.225 -0.922 . . . . 0.0 110.426 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 6.0 ttt -69.12 -45.29 70.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -55.99 -46.94 78.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -59.84 -62.63 1.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.551 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.746 ' SD ' HD12 ' A' ' 124' ' ' ILE . 0.4 OUTLIER -61.19 -39.86 91.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.047 -1.033 . . . . 0.0 110.12 -179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 4.5 tp10 -52.82 -54.98 26.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.794 -1.191 . . . . 0.0 109.54 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -57.55 -38.2 74.36 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.506 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.92 -68.83 0.14 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 25.9 mmtt 39.17 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.588 -0.695 . . . . 0.0 110.281 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -110.08 133.64 53.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.05 -1.031 . . . . 0.0 110.725 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.86 -12.22 59.19 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.406 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 tpt -81.49 161.22 23.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.32 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -82.79 99.34 9.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.344 -0.848 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -49.17 -29.37 5.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 110.379 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -63.37 -35.12 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.966 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -77.19 -41.02 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 110.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 58' ' ' LEU . 23.3 t -68.69 -38.11 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.955 -1.091 . . . . 0.0 110.195 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -68.68 -41.92 78.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.95 -1.094 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.11 81.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.862 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.551 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.9 tp60 -70.25 -34.81 73.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 0.0 110.757 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' HB2' HG21 ' A' ' 43' ' ' ILE . 54.1 m-85 -104.42 21.81 16.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.023 -1.048 . . . . 0.0 110.201 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -86.01 90.91 8.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 110.325 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.1 tp10 -100.33 -2.42 33.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.336 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 32.0 p-10 -136.25 12.33 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' H ' ' A' ' 79' ' ' GLY . 81.4 tttt -56.46 -34.17 66.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.416 -0.802 . . . . 0.0 110.386 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.5 94.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 5.9 ptp180 -98.81 -12.9 20.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.044 -1.035 . . . . 0.0 110.967 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.496 HE22 HD12 ' A' ' 44' ' ' LEU . 53.4 mt-30 -129.05 -38.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.911 -1.118 . . . . 0.0 110.241 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' H ' ' HA ' ' A' ' 75' ' ' LYS . . . 93.23 -12.66 69.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 90.83 -43.79 2.86 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.8 p-10 -124.56 142.74 51.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -1.207 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 40' ' ' VAL . 2.9 pp -136.59 156.08 49.05 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.02 -119.16 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.802 -1.189 . . . . 0.0 111.047 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.601 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 19.0 m-90 -90.7 121.42 32.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.065 -0.668 . . . . 0.0 110.802 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.561 ' SD ' HD13 ' A' ' 82' ' ' LEU . 23.3 ptm -144.38 155.12 43.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 1.5 p -87.0 134.85 33.45 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.907 ' HE ' HG21 ' A' ' 40' ' ' VAL . 50.8 mtt-85 -98.96 46.11 0.99 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.178 . . . . 0.0 112.48 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.08 36.27 4.38 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 106.586 -2.606 . . . . 0.0 106.586 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -137.08 -7.93 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.874 -0.78 . . . . 0.0 111.792 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.93 -166.15 1.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.719 -1.238 . . . . 0.0 110.391 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.27 178.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.883 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.74 -151.54 19.64 Favored Glycine 0 N--CA 1.483 1.799 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.933 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 47.4 Cg_endo -75.16 -24.17 12.83 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.717 1.904 . . . . 0.0 110.664 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 44.6 t80 -45.71 -65.85 0.48 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 87' ' ' ARG . 4.0 tm0? -79.56 -32.04 42.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 41.0 tt0 -56.15 -39.77 72.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.952 -1.092 . . . . 0.0 110.403 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.64 -39.76 19.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' CB ' ' NH1' ' A' ' 87' ' ' ARG . . . -44.99 -59.25 2.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 110.774 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -81.69 -41.02 21.94 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 111.373 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -51.33 -21.22 2.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.974 -1.079 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 101' ' ' LEU . 14.5 tp -45.38 127.4 6.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.077 -1.014 . . . . 0.0 110.008 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -27.3 16.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.944 1.497 . . . . 0.0 110.895 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 103' ' ' VAL . 30.4 m -124.11 125.92 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.112 -0.993 . . . . 0.0 110.629 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 130' ' ' ARG . 69.3 m -131.58 66.79 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.63 65.73 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.7 ttm -52.02 -39.6 59.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.179 -1.189 . . . . 0.0 110.092 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -137.84 -59.09 0.66 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.275 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 19.5 tptm -132.53 143.04 47.11 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 108' ' ' LYS . 42.6 Cg_endo -69.94 130.62 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.882 1.464 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.5 t -134.44 157.49 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.251 -0.905 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 37.4 p90 -122.85 158.87 29.35 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.094 -1.003 . . . . 0.0 110.147 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 116' ' ' VAL . 14.8 m -50.43 97.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.362 -0.836 . . . . 0.0 112.197 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.647 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 46.4 t0 -132.36 118.64 16.08 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 41.4 Cg_endo -66.82 176.42 23.35 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.315 -1.952 . . . . 0.0 111.011 1.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD3' ' HE2' ' A' ' 55' ' ' MET . 47.5 Cg_endo -81.89 -178.76 4.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.16 1.611 . . . . 0.0 110.398 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 112' ' ' THR . 25.2 m -104.49 142.9 16.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.839 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -115.33 124.99 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 109.246 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 69.5 p -137.01 -179.38 5.67 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.621 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 3.9 tttm -68.07 -11.72 59.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.588 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 0.4 OUTLIER -107.56 22.5 15.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.82 -1.175 . . . . 0.0 110.816 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 46' ' ' GLU . . . 104.35 -179.32 24.67 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' HG13 ' A' ' 51' ' ' ILE . 32.7 p90 -101.58 155.28 18.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.942 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.727 ' CE1' HD21 ' A' ' 44' ' ' LEU . 3.0 m-70 -134.25 147.35 50.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.227 -0.921 . . . . 0.0 111.881 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.746 HD12 ' SD ' ' A' ' 55' ' ' MET . 3.0 tt -126.83 115.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.9 mp -104.68 141.57 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 112.354 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 1.3 mmm -113.63 102.69 10.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.76 132.5 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.177 -0.952 . . . . 0.0 111.194 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.13 70.84 1.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 128.14 127.32 2.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 104' ' ' SER . 3.6 ptp180 -126.64 148.74 49.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 1.7 tttp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.155 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.88 ' HB2' HG22 ' A' ' 86' ' ' THR . . . -130.61 164.46 24.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 127' ' ' VAL . 7.3 p -143.33 156.01 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 8.2 tttm -101.05 126.5 47.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.256 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.7 HG23 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -131.05 152.91 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.585 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -136.32 123.26 21.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.712 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.7 p80 -130.01 157.46 42.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.747 -1.22 . . . . 0.0 112.192 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 124' ' ' ILE . 1.4 pt -112.66 131.94 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.681 HD11 ' HE1' ' A' ' 123' ' ' HIS . 1.6 tt -104.77 131.46 52.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.913 -1.117 . . . . 0.0 111.852 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 48.7 t -136.17 156.18 49.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 48' ' ' HIS . 97.5 mt-10 -112.96 -12.68 13.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.044 -1.035 . . . . 0.0 111.774 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 14.9 mmtm -64.72 114.33 4.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 46' ' ' GLU . 7.1 m-70 -89.71 144.07 26.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.855 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 -15.99 58.9 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' NZ ' ' CE1' ' A' ' 71' ' ' TYR . 27.9 tttm -97.37 -9.76 26.82 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.616 HG12 ' CD2' ' A' ' 122' ' ' TYR . 38.9 mt -46.29 -44.86 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.48 ' O ' ' HG2' ' A' ' 55' ' ' MET . 21.2 ptt? -62.45 -36.52 82.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 110.7 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' A' ' 52' ' ' MET . 59.2 tt0 -72.44 -37.46 68.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.318 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.33 -49.2 72.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' MET . 13.8 ptt? -65.29 -31.89 73.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.008 . . . . 0.0 110.385 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -70.96 -44.02 66.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.042 -1.036 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -58.79 -53.45 58.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.107 -0.996 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.021 HD21 ' CE2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -76.57 -27.53 55.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 108.8 179.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 55' ' ' MET . 33.0 tttt 45.83 -99.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -0.789 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.5 p -98.41 -12.47 21.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.897 -1.127 . . . . 0.0 110.561 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 64' ' ' PHE . . . 124.47 2.05 8.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.1 mmm -50.28 -49.86 52.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.029 -1.277 . . . . 0.0 109.745 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -103.82 32.64 3.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.349 -0.845 . . . . 0.0 109.491 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.766 ' HD1' HD12 ' A' ' 58' ' ' LEU . 9.8 t80 -52.22 -48.67 65.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.431 -0.793 . . . . 0.0 110.72 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.91 -47.52 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.73 -42.49 77.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.711 HG13 ' CD2' ' A' ' 71' ' ' TYR . 45.1 t -65.42 -53.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -59.96 -52.62 64.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 110.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.37 -18.43 61.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 111.353 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -24.61 11.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 110.89 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.711 ' CD2' HG13 ' A' ' 67' ' ' VAL . 45.4 m-85 -100.31 6.47 44.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.075 -1.016 . . . . 0.0 109.517 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 28.7 t -72.16 103.74 3.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.386 -0.822 . . . . 0.0 110.575 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG3' ' HA ' ' A' ' 45' ' ' CYS . 11.0 mt-10 -101.01 5.49 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.953 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 78' ' ' GLN . 17.6 t0 -111.8 24.61 12.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HG2' ' OG ' ' A' ' 72' ' ' SER . 20.3 mmtt -62.83 -36.25 82.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.116 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.06 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -101.26 -59.96 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.258 -0.902 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.468 ' O ' ' OD2' ' A' ' 74' ' ' ASP . 8.5 pt20 -169.52 105.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.765 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 74' ' ' ASP . . . -129.45 91.36 0.31 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.84 -96.94 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 82' ' ' LEU . 56.1 p30 -114.76 160.61 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -1.192 . . . . 0.0 110.951 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.754 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.5 mp -103.99 -11.55 17.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 85.65 -143.48 19.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.5 m-90 -106.96 129.59 54.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.567 -0.96 . . . . 0.0 110.349 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 14.3 ptp -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.049 -1.032 . . . . 0.0 109.924 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.88 HG22 ' HB2' ' A' ' 37' ' ' ALA . 24.4 p -101.63 -67.6 0.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 111.457 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 84.8 mtt85 -80.83 -29.19 35.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.163 -0.961 . . . . 0.0 111.24 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 95' ' ' GLN . . . 168.31 -170.28 42.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -142.87 -50.58 0.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -1.195 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -117.63 -95.59 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 111.578 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 6.1 m -114.91 -175.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.875 -1.141 . . . . 0.0 111.941 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.638 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -63.86 -46.36 91.87 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.613 -0.68 . . . . 0.0 111.922 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.6 Cg_endo -66.35 -40.76 13.77 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.066 1.035 . . . . 0.0 110.755 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 87.8 t80 -75.44 -37.22 60.51 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 45.6 tt0 -76.38 -51.73 11.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.773 . . . . 0.0 110.433 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -57.4 -40.19 77.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.979 . . . . 0.0 110.409 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -63.82 -63.52 1.14 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -37.61 -58.57 0.87 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.296 0.57 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.29 -15.34 63.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 111.118 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 102' ' ' PRO . . . -135.15 40.66 2.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.748 -1.22 . . . . 0.0 111.951 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -105.67 67.52 0.17 Allowed Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 120.848 -1.158 . . . . 0.0 111.015 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 42.4 Cg_endo -68.14 93.21 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.616 1.324 . . . . 0.0 110.974 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.566 HG13 ' N ' ' A' ' 104' ' ' SER . 11.2 p -66.24 -40.41 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 109.851 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 103' ' ' VAL . 84.3 p -138.81 -36.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.853 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.95 155.87 15.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.0 ttt -65.11 -37.33 87.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -1.17 . . . . 0.0 110.456 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.463 ' C ' ' CD ' ' A' ' 109' ' ' PRO . 6.8 p-10 -127.31 13.27 7.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.578 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 86.8 mttt -118.19 39.13 0.29 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.0 111.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 51.4 Cg_endo -77.55 149.32 26.99 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.223 1.117 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 126' ' ' MET . 6.4 p -132.18 -21.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.43 -0.794 . . . . 0.0 110.481 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.021 ' CE2' HD21 ' A' ' 58' ' ' LEU . 6.3 t80 -142.91 151.53 41.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.582 ' O ' ' CE1' ' A' ' 111' ' ' PHE . 40.3 m -86.06 111.38 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.672 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -133.23 117.66 14.72 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 50.0 Cg_endo -78.19 173.67 55.59 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.014 -2.078 . . . . 0.0 110.066 0.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 51' ' ' ILE . 42.4 Cg_endo -71.32 177.3 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.848 1.446 . . . . 0.0 110.014 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -105.02 150.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.846 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -116.13 121.1 41.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 67.4 p -135.51 176.01 9.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.666 -1.271 . . . . 0.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.29 -14.48 62.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 110.426 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -105.28 33.31 3.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.293 -0.88 . . . . 0.0 108.706 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA2' ' HE1' ' A' ' 48' ' ' HIS . . . 89.47 174.22 46.01 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 51' ' ' ILE . 35.3 p90 -100.85 151.72 21.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.16 -1.2 . . . . 0.0 108.681 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.681 ' HE1' HD11 ' A' ' 44' ' ' LEU . 3.7 m-70 -130.75 160.22 34.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.893 -1.13 . . . . 0.0 112.532 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.875 HD13 HD11 ' A' ' 43' ' ' ILE . 1.8 mp -126.04 124.96 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 1.7 mt -107.04 136.14 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.821 -1.175 . . . . 0.0 112.759 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.567 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 38.1 tpp -122.89 102.75 8.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.63 HG23 HG12 ' A' ' 40' ' ' VAL . 14.7 p -103.09 129.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.022 -1.049 . . . . 0.0 112.189 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -142.48 135.65 28.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.672 -0.642 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.48 121.51 1.55 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -108.79 151.87 25.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 0.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 67.8 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.131 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.0 t-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.578 0.704 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.02 134.6 44.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 85' ' ' MET . 4.4 p -127.31 153.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.985 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 11.8 tttp -101.64 133.14 46.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.939 . . . . 0.0 109.995 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 82' ' ' LEU . 3.6 t -128.29 139.12 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.09 -1.006 . . . . 0.0 111.342 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 90.2 mtt180 -120.98 121.97 39.14 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.052 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -135.5 150.51 49.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.757 -1.214 . . . . 0.0 111.406 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.825 HD13 HG13 ' A' ' 67' ' ' VAL . 32.9 pt -121.19 133.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.615 HD11 ' HE1' ' A' ' 123' ' ' HIS . 1.1 tt -104.93 134.58 47.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.916 -1.115 . . . . 0.0 112.087 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 7.6 p -139.49 168.01 20.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 109.523 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.3 mm-40 -73.44 -159.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.007 . . . . 0.0 110.747 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 4.4 mtmt -122.9 99.52 6.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.122 -0.986 . . . . 0.0 110.623 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 8.3 m-70 -132.35 30.9 4.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.857 . . . . 0.0 110.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.07 21.38 75.5 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 48' ' ' HIS . 94.4 mttt -93.14 15.91 14.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.652 HG23 ' HG2' ' A' ' 115' ' ' PRO . 56.4 mt -61.89 -43.95 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.075 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.498 ' O ' ' HG2' ' A' ' 55' ' ' MET . 8.0 ttt -70.59 -40.64 73.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.518 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 52.2 mp0 -70.42 -37.2 74.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.872 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . -59.72 -60.73 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.246 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.701 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 15.5 ptt? -52.73 -38.09 60.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 55' ' ' MET . 96.8 mt-10 -73.61 -11.94 60.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.818 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 67' ' ' VAL . 29.8 tptt -80.83 -40.0 25.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.761 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.17 -22.28 18.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.601 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 58.6 mttp 49.3 -142.8 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -52.95 -34.26 54.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.432 -0.792 . . . . 0.0 110.935 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.98 -11.66 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 36.3 ttm -50.64 -34.85 27.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.14 -1.212 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 89.3 mtt180 -112.7 31.12 6.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 109.974 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 78.3 t80 -51.98 -40.46 60.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.443 -0.786 . . . . 0.0 110.083 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -70.69 -33.37 70.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 13.4 tp10 -63.26 -52.4 62.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 110.349 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.825 HG13 HD13 ' A' ' 43' ' ' ILE . 9.4 p -62.28 -36.46 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 109.57 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -65.31 -35.44 81.0 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.243 -0.911 . . . . 0.0 109.111 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.62 68.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.826 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.469 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 7.0 mm-40 -71.61 -19.65 62.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 110.003 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.606 ' HD2' HG22 ' A' ' 67' ' ' VAL . 29.1 m-85 -116.22 23.92 11.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.44 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' ALA . 55.9 p -78.12 76.22 4.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.023 -1.048 . . . . 0.0 109.767 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 80.8 mm-40 -105.76 1.47 27.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.25 13.92 9.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HA ' ' CA ' ' A' ' 79' ' ' GLY . 12.5 tmtt? -48.57 -34.72 11.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.534 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.36 -40.26 96.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -94.7 -61.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.142 -0.974 . . . . 0.0 110.233 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -121.36 -61.56 1.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.893 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 75' ' ' LYS . . . 92.25 -104.19 3.14 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . -103.04 -73.78 0.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.812 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.8 p-10 -81.19 153.27 27.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.29 -1.124 . . . . 0.0 110.781 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 81' ' ' ASP . 9.0 mp -113.82 -12.34 12.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.83 . . . . 0.0 109.794 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.38 -165.36 24.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 93.6 m95 -93.87 136.8 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.533 -0.981 . . . . 0.0 110.091 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.517 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.5 ptp -140.52 135.56 32.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.89 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.41 ' HB ' ' ND2' ' A' ' 36' ' ' ASN . 18.1 p -83.83 -37.63 22.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.482 -0.761 . . . . 0.0 110.443 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -113.41 -38.54 4.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 95' ' ' GLN . . . 58.69 66.2 2.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 31.3 t -113.08 105.63 13.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -1.171 . . . . 0.0 109.437 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.2 tpt -125.69 -60.38 1.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 111.291 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.829 HG13 ' HD2' ' A' ' 93' ' ' PRO . 11.8 p -114.63 -30.22 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.882 -1.137 . . . . 0.0 111.312 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.64 -65.83 0.59 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.006 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 91' ' ' VAL . 49.0 Cg_endo -71.1 -24.76 23.28 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.811 1.427 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -74.3 -35.47 63.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.445 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLY . 64.5 tt0 -78.62 -39.76 36.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.42 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 17.5 pt-20 -63.42 -25.04 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.779 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -88.45 -46.15 9.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.123 -0.986 . . . . 0.0 111.174 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.37 -35.21 75.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.465 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG11 ' A' ' 38' ' ' VAL . 27.2 m-85 -100.85 -1.04 35.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.85 -1.156 . . . . 0.0 111.818 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -99.45 -26.12 14.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.706 -1.246 . . . . 0.0 110.502 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 127' ' ' VAL . 14.4 tp -45.37 135.35 5.61 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.013 . . . . 0.0 110.001 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.44 141.29 42.09 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.974 1.513 . . . . 0.0 110.47 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 103' ' ' VAL . 6.6 p -131.0 101.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' OG ' ' HG2' ' A' ' 108' ' ' LYS . 96.6 p -119.12 8.94 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.38 -123.85 5.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.81 16.74 25.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -1.228 . . . . 0.0 110.388 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -104.32 8.98 36.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HG2' ' OG ' ' A' ' 104' ' ' SER . 74.8 mmtt -122.53 157.58 58.8 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.71 166.23 30.11 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.97 1.51 . . . . 0.0 110.017 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 127' ' ' VAL . 33.7 m -106.74 -14.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.542 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.621 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 3.6 p90 -128.68 177.63 6.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.723 -1.236 . . . . 0.0 111.472 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.545 ' C ' ' HA ' ' A' ' 114' ' ' PRO . 3.2 p -71.58 -105.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.46 -0.775 . . . . 0.0 111.708 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.909 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 28.0 m-20 -79.8 -29.11 0.55 Allowed Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.909 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 38.2 Cg_endo -76.78 -26.04 10.1 Favored 'Cis proline' 0 N--CA 1.487 1.129 0 C-N-CA 124.169 -1.179 . . . . 0.0 115.075 2.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.2 Cg_endo -69.18 121.39 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-O 121.69 0.621 . . . . 0.0 112.422 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 2.9 t -97.5 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HD3' HD13 ' A' ' 51' ' ' ILE . 37.5 mtmm -103.91 112.96 26.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.027 . . . . 0.0 110.253 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.648 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 14.6 p -138.36 166.36 24.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 110.663 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -66.43 -9.35 33.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.648 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.2 OUTLIER -105.78 21.88 16.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.839 -1.163 . . . . 0.0 110.312 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.59 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 108.71 -173.51 17.68 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.855 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 21.3 m-30 -98.97 150.55 21.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.615 ' HE1' HD11 ' A' ' 44' ' ' LEU . 33.3 m-70 -138.31 127.45 24.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.534 -1.354 . . . . 0.0 112.631 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mp -106.83 105.2 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.052 HG22 ' HB2' ' A' ' 42' ' ' HIS . 34.3 pt -108.76 141.47 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 16.7 ttt -119.07 141.87 48.37 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 127' ' ' VAL . 23.3 m -113.5 105.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.0 110.846 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 63.2 tt0 -111.44 132.98 54.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.782 . . . . 0.0 109.674 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 73.31 80.21 0.46 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -110.23 146.64 35.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.518 -0.99 . . . . 0.0 109.712 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 1.3 mmmm . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.055 -1.028 . . . . 0.0 110.288 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 10.4 p30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.532 0.682 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 84' ' ' TRP . . . -112.32 166.59 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.403 -0.81 . . . . 0.0 110.825 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' MET . 26.8 m -138.72 148.43 24.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.709 -0.62 . . . . 0.0 109.808 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' CE ' ' HD2' ' A' ' 130' ' ' ARG . 26.5 mttt -98.64 114.3 26.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 108.74 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 78.5 t -114.61 136.36 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 45.7 ttp180 -130.82 118.35 20.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.919 ' HB2' HG22 ' A' ' 125' ' ' ILE . 4.3 p80 -128.15 177.65 6.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.713 -1.242 . . . . 0.0 112.068 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG21 ' HB3' ' A' ' 71' ' ' TYR . 46.1 mt -126.49 140.69 48.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 1.3 tt -112.32 127.05 55.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.48 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 56.8 m -132.06 138.79 48.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 109.859 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 72.1 mt-10 -59.63 155.58 15.28 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.003 -1.061 . . . . 0.0 108.786 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 4.1 tttt -80.42 118.77 22.34 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.027 -1.046 . . . . 0.0 113.101 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.626 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 8.0 m80 -135.2 1.75 2.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.585 -0.697 . . . . 0.0 110.384 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.16 5.38 73.08 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 18.4 ptpt -99.71 22.17 11.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.745 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 69.6 mt -49.28 -53.1 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.419 -0.801 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.54 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 44.0 ttm -59.38 -34.39 72.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 81.2 mm-40 -63.15 -41.84 99.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -64.75 -52.35 57.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 0.0 110.67 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' ' CB ' ' A' ' 58' ' ' LEU . 2.6 ppp? -69.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 52' ' ' MET . 32.9 mm-40 -68.13 -33.03 73.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.003 -1.061 . . . . 0.0 108.909 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HG2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -87.55 -14.82 39.2 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.91 -29.64 61.03 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.746 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 58' ' ' LEU . 13.0 ptpt -30.9 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.43 0.633 . . . . 0.0 111.385 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -52.4 -42.92 64.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.356 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -45.97 -26.57 2.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.504 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 6.5 tpt -106.44 150.33 26.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -1.137 . . . . 0.0 110.296 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 66' ' ' GLU . 3.3 ptm180 -75.23 109.61 8.88 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.306 1.051 . . . . 0.0 110.72 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.681 ' CE1' HD21 ' A' ' 58' ' ' LEU . 84.2 t80 -41.96 -36.31 1.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.743 -0.598 . . . . 0.0 109.665 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -58.64 -44.62 90.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 110.664 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 35.7 tt0 -65.04 -48.68 72.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.052 . . . . 0.0 110.812 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 58' ' ' LEU . 27.4 m -63.68 -44.12 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.081 -1.448 . . . . 0.0 109.493 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -63.31 -39.42 94.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 109.571 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.69 71.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.436 -0.79 . . . . 0.0 109.699 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -80.31 -7.14 58.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.594 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m-30 -108.79 9.0 26.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 109.858 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.7 t -80.8 83.52 6.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.174 -0.954 . . . . 0.0 111.251 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -99.54 7.02 45.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ARG . 18.8 p30 -104.1 41.46 1.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.686 -0.634 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -50.4 -42.04 53.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 110.586 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 9.38 28.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.6 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 74' ' ' ASP . 2.6 ttt180 -105.29 -15.12 15.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 55.58 55.98 6.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -116.48 25.43 9.16 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -82.74 -60.0 2.14 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 9.5 p-10 -133.5 133.57 42.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.29 . . . . 0.0 111.059 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 82' ' ' LEU . 5.1 mp -104.04 157.07 17.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.849 . . . . 0.0 109.212 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 -127.92 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.177 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 23.5 m-90 -90.92 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.872 -0.781 . . . . 0.0 110.611 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.754 ' O ' HG22 ' A' ' 38' ' ' VAL . 13.9 mmt -132.14 140.82 48.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 87' ' ' ARG . 8.9 t -110.37 -45.49 3.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.314 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' N ' HG23 ' A' ' 86' ' ' THR . 2.2 mmp_? -117.4 1.9 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.443 -0.786 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.557 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 72.8 146.47 0.71 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 38.8 p -146.37 40.67 1.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.594 -1.533 . . . . 0.0 111.541 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.616 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 2.1 tpt -125.48 137.02 53.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.033 -1.042 . . . . 0.0 110.123 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' C ' ' A' ' 90' ' ' MET . 5.8 m 35.0 -110.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.748 -0.595 . . . . 0.0 111.149 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 93' ' ' PRO . . . -148.78 -67.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.432 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 92' ' ' GLY . 38.2 Cg_endo -64.08 -14.07 41.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.709 1.373 . . . . 0.0 110.813 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 90' ' ' MET . 68.5 t80 -68.27 -47.03 68.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.057 -1.027 . . . . 0.0 109.56 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 14.5 mt-30 -71.05 -41.48 70.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 109.285 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.9 mm-40 -58.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.491 -0.756 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.11 -41.41 81.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.449 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -50.19 -51.8 40.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.702 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.41 -1.39 57.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 0.0 111.118 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -116.92 12.2 14.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.85 -1.156 . . . . 0.0 110.891 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.932 HD22 HG22 ' A' ' 112' ' ' THR . 52.5 mt -37.53 97.66 0.14 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.564 -0.71 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.462 ' N ' ' O ' ' A' ' 100' ' ' ALA . 49.6 Cg_endo -77.09 -2.15 12.37 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.041 1.548 . . . . 0.0 110.448 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 104' ' ' SER . 11.7 p -69.56 -44.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.681 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.591 ' N ' HG13 ' A' ' 103' ' ' VAL . 44.1 m -142.54 -42.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 110.282 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.3 -80.27 0.87 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 79.1 mtp -63.96 -42.63 97.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -1.189 . . . . 0.0 109.953 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' C ' ' CD ' ' A' ' 109' ' ' PRO . 94.5 m-20 -107.1 81.86 1.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -116.73 42.9 0.38 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.364 -0.835 . . . . 0.0 111.225 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 50.0 Cg_endo -75.09 -6.85 18.51 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.468 1.247 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.57 HG12 ' HD1' ' A' ' 111' ' ' PHE . 2.1 t -102.33 -140.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 0.0 109.905 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' A' ' 110' ' ' VAL . 33.8 p90 -124.86 156.11 38.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.012 -1.055 . . . . 0.0 110.425 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.932 HG22 HD22 ' A' ' 101' ' ' LEU . 24.8 p -46.16 124.51 5.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.542 -0.724 . . . . 0.0 111.08 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 34.1 t0 -133.35 119.75 15.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 50.7 Cg_endo -79.11 174.33 51.2 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.12 -2.033 . . . . 0.0 110.163 -0.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 124' ' ' ILE . 46.5 Cg_endo -72.12 177.33 7.31 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.863 1.454 . . . . 0.0 109.993 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.32 158.98 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 10.9 ptmm? -119.64 136.23 54.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.587 ' HB ' ' CE2' ' A' ' 120' ' ' PHE . 74.3 p -142.13 168.62 19.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.998 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.62 -23.69 59.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 15.2 p90 -98.81 46.22 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 84.08 175.65 50.9 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 41.8 p90 -98.53 166.12 11.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -1.112 . . . . 0.0 108.844 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 120' ' ' PHE . 22.8 m-70 -141.77 140.49 33.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.802 -1.186 . . . . 0.0 112.624 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.9 HD11 HD23 ' A' ' 58' ' ' LEU . 5.1 pt -128.1 110.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 42' ' ' HIS . 12.0 pt -106.98 149.61 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.055 -1.028 . . . . 0.0 112.867 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 49.5 mtp -107.0 124.43 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.46 107.78 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 111.319 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.35 -3.36 27.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.422 -0.799 . . . . 0.0 109.4 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 58.39 -164.54 8.34 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.498 ' HD2' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tpm_? -134.26 -35.45 0.93 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.776 -0.838 . . . . 0.0 109.894 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' A' ' 36' ' ' ASN . 23.7 mttt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.35 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 23.2 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.082 0.468 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -86.86 129.46 34.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.986 -1.071 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 22.9 m -144.1 151.12 16.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.917 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 2.3 tmtt? -96.11 124.27 40.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.049 -1.032 . . . . 0.0 108.858 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 82' ' ' LEU . 42.9 t -119.75 132.55 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.022 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 53.0 mtm180 -120.25 112.35 18.94 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.081 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.7 p80 -134.86 158.82 43.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.518 -1.364 . . . . 0.0 113.047 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.765 HG21 ' HA ' ' A' ' 68' ' ' ALA . 7.8 pt -119.82 133.42 66.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.0 tt -106.28 136.09 46.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.462 0.649 . . . . 0.0 111.719 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 26.0 m -142.57 144.88 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.975 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.644 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt-10 -59.0 172.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.062 -1.024 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 9.1 ttmt -105.48 113.18 26.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.686 -1.259 . . . . 0.0 113.29 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.644 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 1.5 m80 -134.3 26.56 3.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.56 9.21 82.02 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 ttmt -90.76 -10.65 42.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.622 -0.928 . . . . 0.0 109.975 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.57 HG23 ' N ' ' A' ' 52' ' ' MET . 16.4 tt -44.2 -42.72 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.464 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.57 ' N ' HG23 ' A' ' 51' ' ' ILE . 11.9 ttt -67.09 -29.73 69.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.0 109.139 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' LYS . 65.7 tt0 -72.2 -42.92 65.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.356 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . . . -56.81 -49.85 74.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.787 . . . . 0.0 110.164 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 22.1 ptm -74.1 -22.43 59.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 32.2 tp10 -69.92 -38.03 76.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -80.78 -25.65 37.75 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 124' ' ' ILE . 35.4 tp -76.2 -44.34 38.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.564 0.697 . . . . 0.0 109.275 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 32.1 mtmt 48.43 -112.51 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.598 -0.689 . . . . 0.0 111.081 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.7 p -78.79 -14.37 59.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.954 -1.091 . . . . 0.0 110.261 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 103.33 0.32 47.17 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 61' ' ' GLY . 56.8 ttp -44.72 -34.65 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.268 . . . . 0.0 109.641 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' PHE . 10.6 mtp180 -112.89 19.38 17.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.56 ' HD1' HD11 ' A' ' 58' ' ' LEU . 87.1 t80 -43.72 -40.36 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.786 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 28.9 p-10 -66.12 -40.37 90.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 43.5 mm-40 -70.59 -43.36 69.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 0.0 109.491 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 18.4 t -69.79 -41.02 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.573 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.765 ' HA ' HG21 ' A' ' 43' ' ' ILE . . . -63.68 -43.33 96.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 110.226 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.45 94.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.56 -9.1 59.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 43' ' ' ILE . 8.5 m-85 -111.82 5.51 19.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.942 . . . . 0.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.2 m -73.86 87.44 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 2.6 tm-20 -101.41 32.04 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.59 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 77' ' ' ARG . 78.6 m-20 -100.13 83.55 2.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.564 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' GLN . 14.8 tptt -70.79 -52.21 22.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 111.087 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 77' ' ' ARG . . . -77.05 -13.14 60.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.111 -0.993 . . . . 0.0 110.599 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.543 ' N ' ' CD ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -102.42 -48.6 4.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.129 -0.982 . . . . 0.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 38.1 mm-40 51.56 34.73 13.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 110.035 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -93.64 -55.87 1.49 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 67.86 -64.41 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.595 ' C ' HD12 ' A' ' 82' ' ' LEU . 75.5 m-20 -116.47 131.02 57.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.693 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 81' ' ' ASP . 8.3 mp -102.78 139.86 37.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -71.8 -138.47 0.23 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' HB2' ' A' ' 39' ' ' LYS . 1.5 m95 -91.58 134.18 34.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.467 -1.02 . . . . 0.0 110.343 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.509 ' CE ' ' HA3' ' A' ' 88' ' ' GLY . 21.2 ptm -134.01 150.75 51.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 47.3 p -101.56 -38.67 7.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.953 -1.092 . . . . 0.0 110.126 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -114.01 -92.58 0.49 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.396 -0.815 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' HA3' ' CE ' ' A' ' 85' ' ' MET . . . 73.14 75.12 0.75 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.1 m -110.86 93.28 4.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -31.15 8.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -150.6 -171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.044 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.491 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -88.33 -56.5 2.02 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.314 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -66.55 -29.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.372 1.196 . . . . 0.0 112.343 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 91' ' ' VAL . 32.5 t80 -69.18 -43.4 74.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.71 -1.244 . . . . 0.0 110.756 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' OE1' ' CD1' ' A' ' 99' ' ' PHE . 7.7 tp-100 -72.52 -52.07 17.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.904 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.988 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 mt-10 -59.94 -20.97 60.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.149 -0.969 . . . . 0.0 110.912 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -82.76 -59.24 2.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.905 -1.122 . . . . 0.0 110.557 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.84 -59.31 5.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 111.278 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CD1' ' OE1' ' A' ' 95' ' ' GLN . 29.2 m-85 -74.3 -28.32 61.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 111.236 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -118.11 34.97 4.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.909 -1.119 . . . . 0.0 110.764 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 112' ' ' THR . 8.8 tp -56.68 142.69 70.73 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.113 -0.992 . . . . 0.0 110.345 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.591 ' HD2' HD12 ' A' ' 101' ' ' LEU . 46.1 Cg_endo -71.31 -178.11 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.819 1.431 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.7 t -53.75 122.8 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' HD21 ' A' ' 101' ' ' LEU . 20.1 m -136.61 84.35 2.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.374 -0.829 . . . . 0.0 109.683 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.82 -149.54 33.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 37.4 ttm -66.27 -45.09 81.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.031 -1.276 . . . . 0.0 108.52 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -141.55 -96.32 0.13 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 34.7 mttm -134.15 42.29 0.79 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 47.5 Cg_endo -73.49 -0.93 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.491 1.259 . . . . 0.0 110.792 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' CG2' ' HB3' ' A' ' 104' ' ' SER . 34.5 m -128.65 -156.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.568 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 58' ' ' LEU . 29.2 p90 -119.08 165.03 14.66 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.527 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.967 HG22 HD13 ' A' ' 101' ' ' LEU . 46.0 p -48.22 113.62 0.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 110.776 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 37.3 p-10 -132.26 120.61 17.15 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.765 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.3 Cg_endo -68.77 165.26 74.1 Favored 'Cis proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.769 -2.179 . . . . 0.0 110.248 0.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 1.083 ' HB3' HG22 ' A' ' 124' ' ' ILE . 45.1 Cg_endo -70.46 -179.88 3.56 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.926 1.487 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.8 134.33 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.269 -0.895 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HB2' ' CE ' ' A' ' 47' ' ' LYS . 10.0 ptpt -109.65 126.99 54.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.821 . . . . 0.0 109.187 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.604 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 44.0 p -130.33 -177.6 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.039 -1.038 . . . . 0.0 111.013 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -69.53 -18.8 63.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -0.772 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 p90 -100.36 32.58 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.044 . . . . 0.0 109.88 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.578 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 97.68 177.04 33.96 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 45' ' ' CYS . 53.8 p90 -99.74 162.21 13.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -1.179 . . . . 0.0 109.301 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 7.6 m-70 -141.69 151.49 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.001 -1.062 . . . . 0.0 112.238 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.083 HG22 ' HB3' ' A' ' 115' ' ' PRO . 1.8 pt -133.94 118.92 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.081 HG22 ' HB2' ' A' ' 42' ' ' HIS . 8.2 pt -121.56 142.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.673 -1.267 . . . . 0.0 112.83 -176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 34.8 mmm -97.43 125.04 41.83 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 108' ' ' LYS . 42.9 t -113.16 121.36 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.664 -1.273 . . . . 0.0 111.889 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 39' ' ' LYS . 8.7 pt-20 -115.16 -22.17 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.444 -0.785 . . . . 0.0 109.527 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 38' ' ' VAL . . . 80.9 -167.47 49.9 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.608 ' HD3' ' CE3' ' A' ' 84' ' ' TRP . 12.7 tpt180 -132.66 -75.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.983 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.103 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 36' ' ' ASN . 3.6 p30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.459 0.647 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 86' ' ' THR . . . -130.84 150.98 51.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 110.257 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -111.39 164.93 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HD3' ' CE2' ' A' ' 84' ' ' TRP . 30.0 mtmt -99.05 117.35 33.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 109.544 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 13.1 t -116.67 133.25 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 110.763 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -141.49 113.04 7.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.96 ' CB ' HG22 ' A' ' 125' ' ' ILE . 5.0 p80 -132.16 -179.29 5.33 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.98 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 124' ' ' ILE . 5.2 mt -124.31 117.43 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -102.15 120.19 40.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.864 -1.147 . . . . 0.0 110.596 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.578 ' SG ' HG22 ' A' ' 43' ' ' ILE . 5.4 m -133.54 155.59 49.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.042 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.62 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.27 -163.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.835 -1.165 . . . . 0.0 110.561 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -92.48 106.43 18.42 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.374 -0.829 . . . . 0.0 110.739 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 17.9 m-70 -123.27 -2.83 8.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.7 27.89 73.52 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -107.17 8.97 30.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.54 -0.976 . . . . 0.0 110.11 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 115' ' ' PRO . 75.9 mt -41.23 -43.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.02 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -31.94 72.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 2.1 tp10 -76.18 -37.36 57.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.412 -0.805 . . . . 0.0 110.109 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.83 -52.69 64.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.433 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 14.0 ptm -66.55 -35.46 80.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.387 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 55' ' ' MET . 26.8 tt0 -70.15 -36.06 74.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.55 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -71.0 -35.7 72.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.778 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 59' ' ' LYS . 4.6 pp -97.14 -46.12 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 110.823 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.918 ' N ' HD12 ' A' ' 58' ' ' LEU . 13.4 mttt 37.87 -157.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.0 t -103.01 7.8 39.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.029 -1.044 . . . . 0.0 110.352 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.89 -40.07 0.67 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 33.7 mmt -67.44 166.79 13.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -1.149 . . . . 0.0 110.37 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.3 mtt85 -72.02 97.97 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.439 -0.788 . . . . 0.0 110.715 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -52.33 -31.48 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.25 -35.71 71.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.346 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 43.7 tt0 -63.62 -39.1 93.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.567 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.869 HG21 ' HB3' ' A' ' 58' ' ' LEU . 30.5 t -68.61 -45.75 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.663 -0.648 . . . . 0.0 110.299 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -59.18 -47.98 83.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.36 79.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 111.013 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.1 mm-40 -83.92 -23.54 31.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.026 -1.046 . . . . 0.0 111.395 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' CD2' HG13 ' A' ' 67' ' ' VAL . 21.9 m-30 -112.86 18.79 17.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.933 -1.104 . . . . 0.0 110.677 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -89.15 112.59 23.63 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.75 -4.95 29.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 80' ' ' GLY . 58.5 p30 -104.67 33.77 3.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.708 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -52.89 -41.01 63.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 110.21 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.56 90.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 mtt85 -85.61 -11.33 54.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.158 -0.964 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 58.21 30.58 19.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 110.747 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.748 ' O ' HD11 ' A' ' 82' ' ' LEU . . . -68.83 -25.6 75.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.509 ' N ' ' OD2' ' A' ' 74' ' ' ASP . . . -49.73 -34.3 21.12 Favored Glycine 0 N--CA 1.489 2.19 0 O-C-N 121.127 -1.219 . . . . 0.0 110.391 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' C ' HD12 ' A' ' 82' ' ' LEU . 7.5 t0 -134.59 109.21 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.784 -1.421 . . . . 0.0 111.483 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.825 ' N ' HD12 ' A' ' 82' ' ' LEU . 5.3 mp -100.48 145.06 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.65 -141.27 4.54 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.536 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CE2' ' HD3' ' A' ' 39' ' ' LYS . 77.5 m95 -81.82 100.67 9.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.899 -0.765 . . . . 0.0 109.678 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' MET . 1.8 ptp -139.04 146.66 41.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.011 -1.056 . . . . 0.0 111.149 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -126.3 -0.0 7.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.564 -0.71 . . . . 0.0 109.301 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -90.43 -175.48 4.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.473 ' CA ' ' NE2' ' A' ' 95' ' ' GLN . . . -99.05 124.73 8.32 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.45 -9.98 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.084 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.736 ' HE2' ' CE2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -136.28 -165.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.77 151.74 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.982 -1.074 . . . . 0.0 111.05 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -169.14 19.81 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 40.5 Cg_endo -66.96 -11.23 31.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.161 1.611 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.736 ' CE2' ' HE2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -57.39 -58.38 8.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.107 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 46.4 tt0 -72.1 -40.61 68.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.737 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 31.8 tt0 -64.05 -40.53 96.5 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 93' ' ' PRO . . . -66.26 -56.03 13.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.124 -0.985 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.72 -47.47 5.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.627 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 99' ' ' PHE . 10.5 m-30 -94.87 17.94 12.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.134 -0.978 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -111.24 -21.9 11.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.047 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 103' ' ' VAL . 72.4 mt -49.0 131.32 15.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.03 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.77 -17.84 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.92 1.484 . . . . 0.0 110.507 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 101' ' ' LEU . 29.0 m -67.51 129.18 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 61.9 p -126.1 16.36 7.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.009 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 140.16 15.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -93.25 -5.83 48.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -1.102 . . . . 0.0 110.279 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' OD1' ' HG3' ' A' ' 108' ' ' LYS . 44.6 p-10 -101.35 6.25 42.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.76 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HG3' ' OD1' ' A' ' 107' ' ' ASP . 28.8 mtmt -127.11 62.03 50.64 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.983 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.504 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 46.6 Cg_endo -71.06 124.55 10.65 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.949 1.499 . . . . 0.0 110.344 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 111' ' ' PHE . 64.1 t -142.5 164.43 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 23.9 p90 -114.31 164.42 13.94 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.333 -0.854 . . . . 0.0 109.687 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 125' ' ' ILE . 30.4 p -63.5 109.42 1.63 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 111.654 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.592 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 25.8 p-10 -132.66 113.11 13.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.1 Cg_endo -68.07 166.55 67.19 Favored 'Cis proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.343 0.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.661 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -71.45 -174.79 1.33 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.086 1.572 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 118' ' ' THR . 66.6 t -101.66 136.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.753 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -110.21 120.12 41.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.855 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.659 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 51.2 p -130.69 170.64 14.05 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.721 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -70.25 -14.65 62.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.408 -0.807 . . . . 0.0 110.554 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.659 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -91.57 5.15 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.834 179.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 126.91 -169.84 18.78 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.555 ' CE2' HG13 ' A' ' 51' ' ' ILE . 18.1 m-30 -99.59 159.26 15.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -1.083 . . . . 0.0 108.609 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.432 ' CE1' ' HD2' ' A' ' 120' ' ' PHE . 67.0 m-70 -143.44 110.13 5.53 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.783 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 43' ' ' ILE . 4.4 mp -100.52 111.71 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.96 HG22 ' CB ' ' A' ' 42' ' ' HIS . 33.6 pt -115.67 142.76 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.557 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.504 ' HE3' ' HB2' ' A' ' 109' ' ' PRO . 12.4 tpt -115.11 124.02 50.46 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 101' ' ' LEU . 22.1 t -105.96 131.08 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.107 -0.996 . . . . 0.0 111.373 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 71.1 mt-10 -141.98 143.56 33.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.51 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 128' ' ' GLU . . . 56.9 117.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -113.68 156.68 23.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -1.216 . . . . 0.0 110.137 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.587 ' H ' HG12 ' A' ' 38' ' ' VAL . 13.0 pttm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.326 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB3' ' CB ' ' A' ' 131' ' ' LYS . . . -79.13 115.5 18.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.852 -1.155 . . . . 0.0 109.596 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 13.9 p -127.97 160.91 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 8.7 mttt -98.82 128.96 45.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.373 -0.83 . . . . 0.0 109.61 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 72.8 t -109.82 129.97 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.372 -0.83 . . . . 0.0 111.45 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 83.2 mtt180 -120.69 125.14 46.92 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.621 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -134.98 172.61 12.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 0.0 112.351 -178.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CG2' ' HB3' ' A' ' 71' ' ' TYR . 58.9 mt -126.79 116.58 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.723 HD22 ' OD2' ' A' ' 74' ' ' ASP . 4.6 tt -102.56 124.07 47.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.901 -1.124 . . . . 0.0 111.629 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 122' ' ' TYR . 19.0 m -142.77 160.42 40.35 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.591 ' O ' ' CE2' ' A' ' 122' ' ' TYR . 87.1 mt-10 -71.7 172.31 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.903 -1.123 . . . . 0.0 109.789 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 74.6 tttt -93.12 111.4 23.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.851 -1.156 . . . . 0.0 112.547 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.584 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 5.8 m-70 -132.43 9.61 4.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.47 -8.79 77.96 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 51' ' ' ILE . 7.6 tttp -73.81 -15.44 61.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.708 -0.878 . . . . 0.0 109.611 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 52' ' ' MET . 10.8 tt -40.5 -44.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.798 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.587 ' N ' HG23 ' A' ' 51' ' ' ILE . 50.8 ttp -65.38 -42.61 92.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.25 -0.906 . . . . 0.0 109.542 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 67.0 tt0 -56.49 -44.19 80.43 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.268 -0.895 . . . . 0.0 109.147 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.37 -60.76 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.592 ' HA ' HD11 ' A' ' 58' ' ' LEU . 52.7 ttp -59.93 -33.38 71.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.557 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 45.1 tt0 -62.93 -33.92 76.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 108.793 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.85 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.9 tptt -62.55 -45.68 91.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.493 -0.754 . . . . 0.0 109.185 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 pp -108.76 27.61 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.384 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 56' ' ' GLU . 36.4 tttp -54.74 -60.13 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.398 0.618 . . . . 0.0 110.722 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.4 m -81.37 33.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 74.16 25.59 70.66 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.555 ' CB ' ' HA ' ' A' ' 58' ' ' LEU . 3.7 ttm -53.79 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.837 -1.39 . . . . 0.0 109.572 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CG ' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -70.69 78.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.998 -1.064 . . . . 0.0 111.288 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' ' SD ' ' A' ' 126' ' ' MET . 5.2 t80 -46.65 -27.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.865 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.565 ' OD1' ' CG ' ' A' ' 63' ' ' ARG . 33.9 p-10 -67.68 -46.91 70.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.219 . . . . 0.0 110.092 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 83.9 mt-10 -63.27 -32.47 73.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 109.496 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 57' ' ' LYS . 45.8 t -61.55 -53.63 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -51.11 -60.5 3.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.952 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.48 19.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.802 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' N ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -71.32 -26.71 62.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 48.6 m-85 -111.04 30.05 7.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.385 -0.822 . . . . 0.0 110.282 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 68' ' ' ALA . 43.4 t -100.21 101.95 13.11 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.095 -1.003 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -101.72 2.25 38.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.723 ' OD2' HD22 ' A' ' 44' ' ' LEU . 15.3 m-20 -116.69 30.75 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.741 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -67.42 -23.86 65.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.78 . . . . 0.0 110.255 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.4 -56.34 21.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.143 -0.973 . . . . 0.0 109.181 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 4.2 ttm180 -96.31 -52.01 4.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.482 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 9.6 pt20 179.96 133.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.656 -0.653 . . . . 0.0 109.866 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.39 96.72 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.96 -85.96 0.1 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 95.5 m-20 -121.19 137.2 54.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -1.169 . . . . 0.0 110.731 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.9 mp -100.56 163.55 12.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.822 . . . . 0.0 109.577 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -73.17 -143.68 0.61 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 94.1 m95 -82.78 160.53 22.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.496 -1.002 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -138.13 143.8 40.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.0 109.799 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.598 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.4 t -131.34 -46.43 0.99 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.941 -1.099 . . . . 0.0 111.689 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' N ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -117.48 -5.98 11.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.667 -1.271 . . . . 0.0 112.807 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . 118.65 -168.31 13.21 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 118.949 -1.595 . . . . 0.0 110.611 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 90' ' ' MET . 26.2 t -125.68 -88.8 0.58 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.614 -0.933 . . . . 0.0 110.708 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' GLY . 65.9 mtm -147.43 -85.49 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.046 -1.034 . . . . 0.0 112.87 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -9.0 -58.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' MET . . . 125.34 -72.43 0.44 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.538 -1.351 . . . . 0.0 109.811 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 38.1 Cg_endo -63.42 -37.14 50.94 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.851 1.448 . . . . 0.0 109.333 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.492 ' H ' HG12 ' A' ' 91' ' ' VAL . 74.9 t80 -60.09 -33.78 72.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.561 0.696 . . . . 0.0 109.259 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 38.0 tt0 -75.64 -45.06 39.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.562 -0.711 . . . . 0.0 110.148 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.793 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 46.6 mt-10 -55.62 -42.68 75.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.0 110.566 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -81.02 -58.7 2.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.509 -1.37 . . . . 0.0 110.711 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.41 27.09 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.83 -1.169 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 85' ' ' MET . 2.4 t80 -117.9 -46.92 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.558 -1.339 . . . . 0.0 112.435 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -76.26 -11.18 59.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.841 -1.162 . . . . 0.0 111.575 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 4.2 tp -55.6 141.61 63.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.826 -1.171 . . . . 0.0 109.425 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.433 ' HD2' ' HG ' ' A' ' 101' ' ' LEU . 42.2 Cg_endo -68.88 134.56 30.2 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.948 1.499 . . . . 0.0 110.947 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 103' ' ' VAL . 28.3 m -112.37 117.42 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.426 -0.796 . . . . 0.0 110.025 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.4 m -138.88 76.57 1.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.306 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.72 -24.72 13.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mmm -75.34 -22.96 57.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -1.212 . . . . 0.0 110.447 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -113.98 -56.02 2.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 110.787 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.472 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 6.0 pttm -131.98 164.2 44.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.401 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 108' ' ' LYS . 47.3 Cg_endo -71.57 175.06 10.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.968 1.509 . . . . 0.0 110.357 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.06 33.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 21.0 t80 -108.72 134.41 51.47 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.326 -0.859 . . . . 0.0 109.801 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 115' ' ' PRO . 6.5 m -53.65 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 110.418 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 26.3 p-10 -133.03 113.52 13.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.58 163.3 90.07 Favored 'Cis proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.073 -2.053 . . . . 0.0 110.382 -0.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.72 ' HA ' HG22 ' A' ' 112' ' ' THR . 46.7 Cg_endo -72.87 -179.66 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.99 1.521 . . . . 0.0 110.054 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.6 161.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.005 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 13.8 ptmt -129.93 119.46 23.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.578 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 39.5 p -122.94 -177.16 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.84 -1.162 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -71.49 -16.69 62.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 0.0 110.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -98.87 27.13 5.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.909 -1.119 . . . . 0.0 109.301 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 103.18 179.69 26.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 52.6 p90 -99.22 159.22 15.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.302 . . . . 0.0 109.797 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.59 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 34.8 m-70 -132.66 140.17 48.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.692 ' N ' HD12 ' A' ' 124' ' ' ILE . 3.7 mp -115.55 136.99 50.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.42 ' HB ' ' OG1' ' A' ' 112' ' ' THR . 0.7 OUTLIER -132.98 147.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.32 -1.488 . . . . 0.0 112.066 -177.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.569 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 13.6 ttt -127.17 135.09 50.19 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.55 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.938 -1.101 . . . . 0.0 111.077 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -141.69 160.82 39.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.674 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 78.62 81.38 0.69 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.496 ' HD2' ' OXT' ' A' ' 131' ' ' LYS . 8.5 tmm_? -97.1 142.73 28.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 110.402 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.787 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . 9.6 tttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' THR . 12.3 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.083 0.468 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . . . -131.86 143.42 50.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 0.0 110.684 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 39' ' ' LYS . 7.4 p -142.7 176.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 109.91 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.04 121.97 39.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.919 -1.113 . . . . 0.0 108.353 178.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 77.2 t -108.2 138.27 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.05 0.929 . . . . 0.0 112.946 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -140.76 117.0 10.63 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 1.2 p80 -138.61 -175.04 3.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.446 -1.409 . . . . 0.0 112.565 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 67' ' ' VAL . 73.8 mt -130.91 114.31 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.621 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 5.3 tt -104.54 117.27 33.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 110.555 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 122' ' ' TYR . 41.7 t -142.52 152.06 42.27 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.223 -0.923 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.635 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 18.9 pt-20 -52.5 153.63 2.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 109.372 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.562 ' N ' ' HA2' ' A' ' 121' ' ' GLY . 3.1 tptt -127.24 113.44 16.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.84 -1.163 . . . . 0.0 111.79 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.7 m-70 -133.29 -60.74 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.063 0.935 . . . . 0.0 108.584 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -162.33 25.71 0.23 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -116.14 -10.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.555 -0.968 . . . . 0.0 110.148 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -51.08 -32.61 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -0.799 . . . . 0.0 110.444 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.516 ' O ' ' HG2' ' A' ' 55' ' ' MET . 40.0 mtp -72.01 -34.02 68.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.975 -1.078 . . . . 0.0 109.553 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -74.51 -32.5 62.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.331 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 71' ' ' TYR . . . -67.02 -39.94 87.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.643 -0.661 . . . . 0.0 109.986 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.605 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 4.0 ptt? -70.8 -34.19 71.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -0.968 . . . . 0.0 109.676 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 70.4 tt0 -57.72 -50.48 73.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.603 ' C ' HG21 ' A' ' 67' ' ' VAL . 34.0 mmtt -71.16 -21.16 62.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.903 . . . . 0.0 108.943 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.048 HD22 HD13 ' A' ' 124' ' ' ILE . 39.5 tp -75.77 -15.49 60.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.647 -0.658 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 29.1 mmmt -40.0 136.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.816 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -50.01 -30.4 10.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.98 -21.81 25.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -111.25 157.51 20.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 0.0 110.036 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 65' ' ' ASN . 24.3 ttm180 -66.45 105.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 0.0 111.192 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 58' ' ' LEU . 34.6 t80 -46.82 -30.42 2.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 109.62 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 63' ' ' ARG . 38.9 t30 -64.11 -43.37 95.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -62.21 -43.21 99.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 57' ' ' LYS . 1.9 t -63.14 -42.73 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.914 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -64.91 -43.62 92.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.46 -48.73 76.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 0.0 110.993 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.429 ' CA ' HE21 ' A' ' 70' ' ' GLN . 0.0 OUTLIER -72.1 -30.03 64.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.001 -1.062 . . . . 0.0 111.044 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 54' ' ' ALA . 22.2 m-85 -100.35 15.3 28.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.514 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.1 p -73.93 91.9 2.05 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 50.4 tt0 -101.41 10.62 40.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.11 . . . . 0.0 110.283 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' O ' ' CA ' ' A' ' 78' ' ' GLN . 51.7 t0 -110.91 104.9 13.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 110.312 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.13 -42.66 31.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.359 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -38.49 78.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.558 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -111.42 0.42 16.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.334 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER 54.26 91.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 78' ' ' GLN . . . -44.69 100.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 78' ' ' GLN . . . -174.66 -115.5 0.4 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.744 ' C ' HD12 ' A' ' 82' ' ' LEU . 46.8 p-10 -117.62 142.34 47.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -1.05 . . . . 0.0 110.861 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.814 ' N ' HD12 ' A' ' 82' ' ' LEU . 6.7 mp -110.47 175.84 5.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.49 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.96 -147.63 9.12 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 23.5 m-90 -98.78 117.3 32.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.724 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 20.6 ptm -130.71 171.72 12.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.036 -1.04 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' N ' ' A' ' 87' ' ' ARG . 14.8 t -101.2 -147.95 0.36 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.513 ' N ' HG23 ' A' ' 86' ' ' THR . 33.7 ptt-85 -115.39 119.73 37.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.346 -0.846 . . . . 0.0 110.579 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' ' NE2' ' A' ' 95' ' ' GLN . . . -92.7 -157.06 33.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -141.58 52.26 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -1.151 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 11.6 tpt -100.96 -90.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.829 . . . . 0.0 109.041 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.638 HG23 ' HB3' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -77.84 132.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.024 -1.048 . . . . 0.0 108.799 178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.553 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.95 -53.49 18.79 Favored Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.654 -0.654 . . . . 0.0 112.997 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.4 Cg_endo -65.01 -42.09 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.276 1.146 . . . . 0.0 111.669 -177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 91' ' ' VAL . 56.4 t80 -65.46 -49.18 70.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.103 -0.998 . . . . 0.0 110.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.426 ' NE2' ' H ' ' A' ' 88' ' ' GLY . 12.6 mm100 -72.89 -58.84 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 111.251 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 13.1 mm-40 -53.17 -49.84 65.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.958 -1.089 . . . . 0.0 111.199 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -59.24 -57.98 10.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 0.0 110.35 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -42.11 -52.76 4.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.647 -0.658 . . . . 0.0 111.183 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -93.42 10.36 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 110.555 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -87.65 -48.07 8.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.981 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -62.54 134.14 95.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.5 -58.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.446 1.235 . . . . 0.0 110.048 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.04 134.9 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.459 -0.776 . . . . 0.0 109.885 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 110' ' ' VAL . 83.9 p -101.84 -7.93 22.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 110.0 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 108' ' ' LYS . . . -156.72 148.16 17.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 75.5 mtm -61.93 -41.14 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -1.146 . . . . 0.0 110.881 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 59.4 p30 -130.35 -10.89 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.0 111.104 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 10.5 pttm -132.2 153.26 81.23 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 0.0 110.3 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.451 ' HG3' ' HG3' ' A' ' 128' ' ' GLU . 45.7 Cg_endo -73.0 146.64 41.95 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.936 1.493 . . . . 0.0 110.582 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 111' ' ' PHE . 11.9 t -134.28 -175.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 109.69 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.705 ' H ' HG12 ' A' ' 110' ' ' VAL . 5.4 p90 -114.02 168.8 9.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.012 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 114' ' ' PRO . 26.5 m -56.78 -5.73 0.26 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 111' ' ' PHE . 9.2 p-10 -50.74 126.59 24.27 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.027 -1.671 . . . . 0.0 109.378 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' THR . 45.5 Cg_endo -70.1 134.78 31.5 Favored 'Cis proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.287 -1.964 . . . . 0.0 111.124 0.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.662 ' HG2' HD11 ' A' ' 51' ' ' ILE . 40.3 Cg_endo -66.22 -174.69 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.054 1.555 . . . . 0.0 111.289 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.3 m -108.12 157.72 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.648 . . . . 0.0 109.899 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -113.56 118.21 33.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 30.0 p -130.73 170.98 13.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 110.623 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.35 -17.69 63.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 110.224 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.6 OUTLIER -98.26 24.36 7.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.215 -0.928 . . . . 0.0 109.357 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 98.06 174.43 33.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 45' ' ' CYS . 5.3 p90 -98.49 152.0 20.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.378 -1.072 . . . . 0.0 108.567 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.621 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 3.4 m-70 -131.28 141.48 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.825 -1.172 . . . . 0.0 113.053 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.048 HD13 HD22 ' A' ' 58' ' ' LEU . 57.9 mt -115.51 112.93 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 111' ' ' PHE . 25.0 mt -102.01 144.88 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.665 -1.272 . . . . 0.0 111.065 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ARG . 7.6 tpt -121.12 111.66 17.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.9 t -94.96 102.19 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.036 -1.04 . . . . 0.0 111.65 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . 88.3 tt0 -144.66 135.02 24.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 110.648 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 132.84 7.08 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.12 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -107.74 169.25 8.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.386 -1.067 . . . . 0.0 110.323 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.534 ' CD ' ' HB3' ' A' ' 37' ' ' ALA . 45.2 mtmt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.354 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' ND2' ' HB ' ' A' ' 86' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.395 0.617 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' THR . . . -109.13 155.47 20.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.361 -0.837 . . . . 0.0 109.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 85' ' ' MET . 7.7 p -140.65 156.69 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.024 -1.048 . . . . 0.0 110.517 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD2' ' NE1' ' A' ' 84' ' ' TRP . 1.5 mppt? -100.06 126.27 46.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.098 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -125.38 113.49 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.009 . . . . 0.0 111.57 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HA ' ' CB ' ' A' ' 81' ' ' ASP . 15.3 mtp180 -114.33 115.75 27.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.839 . . . . 0.0 108.819 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.993 ' HB2' HG22 ' A' ' 125' ' ' ILE . 3.7 p80 -138.14 160.81 38.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.968 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.704 ' CG1' HG22 ' A' ' 124' ' ' ILE . 27.3 pt -116.89 124.53 73.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 45' ' ' CYS . 6.2 tt -108.53 129.96 55.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.585 . . . . 0.0 111.055 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.642 ' N ' HD23 ' A' ' 44' ' ' LEU . 32.6 t -142.62 165.42 27.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.239 -0.913 . . . . 0.0 109.985 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 83.0 mt-10 -69.13 154.1 42.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 26.9 tttm -87.88 116.62 26.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.76 -1.212 . . . . 0.0 112.834 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.5 m-70 -131.32 9.08 4.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.502 -0.749 . . . . 0.0 109.268 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.14 41.91 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -88.52 9.09 25.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.489 -1.006 . . . . 0.0 110.378 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.7 HG23 ' HG2' ' A' ' 115' ' ' PRO . 5.5 mt -48.8 -59.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.906 -1.121 . . . . 0.0 110.0 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HA ' ' SD ' ' A' ' 55' ' ' MET . 72.3 mtm -69.06 -28.12 66.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.771 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -73.98 -42.47 60.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.784 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.31 79.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.506 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 25.2 ptm -63.7 -46.18 86.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.995 . . . . 0.0 110.467 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 79.0 tt0 -56.6 -33.46 66.26 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.041 -1.037 . . . . 0.0 110.161 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.695 ' HG2' HG22 ' A' ' 67' ' ' VAL . 66.1 tttt -77.72 -27.78 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.738 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 124' ' ' ILE . 1.0 OUTLIER -104.59 16.18 26.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.871 -1.143 . . . . 0.0 110.582 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 58' ' ' LEU . 38.5 mttm -50.65 -161.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.507 -0.745 . . . . 0.0 110.438 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.2 m -87.0 154.49 20.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.574 -1.329 . . . . 0.0 110.931 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.41 -3.83 86.32 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -113.89 -168.39 1.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.065 -1.256 . . . . 0.0 110.862 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 13.5 mtm180 -95.71 95.34 8.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.411 -0.805 . . . . 0.0 110.378 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -50.65 -35.51 31.07 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.121 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 21.8 p-10 -72.98 -32.26 65.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.481 -0.762 . . . . 0.0 109.797 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.7 tt0 -58.52 -49.02 78.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 57' ' ' LYS . 59.1 t -62.94 -52.27 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 109.922 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . . . -45.2 -50.09 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.44 76.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 110.399 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.48 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.4 tp60 -74.38 -26.05 59.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.995 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -109.89 17.47 21.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.109 . . . . 0.0 110.483 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.5 t -82.1 97.5 8.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.998 -1.064 . . . . 0.0 110.4 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -100.52 1.39 40.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.378 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' HD22 ' A' ' 44' ' ' LEU . 4.0 m-20 -114.07 23.28 13.08 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.459 -0.776 . . . . 0.0 109.538 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -56.6 -35.49 68.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -39.24 68.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.891 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -106.4 -53.3 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.851 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . 54.3 mm-40 -141.01 -80.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 110.05 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.46 24.43 76.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . -144.32 -104.8 0.48 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.614 ' C ' HD12 ' A' ' 82' ' ' LEU . 27.3 p-10 -128.13 171.77 11.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -1.133 . . . . 0.0 110.322 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.1 mp -100.51 16.91 23.11 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.358 -0.838 . . . . 0.0 109.092 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.29 -134.12 33.26 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.532 ' NE1' ' HD2' ' A' ' 39' ' ' LYS . 3.4 m-90 -87.37 125.99 34.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.842 -0.799 . . . . 0.0 109.542 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.78 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.6 ttm -137.65 140.86 41.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.548 ' HB ' ' ND2' ' A' ' 36' ' ' ASN . 76.5 p -111.4 -33.03 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.438 -0.789 . . . . 0.0 109.979 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -66.71 -31.32 71.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.435 -0.791 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 99' ' ' PHE . . . 147.79 -107.01 0.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.609 ' HB3' ' CD2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -143.22 -65.78 0.38 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.403 -1.057 . . . . 0.0 109.502 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.561 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 23.0 mtp -144.08 -77.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.762 . . . . 0.0 110.951 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -175.09 166.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 0.0 110.936 -179.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . 68.36 -143.65 41.2 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 92' ' ' GLY . 40.8 Cg_endo -67.16 -35.92 23.33 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.104 1.581 . . . . 0.0 109.284 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 125' ' ' ILE . 50.5 t80 -51.17 -30.52 17.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.476 ' OE1' ' HA3' ' A' ' 88' ' ' GLY . 16.7 tp60 -83.01 -54.68 4.88 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.597 0.713 . . . . 0.0 109.225 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.61 -45.26 92.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.615 -0.678 . . . . 0.0 110.215 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.44 -52.4 53.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 110.161 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.639 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . . . -41.7 -53.88 3.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 88' ' ' GLY . 4.0 m-30 -81.43 -0.84 43.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.412 -0.805 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.505 ' C ' ' HD3' ' A' ' 102' ' ' PRO . . . -128.25 21.15 6.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.87 -1.144 . . . . 0.0 111.927 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -107.31 67.69 0.25 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.576 -1.327 . . . . 0.0 110.861 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD3' ' C ' ' A' ' 100' ' ' ALA . 47.8 Cg_endo -70.81 127.43 13.75 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.57 1.3 . . . . 0.0 110.364 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.62 142.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.178 -0.951 . . . . 0.0 110.083 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.3 p -120.85 -83.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.86 -124.34 17.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.4 ptm -113.01 -27.07 8.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -105.15 -144.04 0.37 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.614 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 13.3 mtpt -138.68 -68.75 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.876 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.701 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 48.0 Cg_endo -71.49 117.99 5.43 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 O-C-N 123.356 1.187 . . . . 0.0 111.581 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.644 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -141.86 -175.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.779 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.644 ' N ' HG13 ' A' ' 110' ' ' VAL . 38.0 p90 -114.57 164.39 14.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.8 p -74.43 117.4 16.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.515 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 13.5 p-10 -132.58 122.98 18.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 109.574 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 43.5 Cg_endo -69.07 170.27 56.31 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.232 0.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.7 ' HG2' HG23 ' A' ' 51' ' ' ILE . 47.5 Cg_endo -73.57 -175.93 2.29 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.146 1.603 . . . . 0.0 110.081 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 123' ' ' HIS . 11.4 m -100.94 147.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -0.921 . . . . 0.0 109.503 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -118.02 128.59 54.92 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.614 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 77.1 p -131.63 174.4 10.15 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -67.96 -16.95 64.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CE2' ' OG1' ' A' ' 118' ' ' THR . 1.2 p90 -96.67 28.19 3.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 109.614 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 47' ' ' LYS . . . 105.38 -166.13 14.35 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 45' ' ' CYS . 31.6 p90 -116.57 152.79 33.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.39 -1.065 . . . . 0.0 109.905 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.623 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -134.74 136.23 42.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.966 -1.084 . . . . 0.0 112.346 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.074 HD13 HD21 ' A' ' 58' ' ' LEU . 19.0 tt -121.17 108.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.993 HG22 ' HB2' ' A' ' 42' ' ' HIS . 24.9 pt -107.4 157.34 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.935 -1.103 . . . . 0.0 113.289 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 3.9 ttt -121.46 124.6 44.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 101' ' ' LEU . 16.3 m -109.74 120.88 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.649 -1.282 . . . . 0.0 111.903 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 129' ' ' GLY . 46.3 tt0 -115.29 149.21 38.19 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 48.22 95.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -131.56 150.7 52.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -1.0 . . . . 0.0 109.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 120.971 -1.081 . . . . 0.0 110.16 -179.783 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.727 ' O ' HG23 ' A' ' 86' ' ' THR . 45.7 t30 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.787 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -100.69 159.2 15.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.52 -0.737 . . . . 0.0 109.282 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.7 p -143.3 154.68 16.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.8 ttpt -98.49 125.4 43.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 74.5 t -121.97 132.56 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.833 -177.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.2 mtt180 -120.16 130.91 54.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.977 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.7 p80 -143.81 170.34 16.06 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.971 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.995 ' CD1' HG12 ' A' ' 67' ' ' VAL . 2.5 tt -124.32 113.77 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 8.1 tt -107.64 119.43 39.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 53.8 t -141.36 150.64 42.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.573 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 30.2 mt-10 -53.68 168.25 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 108.888 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' C ' ' CD2' ' A' ' 48' ' ' HIS . 8.6 ttmt -99.03 115.22 28.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.594 -1.316 . . . . 0.0 113.021 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' CB ' ' A' ' 46' ' ' GLU . 2.7 m80 -134.73 20.57 3.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.607 . . . . 0.0 109.651 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.14 11.92 83.84 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 tttm -81.2 5.22 17.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.572 -0.958 . . . . 0.0 110.401 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.695 HD11 ' CB ' ' A' ' 122' ' ' TYR . 14.3 mm -51.22 -44.58 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 96.7 mtp -69.25 -43.16 74.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.818 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.77 -57.35 13.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 0.0 110.526 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' OH ' ' A' ' 71' ' ' TYR . . . -55.53 -55.82 27.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 9.8 ptt? -60.84 -41.25 95.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.049 . . . . 0.0 110.3 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' MET . 81.9 tt0 -52.86 -50.18 64.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.925 -1.109 . . . . 0.0 109.173 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 67' ' ' VAL . 12.9 ttmt -74.13 -28.64 61.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -0.768 . . . . 0.0 109.466 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.847 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.98 -24.52 58.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.401 -0.812 . . . . 0.0 109.229 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 58' ' ' LEU . 16.3 tptt -22.37 140.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.41 0.624 . . . . 0.0 112.082 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLY . 53.9 p -50.68 -52.29 41.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.394 -0.816 . . . . 0.0 109.63 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 60' ' ' SER . . . -45.0 -36.12 4.9 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 33.8 mmt -82.68 149.86 27.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -1.098 . . . . 0.0 110.315 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' HG3' ' CB ' ' A' ' 66' ' ' GLU . 1.3 ptm180 -73.55 106.54 5.37 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.961 0.886 . . . . 0.0 110.583 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 58' ' ' LEU . 9.0 t80 -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.484 0.659 . . . . 0.0 110.484 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.91 -56.88 16.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.413 -0.804 . . . . 0.0 111.075 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CB ' ' HG3' ' A' ' 63' ' ' ARG . 10.5 tp10 -55.81 -41.14 73.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.118 -0.989 . . . . 0.0 110.966 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.995 HG12 ' CD1' ' A' ' 43' ' ' ILE . 71.4 t -52.61 -59.09 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.748 -1.22 . . . . 0.0 109.803 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.584 ' CA ' HD11 ' A' ' 43' ' ' ILE . . . -64.94 -54.87 23.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -42.07 -27.1 0.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.413 -0.804 . . . . 0.0 109.838 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.582 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 3.7 tp60 -80.59 -62.85 1.55 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 109.992 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.768 ' OH ' ' HB1' ' A' ' 54' ' ' ALA . 50.9 p90 -109.96 51.16 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.606 -1.308 . . . . 0.0 111.084 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 31.1 t -89.83 131.14 35.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.248 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 45' ' ' CYS . 68.4 mm-40 -102.4 -3.15 27.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.886 -1.134 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 78' ' ' GLN . 84.6 m-20 -104.6 26.89 8.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.922 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.77 -19.96 64.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.895 -179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -75.14 -29.82 60.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.092 -1.005 . . . . 0.0 110.802 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 55.9 mtt180 -118.62 -25.33 6.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.0 110.534 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 170.07 115.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.04 98.95 0.81 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.9 -103.8 0.25 Allowed Glycine 0 N--CA 1.491 2.333 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.2 m-20 -97.21 162.2 13.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -1.092 . . . . 0.0 110.739 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.615 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 1.3 mp -101.64 -35.69 9.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 117.84 -161.99 13.2 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' CZ2' ' HD3' ' A' ' 39' ' ' LYS . 17.1 m-90 -98.6 115.64 29.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.891 -0.77 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 ptm -134.78 138.24 44.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.084 -1.01 . . . . 0.0 110.208 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.787 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 93.3 m -104.14 -14.08 16.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.473 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 88' ' ' GLY . 27.6 ttt180 -100.0 -72.29 0.67 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 111.125 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . 44.83 66.41 1.46 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.6 p -120.44 66.3 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -1.092 . . . . 0.0 110.432 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 37.1 mmt -107.95 -49.06 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 94' ' ' PHE . 72.0 t -114.02 153.96 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.912 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -72.81 -64.77 2.47 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 121.2 -0.937 . . . . 0.0 111.062 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 37.0 Cg_endo -60.89 -30.9 90.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.71 1.374 . . . . 0.0 112.104 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 51.1 t80 -68.93 -40.67 78.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.738 -1.226 . . . . 0.0 110.426 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 42.1 tt0 -72.86 -30.99 64.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.298 -0.876 . . . . 0.0 110.651 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 1.039 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 7.5 mm-40 -62.24 -26.51 68.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.82 . . . . 0.0 111.025 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.02 -54.63 3.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 111.315 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.41 -47.02 76.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.125 -0.984 . . . . 0.0 111.594 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.04 -8.63 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.049 -1.032 . . . . 0.0 111.544 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 1.039 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -130.33 25.88 5.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.698 -1.251 . . . . 0.0 111.89 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.81 135.54 83.19 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.712 -1.243 . . . . 0.0 109.373 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.82 -27.53 26.05 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.837 1.44 . . . . 0.0 110.991 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 103' ' ' VAL . 14.9 m -102.54 112.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.016 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.4 m -143.73 32.71 1.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.575 -0.703 . . . . 0.0 110.211 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.508 ' HA3' ' CG ' ' A' ' 108' ' ' LYS . . . -61.27 154.39 37.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -71.45 -24.86 62.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -1.152 . . . . 0.0 110.335 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -111.31 0.11 16.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.388 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 14.8 ptpt -132.74 43.61 1.11 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 45.8 Cg_endo -73.45 131.77 16.72 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.623 1.328 . . . . 0.0 109.39 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -143.65 -157.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.972 -1.08 . . . . 0.0 111.094 -178.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 39.3 p90 -123.2 164.33 18.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.6 p -50.43 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 110.531 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 67.3 t0 -122.32 116.85 29.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.931 . . . . 0.0 109.756 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 43.9 Cg_endo -70.72 164.33 82.27 Favored 'Cis proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.987 -2.089 . . . . 0.0 110.535 0.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.638 ' HG2' HG23 ' A' ' 51' ' ' ILE . 43.5 Cg_endo -70.85 -176.25 1.72 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.967 1.509 . . . . 0.0 110.291 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.69 155.08 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.988 . . . . 0.0 110.402 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.496 ' HE2' HG13 ' A' ' 51' ' ' ILE . 38.8 ttmt -124.03 127.4 47.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.53 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 120' ' ' PHE . 38.9 p -138.81 -175.85 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 110.945 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -71.74 -35.09 70.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 118' ' ' THR . 1.4 p90 -80.03 7.54 8.88 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.014 -1.054 . . . . 0.0 109.956 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . . . 117.48 175.82 17.24 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.695 ' CB ' HD11 ' A' ' 51' ' ' ILE . 55.6 p90 -101.67 151.72 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -1.056 . . . . 0.0 109.453 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m-70 -132.23 140.68 48.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.867 -1.146 . . . . 0.0 111.95 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.888 HG22 HG22 ' A' ' 43' ' ' ILE . 8.0 tt -118.46 106.22 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.977 HG22 ' HB2' ' A' ' 42' ' ' HIS . 14.8 pt -115.07 149.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.492 -1.38 . . . . 0.0 112.695 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 41' ' ' ARG . 26.1 ptm -122.46 145.53 48.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.3 m -114.78 101.16 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.951 -1.093 . . . . 0.0 111.272 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 76.3 tt0 -143.59 87.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 110.486 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 39' ' ' LYS . . . 162.27 115.68 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.546 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 72.3 ttt180 -130.35 157.3 42.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -1.037 . . . . 0.0 109.533 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 56.5 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.129 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.688 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -105.01 -156.53 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 110.281 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 85' ' ' MET . 2.4 p -139.21 161.15 28.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.484 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 84' ' ' TRP . 47.1 mttt -99.61 111.55 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.885 -1.135 . . . . 0.0 109.309 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.48 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 46.3 mtt-85 -111.86 125.73 54.34 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.777 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -138.47 162.63 34.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.441 -1.412 . . . . 0.0 112.609 -178.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.701 HD11 HD12 ' A' ' 124' ' ' ILE . 10.0 pt -129.85 137.64 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.012 HD13 ' OD2' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -107.74 131.56 54.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.879 . . . . 0.0 111.1 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 71' ' ' TYR . 62.5 m -126.76 168.73 14.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 73.4 tt0 -74.04 158.91 33.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.0 ttpt -96.41 96.02 8.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.043 -1.036 . . . . 0.0 110.565 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 2.2 p-80 -132.71 6.82 4.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.554 -0.716 . . . . 0.0 110.009 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.96 46.77 2.37 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HB3' ' CD2' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -114.72 10.87 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -1.185 . . . . 0.0 110.271 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG23 ' CG ' ' A' ' 115' ' ' PRO . 60.0 mt -53.63 -49.33 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.454 -0.779 . . . . 0.0 111.026 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.6 mmm -65.31 -50.68 64.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.987 . . . . 0.0 110.989 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.02 -42.88 99.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.948 . . . . 0.0 111.334 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 50' ' ' LYS . . . -61.38 -50.41 72.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.372 -0.83 . . . . 0.0 112.198 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.559 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 3.5 ptt? -65.48 -37.74 87.73 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.802 -1.186 . . . . 0.0 111.718 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 55' ' ' MET . 60.7 tt0 -65.39 -46.09 81.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -63.58 -34.19 77.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.962 -1.086 . . . . 0.0 108.594 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.836 HD22 HG21 ' A' ' 124' ' ' ILE . 13.6 tp -71.59 -35.5 70.56 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.558 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 12.9 mttp 46.38 -92.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.504 -0.747 . . . . 0.0 111.161 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' LEU . 75.6 p -122.59 -3.61 8.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.147 -0.971 . . . . 0.0 110.976 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 -9.06 13.8 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 38.6 mmt -50.8 -34.95 29.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -1.159 . . . . 0.0 110.056 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -113.45 27.02 9.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.115 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' CE1' ' HE3' ' A' ' 126' ' ' MET . 8.9 t80 -53.11 -46.1 68.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 0.0 109.841 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 47.9 t30 -60.31 -40.3 90.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.601 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -65.25 -58.36 6.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 71.1 t -60.44 -63.23 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -46.29 -42.46 14.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 65' ' ' ASN . . . -49.5 -56.15 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 109.935 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 8.2 mm-40 -90.04 -0.01 57.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 5.7 m-85 -104.33 3.16 32.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 110.382 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.2 t -99.89 93.65 5.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 0.0 109.729 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 24.6 mp0 -106.27 9.78 31.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.19 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 1.012 ' OD2' HD13 ' A' ' 44' ' ' LEU . 80.8 m-20 -117.29 46.17 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -66.15 -14.71 62.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.481 -0.762 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.72 -37.07 42.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 111.363 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -121.99 15.66 10.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 111.599 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' CD ' ' NE2' ' A' ' 42' ' ' HIS . 0.5 OUTLIER -159.99 154.77 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.792 -1.193 . . . . 0.0 110.687 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.93 9.84 13.98 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 103.39 -52.98 0.75 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 41' ' ' ARG . 93.2 m-20 -115.44 137.94 51.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -1.085 . . . . 0.0 109.68 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 85' ' ' MET . 0.7 OUTLIER -100.52 -13.96 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 109.986 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 89.95 -115.62 4.6 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.356 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.625 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 79.5 m95 -89.46 133.56 34.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.989 . . . . 0.0 111.502 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 38' ' ' VAL . 22.8 ttt -122.59 124.81 44.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.2 m -134.92 -47.22 0.73 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.974 -1.079 . . . . 0.0 112.172 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 86' ' ' THR . 11.8 mtt180 -103.06 -88.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.69 -1.256 . . . . 0.0 111.744 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' ' NE2' ' A' ' 95' ' ' GLN . . . -138.18 151.79 21.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 90' ' ' MET . 9.9 p -143.78 -53.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.273 . . . . 0.0 111.143 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 57.5 mmm -107.69 -98.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 111.362 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 120' ' ' PHE . 5.4 t -129.23 174.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.909 -1.119 . . . . 0.0 111.448 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -42.23 -54.16 4.67 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 121.746 -0.596 . . . . 0.0 112.284 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 43.5 Cg_endo -67.7 -19.75 47.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.459 1.242 . . . . 0.0 111.712 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.576 ' CG ' ' HB2' ' A' ' 90' ' ' MET . 42.6 t80 -79.6 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.797 -1.19 . . . . 0.0 110.107 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.539 ' OE1' ' HE3' ' A' ' 85' ' ' MET . 28.4 mm100 -70.99 -38.23 72.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.769 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 4.7 mm-40 -70.75 -33.98 71.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 93' ' ' PRO . . . -69.7 -48.15 60.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.148 -0.97 . . . . 0.0 110.574 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.0 97.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 111.291 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.82 0.3 57.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.013 -1.054 . . . . 0.0 111.563 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -127.04 4.89 6.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.771 -1.206 . . . . 0.0 111.186 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.02 ' HG ' HG22 ' A' ' 103' ' ' VAL . 41.4 tp -82.08 116.75 65.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.906 -1.121 . . . . 0.0 109.842 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' HD2' HD12 ' A' ' 101' ' ' LEU . 47.2 Cg_endo -72.61 -18.97 25.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.862 1.454 . . . . 0.0 111.591 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.02 HG22 ' HG ' ' A' ' 101' ' ' LEU . 3.9 m -76.19 -21.83 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.866 -1.146 . . . . 0.0 110.559 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.4 m -109.34 107.94 18.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 109.807 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -161.7 9.83 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.313 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.2 ttt -76.01 -21.83 56.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.961 . . . . 0.0 110.954 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 107' ' ' ASP . 53.9 t0 -113.45 -14.78 12.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.052 -1.03 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.26 73.6 73.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.966 -1.084 . . . . 0.0 111.035 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.28 123.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.071 1.564 . . . . 0.0 110.042 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 111' ' ' PHE . 17.5 m -143.31 -147.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.096 -1.002 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CZ ' ' CE ' ' A' ' 126' ' ' MET . 19.1 m-30 -101.42 171.18 7.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.519 -0.738 . . . . 0.0 110.039 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.719 HG21 ' CG2' ' A' ' 116' ' ' VAL . 65.0 m -65.18 -91.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 111.802 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.771 ' N ' ' HA ' ' A' ' 114' ' ' PRO . 99.0 m-20 -93.39 -24.93 0.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 113' ' ' ASP . 42.5 Cg_endo -71.04 -27.36 7.5 Favored 'Cis proline' 0 N--CA 1.493 1.442 0 C-N-CA 124.306 -1.122 . . . . 0.0 114.484 1.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.624 ' HD3' ' CD ' ' A' ' 114' ' ' PRO . 51.5 Cg_endo -80.92 130.68 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 122.404 0.686 . . . . 0.0 112.576 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.719 ' CG2' HG21 ' A' ' 112' ' ' THR . 60.6 t -98.66 143.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 11.9 ptpt -102.51 108.55 19.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.53 -0.731 . . . . 0.0 111.065 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.645 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 19.4 p -136.84 158.37 44.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.299 -0.875 . . . . 0.0 109.977 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -65.82 -13.62 59.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.645 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.6 p90 -100.41 21.56 12.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.78 -1.2 . . . . 0.0 110.039 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 112.66 -169.9 13.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 33.7 m-85 -105.68 156.61 18.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 109.25 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 60.8 m-70 -135.16 128.57 32.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 112.199 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.836 HG21 HD22 ' A' ' 58' ' ' LEU . 95.7 mt -117.93 102.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -106.78 152.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.468 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.634 ' CE ' ' CZ ' ' A' ' 111' ' ' PHE . 20.3 mtt -124.17 136.21 54.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.69 139.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.888 -1.133 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -117.39 -37.57 3.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 110.46 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -145.64 121.6 1.53 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' O ' ' OXT' ' A' ' 131' ' ' LYS . 41.5 ttt180 -110.25 149.4 30.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -1.132 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.128 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.288 0.566 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB2' ' OG1' ' A' ' 86' ' ' THR . . . -90.63 -170.54 2.75 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 85' ' ' MET . 1.6 p -143.46 151.62 16.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.544 -0.723 . . . . 0.0 109.724 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.551 ' HG3' ' CE3' ' A' ' 84' ' ' TRP . 49.7 mtmt -99.27 129.6 45.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 109.257 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 82' ' ' LEU . 5.0 p -139.34 139.39 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.137 -1.025 . . . . 0.0 112.02 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 78.1 mtt-85 -110.74 122.5 47.97 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 80' ' ' GLY . 3.7 p80 -138.27 148.25 44.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.821 -1.174 . . . . 0.0 111.501 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 19.4 mt -102.7 119.35 50.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 120' ' ' PHE . 4.4 tt -101.79 116.31 32.44 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 41.8 t -129.0 163.56 25.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.546 -0.721 . . . . 0.0 109.642 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 32.0 mt-10 -71.55 -178.91 2.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.598 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . 22.7 tttm -97.0 104.27 16.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.024 -1.048 . . . . 0.0 112.639 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.649 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.9 m-70 -133.13 0.42 3.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.254 -0.904 . . . . 0.0 110.504 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 122' ' ' TYR . . . 94.03 11.77 57.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' ILE . 98.0 mttt -85.56 3.85 38.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.253 -1.145 . . . . 0.0 110.739 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG23 ' HG2' ' A' ' 115' ' ' PRO . 67.8 mt -42.28 -53.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 56' ' ' GLU . 98.5 mmm -66.01 -45.19 82.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.144 -0.972 . . . . 0.0 110.637 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.28 -48.1 81.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 110.781 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.0 -61.19 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.539 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.679 ' HA ' HD21 ' A' ' 58' ' ' LEU . 3.9 ppp? -63.19 -36.06 82.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 110.712 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 52' ' ' MET . 39.5 tp10 -71.54 -28.25 63.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.073 -1.017 . . . . 0.0 110.016 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HG3' HG22 ' A' ' 67' ' ' VAL . 9.3 tptt -74.65 -34.77 62.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.846 ' HB3' HG21 ' A' ' 67' ' ' VAL . 3.7 pp -91.56 -16.98 26.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.817 ' O ' HD12 ' A' ' 58' ' ' LEU . 19.3 mtpt 43.45 -135.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.551 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 100.0 p -57.26 -24.98 58.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.138 -0.976 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.03 9.92 2.94 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtp -50.73 -44.79 58.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.892 -1.357 . . . . 0.0 109.723 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 67' ' ' VAL . 65.0 mtt-85 -114.24 38.82 2.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.455 -0.778 . . . . 0.0 109.702 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -52.55 -49.98 63.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.371 -0.831 . . . . 0.0 110.341 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' OD1' ' HG2' ' A' ' 66' ' ' GLU . 16.9 p30 -61.88 -42.26 98.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' OD1' ' A' ' 65' ' ' ASN . 39.5 mm-40 -59.25 -50.93 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.052 -1.03 . . . . 0.0 108.993 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 58' ' ' LEU . 92.4 t -57.5 -52.42 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 0.0 109.817 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 43' ' ' ILE . . . -60.12 -40.57 90.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -49.89 -44.99 50.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.483 -0.761 . . . . 0.0 110.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -94.89 -11.79 28.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 0.0 110.529 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 43' ' ' ILE . 32.9 m-85 -117.81 25.75 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 0.0 111.1 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.9 t -103.68 115.43 30.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.927 -1.108 . . . . 0.0 110.214 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -100.34 -7.51 24.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.488 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 2.1 m-20 -104.92 23.7 13.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.491 -0.755 . . . . 0.0 109.065 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -49.89 -32.17 13.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.673 -0.642 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.63 88.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.473 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 16.4 mtt-85 -112.09 -45.22 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.125 -0.984 . . . . 0.0 110.274 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 mp0 -118.91 149.56 41.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.09 13.23 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 101.58 -5.91 54.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 36.5 p-10 -124.84 140.5 52.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.153 -1.204 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 40' ' ' VAL . 63.3 tp -110.6 127.8 55.39 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.06 -1.025 . . . . 0.0 109.484 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -59.3 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.551 ' CE3' ' HG3' ' A' ' 39' ' ' LYS . 98.3 m95 -80.31 142.21 34.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -1.017 . . . . 0.0 110.727 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.877 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.2 ttt -128.89 121.81 28.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.619 -0.676 . . . . 0.0 109.269 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 37' ' ' ALA . 1.1 m -118.28 -46.65 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.732 -1.23 . . . . 0.0 110.445 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -100.41 -54.48 2.85 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.005 . . . . 0.0 110.502 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' NE2' ' A' ' 95' ' ' GLN . . . 160.74 -165.73 35.22 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -133.19 -75.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.513 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 41.7 mtp -140.37 -80.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.081 -1.012 . . . . 0.0 110.74 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 118' ' ' THR . 97.3 t -50.69 127.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.639 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -68.58 -51.48 30.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 38.9 Cg_endo -65.15 -8.78 19.49 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.461 1.243 . . . . 0.0 110.817 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.462 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 46.9 t80 -80.56 -46.17 16.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.04 . . . . 0.0 109.014 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' NE2' ' HA3' ' A' ' 88' ' ' GLY . 19.9 mt-30 -68.52 -30.72 69.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 79.9 mm-40 -54.41 -40.73 68.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -77.75 -51.08 11.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.55 -53.0 15.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.35 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -77.03 -17.48 58.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.407 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -58.76 -44.68 90.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.99 -1.069 . . . . 0.0 109.253 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 127' ' ' VAL . 69.4 mt -59.07 122.79 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.367 -0.833 . . . . 0.0 109.396 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -77.93 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.888 1.467 . . . . 0.0 112.013 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.0 141.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.178 . . . . 0.0 111.594 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.2 p -126.55 89.73 3.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.598 -0.689 . . . . 0.0 109.421 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.16 142.06 48.31 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -70.44 -12.46 61.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -100.6 -17.35 17.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 62.6 mttt -131.19 57.1 28.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.757 . . . . 0.0 109.596 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 44.9 Cg_endo -70.87 138.43 34.28 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.117 1.588 . . . . 0.0 110.69 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 111' ' ' PHE . 45.6 t -140.74 170.29 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 110.129 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' N ' HG12 ' A' ' 110' ' ' VAL . 50.5 p90 -123.21 157.06 33.9 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 0.0 110.139 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.456 ' CG2' ' HB ' ' A' ' 125' ' ' ILE . 77.3 p -56.86 109.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.405 -0.809 . . . . 0.0 110.642 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.548 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 22.3 p-10 -132.33 124.14 19.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.763 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 113' ' ' ASP . 44.8 Cg_endo -70.79 164.74 81.43 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.208 0.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.614 ' HG2' HG23 ' A' ' 51' ' ' ILE . 46.3 Cg_endo -72.55 -178.5 3.41 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.085 1.571 . . . . 0.0 109.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' A' ' 123' ' ' HIS . 3.7 m -99.61 146.3 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.053 . . . . 0.0 109.396 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HD3' HD11 ' A' ' 51' ' ' ILE . 40.1 ttpt -120.83 134.58 55.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.006 -1.059 . . . . 0.0 110.46 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.583 HG21 HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -141.32 -164.29 1.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.293 -0.88 . . . . 0.0 109.75 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -73.37 -45.91 52.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.992 . . . . 0.0 112.059 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.757 ' CE1' ' NE2' ' A' ' 123' ' ' HIS . 6.8 p90 -53.6 -41.62 66.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.065 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.673 ' N ' ' CG ' ' A' ' 120' ' ' PHE . . . 164.81 -124.4 1.25 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -177.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.563 ' OH ' ' HG3' ' A' ' 47' ' ' LYS . 15.7 m-85 -133.41 162.53 31.59 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.81 -1.406 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.787 ' HB2' HG22 ' A' ' 116' ' ' VAL . 97.6 m-70 -137.58 110.63 7.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.308 -0.87 . . . . 0.0 111.071 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -99.05 118.57 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 125' ' ' ILE . 3.4 mp -105.78 134.89 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.902 -1.124 . . . . 0.0 113.505 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 tpt -118.23 121.76 41.27 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 101' ' ' LEU . 17.0 t -92.8 144.14 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.808 -1.183 . . . . 0.0 111.389 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.2 -48.25 3.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.421 -0.8 . . . . 0.0 110.234 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.14 149.25 16.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.18 157.2 44.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -1.134 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 pttt . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.083 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.368 0.604 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -99.44 155.37 17.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 110.003 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 30.4 m -138.63 158.16 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -100.54 122.48 43.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 109.724 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 82' ' ' LEU . 7.9 p -124.22 162.62 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 118.903 -1.119 . . . . 0.0 112.917 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 126' ' ' MET . 41.1 ttm180 -143.17 128.2 18.52 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.963 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.9 p80 -140.29 175.15 9.83 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.151 -1.593 . . . . 0.0 113.173 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.684 ' HB ' HG22 ' A' ' 124' ' ' ILE . 36.0 mt -128.55 125.15 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 45' ' ' CYS . 3.3 tt -105.56 131.38 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.131 -0.981 . . . . 0.0 110.566 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.765 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.0 m -142.85 162.33 35.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.914 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 85.4 mt-10 -75.91 161.44 28.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 79.5 tttt -72.58 119.5 16.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.195 -0.941 . . . . 0.0 111.692 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 12.3 m-70 -133.32 -1.57 3.19 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.42 -0.8 . . . . 0.0 110.45 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.58 81.74 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HG2' ' HB2' ' A' ' 48' ' ' HIS . 21.7 ptmt -107.34 15.46 24.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.478 -1.013 . . . . 0.0 109.948 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.755 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -46.66 -52.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.386 -0.822 . . . . 0.0 110.44 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.3 ttp -53.95 -38.29 64.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 88.6 mt-10 -70.4 -39.13 74.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -59.04 6.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.655 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.9 ptm -59.01 -33.26 70.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.918 . . . . 0.0 110.171 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' O ' ' CD ' ' A' ' 59' ' ' LYS . 33.8 tp10 -72.93 -32.96 65.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 110.189 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 24.4 mmtp -63.54 -50.74 68.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 59' ' ' LYS . 3.2 pp -73.65 -20.26 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.79 ' O ' HD12 ' A' ' 58' ' ' LEU . 28.9 mmmt 53.66 -137.31 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.878 . . . . 0.0 110.781 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.44 ' O ' HG11 ' A' ' 110' ' ' VAL . 26.2 t -52.35 -39.14 60.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.485 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.08 -9.45 2.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.429 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 16.1 ptp -51.88 -35.44 45.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' N ' ' CG ' ' A' ' 62' ' ' MET . 25.8 mtt180 -101.5 9.19 41.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 110.163 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -44.35 -48.73 9.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.05 -39.22 77.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.233 -0.917 . . . . 0.0 109.849 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.23 -40.84 74.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.602 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 58' ' ' LEU . 42.2 t -67.17 -49.16 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.443 -0.786 . . . . 0.0 110.044 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -58.22 -54.74 43.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.138 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.68 -51.26 16.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.464 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.4 mm-40 -75.7 -15.58 60.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 110.101 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.663 ' CE2' HG13 ' A' ' 67' ' ' VAL . 15.1 m-30 -111.14 18.32 19.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.454 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ALA . 19.4 p -79.48 93.56 5.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.015 -1.053 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 45' ' ' CYS . 3.5 mp0 -108.95 8.26 26.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' HB3' HD13 ' A' ' 44' ' ' LEU . 4.3 p30 -112.12 37.08 3.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -48.81 -31.05 6.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.911 . . . . 0.0 110.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.01 -39.21 51.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -91.19 4.91 51.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.306 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 51.18 51.41 17.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.168 -0.958 . . . . 0.0 109.592 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 74' ' ' ASP . . . -78.06 115.32 4.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.66 -122.79 0.64 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' C ' HD12 ' A' ' 82' ' ' LEU . 40.4 p-10 -86.71 131.55 34.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.128 -1.219 . . . . 0.0 109.007 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.814 ' HB2' HG13 ' A' ' 40' ' ' VAL . 7.2 mp -102.91 162.77 12.66 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.987 -1.071 . . . . 0.0 110.226 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -93.37 -135.39 7.43 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 13.3 m-90 -96.38 133.03 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.968 -0.725 . . . . 0.0 110.8 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -140.52 168.35 20.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.738 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . 31.8 p -128.02 -125.48 0.22 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.301 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -113.91 174.76 5.77 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.915 -1.116 . . . . 0.0 109.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.89 56.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 t -110.36 -29.51 8.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -1.125 . . . . 0.0 110.098 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 95' ' ' GLN . 2.1 ptt? -126.35 176.7 6.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 94' ' ' PHE . 19.3 m -68.44 -174.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.354 -0.841 . . . . 0.0 110.76 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.629 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -77.61 -47.38 8.85 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 121.468 -0.77 . . . . 0.0 111.897 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 39.9 Cg_endo -65.52 -46.77 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.064 1.033 . . . . 0.0 110.986 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.552 ' H ' HG23 ' A' ' 91' ' ' VAL . 1.6 t80 -66.56 -39.88 88.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.938 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 34.9 tt0 -69.64 -44.39 70.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 1.011 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 34.2 tt0 -51.36 -26.83 8.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.38 -38.25 13.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.247 -0.908 . . . . 0.0 110.479 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.57 99.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.399 -0.813 . . . . 0.0 111.642 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 86' ' ' THR . 10.5 m-85 -101.39 -12.85 18.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.162 . . . . 0.0 111.788 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 1.011 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -113.1 8.91 18.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.734 -1.229 . . . . 0.0 111.021 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.711 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.6 pt? -42.66 135.53 2.68 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.038 . . . . 0.0 109.575 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 -15.52 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.841 1.442 . . . . 0.0 111.692 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 109' ' ' PRO . 15.7 m -97.21 115.92 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 110.286 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.1 p -126.36 24.29 6.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.893 . . . . 0.0 110.297 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.497 ' HA2' ' HG3' ' A' ' 109' ' ' PRO . . . 108.9 -10.37 34.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 73.4 mtp -82.65 -29.4 30.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -1.071 . . . . 0.0 110.695 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' OD1' ' HG3' ' A' ' 108' ' ' LYS . 67.8 t0 -128.52 -94.45 0.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.964 -1.085 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 107' ' ' ASP . 18.0 mttm -130.69 86.2 53.44 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.849 -1.157 . . . . 0.0 110.741 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.497 ' HG3' ' HA2' ' A' ' 105' ' ' GLY . 49.6 Cg_endo -75.67 55.21 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.503 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 111' ' ' PHE . 62.2 t -104.32 -102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 110.36 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 124' ' ' ILE . 46.3 p90 -108.52 169.39 8.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 110.962 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.576 ' OG1' HG12 ' A' ' 125' ' ' ILE . 25.3 m -70.07 116.45 10.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.506 -0.746 . . . . 0.0 110.919 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 22.7 p-10 -133.85 112.78 12.59 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 51.7 Cg_endo -77.33 160.2 94.23 Favored 'Cis proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.153 -2.02 . . . . 0.0 110.36 -0.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 46.0 Cg_endo -72.86 -175.86 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.957 1.504 . . . . 0.0 109.908 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 116' ' ' VAL . 22.1 m -102.25 146.53 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.274 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -114.53 138.05 51.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 108.975 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.6 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 81.1 p -136.39 -173.9 3.54 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.708 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 120' ' ' PHE . 15.0 ptpt -76.36 -11.23 59.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -104.38 11.01 35.15 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.736 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.79 -167.1 12.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 45' ' ' CYS . 45.6 p90 -108.86 157.91 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.315 . . . . 0.0 110.948 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.604 ' NE2' ' CE2' ' A' ' 120' ' ' PHE . 12.2 m-70 -133.72 140.54 47.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 111.419 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 124' ' ' ILE . 19.9 tt -128.04 111.21 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.963 HG22 ' CB ' ' A' ' 42' ' ' HIS . 28.8 pt -108.62 161.2 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.789 -1.194 . . . . 0.0 111.836 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.561 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 39.5 mtm -128.05 143.88 51.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 101' ' ' LEU . 16.7 t -118.37 128.59 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.981 -1.074 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -144.26 -38.08 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.985 -1.072 . . . . 0.0 111.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . -89.26 88.32 1.51 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.418 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -118.66 135.89 54.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -1.167 . . . . 0.0 110.04 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.289 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' HG13 ' A' ' 38' ' ' VAL . 57.9 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.16 0.505 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 130' ' ' ARG . . . -59.9 139.43 57.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 110.514 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG12 ' HA2' ' A' ' 129' ' ' GLY . 28.8 m -147.02 165.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.507 -0.746 . . . . 0.0 111.298 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.583 ' HG3' ' CE2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -97.06 126.32 42.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.11 134.05 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.867 -1.145 . . . . 0.0 112.226 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 48.2 mtm-85 -114.15 126.03 54.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.099 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -133.51 151.47 51.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.535 -1.353 . . . . 0.0 112.231 -178.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 67' ' ' VAL . 86.3 mt -113.4 126.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.623 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -113.99 121.17 43.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 110.934 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 122' ' ' TYR . 19.4 p -132.95 177.52 7.59 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.655 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 74.3 mm-40 -64.14 158.16 23.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.573 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.69 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 5.0 ttmt -101.84 73.17 1.4 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.942 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.655 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 30.0 m80 -135.12 51.55 2.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 111.728 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.52 -10.35 55.82 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.759 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -71.15 -15.15 62.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.336 . . . . 0.0 110.675 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 122' ' ' TYR . 7.3 tt -52.95 -36.16 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 110.078 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 55' ' ' MET . 26.0 ttt -67.23 -40.14 86.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 110.143 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -67.56 -34.63 77.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 109.909 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 124' ' ' ILE . . . -61.65 -63.06 1.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 18.5 ptt? -56.32 -34.75 66.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.797 . . . . 0.0 111.0 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 55' ' ' MET . 87.6 tt0 -69.91 -42.02 73.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 111.288 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 62' ' ' MET . 53.0 mtpt -80.27 -24.95 39.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.978 . . . . 0.0 111.246 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 124' ' ' ILE . 2.3 pp -104.35 2.87 31.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 58' ' ' LEU . 6.2 mttt -49.46 178.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.07 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -52.47 139.48 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 110.095 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.05 -10.95 69.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 29.5 mmt -100.9 163.71 12.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -1.049 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.497 ' CG ' ' HG3' ' A' ' 66' ' ' GLU . 4.9 ttm180 -93.77 95.04 8.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -46.24 -31.43 2.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 0.0 110.337 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.61 -41.24 92.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.127 -0.983 . . . . 0.0 110.011 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.497 ' HG3' ' CG ' ' A' ' 63' ' ' ARG . 3.4 mt-10 -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.133 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.826 HG13 ' CE2' ' A' ' 71' ' ' TYR . 53.6 t -68.94 -38.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.897 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 43' ' ' ILE . . . -70.9 -51.38 26.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 110.465 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.12 -31.34 65.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 110.672 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.473 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 8.1 mm-40 -91.42 -19.75 22.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.031 -1.043 . . . . 0.0 110.735 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.826 ' CE2' HG13 ' A' ' 67' ' ' VAL . 17.2 m-30 -108.71 10.44 26.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 0.0 111.078 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 16.7 m -76.44 116.76 17.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.937 -1.102 . . . . 0.0 110.154 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 25.3 tp10 -104.5 10.41 35.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 22.0 t70 -114.9 108.29 16.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.158 -0.964 . . . . 0.0 110.543 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HA ' ' HG3' ' A' ' 78' ' ' GLN . 17.1 ptpt -61.3 -25.18 66.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.04 -21.72 29.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -129.51 25.54 5.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.385 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.557 ' HG3' ' HA ' ' A' ' 75' ' ' LYS . 52.6 mt-30 -43.53 -28.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.93 -15.61 14.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' HIS . . . 61.39 24.03 63.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 55.4 t0 -130.74 142.84 50.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -1.116 . . . . 0.0 110.493 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.739 HD11 ' CD2' ' A' ' 42' ' ' HIS . 8.7 mp -104.04 -20.5 13.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.68 -170.06 34.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 39' ' ' LYS . 28.9 m-90 -84.26 127.75 34.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -1.016 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 19.2 ptp -140.37 137.48 34.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' CE2' ' A' ' 99' ' ' PHE . 49.1 m -76.53 -54.64 6.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -111.14 -173.55 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.385 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HG3' ' A' ' 95' ' ' GLN . . . -149.62 146.07 14.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.6 p -137.9 16.07 2.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -1.182 . . . . 0.0 110.759 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.532 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 6.4 mmt -100.8 108.4 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.241 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.57 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 11.4 t 64.84 117.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.6 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -51.81 -53.05 31.44 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.49 -0.756 . . . . 0.0 111.461 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 40.1 Cg_endo -65.66 -32.7 47.13 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.438 1.231 . . . . 0.0 111.705 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 125' ' ' ILE . 42.1 t80 -63.77 -52.46 60.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.851 -1.156 . . . . 0.0 109.932 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HG3' ' HA3' ' A' ' 88' ' ' GLY . 39.5 tt0 -55.12 -46.05 75.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.4 mt-10 -58.62 -48.63 80.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.12 77.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.343 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.72 -40.23 91.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.713 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 36' ' ' ASN . 6.5 m-85 -103.63 13.23 33.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.957 . . . . 0.0 110.906 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.872 ' O ' HG22 ' A' ' 103' ' ' VAL . . . -130.76 3.33 4.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.133 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 61.0 tp -69.35 -39.24 12.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 101' ' ' LEU . 45.4 Cg_endo -76.44 2.11 7.68 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.308 1.162 . . . . 0.0 111.976 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 100' ' ' ALA . 8.7 m -79.68 -27.88 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.276 . . . . 0.0 110.35 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.6 m -106.54 18.82 21.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.17 123.92 6.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.456 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 89.7 mmm -56.52 -34.24 66.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -1.117 . . . . 0.0 109.98 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 106' ' ' MET . 93.4 m-20 -140.46 -59.08 0.53 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.999 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -128.3 158.84 70.1 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.867 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 102' ' ' PRO . 44.3 Cg_endo -72.82 158.37 50.27 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.935 1.492 . . . . 0.0 111.699 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.815 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.5 p -141.75 -138.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.815 ' N ' HG13 ' A' ' 110' ' ' VAL . 31.4 p90 -102.56 158.06 16.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.828 -1.17 . . . . 0.0 110.134 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 1.009 HG21 HG13 ' A' ' 116' ' ' VAL . 22.4 m -40.61 121.98 1.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 37.8 p-10 -133.51 104.76 12.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.909 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.963 ' O ' HG22 ' A' ' 112' ' ' THR . 49.5 Cg_endo -76.78 176.91 41.88 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.198 -2.001 . . . . 0.0 110.471 0.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 114' ' ' PRO . 41.7 Cg_endo -69.32 166.67 26.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.764 1.402 . . . . 0.0 109.686 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.009 HG13 HG21 ' A' ' 112' ' ' THR . 34.2 m -110.3 139.18 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.01 . . . . 0.0 110.656 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . 1.2 pttp -114.03 131.39 56.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.474 -0.766 . . . . 0.0 108.934 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.617 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 69.8 p -134.75 176.21 8.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.965 -1.084 . . . . 0.0 110.822 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -61.49 -8.73 4.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.74 -0.6 . . . . 0.0 111.369 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.68 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 11.0 p90 -112.73 37.95 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.705 -1.247 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . 99.65 -173.38 25.84 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 51' ' ' ILE . 20.5 m-85 -99.01 158.62 15.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -1.05 . . . . 0.0 108.417 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.68 ' CE1' ' CD2' ' A' ' 120' ' ' PHE . 73.0 m-70 -141.35 137.71 32.54 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.063 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.881 HD13 HD21 ' A' ' 58' ' ' LEU . 69.9 mt -128.29 96.38 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.099 HG22 ' HB2' ' A' ' 42' ' ' HIS . 15.4 pt -103.79 137.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.942 -1.099 . . . . 0.0 112.029 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 48.9 mtp -107.42 142.08 37.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.407 HG23 HD23 ' A' ' 101' ' ' LEU . 30.0 t -119.83 125.2 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.719 -1.238 . . . . 0.0 111.576 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -107.82 -47.62 3.55 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 38' ' ' VAL . . . 119.54 176.83 16.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 46.3 tpt85 -116.96 -48.48 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.968 . . . . 0.0 109.117 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.235 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' HG22 ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.835 0.35 . . . . 0.0 111.912 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.79 ' HB1' ' N ' ' A' ' 85' ' ' MET . . . -117.99 176.62 5.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 0.5 OUTLIER -120.98 151.24 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HG3' ' CZ2' ' A' ' 84' ' ' TRP . 1.9 tmmt? -100.42 121.85 42.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.106 -0.996 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.981 HG23 HG22 ' A' ' 127' ' ' VAL . 10.2 p -142.44 147.94 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 119.344 -0.943 . . . . 0.0 112.876 -178.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' NE ' ' HB2' ' A' ' 81' ' ' ASP . 65.8 mtp180 -130.06 137.38 50.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.556 ' HD2' HD11 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -142.69 167.75 21.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.162 -1.587 . . . . 0.0 113.061 -177.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.49 HD13 ' CG1' ' A' ' 67' ' ' VAL . 5.1 mt -127.55 130.36 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 73' ' ' GLU . 6.7 tt -113.91 118.86 35.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 48.1 t -129.68 154.22 47.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 35.0 tp10 -60.24 163.83 4.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 0.0 109.86 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 18.2 ttpt -97.58 96.74 8.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 0.0 110.38 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 1.8 p-80 -132.07 21.89 4.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.48 19.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 120.107 -1.044 . . . . 0.0 110.603 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 71' ' ' TYR . 8.9 tttt -114.65 18.35 16.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.889 -1.359 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 122' ' ' TYR . 4.2 mt -57.41 -42.39 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.488 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 62.8 ttp -65.86 -46.96 76.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.888 . . . . 0.0 110.869 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 50' ' ' LYS . 72.1 mm-40 -59.89 -47.41 85.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -0.985 . . . . 0.0 110.641 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 124' ' ' ILE . . . -55.0 -60.73 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.529 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' LYS . 3.7 tmm? -62.47 -33.33 74.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 110.088 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 52' ' ' MET . 34.5 tt0 -59.15 -46.13 89.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -60.21 -46.64 89.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.76 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 111' ' ' PHE . 4.1 pp -101.26 25.33 8.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.227 -0.921 . . . . 0.0 110.365 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' MET . 7.9 tptt -35.09 -70.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.744 -0.598 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.4 m -91.3 25.0 2.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.77 32.78 66.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.78 40.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.414 -1.05 . . . . 0.0 110.568 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 71.5 mtt180 -117.71 37.36 3.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 111.715 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CE2' ' CZ ' ' A' ' 111' ' ' PHE . 25.7 t80 -49.28 -46.92 47.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.707 -1.245 . . . . 0.0 109.988 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -63.97 -45.96 86.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 110.73 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . 38.9 tt0 -64.94 -45.2 86.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 110.426 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.893 HG11 HD23 ' A' ' 58' ' ' LEU . 67.2 t -55.1 -41.81 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.749 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -64.13 -59.2 4.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.0 109.638 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.49 -40.21 1.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 0.0 111.688 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.649 ' NE2' ' CD1' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -101.18 -30.27 11.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 112.002 -178.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.649 ' CD1' ' NE2' ' A' ' 70' ' ' GLN . 8.3 m-85 -100.79 28.36 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.641 -1.287 . . . . 0.0 109.945 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 41.0 t -115.82 123.27 47.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 44' ' ' LEU . 64.8 tt0 -101.83 -8.14 21.9 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' GLN . 46.6 p30 -108.04 32.43 4.77 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -60.03 -37.01 78.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.4 71.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.383 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.431 ' C ' ' HG3' ' A' ' 78' ' ' GLN . 13.7 ptp180 -87.58 -47.64 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.8 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' ASP . 20.2 mt-30 -138.6 -127.15 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.256 -0.903 . . . . 0.0 109.726 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.56 25.8 8.48 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.22 -135.43 1.81 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.018 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.623 ' C ' HD12 ' A' ' 82' ' ' LEU . 59.8 t0 -73.98 150.18 40.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -1.099 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.736 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.0 mp -100.9 -15.47 17.54 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.47 -0.769 . . . . 0.0 108.941 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 82.39 -145.34 24.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.6 m-90 -109.08 133.3 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.667 -0.902 . . . . 0.0 110.101 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.79 ' N ' ' HB1' ' A' ' 37' ' ' ALA . 25.0 ptp -141.1 154.37 45.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.404 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 36' ' ' ASN . 32.8 p -115.81 -66.05 1.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 110.371 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' N ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -104.35 37.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.879 . . . . 0.0 110.709 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.2 97.59 1.8 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.424 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 25.2 t -101.69 114.89 29.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.368 -1.078 . . . . 0.0 109.93 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 30.5 mmt -100.42 -106.35 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HD2' ' A' ' 93' ' ' PRO . 70.1 t -64.42 -51.33 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.911 -1.118 . . . . 0.0 110.397 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.64 -67.19 0.45 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.859 ' HD2' HG12 ' A' ' 91' ' ' VAL . 45.1 Cg_endo -70.49 -25.08 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.105 1.581 . . . . 0.0 109.612 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.82 ' CE1' HD11 ' A' ' 125' ' ' ILE . 58.7 t80 -70.61 -33.92 71.57 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.468 -0.77 . . . . 0.0 109.567 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 65.4 tt0 -73.04 -54.88 7.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 110.154 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -48.02 -61.9 1.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -62.13 -66.55 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.422 -0.799 . . . . 0.0 111.504 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -54.3 -63.46 1.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 112.206 -178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 18.5 t80 -41.71 -42.91 2.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.528 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.86 -89.55 0.27 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' HD2' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -119.43 119.46 31.63 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 111.484 -178.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.876 ' HD2' HD13 ' A' ' 101' ' ' LEU . 43.7 Cg_endo -71.18 -32.71 12.56 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.419 1.221 . . . . 0.0 110.453 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 105' ' ' GLY . 28.1 m -120.67 -152.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.145 -0.972 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.2 m -104.93 11.96 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.929 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.77 ' H ' HG23 ' A' ' 103' ' ' VAL . . . -108.81 121.74 6.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.527 ' HA ' HD21 ' A' ' 101' ' ' LEU . 19.2 ptm -102.29 -0.2 33.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -1.1 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -101.9 -35.68 8.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.733 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 48.0 pttt -130.49 55.75 20.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.781 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 44.9 Cg_endo -71.16 115.05 4.11 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -130.38 -93.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.596 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.014 ' CE1' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.34 149.56 23.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.251 179.792 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 115' ' ' PRO . 21.2 m -75.1 101.63 4.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 114' ' ' PRO . 55.3 t0 -132.48 111.94 13.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.146 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 46.6 Cg_endo -72.33 160.45 94.32 Favored 'Cis proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.849 -2.146 . . . . 0.0 110.271 0.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.682 ' HA ' HG22 ' A' ' 112' ' ' THR . 45.0 Cg_endo -72.46 -168.92 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.964 1.508 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.43 HG12 HG23 ' A' ' 118' ' ' THR . 19.4 t -101.21 131.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.529 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 51' ' ' ILE . 8.4 mtmm -102.03 123.14 45.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.312 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.569 ' OG1' ' CE2' ' A' ' 120' ' ' PHE . 41.4 p -134.62 -178.03 4.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -73.02 -16.48 61.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 111.369 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.614 ' CD2' ' NE2' ' A' ' 123' ' ' HIS . 3.8 p90 -97.1 1.6 50.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.738 -1.226 . . . . 0.0 110.983 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 131.52 -171.92 21.02 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.168 -1.491 . . . . 0.0 111.357 178.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 26.2 m-85 -101.23 150.54 22.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.742 -0.858 . . . . 0.0 109.34 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 120' ' ' PHE . 15.0 m-70 -136.31 122.67 20.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.895 -1.128 . . . . 0.0 112.11 -179.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.014 HG22 ' CE1' ' A' ' 111' ' ' PHE . 25.8 mt -102.06 120.89 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.82 HD11 ' CE1' ' A' ' 94' ' ' PHE . 20.3 mt -108.88 126.87 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.777 -1.202 . . . . 0.0 112.54 -177.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 13.5 tpt -110.3 99.01 8.12 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.981 HG22 HG23 ' A' ' 40' ' ' VAL . 11.6 t -107.77 138.04 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.955 . . . . 0.0 111.471 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -143.1 3.72 1.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.365 -0.834 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -125.52 139.78 11.79 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -132.59 133.05 43.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -1.21 . . . . 0.0 110.199 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.965 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.409 0.623 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 84' ' ' TRP . . . -131.25 -177.02 4.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 7.7 p -144.74 156.11 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HE2' ' CZ2' ' A' ' 84' ' ' TRP . 42.1 mttt -98.23 136.18 38.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.08 -1.012 . . . . 0.0 109.411 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 59.7 t -133.53 146.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.874 -179.053 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 126' ' ' MET . 84.0 mtt180 -141.62 123.34 15.18 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.99 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -136.72 -176.55 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.671 -1.268 . . . . 0.0 112.597 -178.342 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.83 ' HB ' HG22 ' A' ' 124' ' ' ILE . 82.5 mt -126.75 131.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 1.3 tt -106.7 126.38 52.21 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 110.68 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.438 ' N ' HD23 ' A' ' 44' ' ' LEU . 16.4 t -137.54 149.89 47.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.639 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 6.6 mm-40 -73.27 -155.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 122' ' ' TYR . 83.9 tttt -98.09 102.81 14.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.881 -1.137 . . . . 0.0 112.231 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.639 ' CE1' ' HB2' ' A' ' 46' ' ' GLU . 3.5 m-70 -132.56 -19.83 2.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.383 -0.823 . . . . 0.0 110.469 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.63 24.99 22.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HD2' ' HB2' ' A' ' 48' ' ' HIS . 19.1 mttt -97.78 14.1 28.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.48 -1.012 . . . . 0.0 110.43 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.943 HG23 ' HG2' ' A' ' 115' ' ' PRO . 2.7 mp -44.37 -62.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.988 . . . . 0.0 109.997 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 22.1 ptm -66.33 -34.5 78.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.0 110.948 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -65.13 -39.71 93.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.082 -1.011 . . . . 0.0 110.499 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.69 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -67.07 -56.68 9.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 110.833 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.562 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -62.46 -31.84 72.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.894 -1.129 . . . . 0.0 110.385 -179.559 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 55' ' ' MET . 18.3 tp10 -62.58 -38.75 91.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.489 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD2' ' OH ' ' A' ' 71' ' ' TYR . 44.8 mttm -76.86 -37.8 54.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.799 ' CB ' HG21 ' A' ' 67' ' ' VAL . 4.2 pp -83.7 -2.28 55.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.911 -1.118 . . . . 0.0 111.128 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HG3' ' HA ' ' A' ' 56' ' ' GLU . 12.1 mttt -48.93 178.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 109.986 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -54.33 139.83 35.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.06 -1.025 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.9 -23.55 29.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.487 ' HA ' ' CE ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -110.45 149.04 30.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.116 . . . . 0.0 110.283 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HG3' ' CG ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -87.16 107.39 18.45 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.043 0.925 . . . . 0.0 110.515 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD11 ' A' ' 43' ' ' ILE . 72.7 t80 -39.28 -40.92 0.83 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.493 0.663 . . . . 0.0 109.906 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -48.99 -46.98 44.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.251 -0.906 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' CG ' ' HG3' ' A' ' 63' ' ' ARG . 80.2 mm-40 -65.35 -43.39 90.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 58' ' ' LEU . 44.2 t -59.95 -41.05 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' SER . . . -55.38 -46.72 76.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.689 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.56 55.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 5.4 mm-40 -64.92 -23.79 67.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 54' ' ' ALA . 12.3 m-85 -118.39 26.38 9.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 109.744 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ALA . 7.1 t -88.24 87.3 7.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 110.942 -179.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 1.1 tm-20 -101.79 5.27 41.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -0.975 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -126.07 12.86 7.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.366 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -53.9 -18.6 3.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.538 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.03 -26.17 56.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.534 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.9 mmm180 -127.44 -2.3 6.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.05 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 77' ' ' ARG . 6.7 tt0 -178.63 150.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.62 38.32 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 42' ' ' HIS . . . 65.24 18.95 65.73 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -128.3 118.34 23.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.126 . . . . 0.0 110.119 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.881 HD11 ' CD2' ' A' ' 42' ' ' HIS . 4.4 mp -101.69 150.91 22.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.928 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -81.72 -122.24 0.61 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 37' ' ' ALA . 61.8 m95 -95.3 143.32 26.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.765 -0.844 . . . . 0.0 110.525 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 38' ' ' VAL . 8.5 mmt -125.64 139.29 53.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.028 179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' ARG . 11.9 t -134.02 -37.59 0.89 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' THR . 15.0 mtp85 -119.67 151.79 38.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 111.849 -177.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' CA ' ' HG3' ' A' ' 95' ' ' GLN . . . -100.92 113.86 4.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p -139.16 12.49 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.324 . . . . 0.0 111.722 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.591 ' CG ' HG12 ' A' ' 91' ' ' VAL . 6.8 ptp -105.26 -26.59 11.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.78 -1.2 . . . . 0.0 110.077 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.61 HG22 ' HD2' ' A' ' 93' ' ' PRO . 11.5 p -167.36 -46.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' N ' HG13 ' A' ' 91' ' ' VAL . . . 132.93 -63.28 0.62 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.63 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 91' ' ' VAL . 38.7 Cg_endo -63.55 -37.68 46.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.907 1.478 . . . . 0.0 112.13 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.72 -45.94 91.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.619 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.513 ' HG3' ' CA ' ' A' ' 88' ' ' GLY . 1.5 tm0? -74.55 -42.04 59.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.15 -0.969 . . . . 0.0 110.791 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -64.75 -39.71 94.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 111.572 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.5 18.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.9 -1.125 . . . . 0.0 110.27 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.63 -42.28 23.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 110.399 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -70.42 -39.4 74.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.351 -0.843 . . . . 0.0 111.659 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . -137.11 51.53 1.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 113.067 -177.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 tt -80.63 111.42 22.92 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.482 -1.386 . . . . 0.0 109.453 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 48.5 Cg_endo -73.03 121.82 7.6 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.692 1.364 . . . . 0.0 110.801 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.707 HG13 ' H ' ' A' ' 104' ' ' SER . 1.0 OUTLIER -130.88 -78.22 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.707 ' H ' HG13 ' A' ' 103' ' ' VAL . 80.3 p -116.19 -2.27 12.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.23 175.06 30.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.5 mmm -77.54 -26.66 51.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -1.22 . . . . 0.0 110.266 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 53.5 t0 -108.95 15.23 23.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 0.0 110.754 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 98.6 mttt -124.43 45.72 1.36 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.086 -1.009 . . . . 0.0 110.433 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 53.1 Cg_endo -77.17 144.23 23.29 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.718 1.378 . . . . 0.0 110.769 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.607 HG12 ' HD2' ' A' ' 111' ' ' PHE . 86.0 t -140.74 -96.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.354 -0.841 . . . . 0.0 109.171 178.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.625 ' CE1' ' HB3' ' A' ' 113' ' ' ASP . 26.4 p90 -131.77 161.13 33.62 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.95 -1.094 . . . . 0.0 109.966 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 114' ' ' PRO . 18.9 m -68.12 118.18 10.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 111.543 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.625 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 32.3 p-10 -133.93 108.34 11.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 0.0 110.447 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 112' ' ' THR . 48.6 Cg_endo -75.28 176.17 44.73 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.093 -2.044 . . . . 0.0 110.344 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.943 ' HG2' HG23 ' A' ' 51' ' ' ILE . 44.2 Cg_endo -69.65 -175.03 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.877 1.462 . . . . 0.0 109.702 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 HG23 ' A' ' 118' ' ' THR . 46.6 t -102.07 137.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 0.0 110.111 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -102.11 125.54 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 109.064 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 38.7 p -142.04 -175.98 4.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.631 -1.293 . . . . 0.0 111.68 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.8 tttt -74.36 -10.67 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.768 -0.582 . . . . 0.0 110.132 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.616 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -103.55 37.92 1.91 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.065 -1.022 . . . . 0.0 109.605 179.117 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.6 -167.71 37.28 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.74 ' CE2' HD11 ' A' ' 51' ' ' ILE . 6.9 m-85 -103.72 144.13 31.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -1.084 . . . . 0.0 108.879 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 120' ' ' PHE . 10.1 m-70 -137.94 135.29 35.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.666 -1.272 . . . . 0.0 112.32 -178.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.83 HG22 ' HB ' ' A' ' 43' ' ' ILE . 11.5 tt -120.64 116.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.99 HG22 ' CB ' ' A' ' 42' ' ' HIS . 12.1 pt -114.46 158.28 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.571 -1.33 . . . . 0.0 112.651 -177.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.534 ' HG2' ' CB ' ' A' ' 111' ' ' PHE . 44.9 mtp -118.87 151.07 38.77 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.3 t -126.91 121.36 57.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.55 -1.344 . . . . 0.0 111.822 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.8 pt-20 -133.67 157.41 45.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 61.45 82.65 0.07 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 131' ' ' LYS . 10.1 ttm180 -116.77 154.1 31.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.513 -0.992 . . . . 0.0 110.173 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.546 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 56.9 mtpt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.184 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.174 0.511 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.811 ' CB ' HG22 ' A' ' 86' ' ' THR . . . -129.65 -170.35 2.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 85' ' ' MET . 1.5 p -128.76 150.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.576 -0.703 . . . . 0.0 109.244 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HD2' ' CD2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -101.0 113.93 27.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.637 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 38' ' ' VAL . 38.6 t -127.14 152.31 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.836 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 93.5 mtt180 -133.73 121.93 22.62 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.114 ' HB2' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -131.06 159.23 38.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.638 -1.289 . . . . 0.0 113.008 -177.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' HB ' ' CG1' ' A' ' 124' ' ' ILE . 24.9 mt -122.82 123.21 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 2.1 tt -104.63 120.97 42.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 7.6 p -133.09 -168.81 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.274 -0.892 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 122' ' ' TYR . 92.4 mt-10 -70.98 176.61 4.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.0 111.419 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.693 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 28.1 pttt -118.66 56.77 0.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.356 -0.84 . . . . 0.0 110.947 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.543 ' N ' ' CE2' ' A' ' 122' ' ' TYR . 19.3 m80 -134.6 64.04 1.61 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 111.576 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 -0.95 34.05 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.88 178.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.78 -10.78 59.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.984 -1.304 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.721 HD12 ' HB3' ' A' ' 122' ' ' TYR . 3.1 tt -62.15 -36.81 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HG3' ' N ' ' A' ' 53' ' ' GLU . 23.3 ptm -74.54 -42.97 57.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.957 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' N ' ' HG3' ' A' ' 52' ' ' MET . 19.1 mm-40 -68.12 -38.82 82.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.675 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.73 -49.38 68.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.893 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.846 ' HA ' HD23 ' A' ' 58' ' ' LEU . 27.1 ptm -61.68 -35.39 77.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.169 -0.957 . . . . 0.0 110.916 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 55' ' ' MET . 91.7 mt-10 -68.44 -33.44 74.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.062 -1.024 . . . . 0.0 110.297 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -68.72 -46.01 70.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -74.45 -27.77 60.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.977 -1.077 . . . . 0.0 110.446 -179.454 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 91.1 mttt 49.82 -126.98 2.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.876 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 62' ' ' MET . 55.7 p -65.45 -28.5 69.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 110.587 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 58' ' ' LEU . . . 130.73 -5.82 5.82 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.434 ' HG3' ' OG ' ' A' ' 60' ' ' SER . 60.0 mtt -49.47 -31.43 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -1.225 . . . . 0.0 110.17 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.72 29.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 30.9 t80 -54.71 -40.99 69.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.904 . . . . 0.0 110.477 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 20.6 p-10 -58.59 -44.48 89.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -69.21 -44.13 72.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.821 HG11 ' HB3' ' A' ' 58' ' ' LEU . 97.2 t -69.75 -26.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 110.413 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -74.16 -57.59 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.11 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.89 62.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.619 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -29.81 33.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.173 -0.954 . . . . 0.0 111.124 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 23.4 m-85 -114.57 26.71 10.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.034 -1.041 . . . . 0.0 111.049 -179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 26.7 t -102.28 116.93 33.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.911 -1.118 . . . . 0.0 110.68 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.32 -7.42 24.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.111 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -111.86 21.22 16.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.508 -0.745 . . . . 0.0 109.212 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 6.4 tmtt? -53.8 -31.3 48.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.625 -0.672 . . . . 0.0 110.68 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.28 81.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.173 -0.955 . . . . 0.0 110.927 -179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.27 9.27 36.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.097 -1.002 . . . . 0.0 110.795 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 2.1 tt0 -169.07 172.62 7.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.054 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.69 27.49 6.83 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 42' ' ' HIS . . . 72.66 11.5 77.4 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.657 ' C ' HD12 ' A' ' 82' ' ' LEU . 41.2 p-10 -133.08 129.46 38.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -1.182 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 82' ' ' LEU . 7.9 mp -110.09 109.29 19.78 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 110.159 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -60.12 -123.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.081 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.692 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 78.2 m95 -76.45 130.26 37.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.795 -0.826 . . . . 0.0 110.808 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.921 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.8 tpt -137.28 136.04 37.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 0.0 109.767 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.811 HG22 ' CB ' ' A' ' 37' ' ' ALA . 19.0 p -122.78 -57.98 1.69 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.827 -1.171 . . . . 0.0 110.675 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' N ' ' OG1' ' A' ' 86' ' ' THR . 21.9 ttm-85 -68.22 -48.99 63.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.739 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . 46.65 64.79 2.46 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -122.93 43.59 2.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -1.06 . . . . 0.0 110.634 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 16.2 mtp -99.78 -32.04 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.768 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 89.9 t -142.96 112.38 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -43.04 -53.93 5.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.514 -0.741 . . . . 0.0 111.874 -178.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 42.8 Cg_endo -69.33 -19.66 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.511 1.269 . . . . 0.0 111.765 -178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.59 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 23.4 t80 -76.56 -54.09 7.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.879 -1.138 . . . . 0.0 110.771 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 7.6 pt20 -66.52 -41.76 88.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.972 . . . . 0.0 110.897 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 14.1 pt-20 -60.23 -25.15 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.894 -1.128 . . . . 0.0 110.42 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -79.61 -50.74 10.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.773 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.32 -54.63 7.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.755 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 58.4 m-85 -56.42 -47.0 79.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 0.0 110.975 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -66.17 -39.69 89.92 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.202 -0.937 . . . . 0.0 111.196 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 102' ' ' PRO . 27.3 tp -57.15 127.82 76.86 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.985 -1.072 . . . . 0.0 110.802 -179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.734 ' HD2' HD12 ' A' ' 101' ' ' LEU . 45.5 Cg_endo -73.25 157.35 50.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.848 1.446 . . . . 0.0 109.864 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 130' ' ' ARG . 20.3 m -105.64 -1.61 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.824 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 105' ' ' GLY . 46.4 m -101.82 -48.02 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 109.906 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 104' ' ' SER . . . 40.79 -140.41 1.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.404 ' O ' ' OD1' ' A' ' 107' ' ' ASP . 82.8 mmm -57.17 -47.5 81.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.99 . . . . 0.0 111.038 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 106' ' ' MET . 78.6 m-20 -143.19 -60.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 110.953 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . 50.7 mtpt -131.72 168.79 15.88 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.374 -179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 108' ' ' LYS . 38.2 Cg_endo -65.36 149.03 88.66 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.823 1.433 . . . . 0.0 109.543 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 111' ' ' PHE . 4.1 p -143.4 -137.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.988 -1.07 . . . . 0.0 111.397 -178.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.828 ' N ' HG13 ' A' ' 110' ' ' VAL . 8.2 t80 -103.62 163.12 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 111.185 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.698 HG21 HD11 ' A' ' 125' ' ' ILE . 1.7 p -84.47 29.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 38.1 p-10 -71.73 130.17 87.42 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.986 -1.071 . . . . 0.0 110.389 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 112' ' ' THR . 49.0 Cg_endo -76.16 146.33 84.72 Favored 'Cis proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.949 -2.105 . . . . 0.0 110.082 -0.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.751 ' CB ' HG22 ' A' ' 124' ' ' ILE . 40.8 Cg_endo -66.34 -174.24 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.097 1.577 . . . . 0.0 110.902 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 28.5 m -101.68 158.44 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 110.248 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 51' ' ' ILE . 42.3 mttm -113.57 142.07 46.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.619 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 24.8 p -143.12 177.12 8.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.758 -1.214 . . . . 0.0 111.078 -179.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -80.85 -11.6 59.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.678 -0.639 . . . . 0.0 109.533 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.619 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.3 p90 -104.82 20.96 17.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 110.01 179.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 45' ' ' CYS . . . 117.13 -173.04 14.52 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.48 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 51' ' ' ILE . 16.4 m-85 -100.25 160.87 13.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.445 -1.033 . . . . 0.0 108.729 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.583 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 63.9 m-70 -141.98 122.48 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.708 -1.245 . . . . 0.0 112.061 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.814 HD12 HD22 ' A' ' 58' ' ' LEU . 30.9 pt -118.46 125.06 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.114 HG22 ' HB2' ' A' ' 42' ' ' HIS . 18.2 pt -123.88 173.03 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.684 -1.26 . . . . 0.0 112.944 -176.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.638 ' HG2' ' CD2' ' A' ' 111' ' ' PHE . 73.1 mtm -133.4 146.71 51.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 109' ' ' PRO . 7.9 m -121.32 120.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.867 -1.145 . . . . 0.0 109.974 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -107.12 -20.86 13.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 111.331 -178.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.481 ' HA3' ' NZ ' ' A' ' 39' ' ' LYS . . . -161.62 156.09 27.5 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.101 -1.523 . . . . 0.0 110.637 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.526 ' HB2' HG11 ' A' ' 103' ' ' VAL . 7.0 ttt180 -126.05 145.51 50.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.922 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 37' ' ' ALA . 58.9 pttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 53.5 p30 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.724 0.773 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . -103.71 168.39 9.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.517 0.675 . . . . 0.0 110.491 -178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 129' ' ' GLY . 1.3 p -128.78 153.63 38.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 110.022 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CE ' ' CZ2' ' A' ' 84' ' ' TRP . 2.9 mtpm? -98.87 132.99 43.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 109.084 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 82.5 t -130.36 143.12 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.292 -178.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 76.4 mtt180 -125.34 120.88 32.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.808 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -144.78 164.95 29.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.738 -1.227 . . . . 0.0 112.256 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.909 HD11 HD12 ' A' ' 124' ' ' ILE . 13.5 pt -126.47 144.6 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -101.34 122.36 43.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.881 -1.137 . . . . 0.0 110.041 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 36.5 m -111.51 170.07 8.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 110.275 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' HB2' ' NE2' ' A' ' 48' ' ' HIS . 27.8 mt-10 -88.45 -158.63 0.49 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 110.318 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 29.1 mtmm -128.04 92.63 3.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.923 -1.111 . . . . 0.0 111.142 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.594 ' NE2' ' HB2' ' A' ' 46' ' ' GLU . 6.3 m-70 -132.88 17.26 4.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.95 2.25 81.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 5.0 ttmt -83.81 -12.95 54.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -1.079 . . . . 0.0 110.089 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -43.22 -41.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 110.298 -179.833 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' MET . 41.7 ttm -60.94 -44.77 96.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.063 -1.023 . . . . 0.0 109.841 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -72.16 -31.73 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.05 -1.031 . . . . 0.0 109.385 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.68 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.757 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.534 ' HA ' HD23 ' A' ' 58' ' ' LEU . 25.5 ptm -65.97 -23.91 66.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 24.1 tp10 -64.35 -41.98 96.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.042 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -79.79 -38.42 33.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 0.0 109.057 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -65.96 -49.14 68.94 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.616 -0.677 . . . . 0.0 109.218 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' GLU . 33.4 mtmt 50.09 -124.66 2.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 0.0 110.384 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -70.66 -31.72 68.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.0 -1.062 . . . . 0.0 109.932 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.94 7.26 5.61 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 ttt -47.73 -42.07 24.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.861 -1.376 . . . . 0.0 109.247 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 27.3 mtt-85 -108.5 30.51 6.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.524 -0.735 . . . . 0.0 109.255 179.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -46.94 -47.8 21.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.886 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -57.74 -39.05 76.45 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 109.461 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 77.4 mt-10 -67.67 -42.65 81.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 58' ' ' LEU . 96.5 t -70.11 -52.09 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.56 -40.25 51.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.092 -1.005 . . . . 0.0 110.331 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.72 91.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 7.6 mm-40 -89.77 8.31 32.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.683 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.556 ' HB3' HD12 ' A' ' 43' ' ' ILE . 33.1 m-85 -134.25 4.37 3.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.916 -1.115 . . . . 0.0 111.289 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -67.86 111.25 4.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 16.7 tt0 -102.06 5.59 40.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.748 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 29.3 t70 -132.98 45.33 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.86 . . . . 0.0 109.975 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -66.65 -32.59 74.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.032 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.94 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 108.842 179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.456 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.4 mmm-85 -104.74 8.25 34.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.65 -0.656 . . . . 0.0 109.408 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 52.86 42.35 31.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.775 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.447 ' HA3' ' OD2' ' A' ' 74' ' ' ASP . . . -79.79 108.5 2.75 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -160.42 -92.45 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 78.1 m-20 -90.39 140.67 29.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -1.149 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -124.61 169.57 11.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . -82.04 -122.99 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.466 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.629 ' CZ2' ' CE ' ' A' ' 39' ' ' LYS . 18.4 m-90 -96.48 144.83 26.22 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.786 0.803 . . . . 0.0 112.116 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.2 ptm -139.88 155.54 47.15 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 31.3 p -129.84 -72.95 0.57 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.554 -1.341 . . . . 0.0 110.315 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 86' ' ' THR . 4.2 ttp85 -116.76 136.57 52.86 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.311 -0.955 . . . . 0.0 111.598 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 87' ' ' ARG . . . 58.34 144.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 90' ' ' MET . 53.2 p -142.37 -66.45 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.042 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.568 ' C ' HG23 ' A' ' 91' ' ' VAL . 20.0 ptm -142.06 -39.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.992 HG12 ' HD2' ' A' ' 93' ' ' PRO . 38.4 t -153.01 157.55 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 110.085 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -37.99 -60.67 1.26 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.992 ' HD2' HG12 ' A' ' 91' ' ' VAL . 37.9 Cg_endo -63.62 -175.55 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.759 1.399 . . . . 0.0 110.334 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 125' ' ' ILE . 59.9 t80 68.48 -78.03 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.611 -0.68 . . . . 0.0 110.473 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 12.0 tm0? -66.51 -47.93 71.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 81.8 mt-10 -61.68 -38.75 88.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 179.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.05 70.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.811 . . . . 0.0 109.003 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.5 83.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.086 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 15.2 m-85 -69.51 -21.48 63.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' C ' ' HD2' ' A' ' 102' ' ' PRO . . . -86.25 -12.8 48.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.468 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 110' ' ' VAL . 9.8 tt -49.99 -45.66 81.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 101' ' ' LEU . 51.1 Cg_endo -75.65 77.64 3.28 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.299 1.157 . . . . 0.0 110.366 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.44 -32.05 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.7 p -128.19 -10.94 5.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.78 0.55 85.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.418 ' HB2' ' HE3' ' A' ' 106' ' ' MET . 76.6 mtm -77.52 -28.37 52.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -128.6 70.84 1.39 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 38.0 tptt -77.61 -42.46 2.38 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.061 -1.024 . . . . 0.0 110.105 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 52.9 Cg_endo -81.66 59.53 7.26 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.452 1.238 . . . . 0.0 109.521 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.87 HG12 HD21 ' A' ' 101' ' ' LEU . 1.4 p -133.78 -166.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.029 . . . . 0.0 111.524 -178.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.933 ' CE1' HG23 ' A' ' 124' ' ' ILE . 7.5 t80 -114.34 153.8 29.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.77 -0.581 . . . . 0.0 110.409 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 101' ' ' LEU . 66.2 p -72.85 119.38 17.0 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.352 -0.842 . . . . 0.0 110.732 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 111' ' ' PHE . 81.3 m-20 -133.45 121.9 16.64 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.257 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 48.8 Cg_endo -78.81 174.59 50.36 Favored 'Cis proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.188 -2.005 . . . . 0.0 110.396 -0.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HG2' HD12 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -70.83 175.78 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.957 1.504 . . . . 0.0 109.926 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 123' ' ' HIS . 32.6 m -103.19 155.44 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -123.08 136.11 54.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.749 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 120' ' ' PHE . 36.4 p -139.02 168.02 20.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.103 -0.998 . . . . 0.0 110.645 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -64.89 -17.28 64.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.427 -0.796 . . . . 0.0 110.017 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.613 ' CZ ' ' HB ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -97.38 19.62 12.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.985 -1.072 . . . . 0.0 110.366 179.526 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.552 ' HA2' ' CG ' ' A' ' 47' ' ' LYS . . . 117.72 -176.91 16.37 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-30 -97.82 158.8 15.31 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CE1' HD21 ' A' ' 44' ' ' LEU . 75.9 m-70 -138.09 140.19 39.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.403 -1.436 . . . . 0.0 112.302 -178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.933 HG23 ' CE1' ' A' ' 111' ' ' PHE . 84.2 mt -123.0 114.49 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.808 HG22 ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -122.43 149.49 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 0.0 112.102 -178.725 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.455 ' HE3' ' HB2' ' A' ' 111' ' ' PHE . 89.8 mtp -128.5 150.75 50.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 38' ' ' VAL . 15.2 t -124.62 138.86 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.75 -1.219 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -114.9 -24.61 8.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 110.93 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.883 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -150.27 132.67 4.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.436 ' HB2' ' HE2' ' A' ' 108' ' ' LYS . 23.4 ttm180 -76.97 -42.67 38.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.969 . . . . 0.0 110.949 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 38.0 mtmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.229 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 49.8 p30 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.411 0.624 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 85' ' ' MET . . . -107.47 164.69 11.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 130' ' ' ARG . 5.9 m -136.72 161.46 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.917 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HD3' ' NE1' ' A' ' 84' ' ' TRP . 7.3 mmmt -99.71 112.09 24.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 109.415 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.114 HG13 ' HB2' ' A' ' 82' ' ' LEU . 4.0 p -127.88 128.4 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.949 . . . . 0.0 111.465 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 46.6 mtm180 -118.42 134.0 55.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.995 ' HB2' HG22 ' A' ' 125' ' ' ILE . 3.7 p80 -135.81 162.86 31.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.59 -1.319 . . . . 0.0 111.704 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' SG ' ' A' ' 45' ' ' CYS . 23.6 mt -116.64 121.86 68.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.616 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 3.8 tt -101.83 101.0 11.39 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.909 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.612 ' SG ' HG22 ' A' ' 43' ' ' ILE . 35.2 m -101.36 162.49 12.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.637 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 71.4 mt-10 -63.35 165.75 7.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.82 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 21.2 tttt -89.7 59.09 4.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.133 -0.979 . . . . 0.0 111.419 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 20.3 m80 -135.87 66.35 1.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.66 -1.275 . . . . 0.0 111.584 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.44 28.47 44.29 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.02 7.22 45.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.992 -1.299 . . . . 0.0 109.445 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 115' ' ' PRO . 43.2 mt -62.51 -50.81 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.541 -0.725 . . . . 0.0 110.581 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 49.2 mtm -69.15 -32.26 71.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.451 -0.781 . . . . 0.0 110.617 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' HG2' ' CE1' ' A' ' 71' ' ' TYR . 14.2 tt0 -62.54 -49.37 75.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.518 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -69.86 -51.32 34.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 111.479 -179.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 28.6 ptm -65.69 -43.9 87.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.315 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' MET . 64.3 tt0 -65.09 -41.23 95.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.956 -1.09 . . . . 0.0 110.686 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 55.3 mmtt -60.23 -56.14 25.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.655 ' CB ' HG21 ' A' ' 67' ' ' VAL . 1.2 pp -68.1 -14.04 62.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.62 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.0 mtpt 45.66 -133.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.795 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -57.87 -21.66 44.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.846 -1.159 . . . . 0.0 110.268 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . 123.45 10.73 5.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 56.4 ttm -51.16 -45.55 61.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -1.232 . . . . 0.0 109.927 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 10.7 mtp180 -109.66 31.6 5.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.903 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.61 -49.1 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -58.28 -46.86 85.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 109.374 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 51.4 mp0 -62.37 -41.53 98.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.299 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 58' ' ' LEU . 54.3 t -65.54 -44.38 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.553 -0.717 . . . . 0.0 109.294 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 72' ' ' SER . . . -57.76 -51.88 67.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.925 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -46.74 88.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.35 -0.844 . . . . 0.0 110.558 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 6.0 mm-40 -73.29 -28.06 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.315 -0.866 . . . . 0.0 111.27 -179.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 63.5 m-85 -108.76 13.82 24.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.057 . . . . 0.0 110.86 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 8.4 t -78.9 105.23 10.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.876 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 31.9 tp10 -101.4 1.34 38.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.734 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB3' HD13 ' A' ' 44' ' ' LEU . 20.4 p30 -103.4 24.56 10.82 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.283 -0.885 . . . . 0.0 110.112 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 43.8 tttm -46.96 -49.25 21.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.87 -50.38 10.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.0 109.734 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 7.1 tpm_? -80.4 -11.55 59.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.348 -0.845 . . . . 0.0 109.605 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 75' ' ' LYS . 84.5 mm-40 54.4 47.9 21.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.531 -0.731 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 81' ' ' ASP . . . -81.61 -76.42 1.07 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.32 -84.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' GLY . 62.9 m-20 -109.25 150.61 27.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.579 -0.953 . . . . 0.0 109.632 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.114 ' HB2' HG13 ' A' ' 40' ' ' VAL . 2.9 mp -102.67 2.76 36.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 49.88 -139.53 18.06 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 57.1 m95 -89.94 114.8 26.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.395 -1.062 . . . . 0.0 110.574 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.496 ' CE ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -126.09 152.21 46.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.209 -0.932 . . . . 0.0 110.186 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 87' ' ' ARG . 24.7 p -100.58 -89.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 110.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.536 ' N ' ' OG1' ' A' ' 86' ' ' THR . 39.3 ptt180 -116.61 138.71 51.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.375 -1.453 . . . . 0.0 110.901 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 95' ' ' GLN . . . -131.56 164.45 23.52 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -137.71 34.24 2.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.842 -1.387 . . . . 0.0 111.209 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.476 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 43.3 mmm -100.65 123.94 45.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 30.2 t 60.11 109.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 109.97 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.627 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -55.31 -43.95 84.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 43.7 Cg_endo -71.89 -12.12 28.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.369 1.194 . . . . 0.0 111.243 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 53.0 t80 -88.65 -54.48 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.0 110.18 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 88' ' ' GLY . 2.0 tt0 -64.7 -43.64 92.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 110.677 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.653 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 47.1 tp10 -59.36 -42.97 92.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.973 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' ALA . . . -60.35 -58.13 9.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.5 -56.33 2.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.473 -0.767 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.483 ' HZ ' ' O ' ' A' ' 86' ' ' THR . 38.0 m-85 -83.16 3.68 29.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.524 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -80.69 -29.74 36.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.193 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -107.99 94.09 12.08 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.465 -0.772 . . . . 0.0 110.165 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 100' ' ' ALA . 50.0 Cg_endo -80.71 -33.89 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.939 1.494 . . . . 0.0 111.205 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.46 -173.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.737 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -113.77 84.31 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.782 . . . . 0.0 109.572 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.58 171.77 3.15 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.3 ttt -60.56 -28.53 68.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.566 -0.961 . . . . 0.0 110.544 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -117.15 23.35 11.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.039 . . . . 0.0 110.186 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -121.33 130.79 24.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.001 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.25 -164.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.955 1.503 . . . . 0.0 110.5 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' MET . 7.2 p -106.83 -11.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 0.6 OUTLIER -118.52 172.37 7.53 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.105 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.557 ' OG1' HG12 ' A' ' 125' ' ' ILE . 2.1 m -76.97 -4.83 46.02 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 65.6 m-20 -48.44 122.48 10.35 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.344 -1.473 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' A' ' 112' ' ' THR . 43.4 Cg_endo -66.38 128.08 8.81 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.359 1.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.666 ' HG2' HG23 ' A' ' 51' ' ' ILE . 38.4 Cg_endo -63.65 -179.3 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.086 1.572 . . . . 0.0 111.616 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 116' ' ' VAL . 31.5 m -102.47 144.87 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.568 -0.707 . . . . 0.0 109.86 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 34.1 pttt -110.28 130.14 55.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.045 -1.035 . . . . 0.0 110.296 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.581 ' HB ' ' CE1' ' A' ' 120' ' ' PHE . 71.8 p -137.35 173.1 12.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.059 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -19.31 65.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.179 -0.95 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 118' ' ' THR . 2.8 p90 -93.46 19.32 8.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.803 -1.185 . . . . 0.0 110.369 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 114.88 -174.11 15.17 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.512 178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 22.6 m-85 -104.12 153.22 21.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.702 -0.881 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.616 ' CE1' ' HG ' ' A' ' 44' ' ' LEU . 13.1 m-70 -141.34 133.48 27.84 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.684 -1.26 . . . . 0.0 112.948 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -125.36 106.14 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.375 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.995 HG22 ' HB2' ' A' ' 42' ' ' HIS . 35.1 pt -105.11 157.0 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.857 -1.152 . . . . 0.0 111.864 -177.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 111' ' ' PHE . 16.3 ptm -133.36 160.86 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.996 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 t -133.74 131.79 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.928 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.09 -4.51 16.55 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.486 -0.759 . . . . 0.0 110.225 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 38' ' ' VAL . . . -172.18 126.75 1.31 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 38' ' ' VAL . 2.2 ttt-85 -127.22 152.6 47.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -1.121 . . . . 0.0 109.857 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 36' ' ' ASN . 30.5 tttm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.063 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 stop_ save_